1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_1	[p1l52t81r142b105],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_1	[p1l155t81r255b105],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_1	[p1l267t81r318b105],
4	Treat	NNP	ORGANIZATION	Treat	dep	9	SENT_1	[p1l331t81r406b105],
5	(	CD	NUMBER	(	num	6	SENT_1	[p1l419t81r510b111],
6	2012	CD	DATE	2012	dep	4	SENT_1	[p1l419t81r510b111],
7	)	CD	NUMBER	)	dep	9	SENT_1	[p1l419t81r510b111],
8	134:40	CD	NUMBER	134:40	num	9	SENT_1	[p1l528t81r621b105],
9	1-4	CD	NUMBER	1-4	dep	14	SENT_1	[p1l626t81r674b105],
10	10	CD	NUMBER	10	num	11	SENT_1	[p1l679t81r710b105],
11	DOI	NNP	O	DOI	dep	9	SENT_1	[p1l52t123r114b149],
12	10.1007	CD	NUMBER	10.1007	num	11	SENT_1	[p1l130t123r528b149],
13	/	:	O	/	punct	14	SENT_1	[p1l130t123r528b149],
14	s10549-012-2054-0	NN	O	s10549-012-2054-0	_	0	SENT_1	[p1l130t123r528b149],

1	CYP2C8	CD	NUMBER	cyp2c8	nsubj	4	SENT_2	[p1l55t341r367b389],
2	*	CD	NUMBER	*	num	3	SENT_2	[p1l55t341r367b389],
3	3	CD	NUMBER	3	dep	1	SENT_2	[p1l55t341r367b389],
4	predicts	VBZ	O	predict	_	0	SENT_2	[p1l392t341r618b401],
5	beneﬁt	NN	O	beneﬁt	nsubj	13	SENT_2	[p1l643t341r962b389],
6	/	:	O	/	punct	8	SENT_2	[p1l643t341r962b389],
7	risk	NN	O	risk	nn	8	SENT_2	[p1l643t341r962b389],
8	proﬁle	NN	O	proﬁle	dep	5	SENT_2	[p1l986t341r1168b401],
9	in	IN	O	in	_	0	SENT_2	[p1l1192t341r1246b387],
10	breast	NN	O	breast	nn	12	SENT_2	[p1l1269t342r1446b388],
11	cancer	NN	O	cancer	nn	12	SENT_2	[p1l1469t355r1656b388],
12	patients	NNS	O	patient	prep_in	8	SENT_2	[p1l1680t341r1902b401],
13	receiving	VBG	O	receive	dep	4	SENT_2	[p1l54t415r310b475],
14	neoadjuvant	JJ	O	neoadjuvant	amod	15	SENT_2	[p1l335t415r687b475],
15	paclitaxel	NN	O	paclitaxel	dobj	13	SENT_2	[p1l710t415r981b475],

1	Daniel	NNP	PERSON	Daniel	_	0	SENT_3	[p1l52t550r167b580],
2	L.	NNP	PERSON	L.	nn	3	SENT_3	[p1l182t550r218b580],
3	Hertz	NNP	PERSON	Hertz	dep	1	SENT_3	[p1l234t550r335b580],
4	-	:	O	-	_	0	SENT_3	[p1l350t561r358b569],
5	Alison	NNP	PERSON	Alison	nn	9	SENT_3	[p1l373t550r485b580],
6	A.	NNP	PERSON	A.	nn	9	SENT_3	[p1l500t550r538b580],
7	Motsinger-Reif	NNP	PERSON	Motsinger-Reif	nn	9	SENT_3	[p1l554t550r827b588],
8	Amy	NNP	PERSON	Amy	nn	9	SENT_3	[p1l839t561r847b569, p1l52t602r137b640],
9	Drobish	NNP	PERSON	Drobish	dep	1	SENT_3	[p1l152t602r294b632],
10	-	:	O	-	_	0	SENT_3	[p1l309t613r317b621],
11	Stacey	NNP	PERSON	Stacey	nn	13	SENT_3	[p1l332t602r446b640],
12	J.	NNP	PERSON	J.	nn	13	SENT_3	[p1l460t602r490b635],
13	Winham	NNP	PERSON	Winham	dep	9	SENT_3	[p1l506t602r659b632],
14	-	:	O	-	_	0	SENT_3	[p1l675t613r683b621],
15	Howard	NNP	PERSON	Howard	nn	20	SENT_3	[p1l697t602r842b632],
16	L.	NNP	PERSON	L.	nn	20	SENT_3	[p1l857t602r893b632],
17	McLeod	NNP	PERSON	McLeod	nn	20	SENT_3	[p1l909t602r1056b632],
18	Lisa	NNP	PERSON	Lisa	nn	20	SENT_3	[p1l1071t613r1079b621, p1l53t654r128b684],
19	A.	NNP	PERSON	A.	nn	20	SENT_3	[p1l142t654r181b684],
20	Carey	NNP	PERSON	Carey	dep	13	SENT_3	[p1l198t654r304b692],
21	-	:	O	-	_	0	SENT_3	[p1l320t665r327b673],
22	E.	NNP	PERSON	E.	nn	24	SENT_3	[p1l342t654r378b684],
23	Claire	NNP	PERSON	Claire	nn	24	SENT_3	[p1l395t654r504b684],
24	Dees	NNP	PERSON	Dees	dep	9	SENT_3	[p1l519t654r601b684],

1	Received	VBN	O	receive	dep	3	SENT_4	[p1l52t767r191b792],
2	:	:	O	:	_	0	SENT_4	[p1l52t767r191b792],
3	10	CD	DATE	10	_	0	SENT_4	[p1l209t767r240b792],
4	January	NNP	DATE	January	nn	5	SENT_4	[p1l253t768r362b799],
5	2012/Accepted	NNP	O	2012/Accepted	dep	3	SENT_4	[p1l376t767r607b799],
6	:	:	O	:	_	0	SENT_4	[p1l376t767r607b799],
7	30	CD	DATE	30	dep	3	SENT_4	[p1l624t767r657b792],
8	March	NNP	DATE	March	nn	10	SENT_4	[p1l670t767r761b792],
9	2012/Published	JJ	DATE	2012/published	amod	10	SENT_4	[p1l774t767r1005b792],
10	online	NN	O	online	dep	7	SENT_4	[p1l1018t767r1112b792],
11	:	:	O	:	_	0	SENT_4	[p1l1018t767r1112b792],
12	18	CD	DATE	18	dep	3	SENT_4	[p1l1131t767r1161b792],
13	April	NNP	DATE	April	tmod	12	SENT_4	[p1l1175t767r1248b799],
14	2012	CD	DATE	2012	num	13	SENT_4	[p1l1262t767r1330b792],
15	©	NNP	O	©	nn	17	SENT_4	[p1l9t819r63b872],
16	Springer	NNP	O	Springer	nn	17	SENT_4	[p1l95t819r356b888],
17	Science	NNP	O	Science	dep	12	SENT_4	[p1l383t819r930b872],
18	+	CC	O	+	_	0	SENT_4	[p1l383t819r930b872],
19	Business	NNP	O	Business	nn	20	SENT_4	[p1l383t819r930b872],
20	Media	NNP	O	Media	dep	12	SENT_4	[p1l959t819r1169b882],
21	,	,	O	,	_	0	SENT_4	[p1l959t819r1169b882],
22	LLC	NNP	ORGANIZATION	LLC	appos	17	SENT_4	[p1l1199t819r1357b872],
23	.	.	O	.	_	0	SENT_4	[p1l1199t819r1357b872],

1	2012	CD	DATE	2012	_	0	SENT_5	[p1l1390t819r1540b872],

1	Abstract	JJ	O	abstract	amod	2	SENT_6	[p1l7t1050r340b1114],
2	Paclitaxel	NN	O	paclitaxel	nsubj	4	SENT_6	[p1l432t1051r782b1114],
3	is	VBZ	O	be	cop	4	SENT_6	[p1l827t1051r882b1114],
4	one	CD	NUMBER	one	_	0	SENT_6	[p1l929t1071r1054b1114],
5	of	IN	O	of	_	0	SENT_6	[p1l1099t1051r1177b1114],
6	the	DT	O	the	det	11	SENT_6	[p1l1214t1051r1321b1114],
7	most	RBS	O	most	advmod	8	SENT_6	[p1l1365t1060r1539b1114],
8	frequently	RB	O	frequently	advmod	9	SENT_6	[p1l1582t1051r1946b1132],
9	used	VBN	O	use	amod	11	SENT_6	[p1l1989t1051r2152b1114],
10	chemotherapeutic	JJ	O	chemotherapeutic	amod	11	SENT_6	[p1l8t1162r640b1243],
11	agents	NNS	O	agent	prep_of	4	SENT_6	[p1l675t1172r898b1243],
12	for	IN	O	for	_	0	SENT_6	[p1l932t1162r1035b1225],
13	the	DT	O	the	det	14	SENT_6	[p1l1065t1162r1171b1225],
14	treatment	NN	O	treatment	prep_for	11	SENT_6	[p1l1204t1172r1542b1225],
15	of	IN	O	of	_	0	SENT_6	[p1l1573t1162r1651b1225],
16	breast	NN	O	breast	nn	18	SENT_6	[p1l1676t1162r1889b1225],
17	cancer	NN	O	cancer	nn	18	SENT_6	[p1l1920t1182r2153b1225],
18	patients	NNS	O	patient	prep_of	14	SENT_6	[p1l6t1273r300b1354],
19	.	.	O	.	_	0	SENT_6	[p1l6t1273r300b1354],

1	Using	VBG	O	use	partmod	8	SENT_7	[p1l329t1273r539b1354],
2	a	DT	O	a	det	5	SENT_7	[p1l566t1293r603b1336],
3	candidate	NN	O	candidate	nn	5	SENT_7	[p1l628t1273r967b1336],
4	gene	NN	O	gene	nn	5	SENT_7	[p1l993t1293r1158b1354],
5	approach	NN	O	approach	dobj	1	SENT_7	[p1l1185t1273r1528b1354],
6	,	,	O	,	_	0	SENT_7	[p1l1185t1273r1528b1354],
7	we	PRP	O	we	nsubj	8	SENT_7	[p1l1556t1293r1657b1336],
8	hypothesized	VBD	O	hypothesize	_	0	SENT_7	[p1l1682t1273r2152b1354],
9	that	IN	O	that	complm	22	SENT_7	[p1l7t1384r141b1447],
10	polymorphisms	NNS	O	polymorphism	nsubjpass	22	SENT_7	[p1l162t1384r714b1465],
11	in	IN	O	in	_	0	SENT_7	[p1l739t1384r807b1446],
12	genes	NNS	O	gene	prep_in	10	SENT_7	[p1l831t1404r1029b1465],
13	relevant	JJ	O	relevant	amod	12	SENT_7	[p1l1053t1384r1342b1447],
14	to	TO	O	to	_	0	SENT_7	[p1l1364t1394r1431b1447],
15	the	DT	O	the	det	16	SENT_7	[p1l1454t1384r1561b1447],
16	metabolism	NN	O	metabolism	prep_to	13	SENT_7	[p1l1585t1384r2002b1447],
17	and	CC	O	and	_	0	SENT_7	[p1l2026t1384r2152b1447],
18	transport	NN	O	transport	prep_to	13	SENT_7	[p1l7t1504r324b1576],
19	of	IN	O	of	_	0	SENT_7	[p1l347t1495r424b1557],
20	paclitaxel	NN	O	paclitaxel	prep_of	16	SENT_7	[p1l440t1495r787b1576],
21	are	VBP	O	be	auxpass	22	SENT_7	[p1l813t1514r918b1557],
22	associated	VBN	O	associate	ccomp	8	SENT_7	[p1l944t1495r1307b1557],
23	with	IN	O	with	_	0	SENT_7	[p1l1331t1495r1487b1558],
24	treatment	NN	O	treatment	nn	25	SENT_7	[p1l1510t1504r1848b1557],
25	efﬁcacy	NN	O	efﬁcacy	prep_with	22	SENT_7	[p1l1871t1495r2150b1576],
26	and	CC	O	and	_	0	SENT_7	[p1l9t1605r136b1667],
27	toxicity	NN	O	toxicity	prep_with	22	SENT_7	[p1l158t1604r447b1686],
28	.	.	O	.	_	0	SENT_7	[p1l158t1604r447b1686],

1	Patient	NN	O	patient	nn	4	SENT_8	[p1l475t1604r722b1667],
2	and	CC	O	and	_	0	SENT_8	[p1l747t1605r874b1667],
3	tumor	NN	O	tumor	conj_and	1	SENT_8	[p1l896t1614r1109b1667],
4	characteristics	NNS	O	characteristic	nsubjpass	9	SENT_8	[p1l1132t1604r1638b1667],
5	and	CC	O	and	_	0	SENT_8	[p1l1666t1605r1792b1667],
6	treatment	NN	O	treatment	nn	7	SENT_8	[p1l1815t1614r2152b1667],
7	outcomes	NNS	O	outcome	nsubjpass	9	SENT_8	[p1l8t1725r346b1778],
8	were	VBD	O	be	auxpass	9	SENT_8	[p1l396t1735r566b1779],
9	collected	VBN	O	collect	_	0	SENT_8	[p1l616t1716r937b1778],
10	prospectively	RB	O	prospectively	advmod	9	SENT_8	[p1l983t1715r1462b1797],
11	for	IN	O	for	_	0	SENT_8	[p1l1511t1715r1614b1778],
12	breast	NN	O	breast	nn	14	SENT_8	[p1l1659t1716r1873b1778],
13	cancer	NN	O	cancer	nn	14	SENT_8	[p1l1920t1735r2153b1778],
14	patients	NNS	O	patient	prep_for	9	SENT_8	[p1l6t1828r282b1909],
15	treated	VBN	O	treat	partmod	14	SENT_8	[p1l318t1828r561b1891],
16	with	IN	O	with	_	0	SENT_8	[p1l597t1828r754b1891],
17	paclitaxel	NN	O	paclitaxel	nn	18	SENT_8	[p1l789t1828r1541b1909],
18	—	NN	O	—	prep_with	15	SENT_8	[p1l789t1828r1541b1909],
19	containing	VBG	O	contain	xcomp	15	SENT_8	[p1l789t1828r1541b1909],
20	regimens	NNS	O	regimen	dobj	19	SENT_8	[p1l1577t1828r1902b1909],
21	in	IN	O	in	_	0	SENT_8	[p1l1940t1828r2008b1890],
22	the	DT	O	the	det	24	SENT_8	[p1l2044t1828r2151b1891],
23	neoadjuvant	JJ	O	neoadjuvant	amod	24	SENT_8	[p1l7t1939r443b2020],
24	setting	NN	O	setting	prep_in	19	SENT_8	[p1l505t1939r755b2020],
25	.	.	O	.	_	0	SENT_8	[p1l505t1939r755b2020],

1	Treatment	NN	O	treatment	nn	2	SENT_9	[p1l819t1941r1187b2002],
2	response	NN	O	response	nsubjpass	17	SENT_9	[p1l1244t1959r1554b2020],
3	was	VBD	O	be	auxpass	4	SENT_9	[p1l1615t1959r1749b2002],
4	measured	VBN	O	measure	conj_and	4	SENT_9	[p1l1811t1939r2152b2002],
5	before	IN	O	before	_	0	SENT_9	[p1l6t2050r233b2113],
6	and	CC	O	and	_	0	SENT_9	[p1l268t2050r395b2113],
7	after	IN	O	after	_	0	SENT_9	[p1l428t2050r590b2113],
8	each	DT	O	each	det	9	SENT_9	[p1l621t2050r783b2113],
9	phase	NN	O	phase	prep_before	4	SENT_9	[p1l815t2050r1017b2131],
10	of	IN	O	of	_	0	SENT_9	[p1l1052t2050r1129b2113],
11	treatment	NN	O	treatment	prep_of	9	SENT_9	[p1l1155t2059r1493b2113],
12	by	IN	O	by	_	0	SENT_9	[p1l1523t2050r1611b2131],
13	clinical	JJ	O	clinical	amod	15	SENT_9	[p1l1646t2050r1906b2113],
14	tumor	NN	O	tumor	nn	15	SENT_9	[p1l1940t2060r2153b2113],
15	measurement	NN	O	measurement	agent	4	SENT_9	[p1l7t2171r483b2224],
16	and	CC	O	and	_	0	SENT_9	[p1l506t2161r633b2224],
17	categorized	VBN	O	categorize	conj_and	4	SENT_9	[p1l655t2161r1065b2242],
18	according	VBG	O	accord	_	0	SENT_9	[p1l1089t2161r1437b2242],
19	to	TO	O	to	prepc_according_to	17	SENT_9	[p1l1459t2171r1526b2224],
20	RECIST	NNP	O	RECIST	nn	21	SENT_9	[p1l1549t2162r1855b2224],
21	criteria	NNS	O	criterion	pobj	17	SENT_9	[p1l1878t2161r2148b2236],
22	,	,	O	,	_	0	SENT_9	[p1l1878t2161r2148b2236],

1	This	DT	O	this	det	2	SENT_10	[p1l7t2461r139b2514],
2	study	NN	O	study	nsubjpass	4	SENT_10	[p1l171t2461r331b2529],
3	was	VBD	O	be	auxpass	4	SENT_10	[p1l360t2477r474b2514],
4	presented	VBN	O	present	_	0	SENT_10	[p1l502t2461r795b2529],
5	in	IN	O	in	_	0	SENT_10	[p1l822t2461r880b2513],
6	part	NN	O	part	prep_in	4	SENT_10	[p1l907t2468r1025b2530],
7	at	IN	O	at	_	0	SENT_10	[p1l1054t2469r1106b2514],
8	the	DT	O	the	det	15	SENT_10	[p1l1133t2461r1224b2514],
9	33rd	JJ	ORDINAL	33rd	amod	15	SENT_10	[p1l1254t2461r1391b2514],
10	Annual	JJ	SET	annual	amod	15	SENT_10	[p1l1418t2461r1640b2514],
11	San	NNP	LOCATION	San	nn	15	SENT_10	[p1l1670t2461r1781b2514],
12	Antonio	NNP	LOCATION	Antonio	nn	15	SENT_10	[p1l1808t2461r2056b2514],
13	Breast	NN	O	breast	nn	15	SENT_10	[p1l7t2550r201b2602],
14	Cancer	NN	O	cancer	nn	15	SENT_10	[p1l229t2549r444b2602],
15	Symposium	NN	O	symposium	prep_at	4	SENT_10	[p1l472t2549r850b2618],
16	,	,	O	,	_	0	SENT_10	[p1l472t2549r850b2618],
17	December	NNP	DATE	December	appos	15	SENT_10	[p1l880t2549r1194b2602],
18	8-10	CD	DATE	8-10	num	17	SENT_10	[p1l1224t2549r1387b2612],
19	,	,	DATE	,	_	0	SENT_10	[p1l1224t2549r1387b2612],
20	2010	CD	DATE	2010	num	17	SENT_10	[p1l1419t2549r1585b2612],
21	,	,	O	,	_	0	SENT_10	[p1l1419t2549r1585b2612],
22	San	NNP	LOCATION	San	nn	23	SENT_10	[p1l1617t2549r1728b2602],
23	Antonio	NNP	LOCATION	Antonio	appos	15	SENT_10	[p1l1755t2549r2019b2612],
24	,	,	O	,	_	0	SENT_10	[p1l1755t2549r2019b2612],
25	Texas	NNP	LOCATION	Texas	appos	15	SENT_10	[p1l7t2638r203b2690],
26	.	.	O	.	_	0	SENT_10	[p1l7t2638r203b2690],

1	Electronic	JJ	O	electronic	amod	3	SENT_11	[p1l7t2814r343b2868],
2	supplementary	JJ	O	supplementary	amod	3	SENT_11	[p1l372t2815r860b2883],
3	material	NN	O	material	dep	11	SENT_11	[p1l887t2814r1164b2868],
4	The	DT	O	the	det	6	SENT_11	[p1l1242t2814r1360b2868],
5	online	JJ	O	online	amod	6	SENT_11	[p1l1390t2814r1579b2868],
6	version	NN	O	version	dep	3	SENT_11	[p1l1607t2814r1832b2868],
7	of	IN	O	of	_	0	SENT_11	[p1l1860t2814r1927b2868],
8	this	DT	O	this	det	9	SENT_11	[p1l1949t2814r2057b2868],
9	article	NN	O	article	prep_of	6	SENT_11	[p1l8t2902r198b2955],
10	(	NN	O	(	dep	11	SENT_11	[p1l229t2902r1271b2968],
11	doi	FW	O	doi	dep	15	SENT_11	[p1l229t2902r1271b2968],
12	:10.1007	CD	NUMBER	:10.1007	dep	11	SENT_11	[p1l229t2902r1271b2968],
13	/	:	O	/	punct	15	SENT_11	[p1l229t2902r1271b2968],
14	s10549-012-2054-0	JJ	O	s10549-012-2054-0	amod	15	SENT_11	[p1l229t2902r1271b2968],
15	)	NN	O	)	_	0	SENT_11	[p1l229t2902r1271b2968],
16	contains	VBZ	O	contain	rcmod	15	SENT_11	[p1l1301t2902r1554b2955],
17	supplementary	JJ	O	supplementary	amod	18	SENT_11	[p1l1585t2902r2034b2971],
18	material	NN	O	material	dobj	16	SENT_11	[p1l7t2991r275b3054],
19	,	,	O	,	_	0	SENT_11	[p1l7t2991r275b3054],
20	which	WDT	O	which	nsubj	22	SENT_11	[p1l306t2991r492b3045],
21	is	VBZ	O	be	cop	22	SENT_11	[p1l519t2991r567b3045],
22	available	JJ	O	available	rcmod	18	SENT_11	[p1l598t2991r873b3045],
23	to	TO	O	to	_	0	SENT_11	[p1l901t2999r958b3045],
24	authorized	VBN	O	authorize	amod	25	SENT_11	[p1l988t2991r1311b3045],
25	users	NNS	O	user	prep_to	22	SENT_11	[p1l1338t3008r1509b3045],
26	.	.	O	.	_	0	SENT_11	[p1l1338t3008r1509b3045],

1	D.	NNP	PERSON	D.	nn	3	SENT_12	[p1l7t3172r75b3224],
2	L.	NNP	PERSON	L.	nn	3	SENT_12	[p1l106t3172r167b3224],
3	Hertz	NNP	PERSON	Hertz	nsubj	5	SENT_12	[p1l198t3172r364b3224],
4	(	CD	NUMBER	(	num	3	SENT_12	[p1l396t3167r527b3237],
5	E	NN	O	e	_	0	SENT_12	[p1l396t3167r527b3237],
6	)	SYM	O	)	dep	13	SENT_12	[p1l396t3167r527b3237],
7	-	:	O	-	_	0	SENT_12	[p1l562t3200r570b3208],
8	H.	NNP	PERSON	H.	nn	13	SENT_12	[p1l602t3172r670b3224],
9	L.	NNP	PERSON	L.	nn	13	SENT_12	[p1l701t3172r762b3224],
10	McLeod	NNP	PERSON	McLeod	nn	13	SENT_12	[p1l793t3171r1051b3224],
11	UNC	NNP	ORGANIZATION	UNC	nn	13	SENT_12	[p1l7t3258r164b3312],
12	Eshelman	NNP	ORGANIZATION	Eshelman	nn	13	SENT_12	[p1l193t3258r493b3311],
13	School	NNP	ORGANIZATION	School	dep	5	SENT_12	[p1l523t3258r730b3311],
14	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l760t3258r826b3311],
15	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	17	SENT_12	[p1l847t3258r1168b3327],
16	,	,	O	,	_	0	SENT_12	[p1l847t3258r1168b3327],
17	Division	NNP	O	Division	prep_of	13	SENT_12	[p1l1198t3258r1459b3311],
18	of	IN	O	of	_	0	SENT_12	[p1l1488t3258r1554b3311],
19	Pharmacotherapy	NNP	O	Pharmacotherapy	prep_of	17	SENT_12	[p1l7t3346r540b3415],
20	and	CC	O	and	_	0	SENT_12	[p1l570t3346r678b3399],
21	Experimental	JJ	O	experimental	amod	22	SENT_12	[p1l704t3346r1115b3415],
22	Therapeutics	NNS	O	therapeutics	prep_of	13	SENT_12	[p1l1144t3346r1553b3415],
23	,	,	O	,	_	0	SENT_12	[p1l1144t3346r1553b3415],
24	University	NNP	ORGANIZATION	University	appos	22	SENT_12	[p1l1584t3346r1904b3415],
25	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l1933t3346r1999b3399],
26	North	NNP	ORGANIZATION	North	nn	27	SENT_12	[p1l7t3434r183b3487],
27	Carolina	NNP	ORGANIZATION	Carolina	prep_of	24	SENT_12	[p1l206t3434r468b3488],
28	at	IN	O	at	_	0	SENT_12	[p1l491t3442r544b3487],
29	Chapel	NN	LOCATION	chapel	prep_at	27	SENT_12	[p1l566t3434r780b3503],
30	Hill	NNP	LOCATION	Hill	nsubj	47	SENT_12	[p1l803t3434r936b3497],
31	,	,	O	,	_	0	SENT_12	[p1l803t3434r936b3497],
32	120	CD	NUMBER	120	num	35	SENT_12	[p1l969t3435r1074b3488],
33	Mason	NNP	ORGANIZATION	Mason	nn	35	SENT_12	[p1l1095t3436r1302b3487],
34	Farm	NNP	ORGANIZATION	Farm	nn	35	SENT_12	[p1l1323t3436r1484b3487],
35	Road	NNP	ORGANIZATION	Road	appos	30	SENT_12	[p1l1505t3434r1681b3497],
36	,	,	O	,	_	0	SENT_12	[p1l1505t3434r1681b3497],
37	CB	NNP	O	CB	appos	30	SENT_12	[p1l1707t3435r1802b3488],
38	7361	CD	NUMBER	7361	num	37	SENT_12	[p1l1828t3434r1995b3497],
39	,	,	O	,	_	0	SENT_12	[p1l1828t3434r1995b3497],
40	Chapel	NN	LOCATION	chapel	nn	41	SENT_12	[p1l8t3522r221b3591],
41	Hill	NNP	LOCATION	Hill	appos	30	SENT_12	[p1l250t3522r383b3585],
42	,	,	O	,	_	0	SENT_12	[p1l250t3522r383b3585],
43	NC	NNP	O	NC	appos	30	SENT_12	[p1l413t3522r516b3575],
44	27599	CD	NUMBER	27599	num	43	SENT_12	[p1l546t3522r750b3585],
45	,	,	O	,	_	0	SENT_12	[p1l546t3522r750b3585],
46	USA	NNP	LOCATION	USA	appos	30	SENT_12	[p1l780t3522r931b3576],
47	e-mail	VB	O	e-mail	rcmod	29	SENT_12	[p1l8t3611r217b3664],
48	:	:	O	:	_	0	SENT_12	[p1l8t3611r217b3664],
49	danhertz@email.unc.edu	NN	O	danhertz@email.unc.edu	dep	29	SENT_12	[p1l251t3611r1012b3665],

1	D.	NNP	PERSON	D.	nn	3	SENT_13	[p2l7t70r75b122],
2	L.	NNP	PERSON	L.	nn	3	SENT_13	[p2l106t70r167b122],
3	Hertz	NNP	PERSON	Hertz	_	0	SENT_13	[p2l198t70r364b122],
4	-	:	O	-	_	0	SENT_13	[p2l399t98r407b106],
5	A.	NN	PERSON	a.	nn	6	SENT_13	[p2l440t69r508b122],
6	A.	NN	PERSON	a.	dep	7	SENT_13	[p2l539t69r607b122],
7	Motsinger-Reif	NNP	PERSON	Motsinger-Reif	dep	3	SENT_13	[p2l638t69r1113b138],
8	-	:	O	-	_	0	SENT_13	[p2l1141t98r1149b106],
9	H.	NNP	PERSON	H.	nn	13	SENT_13	[p2l1182t70r1249b122],
10	L.	NNP	PERSON	L.	nn	13	SENT_13	[p2l1280t70r1341b122],
11	McLeod	NNP	PERSON	McLeod	nn	13	SENT_13	[p2l1372t69r1630b122],
12	UNC	NNP	ORGANIZATION	UNC	nn	13	SENT_13	[p2l7t157r164b210],
13	Institute	NNP	ORGANIZATION	Institute	dep	33	SENT_13	[p2l193t157r441b210],
14	for	IN	ORGANIZATION	for	_	0	SENT_13	[p2l470t157r559b210],
15	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	prep_for	13	SENT_13	[p2l585t157r1180b225],
16	and	CC	O	and	_	0	SENT_13	[p2l1211t157r1318b210],
17	Individualized	NNP	O	Individualized	prep_for	13	SENT_13	[p2l1345t157r1786b210],
18	Therapy	NN	O	therapy	dep	13	SENT_13	[p2l7t245r276b314],
19	,	,	O	,	_	0	SENT_13	[p2l7t245r276b314],
20	University	NNP	ORGANIZATION	University	appos	13	SENT_13	[p2l307t245r627b314],
21	of	IN	ORGANIZATION	of	_	0	SENT_13	[p2l656t245r722b298],
22	North	NNP	ORGANIZATION	North	nn	23	SENT_13	[p2l744t245r921b298],
23	Carolina	NNP	ORGANIZATION	Carolina	prep_of	20	SENT_13	[p2l949t245r1211b298],
24	at	IN	O	at	_	0	SENT_13	[p2l1239t253r1291b298],
25	Chapel	NN	LOCATION	chapel	nn	26	SENT_13	[p2l1319t245r1532b314],
26	Hill	NNP	LOCATION	Hill	prep_at	23	SENT_13	[p2l1561t245r1694b308],
27	,	,	O	,	_	0	SENT_13	[p2l1561t245r1694b308],
28	Chapel	NN	LOCATION	chapel	nn	31	SENT_13	[p2l1726t245r1939b314],
29	Hill	NNP	LOCATION	Hill	nn	31	SENT_13	[p2l7t334r140b397],
30	,	,	O	,	_	0	SENT_13	[p2l7t334r140b397],
31	NC	NNP	O	NC	appos	13	SENT_13	[p2l171t334r291b397],
32	,	,	O	,	_	0	SENT_13	[p2l171t334r291b397],
33	USA	NNP	LOCATION	USA	parataxis	7	SENT_13	[p2l321t334r471b387],

1	A.	NN	PERSON	a.	nn	2	SENT_14	[p2l7t513r75b566],
2	A.	NN	PERSON	a.	_	0	SENT_14	[p2l106t513r175b566],
3	Motsinger	NNP	PERSON	Motsinger	dep	2	SENT_14	[p2l205t513r680b581],
4	.	.	O	.	_	0	SENT_14	[p2l205t513r680b581],

1	—	NN	O	—	_	0	SENT_15	[p2l205t513r680b581],
2	.	.	O	.	_	0	SENT_15	[p2l205t513r680b581],

1	Reif	NNP	ORGANIZATION	Reif	nn	4	SENT_16	[p2l205t513r680b581],
2	Bioinformatics	NNP	ORGANIZATION	Bioinformatics	nn	4	SENT_16	[p2l7t601r463b655],
3	Research	NNP	ORGANIZATION	Research	nn	4	SENT_16	[p2l492t602r771b655],
4	Center	NNP	ORGANIZATION	Center	_	0	SENT_16	[p2l799t602r1016b665],
5	,	,	O	,	_	0	SENT_16	[p2l799t602r1016b665],
6	North	NNP	ORGANIZATION	North	nn	15	SENT_16	[p2l1046t601r1223b655],
7	Carolina	NNP	ORGANIZATION	Carolina	nn	15	SENT_16	[p2l1252t601r1514b655],
8	State	NNP	ORGANIZATION	State	nn	15	SENT_16	[p2l1542t602r1690b655],
9	University	NNP	ORGANIZATION	University	nn	15	SENT_16	[p2l7t690r344b758],
10	,	,	O	,	_	0	SENT_16	[p2l7t690r344b758],
11	Raleigh	NNP	LOCATION	Raleigh	appos	15	SENT_16	[p2l375t690r627b758],
12	,	,	O	,	_	0	SENT_16	[p2l375t690r627b758],
13	NC	NNP	O	NC	appos	15	SENT_16	[p2l657t690r777b752],
14	,	,	O	,	_	0	SENT_16	[p2l657t690r777b752],
15	USA	NNP	LOCATION	USA	appos	4	SENT_16	[p2l807t690r958b743],

1	A.	NN	PERSON	a.	nn	2	SENT_17	[p2l7t869r75b922],
2	A.	NN	PERSON	a.	_	0	SENT_17	[p2l107t869r175b922],
3	Motsinger	NNP	PERSON	Motsinger	dep	2	SENT_17	[p2l205t868r680b937],
4	.	.	O	.	_	0	SENT_17	[p2l205t868r680b937],

1	—	NN	O	—	_	0	SENT_18	[p2l205t868r680b937],
2	.	.	O	.	_	0	SENT_18	[p2l205t868r680b937],

1	Reif	SYM	PERSON	reif	dep	6	SENT_19	[p2l205t868r680b937],
2	-	:	O	-	_	0	SENT_19	[p2l709t897r717b906],
3	S.	NNP	PERSON	S.	nn	6	SENT_19	[p2l751t869r804b922],
4	J.	NNP	PERSON	J.	nn	6	SENT_19	[p2l835t870r878b922],
5	Winham	NNP	PERSON	Winham	nn	6	SENT_19	[p2l909t868r1172b922],
6	Department	NNP	ORGANIZATION	Department	_	0	SENT_19	[p2l7t958r367b1025],
7	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l395t957r461b1010],
8	Statistics	NNPS	ORGANIZATION	Statistics	prep_of	6	SENT_19	[p2l485t957r774b1019],
9	,	,	ORGANIZATION	,	_	0	SENT_19	[p2l485t957r774b1019],
10	North	NNP	ORGANIZATION	North	nn	19	SENT_19	[p2l804t957r981b1010],
11	Carolina	NNP	ORGANIZATION	Carolina	nn	19	SENT_19	[p2l1009t957r1271b1010],
12	State	NNP	ORGANIZATION	State	nn	19	SENT_19	[p2l1300t957r1448b1010],
13	University	NNP	ORGANIZATION	University	nn	19	SENT_19	[p2l1477t957r1813b1025],
14	,	,	O	,	_	0	SENT_19	[p2l1477t957r1813b1025],
15	Raleigh	NNP	LOCATION	Raleigh	appos	19	SENT_19	[p2l7t1044r259b1113],
16	,	,	O	,	_	0	SENT_19	[p2l7t1044r259b1113],
17	NC	NNP	O	NC	appos	19	SENT_19	[p2l290t1045r410b1107],
18	,	,	O	,	_	0	SENT_19	[p2l290t1045r410b1107],
19	USA	NNP	LOCATION	USA	appos	6	SENT_19	[p2l440t1045r590b1098],
20	while	IN	O	while	mark	24	SENT_19	[p2l9t1147r203b1210],
21	toxicity	NN	O	toxicity	nn	22	SENT_19	[p2l226t1147r496b1228],
22	data	NNS	O	datum	nsubjpass	24	SENT_19	[p2l520t1147r667b1210],
23	were	VBD	O	be	auxpass	24	SENT_19	[p2l689t1167r858b1210],
24	collected	VBN	O	collect	dep	19	SENT_19	[p2l882t1147r1203b1210],
25	from	IN	O	from	_	0	SENT_19	[p2l1225t1147r1396b1210],
26	physician	NN	O	physician	nn	27	SENT_19	[p2l1416t1147r1757b1228],
27	notes	NNS	O	note	prep_from	24	SENT_19	[p2l1779t1157r1982b1210],
28	.	.	O	.	_	0	SENT_19	[p2l1779t1157r1982b1210],

1	The	DT	O	the	det	3	SENT_20	[p2l2009t1147r2146b1210],
2	primary	JJ	O	primary	amod	3	SENT_20	[p2l7t1258r288b1339],
3	endpoint	NN	O	endpoint	nsubj	5	SENT_20	[p2l340t1258r650b1339],
4	was	VBD	O	be	cop	5	SENT_20	[p2l699t1278r833b1321],
5	achievement	NN	O	achievement	_	0	SENT_20	[p2l888t1258r1337b1321],
6	of	IN	O	of	_	0	SENT_20	[p2l1387t1258r1464b1321],
7	clinical	JJ	O	clinical	amod	9	SENT_20	[p2l1509t1258r1769b1321],
8	complete	JJ	O	complete	amod	9	SENT_20	[p2l1821t1258r2145b1339],
9	response	NN	O	response	prep_of	5	SENT_20	[p2l7t1389r316b1450],
10	(	CD	NUMBER	(	num	12	SENT_20	[p2l356t1370r566b1447],
11	cCR	NN	O	ccr	nn	12	SENT_20	[p2l356t1370r566b1447],
12	)	NN	O	)	nsubj	16	SENT_20	[p2l356t1370r566b1447],
13	and	CC	O	and	_	0	SENT_20	[p2l607t1369r733b1432],
14	secondary	JJ	O	secondary	amod	15	SENT_20	[p2l771t1369r1127b1450],
15	endpoints	NNS	O	endpoint	conj_and	12	SENT_20	[p2l1164t1369r1505b1450],
16	included	VBD	O	include	rcmod	5	SENT_20	[p2l1544t1369r1850b1432],
17	clinical	JJ	O	clinical	amod	19	SENT_20	[p2l1885t1369r2145b1432],
18	response	NN	O	response	nn	19	SENT_20	[p2l7t1500r316b1561],
19	rate	NN	O	rate	nsubj	20	SENT_20	[p2l358t1490r491b1543],
20	(	VBD	O	(	ccomp	16	SENT_20	[p2l536t1480r888b1561],
21	complete	JJ	O	complete	amod	22	SENT_20	[p2l536t1480r888b1561],
22	response	NN	O	response	dobj	20	SENT_20	[p2l930t1500r1239b1561],
23	+	CC	O	+	_	0	SENT_20	[p2l1275t1489r1335b1549],
24	partial	JJ	O	partial	amod	26	SENT_20	[p2l1369t1480r1595b1561],
25	response	NN	O	response	nn	26	SENT_20	[p2l1638t1481r1974b1561],
26	)	NN	O	)	conj_+	22	SENT_20	[p2l1638t1481r1974b1561],
27	and	CC	O	and	_	0	SENT_20	[p2l2021t1480r2147b1543],
28	grade	NN	O	grade	conj_and	22	SENT_20	[p2l9t1591r203b1672],
29	3	CD	NUMBER	3	num	28	SENT_20	[p2l235t1591r341b1660],
30	+	CC	O	+	_	0	SENT_20	[p2l235t1591r341b1660],
31	peripheral	JJ	O	peripheral	amod	32	SENT_20	[p2l373t1591r733b1672],
32	neuropathy	NN	O	neuropathy	conj_and	22	SENT_20	[p2l762t1591r1178b1672],
33	.	.	O	.	_	0	SENT_20	[p2l762t1591r1178b1672],

1	The	DT	O	the	det	2	SENT_21	[p2l1212t1591r1348b1653],
2	genotypes	NNS	O	genotype	nsubj	7	SENT_21	[p2l1379t1600r1735b1672],
3	and	CC	O	and	_	0	SENT_21	[p2l1767t1591r1893b1653],
4	haplotypes	NNS	O	haplotype	conj_and	2	SENT_21	[p2l1920t1591r2143b1672, p2l8t1711r192b1783],
5	assessed	VBN	O	assess	partmod	2	SENT_21	[p2l221t1702r518b1764],
6	were	VBD	O	be	cop	7	SENT_21	[p2l543t1721r714b1764],
7	CYP1B1	NN	O	cyp1b1	_	0	SENT_21	[p2l740t1702r1166b1775],
8	*	CD	NUMBER	*	number	9	SENT_21	[p2l740t1702r1166b1775],
9	3	CD	NUMBER	3	dep	7	SENT_21	[p2l740t1702r1166b1775],
10	,	,	O	,	_	0	SENT_21	[p2l740t1702r1166b1775],
11	CYP2C8	CD	NUMBER	cyp2c8	number	12	SENT_21	[p2l1195t1702r1621b1776],
12	*	CD	NUMBER	*	conj_and	7	SENT_21	[p2l1195t1702r1621b1776],
13	3	CD	NUMBER	3	dep	12	SENT_21	[p2l1195t1702r1621b1776],
14	,	,	O	,	_	0	SENT_21	[p2l1195t1702r1621b1776],
15	CYP3A4	NN	O	cyp3a4	nn	17	SENT_21	[p2l1650t1702r2148b1765],
16	*	CD	NUMBER	*	num	17	SENT_21	[p2l1650t1702r2148b1765],
17	1B	NN	O	1b	conj_and	7	SENT_21	[p2l1650t1702r2148b1765],
18	/	:	O	/	punct	19	SENT_21	[p2l1650t1702r2148b1765],
19	CYP3A5	NN	O	cyp3a5	dep	17	SENT_21	[p2l9t1811r498b1886],
20	*	CD	NUMBER	*	num	19	SENT_21	[p2l9t1811r498b1886],
21	3C	NN	O	3c	dep	17	SENT_21	[p2l9t1811r498b1886],
22	,	,	O	,	_	0	SENT_21	[p2l9t1811r498b1886],
23	and	CC	O	and	_	0	SENT_21	[p2l535t1812r662b1874],
24	ABCB1	NN	O	abcb1	nn	25	SENT_21	[p2l692t1812r1083b1875],
25	*	NN	O	*	conj_and	7	SENT_21	[p2l692t1812r1083b1875],
26	2	CD	NUMBER	2	dep	25	SENT_21	[p2l692t1812r1083b1875],
27	.	.	O	.	_	0	SENT_21	[p2l692t1812r1083b1875],

1	A	DT	O	a	det	2	SENT_22	[p2l1119t1812r1181b1873],
2	total	NN	O	total	nsubjpass	7	SENT_22	[p2l1213t1812r1369b1874],
3	of	IN	O	of	_	0	SENT_22	[p2l1402t1812r1479b1874],
4	111	CD	NUMBER	111	num	5	SENT_22	[p2l1514t1812r1629b1873],
5	patients	NNS	O	patient	prep_of	2	SENT_22	[p2l1667t1812r1942b1893],
6	were	VBD	O	be	auxpass	7	SENT_22	[p2l1975t1831r2145b1874],
7	included	VBN	O	include	_	0	SENT_22	[p2l8t1924r314b1987],
8	in	IN	O	in	_	0	SENT_22	[p2l339t1924r407b1986],
9	this	DT	O	this	det	10	SENT_22	[p2l433t1924r558b1987],
10	study	NN	O	study	prep_in	7	SENT_22	[p2l589t1924r794b2005],
11	.	.	O	.	_	0	SENT_22	[p2l589t1924r794b2005],

1	Overall	RB	O	overall	advmod	6	SENT_23	[p2l826t1924r1108b1998],
2	,	,	O	,	_	0	SENT_23	[p2l826t1924r1108b1998],
3	cCR	NN	O	ccr	nsubj	6	SENT_23	[p2l1138t1924r1296b1987],
4	was	VBD	O	be	cop	6	SENT_23	[p2l1322t1944r1455b1987],
5	30.1	CD	PERCENT	30.1	num	6	SENT_23	[p2l1486t1924r1629b1987],
6	%	NN	PERCENT	%	_	0	SENT_23	[p2l1672t1924r1736b1987],
7	to	TO	O	to	_	0	SENT_23	[p2l1767t1933r1833b1987],
8	the	DT	O	the	det	10	SENT_23	[p2l1861t1924r1968b1987],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_23	[p2l1993t1944r2143b2005, p2l8t2035r228b2098],
10	component	NN	O	component	prep_to	6	SENT_23	[p2l250t2045r661b2116],
11	.	.	O	.	_	0	SENT_23	[p2l250t2045r661b2116],

1	CYP2C8	CD	NUMBER	cyp2c8	number	2	SENT_24	[p2l686t2035r1088b2098],
2	*	CD	NUMBER	*	num	4	SENT_24	[p2l686t2035r1088b2098],
3	3	CD	NUMBER	3	num	4	SENT_24	[p2l686t2035r1088b2098],
4	carriers	NNS	O	carrier	_	0	SENT_24	[p2l1113t2035r1376b2098],
5	(	VBP	O	(	dep	4	SENT_24	[p2l1399t2035r1690b2112],
6	23/111	CD	NUMBER	23/111	nsubj	11	SENT_24	[p2l1399t2035r1690b2112],
7	,	,	O	,	_	0	SENT_24	[p2l1399t2035r1690b2112],
8	20.7	CD	PERCENT	20.7	num	9	SENT_24	[p2l1714t2035r1864b2098],
9	%	NN	PERCENT	%	appos	6	SENT_24	[p2l1902t2035r1997b2112],
10	)	CD	NUMBER	)	dep	9	SENT_24	[p2l1902t2035r1997b2112],
11	had	VBD	O	have	ccomp	5	SENT_24	[p2l2019t2035r2147b2098],
12	higher	JJR	O	higher	amod	13	SENT_24	[p2l8t2146r236b2227],
13	rates	NNS	O	rate	dobj	11	SENT_24	[p2l260t2156r425b2209],
14	of	IN	O	of	_	0	SENT_24	[p2l455t2146r532b2209],
15	cCR	NN	O	ccr	prep_of	13	SENT_24	[p2l554t2146r711b2209],
16	(	CD	PERCENT	(	number	17	SENT_24	[p2l740t2146r850b2223],
17	55	CD	PERCENT	55	num	18	SENT_24	[p2l740t2146r850b2223],
18	%	NN	PERCENT	%	dep	4	SENT_24	[p2l889t2146r953b2209],
19	vs.	CC	O	vs.	prep	18	SENT_24	[p2l985t2166r1079b2209],
20	23	CD	PERCENT	23	num	21	SENT_24	[p2l1112t2146r1193b2209],
21	%	NN	PERCENT	%	dep	19	SENT_24	[p2l1233t2146r1322b2220],
22	;	:	O	;	_	0	SENT_24	[p2l1233t2146r1322b2220],
23	OR	NN	O	or	dep	18	SENT_24	[p2l1355t2147r1476b2209],
24	=	JJ	O	=	amod	29	SENT_24	[p2l1510t2174r1571b2198],
25	3.92	CD	PERCENT	3.92	number	26	SENT_24	[p2l1608t2146r1758b2210],
26	[	CD	PERCENT	[	prep	24	SENT_24	[p2l1793t2146r1899b2222],
27	95	CD	PERCENT	95	num	28	SENT_24	[p2l1793t2146r1899b2222],
28	%	NN	PERCENT	%	dep	26	SENT_24	[p2l1938t2146r2002b2209],
29	CI	NN	O	ci	dep	23	SENT_24	[p2l2035t2146r2140b2209],
30	:	:	O	:	_	0	SENT_24	[p2l2035t2146r2140b2209],
31	1.46	CD	NUMBER	1.46	number	32	SENT_24	[p2l17t2257r453b2333],
32	—	CD	NUMBER	—	dep	18	SENT_24	[p2l17t2257r453b2333],
33	10.48	CD	NUMBER	10.48	num	34	SENT_24	[p2l17t2257r453b2333],
34	]	NN	O	]	dep	32	SENT_24	[p2l17t2257r453b2333],
35	,	,	O	,	_	0	SENT_24	[p2l17t2257r453b2333],
36	corrected	VBN	O	correct	partmod	4	SENT_24	[p2l490t2257r820b2320],
37	p	NN	O	p	dobj	36	SENT_24	[p2l843t2279r892b2337],
38	=	JJ	O	=	advmod	36	SENT_24	[p2l929t2286r989b2310],
39	0.046	CD	NUMBER	0.046	num	40	SENT_24	[p2l1025t2257r1270b2335],
40	)	NN	O	)	dep	38	SENT_24	[p2l1025t2257r1270b2335],
41	.	.	O	.	_	0	SENT_24	[p2l1025t2257r1270b2335],

1	In	IN	O	in	_	0	SENT_25	[p2l1306t2259r1378b2319],
2	the	DT	O	the	det	5	SENT_25	[p2l1410t2257r1517b2320],
3	secondary	JJ	O	secondary	amod	5	SENT_25	[p2l1552t2257r1907b2338],
4	toxicity	NN	O	toxicity	nn	5	SENT_25	[p2l1940t2257r2143b2320, p2l8t2368r100b2449],
5	analysis	NN	O	analysis	prep_in	8	SENT_25	[p2l147t2368r448b2449],
6	,	,	O	,	_	0	SENT_25	[p2l147t2368r448b2449],
7	we	PRP	O	we	nsubj	8	SENT_25	[p2l497t2388r598b2431],
8	observed	VBD	O	observe	_	0	SENT_25	[p2l645t2368r964b2431],
9	a	DT	O	a	det	10	SENT_25	[p2l1010t2388r1047b2431],
10	trend	NN	O	trend	dobj	8	SENT_25	[p2l1091t2368r1273b2431],
11	toward	IN	O	toward	_	0	SENT_25	[p2l1317t2368r1563b2431],
12	greater	JJR	O	greater	amod	13	SENT_25	[p2l1608t2378r1855b2449],
13	risk	NN	O	risk	prep_toward	8	SENT_25	[p2l1897t2368r2031b2431],
14	of	IN	O	of	_	0	SENT_25	[p2l2075t2368r2152b2431],
15	severe	JJ	O	severe	amod	17	SENT_25	[p2l11t2499r233b2542],
16	neuropathy	NN	O	neuropathy	nn	17	SENT_25	[p2l274t2479r672b2560],
17	(	NN	O	(	prep_of	13	SENT_25	[p2l717t2480r830b2556],
18	22	CD	PERCENT	22	number	19	SENT_25	[p2l717t2480r830b2556],
19	%	NN	PERCENT	%	amod	17	SENT_25	[p2l865t2480r930b2542],
20	vs.	CC	O	vs.	prep	17	SENT_25	[p2l975t2499r1069b2542],
21	8	CD	PERCENT	8	num	22	SENT_25	[p2l1118t2480r1153b2542],
22	%	NN	PERCENT	%	dep	20	SENT_25	[p2l1192t2480r1282b2553],
23	;	:	O	;	_	0	SENT_25	[p2l1192t2480r1282b2553],
24	OR	NN	O	or	dep	13	SENT_25	[p2l1328t2480r1449b2542],
25	=	JJ	O	=	amod	30	SENT_25	[p2l1483t2508r1544b2531],
26	3.13	CD	PERCENT	3.13	number	27	SENT_25	[p2l1581t2480r1728b2542],
27	[	CD	PERCENT	[	prep	25	SENT_25	[p2l1780t2479r1886b2555],
28	95	CD	PERCENT	95	num	29	SENT_25	[p2l1780t2479r1886b2555],
29	%	NN	PERCENT	%	dep	27	SENT_25	[p2l1925t2480r1989b2542],
30	CI	NN	O	ci	dep	24	SENT_25	[p2l2035t2480r2140b2542],
31	:	:	O	:	_	0	SENT_25	[p2l2035t2480r2140b2542],
32	0.89	CD	NUMBER	0.89	num	33	SENT_25	[p2l9t2589r242b2652],
33	—	NN	O	—	dep	13	SENT_25	[p2l9t2589r242b2652],
34	1	CD	NUMBER	1	number	35	SENT_25	[p2l9t2589r242b2652],
35	1.01	CD	NUMBER	1.01	num	36	SENT_25	[p2l261t2589r453b2665],
36	]	NN	O	]	dep	33	SENT_25	[p2l261t2589r453b2665],
37	,	,	O	,	_	0	SENT_25	[p2l261t2589r453b2665],
38	uncorrected	JJ	O	uncorrected	amod	39	SENT_25	[p2l476t2589r896b2651],
39	p	NN	O	p	appos	13	SENT_25	[p2l906t2610r956b2669],
40	=	JJ	O	=	amod	42	SENT_25	[p2l992t2617r1052b2641],
41	0.075	CD	NUMBER	0.075	tmod	40	SENT_25	[p2l1088t2589r1312b2666],
42	)	NN	O	)	dep	39	SENT_25	[p2l1088t2589r1312b2666],
43	in	IN	O	in	_	0	SENT_25	[p2l1334t2589r1402b2651],
44	subjects	NNS	O	subject	prep_in	8	SENT_25	[p2l1424t2589r1703b2670],
45	carrying	VBG	O	carry	partmod	44	SENT_25	[p2l1726t2589r2018b2670],
46	the	DT	O	the	det	50	SENT_25	[p2l2039t2589r2145b2651],
47	CYP2C8	NN	O	cyp2c8	nn	50	SENT_25	[p2l9t2700r411b2763],
48	*	NN	O	*	nn	50	SENT_25	[p2l9t2700r411b2763],
49	3	CD	NUMBER	3	num	50	SENT_25	[p2l9t2700r411b2763],
50	variant	NN	O	variant	dobj	45	SENT_25	[p2l438t2700r701b2762],
51	.	.	O	.	_	0	SENT_25	[p2l438t2700r701b2762],

1	Other	JJ	O	other	amod	2	SENT_26	[p2l729t2700r930b2763],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_26	[p2l949t2700r1500b2781],
3	interrogated	VBN	O	interrogate	partmod	2	SENT_26	[p2l1524t2700r1953b2781],
4	were	VBD	O	be	auxpass	7	SENT_26	[p2l1975t2719r2145b2762],
5	not	RB	O	not	neg	7	SENT_26	[p2l8t2820r122b2873],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_26	[p2l189t2811r624b2892],
7	associated	VBN	O	associate	_	0	SENT_26	[p2l692t2811r1054b2873],
8	with	IN	O	with	_	0	SENT_26	[p2l1120t2811r1275b2874],
9	response	NN	O	response	prep_with	7	SENT_26	[p2l1340t2830r1649b2892],
10	or	CC	O	or	_	0	SENT_26	[p2l1717t2830r1790b2873],
11	toxicity	NN	O	toxicity	conj_or	9	SENT_26	[p2l1853t2811r2142b2892],
12	.	.	O	.	_	0	SENT_26	[p2l1853t2811r2142b2892],

1	Patients	NNS	O	patient	nsubj	8	SENT_27	[p2l8t2923r286b2986],
2	carrying	VBG	O	carry	partmod	1	SENT_27	[p2l336t2923r628b3004],
3	CYP2C8	NN	O	cyp2c8	nn	4	SENT_27	[p2l677t2923r1079b2986],
4	*	NN	O	*	dobj	2	SENT_27	[p2l677t2923r1079b2986],
5	3	CD	NUMBER	3	num	4	SENT_27	[p2l677t2923r1079b2986],
6	are	VBP	O	be	cop	8	SENT_27	[p2l1133t2943r1237b2986],
7	more	RBR	O	more	advmod	8	SENT_27	[p2l1285t2943r1466b2986],
8	likely	JJ	O	likely	_	0	SENT_27	[p2l1513t2923r1713b3004],
9	to	TO	O	to	aux	10	SENT_27	[p2l1761t2933r1827b2986],
10	achieve	VB	O	achieve	xcomp	8	SENT_27	[p2l1877t2923r2145b2986],
11	clinical	JJ	O	clinical	amod	13	SENT_27	[p2l9t3034r268b3097],
12	complete	JJ	O	complete	amod	13	SENT_27	[p2l328t3034r652b3115],
13	response	NN	O	response	dobj	10	SENT_27	[p2l711t3054r1020b3115],
14	from	IN	O	from	_	0	SENT_27	[p2l1080t3034r1251b3097],
15	neoadjuvant	JJ	O	neoadjuvant	amod	16	SENT_27	[p2l1309t3034r1744b3115],
16	paclitaxel	NN	O	paclitaxel	prep_from	10	SENT_27	[p2l1800t3034r2145b3115],

1	A.	NN	PERSON	a.	_	0	SENT_28	[p2l8t3277r76b3330],
2	Drobish	NNP	PERSON	Drobish	dep	1	SENT_28	[p2l107t3277r351b3330],
3	-	:	O	-	_	0	SENT_28	[p2l383t3306r391b3314],
4	H.	NNP	PERSON	H.	nn	6	SENT_28	[p2l423t3278r491b3330],
5	L.	NNP	PERSON	L.	nn	6	SENT_28	[p2l522t3278r582b3330],
6	McLeod	NNP	PERSON	McLeod	dep	1	SENT_28	[p2l613t3277r871b3330],
7	-	:	O	-	_	0	SENT_28	[p2l903t3306r912b3314],
8	L.	NNP	PERSON	L.	nn	10	SENT_28	[p2l943t3278r1003b3330],
9	A.	NNP	PERSON	A.	nn	10	SENT_28	[p2l1035t3277r1103b3330],
10	Carey	NNP	PERSON	Carey	dep	6	SENT_28	[p2l1135t3277r1313b3346],
11	-	:	O	-	_	0	SENT_28	[p2l1347t3306r1355b3314],
12	E.	NNP	ORGANIZATION	E.	nn	15	SENT_28	[p2l1387t3278r1448b3330],
13	C.	NNP	ORGANIZATION	C.	nn	15	SENT_28	[p2l1480t3277r1543b3330],
14	Dees	NNP	ORGANIZATION	Dees	nn	15	SENT_28	[p2l1574t3278r1722b3330],
15	Lineberger	NNP	ORGANIZATION	Lineberger	dep	1	SENT_28	[p2l8t3365r343b3433],
16	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	18	SENT_28	[p2l370t3365r844b3433],
17	Cancer	NNP	ORGANIZATION	Cancer	nn	18	SENT_28	[p2l874t3365r1089b3418],
18	Center	NNP	ORGANIZATION	Center	dep	15	SENT_28	[p2l1115t3365r1332b3427],
19	,	,	O	,	_	0	SENT_28	[p2l1115t3365r1332b3427],
20	Chapel	NN	LOCATION	chapel	nn	21	SENT_28	[p2l1364t3365r1576b3433],
21	Hill	NNP	LOCATION	Hill	appos	18	SENT_28	[p2l1605t3365r1738b3427],
22	,	,	O	,	_	0	SENT_28	[p2l1605t3365r1738b3427],
23	NC	NNP	O	NC	appos	18	SENT_28	[p2l1768t3365r1888b3428],
24	,	,	O	,	_	0	SENT_28	[p2l1768t3365r1888b3428],
25	USA	NNP	LOCATION	USA	appos	18	SENT_28	[p2l8t3454r158b3507],

1	Present	JJ	DATE	present	amod	2	SENT_29	[p2l7t3635r241b3686],
2	Address	NN	O	address	_	0	SENT_29	[p2l261t3633r530b3686],
3	:	:	O	:	_	0	SENT_29	[p2l261t3633r530b3686],
4	S.	NNP	PERSON	S.	nn	6	SENT_29	[p2l10t3722r63b3775],
5	J.	NNP	PERSON	J.	nn	6	SENT_29	[p2l94t3723r137b3775],
6	Winham	NNP	PERSON	Winham	dep	2	SENT_29	[p2l167t3721r430b3775],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_30	[p3l8t26r367b93],
2	of	IN	ORGANIZATION	of	_	0	SENT_30	[p3l395t24r461b78],
3	Health	NNP	ORGANIZATION	Health	nn	5	SENT_30	[p3l483t25r685b78],
4	Sciences	NNP	ORGANIZATION	Sciences	nn	5	SENT_30	[p3l714t25r976b78],
5	Research	NNP	ORGANIZATION	Research	prep_of	1	SENT_30	[p3l1005t24r1298b87],
6	,	,	O	,	_	0	SENT_30	[p3l1005t24r1298b87],
7	Division	NNP	O	Division	appos	5	SENT_30	[p3l1329t24r1589b78],
8	of	IN	O	of	_	0	SENT_30	[p3l1618t24r1683b78],
9	Biostatistics	NNPS	O	Biostatistics	prep_of	7	SENT_30	[p3l8t112r378b166],
10	and	CC	O	and	_	0	SENT_30	[p3l402t113r509b166],
11	Informatics	NNPS	O	Informatics	prep_of	7	SENT_30	[p3l529t112r895b176],
12	,	,	O	,	_	0	SENT_30	[p3l529t112r895b176],
13	Mayo	NNP	ORGANIZATION	Mayo	nn	14	SENT_30	[p3l919t114r1093b181],
14	Clinic	NNP	ORGANIZATION	Clinic	dep	1	SENT_30	[p3l1117t112r1316b175],
15	,	,	O	,	_	0	SENT_30	[p3l1117t112r1316b175],
16	Rochester	NNP	LOCATION	Rochester	appos	14	SENT_30	[p3l1340t113r1659b175],
17	,	,	O	,	_	0	SENT_30	[p3l1340t113r1659b175],
18	MN	NN	O	mn	appos	14	SENT_30	[p3l1684t114r1820b175],
19	,	,	O	,	_	0	SENT_30	[p3l1684t114r1820b175],
20	USA	NNP	LOCATION	USA	appos	14	SENT_30	[p3l1843t113r1993b166],

1	H.	NNP	PERSON	H.	nn	3	SENT_31	[p3l8t293r76b345],
2	L.	NNP	PERSON	L.	nn	3	SENT_31	[p3l107t293r167b345],
3	McLeod	NNP	PERSON	McLeod	_	0	SENT_31	[p3l198t292r455b345],
4	-	:	O	-	_	0	SENT_31	[p3l488t320r496b329],
5	L.	NNP	PERSON	L.	dep	7	SENT_31	[p3l528t293r588b345],
6	A.	NNP	PERSON	A.	nn	7	SENT_31	[p3l619t292r687b345],
7	Carey	NNP	PERSON	Carey	dep	3	SENT_31	[p3l719t292r898b360],
8	-	:	O	-	_	0	SENT_31	[p3l931t320r940b329],
9	E.	NNP	ORGANIZATION	E.	nn	12	SENT_31	[p3l972t293r1032b345],
10	C.	NNP	ORGANIZATION	C.	nn	12	SENT_31	[p3l1064t292r1127b345],
11	Dees	NNP	ORGANIZATION	Dees	nn	12	SENT_31	[p3l1158t293r1307b345],
12	Department	NNP	ORGANIZATION	Department	dep	37	SENT_31	[p3l8t380r367b448],
13	of	IN	ORGANIZATION	of	_	0	SENT_31	[p3l395t379r461b432],
14	Medicine	NNP	ORGANIZATION	Medicine	prep_of	12	SENT_31	[p3l482t379r785b442],
15	,	,	O	,	_	0	SENT_31	[p3l482t379r785b442],
16	Division	NNP	O	Division	appos	12	SENT_31	[p3l816t379r1076b432],
17	of	IN	O	of	_	0	SENT_31	[p3l1105t379r1171b432],
18	Hematology-Oncology	NNP	O	Hematology-Oncology	prep_of	16	SENT_31	[p3l1193t379r1910b448],
19	,	,	O	,	_	0	SENT_31	[p3l1193t379r1910b448],
20	School	NNP	ORGANIZATION	School	appos	12	SENT_31	[p3l10t467r217b521],
21	of	IN	ORGANIZATION	of	_	0	SENT_31	[p3l239t467r305b520],
22	Medicine	NNP	ORGANIZATION	Medicine	prep_of	20	SENT_31	[p3l320t467r623b530],
23	,	,	O	,	_	0	SENT_31	[p3l320t467r623b530],
24	University	NNP	ORGANIZATION	University	appos	12	SENT_31	[p3l647t467r966b536],
25	of	IN	ORGANIZATION	of	_	0	SENT_31	[p3l988t467r1054b520],
26	North	NNP	ORGANIZATION	North	nn	27	SENT_31	[p3l1069t467r1245b520],
27	Carolina	NNP	ORGANIZATION	Carolina	prep_of	24	SENT_31	[p3l1267t467r1528b521],
28	at	IN	O	at	_	0	SENT_31	[p3l1549t475r1602b520],
29	Chapel	NN	LOCATION	chapel	nn	30	SENT_31	[p3l1623t467r1836b536],
30	Hill	NNP	LOCATION	Hill	prep_at	27	SENT_31	[p3l1857t467r1990b530],
31	,	,	O	,	_	0	SENT_31	[p3l1857t467r1990b530],
32	Chapel	NN	LOCATION	chapel	nn	35	SENT_31	[p3l9t556r222b624],
33	Hill	NNP	LOCATION	Hill	nn	35	SENT_31	[p3l250t555r383b618],
34	,	,	O	,	_	0	SENT_31	[p3l250t555r383b618],
35	NC	NNP	O	NC	appos	12	SENT_31	[p3l412t556r532b618],
36	,	,	O	,	_	0	SENT_31	[p3l412t556r532b618],
37	USA	NNP	LOCATION	USA	parataxis	7	SENT_31	[p3l563t556r712b609],

1	@	SYM	O	@	dep	5	SENT_32	[p3l1777t786r1855b881],
2	Springer	NN	PERSON	springer	nn	5	SENT_32	[p3l1884t809r2146b884],
3	402	CD	NUMBER	402	num	5	SENT_32	[p3l52t959r104b984],
4	Breast	NN	ORGANIZATION	breast	nn	5	SENT_32	[p3l1450t959r1540b984],
5	Cancer	NN	ORGANIZATION	cancer	dep	9	SENT_32	[p3l1552t959r1652b984],
6	Res	NNP	ORGANIZATION	Res	nn	7	SENT_32	[p3l1664t959r1716b984],
7	Treat	NNP	ORGANIZATION	Treat	dep	5	SENT_32	[p3l1729t959r1804b984],
8	(	CD	NUMBER	(	num	9	SENT_32	[p3l1817t959r1908b989],
9	2012	CD	DATE	2012	dep	15	SENT_32	[p3l1817t959r1908b989],
10	)	CD	NUMBER	)	num	11	SENT_32	[p3l1817t959r1908b989],
11	l34	NN	O	l34	dep	9	SENT_32	[p3l1925t959r2107b984],
12	:40	CD	NUMBER	:40	num	13	SENT_32	[p3l1925t959r2107b984],
13	l	NN	O	l	tmod	11	SENT_32	[p3l1925t959r2107b984],
14	—	CD	NUMBER	—	num	15	SENT_32	[p3l1925t959r2107b984],
15	4l0	NN	O	4l0	_	0	SENT_32	[p3l1925t959r2107b984],

1	treatment	NN	O	treatment	nsubj	6	SENT_33	[p3l7t1134r362b1199],
2	,	,	O	,	_	0	SENT_33	[p3l7t1134r362b1199],
3	but	CC	O	but	advmod	6	SENT_33	[p3l390t1125r505b1188],
4	may	MD	O	may	aux	6	SENT_33	[p3l529t1145r681b1206],
5	also	RB	O	also	advmod	6	SENT_33	[p3l709t1125r848b1188],
6	be	VB	O	be	_	0	SENT_33	[p3l874t1125r957b1188],
7	at	IN	O	at	_	0	SENT_33	[p3l986t1134r1048b1188],
8	increased	VBN	O	increase	amod	9	SENT_33	[p3l1073t1125r1409b1188],
9	risk	NN	O	risk	prep_at	6	SENT_33	[p3l1432t1125r1567b1188],
10	of	IN	O	of	_	0	SENT_33	[p3l1592t1125r1669b1188],
11	experiencing	VBG	O	experience	prepc_of	9	SENT_33	[p3l1690t1125r2147b1206],
12	severe	JJ	O	severe	amod	14	SENT_33	[p3l10t1256r232b1299],
13	peripheral	JJ	O	peripheral	amod	14	SENT_33	[p3l258t1236r617b1317],
14	neurotoxicity	NN	O	neurotoxicity	dobj	11	SENT_33	[p3l644t1236r1136b1317],
15	.	.	O	.	_	0	SENT_33	[p3l644t1236r1136b1317],

1	Keywords	NNPS	O	Keywords	_	0	SENT_34	[p3l8t1460r393b1539],
2	Paclitaxel	NN	O	paclitaxel	dep	1	SENT_34	[p3l486t1459r840b1522],
3	-	:	O	-	_	0	SENT_34	[p3l879t1493r889b1503],
4	CYP2C8	NN	O	cyp2c8	dep	1	SENT_34	[p3l928t1460r1333b1522],
5	*	CD	NUMBER	*	num	4	SENT_34	[p3l928t1460r1333b1522],
6	3	LS	NUMBER	3	dep	4	SENT_34	[p3l928t1460r1333b1522],
7	-	:	O	-	_	0	SENT_34	[p3l1377t1493r1387b1503],
8	Pharmacogenetics	NNS	O	pharmacogenetic	dep	4	SENT_34	[p3l1425t1459r2076b1540],
9	Neoadjuvant	JJ	O	neoadjuvant	amod	12	SENT_34	[p3l2117t1493r2126b1503, p3l7t1562r466b1643],
10	breast	NN	O	breast	nn	12	SENT_34	[p3l496t1562r711b1625],
11	cancer	NN	O	cancer	nn	12	SENT_34	[p3l743t1582r978b1625],
12	therapy	NN	O	therapy	dep	8	SENT_34	[p3l1008t1562r1275b1643],
13	-	:	O	-	_	0	SENT_34	[p3l1315t1596r1325b1606],
14	Clinical	JJ	O	clinical	amod	16	SENT_34	[p3l1364t1562r1646b1625],
15	complete	JJ	O	complete	amod	16	SENT_34	[p3l1680t1562r2007b1643],
16	response	NN	O	response	dep	4	SENT_34	[p3l6t1684r318b1744],

1	Introduction	NN	O	introduction	_	0	SENT_35	[p3l7t1906r493b1970],

1	Interpatient	JJ	O	interpatient	amod	2	SENT_36	[p3l7t2130r422b2211],
2	variability	NN	O	variability	nsubj	9	SENT_36	[p3l499t2130r867b2211],
3	in	IN	O	in	_	0	SENT_36	[p3l947t2130r1014b2192],
4	toxicity	NN	O	toxicity	prep_in	2	SENT_36	[p3l1092t2130r1365b2211],
5	and	CC	O	and	_	0	SENT_36	[p3l1446t2130r1572b2193],
6	response	NN	O	response	prep_in	2	SENT_36	[p3l1649t2150r1961b2211],
7	are	VBP	O	be	cop	9	SENT_36	[p3l2042t2150r2147b2193],
8	important	JJ	O	important	amod	9	SENT_36	[p3l7t2241r356b2322],
9	problems	NNS	O	problem	_	0	SENT_36	[p3l381t2241r713b2322],
10	in	IN	O	in	_	0	SENT_36	[p3l740t2241r808b2303],
11	the	DT	O	the	det	12	SENT_36	[p3l833t2241r940b2304],
12	use	NN	O	use	prep_in	9	SENT_36	[p3l967t2261r1084b2304],
13	of	IN	O	of	_	0	SENT_36	[p3l1113t2241r1190b2304],
14	cancer	NN	O	cancer	nn	15	SENT_36	[p3l1210t2261r1445b2304],
15	chemotherapy	NN	O	chemotherapy	prep_of	12	SENT_36	[p3l1470t2241r1995b2322],
16	.	.	O	.	_	0	SENT_36	[p3l1470t2241r1995b2322],

1	For	IN	O	for	_	0	SENT_37	[p3l2025t2243r2149b2304],
2	example	NN	O	example	prep_for	20	SENT_37	[p3l8t2352r330b2433],
3	,	,	O	,	_	0	SENT_37	[p3l8t2352r330b2433],
4	paclitaxel	NN	O	paclitaxel	nsubj	20	SENT_37	[p3l392t2352r761b2433],
5	,	,	O	,	_	0	SENT_37	[p3l392t2352r761b2433],
6	one	CD	NUMBER	one	appos	4	SENT_37	[p3l825t2371r950b2414],
7	of	IN	O	of	_	0	SENT_37	[p3l1012t2352r1089b2414],
8	the	DT	O	the	det	12	SENT_37	[p3l1143t2352r1250b2414],
9	most	RBS	O	most	advmod	11	SENT_37	[p3l1311t2361r1484b2414],
10	commonly	RB	O	commonly	advmod	11	SENT_37	[p3l1544t2352r1925b2433],
11	used	VBN	O	use	amod	12	SENT_37	[p3l1985t2352r2148b2414],
12	therapies	NNS	O	therapy	prep_of	6	SENT_37	[p3l7t2463r329b2544],
13	for	IN	O	for	_	0	SENT_37	[p3l365t2463r468b2525],
14	breast	NN	O	breast	nn	15	SENT_37	[p3l499t2463r715b2525],
15	cancer	NN	O	cancer	prep_for	12	SENT_37	[p3l749t2482r983b2525],
16	and	CC	O	and	_	0	SENT_37	[p3l1017t2463r1143b2525],
17	other	JJ	O	other	amod	18	SENT_37	[p3l1178t2463r1361b2525],
18	cancers	NNS	O	cancer	conj_and	15	SENT_37	[p3l1395t2482r1681b2537],
19	,	,	O	,	_	0	SENT_37	[p3l1395t2482r1681b2537],
20	has	VBZ	O	have	_	0	SENT_37	[p3l1718t2463r1833b2525],
21	interpa	NN	O	interpa	nn	22	SENT_37	[p3l1870t2463r2144b2544],
22	—	NN	O	—	dobj	20	SENT_37	[p3l1870t2463r2144b2544],
23	tient	JJ	O	tient	amod	24	SENT_37	[p3l7t2574r167b2637],
24	variability	NN	O	variability	nsubj	38	SENT_37	[p3l205t2574r573b2655],
25	of	IN	O	of	_	0	SENT_37	[p3l614t2574r691b2637],
26	19-26	CD	PERCENT	19-26	num	27	SENT_37	[p3l733t2574r945b2638],
27	%	NN	PERCENT	%	prep_of	24	SENT_37	[p3l982t2575r1046b2637],
28	in	IN	O	in	_	0	SENT_37	[p3l1090t2574r1158b2636],
29	(	NN	O	(	prep_in	27	SENT_37	[p3l1199t2574r1566b2652],
30	unbound	JJ	O	unbound	amod	34	SENT_37	[p3l1199t2574r1566b2652],
31	)	NN	O	)	nn	34	SENT_37	[p3l1199t2574r1566b2652],
32	drug	NN	O	drug	nn	34	SENT_37	[p3l1608t2574r1768b2655],
33	clearance	NN	O	clearance	nn	34	SENT_37	[p3l1809t2574r2146b2637],
34	[	NN	O	[	dep	24	SENT_37	[p3l13t2686r129b2761],
35	1	CD	NUMBER	1	num	36	SENT_37	[p3l13t2686r129b2761],
36	]	NN	O	]	dep	34	SENT_37	[p3l13t2686r129b2761],
37	,	,	O	,	_	0	SENT_37	[p3l13t2686r129b2761],
38	causes	VBZ	O	cause	rcmod	22	SENT_37	[p3l158t2705r387b2748],
39	grade	NN	O	grade	dobj	38	SENT_37	[p3l415t2685r610b2766],
40	3	CD	NUMBER	3	num	39	SENT_37	[p3l639t2686r674b2748],
41	or	CC	O	or	_	0	SENT_37	[p3l705t2705r777b2748],
42	higher	JJR	O	higher	amod	43	SENT_37	[p3l800t2685r1030b2766],
43	neuropathy	NN	O	neuropathy	conj_or	39	SENT_37	[p3l1053t2685r1454b2766],
44	and	CC	O	and	_	0	SENT_37	[p3l1482t2685r1608b2748],
45	neutropenia	NN	O	neutropenia	conj_and	43	SENT_37	[p3l1632t2685r2056b2766],
46	in	IN	O	in	_	0	SENT_37	[p3l2080t2685r2148b2747],
47	5-8	CD	PERCENT	5-8	num	48	SENT_37	[p3l9t2796r136b2859],
48	%	NN	PERCENT	%	prep_in	39	SENT_37	[p3l175t2797r240b2859],
49	and	CC	O	and	_	0	SENT_37	[p3l304t2796r430b2859],
50	2-4	CD	PERCENT	2-4	num	51	SENT_37	[p3l489t2797r619b2858],
51	%	NN	PERCENT	%	prep_in	39	SENT_37	[p3l656t2797r720b2859],
52	of	IN	O	of	_	0	SENT_37	[p3l784t2796r861b2859],
53	patients	NNS	O	patient	prep_of	51	SENT_37	[p3l912t2796r1210b2877],
54	,	,	O	,	_	0	SENT_37	[p3l912t2796r1210b2877],
55	respectively	RB	O	respectively	advmod	39	SENT_37	[p3l1271t2796r1705b2877],
56	[	CD	NUMBER	[	number	57	SENT_37	[p3l1770t2797r1859b2872],
57	2	CD	NUMBER	2	num	58	SENT_37	[p3l1770t2797r1859b2872],
58	]	NN	O	]	dep	39	SENT_37	[p3l1770t2797r1859b2872],
59	and	CC	O	and	_	0	SENT_37	[p3l1926t2796r2052b2859],
60	a	DT	O	a	det	62	SENT_37	[p3l2112t2816r2149b2859],
61	response	NN	O	response	nn	62	SENT_37	[p3l6t2925r318b2987],
62	rate	NN	O	rate	dep	39	SENT_37	[p3l353t2915r487b2968],
63	as	IN	O	as	_	0	SENT_37	[p3l525t2925r594b2968],
64	ﬁrst	NN	O	ﬁrst	nn	65	SENT_37	[p3l631t2906r768b2968],
65	line	NN	O	line	prep_as	62	SENT_37	[p3l803t2906r954b2979],
66	,	,	O	,	_	0	SENT_37	[p3l803t2906r954b2979],
67	single	JJ	O	single	amod	70	SENT_37	[p3l997t2906r1432b2987],
68	—	JJ	O	—	amod	70	SENT_37	[p3l997t2906r1432b2987],
69	agent	NN	O	agent	nn	70	SENT_37	[p3l997t2906r1432b2987],
70	treatment	NN	O	treatment	appos	39	SENT_37	[p3l1467t2915r1807b2968],
71	in	IN	O	in	_	0	SENT_37	[p3l1842t2906r1909b2967],
72	metastatic	JJ	O	metastatic	amod	74	SENT_37	[p3l1945t2915r2145b2968, p3l10t3018r193b3081],
73	breast	NN	O	breast	nn	74	SENT_37	[p3l228t3018r443b3081],
74	cancer	NN	O	cancer	prep_in	70	SENT_37	[p3l477t3038r710b3081],
75	of	IN	O	of	_	0	SENT_37	[p3l744t3018r821b3081],
76	20-30	CD	PERCENT	20-30	num	77	SENT_37	[p3l850t3019r1070b3081],
77	%	NN	PERCENT	%	prep_of	74	SENT_37	[p3l1107t3019r1171b3081],
78	[	CD	NUMBER	[	number	79	SENT_37	[p3l1216t3019r1329b3094],
79	3	CD	NUMBER	3	num	80	SENT_37	[p3l1216t3019r1329b3094],
80	]	NN	O	]	dep	70	SENT_37	[p3l1216t3019r1329b3094],
81	.	.	O	.	_	0	SENT_37	[p3l1216t3019r1329b3094],

1	Studying	VBG	O	study	csubj	25	SENT_38	[p3l1370t3018r1689b3099],
2	host	NN	O	host	nn	3	SENT_38	[p3l1723t3018r1872b3081],
3	factors	NNS	O	factor	nsubj	4	SENT_38	[p3l1905t3018r2146b3081],
4	responsible	JJ	O	responsible	xcomp	1	SENT_38	[p3l6t3129r413b3210],
5	for	IN	O	for	_	0	SENT_38	[p3l466t3129r570b3192],
6	the	DT	O	the	det	7	SENT_38	[p3l618t3129r725b3192],
7	variability	NN	O	variability	prep_for	4	SENT_38	[p3l777t3129r1146b3210],
8	in	IN	O	in	_	0	SENT_38	[p3l1197t3129r1264b3191],
9	chemotherapeutic	JJ	O	chemotherapeutic	amod	10	SENT_38	[p3l1316t3129r1952b3210],
10	outcomes	NNS	O	outcome	prep_in	7	SENT_38	[p3l2006t3139r2145b3192, p3l8t3259r233b3302],
11	and	CC	O	and	_	0	SENT_38	[p3l262t3240r388b3302],
12	developing	VBG	O	develop	conj_and	1	SENT_38	[p3l414t3240r810b3321],
13	strategies	NNS	O	strategy	dobj	12	SENT_38	[p3l840t3240r1173b3321],
14	to	TO	O	to	aux	15	SENT_38	[p3l1199t3249r1266b3302],
15	individualize	VB	O	individualize	xcomp	12	SENT_38	[p3l1293t3240r1760b3302],
16	therapy	NN	O	therapy	dobj	15	SENT_38	[p3l1787t3240r2054b3321],
17	to	TO	O	to	aux	18	SENT_38	[p3l2080t3249r2146b3302],
18	maximize	VB	O	maximize	xcomp	15	SENT_38	[p3l7t3351r360b3413],
19	response	NN	O	response	dobj	18	SENT_38	[p3l393t3370r705b3432],
20	and	CC	O	and	_	0	SENT_38	[p3l741t3351r867b3413],
21	minimize	VB	O	minimize	conj_and	18	SENT_38	[p3l899t3351r1237b3413],
22	toxicity	NN	O	toxicity	dobj	21	SENT_38	[p3l1271t3351r1544b3432],
23	are	VBP	O	be	cop	25	SENT_38	[p3l1579t3370r1684b3413],
24	active	JJ	O	active	amod	25	SENT_38	[p3l1720t3351r1931b3414],
25	areas	NNS	O	area	_	0	SENT_38	[p3l1967t3370r2145b3413],
26	of	IN	O	of	_	0	SENT_38	[p3l8t3462r85b3524],
27	research	NN	O	research	prep_of	25	SENT_38	[p3l116t3462r432b3524],
28	.	.	O	.	_	0	SENT_38	[p3l116t3462r432b3524],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	nsubj	17	SENT_39	[p3l474t3462r1196b3543],
2	,	,	O	,	_	0	SENT_39	[p3l474t3462r1196b3543],
3	study	NN	O	study	appos	1	SENT_39	[p3l1239t3462r1428b3543],
4	of	IN	O	of	_	0	SENT_39	[p3l1467t3462r1544b3524],
5	the	DT	O	the	det	6	SENT_39	[p3l1575t3462r1682b3524],
6	interplay	NN	O	interplay	prep_of	3	SENT_39	[p3l1720t3462r2037b3543],
7	of	IN	O	of	_	0	SENT_39	[p3l2076t3462r2153b3524],
8	genetics	NNS	O	genetics	prep_of	6	SENT_39	[p3l8t3573r299b3654],
9	and	CC	O	and	_	0	SENT_39	[p3l356t3573r482b3636],
10	drug	NN	O	drug	nn	12	SENT_39	[p3l537t3573r697b3654],
11	therapy	NN	O	therapy	nn	12	SENT_39	[p3l751t3573r1018b3654],
12	outcomes	NNS	O	outcome	prep_of	6	SENT_39	[p3l1075t3583r1435b3647],
13	,	,	O	,	_	0	SENT_39	[p3l1075t3583r1435b3647],
14	is	VBZ	O	be	cop	17	SENT_39	[p3l1493t3573r1548b3636],
15	one	CD	NUMBER	one	num	17	SENT_39	[p3l1605t3593r1730b3636],
16	promising	JJ	O	promising	amod	17	SENT_39	[p3l1784t3573r2146b3654],
17	approach	NN	O	approach	_	0	SENT_39	[p3l9t3684r335b3765],
18	to	TO	O	to	_	0	SENT_39	[p3l370t3694r437b3747],
19	achieving	VBG	O	achieve	prepc_to	17	SENT_39	[p3l475t3684r820b3765],
20	individualized	JJ	O	individualized	amod	24	SENT_39	[p3l857t3684r1372b3747],
21	therapy	NN	O	therapy	nn	24	SENT_39	[p3l1406t3684r1673b3765],
22	[	NN	O	[	nn	24	SENT_39	[p3l1716t3685r1829b3760],
23	4	CD	NUMBER	4	num	24	SENT_39	[p3l1716t3685r1829b3760],
24	]	NN	O	]	dobj	19	SENT_39	[p3l1716t3685r1829b3760],
25	.	.	O	.	_	0	SENT_39	[p3l1716t3685r1829b3760],

1	Genetic	JJ	O	genetic	amod	2	SENT_40	[p3l1871t3684r2145b3747],
2	variation	NN	O	variation	nsubj	4	SENT_40	[p4l8t22r325b85],
3	can	MD	O	can	aux	4	SENT_40	[p4l373t42r495b85],
4	inﬂuence	VB	O	inﬂuence	_	0	SENT_40	[p4l541t22r868b85],
5	therapy	NN	O	therapy	dobj	4	SENT_40	[p4l915t22r1182b103],
6	by	IN	O	by	_	0	SENT_40	[p4l1228t22r1316b103],
7	a	DT	O	a	det	8	SENT_40	[p4l1365t42r1402b85],
8	number	NN	O	number	prep_by	4	SENT_40	[p4l1447t22r1721b85],
9	of	IN	O	of	_	0	SENT_40	[p4l1767t22r1844b85],
10	mechanisms	NNS	O	mechanism	prep_of	8	SENT_40	[p4l1884t22r2144b85, p4l7t132r232b194],
11	.	.	O	.	_	0	SENT_40	[p4l1884t22r2144b85, p4l7t132r232b194],

1	Variants	NNS	O	variant	nsubj	11	SENT_41	[p4l281t132r581b194],
2	in	IN	O	in	_	0	SENT_41	[p4l628t132r696b194],
3	genes	NNS	O	gene	prep_in	1	SENT_41	[p4l741t151r940b213],
4	relevant	JJ	O	relevant	amod	3	SENT_41	[p4l986t132r1276b194],
5	to	TO	O	to	_	0	SENT_41	[p4l1320t141r1386b194],
6	drug	NN	O	drug	nn	7	SENT_41	[p4l1433t132r1593b213],
7	disposition	NN	O	disposition	prep_to	4	SENT_41	[p4l1639t131r2031b213],
8	or	CC	O	or	_	0	SENT_41	[p4l2076t151r2149b194],
9	metabolism	NN	O	metabolism	conj_or	7	SENT_41	[p4l7t244r426b307],
10	can	MD	O	can	aux	11	SENT_41	[p4l477t264r599b307],
11	modulate	VB	O	modulate	_	0	SENT_41	[p4l649t244r982b307],
12	the	DT	O	the	det	13	SENT_41	[p4l1033t244r1140b307],
13	patient	NN	O	patient	poss	15	SENT_41	[p4l1190t244r1497b325],
14	’s	POS	O	’s	_	0	SENT_41	[p4l1190t244r1497b325],
15	exposure	NN	O	exposure	dobj	11	SENT_41	[p4l1550t264r1870b325],
16	to	TO	O	to	_	0	SENT_41	[p4l1922t254r1988b307],
17	the	DT	O	the	det	18	SENT_41	[p4l2040t244r2147b307],
18	drug	NN	O	drug	prep_to	11	SENT_41	[p4l8t355r188b436],
19	,	,	O	,	_	0	SENT_41	[p4l8t355r188b436],
20	whereas	IN	O	whereas	mark	31	SENT_41	[p4l224t355r515b418],
21	variation	NN	O	variation	nsubj	31	SENT_41	[p4l549t355r867b418],
22	in	IN	O	in	_	0	SENT_41	[p4l900t355r967b417],
23	genes	NNS	O	gene	prep_in	21	SENT_41	[p4l1001t375r1200b436],
24	that	WDT	O	that	nsubjpass	26	SENT_41	[p4l1234t355r1368b418],
25	are	VBP	O	be	auxpass	26	SENT_41	[p4l1402t375r1507b418],
26	involved	VBN	O	involve	rcmod	23	SENT_41	[p4l1541t355r1853b418],
27	in	IN	O	in	_	0	SENT_41	[p4l1885t355r1953b417],
28	drug	NN	O	drug	nn	29	SENT_41	[p4l1986t355r2146b436],
29	action	NN	O	action	prep_in	26	SENT_41	[p4l9t466r225b528],
30	can	MD	O	can	aux	31	SENT_41	[p4l258t485r380b528],
31	inﬂuence	VB	O	inﬂuence	advcl	11	SENT_41	[p4l411t466r737b528],
32	the	DT	O	the	det	33	SENT_41	[p4l769t466r876b528],
33	patient	NN	O	patient	poss	35	SENT_41	[p4l907t466r1214b547],
34	’s	POS	O	’s	_	0	SENT_41	[p4l907t466r1214b547],
35	sensitivity	NN	O	sensitivity	dobj	31	SENT_41	[p4l1250t466r1633b547],
36	.	.	O	.	_	0	SENT_41	[p4l1250t466r1633b547],

1	For	IN	O	for	_	0	SENT_42	[p4l1669t467r1792b528],
2	example	NN	O	example	prep_for	9	SENT_42	[p4l1822t466r2144b547],
3	,	,	O	,	_	0	SENT_42	[p4l1822t466r2144b547],
4	germline	NN	O	germline	nn	6	SENT_42	[p4l8t577r325b658],
5	genetic	JJ	O	genetic	amod	6	SENT_42	[p4l352t577r607b658],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	9	SENT_42	[p4l633t577r1189b658],
7	have	VBP	O	have	aux	9	SENT_42	[p4l1216t577r1383b639],
8	been	VBN	O	be	auxpass	9	SENT_42	[p4l1408t577r1576b639],
9	discovered	VBN	O	discover	_	0	SENT_42	[p4l1603t577r1990b640],
10	that	IN	O	that	_	0	SENT_42	[p4l2014t577r2149b639],
11	increase	NN	O	increase	prep_that	9	SENT_42	[p4l7t688r300b750],
12	the	DT	O	the	det	13	SENT_42	[p4l347t688r454b750],
13	likelihood	NN	O	likelihood	tmod	9	SENT_42	[p4l504t688r867b750],
14	of	IN	O	of	_	0	SENT_42	[p4l915t688r992b750],
15	a	DT	O	a	det	16	SENT_42	[p4l1035t707r1072b750],
16	patient	NN	O	patient	prep_of	13	SENT_42	[p4l1117t688r1363b769],
17	experiencing	VBG	O	experience	xcomp	9	SENT_42	[p4l1410t688r1871b769],
18	severe	JJ	O	severe	amod	19	SENT_42	[p4l1923t707r2146b751],
19	toxicity	NN	O	toxicity	dobj	17	SENT_42	[p4l7t799r279b880],
20	to	TO	O	to	_	0	SENT_42	[p4l305t808r372b862],
21	irinotecan	JJ	O	irinotecan	amod	22	SENT_42	[p4l399t799r757b862],
22	[	NN	O	[	prep_to	17	SENT_42	[p4l789t799r874b875],
23	5	CD	NUMBER	5	num	22	SENT_42	[p4l789t799r874b875],
24	,	,	O	,	_	0	SENT_42	[p4l789t799r874b875],
25	6	CD	NUMBER	6	num	26	SENT_42	[p4l904t799r969b875],
26	]	NN	O	]	appos	22	SENT_42	[p4l904t799r969b875],
27	or	CC	O	or	_	0	SENT_42	[p4l1001t819r1074b862],
28	modulate	VB	O	modulate	conj_or	9	SENT_42	[p4l1098t799r1430b862],
29	the	DT	O	the	det	31	SENT_42	[p4l1456t799r1563b862],
30	optimal	JJ	O	optimal	amod	31	SENT_42	[p4l1591t799r1862b880],
31	dose	NN	O	dose	dobj	28	SENT_42	[p4l1889t799r2049b862],
32	of	IN	O	of	_	0	SENT_42	[p4l2076t799r2153b862],
33	a	DT	O	a	det	34	SENT_42	[p4l9t930r46b973],
34	patient	NN	O	patient	poss	40	SENT_42	[p4l76t910r384b991],
35	’s	POS	O	’s	_	0	SENT_42	[p4l76t910r384b991],
36	warfarin	NN	O	warfarin	nn	40	SENT_42	[p4l418t910r721b973],
37	therapy	NN	O	therapy	nn	40	SENT_42	[p4l752t910r1020b991],
38	[	NN	O	[	nn	40	SENT_42	[p4l1060t912r1174b986],
39	7	CD	NUMBER	7	num	40	SENT_42	[p4l1060t912r1174b986],
40	]	NN	O	]	prep_of	31	SENT_42	[p4l1060t912r1174b986],
41	.	.	O	.	_	0	SENT_42	[p4l1060t912r1174b986],

1	A	DT	O	a	det	2	SENT_43	[p4l109t1022r172b1083],
2	number	NN	O	number	conj_and	2	SENT_43	[p4l228t1021r502b1084],
3	of	IN	O	of	_	0	SENT_43	[p4l558t1021r635b1084],
4	putative	JJ	O	putative	amod	6	SENT_43	[p4l685t1021r973b1102],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_43	[p4l1030t1021r1643b1102],
6	markers	NNS	O	marker	prep_of	2	SENT_43	[p4l1701t1021r1987b1084],
7	for	IN	O	for	_	0	SENT_43	[p4l2046t1021r2149b1084],
8	paclitaxel	NN	O	paclitaxel	nn	9	SENT_43	[p4l6t1130r356b1212],
9	outcomes	NNS	O	outcome	prep_for	2	SENT_43	[p4l403t1140r763b1204],
10	,	,	O	,	_	0	SENT_43	[p4l403t1140r763b1204],
11	in	IN	O	in	_	0	SENT_43	[p4l813t1131r880b1192],
12	breast	NN	O	breast	nn	13	SENT_43	[p4l924t1131r1138b1193],
13	cancer	NN	O	cancer	prep_in	2	SENT_43	[p4l1184t1150r1418b1193],
14	and	CC	O	and	_	0	SENT_43	[p4l1463t1131r1589b1193],
15	in	IN	O	in	_	0	SENT_43	[p4l1635t1131r1702b1192],
16	other	JJ	O	other	amod	18	SENT_43	[p4l1748t1131r1932b1193],
17	solid	JJ	O	solid	amod	18	SENT_43	[p4l1978t1131r2148b1193],
18	tumors	NNS	O	tumor	prep_in	2	SENT_43	[p4l7t1253r274b1318],
19	,	,	O	,	_	0	SENT_43	[p4l7t1253r274b1318],
20	have	VBP	O	have	aux	22	SENT_43	[p4l307t1243r475b1306],
21	been	VBN	O	be	auxpass	22	SENT_43	[p4l506t1243r675b1306],
22	evaluated	VBN	O	evaluate	_	0	SENT_43	[p4l706t1243r1050b1306],
23	[	CD	NUMBER	[	dobj	22	SENT_43	[p4l1087t1244r1335b1319],
24	8	CD	NUMBER	8	num	27	SENT_43	[p4l1087t1244r1335b1319],
25	—	NN	O	—	nn	27	SENT_43	[p4l1087t1244r1335b1319],
26	17	CD	NUMBER	17	num	27	SENT_43	[p4l1087t1244r1335b1319],
27	]	NN	O	]	nsubjpass	22	SENT_43	[p4l1087t1244r1335b1319],
28	.	.	O	.	_	0	SENT_43	[p4l1087t1244r1335b1319],

1	Most	JJS	O	most	nsubj	5	SENT_44	[p4l1370t1245r1553b1306],
2	of	IN	O	of	_	0	SENT_44	[p4l1585t1243r1662b1306],
3	these	DT	O	these	det	4	SENT_44	[p4l1686t1243r1869b1306],
4	studies	NNS	O	study	prep_of	1	SENT_44	[p4l1903t1243r2146b1306],
5	focused	VBD	O	focus	_	0	SENT_44	[p4l8t1355r285b1418],
6	on	IN	O	on	_	0	SENT_44	[p4l321t1375r407b1418],
7	known	JJ	O	known	amod	8	SENT_44	[p4l441t1355r683b1418],
8	mutations	NNS	O	mutation	prep_on	5	SENT_44	[p4l718t1355r1069b1418],
9	in	IN	O	in	_	0	SENT_44	[p4l1106t1355r1174b1417],
10	biologically	RB	O	biologically	advmod	11	SENT_44	[p4l1207t1355r1636b1436],
11	relevant	JJ	O	relevant	amod	13	SENT_44	[p4l1671t1355r1961b1418],
12	candidate	NN	O	candidate	nn	13	SENT_44	[p4l1996t1375r2145b1418, p4l8t1466r224b1528],
13	genes	NNS	O	gene	prep_in	8	SENT_44	[p4l274t1485r495b1547],
14	,	,	O	,	_	0	SENT_44	[p4l274t1485r495b1547],
15	such	JJ	O	such	_	0	SENT_44	[p4l549t1466r708b1528],
16	as	IN	O	as	_	0	SENT_44	[p4l758t1485r826b1528],
17	CYP2C8	NN	O	cyp2c8	nn	19	SENT_44	[p4l877t1466r1216b1540],
18	,	,	O	,	_	0	SENT_44	[p4l877t1466r1216b1540],
19	CYP3A4	NN	O	cyp3a4	prep_such_as	8	SENT_44	[p4l1268t1466r1612b1540],
20	,	,	O	,	_	0	SENT_44	[p4l1268t1466r1612b1540],
21	and	CC	O	and	_	0	SENT_44	[p4l1665t1466r1791b1528],
22	ABCB1	NN	O	abcb1	prep_such_as	8	SENT_44	[p4l1838t1466r2144b1540],
23	,	,	O	,	_	0	SENT_44	[p4l1838t1466r2144b1540],
24	which	WDT	O	which	nsubj	25	SENT_44	[p4l8t1577r224b1640],
25	code	VBP	O	code	rcmod	19	SENT_44	[p4l297t1577r463b1639],
26	for	IN	O	for	_	0	SENT_44	[p4l536t1577r640b1639],
27	the	DT	O	the	det	28	SENT_44	[p4l710t1577r817b1639],
28	enzymes	NNS	O	enzyme	prep_for	25	SENT_44	[p4l891t1596r1200b1658],
29	involved	VBN	O	involve	partmod	28	SENT_44	[p4l1274t1577r1587b1640],
30	in	IN	O	in	_	0	SENT_44	[p4l1659t1577r1727b1639],
31	paclitaxel	NN	O	paclitaxel	nn	32	SENT_44	[p4l1797t1577r2147b1658],
32	metabolism	NN	O	metabolism	prep_in	29	SENT_44	[p4l7t1688r426b1750],
33	and	CC	O	and	_	0	SENT_44	[p4l470t1688r596b1750],
34	the	DT	O	the	det	35	SENT_44	[p4l638t1688r745b1750],
35	transporters	NNS	O	transporter	prep_such_as	8	SENT_44	[p4l788t1697r1209b1769],
36	that	WDT	O	that	nsubj	37	SENT_44	[p4l1253t1688r1387b1750],
37	inﬂuence	VBP	O	inﬂuence	rcmod	35	SENT_44	[p4l1428t1688r1755b1750],
38	paclitaxel	NN	O	paclitaxel	nn	39	SENT_44	[p4l1797t1688r2147b1769],
39	disposition	NN	O	disposition	dobj	37	SENT_44	[p4l8t1799r417b1880],
40	.	.	O	.	_	0	SENT_44	[p4l8t1799r417b1880],

1	More	RBR	O	more	advmod	8	SENT_45	[p4l458t1801r649b1862],
2	recent	JJ	O	recent	amod	3	SENT_45	[p4l686t1809r907b1862],
3	genome	NN	O	genome	pobj	1	SENT_45	[p4l943t1799r1429b1880],
4	—	CD	NUMBER	—	num	7	SENT_45	[p4l943t1799r1429b1880],
5	wide	JJ	O	wide	amod	7	SENT_45	[p4l943t1799r1429b1880],
6	association	NN	O	association	nn	7	SENT_45	[p4l1468t1799r1864b1862],
7	studies	NNS	O	study	nsubj	8	SENT_45	[p4l1903t1799r2146b1862],
8	used	VBD	O	use	_	0	SENT_45	[p4l7t1910r170b1973],
9	an	DT	O	a	det	11	SENT_45	[p4l195t1930r276b1973],
10	unbiased	JJ	O	unbiased	amod	11	SENT_45	[p4l300t1910r618b1973],
11	approach	NN	O	approach	dobj	8	SENT_45	[p4l644t1910r970b1991],
12	to	TO	O	to	aux	13	SENT_45	[p4l994t1920r1060b1973],
13	examine	VB	O	examine	xcomp	8	SENT_45	[p4l1087t1910r1389b1973],
14	the	DT	O	the	det	16	SENT_45	[p4l1413t1910r1520b1973],
15	entire	JJ	O	entire	amod	16	SENT_45	[p4l1547t1910r1747b1973],
16	genome	NN	O	genome	dobj	13	SENT_45	[p4l1774t1930r2055b1991],
17	to	TO	O	to	aux	18	SENT_45	[p4l2080t1920r2146b1973],
18	address	VB	O	address	xcomp	13	SENT_45	[p4l9t2021r272b2084],
19	this	DT	O	this	det	20	SENT_45	[p4l310t2021r436b2084],
20	question	NN	O	question	dobj	18	SENT_45	[p4l475t2021r795b2102],
21	,	,	O	,	_	0	SENT_45	[p4l475t2021r795b2102],
22	and	CC	O	and	_	0	SENT_45	[p4l837t2021r963b2084],
23	have	VBP	O	have	aux	24	SENT_45	[p4l997t2021r1165b2084],
24	reported	VBN	O	report	conj_and	8	SENT_45	[p4l1201t2021r1501b2102],
25	intriguing	JJ	O	intriguing	amod	27	SENT_45	[p4l1536t2021r1887b2102],
26	candidate	NN	O	candidate	nn	27	SENT_45	[p4l1926t2021r2145b2084, p4l8t2131r154b2193],
27	SNPs	NNS	O	snp	dobj	24	SENT_45	[p4l198t2131r390b2194],
28	in	IN	O	in	_	0	SENT_45	[p4l432t2131r500b2192],
29	genes	NNS	O	gene	prep_in	24	SENT_45	[p4l541t2150r741b2212],
30	not	RB	O	not	neg	32	SENT_45	[p4l782t2140r896b2193],
31	previously	RB	DATE	previously	advmod	32	SENT_45	[p4l935t2131r1313b2212],
32	investigated	VBN	O	investigate	partmod	29	SENT_45	[p4l1354t2131r1788b2212],
33	[	NN	O	[	nsubj	24	SENT_45	[p4l1834t2131r1964b2206],
34	14	CD	NUMBER	14	num	33	SENT_45	[p4l1834t2131r1964b2206],
35	,	,	O	,	_	0	SENT_45	[p4l1834t2131r1964b2206],
36	15	CD	NUMBER	15	num	37	SENT_45	[p4l2017t2130r2143b2206],
37	]	NN	O	]	appos	33	SENT_45	[p4l2017t2130r2143b2206],
38	.	.	O	.	_	0	SENT_45	[p4l2017t2130r2143b2206],

1	The	DT	O	the	det	3	SENT_46	[p4l7t2243r144b2306],
2	clinical	JJ	O	clinical	amod	3	SENT_46	[p4l191t2243r454b2306],
3	phenotypes	NNS	O	phenotype	nsubj	9	SENT_46	[p4l499t2243r906b2324],
4	most	RBS	O	most	advmod	5	SENT_46	[p4l953t2253r1127b2306],
5	often	RB	O	often	advmod	6	SENT_46	[p4l1172t2243r1354b2306],
6	studied	VBN	O	study	partmod	3	SENT_46	[p4l1402t2243r1657b2306],
7	were	VBD	O	be	cop	9	SENT_46	[p4l1703t2263r1873b2306],
8	severe	JJ	O	severe	amod	9	SENT_46	[p4l1923t2263r2146b2306],
9	toxicities	NNS	O	toxicity	_	0	SENT_46	[p4l7t2354r355b2428],
10	,	,	O	,	_	0	SENT_46	[p4l7t2354r355b2428],
11	such	JJ	O	such	_	0	SENT_46	[p4l411t2354r569b2417],
12	as	IN	O	as	_	0	SENT_46	[p4l620t2374r689b2417],
13	neuropathy	NN	O	neuropathy	prep_such_as	9	SENT_46	[p4l740t2354r1162b2435],
14	,	,	O	,	_	0	SENT_46	[p4l740t2354r1162b2435],
15	or	CC	O	or	_	0	SENT_46	[p4l1215t2374r1288b2417],
16	measures	NNS	O	measure	conj_or	9	SENT_46	[p4l1335t2374r1665b2417],
17	of	IN	O	of	_	0	SENT_46	[p4l1718t2354r1795b2417],
18	survival	NN	O	survival	prep_of	16	SENT_46	[p4l1841t2354r2143b2417],
19	.	.	O	.	_	0	SENT_46	[p4l1841t2354r2143b2417],

1	Some	DT	O	some	nsubj	7	SENT_47	[p4l10t2465r208b2528],
2	of	IN	O	of	_	0	SENT_47	[p4l245t2465r322b2527],
3	these	DT	O	these	det	6	SENT_47	[p4l350t2465r532b2527],
4	retrospective	JJ	O	retrospective	amod	5	SENT_47	[p4l567t2465r1030b2546],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_47	[p4l1064t2465r1678b2546],
6	studies	NNS	O	study	prep_of	1	SENT_47	[p4l1717t2465r1960b2527],
7	suggest	VBP	O	suggest	_	0	SENT_47	[p4l1999t2484r2145b2546, p4l8t2585r151b2657],
8	that	IN	O	that	complm	13	SENT_47	[p4l176t2576r310b2638],
9	genetic	JJ	O	genetic	amod	10	SENT_47	[p4l337t2576r593b2657],
10	variability	NN	O	variability	nsubjpass	13	SENT_47	[p4l621t2576r989b2657],
11	may	MD	O	may	aux	13	SENT_47	[p4l1017t2595r1168b2657],
12	be	VB	O	be	auxpass	13	SENT_47	[p4l1195t2576r1278b2638],
13	associated	VBN	O	associate	ccomp	7	SENT_47	[p4l1307t2576r1674b2638],
14	with	IN	O	with	_	0	SENT_47	[p4l1700t2576r1857b2639],
15	clinical	JJ	O	clinical	amod	16	SENT_47	[p4l1884t2576r2147b2638],
16	outcome	NN	O	outcome	prep_with	13	SENT_47	[p4l8t2696r314b2749],
17	to	TO	O	to	_	0	SENT_47	[p4l342t2696r408b2749],
18	paclitaxel	NN	O	paclitaxel	nn	19	SENT_47	[p4l435t2687r784b2768],
19	therapy	NN	O	therapy	prep_to	13	SENT_47	[p4l810t2687r1097b2768],
20	,	,	O	,	_	0	SENT_47	[p4l810t2687r1097b2768],
21	and	CC	O	and	_	0	SENT_47	[p4l1129t2687r1255b2749],
22	others	NNS	O	other	nsubj	23	SENT_47	[p4l1281t2687r1496b2749],
23	do	VBP	O	do	conj_and	7	SENT_47	[p4l1525t2687r1610b2749],
24	not	RB	O	not	neg	23	SENT_47	[p4l1638t2696r1768b2749],
25	.	.	O	.	_	0	SENT_47	[p4l1638t2696r1768b2749],

1	However	RB	O	however	advmod	8	SENT_48	[p4l1799t2688r2144b2761],
2	,	,	O	,	_	0	SENT_48	[p4l1799t2688r2144b2761],
3	the	DT	O	the	det	5	SENT_48	[p4l7t2798r114b2861],
4	toxicity	NN	O	toxicity	nn	5	SENT_48	[p4l161t2798r434b2879],
5	endpoints	NNS	O	endpoint	nsubjpass	8	SENT_48	[p4l481t2798r826b2879],
6	are	VBP	O	be	auxpass	8	SENT_48	[p4l875t2818r980b2861],
7	often	RB	O	often	advmod	8	SENT_48	[p4l1029t2798r1210b2861],
8	confounded	VBN	O	confound	_	0	SENT_48	[p4l1257t2798r1679b2861],
9	by	IN	O	by	_	0	SENT_48	[p4l1723t2798r1811b2879],
10	prior	JJ	O	prior	amod	13	SENT_48	[p4l1856t2798r2031b2879],
11	or	CC	O	or	_	0	SENT_48	[p4l2076t2818r2149b2861],
12	combination	NN	O	combination	conj_or	10	SENT_48	[p4l8t2909r456b2972],
13	therapy	NN	O	therapy	agent	8	SENT_48	[p4l513t2909r799b2990],
14	,	,	O	,	_	0	SENT_48	[p4l513t2909r799b2990],
15	whereas	IN	O	whereas	mark	19	SENT_48	[p4l861t2909r1151b2972],
16	the	DT	O	the	det	18	SENT_48	[p4l1210t2909r1317b2972],
17	survival	NN	O	survival	nn	18	SENT_48	[p4l1378t2909r1662b2972],
18	endpoint	NN	O	endpoint	nsubj	19	SENT_48	[p4l1721t2909r2034b2990],
19	is	VBZ	O	be	dep	13	SENT_48	[p4l2090t2909r2146b2972],

1	@	IN	O	@	amod	2	SENT_49	[p4l6t3152r83b3247],
2	Springer	NNP	PERSON	Springer	nsubj	3	SENT_49	[p4l113t3175r375b3250],
3	confounded	VBN	O	confound	_	0	SENT_49	[p4l8t3277r430b3340],
4	by	IN	O	by	_	0	SENT_49	[p4l464t3277r551b3358],
5	a	DT	O	a	det	6	SENT_49	[p4l589t3297r626b3340],
6	multitude	NN	O	multitude	prep_by	3	SENT_49	[p4l660t3277r1003b3340],
7	of	IN	O	of	_	0	SENT_49	[p4l1040t3277r1117b3340],
8	factors	NNS	O	factor	prep_of	6	SENT_49	[p4l1147t3277r1387b3340],
9	including	VBG	O	include	_	0	SENT_49	[p4l1424t3277r1761b3358],
10	ER	NN	O	er	nn	11	SENT_49	[p4l1797t3279r1911b3339],
11	status	NN	O	status	prep_including	8	SENT_49	[p4l1948t3286r2146b3340],
12	or	CC	O	or	_	0	SENT_49	[p4l8t3408r81b3451],
13	tumor	NN	O	tumor	nn	14	SENT_49	[p4l113t3398r328b3451],
14	subtype	NN	O	subtype	prep_including	8	SENT_49	[p4l362t3388r636b3469],
15	[	CD	NUMBER	[	number	16	SENT_49	[p4l677t3389r811b3464],
16	18	CD	NUMBER	18	num	17	SENT_49	[p4l677t3389r811b3464],
17	]	NN	O	]	dep	14	SENT_49	[p4l677t3389r811b3464],
18	and	CC	O	and	_	0	SENT_49	[p4l853t3388r979b3451],
19	stage	NN	O	stage	conj_and	3	SENT_49	[p4l1016t3398r1194b3469],
20	at	IN	O	at	_	0	SENT_49	[p4l1231t3398r1293b3451],
21	diagnosis	NN	O	diagnosis	prep_at	19	SENT_49	[p4l1326t3388r1661b3469],
22	[	CD	NUMBER	[	number	23	SENT_49	[p4l1702t3389r1861b3464],
23	19	CD	NUMBER	19	num	24	SENT_49	[p4l1702t3389r1861b3464],
24	]	NN	O	]	dep	19	SENT_49	[p4l1702t3389r1861b3464],
25	.	.	O	.	_	0	SENT_49	[p4l1702t3389r1861b3464],

1	To	TO	O	to	_	0	SENT_50	[p4l1899t3390r1995b3451],
2	our	PRP$	O	we	poss	3	SENT_50	[p4l2032t3408r2149b3451],
3	knowledge	NN	O	knowledge	prep_to	11	SENT_50	[p4l6t3498r419b3579],
4	,	,	O	,	_	0	SENT_50	[p4l6t3498r419b3579],
5	no	DT	O	no	det	8	SENT_50	[p4l485t3517r572b3560],
6	published	VBN	O	publish	amod	8	SENT_50	[p4l635t3498r985b3579],
7	pharmacogenomic	JJ	O	pharmacogenomic	amod	8	SENT_50	[p4l1047t3498r1709b3579],
8	study	NN	O	study	nsubj	11	SENT_50	[p4l1778t3498r1966b3579],
9	has	VBZ	O	have	aux	11	SENT_50	[p4l2030t3498r2146b3560],
10	exclusively	RB	O	exclusively	advmod	11	SENT_50	[p4l8t3609r415b3690],
11	utilized	VBN	O	utilize	_	0	SENT_50	[p4l449t3609r719b3671],
12	a	DT	O	a	det	15	SENT_50	[p4l753t3628r790b3671],
13	neoadjuvantly	RB	O	neoadjuvantly	advmod	14	SENT_50	[p4l822t3609r1329b3690],
14	treated	VBN	O	treat	amod	15	SENT_50	[p4l1364t3609r1608b3671],
15	population	NN	O	population	dobj	11	SENT_50	[p4l1640t3609r2043b3690],
16	,	,	O	,	_	0	SENT_50	[p4l1640t3609r2043b3690],
17	in	IN	O	in	_	0	SENT_50	[p4l2080t3609r2148b3670],
18	which	WDT	O	which	rel	28	SENT_50	[p4l8t3720r224b3782],
19	toxicity	NN	O	toxicity	nn	22	SENT_50	[p4l249t3720r521b3801],
20	and	CC	O	and	_	0	SENT_50	[p4l547t3720r674b3782],
21	tumor	NN	O	tumor	conj_and	19	SENT_50	[p4l697t3729r911b3782],
22	response	NN	O	response	nsubjpass	28	SENT_50	[p4l932t3739r1244b3801],
23	to	TO	O	to	_	0	SENT_50	[p4l1269t3729r1336b3782],
24	paclitaxel	NN	O	paclitaxel	nn	25	SENT_50	[p4l1359t3720r1709b3801],
25	therapy	NN	O	therapy	prep_to	22	SENT_50	[p4l1733t3720r2000b3801],
26	can	MD	O	can	aux	28	SENT_50	[p4l2025t3739r2148b3782],
27	be	VB	O	be	auxpass	28	SENT_50	[p5l6t22r89b85],
28	assessed	VBN	O	assess	rcmod	15	SENT_50	[p5l124t22r424b85],
29	in	IN	O	in	_	0	SENT_50	[p5l456t22r524b84],
30	the	DT	O	the	det	31	SENT_50	[p5l556t22r663b85],
31	absence	NN	O	absence	prep_in	28	SENT_50	[p5l698t22r978b85],
32	of	IN	O	of	_	0	SENT_50	[p5l1013t22r1090b85],
33	these	DT	O	these	det	35	SENT_50	[p5l1116t22r1299b85],
34	confounding	JJ	O	confounding	amod	35	SENT_50	[p5l1333t22r1783b103],
35	factors	NNS	O	factor	prep_of	31	SENT_50	[p5l1817t22r2077b85],
36	.	.	O	.	_	0	SENT_50	[p5l1817t22r2077b85],

1	In	IN	O	in	_	0	SENT_51	[p5l109t135r182b195],
2	this	DT	O	this	det	3	SENT_51	[p5l214t133r340b196],
3	study	NN	O	study	prep_in	6	SENT_51	[p5l377t133r584b214],
4	,	,	O	,	_	0	SENT_51	[p5l377t133r584b214],
5	we	PRP	O	we	nsubj	6	SENT_51	[p5l620t153r721b196],
6	genotyped	VBD	O	genotype	_	0	SENT_51	[p5l756t133r1127b214],
7	a	DT	O	a	det	8	SENT_51	[p5l1161t153r1198b196],
8	cohort	NN	O	cohort	dobj	6	SENT_51	[p5l1230t133r1459b196],
9	of	IN	O	of	_	0	SENT_51	[p5l1491t133r1568b196],
10	patients	NNS	O	patient	prep_of	8	SENT_51	[p5l1593t133r1870b214],
11	treated	VBN	O	treat	partmod	10	SENT_51	[p5l1904t133r2148b196],
12	with	IN	O	with	_	0	SENT_51	[p5l8t244r165b307],
13	neoadjuvant	JJ	O	neoadjuvant	amod	14	SENT_51	[p5l203t244r643b325],
14	paclitaxel	NN	O	paclitaxel	prep_with	11	SENT_51	[p5l680t244r1030b325],
15	for	IN	O	for	_	0	SENT_51	[p5l1071t244r1174b306],
16	polymorphisms	NNS	O	polymorphism	prep_for	11	SENT_51	[p5l1210t244r1766b325],
17	that	WDT	O	that	nsubj	20	SENT_51	[p5l1807t244r1941b306],
18	have	VBP	O	have	aux	20	SENT_51	[p5l1979t244r2146b307],
19	previously	RB	DATE	previously	advmod	20	SENT_51	[p5l6t355r384b436],
20	demonstrated	VBN	O	demonstrate	rcmod	16	SENT_51	[p5l419t355r902b418],
21	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_51	[p5l939t355r1310b436],
22	associations	NNS	O	association	dobj	20	SENT_51	[p5l1344t355r1773b418],
23	with	IN	O	with	_	0	SENT_51	[p5l1809t355r1966b418],
24	efﬁ	NN	O	efﬁ	nn	25	SENT_51	[p5l2002t355r2145b418],
25	cacy	NN	O	cacy	prep_with	20	SENT_51	[p5l8t486r169b547],
26	or	CC	O	or	_	0	SENT_51	[p5l210t486r283b529],
27	toxicity	NN	O	toxicity	prep_with	20	SENT_51	[p5l319t466r611b547],
28	.	.	O	.	_	0	SENT_51	[p5l319t466r611b547],

1	These	DT	O	these	det	2	SENT_52	[p5l654t466r866b529],
2	subjects	NNS	O	subject	nsubj	5	SENT_52	[p5l909t466r1191b547],
3	are	VBP	O	be	cop	5	SENT_52	[p5l1233t486r1338b529],
4	uniquely	RB	O	uniquely	advmod	5	SENT_52	[p5l1377t466r1690b547],
5	informative	JJ	O	informative	_	0	SENT_52	[p5l1729t466r2147b529],
6	because	IN	O	because	mark	13	SENT_52	[p5l6t577r289b639],
7	tumor	NN	O	tumor	nn	8	SENT_52	[p5l331t586r545b639],
8	response	NN	O	response	nsubjpass	13	SENT_52	[p5l584t596r896b658],
9	and	CC	O	and	_	0	SENT_52	[p5l940t577r1066b639],
10	toxicity	NN	O	toxicity	nn	11	SENT_52	[p5l1106t577r1379b658],
11	data	NNS	O	datum	nsubjpass	13	SENT_52	[p5l1422t577r1570b639],
12	were	VBD	O	be	auxpass	13	SENT_52	[p5l1611t596r1782b640],
13	collected	VBN	O	collect	ccomp	5	SENT_52	[p5l1825t577r2149b639],
14	exclusively	RB	O	exclusively	advmod	13	SENT_52	[p5l8t687r415b768],
15	for	IN	O	for	_	0	SENT_52	[p5l456t687r560b749],
16	the	DT	O	the	det	19	SENT_52	[p5l599t687r706b749],
17	taxane	NN	O	taxane	nn	19	SENT_52	[p5l748t696r979b749],
18	treatment	NN	O	treatment	nn	19	SENT_52	[p5l1021t696r1362b749],
19	phase	NN	O	phase	prep_for	13	SENT_52	[p5l1400t687r1622b768],
20	.	.	O	.	_	0	SENT_52	[p5l1400t687r1622b768],

1	We	PRP	O	we	nsubj	2	SENT_53	[p5l1666t688r1788b749],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_53	[p5l1830t687r2144b768, p5l10t798r190b860],
3	that	IN	O	that	complm	12	SENT_53	[p5l232t798r366b860],
4	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_53	[p5l406t798r962b879],
5	in	IN	O	in	_	0	SENT_53	[p5l1005t798r1073b859],
6	genes	NNS	O	gene	prep_in	4	SENT_53	[p5l1115t817r1315b879],
7	relevant	JJ	O	relevant	amod	6	SENT_53	[p5l1358t798r1649b860],
8	to	TO	O	to	_	0	SENT_53	[p5l1689t807r1756b860],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_53	[p5l1797t798r2147b879],
10	metabolism	NN	O	metabolism	prep_to	7	SENT_53	[p5l7t910r426b973],
11	(	CD	NUMBER	(	num	12	SENT_53	[p5l536t910r881b987],
12	CYPZC8	NN	O	cypzc8	ccomp	2	SENT_53	[p5l536t910r881b987],
13	&	CC	O	&	_	0	SENT_53	[p5l993t910r1057b973],
14	CYP3A4/3A5	NN	O	cyp3a4/3a5	nn	15	SENT_53	[p5l1167t910r1720b987],
15	)	NN	O	)	nsubj	28	SENT_53	[p5l1167t910r1720b987],
16	,	,	O	,	_	0	SENT_53	[p5l1167t910r1720b987],
17	transport	NN	O	transport	nn	20	SENT_53	[p5l1830t919r2148b991],
18	(	CD	NUMBER	(	num	20	SENT_53	[p5l10t1021r373b1098],
19	ABCB1	NN	O	abcb1	nn	20	SENT_53	[p5l10t1021r373b1098],
20	)	NN	O	)	nsubj	28	SENT_53	[p5l10t1021r373b1098],
21	,	,	O	,	_	0	SENT_53	[p5l10t1021r373b1098],
22	or	CC	O	or	_	0	SENT_53	[p5l419t1041r492b1084],
23	mechanism	NN	O	mechanism	nn	26	SENT_53	[p5l533t1021r941b1084],
24	(	CD	NUMBER	(	num	26	SENT_53	[p5l985t1021r1361b1098],
25	CYPlBl	NN	O	cyplbl	nn	26	SENT_53	[p5l985t1021r1361b1098],
26	)	NN	O	)	conj_or	15	SENT_53	[p5l985t1021r1361b1098],
27	would	MD	O	would	aux	28	SENT_53	[p5l1406t1021r1628b1084],
28	inﬂuence	VB	O	inﬂuence	rcmod	12	SENT_53	[p5l1670t1021r1997b1084],
29	the	DT	O	the	det	30	SENT_53	[p5l2039t1021r2147b1084],
30	likelihood	NN	O	likelihood	dobj	28	SENT_53	[p5l7t1133r371b1196],
31	that	IN	O	that	complm	35	SENT_53	[p5l409t1133r544b1196],
32	a	DT	O	a	det	33	SENT_53	[p5l583t1153r620b1196],
33	patient	NN	O	patient	nsubj	35	SENT_53	[p5l656t1133r901b1214],
34	would	MD	O	would	aux	35	SENT_53	[p5l939t1133r1162b1196],
35	respond	VB	O	respond	ccomp	28	SENT_53	[p5l1198t1133r1482b1214],
36	to	TO	O	to	prep	35	SENT_53	[p5l1519t1142r1606b1207],
37	,	,	O	,	_	0	SENT_53	[p5l1519t1142r1606b1207],
38	or	CC	O	or	dep	41	SENT_53	[p5l1649t1153r1722b1196],
39	experience	NN	O	experience	nn	41	SENT_53	[p5l1760t1133r2146b1214],
40	severe	JJ	O	severe	amod	41	SENT_53	[p5l10t1264r233b1307],
41	toxicity	NN	O	toxicity	dep	12	SENT_53	[p5l267t1244r540b1325],
42	from	IN	O	from	prep	41	SENT_53	[p5l574t1244r764b1318],
43	,	,	O	,	_	0	SENT_53	[p5l574t1244r764b1318],
44	paclitaxel	NN	O	paclitaxel	nn	45	SENT_53	[p5l800t1244r1149b1325],
45	therapy	NN	O	therapy	appos	41	SENT_53	[p5l1182t1244r1467b1325],
46	.	.	O	.	_	0	SENT_53	[p5l1182t1244r1467b1325],

1	Materials	NNPS	O	Materials	_	0	SENT_54	[p5l7t1487r374b1551],
2	and	CC	O	and	_	0	SENT_54	[p5l409t1488r549b1551],
3	methods	NNS	O	method	conj_and	1	SENT_54	[p5l582t1488r903b1551],

1	Patients	NNS	O	patient	_	0	SENT_55	[p5l7t1712r289b1774],
2	and	CC	O	and	_	0	SENT_55	[p5l324t1712r450b1774],
3	treatments	NNS	O	treatment	conj_and	1	SENT_55	[p5l482t1721r854b1774],

1	Relevant	JJ	O	relevant	amod	3	SENT_56	[p5l7t1936r327b1999],
2	candidate	NN	O	candidate	nn	3	SENT_56	[p5l372t1936r713b1999],
3	SNPs	NNS	O	snp	nsubjpass	5	SENT_56	[p5l762t1936r953b1999],
4	were	VBD	O	be	auxpass	5	SENT_56	[p5l1001t1956r1172b1999],
5	evaluated	VBN	O	evaluate	_	0	SENT_56	[p5l1219t1936r1562b1999],
6	in	IN	O	in	_	0	SENT_56	[p5l1607t1936r1675b1998],
7	a	DT	O	a	det	8	SENT_56	[p5l1722t1956r1758b1999],
8	cohort	NN	O	cohort	prep_in	5	SENT_56	[p5l1804t1936r2031b1999],
9	of	IN	O	of	_	0	SENT_56	[p5l2076t1936r2153b1999],
10	patients	NNS	O	patient	prep_of	8	SENT_56	[p5l6t2048r283b2129],
11	treated	VBN	O	treat	dep	10	SENT_56	[p5l319t2048r563b2111],
12	between	IN	O	between	_	0	SENT_56	[p5l595t2048r895b2111],
13	2005	CD	DATE	2005	prep_between	11	SENT_56	[p5l930t2048r1101b2111],
14	and	CC	DATE	and	_	0	SENT_56	[p5l1141t2048r1268b2111],
15	2009	CD	DATE	2009	prep_between	11	SENT_56	[p5l1303t2048r1476b2112],
16	and	CC	O	and	_	0	SENT_56	[p5l1514t2048r1640b2111],
17	derived	VBN	O	derive	dep	10	SENT_56	[p5l1674t2048r1942b2111],
18	from	IN	O	from	_	0	SENT_56	[p5l1976t2048r2148b2111],
19	the	DT	O	the	det	33	SENT_56	[p5l7t2159r114b2222],
20	University	NNP	ORGANIZATION	University	dep	33	SENT_56	[p5l153t2159r530b2240],
21	of	IN	ORGANIZATION	of	_	0	SENT_56	[p5l569t2159r646b2222],
22	North	NNP	ORGANIZATION	North	nn	24	SENT_56	[p5l678t2159r885b2222],
23	Carolina	NNP	ORGANIZATION	Carolina	nn	24	SENT_56	[p5l924t2159r1232b2222],
24	Lineberger	NNP	ORGANIZATION	Lineberger	prep_of	20	SENT_56	[p5l1268t2159r1664b2240],
25	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	29	SENT_56	[p5l1701t2159r2145b2240, p5l10t2270r149b2333],
26	Cancer	NNP	ORGANIZATION	Cancer	nn	29	SENT_56	[p5l182t2271r435b2333],
27	Center	NNP	ORGANIZATION	Center	nn	29	SENT_56	[p5l466t2271r704b2333],
28	(	CD	NUMBER	(	num	29	SENT_56	[p5l736t2271r947b2348],
29	UNC	NNP	O	UNC	dep	24	SENT_56	[p5l736t2271r947b2348],
30	LCCC	NN	O	lccc	dep	20	SENT_56	[p5l980t2271r1239b2347],
31	)	CD	NUMBER	)	num	30	SENT_56	[p5l980t2271r1239b2347],
32	Breast	NN	O	breast	nn	33	SENT_56	[p5l1273t2272r1502b2333],
33	Cancer	NN	O	cancer	prep_from	17	SENT_56	[p5l1532t2271r1786b2333],
34	Neoadju	FW	O	neoadju	nn	37	SENT_56	[p5l1815t2270r2145b2351],
35	—	FW	O	—	nn	37	SENT_56	[p5l1815t2270r2145b2351],
36	vant	NN	O	vant	nn	37	SENT_56	[p5l7t2391r161b2444],
37	Database	NN	O	database	tmod	33	SENT_56	[p5l203t2381r550b2455],
38	,	,	O	,	_	0	SENT_56	[p5l203t2381r550b2455],
39	which	WDT	O	which	nsubj	40	SENT_56	[p5l597t2381r814b2444],
40	includes	VBZ	O	include	rcmod	37	SENT_56	[p5l857t2381r1153b2444],
41	prospective	JJ	O	prospective	amod	42	SENT_56	[p5l1197t2381r1609b2462],
42	annotation	NN	O	annotation	dobj	40	SENT_56	[p5l1656t2381r2032b2444],
43	of	IN	O	of	_	0	SENT_56	[p5l2076t2381r2153b2444],
44	clinical	JJ	O	clinical	amod	45	SENT_56	[p5l8t2492r270b2554],
45	data	NNS	O	datum	prep_of	42	SENT_56	[p5l304t2492r471b2566],
46	,	,	O	,	_	0	SENT_56	[p5l304t2492r471b2566],
47	treatment	NN	O	treatment	nn	48	SENT_56	[p5l506t2501r846b2554],
48	details	NNS	O	detail	prep_of	42	SENT_56	[p5l878t2492r1129b2566],
49	,	,	O	,	_	0	SENT_56	[p5l878t2492r1129b2566],
50	toxicity	NN	O	toxicity	prep_of	42	SENT_56	[p5l1164t2492r1457b2573],
51	,	,	O	,	_	0	SENT_56	[p5l1164t2492r1457b2573],
52	and	CC	O	and	_	0	SENT_56	[p5l1494t2492r1621b2554],
53	outcome	NN	O	outcome	conj_and	45	SENT_56	[p5l1653t2501r1977b2554],
54	.	.	O	.	_	0	SENT_56	[p5l1653t2501r1977b2554],

1	Eligible	JJ	O	eligible	amod	2	SENT_57	[p5l2014t2492r2145b2554, p5l8t2602r184b2683],
2	women	NNS	O	woman	nsubj	3	SENT_57	[p5l235t2621r496b2664],
3	received	VBD	O	receive	_	0	SENT_57	[p5l546t2602r851b2664],
4	neoadjuvant	JJ	O	neoadjuvant	amod	6	SENT_57	[p5l899t2602r1339b2683],
5	paclitaxel	NN	O	paclitaxel	nn	6	SENT_57	[p5l1386t2602r2147b2683],
6	—	NN	O	—	nsubj	21	SENT_57	[p5l1386t2602r2147b2683],
7	containing	VBG	O	contain	dep	6	SENT_57	[p5l1386t2602r2147b2683],
8	regimens	NNS	O	regimen	dobj	7	SENT_57	[p5l6t2713r333b2794],
9	and	CC	O	and	_	0	SENT_57	[p5l369t2713r495b2775],
10	enrolled	VBN	O	enrol	dep	6	SENT_57	[p5l527t2713r821b2775],
11	in	IN	O	in	_	0	SENT_57	[p5l852t2713r920b2774],
12	both	CC	O	both	preconj	16	SENT_57	[p5l951t2713r1109b2775],
13	the	DT	O	the	det	16	SENT_57	[p5l1141t2713r1248b2775],
14	UNC	NNP	O	UNC	nn	16	SENT_57	[p5l1280t2713r1465b2776],
15	neoadjuvant	NN	O	neoadjuvant	nn	16	SENT_57	[p5l1499t2713r1938b2794],
16	database	NN	O	database	prep_in	10	SENT_57	[p5l1970t2713r2145b2775, p5l6t2825r164b2888],
17	and	CC	O	and	_	0	SENT_57	[p5l197t2825r324b2888],
18	a	DT	O	a	det	20	SENT_57	[p5l356t2845r393b2888],
19	concurrent	JJ	O	concurrent	amod	20	SENT_57	[p5l423t2835r806b2888],
20	IRB	NN	ORGANIZATION	irb	conj_and	16	SENT_57	[p5l836t2827r978b2887],
21	approved	VBD	O	approve	ccomp	3	SENT_57	[p5l1016t2825r1346b2906],
22	clinical	JJ	O	clinical	amod	23	SENT_57	[p5l1377t2825r1640b2888],
23	trial	NN	O	trial	dobj	21	SENT_57	[p5l1671t2825r1814b2888],
24	that	WDT	O	that	nsubj	25	SENT_57	[p5l1846t2825r1980b2888],
25	collected	VBD	O	collect	rcmod	23	SENT_57	[p5l2011t2825r2145b2888, p5l7t2936r222b2999],
26	genomic	JJ	O	genomic	amod	27	SENT_57	[p5l243t2936r549b3017],
27	DNA	NN	O	dna	dobj	25	SENT_57	[p5l573t2937r764b2999],
28	from	IN	O	from	_	0	SENT_57	[p5l786t2936r959b2999],
29	all	DT	O	all	det	32	SENT_57	[p5l982t2936r1067b2999],
30	newly	RB	O	newly	advmod	31	SENT_57	[p5l1089t2936r1306b3017],
31	diagnosed	VBN	O	diagnose	amod	32	SENT_57	[p5l1330t2936r1691b3017],
32	patients	NNS	O	patient	prep_from	25	SENT_57	[p5l1712t2936r2008b3017],
33	.	.	O	.	_	0	SENT_57	[p5l1712t2936r2008b3017],

1	All	DT	O	all	det	2	SENT_58	[p5l2035t2936r2147b2998],
2	patients	NNS	O	patient	nsubj	3	SENT_58	[p5l6t3047r283b3128],
3	received	VBD	O	receive	_	0	SENT_58	[p5l321t3047r626b3110],
4	paclitaxel	NN	O	paclitaxel	iobj	3	SENT_58	[p5l661t3047r1010b3128],
5	(	CD	NUMBER	(	num	8	SENT_58	[p5l1050t3048r1157b3124],
6	T	NN	O	t	nn	8	SENT_58	[p5l1050t3048r1157b3124],
7	)	NN	O	)	nn	8	SENT_58	[p5l1050t3048r1157b3124],
8	treatment	NN	O	treatment	dobj	3	SENT_58	[p5l1196t3056r1537b3110],
9	guided	VBN	O	guide	partmod	8	SENT_58	[p5l1573t3047r1816b3128],
10	by	IN	O	by	_	0	SENT_58	[p5l1850t3047r1938b3128],
11	standard	JJ	O	standard	amod	13	SENT_58	[p5l1978t3056r2145b3110, p5l8t3158r165b3221],
12	neoadjuvant	JJ	O	neoadjuvant	amod	13	SENT_58	[p5l194t3158r634b3239],
13	protocols	NNS	O	protocol	agent	9	SENT_58	[p5l661t3158r992b3239],
14	that	WDT	O	that	nsubj	15	SENT_58	[p5l1024t3158r1158b3221],
15	had	VBD	O	have	rcmod	13	SENT_58	[p5l1186t3158r1315b3221],
16	a	DT	O	a	dobj	15	SENT_58	[p5l1346t3178r1383b3221],
17	deﬁned	VBN	O	deﬁned	partmod	16	SENT_58	[p5l1412t3158r1674b3221],
18	and	CC	O	and	_	0	SENT_58	[p5l1705t3158r1831b3221],
19	conventional	JJ	O	conventional	amod	21	SENT_58	[p5l1861t3178r2145b3221, p5l7t3269r209b3332],
20	treatment	NN	O	treatment	nn	21	SENT_58	[p5l233t3279r572b3332],
21	dose	NN	O	dose	dobj	15	SENT_58	[p5l594t3269r774b3344],
22	,	,	O	,	_	0	SENT_58	[p5l594t3269r774b3344],
23	schedule	NN	O	schedule	conj_and	21	SENT_58	[p5l803t3269r1132b3344],
24	,	,	O	,	_	0	SENT_58	[p5l803t3269r1132b3344],
25	and	CC	O	and	_	0	SENT_58	[p5l1159t3269r1285b3332],
26	duration	NN	O	duration	conj_and	21	SENT_58	[p5l1308t3269r1623b3332],
27	.	.	O	.	_	0	SENT_58	[p5l1308t3269r1623b3332],

1	In	IN	O	in	_	0	SENT_59	[p5l1649t3271r1722b3331],
2	most	JJS	O	most	amod	3	SENT_59	[p5l1743t3279r1917b3332],
3	cases	NNS	O	case	prep_in	6	SENT_59	[p5l1939t3289r2144b3344],
4	,	,	O	,	_	0	SENT_59	[p5l1939t3289r2144b3344],
5	patients	NNS	O	patient	nsubj	6	SENT_59	[p5l6t3381r283b3462],
6	received	VBD	O	receive	conj_or	6	SENT_59	[p5l318t3381r623b3444],
7	neoadjuvant	JJ	O	neoadjuvant	amod	8	SENT_59	[p5l656t3381r1096b3462],
8	doxorubicin	NN	O	doxorubicin	dobj	6	SENT_59	[p5l1129t3381r1560b3444],
9	and	CC	O	and	_	0	SENT_59	[p5l1596t3381r1722b3444],
10	cyclophos	NN	O	cyclopho	nn	15	SENT_59	[p5l1756t3381r2145b3462],
11	—	NN	O	—	nn	15	SENT_59	[p5l1756t3381r2145b3462],
12	phamide	NN	O	phamide	nn	15	SENT_59	[p5l6t3492r314b3573],
13	(	CD	NUMBER	(	num	15	SENT_59	[p5l340t3492r516b3569],
14	AC	NN	O	ac	nn	15	SENT_59	[p5l340t3492r516b3569],
15	)	NN	O	)	dobj	6	SENT_59	[p5l340t3492r516b3569],
16	either	CC	O	either	preconj	6	SENT_59	[p5l541t3492r745b3554],
17	before	IN	O	before	_	0	SENT_59	[p5l764t3492r991b3554],
18	or	CC	O	or	_	0	SENT_59	[p5l1015t3511r1088b3554],
19	after	IN	O	after	_	0	SENT_59	[p5l1110t3492r1272b3554],
20	the	DT	O	the	det	21	SENT_59	[p5l1292t3492r1399b3554],
21	paclitaxel	NN	O	paclitaxel	prep_before	6	SENT_59	[p5l1421t3492r1792b3573],
22	;	:	O	;	_	0	SENT_59	[p5l1421t3492r1792b3573],
23	however	RB	O	however	advmod	28	SENT_59	[p5l1817t3492r2144b3566],
24	,	,	O	,	_	0	SENT_59	[p5l1817t3492r2144b3566],
25	the	DT	O	the	det	26	SENT_59	[p5l7t3603r114b3665],
26	tumors	NNS	O	tumor	nsubjpass	28	SENT_59	[p5l150t3612r395b3665],
27	were	VBD	O	be	auxpass	28	SENT_59	[p5l433t3622r603b3666],
28	measured	VBN	O	measure	conj_and	28	SENT_59	[p5l640t3603r983b3665],
29	before	IN	O	before	_	0	SENT_59	[p5l1016t3603r1244b3665],
30	and	CC	O	and	_	0	SENT_59	[p5l1282t3603r1408b3665],
31	after	IN	O	after	_	0	SENT_59	[p5l1444t3603r1607b3665],
32	each	DT	O	each	det	33	SENT_59	[p5l1641t3603r1803b3665],
33	phase	NN	O	phase	prep_before	28	SENT_59	[p5l1837t3603r2039b3684],
34	of	IN	O	of	_	0	SENT_59	[p5l2076t3603r2153b3665],
35	therapy	NN	O	therapy	prep_of	33	SENT_59	[p5l7t3714r274b3795],
36	so	IN	O	so	mark	39	SENT_59	[p5l309t3733r382b3776],
37	that	IN	O	that	dep	39	SENT_59	[p5l413t3714r547b3776],
38	clinical	JJ	O	clinical	amod	39	SENT_59	[p5l577t3714r840b3776],
39	response	NN	O	response	dep	33	SENT_59	[p5l871t3733r1182b3795],
40	to	TO	O	to	_	0	SENT_59	[p5l1214t3723r1281b3776],
41	the	DT	O	the	det	43	SENT_59	[p5l1312t3714r1419b3776],
42	anthracycline	NN	O	anthracycline	nn	43	SENT_59	[p5l1452t3714r1933b3795],
43	component	NN	O	component	prep_to	28	SENT_59	[p5l1966t3733r2145b3776, p6l6t32r250b103],

1	and	CC	O	and	cc	8	SENT_60	[p6l307t22r433b85],
2	the	DT	O	the	det	4	SENT_60	[p6l488t22r595b85],
3	taxane	NN	O	taxane	nn	4	SENT_60	[p6l651t32r884b85],
4	component	NN	O	component	nsubjpass	8	SENT_60	[p6l941t32r1339b103],
5	could	MD	O	could	aux	8	SENT_60	[p6l1394t22r1592b85],
6	be	VB	O	be	auxpass	8	SENT_60	[p6l1645t22r1728b85],
7	separately	RB	O	separately	advmod	8	SENT_60	[p6l1788t22r2147b103],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_60	[p6l7t133r363b196],
9	.	.	O	.	_	0	SENT_60	[p6l7t133r363b196],

1	Some	DT	O	some	det	2	SENT_61	[p6l392t134r591b196],
2	patients	NNS	O	patient	nsubj	7	SENT_61	[p6l613t133r890b214],
3	with	IN	O	with	_	0	SENT_61	[p6l914t133r1071b196],
4	HER2	NN	O	her2	nn	6	SENT_61	[p6l1093t134r1314b195],
5	overexpressing	VBG	O	overexpress	amod	6	SENT_61	[p6l1337t133r1878b214],
6	tumors	NNS	O	tumor	prep_with	2	SENT_61	[p6l1900t143r2145b196],
7	received	VBD	O	receive	_	0	SENT_61	[p6l6t244r312b307],
8	trastuzumab	JJ	O	trastuzumab	amod	9	SENT_61	[p6l333t244r770b307],
9	concurrent	JJ	O	concurrent	acomp	7	SENT_61	[p6l795t254r1178b307],
10	with	IN	O	with	_	0	SENT_61	[p6l1200t244r1357b307],
11	the	DT	O	the	det	12	SENT_61	[p6l1380t244r1487b307],
12	paclitaxel	NN	O	paclitaxel	prep_with	9	SENT_61	[p6l1509t244r1877b325],
13	.	.	O	.	_	0	SENT_61	[p6l1509t244r1877b325],

1	Tumor	NN	O	tumor	nn	2	SENT_62	[p6l1905t246r2149b307],
2	size	NN	O	size	nsubjpass	5	SENT_62	[p6l10t354r144b416],
3	was	VBD	O	be	auxpass	5	SENT_62	[p6l203t373r338b417],
4	clinically	RB	O	clinically	advmod	5	SENT_62	[p6l397t354r730b435],
5	measured	VBN	O	measure	_	0	SENT_62	[p6l789t354r1132b416],
6	by	IN	O	by	_	0	SENT_62	[p6l1187t354r1275b435],
7	the	DT	O	the	det	8	SENT_62	[p6l1333t354r1440b416],
8	patient	NN	O	patient	poss	11	SENT_62	[p6l1497t354r1805b435],
9	’s	POS	O	’s	_	0	SENT_62	[p6l1497t354r1805b435],
10	medical	JJ	O	medical	amod	11	SENT_62	[p6l1864t354r2146b416],
11	oncologist	NN	O	oncologist	agent	5	SENT_62	[p6l8t465r399b546],
12	,	,	O	,	_	0	SENT_62	[p6l8t465r399b546],
13	and	CC	O	and	_	0	SENT_62	[p6l427t465r553b527],
14	percent	NN	O	percent	nn	15	SENT_62	[p6l575t474r839b546],
15	change	NN	O	change	nsubjpass	20	SENT_62	[p6l862t465r1113b546],
16	in	IN	O	in	_	0	SENT_62	[p6l1138t465r1205b526],
17	tumor	NN	O	tumor	nn	18	SENT_62	[p6l1228t474r1442b527],
18	size	NN	O	size	prep_in	15	SENT_62	[p6l1466t465r1600b527],
19	was	VBD	O	be	auxpass	20	SENT_62	[p6l1624t484r1758b527],
20	calculated	VBN	O	calculate	conj_and	5	SENT_62	[p6l1784t465r2148b527],
21	from	IN	O	from	_	0	SENT_62	[p6l8t577r180b640],
22	these	DT	O	these	det	23	SENT_62	[p6l206t577r387b640],
23	measurements	NNS	O	measurement	prep_from	20	SENT_62	[p6l414t587r946b640],
24	.	.	O	.	_	0	SENT_62	[p6l414t587r946b640],

1	Clinical	JJ	O	clinical	amod	2	SENT_63	[p6l977t577r1259b640],
2	response	NN	O	response	nsubjpass	4	SENT_63	[p6l1285t597r1597b658],
3	was	VBD	O	be	auxpass	4	SENT_63	[p6l1625t597r1759b640],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_63	[p6l1788t577r2049b640],
5	as	IN	O	as	_	0	SENT_63	[p6l2077t597r2146b640],
6	complete	JJ	O	complete	amod	7	SENT_63	[p6l8t688r335b769],
7	response	NN	O	response	prep_as	4	SENT_63	[p6l370t708r681b769],
8	(	CD	NUMBER	(	num	9	SENT_63	[p6l720t688r925b765],
9	cCR	NN	O	ccr	dep	7	SENT_63	[p6l720t688r925b765],
10	;	:	O	;	_	0	SENT_63	[p6l720t688r925b765],
11	100	CD	PERCENT	100	number	12	SENT_63	[p6l972t688r1096b751],
12	%	NN	PERCENT	%	amod	13	SENT_63	[p6l1132t688r1197b751],
13	reduction	NN	O	reduction	dep	7	SENT_63	[p6l1235t688r1573b751],
14	in	IN	O	in	_	0	SENT_63	[p6l1608t688r1676b750],
15	tumor	NN	O	tumor	nn	17	SENT_63	[p6l1710t697r1924b751],
16	size	NN	O	size	nn	17	SENT_63	[p6l1961t688r2143b765],
17	)	NN	O	)	prep_in	13	SENT_63	[p6l1961t688r2143b765],
18	,	,	O	,	_	0	SENT_63	[p6l1961t688r2143b765],
19	partial	JJ	O	partial	amod	20	SENT_63	[p6l6t799r235b880],
20	response	NN	O	response	appos	17	SENT_63	[p6l270t818r583b880],
21	(	CD	NUMBER	(	num	22	SENT_63	[p6l622t800r817b876],
22	cPR	NN	O	cpr	dep	20	SENT_63	[p6l622t800r817b876],
23	;	:	O	;	_	0	SENT_63	[p6l622t800r817b876],
24	30-99	CD	PERCENT	30-99	num	27	SENT_63	[p6l860t799r1077b862],
25	%	NN	PERCENT	%	nn	27	SENT_63	[p6l1116t799r1180b862],
26	reduction	NN	O	reduction	nn	27	SENT_63	[p6l1219t799r1607b876],
27	)	NN	O	)	dep	7	SENT_63	[p6l1219t799r1607b876],
28	,	,	O	,	_	0	SENT_63	[p6l1219t799r1607b876],
29	stable	JJ	O	stable	amod	32	SENT_63	[p6l1649t799r1854b861],
30	disease	NN	O	disease	nn	32	SENT_63	[p6l1891t799r2146b861],
31	(	NN	O	(	nn	32	SENT_63	[p6l10t910r210b987],
32	cSD	NN	O	csd	appos	27	SENT_63	[p6l10t910r210b987],
33	;	:	O	;	_	0	SENT_63	[p6l10t910r210b987],
34	29	CD	PERCENT	29	num	36	SENT_63	[p6l267t910r351b973],
35	%	NN	PERCENT	%	nn	36	SENT_63	[p6l389t910r454b973],
36	reduction	NN	O	reduction	dep	7	SENT_63	[p6l509t910r981b973],
37	—	CD	PERCENT	—	number	38	SENT_63	[p6l509t910r981b973],
38	2O	CD	PERCENT	2o	num	39	SENT_63	[p6l509t910r981b973],
39	%	NN	PERCENT	%	dep	36	SENT_63	[p6l1018t910r1083b973],
40	enlargement	NN	O	enlargement	dep	7	SENT_63	[p6l1140t910r1584b991],
41	of	IN	O	of	_	0	SENT_63	[p6l1635t910r1713b972],
42	tumor	NN	O	tumor	nn	43	SENT_63	[p6l1758t911r2020b987],
43	)	NN	O	)	prep_of	40	SENT_63	[p6l1758t911r2020b987],
44	,	,	O	,	_	0	SENT_63	[p6l1758t911r2020b987],
45	or	CC	O	or	_	0	SENT_63	[p6l2076t929r2149b972],
46	progressive	JJ	O	progressive	amod	47	SENT_63	[p6l6t1021r418b1102],
47	disease	NN	O	disease	prep_as	4	SENT_63	[p6l457t1021r712b1084],
48	(	CD	NUMBER	(	num	49	SENT_63	[p6l754t1022r953b1098],
49	cPD	NN	O	cpd	dep	47	SENT_63	[p6l754t1022r953b1098],
50	;	:	O	;	_	0	SENT_63	[p6l754t1022r953b1098],
51	>	JJR	O	>	amod	54	SENT_63	[p6l996t1022r1141b1084],
52	20	CD	PERCENT	20	number	53	SENT_63	[p6l996t1022r1141b1084],
53	%	NN	PERCENT	%	amod	54	SENT_63	[p6l1179t1022r1243b1084],
54	enlargement	NN	O	enlargement	dep	47	SENT_63	[p6l1285t1021r1755b1102],
55	)	CD	NUMBER	)	dep	54	SENT_63	[p6l1285t1021r1755b1102],
56	according	VBG	O	accord	_	0	SENT_63	[p6l1796t1021r2147b1102],
57	to	TO	O	to	prepc_according_to	4	SENT_63	[p6l7t1142r74b1195],
58	RECIST	NNP	O	RECIST	nn	59	SENT_63	[p6l112t1133r419b1195],
59	criteria	NNS	O	criterion	pobj	4	SENT_63	[p6l457t1132r711b1195],
60	[	RB	O	[	advmod	62	SENT_63	[p6l754t1133r912b1208],
61	20	CD	NUMBER	20	num	62	SENT_63	[p6l754t1133r912b1208],
62	]	NN	O	]	rcmod	59	SENT_63	[p6l754t1133r912b1208],
63	.	.	O	.	_	0	SENT_63	[p6l754t1133r912b1208],

1	Patients	NNS	O	patient	nsubj	14	SENT_64	[p6l954t1132r1235b1195],
2	who	WP	O	who	nsubj	3	SENT_64	[p6l1275t1132r1424b1195],
3	achieved	VBD	O	achieve	rcmod	1	SENT_64	[p6l1465t1132r1782b1195],
4	complete	JJ	O	complete	amod	5	SENT_64	[p6l1820t1132r2147b1213],
5	response	NN	O	response	dobj	3	SENT_64	[p6l6t1263r318b1324],
6	to	TO	O	to	_	0	SENT_64	[p6l363t1253r430b1306],
7	AC	NN	O	ac	prep_to	3	SENT_64	[p6l477t1244r597b1306],
8	before	IN	O	before	_	0	SENT_64	[p6l642t1243r870b1306],
9	the	DT	O	the	det	10	SENT_64	[p6l916t1243r1023b1306],
10	start	NN	O	start	prep_before	3	SENT_64	[p6l1072t1252r1222b1306],
11	of	IN	O	of	_	0	SENT_64	[p6l1268t1243r1345b1306],
12	taxane	NN	O	taxane	nn	13	SENT_64	[p6l1384t1253r1616b1306],
13	therapy	NN	O	therapy	prep_of	10	SENT_64	[p6l1662t1243r1929b1324],
14	were	VBD	O	be	_	0	SENT_64	[p6l1976t1263r2146b1306],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_65	[p6l52t1399r142b1424],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_65	[p6l155t1399r255b1424],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_65	[p6l267t1399r318b1424],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_65	[p6l331t1399r406b1424],
5	(	CD	NUMBER	(	num	6	SENT_65	[p6l419t1399r510b1429],
6	2012	CD	DATE	2012	dep	4	SENT_65	[p6l419t1399r510b1429],
7	)	CD	NUMBER	)	number	8	SENT_65	[p6l419t1399r510b1429],
8	134:401	CD	NUMBER	134:401	num	9	SENT_65	[p6l528t1399r710b1424],
9	—	NN	O	—	dep	6	SENT_65	[p6l528t1399r710b1424],
10	410	CD	NUMBER	410	number	11	SENT_65	[p6l528t1399r710b1424],
11	403	CD	NUMBER	403	num	9	SENT_65	[p6l2055t1399r2105b1424],

1	excluded	VBN	O	exclude	_	0	SENT_66	[p6l8t1567r330b1630],
2	from	IN	O	from	_	0	SENT_66	[p6l362t1567r534b1630],
3	the	DT	O	the	det	5	SENT_66	[p6l564t1567r671b1630],
4	efﬁcacy	NN	O	efﬁcacy	nn	5	SENT_66	[p6l703t1567r985b1648],
5	analysis	NN	O	analysis	prep_from	1	SENT_66	[p6l1018t1567r1302b1648],
6	because	IN	O	because	mark	10	SENT_66	[p6l1334t1567r1617b1630],
7	they	PRP	O	they	nsubj	10	SENT_66	[p6l1648t1567r1800b1648],
8	were	VBD	O	be	cop	10	SENT_66	[p6l1832t1587r2003b1630],
9	not	RB	O	not	neg	10	SENT_66	[p6l2035t1577r2149b1630],
10	evaluable	JJ	O	evaluable	advcl	1	SENT_66	[p6l8t1678r350b1741],
11	for	IN	O	for	_	0	SENT_66	[p6l396t1678r500b1741],
12	response	NN	O	response	prep_for	10	SENT_66	[p6l543t1698r854b1759],
13	to	TO	O	to	_	0	SENT_66	[p6l901t1688r968b1741],
14	taxane	NN	O	taxane	nn	15	SENT_66	[p6l1014t1688r1246b1741],
15	treatment	NN	O	treatment	prep_to	10	SENT_66	[p6l1292t1688r1649b1741],
16	.	.	O	.	_	0	SENT_66	[p6l1292t1688r1649b1741],

1	Pathological	JJ	O	pathological	amod	2	SENT_67	[p6l1699t1678r2147b1759],
2	response	NN	O	response	nsubjpass	15	SENT_67	[p6l6t1808r338b1870],
3	,	,	O	,	_	0	SENT_67	[p6l6t1808r338b1870],
4	which	WDT	O	which	nsubjpass	8	SENT_67	[p6l373t1789r590b1852],
5	could	MD	O	could	aux	8	SENT_67	[p6l621t1789r819b1851],
6	not	RB	O	not	neg	8	SENT_67	[p6l849t1798r963b1851],
7	be	VB	O	be	auxpass	8	SENT_67	[p6l991t1789r1074b1851],
8	evaluated	VBN	O	evaluate	rcmod	2	SENT_67	[p6l1106t1789r1449b1852],
9	between	IN	O	between	_	0	SENT_67	[p6l1479t1789r1777b1852],
10	treatment	NN	O	treatment	nn	11	SENT_67	[p6l1809t1798r2148b1851],
11	regimens	NNS	O	regimen	prep_between	8	SENT_67	[p6l6t1900r354b1981],
12	,	,	O	,	_	0	SENT_67	[p6l6t1900r354b1981],
13	was	VBD	O	be	auxpass	15	SENT_67	[p6l382t1919r517b1963],
14	not	RB	O	not	neg	15	SENT_67	[p6l542t1909r656b1962],
15	used	VBN	O	use	_	0	SENT_67	[p6l679t1900r842b1962],
16	as	IN	O	as	_	0	SENT_67	[p6l868t1919r936b1962],
17	an	DT	O	a	det	18	SENT_67	[p6l964t1919r1045b1962],
18	endpoint	NN	O	endpoint	prep_as	15	SENT_67	[p6l1069t1900r1382b1981],
19	in	IN	O	in	_	0	SENT_67	[p6l1405t1900r1473b1962],
20	this	DT	O	this	det	21	SENT_67	[p6l1497t1900r1623b1962],
21	study	NN	O	study	prep_in	18	SENT_67	[p6l1652t1900r1840b1981],
22	because	IN	O	because	_	0	SENT_67	[p6l1864t1900r2146b1962],
23	of	IN	O	of	_	0	SENT_67	[p6l8t2010r85b2072],
24	the	DT	O	the	det	25	SENT_67	[p6l107t2010r214b2072],
25	inability	NN	O	inability	prep_because_of	15	SENT_67	[p6l242t2010r541b2091],
26	to	TO	O	to	aux	27	SENT_67	[p6l569t2019r635b2072],
27	separate	VB	O	separate	infmod	25	SENT_67	[p6l667t2019r956b2091],
28	the	DT	O	the	det	30	SENT_67	[p6l984t2010r1091b2072],
29	confounding	JJ	O	confounding	amod	30	SENT_67	[p6l1121t2009r1571b2091],
30	effects	NNS	O	effect	dobj	27	SENT_67	[p6l1600t2009r1835b2072],
31	of	IN	O	of	_	0	SENT_67	[p6l1866t2010r1943b2072],
32	other	JJ	O	other	amod	34	SENT_67	[p6l1966t2010r2149b2072],
33	chemotherapy	NN	O	chemotherapy	nn	34	SENT_67	[p6l8t2122r515b2203],
34	treatments	NNS	O	treatment	prep_of	30	SENT_67	[p6l541t2132r933b2185],
35	.	.	O	.	_	0	SENT_67	[p6l541t2132r933b2185],

1	Toxicities	NNS	O	toxicity	nsubjpass	3	SENT_68	[p6l964t2122r1320b2185],
2	were	VBD	O	be	auxpass	3	SENT_68	[p6l1348t2142r1519b2185],
3	evaluated	VBN	O	evaluate	ccomp	8	SENT_68	[p6l1547t2122r1890b2185],
4	during	IN	O	during	_	0	SENT_68	[p6l1916t2122r2146b2203],
5	paclitaxel	NN	O	paclitaxel	nn	6	SENT_68	[p6l6t2233r356b2314],
6	treatment	NN	O	treatment	prep_during	3	SENT_68	[p6l387t2242r745b2307],
7	,	,	O	,	_	0	SENT_68	[p6l387t2242r745b2307],
8	recorded	VBD	O	record	_	0	SENT_68	[p6l778t2233r1093b2296],
9	prospectively	RB	O	prospectively	advmod	8	SENT_68	[p6l1121t2233r1625b2314],
10	,	,	O	,	_	0	SENT_68	[p6l1121t2233r1625b2314],
11	and	CC	O	and	_	0	SENT_68	[p6l1661t2233r1787b2296],
12	coded	VBN	O	code	conj_and	8	SENT_68	[p6l1818t2233r2030b2296],
13	by	IN	O	by	_	0	SENT_68	[p6l2059t2233r2147b2314],
14	NCI	NNP	ORGANIZATION	NCI	nn	17	SENT_68	[p6l7t2344r159b2407],
15	CTC	NNP	ORGANIZATION	CTC	nn	17	SENT_68	[p6l200t2344r370b2407],
16	AE	NNP	O	AE	nn	17	SENT_68	[p6l412t2345r529b2406],
17	V4	NNP	O	V4	prep_by	12	SENT_68	[p6l570t2344r743b2407],
18	.0	CD	NUMBER	.0	num	17	SENT_68	[p6l570t2344r743b2407],
19	based	VBN	O	base	partmod	17	SENT_68	[p6l783t2344r987b2407],
20	on	IN	O	on	_	0	SENT_68	[p6l1028t2364r1114b2407],
21	the	DT	O	the	det	22	SENT_68	[p6l1154t2344r1261b2407],
22	physician	NN	O	physician	poss	25	SENT_68	[p6l1301t2344r1707b2425],
23	’s	POS	O	’s	_	0	SENT_68	[p6l1301t2344r1707b2425],
24	description	NN	O	description	nn	25	SENT_68	[p6l1751t2344r2148b2425],
25	[	NN	O	[	prep_on	19	SENT_68	[p6l13t2456r172b2531],
26	21	CD	NUMBER	21	num	27	SENT_68	[p6l13t2456r172b2531],
27	]	NN	O	]	nsubj	8	SENT_68	[p6l13t2456r172b2531],
28	.	.	O	.	_	0	SENT_68	[p6l13t2456r172b2531],

1	Patients	NNS	O	patient	nsubj	10	SENT_69	[p6l213t2455r494b2518],
2	who	WP	O	who	nsubjpass	4	SENT_69	[p6l532t2455r682b2518],
3	were	VBD	O	be	auxpass	4	SENT_69	[p6l720t2475r891b2518],
4	treated	VBN	O	treat	rcmod	1	SENT_69	[p6l929t2455r1172b2518],
5	at	IN	O	at	_	0	SENT_69	[p6l1210t2465r1272b2518],
6	outside	JJ	O	outside	amod	7	SENT_69	[p6l1308t2455r1564b2518],
7	institutions	NNS	O	institution	prep_at	4	SENT_69	[p6l1601t2455r1997b2518],
8	did	VBD	O	do	aux	10	SENT_69	[p6l2036t2455r2148b2518],
9	not	RB	O	not	neg	10	SENT_69	[p6l7t2577r121b2630],
10	have	VB	O	have	_	0	SENT_69	[p6l149t2567r316b2630],
11	toxicity	NN	O	toxicity	nn	12	SENT_69	[p6l347t2567r620b2648],
12	data	NNS	O	datum	dobj	10	SENT_69	[p6l652t2567r800b2630],
13	and	CC	O	and	_	0	SENT_69	[p6l831t2567r957b2630],
14	were	VBD	O	be	auxpass	15	SENT_69	[p6l987t2587r1157b2630],
15	excluded	VBN	O	exclude	conj_and	10	SENT_69	[p6l1190t2567r1512b2630],
16	from	IN	O	from	_	0	SENT_69	[p6l1543t2567r1715b2630],
17	that	DT	O	that	det	18	SENT_69	[p6l1745t2567r1879b2630],
18	part	NN	O	part	prep_from	15	SENT_69	[p6l1906t2577r2046b2648],
19	of	IN	O	of	_	0	SENT_69	[p6l2076t2567r2153b2630],
20	the	DT	O	the	det	21	SENT_69	[p6l7t2678r114b2740],
21	analysis	NN	O	analysis	prep_of	18	SENT_69	[p6l153t2678r457b2759],
22	.	.	O	.	_	0	SENT_69	[p6l153t2678r457b2759],

1	All	DT	O	all	det	2	SENT_70	[p6l497t2678r609b2740],
2	patients	NNS	O	patient	nsubj	9	SENT_70	[p6l645t2678r922b2759],
3	signed	VBD	O	sign	_	0	SENT_70	[p6l964t2678r1193b2759],
4	informed	VBN	O	inform	amod	5	SENT_70	[p6l1229t2678r1557b2740],
5	consent	NN	O	consent	dobj	3	SENT_70	[p6l1593t2687r1866b2740],
6	to	TO	O	to	aux	7	SENT_70	[p6l1901t2687r1967b2740],
7	participate	VB	O	participate	infmod	5	SENT_70	[p6l2004t2697r2145b2759, p6l7t2789r271b2870],
8	and	CC	O	and	_	0	SENT_70	[p6l303t2789r429b2851],
9	agreed	VBD	O	agree	conj_and	3	SENT_70	[p6l459t2789r696b2870],
10	to	TO	O	to	aux	11	SENT_70	[p6l725t2798r792b2851],
11	allow	VB	O	allow	xcomp	9	SENT_70	[p6l824t2789r1019b2852],
12	DNA	NN	O	dna	dobj	11	SENT_70	[p6l1049t2789r1241b2852],
13	to	TO	O	to	aux	15	SENT_70	[p6l1270t2798r1337b2851],
14	be	VB	O	be	auxpass	15	SENT_70	[p6l1366t2789r1449b2851],
15	collected	VBN	O	collect	xcomp	11	SENT_70	[p6l1481t2789r1805b2851],
16	for	IN	O	for	_	0	SENT_70	[p6l1834t2789r1937b2851],
17	additional	JJ	O	additional	amod	19	SENT_70	[p6l1967t2789r2145b2851, p6l7t2900r209b2962],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	19	SENT_70	[p6l258t2900r871b2981],
19	studies	NNS	O	study	prep_for	15	SENT_70	[p6l924t2900r1186b2962],
20	.	.	O	.	_	0	SENT_70	[p6l924t2900r1186b2962],

1	The	DT	O	the	det	3	SENT_71	[p6l1239t2900r1376b2962],
2	study	NN	O	study	nn	3	SENT_71	[p6l1428t2900r1615b2981],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_71	[p6l1664t2900r1962b2981],
4	was	VBD	O	be	auxpass	5	SENT_71	[p6l2011t2919r2146b2963],
5	approved	VBN	O	approve	_	0	SENT_71	[p6l9t3011r340b3092],
6	by	IN	O	by	_	0	SENT_71	[p6l368t3011r455b3092],
7	the	DT	O	the	det	11	SENT_71	[p6l485t3011r593b3074],
8	UNC	NNP	ORGANIZATION	UNC	nn	11	SENT_71	[p6l623t3012r808b3074],
9	Institutional	NNP	ORGANIZATION	Institutional	nn	11	SENT_71	[p6l839t3011r1272b3074],
10	Review	NNP	ORGANIZATION	Review	nn	11	SENT_71	[p6l1302t3011r1573b3074],
11	Board	NNP	ORGANIZATION	Board	agent	5	SENT_71	[p6l1604t3011r1839b3074],
12	.	.	O	.	_	0	SENT_71	[p6l1604t3011r1839b3074],

1	SNP	NN	O	snp	nn	2	SENT_72	[p6l9t3254r169b3317],
2	genotyping	NN	O	genotyping	_	0	SENT_72	[p6l202t3254r602b3335],

1	A	DT	O	a	det	5	SENT_73	[p6l7t3478r70b3539],
2	30	CD	NUMBER	30	num	5	SENT_73	[p6l102t3478r187b3540],
3	mL	NN	O	ml	nn	5	SENT_73	[p6l219t3479r341b3539],
4	blood	NN	O	blood	nn	5	SENT_73	[p6l372t3477r575b3540],
5	sample	NN	O	sample	nsubjpass	7	SENT_73	[p6l609t3477r857b3558],
6	was	VBD	O	be	auxpass	7	SENT_73	[p6l890t3497r1024b3540],
7	collected	VBN	O	collect	_	0	SENT_73	[p6l1059t3477r1382b3540],
8	from	IN	O	from	_	0	SENT_73	[p6l1413t3477r1586b3540],
9	each	DT	O	each	det	10	SENT_73	[p6l1617t3477r1779b3540],
10	patient	NN	O	patient	prep_from	7	SENT_73	[p6l1809t3477r2054b3558],
11	at	IN	O	at	_	0	SENT_73	[p6l2087t3487r2149b3540],
12	the	DT	O	the	det	13	SENT_73	[p6l7t3588r114b3651],
13	time	NN	O	time	prep_at	10	SENT_73	[p6l138t3588r295b3651],
14	of	IN	O	of	_	0	SENT_73	[p6l320t3588r397b3651],
15	study	NN	O	study	nn	16	SENT_73	[p6l417t3588r605b3669],
16	enrollment	NN	O	enrollment	prep_of	13	SENT_73	[p6l629t3588r1034b3651],
17	.	.	O	.	_	0	SENT_73	[p6l629t3588r1034b3651],

1	DNA	NN	O	dna	nsubjpass	14	SENT_74	[p6l1062t3589r1254b3651],
2	used	VBN	O	use	partmod	1	SENT_74	[p6l1275t3588r1438b3651],
3	for	IN	O	for	_	0	SENT_74	[p6l1461t3588r1565b3651],
4	genotyping	VBG	O	genotype	prepc_for	2	SENT_74	[p6l1587t3588r1987b3669],
5	was	VBD	O	be	auxpass	6	SENT_74	[p6l2011t3608r2146b3651],
6	extracted	VBN	O	extract	_	0	SENT_74	[p6l8t3699r336b3761],
7	by	IN	O	by	_	0	SENT_74	[p6l360t3699r447b3780],
8	the	DT	O	the	det	12	SENT_74	[p6l473t3699r580b3761],
9	UNC	NNP	ORGANIZATION	UNC	nn	12	SENT_74	[p6l605t3699r790b3762],
10	Biospecimen	NNP	ORGANIZATION	Biospecimen	nn	12	SENT_74	[p6l817t3699r1285b3780],
11	Processing	NNP	ORGANIZATION	Processing	nn	12	SENT_74	[p6l1310t3699r1695b3780],
12	Facility	NNP	ORGANIZATION	Facility	agent	6	SENT_74	[p6l1721t3699r1994b3780],
13	and	CC	O	and	_	0	SENT_74	[p6l2022t3699r2148b3761],
14	plated	VBN	O	plate	conj_and	6	SENT_74	[p7l6t21r226b102],
15	at	IN	O	at	_	0	SENT_74	[p7l272t31r334b83],
16	5	CD	NUMBER	5	num	17	SENT_74	[p7l378t21r415b84],
17	ng/uL	NN	O	ng/ul	prep_at	14	SENT_74	[p7l452t21r682b102],
18	.	.	O	.	_	0	SENT_74	[p7l452t21r682b102],

1	Target	NN	O	target	nn	2	SENT_75	[p7l731t22r965b102],
2	gene	NN	O	gene	nsubjpass	24	SENT_75	[p7l1010t40r1176b102],
3	region	NN	O	region	nn	4	SENT_75	[p7l1220t21r1448b102],
4	ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	6	SENT_75	[p7l1494t21r1966b102],
5	was	VBD	O	be	auxpass	6	SENT_75	[p7l2011t40r2146b84],
6	carried	VBN	O	carry	rcmod	2	SENT_75	[p7l8t132r256b194],
7	out	RP	O	out	prt	6	SENT_75	[p7l301t141r413b194],
8	by	IN	O	by	_	0	SENT_75	[p7l455t132r542b213],
9	PCR	NN	O	pcr	agent	6	SENT_75	[p7l587t132r754b195],
10	in	IN	O	in	_	0	SENT_75	[p7l798t132r865b193],
11	a	DT	O	a	det	14	SENT_75	[p7l911t151r948b194],
12	20	CD	NUMBER	20	num	14	SENT_75	[p7l992t132r1078b195],
13	uL	NN	O	ul	nn	14	SENT_75	[p7l1115t133r1212b212],
14	reaction	NN	O	reaction	prep_in	6	SENT_75	[p7l1255t132r1545b194],
15	including	VBG	O	include	_	0	SENT_75	[p7l1589t132r1925b213],
16	2	CD	NUMBER	2	number	17	SENT_75	[p7l1973t132r2013b193],
17	[	CD	NUMBER	[	num	18	SENT_75	[p7l2050t133r2148b212],
18	LL	NN	O	ll	npadvmod	19	SENT_75	[p7l2050t133r2148b212],
19	genomic	JJ	O	genomic	amod	20	SENT_75	[p7l8t244r314b325],
20	DNA	NN	MISC	dna	prep_including	14	SENT_75	[p7l356t245r547b307],
21	and	CC	O	and	_	0	SENT_75	[p7l590t244r717b307],
22	polymorphisms	NNS	O	polymorphism	prep_including	14	SENT_75	[p7l756t244r1312b325],
23	were	VBD	O	be	auxpass	24	SENT_75	[p7l1355t264r1526b307],
24	genotyped	VBN	O	genotype	_	0	SENT_75	[p7l1569t244r1941b325],
25	on	IN	O	on	_	0	SENT_75	[p7l1983t264r2069b307],
26	a	DT	O	a	det	30	SENT_75	[p7l2112t264r2149b307],
27	Pyromark	NNP	O	Pyromark	nn	30	SENT_75	[p7l7t355r361b436],
28	Pyrosequencer	NNP	O	Pyrosequencer	nn	30	SENT_75	[p7l388t357r918b436],
29	Q96	NN	O	q96	nn	30	SENT_75	[p7l947t355r1096b433],
30	MD	NN	O	md	prep_on	24	SENT_75	[p7l1126t357r1266b417],
31	as	IN	O	as	mark	33	SENT_75	[p7l1299t375r1367b418],
32	previously	RB	DATE	previously	advmod	33	SENT_75	[p7l1397t355r1775b436],
33	described	VBN	O	describe	dep	30	SENT_75	[p7l1806t355r2148b418],
34	[	NN	O	[	tmod	33	SENT_75	[p7l13t467r144b542],
35	22	CD	NUMBER	22	num	34	SENT_75	[p7l13t467r144b542],
36	,	,	O	,	_	0	SENT_75	[p7l13t467r144b542],
37	23	CD	NUMBER	23	num	38	SENT_75	[p7l240t466r373b542],
38	]	NN	O	]	appos	34	SENT_75	[p7l240t466r373b542],
39	.	.	O	.	_	0	SENT_75	[p7l240t466r373b542],

1	The	DT	O	the	det	2	SENT_76	[p7l469t466r606b529],
2	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_76	[p7l697t466r1254b547],
3	genotyped	VBN	O	genotype	partmod	2	SENT_76	[p7l1348t466r1720b547],
4	were	VBD	O	be	_	0	SENT_76	[p7l1812t486r1983b529],
5	as	IN	O	as	mark	6	SENT_76	[p7l2077t486r2146b529],
6	follows	VBZ	O	follow	advcl	4	SENT_76	[p7l7t577r292b640],
7	:	:	O	:	_	0	SENT_76	[p7l7t577r292b640],
8	CYPlBl	NN	O	cyplbl	dep	10	SENT_76	[p7l347t578r751b640],
9	*	CD	NUMBER	*	number	10	SENT_76	[p7l347t578r751b640],
10	3	CD	NUMBER	3	parataxis	4	SENT_76	[p7l347t578r751b640],
11	(	NN	O	(	nn	12	SENT_76	[p7l805t577r1228b655],
12	rslO56836	NN	O	rslo56836	dep	10	SENT_76	[p7l805t577r1228b655],
13	,	,	O	,	_	0	SENT_76	[p7l805t577r1228b655],
14	4326C	NN	O	4326c	conj_and	10	SENT_76	[p7l1276t577r1687b655],
15	>	JJR	O	>	amod	17	SENT_76	[p7l1276t577r1687b655],
16	G	NN	O	g	nn	17	SENT_76	[p7l1276t577r1687b655],
17	)	NNS	O	)	dep	14	SENT_76	[p7l1276t577r1687b655],
18	,	,	O	,	_	0	SENT_76	[p7l1276t577r1687b655],
19	CYP2C8	NN	O	cyp2c8	conj_and	10	SENT_76	[p7l1737t578r2143b640],
20	*	CD	NUMBER	*	number	21	SENT_76	[p7l1737t578r2143b640],
21	3	CD	NUMBER	3	num	23	SENT_76	[p7l1737t578r2143b640],
22	(	NN	O	(	nn	23	SENT_76	[p7l10t689r478b767],
23	rs1l572080	NN	O	rs1l572080	dep	19	SENT_76	[p7l10t689r478b767],
24	,	,	O	,	_	0	SENT_76	[p7l10t689r478b767],
25	4l6G	NN	O	4l6g	dep	26	SENT_76	[p7l570t689r892b752],
26	>	JJR	O	>	conj_and	10	SENT_76	[p7l570t689r892b752],
27	A	DT	O	a	dep	26	SENT_76	[p7l570t689r892b752],
28	and	CC	O	and	_	0	SENT_76	[p7l982t689r1108b752],
29	rsl050968l	NN	O	rsl050968l	dep	26	SENT_76	[p7l1196t689r1636b764],
30	,	,	O	,	_	0	SENT_76	[p7l1196t689r1636b764],
31	1l96A	NN	O	1l96a	conj_and	10	SENT_76	[p7l1738t689r2144b767],
32	>	JJR	O	>	amod	34	SENT_76	[p7l1738t689r2144b767],
33	G	NN	O	g	nn	34	SENT_76	[p7l1738t689r2144b767],
34	)	NNS	O	)	dep	31	SENT_76	[p7l1738t689r2144b767],
35	,	,	O	,	_	0	SENT_76	[p7l1738t689r2144b767],
36	CYP3A4	NN	O	cyp3a4	nn	38	SENT_76	[p7l8t802r478b864],
37	*	CD	NUMBER	*	num	38	SENT_76	[p7l8t802r478b864],
38	lB	NN	O	lb	conj_and	10	SENT_76	[p7l8t802r478b864],
39	(	CD	NUMBER	(	num	40	SENT_76	[p7l604t801r1027b879],
40	rs2740574	NN	O	rs2740574	dep	38	SENT_76	[p7l604t801r1027b879],
41	,	,	O	,	_	0	SENT_76	[p7l604t801r1027b879],
42	—	CD	NUMBER	—	num	43	SENT_76	[p7l1152t802r1550b879],
43	392A	NN	O	392a	conj_and	10	SENT_76	[p7l1152t802r1550b879],
44	>	JJR	O	>	amod	46	SENT_76	[p7l1152t802r1550b879],
45	G	NN	O	g	nn	46	SENT_76	[p7l1152t802r1550b879],
46	)	NNS	O	)	dep	43	SENT_76	[p7l1152t802r1550b879],
47	,	,	O	,	_	0	SENT_76	[p7l1152t802r1550b879],
48	CYP3A5	NN	O	cyp3a5	nn	50	SENT_76	[p7l1673t801r1994b864],
49	*	CD	NUMBER	*	num	50	SENT_76	[p7l2005t802r2146b864],
50	3C	NN	O	3c	conj_and	10	SENT_76	[p7l2005t802r2146b864],
51	(	CD	NUMBER	(	num	52	SENT_76	[p7l10t913r387b990],
52	rs776746	NN	O	rs776746	dep	50	SENT_76	[p7l10t913r387b990],
53	,	,	O	,	_	0	SENT_76	[p7l10t913r387b990],
54	6986A	NN	O	6986a	parataxis	4	SENT_76	[p7l494t913r907b990],
55	>	JJR	O	>	amod	57	SENT_76	[p7l494t913r907b990],
56	G	NN	O	g	nn	57	SENT_76	[p7l494t913r907b990],
57	)	NNS	O	)	dep	54	SENT_76	[p7l494t913r907b990],
58	,	,	O	,	_	0	SENT_76	[p7l494t913r907b990],
59	and	CC	O	and	_	0	SENT_76	[p7l1014t913r1140b976],
60	ABCBl	NN	O	abcbl	nn	61	SENT_76	[p7l1241t913r1617b976],
61	*	NN	O	*	conj_and	10	SENT_76	[p7l1241t913r1617b976],
62	2	CD	NUMBER	2	number	63	SENT_76	[p7l1241t913r1617b976],
63	(	CD	NUMBER	(	num	64	SENT_76	[p7l1721t913r2144b990],
64	rslO45642	NN	O	rslo45642	dep	61	SENT_76	[p7l1721t913r2144b990],
65	,	,	O	,	_	0	SENT_76	[p7l1721t913r2144b990],
66	3435C	NN	O	3435c	parataxis	4	SENT_76	[p7l10t1024r379b1099],
67	>	JJR	O	>	amod	68	SENT_76	[p7l10t1024r379b1099],
68	T	NN	O	t	dep	66	SENT_76	[p7l10t1024r379b1099],
69	,	,	O	,	_	0	SENT_76	[p7l10t1024r379b1099],
70	rs2032582	NN	O	rs2032582	parataxis	4	SENT_76	[p7l473t1025r870b1099],
71	,	,	O	,	_	0	SENT_76	[p7l473t1025r870b1099],
72	2677G	NN	O	2677g	appos	70	SENT_76	[p7l968t1025r1432b1099],
73	>	JJR	O	>	amod	74	SENT_76	[p7l968t1025r1432b1099],
74	T/A	NN	O	t/a	dep	72	SENT_76	[p7l968t1025r1432b1099],
75	,	,	O	,	_	0	SENT_76	[p7l968t1025r1432b1099],
76	and	CC	O	and	_	0	SENT_76	[p7l1530t1025r1656b1088],
77	rsl	NN	O	rsl	parataxis	4	SENT_76	[p7l1748t1025r1847b1088],
78	128503	CD	NUMBER	128503	num	77	SENT_76	[p7l1866t1024r2144b1099],
79	,	,	O	,	_	0	SENT_76	[p7l1866t1024r2144b1099],
80	l236C	NN	O	l236c	appos	77	SENT_76	[p7l16t1135r407b1213],
81	>	JJR	O	>	amod	83	SENT_76	[p7l16t1135r407b1213],
82	T	NN	O	t	nn	83	SENT_76	[p7l16t1135r407b1213],
83	)	NN	O	)	dep	80	SENT_76	[p7l16t1135r407b1213],
84	.	.	O	.	_	0	SENT_76	[p7l16t1135r407b1213],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_77	[p7l444t1136r864b1217],
2	was	VBD	O	be	auxpass	3	SENT_77	[p7l897t1155r1031b1199],
3	carried	VBN	O	carry	_	0	SENT_77	[p7l1064t1136r1313b1198],
4	out	RP	O	out	prt	3	SENT_77	[p7l1344t1145r1457b1198],
5	blinded	VBN	O	blind	dep	3	SENT_77	[p7l1485t1136r1755b1198],
6	to	TO	O	to	_	0	SENT_77	[p7l1785t1145r1851b1198],
7	clinical	JJ	O	clinical	amod	8	SENT_77	[p7l1884t1136r2147b1198],
8	data	NNS	O	datum	prep_to	5	SENT_77	[p7l8t1248r156b1311],
9	with	IN	O	with	_	0	SENT_77	[p7l177t1248r334b1311],
10	negative	JJ	O	negative	amod	11	SENT_77	[p7l355t1248r658b1329],
11	controls	NNS	O	control	prep_with	8	SENT_77	[p7l681t1248r965b1311],
12	included	VBN	O	include	partmod	11	SENT_77	[p7l989t1248r1297b1311],
13	in	IN	O	in	_	0	SENT_77	[p7l1318t1248r1386b1310],
14	each	DT	O	each	prep_in	12	SENT_77	[p7l1408t1248r1588b1322],
15	,	,	O	,	_	0	SENT_77	[p7l1408t1248r1588b1322],
16	run	VB	O	run	ccomp	5	SENT_77	[p7l1612t1268r1731b1311],
17	and	CC	O	and	_	0	SENT_77	[p7l1753t1248r1880b1311],
18	at	IN	O	at	quantmod	20	SENT_77	[p7l1902t1258r1965b1311],
19	least	JJS	O	least	mwe	18	SENT_77	[p7l1985t1248r2149b1311],
20	5	CD	PERCENT	5	num	21	SENT_77	[p7l9t1359r45b1422],
21	%	NN	PERCENT	%	nsubjpass	25	SENT_77	[p7l86t1359r150b1422],
22	of	IN	O	of	_	0	SENT_77	[p7l183t1359r260b1422],
23	samples	NNS	O	sample	prep_of	21	SENT_77	[p7l286t1359r569b1440],
24	were	VBD	O	be	auxpass	25	SENT_77	[p7l599t1379r770b1422],
25	repeated	VBN	O	repeat	conj_and	3	SENT_77	[p7l799t1359r1103b1440],
26	for	IN	O	for	_	0	SENT_77	[p7l1131t1359r1235b1422],
27	quality	NN	O	quality	nn	28	SENT_77	[p7l1263t1359r1509b1440],
28	control	NN	O	control	prep_for	25	SENT_77	[p7l1539t1359r1790b1422],
29	to	TO	O	to	aux	30	SENT_77	[p7l1819t1368r1886b1422],
30	ensure	VB	O	ensure	xcomp	25	SENT_77	[p7l1916t1379r2147b1422],
31	accuracy	NN	O	accuracy	dobj	30	SENT_77	[p7l9t1490r324b1551],
32	of	IN	O	of	_	0	SENT_77	[p7l358t1470r435b1533],
33	assay	NN	O	assay	nn	34	SENT_77	[p7l462t1490r651b1551],
34	results	NNS	O	result	prep_of	31	SENT_77	[p7l682t1470r933b1533],
35	.	.	O	.	_	0	SENT_77	[p7l682t1470r933b1533],

1	Any	DT	O	any	det	2	SENT_78	[p7l969t1471r1120b1551],
2	assay	NN	O	assay	nsubjpass	15	SENT_78	[p7l1154t1490r1342b1551],
3	with	IN	O	with	_	0	SENT_78	[p7l1375t1470r1532b1533],
4	call	JJ	O	call	amod	5	SENT_78	[p7l1564t1470r1691b1533],
5	rate	NN	O	rate	prep_with	2	SENT_78	[p7l1722t1479r1854b1533],
6	or	CC	O	or	_	0	SENT_78	[p7l1888t1490r1961b1533],
7	concordance	NN	O	concordance	conj_or	5	SENT_78	[p7l1991t1490r2144b1533, p7l8t1581r330b1644],
8	with	IN	O	with	_	0	SENT_78	[p7l357t1581r514b1644],
9	repeated	VBN	O	repeat	amod	10	SENT_78	[p7l539t1581r844b1662],
10	samples	NNS	O	sample	prep_with	5	SENT_78	[p7l874t1581r1156b1662],
11	<	JJR	O	<	amod	10	SENT_78	[p7l1185t1581r1328b1645],
12	95	CD	PERCENT	95	num	13	SENT_78	[p7l1185t1581r1328b1645],
13	%	NN	PERCENT	%	dep	11	SENT_78	[p7l1368t1582r1432b1644],
14	was	VBD	O	be	auxpass	15	SENT_78	[p7l1463t1601r1597b1644],
15	excluded	VBN	O	exclude	_	0	SENT_78	[p7l1626t1581r1949b1644],
16	from	IN	O	from	_	0	SENT_78	[p7l1976t1581r2148b1644],
17	analysis	NN	O	analysis	prep_from	15	SENT_78	[p7l9t1692r313b1773],
18	.	.	O	.	_	0	SENT_78	[p7l9t1692r313b1773],

1	Additional	JJ	O	additional	amod	2	SENT_79	[p7l339t1692r722b1755],
2	details	NNS	O	detail	nsubjpass	12	SENT_79	[p7l746t1692r976b1755],
3	for	IN	O	for	_	0	SENT_79	[p7l1001t1692r1104b1755],
4	gene	NN	O	gene	nn	5	SENT_79	[p7l1126t1712r1292b1773],
5	Variants	NNS	MISC	variant	prep_for	2	SENT_79	[p7l1316t1692r1596b1755],
6	including	VBG	O	include	_	0	SENT_79	[p7l1620t1692r1957b1773],
7	PCR	NN	O	pcr	nn	10	SENT_79	[p7l1981t1693r2148b1755],
8	and	CC	O	and	_	0	SENT_79	[p7l9t1803r135b1866],
9	pyrosequencing	NN	O	pyrosequencing	nn	10	SENT_79	[p7l158t1803r725b1884],
10	primers	NNS	O	primer	prep_including	5	SENT_79	[p7l750t1803r1021b1884],
11	are	VBP	O	be	auxpass	12	SENT_79	[p7l1049t1823r1154b1866],
12	included	VBN	O	include	_	0	SENT_79	[p7l1180t1803r1489b1866],
13	in	IN	O	in	_	0	SENT_79	[p7l1512t1803r1580b1865],
14	Supplementary	NNP	O	Supplementary	nn	15	SENT_79	[p7l1607t1803r2147b1884],
15	Table	NNP	O	Table	prep_in	12	SENT_79	[p7l7t1914r209b1977],
16	l.	VBD	O	l.	partmod	15	SENT_79	[p7l251t1914r303b1977],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_80	[p7l111t2026r1079b2088],
2	*	CD	NUMBER	*	num	3	SENT_80	[p7l111t2026r1079b2088],
3	lB/CYP3A5	NN	O	lb/cyp3a5	nsubjpass	21	SENT_80	[p7l111t2026r1079b2088],
4	*	CD	NUMBER	*	num	5	SENT_80	[p7l111t2026r1079b2088],
5	3C	NN	O	3c	dep	3	SENT_80	[p7l111t2026r1079b2088],
6	and	CC	O	and	_	0	SENT_80	[p7l1157t2026r1283b2088],
7	ABCBl	NN	O	abcbl	nn	8	SENT_80	[p7l1357t2026r1634b2088],
8	1236C	NN	O	1236c	conj_and	3	SENT_80	[p7l1725t2026r1950b2088],
9	>	JJR	O	>	amod	10	SENT_80	[p7l1985t2040r2042b2088],
10	T	NN	O	t	dep	8	SENT_80	[p7l2073t2027r2145b2099],
11	,	,	O	,	_	0	SENT_80	[p7l2073t2027r2145b2099],
12	2677G	NN	O	2677g	conj_and	3	SENT_80	[p7l8t2135r248b2199],
13	>	JJR	O	>	amod	14	SENT_80	[p7l280t2150r337b2198],
14	T/A	NN	O	t/a	dep	12	SENT_80	[p7l368t2136r528b2210],
15	,	,	O	,	_	0	SENT_80	[p7l368t2136r528b2210],
16	and	CC	O	and	_	0	SENT_80	[p7l565t2136r691b2198],
17	3435C	NN	O	3435c	nsubjpass	21	SENT_80	[p7l723t2135r954b2199],
18	>	JJR	O	>	amod	19	SENT_80	[p7l989t2150r1046b2198],
19	T	NN	O	t	dep	17	SENT_80	[p7l1077t2137r1129b2197],
20	were	VBD	O	be	auxpass	21	SENT_80	[p7l1161t2155r1331b2198],
21	included	VBN	O	include	_	0	SENT_80	[p7l1363t2136r1670b2198],
22	in	IN	O	in	_	0	SENT_80	[p7l1700t2136r1767b2197],
23	haplotype	NN	O	haplotype	nn	24	SENT_80	[p7l1798t2136r2147b2217],
24	analyses	NNS	O	analysis	prep_in	21	SENT_80	[p7l9t2248r325b2329],
25	.	.	O	.	_	0	SENT_80	[p7l9t2248r325b2329],

1	Haplotypes	NNS	O	haplotype	nsubjpass	3	SENT_81	[p7l354t2248r755b2329],
2	were	VBD	O	be	auxpass	3	SENT_81	[p7l782t2268r952b2311],
3	inferred	VBN	O	infer	_	0	SENT_81	[p7l978t2248r1258b2311],
4	using	VBG	O	use	xcomp	3	SENT_81	[p7l1281t2248r1472b2329],
5	PHASE	NNP	O	PHASE	nn	6	SENT_81	[p7l1497t2249r1776b2311],
6	Version	NNP	O	Version	dobj	4	SENT_81	[p7l1801t2248r2081b2311],
7	2	CD	NUMBER	2	num	6	SENT_81	[p7l2107t2249r2147b2310],
8	[	CD	NUMBER	[	number	9	SENT_81	[p7l13t2359r142b2435],
9	24	CD	NUMBER	24	amod	6	SENT_81	[p7l13t2359r142b2435],
10	,	,	O	,	_	0	SENT_81	[p7l13t2359r142b2435],
11	25	CD	NUMBER	25	num	12	SENT_81	[p7l166t2359r274b2435],
12	]	NN	O	]	npadvmod	17	SENT_81	[p7l166t2359r274b2435],
13	for	IN	O	for	_	0	SENT_81	[p7l300t2359r404b2422],
14	polymorphisms	NNS	O	polymorphism	prep_for	12	SENT_81	[p7l419t2359r970b2440],
15	with	IN	O	with	_	0	SENT_81	[p7l991t2359r1147b2422],
16	LD	NN	O	ld	prep_with	14	SENT_81	[p7l1165t2361r1281b2421],
17	>	JJR	O	>	dep	9	SENT_81	[p7l1315t2373r1372b2422],
18	0.7	CD	NUMBER	0.7	tmod	4	SENT_81	[p7l1403t2359r1530b2422],
19	.	.	O	.	_	0	SENT_81	[p7l1403t2359r1530b2422],

1	Any	DT	O	any	det	6	SENT_82	[p7l1552t2360r1704b2440],
2	subject	JJ	O	subject	amod	6	SENT_82	[p7l1726t2359r1975b2440],
3	with	IN	O	with	_	0	SENT_82	[p7l1992t2359r2148b2422],
4	missing	VBG	O	miss	prepc_with	2	SENT_82	[p7l7t2470r281b2551],
5	genotype	NN	O	genotype	dobj	4	SENT_82	[p7l310t2479r633b2551],
6	information	NN	O	information	nsubjpass	21	SENT_82	[p7l661t2470r1081b2533],
7	at	IN	O	at	_	0	SENT_82	[p7l1109t2480r1171b2533],
8	any	DT	O	any	det	9	SENT_82	[p7l1199t2490r1324b2551],
9	locus	NN	O	locus	prep_at	6	SENT_82	[p7l1352t2470r1536b2533],
10	of	IN	O	of	_	0	SENT_82	[p7l1565t2470r1642b2533],
11	the	DT	O	the	det	12	SENT_82	[p7l1664t2470r1770b2533],
12	haplotype	NN	O	haplotype	prep_of	9	SENT_82	[p7l1798t2470r2147b2551],
13	was	VBD	O	be	auxpass	14	SENT_82	[p7l8t2601r142b2644],
14	considered	VBN	O	consider	_	0	SENT_82	[p7l167t2581r550b2644],
15	to	TO	O	to	aux	16	SENT_82	[p7l572t2591r639b2644],
16	have	VB	O	have	xcomp	14	SENT_82	[p7l661t2581r828b2644],
17	an	DT	O	a	det	19	SENT_82	[p7l853t2601r933b2644],
18	unknown	JJ	O	unknown	amod	19	SENT_82	[p7l954t2581r1284b2644],
19	haplotype	NN	O	haplotype	dobj	16	SENT_82	[p7l1306t2581r1656b2662],
20	and	CC	O	and	_	0	SENT_82	[p7l1681t2581r1807b2644],
21	excluded	VBN	O	exclude	conj_and	14	SENT_82	[p7l1829t2581r2149b2644],
22	from	IN	O	from	_	0	SENT_82	[p7l8t2692r179b2755],
23	analysis	NN	O	analysis	prep_from	21	SENT_82	[p7l244t2692r543b2773],
24	.	.	O	.	_	0	SENT_82	[p7l244t2692r543b2773],

1	CYP3A4/3A5	NN	O	cyp3a4/3a5	nn	2	SENT_83	[p7l612t2692r1110b2755],
2	haplotypes	NNS	O	haplotype	nsubjpass	4	SENT_83	[p7l1176t2692r1559b2773],
3	were	VBD	O	be	auxpass	4	SENT_83	[p7l1624t2712r1794b2755],
4	grouped	VBN	O	group	_	0	SENT_83	[p7l1859t2692r2149b2773],
5	according	VBG	O	accord	_	0	SENT_83	[p7l9t2803r356b2884],
6	to	TO	O	to	prepc_according_to	4	SENT_83	[p7l394t2813r461b2866],
7	Baker	NNP	PERSON	Baker	pobj	4	SENT_83	[p7l500t2803r712b2866],
8	et	FW	O	et	nn	11	SENT_83	[p7l749t2813r812b2866],
9	al.	FW	O	al.	nn	11	SENT_83	[p7l850t2803r929b2866],
10	(	FW	O	(	nn	11	SENT_83	[p7l974t2804r1106b2881],
11	*	FW	O	*	dep	7	SENT_83	[p7l974t2804r1106b2881],
12	1	CD	NUMBER	1	dep	11	SENT_83	[p7l974t2804r1106b2881],
13	:	:	O	:	_	0	SENT_83	[p7l974t2804r1106b2881],
14	CYP3A4	NN	O	cyp3a4	nn	16	SENT_83	[p7l1151t2803r2145b2878],
15	*	CD	NUMBER	*	num	16	SENT_83	[p7l1151t2803r2145b2878],
16	lA/CYP3A5	NN	O	la/cyp3a5	dep	11	SENT_83	[p7l1151t2803r2145b2878],
17	*	CD	NUMBER	*	num	18	SENT_83	[p7l1151t2803r2145b2878],
18	3C	NN	O	3c	dep	16	SENT_83	[p7l1151t2803r2145b2878],
19	,	,	O	,	_	0	SENT_83	[p7l1151t2803r2145b2878],
20	*	NN	O	*	appos	18	SENT_83	[p7l12t2914r113b2976],
21	2	CD	NUMBER	2	num	20	SENT_83	[p7l12t2914r113b2976],
22	:	:	O	:	_	0	SENT_83	[p7l12t2914r113b2976],
23	CYP3A4	NN	O	cyp3a4	nn	25	SENT_83	[p7l202t2914r1195b2987],
24	*	CD	NUMBER	*	num	25	SENT_83	[p7l202t2914r1195b2987],
25	lB/CYP3A5	NN	O	lb/cyp3a5	dep	11	SENT_83	[p7l202t2914r1195b2987],
26	*	CD	NUMBER	*	num	27	SENT_83	[p7l202t2914r1195b2987],
27	lA	NN	O	la	dep	25	SENT_83	[p7l202t2914r1195b2987],
28	,	,	O	,	_	0	SENT_83	[p7l202t2914r1195b2987],
29	*	CD	NUMBER	*	number	30	SENT_83	[p7l1285t2914r1386b2976],
30	3	CD	NUMBER	3	appos	27	SENT_83	[p7l1285t2914r1386b2976],
31	:	:	O	:	_	0	SENT_83	[p7l1285t2914r1386b2976],
32	CYP3A4	NN	O	cyp3a4	nn	35	SENT_83	[p7l1474t2914r2149b2976],
33	*	CD	NUMBER	*	num	35	SENT_83	[p7l1474t2914r2149b2976],
34	lA/CYP	NN	O	la/cyp	nn	35	SENT_83	[p7l1474t2914r2149b2976],
35	3A5	NN	O	3a5	dep	11	SENT_83	[p7l10t3025r330b3099],
36	*	CD	NUMBER	*	num	37	SENT_83	[p7l10t3025r330b3099],
37	lA	NN	O	la	dep	35	SENT_83	[p7l10t3025r330b3099],
38	,	,	O	,	_	0	SENT_83	[p7l10t3025r330b3099],
39	and	CC	O	and	_	0	SENT_83	[p7l379t3025r505b3088],
40	*	NN	O	*	dep	11	SENT_83	[p7l553t3025r654b3088],
41	4	CD	NUMBER	4	num	40	SENT_83	[p7l553t3025r654b3088],
42	:	:	O	:	_	0	SENT_83	[p7l553t3025r654b3088],
43	CYP3A4	NN	O	cyp3a4	nn	45	SENT_83	[p7l706t3025r1702b3102],
44	*	CD	NUMBER	*	num	45	SENT_83	[p7l706t3025r1702b3102],
45	lB/CYP3A5	NN	O	lb/cyp3a5	dep	11	SENT_83	[p7l706t3025r1702b3102],
46	*	CD	NUMBER	*	num	47	SENT_83	[p7l706t3025r1702b3102],
47	3C	NN	O	3c	dep	45	SENT_83	[p7l706t3025r1702b3102],
48	)	CD	NUMBER	)	number	49	SENT_83	[p7l706t3025r1702b3102],
49	[	CD	NUMBER	[	dep	45	SENT_83	[p7l1756t3025r1913b3101],
50	26	CD	NUMBER	26	num	51	SENT_83	[p7l1756t3025r1913b3101],
51	]	NN	O	]	dep	49	SENT_83	[p7l1756t3025r1913b3101],
52	.	.	O	.	_	0	SENT_83	[p7l1756t3025r1913b3101],

1	After	IN	O	after	dep	10	SENT_84	[p7l1962t3025r2150b3088],
2	ABCBl	NN	O	abcbl	nn	4	SENT_84	[p7l7t3136r284b3199],
3	haplotype	NN	O	haplotype	nn	4	SENT_84	[p7l338t3136r688b3217],
4	inference	NN	O	inference	pobj	1	SENT_84	[p7l734t3136r1063b3198],
5	(	CD	NUMBER	(	num	8	SENT_84	[p7l1113t3136r1498b3217],
6	wild	JJ	O	wild	amod	8	SENT_84	[p7l1113t3136r1498b3217],
7	—	NN	O	—	nn	8	SENT_84	[p7l1113t3136r1498b3217],
8	type	NN	O	type	dep	4	SENT_84	[p7l1113t3136r1498b3217],
9	:	:	O	:	_	0	SENT_84	[p7l1113t3136r1498b3217],
10	C	NN	O	c	_	0	SENT_84	[p7l1550t3136r1809b3210],
11	.	.	O	.	_	0	SENT_84	[p7l1550t3136r1809b3210],

1	—	NN	O	—	_	0	SENT_85	[p7l1550t3136r1809b3210],
2	.	.	O	.	_	0	SENT_85	[p7l1550t3136r1809b3210],

1	G	NN	O	g	_	0	SENT_86	[p7l1550t3136r1809b3210],
2	.	.	O	.	_	0	SENT_86	[p7l1550t3136r1809b3210],

1	—	NN	O	—	_	0	SENT_87	[p7l1550t3136r1809b3210],
2	.	.	O	.	_	0	SENT_87	[p7l1550t3136r1809b3210],

1	C	NN	O	c	_	0	SENT_88	[p7l1550t3136r1809b3210],
2	,	,	O	,	_	0	SENT_88	[p7l1550t3136r1809b3210],
3	Variant	JJ	O	variant	appos	1	SENT_88	[p7l1858t3136r2142b3198],
4	:	:	O	:	_	0	SENT_88	[p7l1858t3136r2142b3198],
5	T	NN	O	t	dep	1	SENT_88	[p7l7t3249r385b3325],
6	.	.	O	.	_	0	SENT_88	[p7l7t3249r385b3325],

1	—	NN	O	—	_	0	SENT_89	[p7l7t3249r385b3325],
2	.	.	O	.	_	0	SENT_89	[p7l7t3249r385b3325],

1	T	NN	O	t	_	0	SENT_90	[p7l7t3249r385b3325],
2	(	CD	NUMBER	(	num	1	SENT_90	[p7l7t3249r385b3325],
3	A	DT	O	a	det	4	SENT_90	[p7l7t3249r385b3325],
4	)	NN	O	)	dep	1	SENT_90	[p7l7t3249r385b3325],
5	.	.	O	.	_	0	SENT_90	[p7l7t3249r385b3325],

1	—	NN	O	—	_	0	SENT_91	[p7l7t3249r385b3325],
2	.	.	O	.	_	0	SENT_91	[p7l7t3249r385b3325],

1	T	NN	O	t	_	0	SENT_92	[p7l7t3249r385b3325],
2	,	,	O	,	_	0	SENT_92	[p7l7t3249r385b3325],
3	mixed	JJ	O	mixed	amod	1	SENT_92	[p7l418t3248r658b3311],
4	:	:	O	:	_	0	SENT_92	[p7l418t3248r658b3311],
5	other	JJ	O	other	amod	6	SENT_92	[p7l694t3248r923b3325],
6	)	NN	O	)	dep	11	SENT_92	[p7l694t3248r923b3325],
7	,	,	O	,	_	0	SENT_92	[p7l694t3248r923b3325],
8	each	DT	O	each	det	9	SENT_92	[p7l955t3248r1117b3311],
9	patient	NN	O	patient	appos	6	SENT_92	[p7l1145t3248r1388b3329],
10	was	VBD	O	be	aux	11	SENT_92	[p7l1416t3268r1551b3311],
11	assigned	VBN	O	assign	dep	1	SENT_92	[p7l1583t3248r1886b3329],
12	a	DT	O	a	det	17	SENT_92	[p7l1916t3268r1953b3311],
13	diplotype	NN	O	diplotype	nn	17	SENT_92	[p7l1983t3248r2146b3329, p7l8t3369r203b3440],
14	number	NN	O	number	nn	17	SENT_92	[p7l231t3359r504b3422],
15	(	CD	NUMBER	(	number	16	SENT_92	[p7l533t3359r718b3436],
16	1-5	CD	NUMBER	1-5	num	17	SENT_92	[p7l533t3359r718b3436],
17	)	NN	O	)	dobj	11	SENT_92	[p7l533t3359r718b3436],
18	in	IN	O	in	_	0	SENT_92	[p7l748t3359r816b3421],
19	order	NN	O	order	prep_in	17	SENT_92	[p7l844t3359r1031b3422],
20	of	IN	O	of	_	0	SENT_92	[p7l1058t3359r1135b3422],
21	increasing	VBG	O	increase	amod	23	SENT_92	[p7l1157t3359r1520b3440],
22	genetic	JJ	O	genetic	amod	23	SENT_92	[p7l1550t3359r1804b3440],
23	Variation	NN	O	variation	prep_of	19	SENT_92	[p7l1833t3359r2149b3422],
24	as	IN	O	as	_	0	SENT_92	[p7l9t3490r78b3533],
25	described	VBN	O	describe	dep	1	SENT_92	[p7l106t3470r446b3533],
26	in	IN	O	in	_	0	SENT_92	[p7l471t3470r539b3532],
27	Sissung	NNP	LOCATION	Sissung	prep_in	25	SENT_92	[p7l567t3470r837b3551],
28	et	FW	O	et	nn	30	SENT_92	[p7l865t3480r928b3533],
29	al.	FW	O	al.	nn	30	SENT_92	[p7l955t3470r1034b3533],
30	[	FW	O	[	dobj	11	SENT_92	[p7l1070t3471r1228b3546],
31	27	CD	NUMBER	27	num	32	SENT_92	[p7l1070t3471r1228b3546],
32	]	NN	O	]	nsubj	11	SENT_92	[p7l1070t3471r1228b3546],
33	.	.	O	.	_	0	SENT_92	[p7l1070t3471r1228b3546],

1	Statistical	JJ	O	statistical	amod	2	SENT_93	[p7l17t3582r367b3645],
2	analysis	NN	O	analysis	_	0	SENT_93	[p7l402t3582r686b3663],

1	Genotype	NN	O	genotype	nn	2	SENT_94	[p8l16t78r361b159],
2	calls	NNS	O	call	nsubjpass	4	SENT_94	[p8l387t78r547b140],
3	were	VBD	O	be	auxpass	4	SENT_94	[p8l575t97r746b141],
4	assessed	VBN	O	assess	_	0	SENT_94	[p8l774t78r1074b140],
5	for	IN	O	for	_	0	SENT_94	[p8l1099t78r1202b140],
6	concordance	NN	O	concordance	prep_for	4	SENT_94	[p8l1226t78r1677b140],
7	with	IN	O	with	_	0	SENT_94	[p8l1704t78r1860b141],
8	HardyWeinberg	NN	ORGANIZATION	hardyweinberg	nn	9	SENT_94	[p8l1885t78r2153b159, p8l13t189r366b270],
9	Equilibrium	NN	ORGANIZATION	equilibrium	prep_with	6	SENT_94	[p8l391t189r825b270],
10	(	CD	NUMBER	(	num	12	SENT_94	[p8l850t190r1106b267],
11	HWE	NN	O	hwe	nn	12	SENT_94	[p8l850t190r1106b267],
12	)	NN	O	)	dobj	4	SENT_94	[p8l850t190r1106b267],
13	using	VBG	O	use	partmod	12	SENT_94	[p8l1133t189r1324b270],
14	a	DT	O	a	det	20	SENT_94	[p8l1351t209r1387b252],
15	Pearson	NNP	O	Pearson	poss	18	SENT_94	[p8l1410t190r1753b252],
16	’s	POS	O	’s	_	0	SENT_94	[p8l1410t190r1753b252],
17	chi	NN	O	chus	nn	18	SENT_94	[p8l1781t189r2150b270],
18	—	NN	O	—	nn	20	SENT_94	[p8l1781t189r2150b270],
19	square	JJ	O	square	amod	20	SENT_94	[p8l1781t189r2150b270],
20	test	NN	O	test	dobj	13	SENT_94	[p8l14t310r138b363],
21	with	IN	O	with	_	0	SENT_94	[p8l171t300r327b363],
22	df	NN	O	df	prep_with	20	SENT_94	[p8l361t300r438b363],
23	=	JJ	O	=	amod	22	SENT_94	[p8l467t329r528b352],
24	1	CD	NUMBER	1	tmod	23	SENT_94	[p8l572t301r624b363],
25	.	.	O	.	_	0	SENT_94	[p8l572t301r624b363],

1	Assays	NNS	O	assay	nsubjpass	13	SENT_95	[p8l661t301r909b381],
2	with	IN	O	with	_	0	SENT_95	[p8l944t300r1101b363],
3	HWE	NN	O	hwe	nn	5	SENT_95	[p8l1134t302r1336b363],
4	p	NN	O	p	nn	5	SENT_95	[p8l1360t322r1410b380],
5	value	NN	O	value	prep_with	1	SENT_95	[p8l1443t300r1635b363],
6	<	JJR	O	<	amod	5	SENT_95	[p8l1669t314r1726b363],
7	0.05	CD	NUMBER	0.05	dep	6	SENT_95	[p8l1758t300r1907b363],
8	in	IN	O	in	dep	7	SENT_95	[p8l1944t300r2012b362],
9	the	DT	O	the	det	10	SENT_95	[p8l2044t300r2151b363],
10	cohort	NN	O	cohort	pobj	8	SENT_95	[p8l15t411r243b474],
11	were	VBD	O	be	auxpass	13	SENT_95	[p8l294t431r464b474],
12	then	RB	O	then	advmod	13	SENT_95	[p8l517t411r669b474],
13	tested	VBN	O	test	dep	21	SENT_95	[p8l721t411r929b474],
14	in	IN	O	in	_	0	SENT_95	[p8l980t411r1048b473],
15	the	DT	O	the	det	17	SENT_95	[p8l1098t411r1205b474],
16	Caucasian	JJ	MISC	caucasian	amod	17	SENT_95	[p8l1259t411r1626b474],
17	subcohort	NN	O	subcohort	prep_in	13	SENT_95	[p8l1680t411r2029b474],
18	as	IN	O	as	_	0	SENT_95	[p8l2082t431r2150b474],
19	population	NN	O	population	nn	20	SENT_95	[p8l13t522r397b603],
20	admixture	NN	O	admixture	prep_as	17	SENT_95	[p8l444t522r804b584],
21	violates	VBZ	O	violate	_	0	SENT_95	[p8l850t522r1126b584],
22	key	JJ	O	key	amod	23	SENT_95	[p8l1173t522r1300b603],
23	assumptions	NNS	O	assumption	dobj	21	SENT_95	[p8l1348t522r1785b603],
24	of	IN	O	of	_	0	SENT_95	[p8l1834t522r1911b584],
25	HWE	NN	O	hwe	prep_of	23	SENT_95	[p8l1950t523r2152b584],
26	[	CD	NUMBER	[	num	25	SENT_95	[p8l21t633r180b708],
27	28	CD	NUMBER	28	num	28	SENT_95	[p8l21t633r180b708],
28	]	NN	O	]	nsubj	21	SENT_95	[p8l21t633r180b708],
29	.	.	O	.	_	0	SENT_95	[p8l21t633r180b708],

1	Each	DT	O	each	det	2	SENT_96	[p8l221t633r399b695],
2	genotype	NN	O	genotype	nsubjpass	7	SENT_96	[p8l437t642r762b714],
3	or	CC	O	or	_	0	SENT_96	[p8l802t652r875b695],
4	haplotype	NN	O	haplotype	conj_or	2	SENT_96	[p8l910t633r1262b714],
5	was	VBD	O	be	auxpass	7	SENT_96	[p8l1301t652r1435b696],
6	individually	RB	O	individually	advmod	7	SENT_96	[p8l1474t633r1906b714],
7	tested	VBN	O	test	_	0	SENT_96	[p8l1944t633r2153b695],
8	for	IN	O	for	_	0	SENT_96	[p8l15t745r118b808],
9	an	DT	O	a	det	10	SENT_96	[p8l158t765r239b808],
10	association	NN	O	association	prep_for	7	SENT_96	[p8l280t745r676b808],
11	with	IN	O	with	_	0	SENT_96	[p8l715t745r873b808],
12	efﬁcacy	NN	O	efﬁcacy	prep_with	10	SENT_96	[p8l913t745r1193b826],
13	or	CC	O	or	_	0	SENT_96	[p8l1235t765r1308b808],
14	toxicity	NN	O	toxicity	conj_or	12	SENT_96	[p8l1345t745r1617b826],
15	using	VBG	O	use	xcomp	7	SENT_96	[p8l1657t745r1849b826],
16	logistic	JJ	O	logistic	amod	18	SENT_96	[p8l1890t745r2150b826],
17	regression	NN	O	regression	nn	18	SENT_96	[p8l14t856r381b937],
18	modeling	NN	O	modeling	dobj	15	SENT_96	[p8l416t856r771b937],
19	.	.	O	.	_	0	SENT_96	[p8l416t856r771b937],

1	In	IN	O	in	_	0	SENT_97	[p8l811t858r883b918],
2	the	DT	O	the	det	4	SENT_97	[p8l918t856r1025b919],
3	haplotype	NN	O	haplotype	nn	4	SENT_97	[p8l1060t856r1412b937],
4	analysis	NN	O	analysis	prep_in	14	SENT_97	[p8l1450t856r1754b937],
5	,	,	O	,	_	0	SENT_97	[p8l1450t856r1754b937],
6	the	DT	O	the	det	12	SENT_97	[p8l1792t856r1899b919],
7	“	NN	O	“	nn	12	SENT_97	[p8l1944t856r2149b919],
8	vari	NN	O	varus	nn	12	SENT_97	[p8l1944t856r2149b919],
9	—	CD	NUMBER	—	num	12	SENT_97	[p8l1944t856r2149b919],
10	ant	NN	O	ant	nn	12	SENT_97	[p8l17t968r163b1030],
11	”	NN	O	”	nn	12	SENT_97	[p8l17t968r163b1030],
12	group	NN	O	group	nsubjpass	14	SENT_97	[p8l238t987r442b1048],
13	was	VBD	O	be	auxpass	14	SENT_97	[p8l508t987r642b1030],
14	deﬁned	VBN	O	deﬁned	_	0	SENT_97	[p8l709t967r970b1030],
15	by	IN	O	by	_	0	SENT_97	[p8l1033t967r1121b1048],
16	grouping	VBG	O	group	amod	17	SENT_97	[p8l1187t967r1505b1048],
17	diplotypes	NNS	O	diplotype	agent	14	SENT_97	[p8l1573t967r1961b1048],
18	.	.	O	.	_	0	SENT_97	[p8l1573t967r1961b1048],

1	For	IN	O	for	_	0	SENT_98	[p8l2030t969r2153b1030],
2	CYP3A4/3A5	NN	O	cyp3a4/3a5	prep_for	19	SENT_98	[p8l16t1078r538b1152],
3	,	,	O	,	_	0	SENT_98	[p8l16t1078r538b1152],
4	any	DT	O	any	det	5	SENT_98	[p8l590t1098r714b1159],
5	individual	JJ	O	individual	nsubjpass	19	SENT_98	[p8l761t1078r1123b1141],
6	carrying	VBG	O	carry	partmod	5	SENT_98	[p8l1170t1078r1466b1159],
7	the	DT	O	the	det	17	SENT_98	[p8l1513t1078r1620b1141],
8	*	NN	O	*	nn	17	SENT_98	[p8l1671t1078r1753b1140],
9	2	CD	NUMBER	2	num	17	SENT_98	[p8l1671t1078r1753b1140],
10	haplotype	NN	O	haplotype	nn	17	SENT_98	[p8l1799t1078r2151b1159],
11	(	CD	NUMBER	(	num	17	SENT_98	[p8l18t1189r1053b1267],
12	CYP3A4	NN	O	cyp3a4	nn	17	SENT_98	[p8l18t1189r1053b1267],
13	*	CD	NUMBER	*	num	17	SENT_98	[p8l18t1189r1053b1267],
14	1B/CYP3A5	NN	O	1b/cyp3a5	nn	17	SENT_98	[p8l18t1189r1053b1267],
15	*	CD	NUMBER	*	num	17	SENT_98	[p8l18t1189r1053b1267],
16	1A	NN	O	1a	nn	17	SENT_98	[p8l18t1189r1053b1267],
17	)	NN	O	)	dobj	6	SENT_98	[p8l18t1189r1053b1267],
18	was	VBD	O	be	auxpass	19	SENT_98	[p8l1087t1209r1221b1252],
19	considered	VBN	O	consider	_	0	SENT_98	[p8l1253t1189r1641b1252],
20	a	DT	O	a	det	22	SENT_98	[p8l1671t1209r1708b1252],
21	variant	JJ	O	variant	amod	22	SENT_98	[p8l1737t1189r1985b1252],
22	carrier	NN	O	carrier	dobj	19	SENT_98	[p8l2015t1209r2149b1252, p8l14t1301r155b1364],
23	.	.	O	.	_	0	SENT_98	[p8l2015t1209r2149b1252, p8l14t1301r155b1364],

1	For	IN	O	for	_	0	SENT_99	[p8l188t1303r312b1364],
2	ABCB1	NN	O	abcb1	prep_for	12	SENT_99	[p8l338t1302r643b1375],
3	,	,	O	,	_	0	SENT_99	[p8l338t1302r643b1375],
4	any	DT	O	any	det	5	SENT_99	[p8l677t1321r802b1382],
5	individual	JJ	O	individual	nsubjpass	12	SENT_99	[p8l831t1301r1193b1364],
6	with	IN	O	with	_	0	SENT_99	[p8l1223t1301r1379b1364],
7	diplotype	NN	O	diplotype	prep_with	5	SENT_99	[p8l1409t1301r1744b1382],
8	4	CD	NUMBER	4	num	7	SENT_99	[p8l1773t1302r1815b1363],
9	or	CC	O	or	_	0	SENT_99	[p8l1845t1321r1918b1364],
10	5	CD	NUMBER	5	num	7	SENT_99	[p8l1946t1301r1983b1364],
11	was	VBD	O	be	auxpass	12	SENT_99	[p8l2016t1321r2150b1364],
12	considered	VBN	O	consider	_	0	SENT_99	[p8l15t1412r403b1475],
13	a	DT	O	a	det	15	SENT_99	[p8l440t1432r477b1475],
14	variant	JJ	O	variant	amod	15	SENT_99	[p8l514t1412r762b1475],
15	carrier	NN	O	carrier	dobj	12	SENT_99	[p8l799t1412r1033b1475],
16	and	CC	O	and	_	0	SENT_99	[p8l1070t1412r1196b1475],
17	was	VBD	O	be	auxpass	18	SENT_99	[p8l1233t1432r1367b1475],
18	compared	VBN	O	compare	conj_and	12	SENT_99	[p8l1407t1412r1759b1493],
19	with	IN	O	with	_	0	SENT_99	[p8l1796t1412r1953b1475],
20	noncarrier	JJ	O	noncarrier	amod	21	SENT_99	[p8l1990t1432r2149b1475, p8l15t1522r249b1584],
21	diplotypes	NNS	O	diplotype	prep_with	18	SENT_99	[p8l284t1522r653b1603],
22	1-3	CD	NUMBER	1-3	dobj	12	SENT_99	[p8l699t1522r841b1585],
23	.	.	O	.	_	0	SENT_99	[p8l699t1522r841b1585],

1	For	IN	O	for	_	0	SENT_100	[p8l880t1523r1004b1584],
2	the	DT	O	the	det	4	SENT_100	[p8l1038t1522r1145b1584],
3	genotype	NN	O	genotype	nn	4	SENT_100	[p8l1182t1531r1507b1603],
4	analyses	NNS	O	analysis	prep_for	9	SENT_100	[p8l1546t1522r1865b1603],
5	,	,	O	,	_	0	SENT_100	[p8l1546t1522r1865b1603],
6	variant	JJ	O	variant	amod	7	SENT_100	[p8l1904t1522r2153b1584],
7	carriers	NNS	O	carrier	nsubjpass	9	SENT_100	[p8l15t1633r280b1695],
8	were	VBD	O	be	auxpass	9	SENT_100	[p8l318t1652r488b1695],
9	compared	VBN	O	compare	_	0	SENT_100	[p8l526t1633r878b1714],
10	with	IN	O	with	_	0	SENT_100	[p8l913t1633r1069b1695],
11	homozygotic	JJ	O	homozygotic	amod	13	SENT_100	[p8l1104t1633r1570b1714],
12	wild	JJ	O	wild	amod	13	SENT_100	[p8l1608t1633r1948b1714],
13	—	NN	O	—	prep_with	9	SENT_100	[p8l1608t1633r1948b1714],
14	type	NN	O	type	nn	15	SENT_100	[p8l1608t1633r1948b1714],
15	individuals	NNS	O	individual	nsubj	16	SENT_100	[p8l1985t1633r2149b1695, p8l15t1744r269b1806],
16	(	VBP	O	(	rcmod	13	SENT_100	[p8l321t1744r686b1821],
17	dominant	JJ	O	dominant	amod	20	SENT_100	[p8l321t1744r686b1821],
18	genetic	JJ	O	genetic	amod	20	SENT_100	[p8l733t1744r988b1825],
19	model	NN	O	model	nn	20	SENT_100	[p8l1037t1744r1306b1821],
20	)	NN	O	)	dobj	16	SENT_100	[p8l1037t1744r1306b1821],
21	.	.	O	.	_	0	SENT_100	[p8l1037t1744r1306b1821],

1	The	DT	O	the	det	4	SENT_101	[p8l1357t1744r1493b1806],
2	primary	JJ	O	primary	amod	4	SENT_101	[p8l1540t1744r1822b1825],
3	efﬁcacy	NN	O	efﬁcacy	nn	4	SENT_101	[p8l1870t1743r2151b1825],
4	endpoint	NN	O	endpoint	nsubj	8	SENT_101	[p8l15t1856r329b1937],
5	was	VBD	O	be	cop	8	SENT_101	[p8l366t1876r500b1919],
6	clinical	JJ	O	clinical	amod	8	SENT_101	[p8l541t1856r803b1919],
7	complete	JJ	O	complete	amod	8	SENT_101	[p8l843t1856r1170b1937],
8	response	NN	O	response	_	0	SENT_101	[p8l1207t1876r1519b1937],
9	(	CD	NUMBER	(	num	10	SENT_101	[p8l1561t1856r1772b1933],
10	cCR	NN	O	ccr	dep	8	SENT_101	[p8l1561t1856r1772b1933],
11	)	CD	NUMBER	)	dep	10	SENT_101	[p8l1561t1856r1772b1933],
12	to	TO	O	to	_	0	SENT_101	[p8l1813t1866r1879b1919],
13	taxane	JJ	O	taxane	amod	15	SENT_101	[p8l1919t1865r2151b1919],
14	therapy	NN	O	therapy	nn	15	SENT_101	[p8l14t1967r281b2048],
15	(	NN	O	(	prep_to	8	SENT_101	[p8l309t1968r451b2048],
16	yes	RB	O	yes	advmod	15	SENT_101	[p8l309t1968r451b2048],
17	vs.	IN	O	vs.	_	0	SENT_101	[p8l477t1987r571b2030],
18	no	DT	O	no	det	19	SENT_101	[p8l600t1968r735b2044],
19	)	NN	O	)	prep_vs.	15	SENT_101	[p8l600t1968r735b2044],
20	.	.	O	.	_	0	SENT_101	[p8l600t1968r735b2044],

1	The	DT	O	the	det	4	SENT_102	[p8l763t1967r900b2030],
2	primary	JJ	O	primary	amod	4	SENT_102	[p8l924t1967r1206b2048],
3	toxicity	NN	O	toxicity	nn	4	SENT_102	[p8l1231t1967r1503b2048],
4	endpoint	NN	O	endpoint	nsubj	7	SENT_102	[p8l1529t1967r1842b2048],
5	was	VBD	O	be	cop	7	SENT_102	[p8l1865t1987r1999b2030],
6	any	DT	O	any	det	7	SENT_102	[p8l2027t1987r2151b2048],
7	grade	NN	O	grade	_	0	SENT_102	[p8l16t2078r211b2159],
8	3	CD	NUMBER	3	amod	7	SENT_102	[p8l243t2078r278b2141],
9	or	CC	O	or	_	0	SENT_102	[p8l312t2097r385b2140],
10	higher	JJR	O	higher	amod	7	SENT_102	[p8l410t2078r640b2159],
11	adverse	JJ	O	adverse	amod	12	SENT_102	[p8l669t2078r938b2141],
12	event	NN	O	event	dep	17	SENT_102	[p8l968t2087r1160b2141],
13	during	IN	O	during	_	0	SENT_102	[p8l1189t2078r1419b2159],
14	taxane	NN	O	taxane	nn	15	SENT_102	[p8l1448t2087r1680b2140],
15	therapy	NN	O	therapy	prep_during	12	SENT_102	[p8l1709t2078r1975b2159],
16	(	CD	NUMBER	(	num	15	SENT_102	[p8l2008t2079r2150b2159],
17	yes	UH	O	yes	dep	7	SENT_102	[p8l2008t2079r2150b2159],
18	vs.	CC	O	vs.	prep	7	SENT_102	[p8l15t2209r109b2252],
19	no	DT	O	no	det	20	SENT_102	[p8l145t2190r280b2267],
20	)	NN	O	)	dep	18	SENT_102	[p8l145t2190r280b2267],
21	.	.	O	.	_	0	SENT_102	[p8l145t2190r280b2267],

1	Secondary	JJ	O	secondary	amod	2	SENT_103	[p8l318t2189r692b2270],
2	endpoints	NNS	O	endpoint	nsubj	10	SENT_103	[p8l724t2189r1068b2270],
3	of	IN	O	of	_	0	SENT_103	[p8l1102t2189r1179b2252],
4	efﬁcacy	NN	O	efﬁcacy	prep_of	2	SENT_103	[p8l1205t2189r1485b2270],
5	and	CC	O	and	_	0	SENT_103	[p8l1520t2189r1645b2252],
6	toxicity	NN	O	toxicity	prep_of	2	SENT_103	[p8l1675t2189r1948b2270],
7	were	VBD	O	be	cop	10	SENT_103	[p8l1980t2209r2151b2252],
8	clinical	JJ	O	clinical	amod	10	SENT_103	[p8l15t2300r277b2363],
9	response	NN	O	response	nn	10	SENT_103	[p8l300t2320r611b2381],
10	rate	NN	O	rate	_	0	SENT_103	[p8l635t2310r767b2363],
11	(	CD	NUMBER	(	num	12	SENT_103	[p8l794t2301r999b2378],
12	cRR	NN	O	crr	dep	10	SENT_103	[p8l794t2301r999b2378],
13	;	:	O	;	_	0	SENT_103	[p8l794t2301r999b2378],
14	cCR	NN	O	ccr	dep	10	SENT_103	[p8l1027t2301r1185b2363],
15	+	CC	O	+	_	0	SENT_103	[p8l1219t2309r1280b2369],
16	cPR	NN	O	cpr	dep	10	SENT_103	[p8l1316t2302r1464b2363],
17	=	JJ	O	=	amod	19	SENT_103	[p8l1498t2329r1559b2352],
18	cRR	NN	O	crr	nn	19	SENT_103	[p8l1595t2301r1779b2377],
19	)	NN	O	)	dep	16	SENT_103	[p8l1595t2301r1779b2377],
20	and	CC	O	and	_	0	SENT_103	[p8l1807t2300r1932b2363],
21	grade	NN	O	grade	conj_and	10	SENT_103	[p8l1956t2300r2151b2381],
22	3	CD	NUMBER	3	num	21	SENT_103	[p8l17t2412r52b2474],
23	or	CC	O	or	_	0	SENT_103	[p8l96t2431r169b2474],
24	higher	JJR	O	higher	amod	25	SENT_103	[p8l205t2411r434b2492],
25	neuropathy	NN	O	neuropathy	conj_and	10	SENT_103	[p8l470t2411r871b2492],
26	during	IN	O	during	_	0	SENT_103	[p8l911t2411r1141b2492],
27	paclitaxel	NN	O	paclitaxel	nn	28	SENT_103	[p8l1179t2411r1529b2492],
28	therapy	NN	O	therapy	prep_during	10	SENT_103	[p8l1567t2411r1853b2492],
29	,	,	O	,	_	0	SENT_103	[p8l1567t2411r1853b2492],
30	respectively	RB	O	respectively	advmod	10	SENT_103	[p8l1894t2431r2149b2492, p8l14t2521r235b2602],
31	.	.	O	.	_	0	SENT_103	[p8l1894t2431r2149b2492, p8l14t2521r235b2602],

1	Following	VBG	O	follow	_	0	SENT_104	[p8l281t2521r647b2602],
2	univariate	JJ	O	univariate	amod	3	SENT_104	[p8l689t2521r1047b2583],
3	testing	NN	O	testing	prep_following	35	SENT_104	[p8l1089t2521r1345b2602],
4	,	,	O	,	_	0	SENT_104	[p8l1089t2521r1345b2602],
5	additional	JJ	O	additional	amod	6	SENT_104	[p8l1392t2521r1747b2583],
6	covariates	NNS	O	covariate	appos	3	SENT_104	[p8l1790t2521r2150b2583],
7	for	IN	O	for	_	0	SENT_104	[p8l15t2631r118b2694],
8	efﬁcacy	NN	O	efﬁcacy	nn	11	SENT_104	[p8l160t2631r441b2713],
9	(	CD	NUMBER	(	num	11	SENT_104	[p8l488t2632r816b2713],
10	estrogen	NN	O	estrogen	nn	11	SENT_104	[p8l488t2632r816b2713],
11	receptor	NN	O	receptor	prep_for	6	SENT_104	[p8l859t2641r1154b2713],
12	(	CD	NUMBER	(	num	15	SENT_104	[p8l1197t2632r1365b2709],
13	ER	NN	O	er	nn	15	SENT_104	[p8l1197t2632r1365b2709],
14	)	NN	O	)	nn	15	SENT_104	[p8l1197t2632r1365b2709],
15	status	NN	O	status	nsubjpass	35	SENT_104	[p8l1413t2641r1631b2706],
16	,	,	O	,	_	0	SENT_104	[p8l1413t2641r1631b2706],
17	tumor	NN	O	tumor	nn	18	SENT_104	[p8l1677t2641r1891b2694],
18	grade	NN	O	grade	appos	15	SENT_104	[p8l1933t2632r2148b2713],
19	,	,	O	,	_	0	SENT_104	[p8l1933t2632r2148b2713],
20	concurrent	JJ	O	concurrent	amod	22	SENT_104	[p8l15t2752r398b2805],
21	trastuzumab	NN	O	trastuzumab	nn	22	SENT_104	[p8l477t2743r913b2805],
22	treatment	NN	O	treatment	appos	15	SENT_104	[p8l995t2752r1352b2817],
23	,	,	O	,	_	0	SENT_104	[p8l995t2752r1352b2817],
24	whether	IN	O	whether	dep	28	SENT_104	[p8l1437t2743r1724b2806],
25	paclitaxel	NN	O	paclitaxel	nn	26	SENT_104	[p8l1802t2743r2151b2824],
26	treatment	NN	O	treatment	nsubjpass	28	SENT_104	[p8l14t2864r354b2918],
27	was	VBD	O	be	auxpass	28	SENT_104	[p8l377t2875r511b2918],
28	preceded	VBN	O	precede	dep	15	SENT_104	[p8l534t2855r858b2936],
29	by	IN	O	by	_	0	SENT_104	[p8l879t2855r967b2936],
30	other	JJ	O	other	amod	33	SENT_104	[p8l991t2855r1174b2918],
31	chemotherapy	NN	O	chemotherapy	nn	33	SENT_104	[p8l1196t2855r1701b2936],
32	phase	NN	O	phase	nn	33	SENT_104	[p8l1724t2855r1955b2936],
33	)	NN	O	)	agent	28	SENT_104	[p8l1724t2855r1955b2936],
34	were	VBD	O	be	auxpass	35	SENT_104	[p8l1980t2875r2151b2918],
35	included	VBN	O	include	_	0	SENT_104	[p8l15t2966r323b3029],
36	in	IN	O	in	_	0	SENT_104	[p8l354t2966r421b3028],
37	a	DT	O	a	det	39	SENT_104	[p8l455t2986r492b3029],
38	multivariable	JJ	O	multivariable	amod	39	SENT_104	[p8l523t2966r1001b3029],
39	model	NN	O	model	prep_in	35	SENT_104	[p8l1034t2966r1255b3029],
40	to	TO	O	to	aux	41	SENT_104	[p8l1288t2976r1354b3029],
41	adjust	VB	O	adjust	xcomp	35	SENT_104	[p8l1389t2966r1601b3047],
42	for	IN	O	for	_	0	SENT_104	[p8l1632t2966r1736b3029],
43	their	PRP$	O	they	poss	45	SENT_104	[p8l1765t2966r1929b3029],
44	prognostic	JJ	O	prognostic	amod	45	SENT_104	[p8l1960t2986r2149b3047, p8l14t3077r225b3139],
45	importance	NN	O	importance	prep_for	41	SENT_104	[p8l261t3077r682b3158],
46	.	.	O	.	_	0	SENT_104	[p8l261t3077r682b3158],

1	Backward	RB	MISC	backward	advmod	4	SENT_105	[p8l722t3077r1083b3139],
2	selection	NN	O	selection	nsubjpass	4	SENT_105	[p8l1120t3077r1436b3139],
3	was	VBD	O	be	auxpass	4	SENT_105	[p8l1470t3096r1604b3139],
4	used	VBN	O	use	_	0	SENT_105	[p8l1640t3077r1803b3139],
5	to	TO	O	to	aux	6	SENT_105	[p8l1837t3086r1903b3139],
6	eliminate	VB	O	eliminate	xcomp	4	SENT_105	[p8l1939t3077r2149b3139, p8l14t3198r161b3251],
7	covariates	NNS	O	covariate	dobj	6	SENT_105	[p8l199t3188r559b3251],
8	that	WDT	O	that	nsubj	9	SENT_105	[p8l598t3188r732b3251],
9	did	VBD	O	do	rcmod	7	SENT_105	[p8l768t3188r880b3251],
10	not	RB	O	not	neg	11	SENT_105	[p8l915t3198r1028b3251],
11	signiﬁcantly	JJ	O	signiﬁcantly	nsubj	12	SENT_105	[p8l1067t3188r1504b3269],
12	contribute	VBP	O	contribute	ccomp	9	SENT_105	[p8l1542t3188r1903b3251],
13	to	TO	O	to	_	0	SENT_105	[p8l1940t3198r2007b3251],
14	the	DT	O	the	det	15	SENT_105	[p8l2044t3188r2151b3251],
15	model	NN	O	model	prep_to	12	SENT_105	[p8l15t3299r236b3362],
16	using	VBG	O	use	partmod	15	SENT_105	[p8l262t3299r453b3380],
17	AIC	NNP	ORGANIZATION	AIC	dobj	16	SENT_105	[p8l479t3300r628b3362],
18	as	IN	O	as	_	0	SENT_105	[p8l657t3319r725b3362],
19	a	DT	O	a	det	21	SENT_105	[p8l754t3319r791b3362],
20	selection	NN	O	selection	nn	21	SENT_105	[p8l818t3299r1132b3362],
21	criterion	NN	O	criterion	prep_as	17	SENT_105	[p8l1158t3299r1478b3362],
22	.	.	O	.	_	0	SENT_105	[p8l1158t3299r1478b3362],

1	Self	NN	MISC	self	nn	2	SENT_106	[p8l1509t3299r1979b3380],
2	—	NN	MISC	—	nsubj	3	SENT_106	[p8l1509t3299r1979b3380],
3	reported	VBD	O	report	_	0	SENT_106	[p8l1509t3299r1979b3380],
4	race	NN	O	race	nsubjpass	6	SENT_106	[p8l2003t3319r2151b3362],
5	was	VBD	O	be	auxpass	6	SENT_106	[p8l15t3430r149b3473],
6	used	VBN	O	use	ccomp	3	SENT_106	[p8l180t3410r343b3473],
7	as	IN	O	as	_	0	SENT_106	[p8l374t3430r442b3473],
8	stratiﬁcation	NN	O	stratiﬁcation	nn	9	SENT_106	[p8l476t3410r921b3473],
9	factor	NN	O	factor	prep_as	6	SENT_106	[p8l950t3410r1159b3473],
10	for	IN	O	for	_	0	SENT_106	[p8l1188t3410r1291b3473],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_106	[p8l1321t3410r1692b3491],
12	associations	NNS	O	association	prep_for	9	SENT_106	[p8l1722t3410r2150b3473],
13	to	TO	O	to	aux	14	SENT_106	[p8l14t3529r81b3582],
14	account	VB	O	account	xcomp	6	SENT_106	[p8l110t3529r387b3582],
15	for	IN	O	for	_	0	SENT_106	[p8l412t3520r515b3582],
16	racial	JJ	O	racial	amod	17	SENT_106	[p8l539t3520r737b3582],
17	heterogeneity	NN	O	heterogeneity	prep_for	14	SENT_106	[p8l764t3520r1251b3601],
18	in	IN	O	in	_	0	SENT_106	[p8l1278t3520r1346b3581],
19	the	DT	O	the	det	20	SENT_106	[p8l1371t3520r1478b3582],
20	cohort	NN	O	cohort	prep_in	17	SENT_106	[p8l1506t3520r1750b3582],
21	.	.	O	.	_	0	SENT_106	[p8l1506t3520r1750b3582],

1	To	TO	O	to	aux	2	SENT_107	[p8l1781t3521r1877b3582],
2	correct	VB	O	correct	dep	26	SENT_107	[p8l1905t3529r2153b3582],
3	the	DT	O	the	det	6	SENT_107	[p8l14t3631r122b3693],
4	primary	JJ	O	primary	amod	6	SENT_107	[p8l149t3631r432b3712],
5	efﬁcacy	NN	O	efﬁcacy	nn	6	SENT_107	[p8l461t3630r742b3712],
6	analysis	NN	O	analysis	dobj	2	SENT_107	[p8l773t3631r1056b3712],
7	for	IN	O	for	_	0	SENT_107	[p8l1086t3631r1190b3693],
8	multiple	JJ	O	multiple	amod	9	SENT_107	[p8l1216t3631r1514b3712],
9	comparisons	NNS	O	comparison	prep_for	2	SENT_107	[p8l1543t3631r2013b3712],
10	,	,	O	,	_	0	SENT_107	[p8l1543t3631r2013b3712],
11	the	DT	O	the	det	13	SENT_107	[p8l2044t3631r2151b3693],
12	p	NN	O	p	nn	13	SENT_107	[p9l7t43r56b102],
13	Values	NNS	O	value	nsubjpass	15	SENT_107	[p9l89t22r314b84],
14	were	VBD	O	be	auxpass	15	SENT_107	[p9l348t41r519b84],
15	multiplied	VBN	O	multiply	parataxis	26	SENT_107	[p9l552t22r921b103],
16	by	IN	O	by	_	0	SENT_107	[p9l950t22r1038b103],
17	7	CD	NUMBER	7	agent	15	SENT_107	[p9l1071t23r1132b96],
18	,	,	O	,	_	0	SENT_107	[p9l1071t23r1132b96],
19	the	DT	O	the	det	20	SENT_107	[p9l1167t22r1274b84],
20	number	NN	O	number	nsubj	26	SENT_107	[p9l1306t22r1580b84],
21	of	IN	O	of	_	0	SENT_107	[p9l1612t22r1688b84],
22	independent	JJ	O	independent	amod	24	SENT_107	[p9l1714t22r2152b103],
23	statistical	JJ	O	statistical	amod	24	SENT_107	[p9l18t134r352b197],
24	associations	NNS	O	association	prep_of	20	SENT_107	[p9l390t134r818b197],
25	performed	VBN	O	perform	partmod	24	SENT_107	[p9l853t134r1226b215],
26	(	VBD	O	(	_	0	SENT_107	[p9l1264t135r1329b211],
27	a	DT	O	a	det	29	SENT_107	[p9l1264t135r1329b211],
28	Bonferroni	NNP	LOCATION	Bonferroni	nn	29	SENT_107	[p9l1363t134r1753b197],
29	correction	NN	O	correction	nsubj	33	SENT_107	[p9l1790t134r2152b197],
30	for	IN	O	for	_	0	SENT_107	[p9l15t245r118b308],
31	multiple	JJ	O	multiple	amod	32	SENT_107	[p9l154t245r451b326],
32	comparisons	NNS	O	comparison	prep_for	29	SENT_107	[p9l490t245r968b326],
33	)	VBP	O	)	ccomp	26	SENT_107	[p9l490t245r968b326],
34	so	RB	O	so	advmod	52	SENT_107	[p9l1011t265r1083b308],
35	that	IN	O	that	dep	52	SENT_107	[p9l1122t245r1256b308],
36	the	DT	O	the	det	38	SENT_107	[p9l1291t245r1398b308],
37	p	NN	O	p	nn	38	SENT_107	[p9l1428t266r1477b325],
38	Value	NN	O	value	nsubj	52	SENT_107	[p9l1516t245r1708b308],
39	to	TO	O	to	aux	41	SENT_107	[p9l1745t254r1811b308],
40	be	VB	O	be	auxpass	41	SENT_107	[p9l1849t245r1931b308],
41	compared	VBN	O	compare	infmod	38	SENT_107	[p9l1970t265r2149b308, p9l13t355r212b436],
42	with	IN	O	with	_	0	SENT_107	[p9l243t355r400b418],
43	the	DT	O	the	det	46	SENT_107	[p9l430t355r537b417],
44	standard	JJ	O	standard	amod	46	SENT_107	[p9l572t355r871b417],
45	signiﬁcance	NN	O	signiﬁcance	nn	46	SENT_107	[p9l904t355r1327b436],
46	threshold	NN	O	threshold	prep_with	41	SENT_107	[p9l1358t355r1691b417],
47	of	IN	O	of	_	0	SENT_107	[p9l1722t355r1799b417],
48	ac	NN	O	ac	prep_of	46	SENT_107	[p9l1826t375r1865b417],
49	=	JJ	O	=	amod	48	SENT_107	[p9l1901t383r1962b407],
50	0.05	CD	NUMBER	0.05	tmod	49	SENT_107	[p9l1998t355r2148b418],
51	is	VBZ	O	be	cop	52	SENT_107	[p9l15t467r70b530],
52	Valid	JJ	O	valid	advcl	33	SENT_107	[p9l116t467r310b530],
53	.	.	O	.	_	0	SENT_107	[p9l116t467r310b530],

1	P	NN	O	p	nn	2	SENT_108	[p9l357t470r412b529],
2	Values	NNS	O	value	nsubj	11	SENT_108	[p9l453t467r679b530],
3	of	IN	O	of	_	0	SENT_108	[p9l725t467r802b530],
4	all	DT	O	all	dep	5	SENT_108	[p9l841t467r926b530],
5	secondary	JJ	O	secondary	prep_of	2	SENT_108	[p9l973t467r1331b548],
6	and	CC	O	and	_	0	SENT_108	[p9l1377t467r1503b530],
7	sub	JJ	O	sub	amod	9	SENT_108	[p9l1548t467r1999b548],
8	—	NN	O	—	nn	9	SENT_108	[p9l1548t467r1999b548],
9	analyses	NNS	O	analysis	conj_and	5	SENT_108	[p9l1548t467r1999b548],
10	are	VBP	O	be	cop	11	SENT_108	[p9l2046t487r2151b530],
11	uncorrected	JJ	O	uncorrected	_	0	SENT_108	[p9l14t578r437b641],
12	as	IN	O	as	mark	15	SENT_108	[p9l462t598r530b641],
13	these	DT	O	these	nsubjpass	21	SENT_108	[p9l555t578r736b641],
14	are	VBP	O	be	cop	15	SENT_108	[p9l762t598r866b641],
15	exploratory	JJ	O	exploratory	ccomp	11	SENT_108	[p9l891t578r1301b659],
16	in	IN	O	in	_	0	SENT_108	[p9l1325t578r1393b640],
17	nature	NN	O	nature	prep_in	15	SENT_108	[p9l1415t588r1637b641],
18	and	CC	O	and	_	0	SENT_108	[p9l1662t578r1788b641],
19	should	MD	O	should	aux	21	SENT_108	[p9l1813t578r2048b641],
20	be	VB	O	be	auxpass	21	SENT_108	[p9l2068t578r2151b641],
21	interpreted	VBN	O	interpret	conj_and	15	SENT_108	[p9l15t689r403b770],
22	as	IN	O	as	_	0	SENT_108	[p9l432t709r501b752],
23	such	JJ	O	such	prep_such_as	21	SENT_108	[p9l534t689r710b752],
24	.	.	O	.	_	0	SENT_108	[p9l534t689r710b752],

1	All	DT	O	all	det	3	SENT_109	[p9l743t689r855b751],
2	statistical	JJ	O	statistical	amod	3	SENT_109	[p9l887t689r1221b752],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_109	[p9l1251t689r1549b770],
4	were	VBD	O	be	auxpass	5	SENT_109	[p9l1580t709r1751b752],
5	performed	VBN	O	perform	_	0	SENT_109	[p9l1779t689r2152b770],
6	in	IN	O	in	_	0	SENT_109	[p9l15t799r82b861],
7	R	NN	O	r	prep_in	5	SENT_109	[p9l120t800r178b860],
8	Statistical	JJ	O	statistical	amod	9	SENT_109	[p9l217t799r566b862],
9	Software	NNP	O	Software	dep	7	SENT_109	[p9l608t798r946b872],
10	,	,	O	,	_	0	SENT_109	[p9l608t798r946b872],
11	Version	NNP	O	Version	nn	16	SENT_109	[p9l987t799r1248b861],
12	2.13.0	CD	NUMBER	2.13.0	num	16	SENT_109	[p9l1287t799r1506b862],
13	(	CD	NUMBER	(	num	16	SENT_109	[p9l1548t799r1633b876],
14	R	NNP	O	R	nn	16	SENT_109	[p9l1548t799r1633b876],
15	Development	NNP	O	Development	nn	16	SENT_109	[p9l1670t799r2152b880],
16	Core	NNP	O	Core	appos	7	SENT_109	[p9l16t911r186b974],
17	Team	NNP	O	Team	nn	21	SENT_109	[p9l216t912r438b985],
18	,	,	O	,	_	0	SENT_109	[p9l216t912r438b985],
19	Vienna	NNP	LOCATION	Vienna	appos	21	SENT_109	[p9l471t911r748b985],
20	,	,	O	,	_	0	SENT_109	[p9l471t911r748b985],
21	Austria	NNP	LOCATION	Austria	dep	16	SENT_109	[p9l780t911r1089b988],
22	)	CD	NUMBER	)	num	21	SENT_109	[p9l780t911r1089b988],
23	.	.	O	.	_	0	SENT_109	[p9l780t911r1089b988],

1	Results	NNS	O	result	_	0	SENT_110	[p9l15t1150r290b1213],

1	Patient	NN	O	patient	nn	2	SENT_111	[p9l14t1373r263b1436],
2	population	NN	O	population	_	0	SENT_111	[p9l294t1373r678b1454],

1	A	DT	O	a	det	2	SENT_112	[p9l14t1598r77b1659],
2	total	NN	O	total	nsubj	16	SENT_112	[p9l114t1597r271b1660],
3	of	IN	O	of	_	0	SENT_112	[p9l311t1597r388b1660],
4	111	CD	NUMBER	111	num	5	SENT_112	[p9l428t1598r543b1659],
5	patients	NNS	O	patient	prep_of	2	SENT_112	[p9l587t1597r863b1678],
6	neoadjuvantly	RB	O	neoadjuvantly	advmod	7	SENT_112	[p9l904t1597r1410b1678],
7	treated	VBN	O	treat	partmod	5	SENT_112	[p9l1448t1597r1693b1660],
8	with	IN	O	with	_	0	SENT_112	[p9l1729t1597r1886b1660],
9	paclit	NN	O	paclit	nn	12	SENT_112	[p9l1922t1597r2149b1678],
10	—	CD	NUMBER	—	num	12	SENT_112	[p9l1922t1597r2149b1678],
11	axel	NN	O	axel	nn	12	SENT_112	[p9l17t1707r571b1788],
12	—	NN	O	—	prep_with	7	SENT_112	[p9l17t1707r571b1788],
13	containing	VBG	O	contain	xcomp	7	SENT_112	[p9l17t1707r571b1788],
14	regimens	NNS	O	regimen	dobj	13	SENT_112	[p9l607t1707r934b1788],
15	were	VBD	O	be	cop	16	SENT_112	[p9l971t1726r1142b1769],
16	eligible	JJ	O	eligible	_	0	SENT_112	[p9l1179t1707r1446b1788],
17	for	IN	O	for	_	0	SENT_112	[p9l1483t1707r1586b1769],
18	analysis	NN	O	analysis	prep_for	16	SENT_112	[p9l1622t1707r1924b1788],
19	.	.	O	.	_	0	SENT_112	[p9l1622t1707r1924b1788],

1	After	IN	O	after	_	0	SENT_113	[p9l1965t1706r2153b1769],
2	excluding	VBG	O	exclude	pcomp	1	SENT_113	[p9l15t1818r366b1899],
3	subjects	NNS	O	subject	dobj	2	SENT_113	[p9l411t1818r694b1899],
4	missing	VBG	O	miss	partmod	3	SENT_113	[p9l738t1818r1013b1899],
5	efﬁcacy	NN	O	efﬁcacy	nn	8	SENT_113	[p9l1056t1818r1338b1899],
6	or	CC	O	or	_	0	SENT_113	[p9l1381t1837r1453b1880],
7	toxicity	NN	O	toxicity	nn	8	SENT_113	[p9l1494t1818r1766b1899],
8	data	NNS	O	datum	dobj	4	SENT_113	[p9l1809t1818r1975b1892],
9	,	,	O	,	_	0	SENT_113	[p9l1809t1818r1975b1892],
10	103	CD	NUMBER	103	appos	8	SENT_113	[p9l2029t1818r2147b1881],

1	@	SYM	O	@	dep	2	SENT_114	[p9l1784t2061r1861b2156],
2	Springer	NN	PERSON	springer	dep	7	SENT_114	[p9l1891t2084r2153b2159],
3	404	CD	NUMBER	404	num	2	SENT_114	[p9l52t2234r104b2259],
4	Breast	NN	O	breast	nn	7	SENT_114	[p9l1450t2234r1540b2259],
5	Cancer	NN	O	cancer	nn	7	SENT_114	[p9l1552t2234r1652b2259],
6	Res	NNP	O	Res	nn	7	SENT_114	[p9l1664t2234r1716b2259],
7	Treat	NNP	O	Treat	dep	12	SENT_114	[p9l1729t2234r1804b2259],
8	(	CD	NUMBER	(	num	9	SENT_114	[p9l1817t2234r1908b2264],
9	2012	CD	DATE	2012	dep	7	SENT_114	[p9l1817t2234r1908b2264],
10	)	CD	NUMBER	)	number	11	SENT_114	[p9l1817t2234r1908b2264],
11	134:401	CD	NUMBER	134:401	dep	9	SENT_114	[p9l1925t2234r2107b2259],
12	—	NN	O	—	_	0	SENT_114	[p9l1925t2234r2107b2259],
13	410	CD	NUMBER	410	num	12	SENT_114	[p9l1925t2234r2107b2259],

1	subjects	NNS	O	subject	nsubjpass	3	SENT_115	[p9l17t2402r299b2483],
2	were	VBD	O	be	auxpass	3	SENT_115	[p9l334t2422r504b2465],
3	included	VBN	O	include	_	0	SENT_115	[p9l539t2402r847b2465],
4	in	IN	O	in	_	0	SENT_115	[p9l879t2402r946b2464],
5	the	DT	O	the	det	6	SENT_115	[p9l979t2402r1086b2465],
6	efﬁcacy	NN	O	efﬁcacy	prep_in	3	SENT_115	[p9l1121t2402r1401b2483],
7	and	CC	O	and	_	0	SENT_115	[p9l1437t2402r1563b2465],
8	109	CD	NUMBER	109	num	9	SENT_115	[p9l1605t2403r1725b2466],
9	subjects	NNS	O	subject	prep_in	3	SENT_115	[p9l1764t2402r2044b2483],
10	in	IN	O	in	_	0	SENT_115	[p9l2080t2402r2148b2464],
11	the	DT	O	the	det	13	SENT_115	[p9l13t2512r120b2575],
12	toxicity	NN	O	toxicity	nn	13	SENT_115	[p9l156t2512r427b2593],
13	analysis	NN	O	analysis	prep_in	3	SENT_115	[p9l465t2512r768b2593],
14	.	.	O	.	_	0	SENT_115	[p9l465t2512r768b2593],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_116	[p9l807t2512r1291b2593],
2	data	NNS	O	datum	nsubjpass	16	SENT_116	[p9l1329t2512r1477b2575],
3	including	VBG	O	include	_	0	SENT_116	[p9l1511t2512r1846b2593],
4	patient	NN	O	patient	prep_including	2	SENT_116	[p9l1881t2512r2144b2593],
5	,	,	O	,	_	0	SENT_116	[p9l1881t2512r2144b2593],
6	treatment	NN	O	treatment	prep_including	2	SENT_116	[p9l13t2631r371b2696],
7	,	,	O	,	_	0	SENT_116	[p9l13t2631r371b2696],
8	and	CC	O	and	_	0	SENT_116	[p9l417t2622r543b2684],
9	tumor	NN	O	tumor	nn	10	SENT_116	[p9l584t2631r797b2684],
10	characteristics	NNS	O	characteristic	conj_and	4	SENT_116	[p9l838t2622r1348b2684],
11	for	IN	O	for	_	0	SENT_116	[p9l1392t2622r1495b2684],
12	the	DT	O	the	det	14	SENT_116	[p9l1534t2622r1641b2684],
13	whole	JJ	O	whole	amod	14	SENT_116	[p9l1684t2622r1899b2685],
14	population	NN	O	population	prep_for	10	SENT_116	[p9l1940t2641r2145b2703, p9l14t2732r216b2794],
15	are	VBP	O	be	auxpass	16	SENT_116	[p9l250t2751r355b2794],
16	presented	VBN	O	present	_	0	SENT_116	[p9l387t2732r731b2813],
17	in	IN	O	in	_	0	SENT_116	[p9l763t2732r830b2794],
18	Table	NNP	O	Table	prep_in	16	SENT_116	[p9l863t2732r1064b2794],
19	1	CD	NUMBER	1	num	18	SENT_116	[p9l1106t2732r1157b2794],
20	.	.	O	.	_	0	SENT_116	[p9l1106t2732r1157b2794],

1	Allele	NN	O	allele	nn	2	SENT_117	[p9l14t2955r230b3018],
2	frequencies	NNS	O	frequency	_	0	SENT_117	[p9l264t2955r673b3036],

1	The	DT	O	the	det	5	SENT_118	[p9l14t3179r150b3242],
2	two	CD	NUMBER	two	num	5	SENT_118	[p9l190t3188r320b3242],
3	highly	RB	O	highly	advmod	4	SENT_118	[p9l359t3179r586b3260],
4	linked	VBN	O	link	amod	5	SENT_118	[p9l626t3179r849b3242],
5	SNPs	NNS	O	snp	nsubj	25	SENT_118	[p9l889t3179r1080b3242],
6	in	IN	O	in	_	0	SENT_118	[p9l1121t3179r1188b3241],
7	CYP2C8	NN	O	cyp2c8	prep_in	5	SENT_118	[p9l1228t3179r1631b3242],
8	*	CD	NUMBER	*	number	9	SENT_118	[p9l1228t3179r1631b3242],
9	3	CD	NUMBER	3	num	11	SENT_118	[p9l1228t3179r1631b3242],
10	(	NN	O	(	nn	11	SENT_118	[p9l1678t3179r2145b3256],
11	rsll572080	NN	O	rsll572080	dep	7	SENT_118	[p9l1678t3179r2145b3256],
12	,	,	O	,	_	0	SENT_118	[p9l1678t3179r2145b3256],
13	416G	CD	NUMBER	416g	num	14	SENT_118	[p9l13t3290r334b3353],
14	>	JJR	O	>	appos	7	SENT_118	[p9l13t3290r334b3353],
15	A	DT	O	a	dep	14	SENT_118	[p9l13t3290r334b3353],
16	and	CC	O	and	_	0	SENT_118	[p9l391t3290r517b3353],
17	rs10509681	NN	O	rs10509681	dep	14	SENT_118	[p9l572t3290r1012b3365],
18	,	,	O	,	_	0	SENT_118	[p9l572t3290r1012b3365],
19	1196A	NN	O	1196a	appos	7	SENT_118	[p9l1080t3290r1463b3368],
20	>	JJR	O	>	amod	22	SENT_118	[p9l1080t3290r1463b3368],
21	G	NN	O	g	nn	22	SENT_118	[p9l1080t3290r1463b3368],
22	)	NNS	O	)	dep	19	SENT_118	[p9l1080t3290r1463b3368],
23	were	VBD	O	be	cop	25	SENT_118	[p9l1522t3310r1692b3353],
24	completely	RB	O	completely	advmod	25	SENT_118	[p9l1751t3290r2147b3371],
25	concordant	JJ	O	concordant	_	0	SENT_118	[p9l15t3401r412b3464],
26	in	IN	O	in	_	0	SENT_118	[p9l438t3401r505b3463],
27	this	DT	O	this	det	28	SENT_118	[p9l532t3401r657b3464],
28	population	NN	O	population	prep_in	25	SENT_118	[p9l685t3401r1086b3482],
29	.	.	O	.	_	0	SENT_118	[p9l685t3401r1086b3482],

1	CYP3A4	NN	O	cyp3a4	nsubj	4	SENT_119	[p9l1118t3402r1442b3464],
2	and	CC	O	and	_	0	SENT_119	[p9l1471t3401r1597b3464],
3	CYP3A5	NN	O	cyp3a5	conj_and	1	SENT_119	[p9l1625t3401r1944b3464],
4	were	VBD	O	be	_	0	SENT_119	[p9l1976t3421r2147b3464],
5	out	IN	O	out	_	0	SENT_119	[p9l15t3521r127b3574],
6	of	IN	O	of	_	0	SENT_119	[p9l157t3512r234b3574],
7	HWE	NN	O	hwe	prep_out_of	4	SENT_119	[p9l258t3513r460b3574],
8	before	IN	O	before	_	0	SENT_119	[p9l489t3512r716b3574],
9	accounting	VBG	O	account	prepc_before	4	SENT_119	[p9l749t3512r1138b3593],
10	for	IN	O	for	_	0	SENT_119	[p9l1169t3512r1272b3574],
11	race	NN	O	race	prep_for	9	SENT_119	[p9l1300t3531r1468b3586],
12	,	,	O	,	_	0	SENT_119	[p9l1300t3531r1468b3586],
13	as	IN	O	as	prep	4	SENT_119	[p9l1503t3531r1571b3574],
14	expected	VBN	O	expect	dep	13	SENT_119	[p9l1604t3512r1921b3593],
15	given	VBN	O	give	prep	14	SENT_119	[p9l1952t3512r2148b3593],
16	the	DT	O	the	det	18	SENT_119	[p9l14t3623r120b3685],
17	large	JJ	O	large	amod	18	SENT_119	[p9l151t3623r327b3704],
18	difference	NN	O	difference	npadvmod	19	SENT_119	[p9l358t3623r718b3685],
19	in	IN	O	in	pcomp	15	SENT_119	[p9l749t3623r817b3685],
20	allele	NN	O	allele	nn	21	SENT_119	[p9l848t3623r1038b3685],
21	frequencies	NNS	O	frequency	pobj	19	SENT_119	[p9l1069t3623r1478b3704],
22	among	IN	O	among	_	0	SENT_119	[p9l1512t3642r1750b3704],
23	Caucasian	JJ	MISC	caucasian	prep_among	21	SENT_119	[p9l1782t3623r2148b3686],
24	and	CC	O	and	_	0	SENT_119	[p10l16t22r142b84],
25	African	JJ	MISC	african	conj_and	14	SENT_119	[p10l176t22r833b84],
26	.	.	O	.	_	0	SENT_119	[p10l176t22r833b84],

1	—	NN	O	—	_	0	SENT_120	[p10l176t22r833b84],
2	.	.	O	.	_	0	SENT_120	[p10l176t22r833b84],

1	American	JJ	MISC	american	amod	2	SENT_121	[p10l176t22r833b84],
2	individuals	NNS	O	individual	nsubj	3	SENT_121	[p10l868t22r1263b85],
3	[	VBP	O	[	_	0	SENT_121	[p10l1307t22r1466b98],
4	29	CD	NUMBER	29	num	5	SENT_121	[p10l1307t22r1466b98],
5	]	CD	NUMBER	]	dobj	3	SENT_121	[p10l1307t22r1466b98],
6	,	,	O	,	_	0	SENT_121	[p10l1307t22r1466b98],
7	but	CC	O	but	_	0	SENT_121	[p10l1505t22r1619b84],
8	no	DT	O	no	det	10	SENT_121	[p10l1653t41r1739b84],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_121	[p10l1779t22r2148b103],
10	deviations	NNS	O	deviation	nsubjpass	12	SENT_121	[p10l14t133r378b196],
11	were	VBD	O	be	auxpass	12	SENT_121	[p10l414t153r584b196],
12	seen	VBN	O	see	conj_but	3	SENT_121	[p10l622t153r775b196],
13	in	IN	O	in	_	0	SENT_121	[p10l808t133r876b195],
14	stratiﬁed	JJ	O	stratiﬁed	amod	15	SENT_121	[p10l912t133r1221b196],
15	samples	NNS	O	sample	prep_in	12	SENT_121	[p10l1256t133r1558b214],
16	.	.	O	.	_	0	SENT_121	[p10l1256t133r1558b214],

1	Allele	NN	O	allele	nn	2	SENT_122	[p10l1596t133r1812b196],
2	frequencies	NNS	O	frequency	nsubj	10	SENT_122	[p10l1846t133r2144b214, p10l14t244r149b307],
3	in	IN	O	in	_	0	SENT_122	[p10l186t244r253b306],
4	Caucasian	JJ	LOCATION	caucasian	amod	5	SENT_122	[p10l288t244r654b307],
5	subjects	NNS	O	subject	prep_in	2	SENT_122	[p10l692t244r973b325],
6	for	IN	O	for	_	0	SENT_122	[p10l1010t244r1113b307],
7	all	DT	O	all	det	8	SENT_122	[p10l1148t244r1233b307],
8	variants	NNS	O	variant	prep_for	5	SENT_122	[p10l1269t244r1549b307],
9	were	VBD	O	be	cop	10	SENT_122	[p10l1585t264r1755b307],
10	consistent	JJ	O	consistent	_	0	SENT_122	[p10l1792t244r2149b307],
11	with	IN	O	with	_	0	SENT_122	[p10l14t355r171b418],
12	those	DT	O	those	det	21	SENT_122	[p10l209t355r395b418],
13	reported	VBN	O	report	amod	21	SENT_122	[p10l433t355r732b436],
14	in	IN	O	in	_	0	SENT_122	[p10l769t355r837b417],
15	The	DT	O	the	det	18	SENT_122	[p10l875t355r1011b418],
16	International	NNP	O	International	nn	18	SENT_122	[p10l1050t355r1507b418],
17	HapMap	NNP	O	HapMap	nn	18	SENT_122	[p10l1547t357r1856b436],
18	Project	NNP	O	Project	prep_in	13	SENT_122	[p10l1895t355r2149b436],
19	[	CD	NUMBER	[	number	20	SENT_122	[p10l20t465r155b540],
20	30	CD	NUMBER	30	num	21	SENT_122	[p10l20t465r155b540],
21	]	NN	O	]	prep_with	10	SENT_122	[p10l20t465r155b540],
22	or	CC	O	or	_	0	SENT_122	[p10l195t484r268b527],
23	the	DT	O	the	det	26	SENT_122	[p10l299t465r406b527],
24	NCBI	NN	ORGANIZATION	ncbus	nn	26	SENT_122	[p10l440t465r651b528],
25	EntrezSNP	NN	O	entrezsnp	nn	26	SENT_122	[p10l684t465r1081b527],
26	database	NN	O	database	conj_or	21	SENT_122	[p10l1114t465r1420b527],
27	[	CD	NUMBER	[	number	28	SENT_122	[p10l1461t465r1595b540],
28	31	CD	NUMBER	31	num	29	SENT_122	[p10l1461t465r1595b540],
29	]	NN	O	]	dep	26	SENT_122	[p10l1461t465r1595b540],
30	and	CC	O	and	_	0	SENT_122	[p10l1636t465r1762b527],
31	replicated	VBN	O	replicate	conj_and	10	SENT_122	[p10l1793t465r2148b546],
32	samples	NNS	O	sample	nsubj	36	SENT_122	[p10l17t577r299b658],
33	were	VBD	O	be	cop	36	SENT_122	[p10l326t597r497b640],
34	100	CD	PERCENT	100	num	35	SENT_122	[p10l530t578r653b640],
35	%	NN	PERCENT	%	npadvmod	36	SENT_122	[p10l690t578r754b640],
36	concordant	JJ	O	concordant	ccomp	31	SENT_122	[p10l783t577r1180b640],
37	with	IN	O	with	_	0	SENT_122	[p10l1205t577r1362b640],
38	the	DT	O	the	det	40	SENT_122	[p10l1386t577r1493b640],
39	original	JJ	O	original	amod	40	SENT_122	[p10l1520t577r1795b658],
40	genotype	NN	O	genotype	prep_with	36	SENT_122	[p10l1822t587r2147b658],
41	calls	VBZ	O	call	dep	40	SENT_122	[p10l14t688r197b762],
42	;	:	O	;	_	0	SENT_122	[p10l14t688r197b762],
43	thus	RB	O	thus	advmod	48	SENT_122	[p10l241t688r407b762],
44	,	,	O	,	_	0	SENT_122	[p10l241t688r407b762],
45	no	DT	O	no	det	46	SENT_122	[p10l449t708r536b751],
46	assays	NNS	O	assay	nsubjpass	48	SENT_122	[p10l578t708r800b769],
47	were	VBD	O	be	auxpass	48	SENT_122	[p10l842t708r1012b751],
48	excluded	VBN	O	exclude	parataxis	10	SENT_122	[p10l1053t688r1376b751],
49	from	IN	O	from	_	0	SENT_122	[p10l1414t688r1587b751],
50	analysis	NN	O	analysis	nn	53	SENT_122	[p10l1627t688r1910b769],
51	(	CD	NUMBER	(	num	53	SENT_122	[p10l1954t689r2145b769, p10l12t799r415b880],
52	Supplementary	NNP	O	Supplementary	nn	53	SENT_122	[p10l1954t689r2145b769, p10l12t799r415b880],
53	Table	NNP	O	Table	prep_from	48	SENT_122	[p10l443t799r644b861],
54	2	CD	NUMBER	2	number	55	SENT_122	[p10l679t799r766b876],
55	)	CD	NUMBER	)	dep	53	SENT_122	[p10l679t799r766b876],
56	.	.	O	.	_	0	SENT_122	[p10l679t799r766b876],

1	As	IN	O	as	mark	2	SENT_123	[p10l798t799r892b861],
2	expected	VBN	O	expect	advcl	7	SENT_123	[p10l921t799r1257b880],
3	,	,	O	,	_	0	SENT_123	[p10l921t799r1257b880],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_123	[p10l1290t799r1660b880],
5	LD	NN	O	ld	nsubjpass	7	SENT_123	[p10l1684t800r1800b861],
6	was	VBD	O	be	auxpass	7	SENT_123	[p10l1828t818r1962b862],
7	seen	VBN	O	see	_	0	SENT_123	[p10l1994t818r2147b861],
8	between	IN	O	between	_	0	SENT_123	[p10l12t910r311b973],
9	CYP3A4	NN	O	cyp3a4	nn	11	SENT_123	[p10l337t910r805b973],
10	*	CD	NUMBER	*	num	11	SENT_123	[p10l337t910r805b973],
11	lB	NN	O	lb	prep_between	7	SENT_123	[p10l337t910r805b973],
12	and	CC	O	and	_	0	SENT_123	[p10l837t910r962b973],
13	CYP3A5	NN	O	cyp3a5	nn	16	SENT_123	[p10l988t910r1460b973],
14	*	CD	NUMBER	*	num	16	SENT_123	[p10l988t910r1460b973],
15	3C	NN	O	3c	nn	16	SENT_123	[p10l988t910r1460b973],
16	(	NN	O	(	conj_and	11	SENT_123	[p10l1489t911r1552b987],
17	r	NN	O	r	dep	11	SENT_123	[p10l1489t911r1552b987],
18	=	JJ	O	=	amod	20	SENT_123	[p10l1583t938r1643b962],
19	0.93	CD	NUMBER	0.93	tmod	18	SENT_123	[p10l1680t910r1860b987],
20	)	NN	O	)	dep	17	SENT_123	[p10l1680t910r1860b987],
21	and	CC	O	and	_	0	SENT_123	[p10l1890t910r2016b973],
22	the	DT	O	the	det	24	SENT_123	[p10l2040t910r2147b973],
23	three	CD	NUMBER	three	num	24	SENT_123	[p10l13t1022r190b1084],
24	polymorphisms	NNS	O	polymorphism	conj_and	11	SENT_123	[p10l243t1022r797b1103],
25	in	IN	O	in	_	0	SENT_123	[p10l851t1022r919b1084],
26	ABCB1	NN	O	abcb1	prep_in	24	SENT_123	[p10l971t1022r1249b1085],
27	(	CD	NUMBER	(	num	28	SENT_123	[p10l1312t1023r1375b1099],
28	r	NN	O	r	npadvmod	29	SENT_123	[p10l1312t1023r1375b1099],
29	>	JJR	O	>	amod	26	SENT_123	[p10l1404t1036r1461b1085],
30	0.7	CD	NUMBER	0.7	num	31	SENT_123	[p10l1493t1022r1650b1099],
31	)	NN	O	)	tmod	7	SENT_123	[p10l1493t1022r1650b1099],
32	,	,	O	,	_	0	SENT_123	[p10l1493t1022r1650b1099],
33	which	WDT	O	which	nsubjpass	36	SENT_123	[p10l1707t1022r1923b1085],
34	were	VBD	O	be	auxpass	36	SENT_123	[p10l1976t1041r2146b1085],
35	then	RB	O	then	advmod	36	SENT_123	[p10l13t1133r166b1196],
36	grouped	VBN	O	group	rcmod	31	SENT_123	[p10l207t1133r498b1214],
37	into	IN	O	into	_	0	SENT_123	[p10l538t1133r674b1196],
38	haplotypes	NNS	O	haplotype	prep_into	36	SENT_123	[p10l714t1133r1100b1214],
39	as	IN	O	as	_	0	SENT_123	[p10l1144t1153r1212b1196],
40	planned	VBN	O	plan	amod	41	SENT_123	[p10l1253t1133r1536b1214],
41	(	NN	O	(	prep_as	36	SENT_123	[p10l1579t1133r2147b1214],
42	Supplementary	NNP	O	Supplementary	nn	43	SENT_123	[p10l1579t1133r2147b1214],
43	Table	NNP	O	Table	dep	41	SENT_123	[p10l13t1243r215b1305],
44	3	CD	NUMBER	3	num	45	SENT_123	[p10l250t1243r339b1319],
45	)	NN	O	)	dep	31	SENT_123	[p10l250t1243r339b1319],
46	.	.	O	.	_	0	SENT_123	[p10l250t1243r339b1319],

1	Response	NN	O	response	_	0	SENT_124	[p10l13t1467r354b1546],
2	by	IN	O	by	dep	1	SENT_124	[p10l386t1465r473b1546],
3	genotype	NN	O	genotype	pobj	2	SENT_124	[p10l507t1475r832b1546],

1	Clinical	JJ	O	clinical	amod	3	SENT_125	[p10l15t1689r296b1752],
2	complete	JJ	O	complete	amod	3	SENT_125	[p10l341t1689r667b1770],
3	response	NN	O	response	nsubj	12	SENT_125	[p10l711t1709r1021b1770],
4	to	TO	O	to	_	0	SENT_125	[p10l1066t1699r1132b1752],
5	paclitaxel	NN	O	paclitaxel	prep_to	3	SENT_125	[p10l1176t1689r1524b1770],
6	for	IN	O	for	_	0	SENT_125	[p10l1569t1689r1672b1752],
7	the	DT	O	the	det	9	SENT_125	[p10l1714t1689r1821b1752],
8	efﬁcacy	NN	O	efﬁcacy	nn	9	SENT_125	[p10l1866t1689r2147b1770],
9	cohort	NN	O	cohort	prep_for	5	SENT_125	[p10l14t1800r242b1862],
10	was	VBD	O	be	cop	12	SENT_125	[p10l269t1819r403b1863],
11	30.1	CD	PERCENT	30.1	num	12	SENT_125	[p10l435t1800r579b1863],
12	%	NN	PERCENT	%	_	0	SENT_125	[p10l623t1800r687b1863],
13	and	CC	O	and	_	0	SENT_125	[p10l721t1800r847b1862],
14	the	DT	O	the	det	16	SENT_125	[p10l874t1800r981b1862],
15	mean	JJ	O	mean	amod	16	SENT_125	[p10l1010t1819r1203b1862],
16	change	NN	O	change	nsubj	26	SENT_125	[p10l1231t1800r1481b1881],
17	in	IN	O	in	_	0	SENT_125	[p10l1510t1800r1578b1862],
18	tumor	NN	O	tumor	nn	19	SENT_125	[p10l1606t1809r1819b1862],
19	size	NN	O	size	prep_in	16	SENT_125	[p10l1849t1800r1982b1862],
20	was	VBD	O	be	cop	26	SENT_125	[p10l2012t1819r2146b1863],
21	a	DT	O	a	det	26	SENT_125	[p10l16t1930r52b1973],
22	49	CD	PERCENT	49	number	23	SENT_125	[p10l107t1911r193b1974],
23	%	NN	PERCENT	%	amod	26	SENT_125	[p10l231t1911r295b1974],
24	reduction	NN	O	reduction	nn	26	SENT_125	[p10l355t1911r693b1973],
25	(	CD	NUMBER	(	num	26	SENT_125	[p10l753t1911r981b1988],
26	Table	NNP	O	Table	conj_and	12	SENT_125	[p10l753t1911r981b1988],
27	2	CD	NUMBER	2	number	28	SENT_125	[p10l1016t1911r1104b1988],
28	)	CD	NUMBER	)	dep	26	SENT_125	[p10l1016t1911r1104b1988],
29	.	.	O	.	_	0	SENT_125	[p10l1016t1911r1104b1988],

1	Response	NN	O	response	nsubjpass	5	SENT_126	[p10l1165t1912r1505b1992],
2	by	IN	O	by	_	0	SENT_126	[p10l1562t1911r1649b1992],
3	genotype	NN	O	genotype	prep_by	1	SENT_126	[p10l1708t1920r2032b1992],
4	is	VBZ	O	be	auxpass	5	SENT_126	[p10l2091t1911r2146b1973],
5	presented	VBN	O	present	_	0	SENT_126	[p10l12t2021r356b2102],
6	in	IN	O	in	_	0	SENT_126	[p10l394t2021r461b2082],
7	Table	NNP	O	Table	prep_in	5	SENT_126	[p10l499t2021r701b2083],
8	3	CD	NUMBER	3	num	7	SENT_126	[p10l736t2021r795b2094],
9	,	,	O	,	_	0	SENT_126	[p10l736t2021r795b2094],
10	demonstrating	VBG	O	demonstrate	xcomp	5	SENT_126	[p10l837t2021r1347b2102],
11	signiﬁcance	NN	O	signiﬁcance	dobj	10	SENT_126	[p10l1389t2020r1812b2102],
12	only	RB	O	only	advmod	11	SENT_126	[p10l1852t2021r2007b2102],
13	for	IN	O	for	_	0	SENT_126	[p10l2046t2020r2149b2083],
14	CYP2C8	NN	O	cyp2c8	prep_for	11	SENT_126	[p10l15t2134r355b2207],
15	;	:	O	;	_	0	SENT_126	[p10l15t2134r355b2207],
16	the	DT	O	the	det	18	SENT_126	[p10l431t2133r538b2196],
17	odds	NNS	O	odds	nn	18	SENT_126	[p10l613t2133r776b2196],
18	ratio	NN	O	ratio	dep	11	SENT_126	[p10l850t2133r1012b2196],
19	for	IN	O	for	_	0	SENT_126	[p10l1087t2133r1190b2196],
20	an	DT	O	a	det	52	SENT_126	[p10l1263t2153r1343b2196],
21	individual	JJ	O	individual	amod	52	SENT_126	[p10l1416t2133r1777b2196],
22	carrying	VBG	O	carry	dep	21	SENT_126	[p10l1851t2133r2147b2214],
23	CYP2C8	NN	O	cyp2c8	nn	24	SENT_126	[p10l15t2244r419b2307],
24	*	NN	O	*	dobj	22	SENT_126	[p10l15t2244r419b2307],
25	3	CD	NUMBER	3	num	24	SENT_126	[p10l15t2244r419b2307],
26	to	TO	O	to	aux	27	SENT_126	[p10l451t2254r517b2307],
27	achieve	VB	O	achieve	xcomp	22	SENT_126	[p10l547t2244r817b2307],
28	clinical	JJ	O	clinical	amod	30	SENT_126	[p10l846t2244r1108b2307],
29	complete	JJ	O	complete	amod	30	SENT_126	[p10l1137t2244r1463b2325],
30	response	NN	O	response	nsubj	43	SENT_126	[p10l1491t2264r1801b2325],
31	was	VBD	O	be	cop	43	SENT_126	[p10l1830t2264r1964b2307],
32	3.92	CD	NUMBER	3.92	advmod	43	SENT_126	[p10l1996t2244r2147b2308],
33	with	IN	O	with	_	0	SENT_126	[p10l14t2354r171b2416],
34	a	DT	O	a	det	38	SENT_126	[p10l209t2374r246b2416],
35	95	CD	PERCENT	95	number	36	SENT_126	[p10l282t2354r364b2417],
36	%	NN	PERCENT	%	amod	38	SENT_126	[p10l404t2354r468b2416],
37	conﬁdence	NN	O	conﬁdence	nn	38	SENT_126	[p10l509t2354r894b2416],
38	interval	NN	O	interval	prep_with	32	SENT_126	[p10l931t2354r1203b2416],
39	of	IN	O	of	_	0	SENT_126	[p10l1241t2354r1318b2416],
40	l.	NN	O	l.	prep_of	38	SENT_126	[p10l1357t2354r1746b2416],
41	46	CD	NUMBER	46	number	42	SENT_126	[p10l1357t2354r1746b2416],
42	—	CD	NUMBER	—	num	43	SENT_126	[p10l1357t2354r1746b2416],
43	l0	NN	O	l0	ccomp	27	SENT_126	[p10l1357t2354r1746b2416],
44	.48	CD	NUMBER	.48	number	45	SENT_126	[p10l1357t2354r1746b2416],
45	(	CD	NUMBER	(	num	47	SENT_126	[p10l1788t2354r2148b2430],
46	corrected	VBN	O	correct	amod	47	SENT_126	[p10l1788t2354r2148b2430],
47	p	NN	O	p	dep	43	SENT_126	[p10l6t2487r55b2545],
48	=	JJ	O	=	amod	47	SENT_126	[p10l91t2494r152b2518],
49	0.046	CD	NUMBER	0.046	tmod	48	SENT_126	[p10l188t2465r413b2542],
50	)	CD	NUMBER	)	number	51	SENT_126	[p10l188t2465r413b2542],
51	(	CD	NUMBER	(	num	52	SENT_126	[p10l485t2465r647b2546],
52	Fig	NN	O	fig	prep_for	18	SENT_126	[p10l485t2465r647b2546],
53	.	.	O	.	_	0	SENT_126	[p10l485t2465r647b2546],

1	1	CD	NUMBER	1	_	0	SENT_127	[p10l692t2466r773b2543],
2	)	NN	O	)	dep	1	SENT_127	[p10l692t2466r773b2543],
3	.	.	O	.	_	0	SENT_127	[p10l692t2466r773b2543],

1	Of	IN	O	of	_	0	SENT_128	[p10l845t2465r941b2528],
2	the	DT	O	the	det	4	SENT_128	[p10l1000t2465r1107b2528],
3	22	CD	NUMBER	22	num	4	SENT_128	[p10l1174t2466r1259b2527],
4	subjects	NNS	O	subject	nsubj	5	SENT_128	[p10l1329t2465r1611b2546],
5	carrying	VBG	O	carry	prepc_of	13	SENT_128	[p10l1678t2465r1973b2546],
6	the	DT	O	the	det	10	SENT_128	[p10l2040t2465r2147b2528],
7	CYP2C8	NN	O	cyp2c8	nn	10	SENT_128	[p10l15t2577r419b2639],
8	*	NN	O	*	nn	10	SENT_128	[p10l15t2577r419b2639],
9	3	CD	NUMBER	3	num	10	SENT_128	[p10l15t2577r419b2639],
10	variant	NN	O	variant	dobj	5	SENT_128	[p10l448t2576r715b2650],
11	,	,	O	,	_	0	SENT_128	[p10l448t2576r715b2650],
12	12	CD	NUMBER	12	nsubj	13	SENT_128	[p10l751t2577r829b2638],
13	achieved	VBD	O	achieve	_	0	SENT_128	[p10l856t2576r1172b2639],
14	clinical	JJ	O	clinical	amod	17	SENT_128	[p10l1197t2576r1459b2639],
15	complete	JJ	O	complete	amod	17	SENT_128	[p10l1485t2576r1811b2657],
16	response	NN	O	response	nn	17	SENT_128	[p10l1836t2596r2146b2657],
17	(	NN	O	(	dobj	13	SENT_128	[p10l17t2687r126b2765],
18	55	CD	PERCENT	55	number	19	SENT_128	[p10l17t2687r126b2765],
19	%	NN	PERCENT	%	amod	17	SENT_128	[p10l167t2688r262b2765],
20	)	CD	NUMBER	)	npadvmod	21	SENT_128	[p10l167t2688r262b2765],
21	as	IN	O	as	advmod	13	SENT_128	[p10l300t2707r368b2750],
22	compared	VBN	O	compare	_	0	SENT_128	[p10l405t2687r756b2768],
23	with	IN	O	with	prepc_compared_with	13	SENT_128	[p10l791t2687r947b2750],
24	only	RB	O	only	quantmod	25	SENT_128	[p10l982t2687r1137b2768],
25	19	CD	NUMBER	19	dep	13	SENT_128	[p10l1180t2688r1256b2751],
26	out	IN	O	out	_	0	SENT_128	[p10l1293t2697r1405b2750],
27	of	IN	O	of	_	0	SENT_128	[p10l1439t2687r1516b2750],
28	the	DT	O	the	det	31	SENT_128	[p10l1544t2687r1650b2750],
29	81	CD	NUMBER	81	num	31	SENT_128	[p10l1689t2688r1764b2750],
30	wild-type	JJ	O	wild-type	amod	31	SENT_128	[p10l1806t2687r2147b2768],
31	subjects	NNS	O	subject	prep_out_of	32	SENT_128	[p10l17t2798r299b2879],
32	(	VBP	O	(	dep	25	SENT_128	[p10l333t2798r443b2875],
33	23	CD	PERCENT	23	num	34	SENT_128	[p10l333t2798r443b2875],
34	%	NN	PERCENT	%	dobj	32	SENT_128	[p10l484t2798r599b2875],
35	)	CD	NUMBER	)	dep	25	SENT_128	[p10l484t2798r599b2875],
36	.	.	O	.	_	0	SENT_128	[p10l484t2798r599b2875],

1	To	TO	O	to	aux	2	SENT_129	[p10l634t2799r730b2860],
2	ascertain	VB	O	ascertain	purpcl	38	SENT_129	[p10l764t2798r1079b2860],
3	whether	IN	O	whether	complm	7	SENT_129	[p10l1110t2798r1398b2861],
4	this	DT	O	this	det	5	SENT_129	[p10l1427t2798r1552b2860],
5	association	NN	O	association	nsubj	7	SENT_129	[p10l1586t2798r1981b2860],
6	was	VBD	O	be	cop	7	SENT_129	[p10l2012t2817r2146b2861],
7	independent	JJ	O	independent	ccomp	2	SENT_129	[p10l14t2909r452b2990],
8	of	IN	O	of	_	0	SENT_129	[p10l500t2909r577b2971],
9	other	JJ	O	other	amod	11	SENT_129	[p10l619t2909r802b2971],
10	prognostic	JJ	O	prognostic	amod	11	SENT_129	[p10l848t2909r1222b2990],
11	factors	NNS	O	factor	prep_of	7	SENT_129	[p10l1272t2909r1533b2983],
12	,	,	O	,	_	0	SENT_129	[p10l1272t2909r1533b2983],
13	a	DT	O	a	det	15	SENT_129	[p10l1586t2928r1623b2971],
14	multivariable	JJ	O	multivariable	amod	15	SENT_129	[p10l1669t2909r2146b2972],
15	model	NN	O	model	nsubjpass	38	SENT_129	[p10l14t3019r235b3081],
16	that	WDT	O	that	nsubj	17	SENT_129	[p10l273t3019r407b3081],
17	included	VBD	O	include	rcmod	15	SENT_129	[p10l443t3019r751b3081],
18	tumor	NN	O	tumor	nn	19	SENT_129	[p10l788t3028r1001b3081],
19	grade	NN	O	grade	dobj	17	SENT_129	[p10l1038t3019r1254b3100],
20	,	,	O	,	_	0	SENT_129	[p10l1038t3019r1254b3100],
21	ER	NN	O	er	nn	22	SENT_129	[p10l1294t3020r1407b3080],
22	status	NN	O	status	conj_and	19	SENT_129	[p10l1447t3028r1664b3092],
23	,	,	O	,	_	0	SENT_129	[p10l1447t3028r1664b3092],
24	concomitant	JJ	O	concomitant	amod	25	SENT_129	[p10l1706t3019r2149b3081],
25	trastuzumab	NN	O	trastuzumab	conj_and	19	SENT_129	[p10l13t3131r469b3205],
26	,	,	O	,	_	0	SENT_129	[p10l13t3131r469b3205],
27	and	CC	O	and	_	0	SENT_129	[p10l536t3131r662b3194],
28	whether	IN	O	whether	complm	31	SENT_129	[p10l723t3131r1011b3194],
29	paclitaxel	NN	O	paclitaxel	nsubjpass	31	SENT_129	[p10l1069t3131r1418b3212],
30	was	VBD	O	be	auxpass	31	SENT_129	[p10l1480t3151r1614b3194],
31	preceded	VBN	O	precede	conj_and	19	SENT_129	[p10l1676t3131r2000b3212],
32	by	IN	O	by	_	0	SENT_129	[p10l2059t3131r2147b3212],
33	another	DT	O	another	det	34	SENT_129	[p10l16t3242r282b3305],
34	phase	NN	O	phase	agent	31	SENT_129	[p10l306t3242r508b3323],
35	of	IN	O	of	_	0	SENT_129	[p10l537t3242r614b3305],
36	chemotherapy	NN	O	chemotherapy	prep_of	34	SENT_129	[p10l636t3242r1141b3323],
37	was	VBD	O	be	auxpass	38	SENT_129	[p10l1169t3262r1303b3305],
38	tested	VBN	O	test	_	0	SENT_129	[p10l1331t3242r1557b3305],
39	.	.	O	.	_	0	SENT_129	[p10l1331t3242r1557b3305],

1	After	IN	O	after	_	0	SENT_130	[p10l1588t3242r1776b3305],
2	backward	RB	O	backward	advmod	3	SENT_130	[p10l1800t3242r2149b3305],
3	elimination	NN	O	elimination	prep_after	14	SENT_130	[p10l14t3353r422b3416],
4	of	IN	O	of	_	0	SENT_130	[p10l450t3353r527b3416],
5	covariates	NNS	O	covariate	prep_of	3	SENT_130	[p10l549t3353r908b3416],
6	that	WDT	O	that	nsubj	9	SENT_130	[p10l937t3353r1071b3416],
7	were	VBD	O	be	cop	9	SENT_130	[p10l1097t3373r1267b3416],
8	not	RB	O	not	neg	9	SENT_130	[p10l1296t3362r1409b3416],
9	signiﬁcant	JJ	O	signiﬁcant	rcmod	5	SENT_130	[p10l1438t3353r1825b3434],
10	,	,	O	,	_	0	SENT_130	[p10l1438t3353r1825b3434],
11	the	DT	O	the	det	13	SENT_130	[p10l1856t3353r1963b3416],
12	ﬁnal	JJ	O	ﬁnal	amod	13	SENT_130	[p10l1992t3353r2147b3416],
13	model	NN	O	model	nsubj	14	SENT_130	[p10l14t3464r235b3527],
14	included	VBD	O	include	_	0	SENT_130	[p10l278t3464r586b3527],
15	tumor	NN	O	tumor	nn	16	SENT_130	[p10l628t3474r842b3527],
16	grade	NN	O	grade	dobj	14	SENT_130	[p10l883t3464r1079b3545],
17	and	CC	O	and	_	0	SENT_130	[p10l1124t3464r1250b3527],
18	whether	IN	O	whether	dep	21	SENT_130	[p10l1292t3464r1580b3527],
19	paclitaxel	NN	O	paclitaxel	nsubjpass	21	SENT_130	[p10l1620t3464r1968b3545],
20	was	VBD	O	be	auxpass	21	SENT_130	[p10l2012t3484r2146b3527],
21	preceded	VBN	O	precede	conj_and	14	SENT_130	[p10l12t3575r336b3656],
22	by	IN	O	by	_	0	SENT_130	[p10l379t3575r467b3656],
23	another	DT	O	another	det	24	SENT_130	[p10l514t3575r780b3638],
24	phase	NN	O	phase	agent	21	SENT_130	[p10l822t3575r1024b3656],
25	of	IN	O	of	_	0	SENT_130	[p10l1071t3575r1147b3638],
26	chemotherapy	NN	O	chemotherapy	prep_of	24	SENT_130	[p10l1187t3575r1710b3656],
27	.	.	O	.	_	0	SENT_130	[p10l1187t3575r1710b3656],

1	After	IN	O	after	_	0	SENT_131	[p10l1759t3575r1948b3638],
2	controlling	VBG	O	control	pcomp	1	SENT_131	[p10l1991t3595r2144b3638, p10l13t3686r274b3767],
3	for	IN	O	for	_	0	SENT_131	[p10l330t3686r433b3749],
4	these	DT	O	these	det	6	SENT_131	[p10l484t3686r665b3749],
5	prognostic	JJ	O	prognostic	amod	6	SENT_131	[p10l718t3686r1093b3767],
6	factors	NNS	O	factor	prep_for	2	SENT_131	[p10l1148t3686r1409b3760],
7	,	,	O	,	_	0	SENT_131	[p10l1148t3686r1409b3760],
8	the	DT	O	the	det	9	SENT_131	[p10l1465t3686r1572b3749],
9	association	NN	O	association	appos	6	SENT_131	[p10l1627t3686r2023b3749],
10	of	IN	O	of	prep	9	SENT_131	[p10l2076t3686r2153b3749],

1	CYP2C8	CD	NUMBER	cyp2c8	num	2	SENT_132	[p11l15t22r419b85],
2	*	CD	NUMBER	*	nsubj	6	SENT_132	[p11l15t22r419b85],
3	3	CD	NUMBER	3	num	4	SENT_132	[p11l15t22r419b85],
4	status	NN	O	status	dep	2	SENT_132	[p11l464t31r661b84],
5	remained	VBD	O	remain	cop	6	SENT_132	[p11l700t22r1033b84],
6	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_132	[p11l1074t22r1443b103],
7	in	IN	O	in	_	0	SENT_132	[p11l1480t22r1548b84],
8	the	DT	O	the	det	13	SENT_132	[p11l1585t22r1692b84],
9	ﬁnal	JJ	O	ﬁnal	amod	13	SENT_132	[p11l1732t22r1886b84],
10	model	NN	O	model	npadvmod	12	SENT_132	[p11l1925t22r2147b84],
11	(	CD	NUMBER	(	num	10	SENT_132	[p11l17t132r466b209],
12	uncorrected	JJ	O	uncorrected	amod	13	SENT_132	[p11l17t132r466b209],
13	p	NN	O	p	prep_in	6	SENT_132	[p11l502t153r552b212],
14	=	JJ	O	=	amod	13	SENT_132	[p11l588t160r649b184],
15	0.003	CD	NUMBER	0.003	tmod	14	SENT_132	[p11l685t132r902b206],
16	,	,	O	,	_	0	SENT_132	[p11l685t132r902b206],
17	corrected	VBN	O	correct	partmod	13	SENT_132	[p11l951t132r1283b194],
18	p	NN	O	p	dobj	17	SENT_132	[p11l1320t153r1369b212],
19	=	JJ	O	=	advmod	17	SENT_132	[p11l1406t160r1466b184],
20	0.022	CD	NUMBER	0.022	num	21	SENT_132	[p11l1502t132r1750b209],
21	)	NN	O	)	dep	19	SENT_132	[p11l1502t132r1750b209],
22	,	,	O	,	_	0	SENT_132	[p11l1502t132r1750b209],
23	while	IN	O	while	mark	30	SENT_132	[p11l1799t132r1994b195],
24	the	DT	O	the	det	26	SENT_132	[p11l2040t132r2147b194],
25	other	JJ	O	other	amod	26	SENT_132	[p11l15t243r197b305],
26	covariates	NNS	O	covariate	nsubjpass	30	SENT_132	[p11l254t243r612b305],
27	were	VBD	O	be	auxpass	30	SENT_132	[p11l672t262r842b305],
28	not	RB	O	not	neg	30	SENT_132	[p11l900t252r1013b305],
29	signiﬁcantly	RB	O	signiﬁcantly	advmod	30	SENT_132	[p11l1072t243r1509b324],
30	associated	VBN	O	associate	advcl	17	SENT_132	[p11l1569t243r1935b305],
31	with	IN	O	with	_	0	SENT_132	[p11l1991t243r2148b305],
32	achievement	NN	O	achievement	prep_with	30	SENT_132	[p11l15t355r468b418],
33	of	IN	O	of	_	0	SENT_132	[p11l493t355r570b418],
34	clinical	JJ	O	clinical	amod	36	SENT_132	[p11l590t355r852b418],
35	complete	JJ	O	complete	amod	36	SENT_132	[p11l880t355r1205b436],
36	response	NN	O	response	prep_of	32	SENT_132	[p11l1231t375r1542b436],
37	(	CD	NUMBER	(	num	38	SENT_132	[p11l1572t355r1800b433],
38	Table	NNP	O	Table	dep	36	SENT_132	[p11l1572t355r1800b433],
39	4	CD	NUMBER	4	number	40	SENT_132	[p11l1833t356r1923b432],
40	)	CD	NUMBER	)	dep	38	SENT_132	[p11l1833t356r1923b432],
41	.	.	O	.	_	0	SENT_132	[p11l1833t356r1923b432],

1	Next	RB	O	next	advmod	14	SENT_133	[p11l1953t357r2144b429],
2	,	,	O	,	_	0	SENT_133	[p11l1953t357r2144b429],
3	the	DT	O	the	det	4	SENT_133	[p11l13t466r120b529],
4	association	NN	O	association	nsubjpass	14	SENT_133	[p11l194t466r590b529],
5	of	IN	O	of	_	0	SENT_133	[p11l663t466r739b529],
6	CYP2C8	NN	O	cyp2c8	prep_of	4	SENT_133	[p11l806t466r1210b529],
7	*	CD	NUMBER	*	number	8	SENT_133	[p11l806t466r1210b529],
8	3	CD	NUMBER	3	dep	6	SENT_133	[p11l806t466r1210b529],
9	and	CC	O	and	_	0	SENT_133	[p11l1288t466r1414b529],
10	clinical	JJ	O	clinical	amod	12	SENT_133	[p11l1485t466r1747b529],
11	complete	JJ	O	complete	amod	12	SENT_133	[p11l1821t466r2147b547],
12	response	NN	O	response	prep_of	4	SENT_133	[p11l13t597r324b658],
13	was	VBD	O	be	auxpass	14	SENT_133	[p11l389t597r523b640],
14	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_133	[p11l592t577r901b640],
15	by	IN	O	by	_	0	SENT_133	[p11l963t577r1051b658],
16	race	NN	O	race	agent	14	SENT_133	[p11l1114t597r1262b640],
17	to	TO	O	to	aux	18	SENT_133	[p11l1326t586r1393b640],
18	ensure	VB	O	ensure	xcomp	14	SENT_133	[p11l1459t597r1688b640],
19	that	IN	O	that	_	0	SENT_133	[p11l1753t577r1887b640],
20	racial	JJ	O	racial	prep_that	18	SENT_133	[p11l1949t577r2147b640],

1	@	IN	O	@	_	0	SENT_134	[p11l12t820r90b915],
2	Springer	NNP	O	Springer	nn	3	SENT_134	[p11l119t843r380b918],
3	Table	NNP	O	Table	prep_@	7	SENT_134	[p11l13t943r196b996],
4	1	CD	NUMBER	1	num	6	SENT_134	[p11l228t942r257b995],
5	Patient	NN	O	patient	nn	6	SENT_134	[p11l308t943r519b996],
6	characteristics	NNS	O	characteristic	dep	3	SENT_134	[p11l546t943r979b996],
7	(	VBP	O	(	_	0	SENT_134	[p11l1011t943r1089b1008],
8	N	NN	O	n	dep	9	SENT_134	[p11l1011t943r1089b1008],
9	=	JJ	O	=	acomp	7	SENT_134	[p11l1113t967r1164b988],
10	111	CD	NUMBER	111	num	11	SENT_134	[p11l1202t943r1329b1008],
11	)	NN	O	)	nsubj	7	SENT_134	[p11l1202t943r1329b1008],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_135	[p11l12t1087r424b1156],
2	data	NNS	O	datum	_	0	SENT_135	[p11l454t1087r580b1140],
3	of	IN	O	of	_	0	SENT_135	[p11l607t1087r673b1140],
4	patients	NNS	O	patient	prep_of	2	SENT_135	[p11l694t1087r929b1156],

1	Self	NN	O	self	nn	2	SENT_136	[p11l15t1281r414b1350],
2	—	NN	O	—	nsubj	3	SENT_136	[p11l15t1281r414b1350],
3	reported	VBD	O	report	_	0	SENT_136	[p11l15t1281r414b1350],
4	race	NN	O	race	dep	12	SENT_136	[p11l440t1298r566b1335],
5	Caucasian	JJ	MISC	caucasian	amod	6	SENT_136	[p11l64t1382r375b1435],
6	79	CD	PERCENT	79	dep	4	SENT_136	[p11l1836t1382r1908b1436],
7	(	CD	PERCENT	(	number	8	SENT_136	[p11l1939t1382r2029b1448],
8	71	CD	PERCENT	71	num	9	SENT_136	[p11l1939t1382r2029b1448],
9	%	NN	PERCENT	%	dep	6	SENT_136	[p11l2067t1382r2148b1447],
10	)	CD	NUMBER	)	dep	12	SENT_136	[p11l2067t1382r2148b1447],
11	African-American	JJ	MISC	african-american	amod	12	SENT_136	[p11l63t1481r620b1534],
12	27	CD	PERCENT	27	dep	16	SENT_136	[p11l1836t1482r1907b1534],
13	(	CD	PERCENT	(	num	15	SENT_136	[p11l1939t1481r2036b1547],
14	24	CD	PERCENT	24	num	15	SENT_136	[p11l1939t1481r2036b1547],
15	%	NN	PERCENT	%	dep	12	SENT_136	[p11l2067t1481r2148b1547],
16	)	CD	NUMBER	)	dep	3	SENT_136	[p11l2067t1481r2148b1547],
17	Other	JJ	O	other	amod	19	SENT_136	[p11l64t1582r236b1635],
18	5	CD	PERCENT	5	number	19	SENT_136	[p11l1837t1581r1868b1635],
19	(	CD	PERCENT	(	dobj	3	SENT_136	[p11l1902t1581r1957b1647],
20	5	CD	PERCENT	5	number	21	SENT_136	[p11l1902t1581r1957b1647],
21	%	NN	PERCENT	%	amod	19	SENT_136	[p11l1990t1582r2071b1647],
22	)	CD	NUMBER	)	tmod	19	SENT_136	[p11l1990t1582r2071b1647],

1	Age	NNP	O	Age	dep	6	SENT_137	[p11l13t1681r137b1749],
2	(	CD	NUMBER	(	num	3	SENT_137	[p11l167t1681r372b1749],
3	years	NNS	NUMBER	year	dep	1	SENT_137	[p11l167t1681r372b1749],
4	)	CD	NUMBER	)	dep	6	SENT_137	[p11l167t1681r372b1749],
5	Median	JJ	O	median	amod	6	SENT_137	[p11l62t1780r294b1833],
6	50	CD	NUMBER	50	dep	12	SENT_137	[p11l1837t1780r1909b1834],
7	(	CD	NUMBER	(	number	8	SENT_137	[p11l1939t1781r2116b1846],
8	11.2	CD	NUMBER	11.2	num	9	SENT_137	[p11l1939t1781r2116b1846],
9	)	NN	O	)	dep	6	SENT_137	[p11l1939t1781r2116b1846],
10	Range	NNP	O	Range	dep	9	SENT_137	[p11l63t1881r255b1948],
11	27	CD	NUMBER	27	num	10	SENT_137	[p11l1836t1880r2021b1933],
12	—	NN	O	—	_	0	SENT_137	[p11l1836t1880r2021b1933],
13	78	CD	NUMBER	78	num	12	SENT_137	[p11l1836t1880r2021b1933],

1	Menopausal	JJ	O	menopausal	amod	2	SENT_138	[p11l12t1979r383b2047],
2	status	NN	O	status	_	0	SENT_138	[p11l413t1987r581b2032],

1	Pre-menopausal	JJ	O	pre-menopausal	_	0	SENT_139	[p11l63t2078r552b2147],
2	57	CD	PERCENT	57	number	3	SENT_139	[p11l1837t2078r1907b2131],
3	(	CD	PERCENT	(	prep	1	SENT_139	[p11l1939t2078r2029b2143],
4	51	CD	PERCENT	51	num	5	SENT_139	[p11l1939t2078r2029b2143],
5	%	NN	PERCENT	%	dep	3	SENT_139	[p11l2067t2078r2148b2143],
6	)	CD	NUMBER	)	tmod	1	SENT_139	[p11l2067t2078r2148b2143],
7	Post-menopausal	JJ	O	post-menopausal	amod	1	SENT_139	[p11l63t2176r581b2245],
8	54	CD	PERCENT	54	number	9	SENT_139	[p11l1837t2176r1909b2230],
9	(	CD	PERCENT	(	amod	1	SENT_139	[p11l1939t2177r2034b2242],
10	49	CD	PERCENT	49	num	11	SENT_139	[p11l1939t2177r2034b2242],
11	%	NN	PERCENT	%	dep	9	SENT_139	[p11l2067t2177r2148b2242],
12	)	CD	NUMBER	)	num	13	SENT_139	[p11l2067t2177r2148b2242],
13	Grade	NNP	O	Grade	dep	1	SENT_139	[p11l14t2275r196b2329],
14	at	IN	O	at	_	0	SENT_139	[p11l226t2283r279b2329],
15	diagnosis	NN	O	diagnosis	prep_at	13	SENT_139	[p11l306t2275r589b2344],

1	1	CD	NUMBER	1	num	3	SENT_140	[p11l70t2376r92b2428],
2	7	CD	NUMBER	7	num	3	SENT_140	[p11l1836t2377r1869b2428],
3	(	NN	O	(	dep	17	SENT_140	[p11l1902t2375r1959b2441],
4	6	CD	PERCENT	6	num	5	SENT_140	[p11l1902t2375r1959b2441],
5	%	NN	PERCENT	%	dep	3	SENT_140	[p11l1990t2376r2071b2441],
6	)	CD	NUMBER	)	number	7	SENT_140	[p11l1990t2376r2071b2441],
7	2	CD	NUMBER	2	num	5	SENT_140	[p11l64t2476r98b2528],
8	29	CD	PERCENT	29	num	9	SENT_140	[p11l1836t2476r1908b2530],
9	(	NN	PERCENT	(	dep	5	SENT_140	[p11l1939t2476r2035b2541],
10	26	CD	PERCENT	26	num	11	SENT_140	[p11l1939t2476r2035b2541],
11	%	NN	PERCENT	%	dep	9	SENT_140	[p11l2067t2476r2148b2541],
12	)	CD	NUMBER	)	number	13	SENT_140	[p11l2067t2476r2148b2541],
13	3	CD	NUMBER	3	num	11	SENT_140	[p11l65t2575r95b2628],
14	60	CD	NUMBER	60	num	15	SENT_140	[p11l1837t2575r1909b2628],
15	(	NN	O	(	dep	17	SENT_140	[p11l1939t2575r2036b2641],
16	54	CD	PERCENT	54	num	17	SENT_140	[p11l1939t2575r2036b2641],
17	%	NN	PERCENT	%	dep	24	SENT_140	[p11l2067t2575r2148b2640],
18	)	CD	NUMBER	)	dep	17	SENT_140	[p11l2067t2575r2148b2640],
19	Unknown	JJ	O	unknown	amod	18	SENT_140	[p11l63t2675r361b2729],
20	15	CD	PERCENT	15	number	21	SENT_140	[p11l1842t2675r1906b2729],
21	(	CD	PERCENT	(	prep	19	SENT_140	[p11l1939t2676r2035b2741],
22	14	CD	PERCENT	14	num	23	SENT_140	[p11l1939t2676r2035b2741],
23	%	NN	PERCENT	%	dep	21	SENT_140	[p11l2067t2676r2148b2741],
24	)	CD	NUMBER	)	_	0	SENT_140	[p11l2067t2676r2148b2741],

1	Receptor	NN	O	receptor	_	0	SENT_141	[p11l13t2777r288b2844],
2	status	NN	O	status	nn	3	SENT_141	[p11l317t2783r484b2829],
3	ER	NN	O	er	dep	1	SENT_141	[p11l62t2877r215b2935],
4	+	CC	O	+	_	0	SENT_141	[p11l62t2877r215b2935],
5	56	CD	PERCENT	56	number	6	SENT_141	[p11l1837t2876r1908b2929],
6	(	CD	PERCENT	(	conj_+	3	SENT_141	[p11l1939t2876r2036b2942],
7	50	CD	PERCENT	50	num	8	SENT_141	[p11l1939t2876r2036b2942],
8	%	NN	PERCENT	%	dep	6	SENT_141	[p11l2067t2876r2148b2941],
9	)	CD	NUMBER	)	num	10	SENT_141	[p11l2067t2876r2148b2941],
10	ER	NN	O	er	dep	1	SENT_141	[p11l62t2976r159b3028],
11	or	CC	O	or	_	0	SENT_141	[p11l187t2992r249b3028],
12	PR	NN	O	pr	conj_or	10	SENT_141	[p11l274t2976r422b3034],
13	+	CC	O	+	_	0	SENT_141	[p11l274t2976r422b3034],
14	63	CD	PERCENT	63	number	15	SENT_141	[p11l1837t2975r1905b3029],
15	(	CD	PERCENT	(	conj_+	10	SENT_141	[p11l1939t2975r2034b3041],
16	57	CD	PERCENT	57	num	17	SENT_141	[p11l1939t2975r2034b3041],
17	%	NN	PERCENT	%	dep	15	SENT_141	[p11l2067t2975r2148b3041],
18	)	CD	NUMBER	)	num	19	SENT_141	[p11l2067t2975r2148b3041],
19	HER2	NN	O	her2	dep	1	SENT_141	[p11l63t3076r308b3135],
20	+	CC	O	+	_	0	SENT_141	[p11l63t3076r308b3135],
21	31	CD	PERCENT	31	number	22	SENT_141	[p11l1837t3076r1903b3129],
22	(	CD	PERCENT	(	conj_+	19	SENT_141	[p11l1939t3076r2033b3141],
23	28	CD	PERCENT	28	num	24	SENT_141	[p11l1939t3076r2033b3141],
24	%	NN	PERCENT	%	dep	22	SENT_141	[p11l2067t3076r2148b3141],
25	)	CD	NUMBER	)	num	26	SENT_141	[p11l2067t3076r2148b3141],
26	Stage	NN	O	stage	dep	1	SENT_141	[p11l15t3175r180b3243],
27	at	IN	O	at	_	0	SENT_141	[p11l209t3183r262b3228],
28	diagnosis	NN	O	diagnosis	nn	29	SENT_141	[p11l289t3175r572b3244],
29	IIA	NN	O	iium	prep_at	26	SENT_141	[p11l63t3275r301b3327],
30	.	.	O	.	_	0	SENT_141	[p11l63t3275r301b3327],

1	—	NN	O	—	_	0	SENT_142	[p11l63t3275r301b3327],
2	.	.	O	.	_	0	SENT_142	[p11l63t3275r301b3327],

1	IIB	NNP	O	IIB	_	0	SENT_143	[p11l63t3275r301b3327],
2	42	CD	PERCENT	42	num	1	SENT_143	[p11l1835t3274r1909b3327],
3	(	CD	PERCENT	(	number	4	SENT_143	[p11l1939t3275r2033b3340],
4	38	CD	PERCENT	38	num	5	SENT_143	[p11l1939t3275r2033b3340],
5	%	NN	PERCENT	%	dep	1	SENT_143	[p11l2067t3274r2148b3340],
6	)	CD	NUMBER	)	num	7	SENT_143	[p11l2067t3274r2148b3340],
7	IIIA	NN	O	iium	dep	5	SENT_143	[p11l63t3375r355b3428],
8	.	.	O	.	_	0	SENT_143	[p11l63t3375r355b3428],

1	—	NN	O	—	_	0	SENT_144	[p11l63t3375r355b3428],
2	.	.	O	.	_	0	SENT_144	[p11l63t3375r355b3428],

1	IIIC	NNP	ORGANIZATION	IIIC	_	0	SENT_145	[p11l63t3375r355b3428],
2	59	CD	PERCENT	59	num	1	SENT_145	[p11l1837t3374r1908b3428],
3	(	CD	PERCENT	(	num	5	SENT_145	[p11l1939t3374r2032b3440],
4	53	CD	PERCENT	53	num	5	SENT_145	[p11l1939t3374r2032b3440],
5	%	NN	PERCENT	%	dep	1	SENT_145	[p11l2067t3375r2148b3440],
6	)	CD	PERCENT	)	number	7	SENT_145	[p11l2067t3375r2148b3440],
7	IV	CD	PERCENT	iv	num	9	SENT_145	[p11l63t3476r141b3528],
8	10	CD	PERCENT	10	number	9	SENT_145	[p11l1843t3475r1909b3528],
9	(	CD	PERCENT	(	dep	5	SENT_145	[p11l1939t3475r1996b3540],
10	9	CD	PERCENT	9	number	11	SENT_145	[p11l1939t3475r1996b3540],
11	%	NN	PERCENT	%	amod	9	SENT_145	[p11l2029t3475r2110b3540],
12	)	CD	NUMBER	)	dep	1	SENT_145	[p11l2029t3475r2110b3540],

1	Taxane	NN	O	taxane	nn	2	SENT_146	[p11l13t3575r235b3627],
2	regimena	NN	O	regimena	_	0	SENT_146	[p11l262t3569r538b3643],

1	T	NN	O	t	nn	2	SENT_147	[p11l63t3675r107b3726],
2	l6	NN	O	l6	_	0	SENT_147	[p11l1842t3673r1908b3727],
3	(	CD	PERCENT	(	num	5	SENT_147	[p11l1939t3674r2035b3739],
4	l4	CD	PERCENT	l4	num	5	SENT_147	[p11l1939t3674r2035b3739],
5	%	NN	PERCENT	%	dep	2	SENT_147	[p11l2067t3674r2148b3739],
6	)	CD	NUMBER	)	dep	2	SENT_147	[p11l2067t3674r2148b3739],

1	TC	NN	O	tc	nn	3	SENT_148	[p12l63t24r157b77],
2	2	CD	NUMBER	2	num	3	SENT_148	[p12l1836t24r1871b76],
3	(	NN	O	(	dep	9	SENT_148	[p12l1902t24r1960b89],
4	2	CD	PERCENT	2	num	5	SENT_148	[p12l1902t24r1960b89],
5	%	NN	PERCENT	%	dep	3	SENT_148	[p12l1990t24r2071b89],
6	)	CD	NUMBER	)	num	7	SENT_148	[p12l1990t24r2071b89],
7	TCH	NN	ORGANIZATION	tch	dep	9	SENT_148	[p12l63t124r213b177],
8	1	CD	NUMBER	1	num	9	SENT_148	[p12l1843t125r1864b176],
9	(	NN	O	(	dep	13	SENT_148	[p12l1902t124r1954b189],
10	1	CD	PERCENT	1	num	11	SENT_148	[p12l1902t124r1954b189],
11	%	NN	PERCENT	%	dep	9	SENT_148	[p12l1990t124r2071b189],
12	)	CD	NUMBER	)	num	13	SENT_148	[p12l1990t124r2071b189],
13	TH	NN	O	th	dep	15	SENT_148	[p12l63t225r163b276],
14	1	CD	NUMBER	1	num	15	SENT_148	[p12l1843t224r1865b276],
15	(	NN	O	(	dep	19	SENT_148	[p12l1902t224r1954b289],
16	1	CD	PERCENT	1	num	17	SENT_148	[p12l1902t224r1954b289],
17	%	NN	PERCENT	%	dep	15	SENT_148	[p12l1990t224r2071b289],
18	)	CD	NUMBER	)	num	19	SENT_148	[p12l1990t224r2071b289],
19	AC-T	NN	O	ac-t	dep	25	SENT_148	[p12l63t323r238b376],
20	73	CD	PERCENT	73	number	21	SENT_148	[p12l1836t323r1905b377],
21	(	CD	PERCENT	(	dep	19	SENT_148	[p12l1939t323r2035b389],
22	66	CD	PERCENT	66	num	23	SENT_148	[p12l1939t323r2035b389],
23	%	NN	PERCENT	%	dep	21	SENT_148	[p12l2067t323r2148b389],
24	)	CD	NUMBER	)	num	25	SENT_148	[p12l2067t323r2148b389],
25	AC-TH	NN	O	ac-th	dep	30	SENT_148	[p12l63t424r293b477],
26	18	CD	PERCENT	18	number	27	SENT_148	[p12l1842t424r1906b477],
27	(	CD	PERCENT	(	dep	25	SENT_148	[p12l1939t423r2035b489],
28	16	CD	PERCENT	16	num	29	SENT_148	[p12l1939t423r2035b489],
29	%	NN	PERCENT	%	dep	27	SENT_148	[p12l2067t424r2148b489],
30	)	CD	NUMBER	)	_	0	SENT_148	[p12l2067t424r2148b489],

1	Taxane	NN	O	taxane	nn	2	SENT_149	[p12l13t524r235b576],
2	schedule	NN	O	schedule	dep	11	SENT_149	[p12l266t522r527b576],
3	and	CC	O	and	_	0	SENT_149	[p12l558t523r665b576],
4	dose	NN	O	dose	conj_and	2	SENT_149	[p12l692t523r828b576],
5	Weekly	NNP	SET	Weekly	dep	2	SENT_149	[p12l62t622r297b691],
6	(	CD	NUMBER	(	num	5	SENT_149	[p12l329t622r540b687],
7	80-90	CD	NUMBER	80-90	num	8	SENT_149	[p12l329t622r540b687],
8	mg/m2	NN	O	mg/m2	dep	11	SENT_149	[p12l567t606r795b691],
9	)	CD	NUMBER	)	number	10	SENT_149	[p12l567t606r795b691],
10	36	CD	NUMBER	36	num	11	SENT_149	[p12l1837t622r1908b675],
11	(	NN	O	(	dep	17	SENT_149	[p12l1939t622r2035b687],
12	32	CD	PERCENT	32	num	13	SENT_149	[p12l1939t622r2035b687],
13	%	NN	PERCENT	%	dep	11	SENT_149	[p12l2067t622r2148b687],
14	)	CD	NUMBER	)	num	16	SENT_149	[p12l2067t622r2148b687],
15	Q2	NN	O	q2	nn	16	SENT_149	[p12l64t721r153b786],
16	Weeks	NNS	DURATION	week	nsubj	17	SENT_149	[p12l180t720r385b774],
17	(	VBP	O	(	dep	28	SENT_149	[p12l417t720r548b786],
18	175	CD	NUMBER	175	num	20	SENT_149	[p12l417t720r548b786],
19	mg/m2	JJ	O	mg/m2	amod	20	SENT_149	[p12l579t704r807b789],
20	)	NN	O	)	dobj	17	SENT_149	[p12l579t704r807b789],
21	52	CD	PERCENT	52	number	22	SENT_149	[p12l1837t720r1909b774],
22	(	CD	PERCENT	(	amod	20	SENT_149	[p12l1939t721r2034b786],
23	47	CD	PERCENT	47	num	24	SENT_149	[p12l1939t721r2034b786],
24	%	NN	PERCENT	%	dep	22	SENT_149	[p12l2067t721r2148b786],
25	)	CD	NUMBER	)	num	27	SENT_149	[p12l2067t721r2148b786],
26	Q3	NN	O	q3	nn	27	SENT_149	[p12l64t820r150b885],
27	Weeks	NNS	DURATION	week	nsubj	28	SENT_149	[p12l180t820r385b873],
28	(	VBP	O	(	dep	40	SENT_149	[p12l417t819r548b885],
29	175	CD	NUMBER	175	num	31	SENT_149	[p12l417t819r548b885],
30	mg/m2	JJ	O	mg/m2	amod	31	SENT_149	[p12l579t804r807b888],
31	)	NN	O	)	dobj	28	SENT_149	[p12l579t804r807b888],
32	22	CD	PERCENT	22	number	33	SENT_149	[p12l1836t820r1909b872],
33	(	CD	PERCENT	(	amod	31	SENT_149	[p12l1939t820r2036b885],
34	20	CD	PERCENT	20	num	35	SENT_149	[p12l1939t820r2036b885],
35	%	NN	PERCENT	%	dep	33	SENT_149	[p12l2067t820r2148b885],
36	)	CD	NUMBER	)	num	37	SENT_149	[p12l2067t820r2148b885],
37	Q2	NN	O	q2	tmod	28	SENT_149	[p12l64t919r207b985],
38	.5	CD	DURATION	.5	num	39	SENT_149	[p12l64t919r207b985],
39	Weeks	NNS	DURATION	week	dep	37	SENT_149	[p12l237t919r442b972],
40	(	VBP	O	(	_	0	SENT_149	[p12l474t919r606b984],
41	175	CD	NUMBER	175	num	43	SENT_149	[p12l474t919r606b984],
42	mg/m2	JJ	O	mg/m2	amod	43	SENT_149	[p12l636t903r864b988],
43	)	NN	O	)	nsubj	45	SENT_149	[p12l636t903r864b988],
44	1	CD	NUMBER	1	num	45	SENT_149	[p12l1842t920r1864b971],
45	(	NN	O	(	xcomp	40	SENT_149	[p12l1902t919r1954b984],
46	1	CD	PERCENT	1	number	47	SENT_149	[p12l1902t919r1954b984],
47	%	NN	PERCENT	%	amod	45	SENT_149	[p12l1990t919r2071b984],
48	)	CD	NUMBER	)	nsubj	40	SENT_149	[p12l1990t919r2071b984],

1	Early	RB	O	early	dep	3	SENT_150	[p12l12t1017r176b1086],
2	paclitaxel	NN	O	paclitaxel	nn	3	SENT_150	[p12l203t1017r499b1086],
3	discontinuation	NN	O	discontinuation	_	0	SENT_150	[p12l528t1017r996b1070],

1	Toxicity	NN	O	toxicity	dep	12	SENT_151	[p12l63t1116r319b1185],
2	11	CD	PERCENT	11	num	1	SENT_151	[p12l1842t1117r1903b1169],
3	(	CD	PERCENT	(	number	4	SENT_151	[p12l1939t1117r2036b1182],
4	10	CD	PERCENT	10	num	5	SENT_151	[p12l1939t1117r2036b1182],
5	%	NN	PERCENT	%	dep	1	SENT_151	[p12l2067t1117r2148b1182],
6	)	CD	NUMBER	)	num	8	SENT_151	[p12l2067t1117r2148b1182],
7	Disease	NN	O	disease	nn	8	SENT_151	[p12l63t1216r297b1269],
8	progression	NN	O	progression	dep	5	SENT_151	[p12l324t1216r678b1284],
9	1	CD	NUMBER	1	num	10	SENT_151	[p12l1843t1216r1864b1268],
10	(	NN	O	(	dep	12	SENT_151	[p12l1902t1216r1954b1281],
11	1	CD	PERCENT	1	num	12	SENT_151	[p12l1902t1216r1954b1281],
12	%	NN	PERCENT	%	_	0	SENT_151	[p12l1990t1216r2071b1281],
13	)	CD	NUMBER	)	dep	12	SENT_151	[p12l1990t1216r2071b1281],

1	Total	JJ	O	total	amod	2	SENT_152	[p12l13t1316r172b1369],
2	weeks	NNS	DURATION	week	_	0	SENT_152	[p12l200t1316r387b1369],
3	of	IN	O	of	_	0	SENT_152	[p12l417t1316r482b1369],
4	Taxane	NNP	MISC	Taxane	prep_of	2	SENT_152	[p12l504t1317r726b1369],
5	Median	JJ	MISC	median	amod	4	SENT_152	[p12l62t1415r294b1468],
6	9.0	CD	NUMBER	9.0	number	7	SENT_152	[p12l1836t1416r1928b1469],
7	(	CD	NUMBER	(	dep	2	SENT_152	[p12l1959t1416r2097b1481],
8	2.9	CD	NUMBER	2.9	num	9	SENT_152	[p12l1959t1416r2097b1481],
9	)	NN	O	)	dep	7	SENT_152	[p12l1959t1416r2097b1481],
10	Range	NNP	O	Range	dep	7	SENT_152	[p12l63t1516r255b1583],
11	1-23	CD	NUMBER	1-23	num	10	SENT_152	[p12l1843t1515r1982b1568],

1	Counts	NNS	O	count	nsubjpass	9	SENT_153	[p12l13t1662r224b1715],
2	and	CC	O	and	_	0	SENT_153	[p12l251t1661r358b1715],
3	percentages	NNS	O	percentage	nsubjpass	9	SENT_153	[p12l381t1670r739b1730],
4	(	RB	O	(	advmod	9	SENT_153	[p12l767t1661r848b1727],
5	in	IN	O	in	_	0	SENT_153	[p12l767t1661r848b1727],
6	parentheses	NNS	O	parenthesis	prep_in	9	SENT_153	[p12l871t1662r1248b1730],
7	)	CD	NUMBER	)	nsubjpass	9	SENT_153	[p12l871t1662r1248b1730],
8	are	VBP	O	be	auxpass	9	SENT_153	[p12l1277t1678r1366b1715],
9	presented	VBN	O	present	_	0	SENT_153	[p12l1389t1662r1681b1730],
10	for	IN	O	for	_	0	SENT_153	[p12l1706t1661r1794b1715],
11	categorical	JJ	O	categorical	amod	12	SENT_153	[p12l1817t1661r2149b1730],
12	data	NNS	O	datum	prep_for	9	SENT_153	[p12l13t1751r153b1804],
13	.	.	O	.	_	0	SENT_153	[p12l13t1751r153b1804],

1	Medians	NNPS	MISC	Medians	nsubj	5	SENT_154	[p12l183t1751r442b1804],
2	and	CC	O	and	_	0	SENT_154	[p12l472t1751r579b1804],
3	standard	JJ	O	standard	amod	4	SENT_154	[p12l608t1751r861b1804],
4	deviations	NNS	O	deviation	conj_and	1	SENT_154	[p12l889t1751r1199b1804],
5	(	VBP	O	(	_	0	SENT_154	[p12l1229t1751r1310b1816],
6	in	IN	O	in	_	0	SENT_154	[p12l1229t1751r1310b1816],
7	parentheses	NNS	O	parenthesis	prep_in	5	SENT_154	[p12l1335t1751r1712b1819],
8	)	CD	NUMBER	)	nsubjpass	10	SENT_154	[p12l1335t1751r1712b1819],
9	are	VBP	O	be	auxpass	10	SENT_154	[p12l1743t1767r1832b1804],
10	presented	VBN	O	present	conj_negcc	10	SENT_154	[p12l1859t1751r2151b1819],
11	for	IN	O	for	_	0	SENT_154	[p12l12t1840r100b1893],
12	quantitative	JJ	O	quantitative	amod	18	SENT_154	[p12l127t1840r485b1908],
13	data	NN	O	datum	nn	18	SENT_154	[p12l514t1840r640b1893],
14	A	NN	O	a	nn	18	SENT_154	[p12l7t1939r55b1991],
15	doxorubicin	NN	O	doxorubicin	nn	18	SENT_154	[p12l83t1938r449b1991],
16	(	CD	NUMBER	(	num	18	SENT_154	[p12l477t1938r904b2007],
17	Adriamycin	NN	O	adriamycin	nn	18	SENT_154	[p12l477t1938r904b2007],
18	)	NN	O	)	prep_for	10	SENT_154	[p12l477t1938r904b2007],
19	,	,	O	,	_	0	SENT_154	[p12l477t1938r904b2007],
20	C	NN	O	c	nn	21	SENT_154	[p12l937t1939r984b1992],
21	cyclophosphamide	NN	O	cyclophosphamide	appos	18	SENT_154	[p12l1008t1938r1577b2007],
22	(	CD	NUMBER	(	num	24	SENT_154	[p12l1605t1938r1926b2007],
23	Cytoxan	NNP	MISC	Cytoxan	nn	24	SENT_154	[p12l1605t1938r1926b2007],
24	)	NN	O	)	nsubj	39	SENT_154	[p12l1605t1938r1926b2007],
25	,	,	O	,	_	0	SENT_154	[p12l1605t1938r1926b2007],
26	T	NN	O	t	nn	27	SENT_154	[p12l1958t1940r2002b1991],
27	paclitaxel	NN	O	paclitaxel	dep	35	SENT_154	[p12l2020t1955r2148b2007, p12l12t2027r201b2080],
28	(	CD	NUMBER	(	num	30	SENT_154	[p12l232t2027r472b2092],
29	Taxol	NN	ORGANIZATION	taxol	nn	30	SENT_154	[p12l232t2027r472b2092],
30	)	NN	O	)	dep	27	SENT_154	[p12l232t2027r472b2092],
31	,	,	O	,	_	0	SENT_154	[p12l232t2027r472b2092],
32	H	NN	O	h	appos	30	SENT_154	[p12l501t2029r561b2079],
33	trastuzumab	NN	O	trastuzumab	dep	35	SENT_154	[p12l583t2027r953b2080],
34	(	CD	NUMBER	(	num	33	SENT_154	[p12l984t2027r1329b2095],
35	Herceptin	NNP	O	Herceptin	dep	39	SENT_154	[p12l984t2027r1329b2095],
36	)	CD	NUMBER	)	dep	35	SENT_154	[p12l984t2027r1329b2095],
37	a	DT	O	a	det	38	SENT_154	[p12l13t2120r37b2145],
38	Regimen	NN	MISC	regimen	nsubj	39	SENT_154	[p12l76t2125r350b2194],
39	includes	VBZ	O	include	rcmod	21	SENT_154	[p12l412t2125r663b2178],
40	all	DT	O	all	det	41	SENT_154	[p12l728t2125r801b2178],
41	drugs	NNS	O	drug	dobj	39	SENT_154	[p12l864t2125r1029b2194],
42	taken	VBN	O	take	partmod	41	SENT_154	[p12l1092t2125r1256b2178],
43	before	RB	O	before	dep	42	SENT_154	[p12l1318t2125r1511b2178],
44	or	CC	O	or	_	0	SENT_154	[p12l1574t2142r1637b2178],
45	during	IN	O	during	dep	42	SENT_154	[p12l1698t2125r1893b2194],
46	paclit	NN	O	paclit	nn	49	SENT_154	[p12l1956t2125r2148b2194],
47	—	CD	NUMBER	—	num	49	SENT_154	[p12l1956t2125r2148b2194],
48	axel	NN	O	axel	nn	49	SENT_154	[p12l14t2213r137b2266],
49	treatment	NN	O	treatment	pobj	45	SENT_154	[p12l186t2221r474b2266],
50	but	CC	O	but	_	0	SENT_154	[p12l520t2213r618b2266],
51	not	RB	O	not	_	0	SENT_154	[p12l665t2221r761b2266],
52	after	IN	O	after	_	0	SENT_154	[p12l810t2213r962b2266],
53	.	.	O	.	_	0	SENT_154	[p12l810t2213r962b2266],

1	“	NN	O	“	_	0	SENT_155	[p12l1021t2214r1126b2251],
2	.	.	O	.	_	0	SENT_155	[p12l1021t2214r1126b2251],

1	—	NN	O	—	_	0	SENT_156	[p12l1021t2214r1126b2251],
2	.	.	O	.	_	0	SENT_156	[p12l1021t2214r1126b2251],

1	”	NN	O	”	nsubj	2	SENT_157	[p12l1021t2214r1126b2251],
2	indicates	VBZ	O	indicate	_	0	SENT_157	[p12l1182t2213r1450b2266],
3	these	DT	O	these	nsubj	6	SENT_157	[p12l1499t2213r1654b2266],
4	are	VBP	O	be	cop	6	SENT_157	[p12l1704t2230r1794b2266],
5	sequential	JJ	O	sequential	amod	6	SENT_157	[p12l1845t2213r2150b2282],
6	treatments	NNS	O	treatment	ccomp	2	SENT_157	[p12l12t2310r327b2354],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_158	[p12l52t2430r142b2454],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_158	[p12l155t2429r255b2455],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_158	[p12l267t2430r318b2454],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_158	[p12l331t2430r406b2454],
5	(	CD	NUMBER	(	num	6	SENT_158	[p12l419t2429r510b2460],
6	2012	CD	DATE	2012	dep	4	SENT_158	[p12l419t2429r510b2460],
7	)	CD	NUMBER	)	number	8	SENT_158	[p12l419t2429r510b2460],
8	134:401	CD	NUMBER	134:401	num	9	SENT_158	[p12l528t2429r710b2455],
9	—	NN	O	—	dep	6	SENT_158	[p12l528t2429r710b2455],
10	410	CD	NUMBER	410	number	11	SENT_158	[p12l528t2429r710b2455],
11	405	CD	NUMBER	405	num	9	SENT_158	[p12l2055t2429r2106b2455],

1	Table	NNP	O	Table	nn	3	SENT_159	[p12l8t2612r191b2665],
2	2	CD	NUMBER	2	num	3	SENT_159	[p12l219t2611r255b2664],
3	Response	NN	O	response	dep	12	SENT_159	[p12l303t2613r593b2680],
4	to	TO	O	to	_	0	SENT_159	[p12l618t2619r675b2665],
5	paclitaxel	NN	O	paclitaxel	nn	6	SENT_159	[p12l699t2612r997b2680],
6	therapy	NN	O	therapy	prep_to	3	SENT_159	[p12l1022t2612r1249b2680],
7	in	IN	O	in	_	0	SENT_159	[p12l1274t2612r1332b2664],
8	efﬁcacy	NN	O	efﬁcacy	nn	11	SENT_159	[p12l1357t2612r1596b2680],
9	cohort	NN	O	cohort	nn	11	SENT_159	[p12l1622t2612r1816b2665],
10	(	NN	O	(	nn	11	SENT_159	[p12l1842t2612r1900b2677],
11	n	NN	O	n	prep_in	6	SENT_159	[p12l1842t2612r1900b2677],
12	=	JJ	O	=	_	0	SENT_159	[p12l1931t2636r1983b2656],
13	103	CD	NUMBER	103	num	14	SENT_159	[p12l2021t2612r2149b2677],
14	)	NN	O	)	dep	12	SENT_159	[p12l2021t2612r2149b2677],

1	Therapy	NN	O	therapy	_	0	SENT_160	[p12l7t2756r259b2825],
2	response	NN	O	response	nn	3	SENT_160	[p12l287t2773r552b2825],
3	Data	NNS	O	datum	dep	1	SENT_160	[p12l1654t2757r1798b2809],

1	Percentage	NN	O	percentage	nn	2	SENT_161	[p12l8t2948r341b3015],
2	change	NN	O	change	dep	8	SENT_161	[p12l370t2947r584b3015],
3	in	IN	O	in	_	0	SENT_161	[p12l612t2946r669b2999],
4	tumor	NN	O	tumor	prep_in	2	SENT_161	[p12l697t2954r879b3000],
5	size	NN	O	size	nn	6	SENT_161	[p12l908t2946r1021b3000],
6	Mean	NN	O	mean	dep	8	SENT_161	[p12l57t3042r230b3094],
7	-49	CD	PERCENT	-49	num	8	SENT_161	[p12l1660t3041r1787b3095],
8	%	NN	PERCENT	%	dep	11	SENT_161	[p12l1820t3041r1874b3094],
9	Median	JJ	MISC	median	dep	8	SENT_161	[p12l57t3134r289b3187],
10	-43	CD	PERCENT	-43	num	11	SENT_161	[p12l1660t3134r1784b3187],
11	%	NN	PERCENT	%	_	0	SENT_161	[p12l1820t3134r1874b3187],
12	Maximum	NNP	O	Maximum	nsubj	13	SENT_161	[p12l57t3228r375b3282],
13	decrease	VB	O	decrease	rcmod	11	SENT_161	[p12l403t3229r663b3282],
14	100	CD	PERCENT	100	num	15	SENT_161	[p12l1683t3229r1788b3282],
15	%	NN	PERCENT	%	dobj	13	SENT_161	[p12l1820t3229r1874b3282],
16	Maximum	NNP	O	Maximum	nsubj	17	SENT_161	[p12l57t3323r375b3376],
17	increase	VB	O	increase	dep	13	SENT_161	[p12l402t3323r651b3376],
18	29	CD	PERCENT	29	num	19	SENT_161	[p12l1715t3323r1787b3377],
19	%	NN	PERCENT	%	iobj	17	SENT_161	[p12l1820t3323r1874b3376],
20	Clinical	JJ	O	clinical	amod	21	SENT_161	[p12l8t3416r248b3469],
21	response	NN	O	response	dobj	17	SENT_161	[p12l275t3433r541b3485],

1	Clinical	JJ	O	clinical	amod	3	SENT_162	[p12l59t3510r298b3564],
2	complete	JJ	O	complete	amod	3	SENT_162	[p12l327t3510r605b3579],
3	response	NN	O	response	dep	11	SENT_162	[p12l633t3527r898b3579],
4	31	CD	PERCENT	31	num	5	SENT_162	[p12l1780t3511r1845b3564],
5	(	CD	PERCENT	(	dep	3	SENT_162	[p12l1882t3511r2030b3576],
6	30.1	CD	PERCENT	30.1	num	7	SENT_162	[p12l1882t3511r2030b3576],
7	%	NN	PERCENT	%	dep	11	SENT_162	[p12l2068t3511r2149b3576],
8	)	CD	NUMBER	)	num	11	SENT_162	[p12l2068t3511r2149b3576],
9	Clinical	JJ	O	clinical	amod	11	SENT_162	[p12l59t3605r298b3658],
10	partial	JJ	O	partial	amod	11	SENT_162	[p12l325t3605r520b3673],
11	response	NN	O	response	dep	19	SENT_162	[p12l547t3621r812b3673],
12	34	CD	PERCENT	34	number	13	SENT_162	[p12l1780t3605r1851b3658],
13	(	CD	PERCENT	(	dep	11	SENT_162	[p12l1882t3605r2036b3670],
14	33.0	CD	PERCENT	33.0	num	15	SENT_162	[p12l1882t3605r2036b3670],
15	%	NN	PERCENT	%	dep	13	SENT_162	[p12l2068t3605r2149b3670],
16	)	CD	NUMBER	)	num	19	SENT_162	[p12l2068t3605r2149b3670],
17	Clinical	JJ	O	clinical	amod	19	SENT_162	[p12l59t3699r298b3752],
18	stable	JJ	O	stable	amod	19	SENT_162	[p12l329t3699r503b3752],
19	disease	NN	O	disease	dep	24	SENT_162	[p12l532t3699r749b3752],
20	36	CD	PERCENT	36	number	21	SENT_162	[p12l1780t3699r1851b3752],
21	(	CD	PERCENT	(	dep	19	SENT_162	[p12l1882t3699r2036b3765],
22	35.0	CD	PERCENT	35.0	num	23	SENT_162	[p12l1882t3699r2036b3765],
23	%	NN	PERCENT	%	dep	21	SENT_162	[p12l2068t3699r2149b3764],
24	)	CD	NUMBER	)	_	0	SENT_162	[p12l2068t3699r2149b3764],

1	Clinical	JJ	O	clinical	amod	3	SENT_163	[p13l59t21r298b75],
2	progressive	JJ	O	progressive	amod	3	SENT_163	[p13l326t21r676b90],
3	disease	NN	O	disease	dep	9	SENT_163	[p13l705t21r922b74],
4	2	CD	PERCENT	2	num	3	SENT_163	[p13l1817t22r1851b74],
5	(	CD	PERCENT	(	number	6	SENT_163	[p13l1882t22r1997b87],
6	1.9	CD	PERCENT	1.9	num	7	SENT_163	[p13l1882t22r1997b87],
7	%	NN	PERCENT	%	dep	3	SENT_163	[p13l2030t22r2111b87],
8	)	CD	NUMBER	)	num	7	SENT_163	[p13l2030t22r2111b87],
9	Excluded	VBD	O	exclude	_	0	SENT_163	[p13l57t115r346b169],
10	(	CD	NUMBER	(	num	12	SENT_163	[p13l375t115r789b181],
11	unevaluable	JJ	O	unevaluable	amod	12	SENT_163	[p13l375t115r789b181],
12	)	NN	O	)	nsubj	9	SENT_163	[p13l375t115r789b181],
13	8	CD	NUMBER	8	num	12	SENT_163	[p13l1845t116r1875b169],

1	Counts	NNS	O	count	nsubjpass	9	SENT_164	[p13l8t263r220b316],
2	and	CC	O	and	_	0	SENT_164	[p13l247t262r354b316],
3	percentages	NNS	O	percentage	nsubjpass	9	SENT_164	[p13l377t271r736b331],
4	(	RB	O	(	advmod	1	SENT_164	[p13l764t263r845b328],
5	in	IN	O	in	_	0	SENT_164	[p13l764t263r845b328],
6	parentheses	NNS	O	parenthesis	prep_in	1	SENT_164	[p13l868t263r1247b331],
7	)	CD	NUMBER	)	dep	6	SENT_164	[p13l868t263r1247b331],
8	are	VBP	O	be	auxpass	9	SENT_164	[p13l1275t279r1365b316],
9	presented	VBN	O	present	_	0	SENT_164	[p13l1388t262r1681b331],
10	for	IN	O	for	_	0	SENT_164	[p13l1705t262r1794b316],
11	categorical	JJ	O	categorical	amod	12	SENT_164	[p13l1817t262r2150b331],
12	data	NNS	O	datum	prep_for	9	SENT_164	[p13l8t352r134b405],

1	Table	NNP	O	Table	_	0	SENT_165	[p13l8t568r191b621],
2	3	CD	NUMBER	3	num	1	SENT_165	[p13l219t567r254b621],
3	Clinical	JJ	O	clinical	amod	5	SENT_165	[p13l304t568r544b621],
4	complete	JJ	O	complete	amod	5	SENT_165	[p13l577t568r855b636],
5	response	NN	O	response	nsubj	13	SENT_165	[p13l887t584r1152b636],
6	to	TO	O	to	_	0	SENT_165	[p13l1186t576r1242b621],
7	treatment	NN	O	treatment	prep_to	5	SENT_165	[p13l1275t576r1564b621],
8	in	IN	O	in	_	0	SENT_165	[p13l1595t568r1653b620],
9	efﬁcacy	NN	O	efﬁcacy	nn	12	SENT_165	[p13l1686t568r1925b636],
10	cohort	NN	O	cohort	nn	12	SENT_165	[p13l1958t568r2152b621],
11	(	NN	O	(	nn	12	SENT_165	[p13l9t657r68b721],
12	n	NN	O	n	prep_in	7	SENT_165	[p13l9t657r68b721],
13	=	JJ	O	=	rcmod	1	SENT_165	[p13l99t680r151b700],
14	103	CD	NUMBER	103	num	15	SENT_165	[p13l188t656r317b722],
15	)	NN	O	)	dobj	13	SENT_165	[p13l188t656r317b722],
16	by	IN	O	by	_	0	SENT_165	[p13l343t656r417b725],
17	genotype	NN	O	genotype	prep_by	15	SENT_165	[p13l444t664r721b725],
18	or	CC	O	or	_	0	SENT_165	[p13l748t673r810b709],
19	haplotype	NN	O	haplotype	prep_by	15	SENT_165	[p13l833t656r1149b725],
20	,	,	O	,	_	0	SENT_165	[p13l833t656r1149b725],
21	comparing	VBG	O	compare	partmod	15	SENT_165	[p13l1178t656r1502b725],
22	Variant	JJ	O	variant	amod	23	SENT_165	[p13l1529t656r1740b709],
23	carriers	NNS	O	carrier	dobj	21	SENT_165	[p13l1765t656r1990b709],
24	with	IN	O	with	_	0	SENT_165	[p13l2018t656r2152b709],
25	wild	JJ	O	wild	amod	29	SENT_165	[p13l7t744r298b812],
26	—	NN	O	—	nn	29	SENT_165	[p13l7t744r298b812],
27	type	NN	O	type	nn	29	SENT_165	[p13l7t744r298b812],
28	homozygous	JJ	O	homozygous	amod	29	SENT_165	[p13l325t744r713b812],
29	patients	NNS	O	patient	prep_with	13	SENT_165	[p13l741t744r977b812],

1	Gene	NNP	O	Gene	nn	3	SENT_166	[p13l8t889r165b942],
2	Variant	JJ	O	variant	amod	3	SENT_166	[p13l194t889r406b942],
3	Odds	NNS	O	odds	nsubj	7	SENT_166	[p13l589t889r745b942],
4	ratio	NN	O	ratio	nn	6	SENT_166	[p13l773t889r912b942],
5	Uncorrected	JJ	O	uncorrected	amod	6	SENT_166	[p13l1290t889r1667b942],
6	Bonferroni	NNS	PERSON	bonferronus	dep	3	SENT_166	[p13l1817t889r2150b942],
7	(	VBP	O	(	_	0	SENT_166	[p13l590t976r684b1042],
8	95	CD	PERCENT	95	number	9	SENT_166	[p13l590t976r684b1042],
9	%	NN	PERCENT	%	amod	10	SENT_166	[p13l744t977r799b1030],
10	CI	NN	O	ci	dobj	7	SENT_166	[p13l830t977r927b1042],
11	)	NN	O	)	nn	13	SENT_166	[p13l830t977r927b1042],
12	p	NN	O	p	nn	13	SENT_166	[p13l1283t995r1325b1045],
13	Value	NN	O	value	dep	10	SENT_166	[p13l1355t977r1517b1030],
14	corrected	VBN	O	correct	partmod	13	SENT_166	[p13l1818t977r2101b1030],
15	p	NN	O	p	nn	16	SENT_166	[p13l1811t1084r1853b1134],
16	Value	NN	O	value	dobj	14	SENT_166	[p13l1882t1066r2045b1119],

1	CYP1B1	NN	O	cyp1b1	dep	11	SENT_167	[p13l8t1256r353b1309],
2	*	CD	NUMBER	*	num	1	SENT_167	[p13l8t1256r353b1309],
3	3	CD	NUMBER	3	num	5	SENT_167	[p13l8t1256r353b1309],
4	0.53	CD	NUMBER	0.53	num	5	SENT_167	[p13l589t1256r716b1309],
5	(	NN	O	(	dep	1	SENT_167	[p13l749t1256r1099b1322],
6	0.21	CD	NUMBER	0.21	number	7	SENT_167	[p13l749t1256r1099b1322],
7	—	CD	NUMBER	—	dep	5	SENT_167	[p13l749t1256r1099b1322],
8	1.33	CD	NUMBER	1.33	num	9	SENT_167	[p13l749t1256r1099b1322],
9	)	NN	O	)	dep	11	SENT_167	[p13l749t1256r1099b1322],
10	0.1761	CD	NUMBER	0.1761	num	11	SENT_167	[p13l1291t1256r1491b1309],
11	1.0000	CD	NUMBER	1.0000	dep	18	SENT_167	[p13l1825t1256r2025b1309],
12	CYP2C8	NN	O	cyp2c8	dep	11	SENT_167	[p13l8t1352r353b1406],
13	*	CD	NUMBER	*	num	12	SENT_167	[p13l8t1352r353b1406],
14	3	CD	NUMBER	3	number	15	SENT_167	[p13l8t1352r353b1406],
15	3.92	CD	NUMBER	3.92	num	16	SENT_167	[p13l590t1352r719b1406],
16	(	NN	O	(	dep	12	SENT_167	[p13l749t1352r1137b1418],
17	1.46	CD	NUMBER	1.46	num	18	SENT_167	[p13l749t1352r1137b1418],
18	—	CD	NUMBER	—	dep	23	SENT_167	[p13l749t1352r1137b1418],
19	10.48	CD	NUMBER	10.48	num	20	SENT_167	[p13l749t1352r1137b1418],
20	)	NN	O	)	dep	18	SENT_167	[p13l749t1352r1137b1418],
21	0.0066	CD	NUMBER	0.0066	number	22	SENT_167	[p13l1291t1352r1497b1405],
22	0.0459	CD	NUMBER	0.0459	dep	20	SENT_167	[p13l1818t1352r2024b1406],
23	CYP3A4	NN	O	cyp3a4	dep	25	SENT_167	[p13l8t1451r407b1504],
24	*	CD	NUMBER	*	num	23	SENT_167	[p13l8t1451r407b1504],
25	1B	NN	O	1b	dep	29	SENT_167	[p13l8t1451r407b1504],
26	0.88	CD	NUMBER	0.88	num	25	SENT_167	[p13l589t1451r717b1504],
27	(	CD	NUMBER	(	num	29	SENT_167	[p13l749t1451r1099b1516],
28	0.32	CD	NUMBER	0.32	num	29	SENT_167	[p13l749t1451r1099b1516],
29	—	NN	O	—	dep	36	SENT_167	[p13l749t1451r1099b1516],
30	2.37	CD	NUMBER	2.37	number	31	SENT_167	[p13l749t1451r1099b1516],
31	)	CD	NUMBER	)	dep	29	SENT_167	[p13l749t1451r1099b1516],
32	0.7929	CD	NUMBER	0.7929	num	34	SENT_167	[p13l1291t1451r1496b1504],
33	1.0000	CD	NUMBER	1.0000	num	34	SENT_167	[p13l1825t1451r2025b1504],
34	CYP3A4/3A5	NN	O	cyp3a4/3a5	dep	31	SENT_167	[p13l8t1547r433b1601],
35	1.16	CD	NUMBER	1.16	num	36	SENT_167	[p13l595t1548r719b1601],
36	(	CD	NUMBER	(	dep	42	SENT_167	[p13l749t1548r1099b1613],
37	0.42	CD	NUMBER	0.42	num	38	SENT_167	[p13l749t1548r1099b1613],
38	—	NN	O	—	dep	36	SENT_167	[p13l749t1548r1099b1613],
39	3.21	CD	NUMBER	3.21	number	40	SENT_167	[p13l749t1548r1099b1613],
40	)	CD	NUMBER	)	dep	38	SENT_167	[p13l749t1548r1099b1613],
41	0.7798	CD	NUMBER	0.7798	num	42	SENT_167	[p13l1291t1548r1495b1602],
42	1.0000	CD	NUMBER	1.0000	_	0	SENT_167	[p13l1825t1548r2025b1601],

1	haplotype	NN	O	haplotype	_	0	SENT_168	[p13l61t1636r361b1705],

1	ABCB1	NN	O	abcb1	dep	8	SENT_169	[p13l7t1733r244b1786],
2	3435	CD	NUMBER	3435	num	3	SENT_169	[p13l281t1732r426b1786],
3	1.23	CD	NUMBER	1.23	dep	1	SENT_169	[p13l595t1733r716b1786],
4	(	NN	O	(	dep	8	SENT_169	[p13l749t1732r1099b1798],
5	0.50	CD	NUMBER	0.50	num	4	SENT_169	[p13l749t1732r1099b1798],
6	—	CD	NUMBER	—	num	8	SENT_169	[p13l749t1732r1099b1798],
7	3.0	CD	NUMBER	3.0	num	8	SENT_169	[p13l749t1732r1099b1798],
8	l	NN	O	l	dep	19	SENT_169	[p13l749t1732r1099b1798],
9	)	CD	NUMBER	)	number	10	SENT_169	[p13l749t1732r1099b1798],
10	0.6548	CD	NUMBER	0.6548	dep	8	SENT_169	[p13l1291t1732r1495b1786],
11	1.0000	CD	NUMBER	1.0000	num	12	SENT_169	[p13l1825t1732r2025b1786],
12	ABCB1	NN	O	abcb1	dep	10	SENT_169	[p13l7t1830r244b1883],
13	2677	CD	DATE	2677	number	14	SENT_169	[p13l279t1829r427b1883],
14	1.98	CD	NUMBER	1.98	num	15	SENT_169	[p13l595t1830r717b1883],
15	(	NN	O	(	dep	10	SENT_169	[p13l749t1830r1099b1895],
16	0.83	CD	NUMBER	0.83	number	17	SENT_169	[p13l749t1830r1099b1895],
17	—	CD	NUMBER	—	num	15	SENT_169	[p13l749t1830r1099b1895],
18	4.73	CD	NUMBER	4.73	num	19	SENT_169	[p13l749t1830r1099b1895],
19	)	NN	O	)	dep	22	SENT_169	[p13l749t1830r1099b1895],
20	0.1245	CD	NUMBER	0.1245	num	22	SENT_169	[p13l1291t1829r1494b1883],
21	0.8716	CD	NUMBER	0.8716	num	22	SENT_169	[p13l1818t1829r2024b1883],
22	ABCB1	NN	O	abcb1	dep	27	SENT_169	[p13l7t1928r244b1981],
23	0.49	CD	NUMBER	0.49	number	24	SENT_169	[p13l589t1928r718b1982],
24	(	CD	NUMBER	(	dep	22	SENT_169	[p13l749t1928r1099b1993],
25	0.15	CD	NUMBER	0.15	num	26	SENT_169	[p13l749t1928r1099b1993],
26	—	CD	NUMBER	—	dep	24	SENT_169	[p13l749t1928r1099b1993],
27	l.	NN	O	l.	dep	29	SENT_169	[p13l749t1928r1099b1993],
28	61	CD	NUMBER	61	num	27	SENT_169	[p13l749t1928r1099b1993],
29	)	CD	NUMBER	)	dep	31	SENT_169	[p13l749t1928r1099b1993],
30	0.2389	CD	NUMBER	0.2389	num	31	SENT_169	[p13l1291t1928r1496b1982],
31	1.0000	CD	NUMBER	1.0000	_	0	SENT_169	[p13l1825t1928r2025b1981],

1	haplotype	NN	O	haplotype	nn	2	SENT_170	[p13l61t2015r361b2084],
2	heterogeneity	NN	O	heterogeneity	nsubj	6	SENT_170	[p13l7t2290r496b2371],
3	was	VBD	O	be	aux	6	SENT_170	[p13l537t2310r671b2353],
4	not	RB	O	not	neg	6	SENT_170	[p13l712t2300r826b2353],
5	falsely	RB	O	falsely	advmod	6	SENT_170	[p13l865t2290r1102b2371],
6	inﬂating	VBG	O	inﬂating	_	0	SENT_170	[p13l1142t2290r1439b2371],
7	our	PRP$	O	we	poss	8	SENT_170	[p13l1481t2310r1599b2353],
8	results	NNS	O	result	dobj	6	SENT_170	[p13l1636t2290r1887b2353],
9	.	.	O	.	_	0	SENT_170	[p13l1636t2290r1887b2353],

1	In	IN	O	in	_	0	SENT_171	[p13l1931t2292r2004b2352],
2	the	DT	O	the	det	3	SENT_171	[p13l2043t2290r2150b2353],
3	self	NN	O	self	prep_in	15	SENT_171	[p13l10t2401r466b2482],
4	—	RB	O	—	advmod	5	SENT_171	[p13l10t2401r466b2482],
5	reported	VBD	O	report	partmod	3	SENT_171	[p13l10t2401r466b2482],
6	Caucasian	JJ	MISC	caucasian	amod	7	SENT_171	[p13l508t2401r875b2464],
7	subjects	NNS	O	subject	dobj	5	SENT_171	[p13l919t2401r1222b2482],
8	,	,	O	,	_	0	SENT_171	[p13l919t2401r1222b2482],
9	the	DT	O	the	det	10	SENT_171	[p13l1266t2401r1373b2464],
10	magnitude	NN	O	magnitude	nsubj	19	SENT_171	[p13l1415t2401r1792b2482],
11	of	IN	O	of	_	0	SENT_171	[p13l1835t2401r1913b2464],
12	effect	NN	O	effect	prep_of	10	SENT_171	[p13l1948t2401r2152b2464],
13	was	VBD	O	be	cop	15	SENT_171	[p13l8t2531r142b2575],
14	marginally	RB	O	marginally	advmod	15	SENT_171	[p13l177t2512r565b2593],
15	greater	JJR	O	greater	_	0	SENT_171	[p13l599t2521r847b2593],
16	and	CC	O	and	_	0	SENT_171	[p13l879t2512r1006b2574],
17	the	DT	O	the	det	18	SENT_171	[p13l1038t2512r1144b2574],
18	signiﬁcance	NN	O	signiﬁcance	npadvmod	19	SENT_171	[p13l1180t2512r1604b2593],
19	similar	JJ	O	similar	conj_and	15	SENT_171	[p13l1640t2512r1888b2574],
20	to	TO	O	to	_	0	SENT_171	[p13l1918t2521r1984b2574],
21	that	DT	O	that	prep_to	15	SENT_171	[p13l2017t2512r2152b2574],
22	seen	VBN	O	see	partmod	21	SENT_171	[p13l10t2641r165b2684],
23	in	IN	O	in	_	0	SENT_171	[p13l206t2622r274b2683],
24	the	DT	O	the	det	29	SENT_171	[p13l315t2622r422b2684],
25	entire	JJ	O	entire	amod	29	SENT_171	[p13l465t2622r666b2684],
26	efﬁcacy	NN	O	efﬁcacy	nn	29	SENT_171	[p13l710t2622r990b2703],
27	cohort	NN	O	cohort	nn	29	SENT_171	[p13l1034t2622r1262b2684],
28	(	NN	O	(	nn	29	SENT_171	[p13l1305t2622r1455b2699],
29	OR	NN	O	or	prep_in	22	SENT_171	[p13l1305t2622r1455b2699],
30	=	JJ	O	=	amod	29	SENT_171	[p13l1490t2650r1551b2674],
31	5.31	CD	NUMBER	5.31	tmod	30	SENT_171	[p13l1588t2621r1760b2696],
32	,	,	O	,	_	0	SENT_171	[p13l1588t2621r1760b2696],
33	95	CD	PERCENT	95	number	34	SENT_171	[p13l1806t2621r1888b2685],
34	%	NN	PERCENT	%	amod	35	SENT_171	[p13l1929t2622r1993b2684],
35	CI	NN	O	ci	appos	29	SENT_171	[p13l2039t2622r2144b2685],
36	:	:	O	:	_	0	SENT_171	[p13l2039t2622r2144b2685],
37	l.	VB	O	l.	ccomp	22	SENT_171	[p13l16t2732r428b2807],
38	59	CD	NUMBER	59	number	39	SENT_171	[p13l16t2732r428b2807],
39	—	CD	NUMBER	—	dobj	37	SENT_171	[p13l16t2732r428b2807],
40	l7	NN	O	l7	dep	39	SENT_171	[p13l16t2732r428b2807],
41	.67	CD	NUMBER	.67	num	40	SENT_171	[p13l16t2732r428b2807],
42	,	,	O	,	_	0	SENT_171	[p13l16t2732r428b2807],
43	corrected	VBN	O	correct	amod	44	SENT_171	[p13l479t2733r813b2795],
44	p	NN	O	p	appos	39	SENT_171	[p13l850t2754r900b2813],
45	=	JJ	O	=	amod	44	SENT_171	[p13l936t2761r997b2785],
46	0.049	CD	NUMBER	0.049	num	47	SENT_171	[p13l1033t2733r1280b2810],
47	)	NN	O	)	dep	45	SENT_171	[p13l1033t2733r1280b2810],
48	.	.	O	.	_	0	SENT_171	[p13l1033t2733r1280b2810],

1	Only	RB	O	only	advmod	2	SENT_172	[p13l1332t2733r1507b2814],
2	two	CD	NUMBER	two	dep	3	SENT_172	[p13l1554t2742r1685b2795],
3	non	JJ	O	non	_	0	SENT_172	[p13l1733t2733r2148b2796],
4	.	.	O	.	_	0	SENT_172	[p13l1733t2733r2148b2796],

1	—	NN	O	—	_	0	SENT_173	[p13l1733t2733r2148b2796],
2	.	.	O	.	_	0	SENT_173	[p13l1733t2733r2148b2796],

1	Cauca	NNP	LOCATION	Cauca	nn	2	SENT_174	[p13l1733t2733r2148b2796],
2	sians	NNS	O	sian	nsubj	3	SENT_174	[p13l10t2845r182b2908],
3	carried	VBD	O	carry	_	0	SENT_174	[p13l213t2845r462b2908],
4	the	DT	O	the	det	5	SENT_174	[p13l488t2845r596b2908],
5	*	NN	O	*	dobj	3	SENT_174	[p13l629t2846r707b2908],
6	3	CD	NUMBER	3	number	7	SENT_174	[p13l629t2846r707b2908],
7	Variant	JJ	O	variant	amod	5	SENT_174	[p13l740t2845r988b2908],
8	in	IN	O	in	_	0	SENT_174	[p13l1015t2845r1083b2907],
9	our	PRP$	O	we	poss	10	SENT_174	[p13l1112t2865r1230b2908],
10	cohort	NN	O	cohort	prep_in	3	SENT_174	[p13l1257t2845r1485b2908],
11	so	IN	O	so	advmod	3	SENT_174	[p13l1515t2865r1588b2908],
12	the	DT	O	the	det	13	SENT_174	[p13l1616t2845r1724b2908],
13	association	NN	O	association	pobj	11	SENT_174	[p13l1754t2845r2151b2908],
14	in	IN	O	in	_	0	SENT_174	[p13l7t2957r75b3019],
15	non	JJ	O	non	prep_in	11	SENT_174	[p13l107t2957r673b3020],
16	.	.	O	.	_	0	SENT_174	[p13l107t2957r673b3020],

1	—	NN	O	—	_	0	SENT_175	[p13l107t2957r673b3020],
2	.	.	O	.	_	0	SENT_175	[p13l107t2957r673b3020],

1	Caucasians	NNS	MISC	caucasian	nsubjpass	4	SENT_176	[p13l107t2957r673b3020],
2	was	VBD	O	be	auxpass	4	SENT_176	[p13l709t2977r843b3020],
3	not	RB	O	not	neg	4	SENT_176	[p13l878t2967r992b3020],
4	analyzed	VBN	O	analyze	_	0	SENT_176	[p13l1025t2957r1360b3038],
5	.	.	O	.	_	0	SENT_176	[p13l1025t2957r1360b3038],

1	To	TO	O	to	aux	2	SENT_177	[p13l110t3070r206b3131],
2	evaluate	VB	O	evaluate	purpcl	14	SENT_177	[p13l245t3068r543b3131],
3	the	DT	O	the	det	4	SENT_177	[p13l580t3068r687b3131],
4	robustness	NN	O	robustness	dobj	2	SENT_177	[p13l724t3068r1100b3131],
5	of	IN	O	of	_	0	SENT_177	[p13l1139t3068r1217b3131],
6	our	PRP$	O	we	poss	7	SENT_177	[p13l1249t3088r1367b3131],
7	ﬁnding	NN	O	ﬁnding	prep_of	4	SENT_177	[p13l1403t3068r1673b3149],
8	,	,	O	,	_	0	SENT_177	[p13l1403t3068r1673b3149],
9	a	DT	O	a	det	12	SENT_177	[p13l1716t3088r1752b3131],
10	secondary	JJ	O	secondary	amod	12	SENT_177	[p13l1791t3068r2149b3149],
11	efﬁcacy	NN	O	efﬁcacy	nn	12	SENT_177	[p13l8t3179r289b3260],
12	analysis	NN	O	analysis	nsubjpass	14	SENT_177	[p13l318t3179r602b3260],
13	was	VBD	O	be	auxpass	14	SENT_177	[p13l631t3199r765b3242],
14	carried	VBN	O	carry	_	0	SENT_177	[p13l793t3179r1042b3242],
15	outwith	JJ	O	outwith	amod	18	SENT_177	[p13l1068t3179r1363b3242],
16	clinical	JJ	O	clinical	amod	18	SENT_177	[p13l1390t3179r1653b3242],
17	response	NN	O	response	nn	18	SENT_177	[p13l1678t3199r1991b3260],
18	rate	NN	O	rate	xcomp	14	SENT_177	[p13l2017t3189r2150b3242],
19	(	CD	NUMBER	(	num	20	SENT_177	[p13l10t3291r195b3367],
20	cRR	NN	O	crr	dep	18	SENT_177	[p13l10t3291r195b3367],
21	=	JJ	O	=	amod	22	SENT_177	[p13l231t3319r291b3343],
22	cCR	NN	O	ccr	dep	18	SENT_177	[p13l328t3291r485b3353],
23	+	CC	O	+	_	0	SENT_177	[p13l520t3299r581b3359],
24	cPR	NN	O	cpr	nn	25	SENT_177	[p13l618t3291r812b3367],
25	)	NN	O	)	dep	18	SENT_177	[p13l618t3291r812b3367],
26	.	.	O	.	_	0	SENT_177	[p13l618t3291r812b3367],

1	The	DT	O	the	det	4	SENT_178	[p13l868t3290r1006b3353],
2	clinical	JJ	O	clinical	amod	4	SENT_178	[p13l1059t3290r1321b3353],
3	response	NN	O	response	nn	4	SENT_178	[p13l1373t3310r1686b3371],
4	rate	NN	O	rate	nsubj	10	SENT_178	[p13l1737t3299r1871b3353],
5	in	IN	O	in	_	0	SENT_178	[p13l1924t3290r1991b3352],
6	the	DT	O	the	det	7	SENT_178	[p13l2043t3290r2150b3353],
7	cohort	NN	O	cohort	prep_in	4	SENT_178	[p13l8t3401r237b3463],
8	was	VBD	O	be	cop	10	SENT_178	[p13l289t3420r424b3464],
9	63	CD	PERCENT	63	num	10	SENT_178	[p13l481t3401r562b3464],
10	%	NN	PERCENT	%	_	0	SENT_178	[p13l603t3401r667b3464],
11	(	CD	NUMBER	(	number	12	SENT_178	[p13l727t3401r868b3478],
12	65	CD	NUMBER	65	num	10	SENT_178	[p13l727t3401r868b3478],
13	/	:	O	/	punct	15	SENT_178	[p13l727t3401r868b3478],
14	103	CD	NUMBER	103	num	15	SENT_178	[p13l879t3401r1050b3478],
15	)	NN	O	)	dep	10	SENT_178	[p13l879t3401r1050b3478],
16	.	.	O	.	_	0	SENT_178	[p13l879t3401r1050b3478],

1	In	IN	O	in	_	0	SENT_179	[p13l1108t3402r1181b3463],
2	the	DT	O	the	det	4	SENT_179	[p13l1233t3401r1341b3463],
3	CYP2C8	NN	O	cyp2c8	nn	4	SENT_179	[p13l1396t3401r1803b3464],
4	*	NN	O	*	prep_in	13	SENT_179	[p13l1396t3401r1803b3464],
5	3	CD	NUMBER	3	num	6	SENT_179	[p13l1396t3401r1803b3464],
6	carriers	NNS	O	carrier	dep	4	SENT_179	[p13l1861t3401r2147b3475],
7	,	,	O	,	_	0	SENT_179	[p13l1861t3401r2147b3475],
8	the	DT	O	the	det	10	SENT_179	[p13l7t3512r114b3574],
9	response	NN	O	response	nn	10	SENT_179	[p13l142t3531r454b3593],
10	rate	NN	O	rate	nsubj	13	SENT_179	[p13l482t3521r615b3574],
11	was	VBD	O	be	cop	13	SENT_179	[p13l644t3531r779b3574],
12	82	CD	PERCENT	82	num	13	SENT_179	[p13l812t3512r895b3575],
13	%	NN	PERCENT	%	_	0	SENT_179	[p13l932t3512r997b3574],
14	(	CD	NUMBER	(	number	15	SENT_179	[p13l1031t3512r1288b3589],
15	18/22	CD	NUMBER	18/22	num	13	SENT_179	[p13l1031t3512r1288b3589],
16	)	CD	NUMBER	)	dep	22	SENT_179	[p13l1031t3512r1288b3589],
17	Versus	NNP	O	Versus	dep	16	SENT_179	[p13l1319t3531r1544b3574],
18	58	CD	PERCENT	58	num	19	SENT_179	[p13l1575t3511r1658b3575],
19	%	NN	PERCENT	%	dep	22	SENT_179	[p13l1697t3512r1762b3575],
20	(	CD	NUMBER	(	number	21	SENT_179	[p13l1796t3512r2053b3589],
21	47/81	CD	NUMBER	47/81	num	22	SENT_179	[p13l1796t3512r2053b3589],
22	)	NN	O	)	dep	13	SENT_179	[p13l1796t3512r2053b3589],
23	in	IN	O	in	_	0	SENT_179	[p13l2083t3512r2151b3573],
24	the	DT	O	the	det	29	SENT_179	[p13l7t3623r114b3685],
25	CYP2C8	NN	O	cyp2c8	nn	29	SENT_179	[p13l153t3623r470b3686],
26	wild	JJ	O	wild	amod	29	SENT_179	[p13l511t3623r853b3704],
27	—	NN	O	—	nn	29	SENT_179	[p13l511t3623r853b3704],
28	type	NN	O	type	nn	29	SENT_179	[p13l511t3623r853b3704],
29	subjects	NNS	O	subject	prep_in	22	SENT_179	[p13l893t3623r1196b3704],
30	.	.	O	.	_	0	SENT_179	[p13l893t3623r1196b3704],

1	In	IN	O	in	_	0	SENT_180	[p13l1238t3624r1310b3684],
2	the	DT	O	the	det	6	SENT_180	[p13l1347t3623r1454b3685],
3	univariate	JJ	O	univariate	amod	6	SENT_180	[p13l1491t3623r1849b3685],
4	logistic	JJ	O	logistic	amod	6	SENT_180	[p13l1888t3623r2149b3704],
5	regression	NN	O	regression	nn	6	SENT_180	[p14l6t22r375b103],
6	model	NN	O	model	prep_in	10	SENT_180	[p14l403t22r644b96],
7	,	,	O	,	_	0	SENT_180	[p14l403t22r644b96],
8	this	DT	O	this	det	9	SENT_180	[p14l676t22r802b85],
9	association	NN	O	association	nsubj	10	SENT_180	[p14l833t22r1230b85],
10	showed	VBD	O	show	_	0	SENT_180	[p14l1261t22r1530b85],
11	a	DT	O	a	det	13	SENT_180	[p14l1559t42r1596b85],
12	strong	JJ	O	strong	amod	13	SENT_180	[p14l1625t32r1844b103],
13	trend	NN	O	trend	dobj	10	SENT_180	[p14l1872t22r2056b85],
14	in	IN	O	in	prep	10	SENT_180	[p14l2083t22r2151b84],

1	A	DT	O	a	det	3	SENT_181	[p14l71t264r132b333],
2	1nae	JJ	O	1nae	amod	3	SENT_181	[p14l261t264r421b316],
3	F	NN	O	f	_	0	SENT_181	[p14l447t293r473b346],
4	+	CC	O	+	_	0	SENT_181	[p14l447t293r473b346],
5	90	CD	PERCENT	90	number	6	SENT_181	[p14l296t385r421b437],
6	%	NN	PERCENT	%	amod	7	SENT_181	[p14l296t385r421b437],
7	ouE	NN	O	oue	conj_+	3	SENT_181	[p14l460t347r473b466],
8	+	CC	O	+	_	0	SENT_181	[p14l460t347r473b466],
9	ene	NN	O	ene	conj_+	3	SENT_181	[p14l296t505r421b557],
10	`	``	O	`	_	0	SENT_181	[p14l447t467r473b540],
11	xE	NN	O	xe	dep	3	SENT_181	[p14l447t467r473b540],
12	+	CC	O	+	_	0	SENT_181	[p14l447t467r473b540],
13	nae	FW	O	nae	conj_+	11	SENT_181	[p14l296t626r421b678],
14	@	SYM	O	@	dep	15	SENT_181	[p14l471t611r473b702],
15	A	DT	O	a	rcmod	13	SENT_181	[p14l471t611r473b702],
16	+	CC	O	+	_	0	SENT_181	[p14l471t611r473b702],
17	area	NN	O	area	nn	18	SENT_181	[p14l296t747r421b795],
18	F	NN	O	f	conj_+	11	SENT_181	[p14l471t703r473b747],
19	+	CC	O	+	rcmod	18	SENT_181	[p14l471t703r473b747],

1	Percentage	NN	O	percentage	_	0	SENT_182	[p14l41t712r124b1134],
2	of	IN	O	of	prep	1	SENT_182	[p14l37t609r107b687],

1	Patients	NNS	O	patient	_	0	SENT_183	[p14l158t721r223b1027],

1	U	NNP	O	U	nn	2	SENT_184	[p14l296t863r327b915],
2	‘	NNP	O	‘	_	0	SENT_184	[p14l296t863r327b915],
3	!	.	O	!	_	0	SENT_184	[p14l296t863r327b915],

1	G	NN	O	g	nn	2	SENT_185	[p14l335t863r369b915],
2	ea	NNS	O	ea	_	0	SENT_185	[p14l373t863r421b915],

1	TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT	NN	O	ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt	_	0	SENT_186	[p14l486t1486r793b1487],
2	w	SYM	O	w	dep	10	SENT_186	[p14l794t1485r857b1570],
3	"	``	O	"	punct	6	SENT_186	[p14l878t1509r943b1565],
4	*	NN	O	*	nn	6	SENT_186	[p14l878t1509r943b1565],
5	3	CD	NUMBER	3	num	6	SENT_186	[p14l878t1509r943b1565],
6	Carrier	NN	O	carrier	nsubj	10	SENT_186	[p14l964t1513r1160b1565],
7	U	NNP	O	U	nn	10	SENT_186	[p14l1216t1514r1264b1561],
8	Hnmuzae-nus	NNP	O	Hnmuzae-nus	nn	10	SENT_186	[p14l1285t1513r1665b1574],
9	Wil	NNP	O	Wil	nn	10	SENT_186	[p14l1681t1485r1973b1574],
10	TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT	NNP	O	TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT	dep	1	SENT_186	[p14l1974t1486r2097b1487],
11	w	NN	O	w	amod	10	SENT_186	[p14l2098t1484r2117b1487],

1	3	CD	NUMBER	3	num	2	SENT_187	[p14l67t1656r124b1725],
2	Lane	NNP	O	Lane	_	0	SENT_187	[p14l262t1686r426b1742],
3	nae	FW	O	nae	dep	2	SENT_187	[p14l300t1811r429b1863],
4	area	NN	O	area	dep	3	SENT_187	[p14l300t1936r430b1988],
5	.	.	O	.	_	0	SENT_187	[p14l300t1936r430b1988],

1	ms	NNS	O	m	nn	2	SENT_188	[p14l300t2053r426b2105],
2	area	NN	O	area	_	0	SENT_188	[p14l300t2174r426b2226],
3	a	DT	O	a	nsubj	4	SENT_188	[p14l478t2205r481b2207],
4	see	VB	O	see	rcmod	2	SENT_188	[p14l300t2294r426b2346],
5	a	DT	O	a	det	8	SENT_188	[p14l457t2325r460b2327],
6	411	CD	PERCENT	411	num	8	SENT_188	[p14l300t2415r426b2463],
7	%	NN	PERCENT	%	nn	8	SENT_188	[p14l300t2415r426b2463],
8	area	NN	O	area	dobj	4	SENT_188	[p14l300t2535r426b2583],
9	a	DT	O	a	dep	8	SENT_188	[p14l1075t2557r1078b2560],

1	1095	CD	DATE	1095	num	2	SENT_189	[p14l304t2772r426b2824],
2	7	CD	NUMBER	7	_	0	SENT_189	[p14l1303t2823r1306b2824],
3	`	``	O	`	_	0	SENT_189	[p14l1538t2798r2127b2824],
4	)	NN	O	)	dep	2	SENT_189	[p14l1538t2798r2127b2824],
5	+	CC	O	+	_	0	SENT_189	[p14l1538t2798r2127b2824],
6	W	NN	O	w	dep	2	SENT_189	[p14l335t2889r426b2941],
7	—	CD	NUMBER	—	num	6	SENT_189	[p14l1307t2829r1768b2919],

1	I	PRP	O	I	nsubj	2	SENT_190	[p14l813t2971r857b3018],
2	*	VBP	O	*	_	0	SENT_190	[p14l878t2962r947b3014],
3	3	CD	NUMBER	3	num	4	SENT_190	[p14l878t2962r947b3014],
4	Carrier	NN	O	carrier	nsubj	9	SENT_190	[p14l965t2962r1168b3014],
5	II	CD	NUMBER	ii	dep	4	SENT_190	[p14l1203t2971r1255b3018],
6	:	:	O	:	_	0	SENT_190	[p14l1203t2971r1255b3018],
7	I	PRP	O	I	dep	4	SENT_190	[p14l1203t2971r1255b3018],
8	Humaavgaus	NNP	O	Humaavgaus	dep	7	SENT_190	[p14l1276t2967r1656b3027],
9	Wriild-type	JJ	O	wriild-type	xcomp	2	SENT_190	[p14l1673t2962r1966b3027],

1	Percentage	NN	O	percentage	_	0	SENT_191	[p14l41t2169r124b2591],
2	of	IN	O	of	prep	1	SENT_191	[p14l37t2066r107b2144],

1	Patients	NNS	O	patient	_	0	SENT_192	[p14l158t2178r227b2488],

1	Fig	NN	O	fig	_	0	SENT_193	[p15l13t60r135b128],
2	.	.	O	.	_	0	SENT_193	[p15l13t60r135b128],

1	1	CD	NUMBER	1	num	2	SENT_194	[p15l167t60r197b113],
2	Percentage	NN	O	percentage	_	0	SENT_194	[p15l247t62r580b129],
3	of	IN	O	of	_	0	SENT_194	[p15l622t60r687b113],
4	patients	NNS	O	patient	prep_of	2	SENT_194	[p15l721t60r956b129],
5	carrying	VBG	O	carry	dep	2	SENT_194	[p15l998t60r1249b129],
6	CYP2C8	NN	O	cyp2c8	nn	7	SENT_194	[p15l1291t61r1634b114],
7	*	NN	O	*	dobj	5	SENT_194	[p15l1291t61r1634b114],
8	3	CD	NUMBER	3	num	7	SENT_194	[p15l1291t61r1634b114],
9	vs.	CC	O	vs.	prep	5	SENT_194	[p15l1678t77r1759b113],
10	CYP2C8	CD	NUMBER	cyp2c8	num	11	SENT_194	[p15l1803t61r2144b114],
11	*	NN	O	*	dep	9	SENT_194	[p15l1803t61r2144b114],
12	1	CD	NUMBER	1	num	14	SENT_194	[p15l1803t61r2144b114],
13	wild-type	JJ	O	wild-type	amod	14	SENT_194	[p15l14t149r303b218],
14	homozygotes	NNS	O	homozygote	nsubj	19	SENT_194	[p15l329t149r732b218],
15	achieving	VBG	O	achieve	partmod	14	SENT_194	[p15l760t149r1053b218],
16	clinical	JJ	O	clinical	amod	18	SENT_194	[p15l1080t149r1302b202],
17	complete	JJ	O	complete	amod	18	SENT_194	[p15l1329t149r1606b218],
18	response	NN	O	response	dobj	15	SENT_194	[p15l1631t166r1896b218],
19	(	VBD	O	(	rcmod	11	SENT_194	[p15l1924t150r1999b214],
20	a	DT	O	a	nsubj	22	SENT_194	[p15l1924t150r1999b214],
21	:	:	O	:	_	0	SENT_194	[p15l1924t150r1999b214],
22	left	VBD	O	leave	ccomp	19	SENT_194	[p15l2031t149r2149b217],
23	)	CD	NUMBER	)	dobj	22	SENT_194	[p15l2031t149r2149b217],
24	or	CC	O	or	_	0	SENT_194	[p15l14t253r76b289],
25	experiencing	VBG	O	experience	conj_or	5	SENT_194	[p15l121t236r513b305],
26	severe	JJ	O	severe	amod	28	SENT_194	[p15l563t253r752b289],
27	peripheral	JJ	O	peripheral	amod	28	SENT_194	[p15l799t236r1107b305],
28	neuropathy	NN	O	neuropathy	iobj	25	SENT_194	[p15l1154t236r1494b305],
29	(	NN	O	(	nn	30	SENT_194	[p15l1544t236r1623b302],
30	b	NN	O	b	dobj	25	SENT_194	[p15l1544t236r1623b302],
31	:	:	O	:	_	0	SENT_194	[p15l1544t236r1623b302],
32	right	JJ	O	right	amod	33	SENT_194	[p15l1677t236r1861b304],
33	)	NN	O	)	dep	30	SENT_194	[p15l1677t236r1861b304],
34	.	.	O	.	_	0	SENT_194	[p15l1677t236r1861b304],

1	Patients	NNS	O	patient	nsubj	8	SENT_195	[p15l1911t236r2149b289],
2	carrying	VBG	O	carry	partmod	1	SENT_195	[p15l14t324r265b393],
3	CYP2C8	NN	O	cyp2c8	nn	4	SENT_195	[p15l300t325r644b378],
4	*	NN	O	*	dobj	2	SENT_195	[p15l300t325r644b378],
5	3	CD	NUMBER	3	num	4	SENT_195	[p15l300t325r644b378],
6	were	VBD	O	be	cop	8	SENT_195	[p15l683t341r828b378],
7	more	RBR	O	more	advmod	8	SENT_195	[p15l862t341r1016b377],
8	likely	JJ	O	likely	_	0	SENT_195	[p15l1052t324r1223b393],
9	to	TO	O	to	aux	10	SENT_195	[p15l1258t333r1314b377],
10	achieve	VB	O	achieve	xcomp	8	SENT_195	[p15l1350t324r1580b377],
11	clinical	JJ	O	clinical	amod	31	SENT_195	[p15l1616t324r1838b377],
12	complete	JJ	O	complete	amod	31	SENT_195	[p15l1873t324r2150b393],
13	response	NN	O	response	amod	31	SENT_195	[p15l12t429r277b481],
14	(	CD	NUMBER	(	num	13	SENT_195	[p15l317t413r444b478],
15	OR	NN	O	or	dep	13	SENT_195	[p15l317t413r444b478],
16	=	JJ	O	=	quantmod	17	SENT_195	[p15l473t437r525b457],
17	3.92	CD	NUMBER	3.92	dep	15	SENT_195	[p15l557t413r703b475],
18	,	,	O	,	_	0	SENT_195	[p15l557t413r703b475],
19	95	CD	PERCENT	95	number	20	SENT_195	[p15l743t412r813b466],
20	%	NN	PERCENT	%	amod	21	SENT_195	[p15l847t413r901b466],
21	CI	NN	O	ci	appos	15	SENT_195	[p15l943t413r1032b466],
22	:	:	O	:	_	0	SENT_195	[p15l943t413r1032b466],
23	1.46	CD	NUMBER	1.46	number	24	SENT_195	[p15l1081t412r1431b476],
24	—	CD	NUMBER	—	dep	21	SENT_195	[p15l1081t412r1431b476],
25	10.48	CD	NUMBER	10.48	amod	21	SENT_195	[p15l1081t412r1431b476],
26	,	,	O	,	_	0	SENT_195	[p15l1081t412r1431b476],
27	corrected	VBN	O	correct	partmod	21	SENT_195	[p15l1471t413r1753b466],
28	p	NN	O	p	nsubj	29	SENT_195	[p15l1783t431r1825b480],
29	=	JJ	O	=	xcomp	27	SENT_195	[p15l1856t437r1907b457],
30	0.046	CD	NUMBER	0.046	num	31	SENT_195	[p15l1938t412r2147b478],
31	)	NN	O	)	dobj	10	SENT_195	[p15l1938t412r2147b478],
32	.	.	O	.	_	0	SENT_195	[p15l1938t412r2147b478],

1	There	EX	O	there	expl	2	SENT_196	[p15l13t500r189b553],
2	was	VBD	O	be	_	0	SENT_196	[p15l212t517r325b553],
3	a	DT	O	a	det	4	SENT_196	[p15l351t517r382b553],
4	trend	NN	O	trend	nsubj	2	SENT_196	[p15l403t500r558b553],
5	toward	IN	O	toward	_	0	SENT_196	[p15l579t500r789b553],
6	greater	JJR	O	greater	amod	7	SENT_196	[p15l811t508r1022b569],
7	risk	NN	O	risk	prep_toward	2	SENT_196	[p15l1042t500r1156b553],
8	of	IN	O	of	_	0	SENT_196	[p15l1177t500r1242b553],
9	severe	JJ	O	severe	amod	10	SENT_196	[p15l1262t517r1451b553],
10	neuropathy	NN	O	neuropathy	prep_of	7	SENT_196	[p15l1474t500r1814b569],
11	in	IN	O	in	_	0	SENT_196	[p15l1836t500r1894b553],
12	patients	NNS	O	patient	prep_in	10	SENT_196	[p15l1915t500r2149b569],
13	carrying	VBG	O	carry	partmod	12	SENT_196	[p15l14t588r265b657],
14	the	DT	O	the	det	17	SENT_196	[p15l325t588r416b641],
15	*	NN	O	*	nn	17	SENT_196	[p15l479t589r545b642],
16	3	CD	NUMBER	3	num	17	SENT_196	[p15l479t589r545b642],
17	variant	NN	O	variant	dobj	13	SENT_196	[p15l608t588r834b651],
18	,	,	O	,	_	0	SENT_196	[p15l608t588r834b651],
19	though	IN	O	though	mark	23	SENT_196	[p15l896t588r1106b657],
20	it	PRP	O	it	nsubj	23	SENT_196	[p15l1165t588r1206b641],
21	did	VBD	O	do	aux	23	SENT_196	[p15l1265t588r1361b641],
22	not	RB	O	not	neg	23	SENT_196	[p15l1419t597r1515b641],
23	achieve	VB	O	achieve	advcl	2	SENT_196	[p15l1575t588r1804b641],
24	statistical	JJ	O	statistical	amod	25	SENT_196	[p15l1866t588r2150b641],
25	signiﬁcance	NN	O	signiﬁcance	dobj	23	SENT_196	[p15l16t676r375b745],
26	(	CD	NUMBER	(	num	27	SENT_196	[p15l460t677r587b742],
27	OR	NN	O	or	dep	25	SENT_196	[p15l460t677r587b742],
28	=	JJ	O	=	quantmod	29	SENT_196	[p15l616t701r668b721],
29	3.13	CD	NUMBER	3.13	dep	27	SENT_196	[p15l700t677r846b739],
30	,	,	O	,	_	0	SENT_196	[p15l700t677r846b739],
31	95	CD	PERCENT	95	number	32	SENT_196	[p15l931t676r1000b730],
32	%	NN	PERCENT	%	amod	33	SENT_196	[p15l1035t677r1090b730],
33	CI	NN	O	ci	appos	25	SENT_196	[p15l1175t677r1264b730],
34	:	:	O	:	_	0	SENT_196	[p15l1175t677r1264b730],
35	0.89	CD	NUMBER	0.89	number	36	SENT_196	[p15l1352t677r1708b739],
36	—	CD	NUMBER	—	dep	33	SENT_196	[p15l1352t677r1708b739],
37	11.01	CD	NUMBER	11.01	dep	36	SENT_196	[p15l1352t677r1708b739],
38	,	,	O	,	_	0	SENT_196	[p15l1352t677r1708b739],
39	uncorrected	JJ	O	uncorrected	amod	40	SENT_196	[p15l1792t676r2151b729],
40	p	NN	O	p	appos	25	SENT_196	[p15l7t783r48b833],
41	=	JJ	O	=	amod	43	SENT_196	[p15l79t789r131b809],
42	0.075	CD	NUMBER	0.075	tmod	41	SENT_196	[p15l162t765r353b831],
43	)	NN	O	)	dep	40	SENT_196	[p15l162t765r353b831],

1	Table	NNP	O	Table	_	0	SENT_197	[p15l14t995r197b1048],
2	4	CD	NUMBER	4	num	1	SENT_197	[p15l225t995r261b1048],
3	Final	JJ	O	final	amod	5	SENT_197	[p15l309t995r463b1048],
4	multivariable	JJ	O	multivariable	amod	5	SENT_197	[p15l493t995r899b1048],
5	model	NN	O	model	nsubj	15	SENT_197	[p15l929t995r1117b1048],
6	of	IN	O	of	_	0	SENT_197	[p15l1149t995r1214b1048],
7	clinical	JJ	O	clinical	amod	9	SENT_197	[p15l1239t995r1461b1048],
8	complete	JJ	O	complete	amod	9	SENT_197	[p15l1493t995r1770b1064],
9	response	NN	O	response	prep_of	5	SENT_197	[p15l1799t1012r2064b1064],
10	in	IN	O	in	_	0	SENT_197	[p15l2094t995r2151b1048],
11	efﬁcacy	NN	O	efﬁcacy	nn	14	SENT_197	[p15l14t1083r252b1152],
12	cohort	NN	O	cohort	nn	14	SENT_197	[p15l282t1083r474b1136],
13	(	NN	O	(	nn	14	SENT_197	[p15l503t1084r562b1149],
14	n	NN	O	n	prep_in	9	SENT_197	[p15l503t1084r562b1149],
15	=	JJ	O	=	rcmod	1	SENT_197	[p15l592t1108r644b1128],
16	103	CD	NUMBER	103	num	17	SENT_197	[p15l682t1084r809b1149],
17	)	NN	O	)	dobj	15	SENT_197	[p15l682t1084r809b1149],
18	including	VBG	O	include	_	0	SENT_197	[p15l839t1083r1125b1152],
19	CYP2C8	NN	O	cyp2c8	nn	20	SENT_197	[p15l1154t1084r1497b1137],
20	*	NN	O	*	prep_including	17	SENT_197	[p15l1154t1084r1497b1137],
21	3	CD	NUMBER	3	dep	20	SENT_197	[p15l1154t1084r1497b1137],
22	and	CC	O	and	_	0	SENT_197	[p15l1531t1083r1638b1136],
23	relevant	JJ	O	relevant	amod	24	SENT_197	[p15l1664t1083r1910b1137],
24	covariates	NNS	O	covariate	prep_including	17	SENT_197	[p15l1937t1083r2149b1137, p15l15t1179r129b1224],
25	selected	VBN	O	select	partmod	24	SENT_197	[p15l160t1171r402b1224],
26	by	IN	O	by	_	0	SENT_197	[p15l429t1171r503b1240],
27	backward	RB	O	backward	advmod	28	SENT_197	[p15l530t1171r826b1224],
28	elimination	NN	O	elimination	agent	25	SENT_197	[p15l853t1171r1200b1224],

1	Odds	NNS	O	odds	_	0	SENT_198	[p15l990t1316r1145b1369],
2	95	CD	PERCENT	95	num	3	SENT_198	[p15l1290t1316r1359b1370],
3	%	NN	PERCENT	%	dep	1	SENT_198	[p15l1394t1316r1448b1369],
4	Uncorrected	JJ	O	uncorrected	amod	9	SENT_198	[p15l1775t1316r2151b1369],
5	ratio	NN	O	ratio	nn	9	SENT_198	[p15l988t1406r1126b1459],
6	Conﬁdence	NN	O	conﬁdence	nn	9	SENT_198	[p15l1289t1406r1633b1459],
7	p	NN	O	p	nn	9	SENT_198	[p15l1769t1424r1811b1474],
8	value	NN	O	value	nn	9	SENT_198	[p15l1839t1406r2002b1459],
9	interval	NN	O	interval	dep	1	SENT_198	[p15l1289t1495r1520b1549],

1	CYP2C8	NN	O	cyp2c8	dep	8	SENT_199	[p15l15t1664r283b1718],
2	5.11	CD	NUMBER	5.11	num	3	SENT_199	[p15l990t1664r1113b1717],
3	1.73	CD	NUMBER	1.73	dep	1	SENT_199	[p15l1296t1664r1628b1718],
4	—	NN	O	—	dep	8	SENT_199	[p15l1296t1664r1628b1718],
5	15.12	CD	NUMBER	15.12	num	4	SENT_199	[p15l1296t1664r1628b1718],
6	0.003	CD	NUMBER	0.003	num	8	SENT_199	[p15l1776t1664r1941b1718],
7	Tumor	NN	O	tumor	nn	8	SENT_199	[p15l14t1760r221b1812],
8	grade	NN	O	grade	dep	12	SENT_199	[p15l247t1759r414b1827],
9	1.08	CD	NUMBER	1.08	num	10	SENT_199	[p15l996t1759r1117b1812],
10	0.50-2	CD	NUMBER	0.50-2	dep	8	SENT_199	[p15l1289t1758r1587b1812],
11	.35	CD	NUMBER	.35	num	12	SENT_199	[p15l1289t1758r1587b1812],
12	0.840	CD	NUMBER	0.840	_	0	SENT_199	[p15l1776t1759r1945b1812],
13	Preceded	VBN	O	precede	partmod	12	SENT_199	[p15l14t1853r292b1906],
14	by	IN	O	by	_	0	SENT_199	[p15l318t1853r392b1921],
15	another	DT	O	another	det	16	SENT_199	[p15l422t1853r649b1906],
16	phase	NN	O	phase	agent	13	SENT_199	[p15l674t1853r846b1921],
17	0.59	CD	NUMBER	0.59	num	18	SENT_199	[p15l989t1852r1118b1907],
18	0.19-1	CD	NUMBER	0.19-1	dep	16	SENT_199	[p15l1289t1853r1589b1907],
19	.79	CD	NUMBER	.79	number	20	SENT_199	[p15l1289t1853r1589b1907],
20	0.350	CD	NUMBER	0.350	dep	18	SENT_199	[p15l1776t1852r1945b1906],

1	of	IN	O	of	dep	5	SENT_200	[p15l68t1941r134b1994],
2	chemotherapy	NN	O	chemotherapy	pobj	1	SENT_200	[p15l157t1941r586b2010],
3	the	DT	O	the	det	5	SENT_200	[p15l13t2215r120b2278],
4	same	JJ	O	same	amod	5	SENT_200	[p15l164t2235r343b2278],
5	direction	NN	O	direction	dep	27	SENT_200	[p15l384t2215r702b2278],
6	with	IN	O	with	_	0	SENT_200	[p15l742t2215r899b2278],
7	an	DT	O	a	det	9	SENT_200	[p15l941t2235r1022b2278],
8	odds	NNS	O	odds	nn	9	SENT_200	[p15l1062t2215r1226b2278],
9	ratio	NN	O	ratio	prep_with	5	SENT_200	[p15l1267t2215r1429b2278],
10	of	IN	O	of	_	0	SENT_200	[p15l1472t2215r1549b2278],
11	3.16	CD	PERCENT	3.16	number	12	SENT_200	[p15l1585t2215r1736b2278],
12	(	CD	PERCENT	(	amod	15	SENT_200	[p15l1780t2215r1890b2293],
13	95	CD	PERCENT	95	num	14	SENT_200	[p15l1780t2215r1890b2293],
14	%	NN	PERCENT	%	dep	12	SENT_200	[p15l1930t2216r1995b2278],
15	CI	NN	O	ci	prep_of	5	SENT_200	[p15l2040t2216r2144b2278],
16	:	:	O	:	_	0	SENT_200	[p15l2040t2216r2144b2278],
17	0.98	CD	NUMBER	0.98	number	18	SENT_200	[p15l14t2328r419b2402],
18	—	CD	NUMBER	—	num	19	SENT_200	[p15l14t2328r419b2402],
19	10.19	CD	NUMBER	10.19	nsubj	27	SENT_200	[p15l14t2328r419b2402],
20	,	,	O	,	_	0	SENT_200	[p15l14t2328r419b2402],
21	uncorrected	JJ	O	uncorrected	amod	22	SENT_200	[p15l473t2327r896b2390],
22	p	NN	O	p	appos	19	SENT_200	[p15l938t2349r988b2407],
23	=	JJ	O	=	amod	25	SENT_200	[p15l1024t2356r1085b2380],
24	0.054	CD	NUMBER	0.054	tmod	23	SENT_200	[p15l1121t2327r1369b2405],
25	)	NN	O	)	dep	22	SENT_200	[p15l1121t2327r1369b2405],
26	,	,	O	,	_	0	SENT_200	[p15l1121t2327r1369b2405],
27	supporting	VBG	O	support	_	0	SENT_200	[p15l1426t2327r1803b2408],
28	our	PRP$	O	we	poss	30	SENT_200	[p15l1856t2347r1974b2390],
29	primary	JJ	O	primary	amod	30	SENT_200	[p15l2022t2327r2148b2408, p15l13t2457r195b2519],
30	ﬁndings	NNS	O	ﬁndings	dobj	27	SENT_200	[p15l230t2438r533b2519],
31	.	.	O	.	_	0	SENT_200	[p15l230t2438r533b2519],

1	To	TO	O	to	aux	2	SENT_201	[p15l116t2550r212b2611],
2	examine	VB	O	examine	purpcl	17	SENT_201	[p15l248t2549r550b2611],
3	whether	IN	O	whether	complm	11	SENT_201	[p15l586t2549r891b2623],
4	,	,	O	,	_	0	SENT_201	[p15l586t2549r891b2623],
5	as	IN	O	as	mark	6	SENT_201	[p15l932t2568r1000b2611],
6	hypothesized	VBN	O	hypothesize	advcl	11	SENT_201	[p15l1036t2549r1527b2630],
7	,	,	O	,	_	0	SENT_201	[p15l1036t2549r1527b2630],
8	this	DT	O	this	det	9	SENT_201	[p15l1566t2549r1692b2611],
9	ﬁnding	NN	O	ﬁnding	nsubj	11	SENT_201	[p15l1729t2549r1978b2630],
10	was	VBD	O	be	cop	11	SENT_201	[p15l2015t2568r2149b2612],
11	speciﬁc	JJ	O	speciﬁc	ccomp	2	SENT_201	[p15l17t2658r283b2740],
12	to	TO	O	to	_	0	SENT_201	[p15l351t2668r418b2721],
13	paclitaxel	NN	O	paclitaxel	prep_to	11	SENT_201	[p15l483t2659r852b2740],
14	,	,	O	,	_	0	SENT_201	[p15l483t2659r852b2740],
15	we	PRP	O	we	nsubj	17	SENT_201	[p15l921t2678r1022b2721],
16	then	RB	O	then	advmod	17	SENT_201	[p15l1088t2659r1241b2721],
17	tested	VBD	O	test	_	0	SENT_201	[p15l1307t2659r1515b2721],
18	the	DT	O	the	det	19	SENT_201	[p15l1580t2659r1687b2721],
19	association	NN	O	association	dobj	17	SENT_201	[p15l1755t2659r2151b2721],
20	between	IN	O	between	_	0	SENT_201	[p15l12t2771r311b2834],
21	CYP2C8	CD	NUMBER	cyp2c8	number	22	SENT_201	[p15l345t2772r750b2834],
22	*	CD	NUMBER	*	prep_between	19	SENT_201	[p15l345t2772r750b2834],
23	3	CD	NUMBER	3	num	24	SENT_201	[p15l345t2772r750b2834],
24	status	NN	O	status	tmod	17	SENT_201	[p15l790t2780r987b2834],
25	and	CC	O	and	_	0	SENT_201	[p15l1024t2771r1150b2834],
26	clinical	JJ	O	clinical	amod	28	SENT_201	[p15l1182t2771r1445b2834],
27	complete	JJ	O	complete	amod	28	SENT_201	[p15l1479t2771r1806b2852],
28	response	NN	O	response	conj_and	24	SENT_201	[p15l1839t2791r2149b2852],

1	@	IN	O	@	_	0	SENT_202	[p15l1783t3014r1860b3109],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_202	[p15l1890t3037r2152b3112],

1	406	CD	NUMBER	406	num	3	SENT_203	[p15l52t3187r104b3212],
2	Breast	NN	O	breast	nn	3	SENT_203	[p15l1450t3187r1540b3212],
3	Cancer	NN	O	cancer	_	0	SENT_203	[p15l1552t3187r1652b3212],
4	Res	NNP	O	Res	nn	5	SENT_203	[p15l1664t3187r1716b3212],
5	Treat	NNP	O	Treat	dep	3	SENT_203	[p15l1729t3187r1804b3212],
6	(	CD	NUMBER	(	num	7	SENT_203	[p15l1817t3187r1908b3217],
7	2012	CD	DATE	2012	dep	5	SENT_203	[p15l1817t3187r1908b3217],
8	)	CD	NUMBER	)	number	9	SENT_203	[p15l1817t3187r1908b3217],
9	134:401	CD	NUMBER	134:401	num	10	SENT_203	[p15l1925t3187r2107b3212],
10	—	NN	O	—	dep	7	SENT_203	[p15l1925t3187r2107b3212],
11	410	CD	NUMBER	410	dep	3	SENT_203	[p15l1925t3187r2107b3212],

1	Table	NNP	O	Table	nsubj	5	SENT_204	[p15l8t3354r191b3407],
2	5	CD	NUMBER	5	num	4	SENT_204	[p15l219t3354r254b3406],
3	Severe	JJ	O	severe	amod	4	SENT_204	[p15l305t3354r508b3407],
4	toxicities	NNS	O	toxicity	dep	1	SENT_204	[p15l536t3353r813b3407],
5	. . .	VBP	O	. . .	_	0	SENT_204	[p15l1381t3396r1390b3405],[p15l1283t3396r1291b3404],

1	Tox1c1t1es	NNP	O	Tox1c1t1es	nn	2	SENT_205	[p15l1155t3398r1458b3449],
2	Data	NNP	O	Data	_	0	SENT_205	[p15l1832t3398r1975b3449],

1	(	NN	O	(	nn	3	SENT_206	[p15l9t3444r83b3509],
2	3	CD	NUMBER	3	num	3	SENT_206	[p15l9t3444r83b3509],
3	grade	NN	O	grade	_	0	SENT_206	[p15l116t3443r283b3512],
4	3	CD	NUMBER	3	num	5	SENT_206	[p15l312t3443r369b3508],
5	)	NN	O	)	dep	3	SENT_206	[p15l312t3443r369b3508],
6	during	IN	O	during	_	0	SENT_206	[p15l400t3443r596b3512],
7	paclitaxel	NN	O	paclitaxel	nn	8	SENT_206	[p15l623t3443r920b3512],
8	treatment	NN	O	treatment	prep_during	5	SENT_206	[p15l7t3541r295b3586],
9	in	IN	O	in	_	0	SENT_206	[p15l322t3533r380b3586],
10	toxicity	NN	O	toxicity	nn	11	SENT_206	[p15l407t3533r639b3602],
11	cohort	NN	O	cohort	prep_in	8	SENT_206	[p15l668t3533r861b3586],

1	A	DT	O	a	det	2	SENT_207	[p15l1155t3566r1209b3618],
2	t	NN	O	t	poss	5	SENT_207	[p15l1312t3574r1332b3619],
3	'	POS	O	'	_	0	SENT_207	[p15l1414t3565r1422b3574],
4	‘	NN	O	‘	nn	5	SENT_207	[p15l1469t3565r1507b3619],
5	t	NN	O	t	_	0	SENT_207	[p15l1469t3565r1507b3619],
6	(	CD	NUMBER	(	num	7	SENT_207	[p15l9t3624r68b3689],
7	n	NN	O	n	npadvmod	8	SENT_207	[p15l9t3624r68b3689],
8	=	JJ	O	=	amod	5	SENT_207	[p15l99t3647r151b3668],
9	109	CD	NUMBER	109	number	10	SENT_207	[p15l188t3624r316b3689],
10	)	CD	NUMBER	)	dep	5	SENT_207	[p15l188t3624r316b3689],
11	ny	NN	O	ny	nn	13	SENT_207	[p15l1210t3582r1284b3635],
12	ox1c1	NN	O	ox1c1	nn	13	SENT_207	[p15l1334t3582r1483b3619],
13	y	NN	O	y	dep	10	SENT_207	[p15l1507t3583r1543b3635],

1	Any	DT	O	any	det	3	SENT_208	[p15l1206t3681r1334b3749],
2	34	CD	NUMBER	34	num	3	SENT_208	[p15l1834t3681r1906b3734],
3	(	NN	O	(	_	0	SENT_208	[p15l1937t3681r2027b3746],
4	31	CD	PERCENT	31	num	5	SENT_208	[p15l1937t3681r2027b3746],
5	%	NN	PERCENT	%	dep	3	SENT_208	[p15l2065t3681r2146b3746],
6	)	CD	NUMBER	)	dep	3	SENT_208	[p15l2065t3681r2146b3746],

1	None	NN	O	none	nsubj	7	SENT_209	[p16l1205t31r1368b83],
2	75	CD	PERCENT	75	num	1	SENT_209	[p16l1833t30r1904b83],
3	(	CD	PERCENT	(	number	4	SENT_209	[p16l1937t30r2032b95],
4	69	CD	PERCENT	69	num	5	SENT_209	[p16l1937t30r2032b95],
5	%	NN	PERCENT	%	dep	1	SENT_209	[p16l2065t30r2146b95],
6	)	CD	NUMBER	)	dep	1	SENT_209	[p16l2065t30r2146b95],
7	Excluded	VBD	O	exclude	_	0	SENT_209	[p16l1205t125r1493b178],
8	2	CD	NUMBER	2	num	10	SENT_209	[p16l1833t125r1868b177],
9	Speciﬁc	NN	O	speciﬁc	nn	10	SENT_209	[p16l1158t219r1398b288],
10	toxicities	NNS	O	toxicity	iobj	7	SENT_209	[p16l1427t219r1704b272],
11	Neuropathy	NNP	O	Neuropathy	dobj	7	SENT_209	[p16l1205t315r1563b383],
12	12	CD	PERCENT	12	num	11	SENT_209	[p16l1840t315r1906b367],
13	(	CD	PERCENT	(	number	14	SENT_209	[p16l1937t315r2027b380],
14	ll	CD	PERCENT	ll	dep	15	SENT_209	[p16l1937t315r2027b380],
15	%	NN	PERCENT	%	dep	11	SENT_209	[p16l2065t315r2146b380],
16	)	CD	NUMBER	)	nn	17	SENT_209	[p16l2065t315r2146b380],
17	Neutropenia	NNP	O	Neutropenia	dobj	7	SENT_209	[p16l1205t410r1582b479],
18	lo	FW	O	lo	nn	19	SENT_209	[p16l1840t410r1906b463],
19	(	FW	O	(	dobj	7	SENT_209	[p16l1937t410r1994b475],
20	9	CD	PERCENT	9	number	21	SENT_209	[p16l1937t410r1994b475],
21	%	NN	PERCENT	%	amod	19	SENT_209	[p16l2026t410r2108b475],
22	)	CD	NUMBER	)	num	25	SENT_209	[p16l2026t410r2108b475],
23	Myalgia	NNP	ORGANIZATION	Myalgia	nn	25	SENT_209	[p16l1205t504r1459b573],
24	9	CD	NUMBER	9	num	25	SENT_209	[p16l1833t505r1867b558],
25	(	NN	O	(	dobj	7	SENT_209	[p16l1898t504r1954b570],
26	8	CD	PERCENT	8	number	27	SENT_209	[p16l1898t504r1954b570],
27	%	NN	PERCENT	%	amod	25	SENT_209	[p16l1988t504r2069b569],
28	)	CD	NUMBER	)	num	29	SENT_209	[p16l1988t504r2069b569],
29	Hypersensitivity	NN	ORGANIZATION	hypersensitivity	dobj	7	SENT_209	[p16l1206t599r1707b668],
30	7	CD	NUMBER	7	num	31	SENT_209	[p16l1833t601r1866b652],
31	(	NN	O	(	dep	29	SENT_209	[p16l1898t599r1956b665],
32	6	CD	PERCENT	6	number	33	SENT_209	[p16l1898t599r1956b665],
33	%	NN	PERCENT	%	amod	29	SENT_209	[p16l1988t600r2069b665],
34	)	CD	NUMBER	)	num	35	SENT_209	[p16l1988t600r2069b665],
35	Fatigue	NN	O	fatigue	dobj	7	SENT_209	[p16l1205t695r1432b763],
36	4	CD	NUMBER	4	num	37	SENT_209	[p16l1832t695r1868b747],
37	(	NN	O	(	dep	35	SENT_209	[p16l1898t695r1957b760],
38	4	CD	PERCENT	4	number	39	SENT_209	[p16l1898t695r1957b760],
39	%	NN	PERCENT	%	amod	35	SENT_209	[p16l1988t695r2069b760],
40	)	CD	NUMBER	)	num	43	SENT_209	[p16l1988t695r2069b760],
41	Gastrointestinal	JJ	O	gastrointestinal	amod	43	SENT_209	[p16l1207t789r1687b842],
42	3	CD	NUMBER	3	tmod	41	SENT_209	[p16l1835t790r1865b843],
43	(	NN	O	(	dobj	7	SENT_209	[p16l1898t789r1953b855],
44	3	CD	PERCENT	3	number	45	SENT_209	[p16l1898t789r1953b855],
45	%	NN	PERCENT	%	amod	43	SENT_209	[p16l1988t789r2069b855],
46	)	CD	NUMBER	)	num	47	SENT_209	[p16l1988t789r2069b855],
47	Anemia	NN	O	anemia	dobj	7	SENT_209	[p16l1206t884r1447b937],
48	2	CD	NUMBER	2	num	49	SENT_209	[p16l1834t885r1868b937],
49	(	NN	O	(	dep	47	SENT_209	[p16l1898t885r1957b950],
50	2	CD	PERCENT	2	number	51	SENT_209	[p16l1898t885r1957b950],
51	%	NN	PERCENT	%	amod	47	SENT_209	[p16l1988t885r2069b950],
52	)	CD	NUMBER	)	num	53	SENT_209	[p16l1988t885r2069b950],
53	Counts	NNS	O	count	dobj	7	SENT_209	[p16l8t972r219b1024],
54	and	CC	O	and	_	0	SENT_209	[p16l250t971r357b1024],
55	percentages	NNS	O	percentage	dobj	7	SENT_209	[p16l383t979r742b1040],
56	(	RB	O	(	amod	53	SENT_209	[p16l774t971r854b1037],
57	in	IN	O	in	_	0	SENT_209	[p16l774t971r854b1037],
58	other	JJ	O	other	amod	59	SENT_209	[p16l1207t998r1379b1051],
59	4	CD	PERCENT	4	prep_in	56	SENT_209	[p16l1832t998r1868b1050],
60	(	CD	PERCENT	(	number	61	SENT_209	[p16l1898t998r1957b1063],
61	4	CD	PERCENT	4	num	62	SENT_209	[p16l1898t998r1957b1063],
62	%	NN	PERCENT	%	dobj	7	SENT_209	[p16l1988t998r2069b1063],
63	)	CD	NUMBER	)	num	64	SENT_209	[p16l1988t998r2069b1063],
64	parentheses	NNS	O	parenthesis	dep	7	SENT_209	[p16l6t1060r384b1130],
65	)	CD	NUMBER	)	nsubjpass	67	SENT_209	[p16l6t1060r384b1130],
66	are	VBP	O	be	auxpass	67	SENT_209	[p16l416t1078r505b1114],
67	presented	VBN	O	present	rcmod	64	SENT_209	[p16l533t1061r825b1130],
68	to	TO	O	to	_	0	SENT_209	[p16l7t1302r74b1355],
69	the	DT	O	the	det	76	SENT_209	[p16l106t1293r213b1355],
70	doxorubicin	NN	O	doxorubicin	nn	76	SENT_209	[p16l246t1293r1397b1374],
71	—	NN	O	—	nn	76	SENT_209	[p16l246t1293r1397b1374],
72	cyclophosphamide	NN	O	cyclophosphamide	nn	76	SENT_209	[p16l246t1293r1397b1374],
73	(	CD	NUMBER	(	num	76	SENT_209	[p16l1433t1293r1609b1370],
74	AC	NN	ORGANIZATION	ac	nn	76	SENT_209	[p16l1433t1293r1609b1370],
75	)	NN	O	)	nn	76	SENT_209	[p16l1433t1293r1609b1370],
76	phase	NN	O	phase	prep_to	67	SENT_209	[p16l1641t1293r1844b1374],
77	of	IN	O	of	_	0	SENT_209	[p16l1877t1293r1954b1355],
78	therapy	NN	O	therapy	prep_of	76	SENT_209	[p16l1980t1293r2145b1355, p16l9t1424r134b1485],
79	in	IN	O	in	_	0	SENT_209	[p16l168t1404r235b1466],
80	patients	NNS	O	patient	prep_in	67	SENT_209	[p16l267t1404r544b1485],
81	who	WP	O	who	nsubj	82	SENT_209	[p16l579t1404r730b1467],
82	received	VBD	O	receive	rcmod	80	SENT_209	[p16l763t1404r1068b1467],
83	the	DT	O	the	det	84	SENT_209	[p16l1101t1404r1208b1467],
84	combination	NN	O	combination	dobj	82	SENT_209	[p16l1242t1404r1708b1467],
85	.	.	O	.	_	0	SENT_209	[p16l1242t1404r1708b1467],

1	Out	IN	O	out	_	0	SENT_210	[p16l1747t1405r1878b1467],
2	of	IN	O	of	prepc_out_of	24	SENT_210	[p16l1911t1404r1989b1467],
3	100	CD	NUMBER	100	num	4	SENT_210	[p16l2024t1405r2147b1467],
4	subjects	NNS	O	subject	pobj	24	SENT_210	[p16l10t1515r293b1596],
5	who	WP	O	who	nsubj	6	SENT_210	[p16l323t1515r473b1578],
6	received	VBD	O	receive	rcmod	4	SENT_210	[p16l500t1515r805b1578],
7	the	DT	O	the	det	9	SENT_210	[p16l831t1515r938b1578],
8	AC	NN	O	ac	nn	9	SENT_210	[p16l966t1515r1086b1578],
9	combination	NN	O	combination	dobj	6	SENT_210	[p16l1116t1515r1564b1578],
10	who	WP	O	who	nsubj	11	SENT_210	[p16l1591t1515r1742b1578],
11	had	VBD	O	have	rcmod	9	SENT_210	[p16l1769t1515r1898b1578],
12	evaluable	JJ	O	evaluable	amod	13	SENT_210	[p16l1926t1515r2144b1578, p16l9t1626r154b1688],
13	response	NN	O	response	dobj	11	SENT_210	[p16l176t1645r507b1707],
14	,	,	O	,	_	0	SENT_210	[p16l176t1645r507b1707],
15	the	DT	O	the	det	16	SENT_210	[p16l532t1626r639b1688],
16	rate	NN	O	rate	appos	13	SENT_210	[p16l660t1635r793b1688],
17	of	IN	O	of	_	0	SENT_210	[p16l817t1626r894b1688],
18	clinical	JJ	O	clinical	amod	20	SENT_210	[p16l910t1626r1172b1688],
19	complete	JJ	O	complete	amod	20	SENT_210	[p16l1195t1626r1522b1707],
20	response	NN	O	response	prep_of	16	SENT_210	[p16l1543t1645r1854b1707],
21	was	VBD	O	be	cop	24	SENT_210	[p16l1878t1645r2012b1689],
22	not	RB	O	not	neg	24	SENT_210	[p16l2035t1635r2149b1688],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	24	SENT_210	[p16l10t1737r449b1818],
24	different	JJ	O	different	_	0	SENT_210	[p16l486t1737r793b1799],
25	between	IN	O	between	_	0	SENT_210	[p16l826t1737r1125b1800],
26	*	CD	NUMBER	*	number	27	SENT_210	[p16l1165t1737r1243b1800],
27	3	CD	NUMBER	3	num	28	SENT_210	[p16l1165t1737r1243b1800],
28	carriers	NNS	O	carrier	nsubj	29	SENT_210	[p16l1282t1737r1547b1799],
29	(	VBP	O	(	prepc_between	24	SENT_210	[p16l1587t1737r1771b1814],
30	2/22	CD	NUMBER	2/22	nsubj	31	SENT_210	[p16l1587t1737r1771b1814],
31	=	JJ	O	=	ccomp	29	SENT_210	[p16l1807t1765r1868b1789],
32	9.0	CD	PERCENT	9.0	num	33	SENT_210	[p16l1905t1737r2013b1800],
33	%	NN	PERCENT	%	iobj	31	SENT_210	[p16l2049t1737r2145b1814],
34	)	CD	NUMBER	)	dobj	31	SENT_210	[p16l2049t1737r2145b1814],
35	and	CC	O	and	_	0	SENT_210	[p16l9t1848r136b1911],
36	wild	JJ	O	wild	amod	39	SENT_210	[p16l166t1848r507b1929],
37	—	NN	O	—	nn	39	SENT_210	[p16l166t1848r507b1929],
38	type	NN	O	type	nn	39	SENT_210	[p16l166t1848r507b1929],
39	homozygotes	NNS	O	homozygote	nsubj	40	SENT_210	[p16l539t1848r1015b1929],
40	(	VBP	O	(	conj_and	29	SENT_210	[p16l1050t1849r1231b1926],
41	8/78	CD	NUMBER	8/78	dobj	40	SENT_210	[p16l1050t1849r1231b1926],
42	=	JJ	O	=	dep	41	SENT_210	[p16l1271t1877r1331b1900],
43	10.3	CD	PERCENT	10.3	num	44	SENT_210	[p16l1375t1849r1517b1911],
44	%	NN	PERCENT	%	iobj	42	SENT_210	[p16l1558t1849r1653b1925],
45	)	CD	NUMBER	)	number	46	SENT_210	[p16l1558t1849r1653b1925],
46	(	CD	NUMBER	(	num	47	SENT_210	[p16l1690t1849r1839b1925],
47	OR	NN	O	or	dobj	42	SENT_210	[p16l1690t1849r1839b1925],
48	=	JJ	O	=	amod	47	SENT_210	[p16l1874t1877r1935b1900],
49	1.14	CD	NUMBER	1.14	tmod	48	SENT_210	[p16l1979t1849r2144b1922],
50	,	,	O	,	_	0	SENT_210	[p16l1979t1849r2144b1922],
51	95	CD	PERCENT	95	number	52	SENT_210	[p16l8t1958r90b2022],
52	%	NN	PERCENT	%	amod	53	SENT_210	[p16l131t1959r195b2021],
53	CI	NN	O	ci	appos	41	SENT_210	[p16l226t1959r331b2021],
54	:	:	O	:	_	0	SENT_210	[p16l226t1959r331b2021],
55	0.62	CD	NUMBER	0.62	number	56	SENT_210	[p16l365t1958r786b2032],
56	—	CD	NUMBER	—	dep	53	SENT_210	[p16l365t1958r786b2032],
57	l5	NN	O	l5	nsubj	24	SENT_210	[p16l365t1958r786b2032],
58	.96	CD	NUMBER	.96	num	57	SENT_210	[p16l365t1958r786b2032],
59	,	,	O	,	_	0	SENT_210	[p16l365t1958r786b2032],
60	uncorrected	JJ	O	uncorrected	amod	61	SENT_210	[p16l816t1958r1239b2021],
61	p	NN	O	p	appos	57	SENT_210	[p16l1258t1980r1307b2038],
62	=	JJ	O	=	amod	64	SENT_210	[p16l1344t1987r1405b2010],
63	0.872	CD	NUMBER	0.872	tmod	62	SENT_210	[p16l1441t1959r1688b2035],
64	)	NN	O	)	dep	61	SENT_210	[p16l1441t1959r1688b2035],
65	.	.	O	.	_	0	SENT_210	[p16l1441t1959r1688b2035],

1	Toxicity	NN	O	toxicity	_	0	SENT_211	[p16l7t2200r310b2281],
2	by	IN	O	by	dep	1	SENT_211	[p16l342t2200r429b2281],
3	genotype	NN	O	genotype	pobj	2	SENT_211	[p16l464t2209r790b2281],

1	Of	IN	O	of	_	0	SENT_212	[p16l9t2423r105b2486],
2	the	DT	O	the	det	4	SENT_212	[p16l140t2423r247b2486],
3	109	CD	NUMBER	109	num	4	SENT_212	[p16l297t2424r418b2487],
4	subjects	NNS	O	subject	prep_of	12	SENT_212	[p16l465t2423r747b2504],
5	included	VBD	O	include	partmod	4	SENT_212	[p16l790t2423r1098b2486],
6	in	IN	O	in	_	0	SENT_212	[p16l1139t2423r1206b2485],
7	the	DT	O	the	det	9	SENT_212	[p16l1247t2423r1354b2486],
8	toxicity	NN	O	toxicity	nn	9	SENT_212	[p16l1396t2423r1668b2504],
9	analysis	NN	O	analysis	prep_in	5	SENT_212	[p16l1712t2423r2016b2504],
10	,	,	O	,	_	0	SENT_212	[p16l1712t2423r2016b2504],
11	34	CD	NUMBER	34	nsubj	12	SENT_212	[p16l2063t2424r2147b2486],
12	experienced	VBD	O	experience	_	0	SENT_212	[p16l8t2534r441b2615],
13	at	IN	O	at	quantmod	15	SENT_212	[p16l467t2544r529b2597],
14	least	JJS	O	least	mwe	13	SENT_212	[p16l553t2534r717b2597],
15	one	CD	NUMBER	one	dobj	12	SENT_212	[p16l741t2554r867b2597],
16	grade	NN	O	grade	dep	15	SENT_212	[p16l894t2534r1089b2615],
17	3	CD	NUMBER	3	num	16	SENT_212	[p16l1117t2535r1152b2597],
18	or	CC	O	or	_	0	SENT_212	[p16l1183t2554r1256b2597],
19	higher	JJR	O	higher	amod	20	SENT_212	[p16l1278t2534r1508b2615],
20	toxicity	NN	O	toxicity	dobj	12	SENT_212	[p16l1531t2534r1803b2615],
21	(	CD	PERCENT	(	number	22	SENT_212	[p16l1831t2535r2012b2611],
22	31.2	CD	PERCENT	31.2	num	23	SENT_212	[p16l1831t2535r2012b2611],
23	%	NN	PERCENT	%	dep	20	SENT_212	[p16l2049t2535r2145b2611],
24	)	CD	NUMBER	)	number	25	SENT_212	[p16l2049t2535r2145b2611],
25	(	CD	NUMBER	(	num	28	SENT_212	[p16l10t2645r239b2722],
26	Table	NNP	O	Table	nn	28	SENT_212	[p16l10t2645r239b2722],
27	5	CD	NUMBER	5	num	28	SENT_212	[p16l274t2645r366b2722],
28	)	NN	O	)	dep	20	SENT_212	[p16l274t2645r366b2722],
29	;	:	O	;	_	0	SENT_212	[p16l274t2645r366b2722],
30	however	RB	O	however	advmod	38	SENT_212	[p16l424t2645r750b2719],
31	,	,	O	,	_	0	SENT_212	[p16l424t2645r750b2719],
32	none	NN	O	none	nsubjpass	38	SENT_212	[p16l807t2665r979b2708],
33	of	IN	O	of	_	0	SENT_212	[p16l1035t2645r1112b2708],
34	the	DT	O	the	det	36	SENT_212	[p16l1160t2645r1267b2708],
35	genetic	JJ	O	genetic	amod	36	SENT_212	[p16l1322t2645r1578b2726],
36	markers	NNS	O	marker	prep_of	32	SENT_212	[p16l1634t2645r1920b2708],
37	were	VBD	O	be	auxpass	38	SENT_212	[p16l1976t2665r2146b2708],
38	associated	VBN	O	associate	parataxis	12	SENT_212	[p16l9t2755r376b2817],
39	with	IN	O	with	_	0	SENT_212	[p16l404t2755r562b2817],
40	this	DT	O	this	det	42	SENT_212	[p16l590t2755r716b2817],
41	cumulative	JJ	O	cumulative	amod	42	SENT_212	[p16l747t2755r1144b2817],
42	endpoint	NN	O	endpoint	prep_with	38	SENT_212	[p16l1175t2755r1488b2836],
43	(	CD	NUMBER	(	num	44	SENT_212	[p16l1519t2755r1695b2832],
44	data	NNS	O	datum	npadvmod	45	SENT_212	[p16l1519t2755r1695b2832],
45	not	RB	O	not	neg	46	SENT_212	[p16l1722t2764r1836b2817],
46	shown	VBN	O	show	partmod	42	SENT_212	[p16l1867t2755r2142b2832],
47	)	NN	O	)	dobj	46	SENT_212	[p16l1867t2755r2142b2832],
48	.	.	O	.	_	0	SENT_212	[p16l1867t2755r2142b2832],

1	Analysis	NN	O	analysis	nsubj	15	SENT_213	[p16l7t2866r317b2947],
2	of	IN	O	of	_	0	SENT_213	[p16l366t2866r443b2928],
3	the	DT	O	the	det	6	SENT_213	[p16l483t2866r589b2928],
4	secondary	JJ	O	secondary	amod	6	SENT_213	[p16l639t2866r998b2947],
5	toxicity	NN	O	toxicity	nn	6	SENT_213	[p16l1044t2865r1317b2947],
6	endpoint	NN	O	endpoint	prep_of	1	SENT_213	[p16l1364t2866r1695b2947],
7	,	,	O	,	_	0	SENT_213	[p16l1364t2866r1695b2947],
8	grade	NN	O	grade	appos	6	SENT_213	[p16l1745t2866r1940b2947],
9	3	CD	NUMBER	3	num	8	SENT_213	[p16l1990t2866r2025b2929],
10	or	CC	O	or	_	0	SENT_213	[p16l2076t2885r2149b2928],
11	higher	JJR	O	higher	amod	13	SENT_213	[p16l7t2978r236b3059],
12	peripheral	JJ	O	peripheral	amod	13	SENT_213	[p16l293t2978r655b3059],
13	neuropathy	NN	O	neuropathy	conj_or	8	SENT_213	[p16l716t2978r1137b3059],
14	,	,	O	,	_	0	SENT_213	[p16l716t2978r1137b3059],
15	revealed	VBD	O	reveal	dep	40	SENT_213	[p16l1199t2978r1503b3041],
16	a	DT	O	a	det	17	SENT_213	[p16l1564t2998r1601b3041],
17	trend	NN	O	trend	dobj	15	SENT_213	[p16l1659t2978r1842b3041],
18	toward	IN	O	toward	_	0	SENT_213	[p16l1900t2978r2149b3041],
19	increased	VBN	O	increase	amod	20	SENT_213	[p16l7t3089r343b3152],
20	neuropathy	NN	O	neuropathy	prep_toward	15	SENT_213	[p16l383t3089r780b3170],
21	in	IN	O	in	_	0	SENT_213	[p16l822t3089r890b3151],
22	subjects	NNS	O	subject	prep_in	20	SENT_213	[p16l934t3089r1213b3170],
23	carrying	VBG	O	carry	partmod	22	SENT_213	[p16l1257t3089r1550b3170],
24	the	DT	O	the	det	30	SENT_213	[p16l1591t3089r1698b3152],
25	CYP2C8	NN	O	cyp2c8	nn	30	SENT_213	[p16l1740t3089r2144b3152],
26	*	NN	O	*	nn	30	SENT_213	[p16l1740t3089r2144b3152],
27	3	CD	NUMBER	3	num	30	SENT_213	[p16l1740t3089r2144b3152],
28	variant	JJ	O	variant	amod	30	SENT_213	[p16l7t3199r254b3262],
29	(	NN	O	(	nn	30	SENT_213	[p16l279t3198r457b3276],
30	5/23	NN	O	5/23	nsubj	31	SENT_213	[p16l279t3198r457b3276],
31	=	JJ	O	=	ccomp	23	SENT_213	[p16l497t3227r558b3251],
32	22	CD	PERCENT	22	num	33	SENT_213	[p16l594t3199r679b3261],
33	%	NN	PERCENT	%	iobj	31	SENT_213	[p16l715t3199r811b3276],
34	)	CD	NUMBER	)	dobj	31	SENT_213	[p16l715t3199r811b3276],
35	versus	CC	O	versus	prep	23	SENT_213	[p16l836t3218r1059b3262],
36	wild	JJ	O	wild	amod	39	SENT_213	[p16l1085t3199r1422b3280],
37	—	NN	O	—	nn	39	SENT_213	[p16l1085t3199r1422b3280],
38	type	NN	O	type	nn	39	SENT_213	[p16l1085t3199r1422b3280],
39	individuals	NNS	O	individual	dep	35	SENT_213	[p16l1446t3199r1838b3261],
40	(	VBP	O	(	_	0	SENT_213	[p16l1866t3199r2047b3276],
41	7/86	CD	NUMBER	7/86	dobj	40	SENT_213	[p16l1866t3199r2047b3276],
42	=	JJ	O	=	dep	41	SENT_213	[p16l2084t3227r2144b3251],
43	8	CD	PERCENT	8	num	44	SENT_213	[p16l11t3310r46b3373],
44	%	NN	PERCENT	%	iobj	42	SENT_213	[p16l86t3310r181b3387],
45	)	CD	NUMBER	)	number	46	SENT_213	[p16l86t3310r181b3387],
46	(	CD	NUMBER	(	num	47	SENT_213	[p16l261t3310r411b3387],
47	OR	NN	O	or	dobj	42	SENT_213	[p16l261t3310r411b3387],
48	=	JJ	O	=	amod	47	SENT_213	[p16l445t3338r506b3362],
49	3.13	CD	NUMBER	3.13	tmod	48	SENT_213	[p16l545t3310r716b3384],
50	,	,	O	,	_	0	SENT_213	[p16l545t3310r716b3384],
51	95	CD	PERCENT	95	number	52	SENT_213	[p16l794t3310r876b3373],
52	%	NN	PERCENT	%	amod	53	SENT_213	[p16l916t3310r981b3373],
53	CI	NN	O	ci	appos	41	SENT_213	[p16l1060t3310r1165b3373],
54	:	:	O	:	_	0	SENT_213	[p16l1060t3310r1165b3373],
55	0.89	CD	NUMBER	0.89	number	56	SENT_213	[p16l1246t3310r1666b3384],
56	—	CD	NUMBER	—	dep	53	SENT_213	[p16l1246t3310r1666b3384],
57	ll	NN	O	ll	nsubj	40	SENT_213	[p16l1246t3310r1666b3384],
58	.01	CD	NUMBER	.01	num	57	SENT_213	[p16l1246t3310r1666b3384],
59	,	,	O	,	_	0	SENT_213	[p16l1246t3310r1666b3384],
60	p	NN	O	p	appos	57	SENT_213	[p16l1736t3331r1785b3390],
61	=	JJ	O	=	advmod	65	SENT_213	[p16l1822t3338r1883b3362],
62	0.075	CD	NUMBER	0.075	dep	61	SENT_213	[p16l1919t3309r2145b3387],
63	)	CD	NUMBER	)	number	64	SENT_213	[p16l1919t3309r2145b3387],
64	(	CD	NUMBER	(	num	65	SENT_213	[p16l10t3422r172b3503],
65	Fig	NN	O	fig	rcmod	60	SENT_213	[p16l10t3422r172b3503],
66	.	.	O	.	_	0	SENT_213	[p16l10t3422r172b3503],

1	1	CD	NUMBER	1	_	0	SENT_214	[p16l217t3423r270b3496],
2	,	,	O	,	_	0	SENT_214	[p16l217t3423r270b3496],
3	Supplementary	NNP	O	Supplementary	nn	4	SENT_214	[p16l305t3422r845b3503],
4	Table	NNP	O	Table	appos	1	SENT_214	[p16l876t3422r1078b3485],
5	4	CD	NUMBER	4	number	6	SENT_214	[p16l1111t3423r1202b3499],
6	)	CD	NUMBER	)	dep	4	SENT_214	[p16l1111t3423r1202b3499],
7	.	.	O	.	_	0	SENT_214	[p16l1111t3423r1202b3499],

1	Discussion	NN	O	discussion	_	0	SENT_215	[p16l7t3665r408b3728],

1	This	DT	O	this	det	2	SENT_216	[p17l7t116r163b179],
2	study	NN	O	study	nsubj	3	SENT_216	[p17l230t116r419b197],
3	investigated	VBD	O	investigate	_	0	SENT_216	[p17l482t116r915b197],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_216	[p17l977t116r1590b197],
5	predictors	NNS	O	predictor	dobj	3	SENT_216	[p17l1654t116r2011b197],
6	of	IN	O	of	_	0	SENT_216	[p17l2076t116r2153b179],
7	breast	NN	O	breast	nn	10	SENT_216	[p17l6t226r220b288],
8	cancer	NN	O	cancer	nn	10	SENT_216	[p17l266t245r500b288],
9	treatment	NN	O	treatment	nn	10	SENT_216	[p17l544t235r884b288],
10	outcomes	NNS	O	outcome	prep_of	5	SENT_216	[p17l929t235r1269b288],
11	following	VBG	O	follow	_	0	SENT_216	[p17l1317t226r1663b307],
12	neoadjuvant	JJ	O	neoadjuvant	amod	13	SENT_216	[p17l1709t226r2149b307],
13	paclitaxel	NN	O	paclitaxel	prep_following	5	SENT_216	[p17l6t336r374b418],
14	.	.	O	.	_	0	SENT_216	[p17l6t336r374b418],

1	By	IN	O	by	_	0	SENT_217	[p17l415t338r517b418],
2	measuring	VBG	O	measure	conj_and	2	SENT_217	[p17l554t337r926b418],
3	the	DT	O	the	det	4	SENT_217	[p17l963t337r1070b399],
4	tumor	NN	O	tumor	dobj	2	SENT_217	[p17l1108t346r1322b399],
5	before	IN	O	before	_	0	SENT_217	[p17l1356t336r1583b399],
6	and	CC	O	and	_	0	SENT_217	[p17l1623t337r1749b399],
7	after	IN	O	after	_	0	SENT_217	[p17l1787t337r1949b399],
8	each	DT	O	each	det	9	SENT_217	[p17l1985t337r2147b399],
9	phase	NN	O	phase	prep_before	2	SENT_217	[p17l6t448r208b529],
10	of	IN	O	of	_	0	SENT_217	[p17l247t447r324b510],
11	sequential	JJ	O	sequential	amod	12	SENT_217	[p17l357t448r717b529],
12	chemotherapy	NN	O	chemotherapy	prep_of	9	SENT_217	[p17l754t448r1281b529],
13	,	,	O	,	_	0	SENT_217	[p17l754t448r1281b529],
14	and	CC	O	and	_	0	SENT_217	[p17l1322t448r1449b510],
15	collecting	VBG	O	collect	conj_and	2	SENT_217	[p17l1485t448r1837b529],
16	toxicity	NN	O	toxicity	dobj	15	SENT_217	[p17l1874t448r2147b529],
17	during	IN	O	during	_	0	SENT_217	[p17l8t560r238b641],
18	each	DT	O	each	det	19	SENT_217	[p17l276t560r439b623],
19	phase	NN	O	phase	prep_during	15	SENT_217	[p17l474t560r676b641],
20	separately	RB	O	separately	advmod	15	SENT_217	[p17l717t560r1096b641],
21	,	,	O	,	_	0	SENT_217	[p17l717t560r1096b641],
22	we	PRP	O	we	nsubj	24	SENT_217	[p17l1136t580r1236b623],
23	were	VBD	O	be	cop	24	SENT_217	[p17l1274t580r1445b623],
24	able	JJ	O	able	_	0	SENT_217	[p17l1484t560r1629b623],
25	to	TO	O	to	aux	26	SENT_217	[p17l1666t569r1733b623],
26	isolate	VB	O	isolate	xcomp	24	SENT_217	[p17l1771t560r2002b623],
27	the	DT	O	the	det	31	SENT_217	[p17l2040t560r2147b623],
28	taXane	NN	O	taxane	nn	31	SENT_217	[p17l7t671r543b752],
29	—	NN	O	—	nn	31	SENT_217	[p17l7t671r543b752],
30	speciﬁc	NN	O	speciﬁc	nn	31	SENT_217	[p17l7t671r543b752],
31	outcomes	NNS	O	outcome	dobj	26	SENT_217	[p17l580t680r920b734],
32	from	IN	O	from	_	0	SENT_217	[p17l956t671r1129b734],
33	the	DT	O	the	det	35	SENT_217	[p17l1162t671r1269b734],
34	sequential	JJ	O	sequential	amod	35	SENT_217	[p17l1307t671r1666b752],
35	therapy	NN	O	therapy	prep_from	26	SENT_217	[p17l1700t671r1986b752],
36	.	.	O	.	_	0	SENT_217	[p17l1700t671r1986b752],

1	We	PRP	O	we	nsubj	2	SENT_218	[p17l2023t673r2147b734],
2	employed	VBD	O	employ	_	0	SENT_218	[p17l8t782r361b863],
3	a	DT	O	a	det	5	SENT_218	[p17l420t801r457b844],
4	candidate	NN	O	candidate	nn	5	SENT_218	[p17l515t782r857b844],
5	polymorphism	NN	O	polymorphism	nsubj	6	SENT_218	[p17l915t782r1440b863],
6	replicate	VBP	O	replicate	ccomp	2	SENT_218	[p17l1496t782r1805b863],
7	strategy	NN	O	strategy	dobj	6	SENT_218	[p17l1868t791r2146b863],
8	based	VBN	O	base	_	0	SENT_218	[p17l6t893r210b956],
9	on	IN	O	on	prepc_based_on	6	SENT_218	[p17l252t913r338b956],
10	reported	VBN	O	report	amod	11	SENT_218	[p17l378t893r678b974],
11	associations	NNS	O	association	pobj	6	SENT_218	[p17l720t893r1149b956],
12	with	IN	O	with	_	0	SENT_218	[p17l1192t893r1350b956],
13	clinical	JJ	O	clinical	amod	14	SENT_218	[p17l1392t893r1654b956],
14	outcomes	NNS	O	outcome	prep_with	11	SENT_218	[p17l1697t903r2037b956],
15	in	IN	O	in	_	0	SENT_218	[p17l2080t893r2148b955],
16	previous	JJ	O	previous	amod	18	SENT_218	[p17l6t1005r312b1086],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_218	[p17l345t1005r959b1086],
18	studies	NNS	O	study	prep_in	14	SENT_218	[p17l996t1005r1238b1068],
19	in	IN	O	in	_	0	SENT_218	[p17l1273t1005r1340b1067],
20	taXane	NN	O	taxane	nn	21	SENT_218	[p17l1372t1005r1882b1068],
21	—	NN	O	—	prep_in	18	SENT_218	[p17l1372t1005r1882b1068],
22	treated	VBN	O	treat	partmod	21	SENT_218	[p17l1372t1005r1882b1068],
23	cancer	NN	O	cancer	nn	24	SENT_218	[p17l1915t1025r2149b1068],
24	patients	NNS	O	patient	dobj	22	SENT_218	[p17l6t1116r302b1197],
25	.	.	O	.	_	0	SENT_218	[p17l6t1116r302b1197],

1	These	DT	O	these	det	3	SENT_219	[p17l347t1116r559b1179],
2	candidate	NN	O	candidate	nn	3	SENT_219	[p17l601t1116r943b1179],
3	genes	NNS	O	gene	nsubj	4	SENT_219	[p17l985t1136r1184b1197],
4	covered	VBD	O	cover	_	0	SENT_219	[p17l1227t1116r1509b1179],
5	the	DT	O	the	det	8	SENT_219	[p17l1548t1116r1655b1179],
6	major	JJ	O	major	amod	8	SENT_219	[p17l1697t1116r1906b1197],
7	metabolic	JJ	O	metabolic	amod	8	SENT_219	[p17l1944t1126r2144b1179, p17l6t1226r183b1288],
8	pathways	NNS	O	pathway	dobj	4	SENT_219	[p17l218t1226r555b1307],
9	of	IN	O	of	_	0	SENT_219	[p17l591t1226r669b1288],
10	paclitaxel	NN	O	paclitaxel	prep_of	8	SENT_219	[p17l696t1226r1065b1307],
11	,	,	O	,	_	0	SENT_219	[p17l696t1226r1065b1307],
12	CYP3A4/3A5	NN	O	cyp3a4/3a5	prep_of	8	SENT_219	[p17l1104t1225r1604b1289],
13	and	CC	O	and	_	0	SENT_219	[p17l1644t1226r1771b1288],
14	CYP2C8	NN	O	cyp2c8	prep_of	8	SENT_219	[p17l1805t1226r2144b1300],
15	,	,	O	,	_	0	SENT_219	[p17l1805t1226r2144b1300],

1	@	IN	O	@	_	0	SENT_220	[p17l6t1469r83b1564],
2	Springer	NNP	PERSON	Springer	prep_@	13	SENT_220	[p17l113t1492r375b1567],
3	the	DT	O	the	det	6	SENT_220	[p17l7t1594r114b1657],
4	efﬂux	NN	O	efﬂux	nn	6	SENT_220	[p17l149t1594r355b1657],
5	transporter	NN	O	transporter	nn	6	SENT_220	[p17l388t1604r778b1675],
6	ABCB1	NN	O	abcb1	dep	2	SENT_220	[p17l809t1595r1115b1669],
7	,	,	O	,	_	0	SENT_220	[p17l809t1595r1115b1669],
8	and	CC	O	and	_	0	SENT_220	[p17l1153t1594r1279b1657],
9	CYPlB1	NN	O	cyplb1	prep_@	13	SENT_220	[p17l1313t1595r1626b1657],
10	that	WDT	O	that	nsubjpass	13	SENT_220	[p17l1666t1594r1801b1657],
11	has	VBZ	O	have	aux	13	SENT_220	[p17l1832t1594r1948b1657],
12	been	VBN	O	be	auxpass	13	SENT_220	[p17l1982t1594r2151b1657],
13	shown	VBN	O	show	_	0	SENT_220	[p17l10t1705r239b1768],
14	to	TO	O	to	_	0	SENT_220	[p17l271t1714r338b1768],
15	inﬂuence	NN	O	inﬂuence	nn	18	SENT_220	[p17l372t1705r699b1768],
16	taxane	NN	O	taxane	nn	18	SENT_220	[p17l732t1715r965b1768],
17	treatment	NN	O	treatment	nn	18	SENT_220	[p17l999t1715r1339b1768],
18	efﬁcacy	NN	O	efﬁcacy	prep_to	13	SENT_220	[p17l1371t1705r1671b1786],
19	.	.	O	.	_	0	SENT_220	[p17l1371t1705r1671b1786],

1	Our	PRP$	O	we	poss	2	SENT_221	[p17l111t1816r248b1879],
2	results	NNS	O	result	nsubj	3	SENT_221	[p17l340t1816r572b1878],
3	indicate	VBP	O	indicate	_	0	SENT_221	[p17l669t1816r952b1878],
4	that	IN	O	that	complm	14	SENT_221	[p17l1048t1816r1182b1878],
5	patients	NNS	O	patient	nsubj	14	SENT_221	[p17l1275t1816r1553b1897],
6	carrying	VBG	O	carry	partmod	5	SENT_221	[p17l1650t1816r1947b1897],
7	the	DT	O	the	det	11	SENT_221	[p17l2043t1816r2150b1878],
8	CYP2C8	NN	O	cyp2c8	nn	11	SENT_221	[p17l8t1926r415b1989],
9	*	NN	O	*	nn	11	SENT_221	[p17l8t1926r415b1989],
10	3	CD	NUMBER	3	num	11	SENT_221	[p17l8t1926r415b1989],
11	polymorphism	NN	O	polymorphism	dobj	6	SENT_221	[p17l480t1926r1005b2007],
12	are	VBP	O	be	cop	14	SENT_221	[p17l1068t1945r1173b1988],
13	more	RBR	O	more	advmod	14	SENT_221	[p17l1236t1945r1419b1988],
14	likely	JJ	O	likely	ccomp	3	SENT_221	[p17l1482t1926r1684b2007],
15	to	TO	O	to	aux	16	SENT_221	[p17l1747t1935r1814b1988],
16	achieve	VB	O	achieve	xcomp	14	SENT_221	[p17l1879t1926r2149b1988],
17	clinical	JJ	O	clinical	amod	19	SENT_221	[p17l8t2037r270b2099],
18	complete	JJ	O	complete	amod	19	SENT_221	[p17l314t2037r641b2118],
19	response	NN	O	response	dobj	16	SENT_221	[p17l682t2056r994b2118],
20	than	IN	O	than	_	0	SENT_221	[p17l1036t2037r1189b2099],
21	patients	NNS	O	patient	prep_than	16	SENT_221	[p17l1229t2037r1507b2118],
22	homozygous	JJ	O	homozygous	amod	21	SENT_221	[p17l1549t2037r2005b2118],
23	for	IN	O	for	_	0	SENT_221	[p17l2049t2037r2153b2099],
24	the	DT	O	the	det	28	SENT_221	[p17l7t2149r114b2212],
25	wild	JJ	O	wild	amod	28	SENT_221	[p17l160t2149r502b2230],
26	—	NN	O	—	nn	28	SENT_221	[p17l160t2149r502b2230],
27	type	NN	O	type	nn	28	SENT_221	[p17l160t2149r502b2230],
28	isozyme	NN	O	isozyme	prep_for	22	SENT_221	[p17l548t2149r864b2230],
29	.	.	O	.	_	0	SENT_221	[p17l548t2149r864b2230],

1	This	DT	O	this	det	2	SENT_222	[p17l913t2149r1068b2212],
2	ﬁnding	NN	O	ﬁnding	nsubjpass	4	SENT_222	[p17l1116t2149r1366b2230],
3	is	VBZ	O	be	auxpass	4	SENT_222	[p17l1412t2149r1467b2212],
4	supported	VBN	O	support	_	0	SENT_222	[p17l1517t2149r1867b2230],
5	by	IN	O	by	_	0	SENT_222	[p17l1909t2149r1997b2230],
6	the	DT	O	the	det	8	SENT_222	[p17l2043t2149r2150b2212],
7	strong	JJ	O	strong	amod	8	SENT_222	[p17l10t2270r228b2341],
8	trend	NN	O	trend	agent	4	SENT_222	[p17l255t2260r438b2323],
9	in	IN	O	in	_	0	SENT_222	[p17l462t2260r531b2322],
10	the	DT	O	the	det	12	SENT_222	[p17l555t2260r663b2323],
11	same	JJ	O	same	amod	12	SENT_222	[p17l692t2280r871b2323],
12	direction	NN	O	direction	prep_in	8	SENT_222	[p17l898t2260r1215b2323],
13	for	IN	O	for	_	0	SENT_222	[p17l1241t2260r1345b2323],
14	clinical	JJ	O	clinical	amod	16	SENT_222	[p17l1369t2260r1632b2323],
15	response	NN	O	response	nn	16	SENT_222	[p17l1657t2280r1968b2341],
16	rate	NN	O	rate	prep_for	12	SENT_222	[p17l1994t2270r2146b2323],
17	.	.	O	.	_	0	SENT_222	[p17l1994t2270r2146b2323],

1	The	DT	O	the	det	2	SENT_223	[p17l7t2371r144b2434],
2	association	NN	O	association	nsubj	7	SENT_223	[p17l183t2371r580b2434],
3	with	IN	O	with	_	0	SENT_223	[p17l617t2371r774b2434],
4	tumor	NN	O	tumor	nn	5	SENT_223	[p17l810t2381r1024b2434],
5	response	NN	O	response	prep_with	2	SENT_223	[p17l1058t2391r1370b2452],
6	remained	VBD	O	remain	cop	7	SENT_223	[p17l1406t2371r1742b2434],
7	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_223	[p17l1781t2371r2151b2452],
8	after	IN	O	after	_	0	SENT_223	[p17l9t2482r172b2545],
9	adjustment	NN	O	adjustment	prep_after	7	SENT_223	[p17l215t2482r608b2563],
10	for	IN	O	for	_	0	SENT_223	[p17l650t2482r754b2545],
11	covariates	NNS	O	covariate	prep_for	9	SENT_223	[p17l795t2482r1157b2545],
12	and	CC	O	and	_	0	SENT_223	[p17l1203t2482r1329b2545],
13	stratiﬁcation	NN	O	stratiﬁcation	prep_for	9	SENT_223	[p17l1375t2482r1821b2545],
14	by	IN	O	by	_	0	SENT_223	[p17l1862t2482r1950b2563],
15	selfreported	JJ	O	selfreported	amod	16	SENT_223	[p17l1996t2482r2148b2545, p17l6t2593r307b2674],
16	race	NN	O	race	prep_by	7	SENT_223	[p17l336t2613r503b2656],
17	.	.	O	.	_	0	SENT_223	[p17l336t2613r503b2656],

1	There	EX	O	there	expl	20	SENT_224	[p17l540t2593r747b2656],
2	was	VBD	O	be	cop	20	SENT_224	[p17l781t2613r916b2656],
3	no	DT	O	no	det	4	SENT_224	[p17l949t2613r1036b2656],
4	association	NN	O	association	nsubj	20	SENT_224	[p17l1070t2593r1467b2656],
5	between	IN	O	between	_	0	SENT_224	[p17l1498t2593r1797b2656],
6	CYP2C8	NN	O	cyp2c8	nn	7	SENT_224	[p17l1830t2594r2148b2656],
7	genotype	NN	O	genotype	prep_between	4	SENT_224	[p17l8t2713r335b2785],
8	and	CC	O	and	_	0	SENT_224	[p17l373t2704r499b2766],
9	clinical	JJ	O	clinical	amod	11	SENT_224	[p17l534t2704r797b2766],
10	complete	JJ	O	complete	amod	11	SENT_224	[p17l834t2704r1161b2785],
11	response	NN	O	response	conj_and	7	SENT_224	[p17l1197t2723r1509b2785],
12	to	TO	O	to	_	0	SENT_224	[p17l1545t2713r1611b2766],
13	the	DT	O	the	det	15	SENT_224	[p17l1648t2704r1755b2766],
14	AC	NN	O	ac	nn	15	SENT_224	[p17l1791t2704r1911b2767],
15	phase	NN	O	phase	prep_to	20	SENT_224	[p17l1947t2704r2149b2785],
16	of	IN	O	of	_	0	SENT_224	[p17l8t2815r86b2877],
17	sequential	JJ	O	sequential	amod	18	SENT_224	[p17l152t2815r512b2896],
18	therapy	NN	O	therapy	prep_of	15	SENT_224	[p17l583t2815r870b2896],
19	,	,	O	,	_	0	SENT_224	[p17l583t2815r870b2896],
20	dismissing	VBG	O	dismiss	_	0	SENT_224	[p17l945t2815r1325b2896],
21	the	DT	O	the	det	22	SENT_224	[p17l1397t2815r1503b2877],
22	possibility	NN	O	possibility	dobj	20	SENT_224	[p17l1573t2815r1947b2896],
23	that	IN	O	that	complm	29	SENT_224	[p17l2017t2815r2152b2877],
24	patients	NNS	O	patient	nsubj	29	SENT_224	[p17l6t2925r283b3006],
25	carrying	VBG	O	carry	partmod	24	SENT_224	[p17l345t2925r640b3006],
26	CYP2C8	NN	O	cyp2c8	nn	27	SENT_224	[p17l701t2925r1107b2988],
27	*	NN	O	*	dobj	25	SENT_224	[p17l701t2925r1107b2988],
28	3	CD	NUMBER	3	num	27	SENT_224	[p17l701t2925r1107b2988],
29	had	VBD	O	have	ccomp	20	SENT_224	[p17l1169t2925r1298b2987],
30	more	RBR	O	more	advmod	31	SENT_224	[p17l1356t2944r1538b2987],
31	chemosensitive	JJ	O	chemosensitive	amod	32	SENT_224	[p17l1598t2925r2150b2987],
32	tumors	NNS	O	tumor	dobj	29	SENT_224	[p17l7t3047r273b3100],
33	.	.	O	.	_	0	SENT_224	[p17l7t3047r273b3100],

1	Thus	RB	O	thus	advmod	4	SENT_225	[p17l319t3037r516b3111],
2	,	,	O	,	_	0	SENT_225	[p17l319t3037r516b3111],
3	there	EX	O	there	expl	4	SENT_225	[p17l561t3037r738b3100],
4	seems	VBZ	O	seem	_	0	SENT_225	[p17l785t3057r997b3100],
5	to	TO	O	to	aux	10	SENT_225	[p17l1041t3046r1108b3100],
6	be	VB	O	be	cop	10	SENT_225	[p17l1150t3037r1233b3100],
7	a	DT	O	a	det	10	SENT_225	[p17l1278t3057r1315b3100],
8	true	JJ	O	true	amod	9	SENT_225	[p17l1356t3047r1493b3100],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_225	[p17l1534t3037r2149b3118],
10	association	NN	O	association	xcomp	4	SENT_225	[p17l9t3148r406b3211],
11	between	IN	O	between	_	0	SENT_225	[p17l460t3148r760b3211],
12	the	DT	O	the	det	16	SENT_225	[p17l815t3148r921b3211],
13	CYP2C8	NN	O	cyp2c8	nn	16	SENT_225	[p17l978t3148r1385b3211],
14	*	NN	O	*	nn	16	SENT_225	[p17l978t3148r1385b3211],
15	3	CD	NUMBER	3	num	16	SENT_225	[p17l978t3148r1385b3211],
16	polymorphism	NN	O	polymorphism	prep_between	10	SENT_225	[p17l1443t3148r1968b3229],
17	and	CC	O	and	_	0	SENT_225	[p17l2025t3148r2151b3211],
18	clinical	JJ	O	clinical	amod	19	SENT_225	[p17l8t3259r270b3322],
19	response	NN	O	response	prep_between	10	SENT_225	[p17l303t3279r615b3340],
20	to	TO	O	to	_	0	SENT_225	[p17l649t3269r716b3322],
21	neoadjuvant	JJ	O	neoadjuvant	amod	23	SENT_225	[p17l749t3259r1189b3340],
22	paclitaxel	NN	O	paclitaxel	nn	23	SENT_225	[p17l1220t3259r1570b3340],
23	therapy	NN	O	therapy	prep_to	16	SENT_225	[p17l1603t3259r1888b3340],
24	.	.	O	.	_	0	SENT_225	[p17l1603t3259r1888b3340],

1	Clinical	JJ	O	clinical	amod	2	SENT_226	[p17l111t3370r393b3433],
2	response	NN	O	response	nsubjpass	26	SENT_226	[p17l430t3390r762b3451],
3	,	,	O	,	_	0	SENT_226	[p17l430t3390r762b3451],
4	instead	RB	O	instead	_	0	SENT_226	[p17l804t3370r1057b3433],
5	of	IN	O	of	_	0	SENT_226	[p17l1096t3370r1173b3433],
6	the	DT	O	the	det	10	SENT_226	[p17l1204t3370r1312b3433],
7	more	JJR	O	more	amod	10	SENT_226	[p17l1350t3390r1532b3433],
8	accepted	VBN	O	accept	amod	10	SENT_226	[p17l1573t3370r1886b3451],
9	pathological	JJ	O	pathological	amod	10	SENT_226	[p17l1922t3370r2148b3451, p17l7t3481r250b3562],
10	response	NN	O	response	prep_instead_of	2	SENT_226	[p17l301t3501r633b3562],
11	,	,	O	,	_	0	SENT_226	[p17l301t3501r633b3562],
12	which	WDT	O	which	nsubj	13	SENT_226	[p17l688t3481r905b3544],
13	has	VBZ	O	have	rcmod	10	SENT_226	[p17l956t3481r1072b3544],
14	prognostic	JJ	O	prognostic	amod	15	SENT_226	[p17l1123t3481r1500b3562],
15	implications	NNS	O	implication	dobj	13	SENT_226	[p17l1553t3481r1995b3562],
16	for	IN	O	for	_	0	SENT_226	[p17l2049t3481r2153b3544],
17	future	JJ	DATE	future	amod	18	SENT_226	[p17l7t3592r219b3655],
18	survival	NN	O	survival	prep_for	15	SENT_226	[p17l262t3592r546b3655],
19	[	CD	NUMBER	[	number	20	SENT_226	[p17l592t3593r887b3668],
20	32	CD	NUMBER	32	num	21	SENT_226	[p17l592t3593r887b3668],
21	—	NN	O	—	dep	18	SENT_226	[p17l592t3593r887b3668],
22	34	CD	NUMBER	34	num	23	SENT_226	[p17l592t3593r887b3668],
23	]	NN	O	]	dep	21	SENT_226	[p17l592t3593r887b3668],
24	,	,	O	,	_	0	SENT_226	[p17l592t3593r887b3668],
25	was	VBD	O	be	auxpass	26	SENT_226	[p17l929t3612r1064b3655],
26	selected	VBN	O	select	_	0	SENT_226	[p17l1109t3592r1394b3655],
27	because	IN	O	because	_	0	SENT_226	[p17l1432t3592r1715b3655],
28	of	IN	O	of	_	0	SENT_226	[p17l1756t3592r1833b3655],
29	the	DT	O	the	det	30	SENT_226	[p17l1866t3592r1974b3655],
30	collection	NN	O	collection	prep_because_of	26	SENT_226	[p17l2014t3592r2148b3655, p17l7t3704r251b3766],
31	of	IN	O	of	_	0	SENT_226	[p17l297t3704r374b3766],
32	tumor	NN	O	tumor	nn	34	SENT_226	[p17l412t3713r627b3766],
33	size	NN	O	size	nn	34	SENT_226	[p17l673t3704r807b3766],
34	data	NNS	O	datum	prep_of	30	SENT_226	[p17l853t3704r1001b3766],
35	between	IN	O	between	_	0	SENT_226	[p17l1044t3704r1343b3767],
36	phases	NNS	O	phase	prep_between	34	SENT_226	[p17l1387t3704r1623b3785],
37	of	IN	O	of	_	0	SENT_226	[p17l1671t3704r1748b3766],
38	sequential	JJ	O	sequential	amod	39	SENT_226	[p17l1790t3704r2150b3785],
39	therapy	NN	O	therapy	prep_of	36	SENT_226	[p18l7t22r294b103],
40	,	,	O	,	_	0	SENT_226	[p18l7t22r294b103],
41	which	WDT	O	which	nsubj	42	SENT_226	[p18l342t22r559b85],
42	enables	VBZ	O	enable	rcmod	39	SENT_226	[p18l604t22r869b84],
43	us	PRP	O	we	nsubj	45	SENT_226	[p18l914t41r990b84],
44	to	TO	O	to	aux	45	SENT_226	[p18l1035t31r1102b84],
45	isolate	VB	O	isolate	xcomp	42	SENT_226	[p18l1147t22r1379b84],
46	the	DT	O	the	det	47	SENT_226	[p18l1424t22r1530b84],
47	response	NN	O	response	dobj	45	SENT_226	[p18l1574t41r1887b103],
48	to	TO	O	to	_	0	SENT_226	[p18l1931t31r1998b84],
49	the	DT	O	the	det	51	SENT_226	[p18l2043t22r2150b84],
50	paclitaxel	NN	O	paclitaxel	nn	51	SENT_226	[p18l6t132r356b213],
51	phase	NN	O	phase	prep_to	45	SENT_226	[p18l419t132r622b213],
52	of	IN	O	of	_	0	SENT_226	[p18l688t132r766b194],
53	treatment	NN	O	treatment	prep_of	51	SENT_226	[p18l823t141r1164b194],
54	from	IN	O	from	_	0	SENT_226	[p18l1227t131r1400b194],
55	that	DT	O	that	prep_from	45	SENT_226	[p18l1463t132r1597b194],
56	of	IN	O	of	_	0	SENT_226	[p18l1661t131r1738b194],
57	the	DT	O	the	det	60	SENT_226	[p18l1796t132r1903b194],
58	other	JJ	O	other	dep	59	SENT_226	[p18l1969t132r2152b194],
59	administered	VBN	O	administer	amod	60	SENT_226	[p18l9t244r472b307],
60	therapy	NN	O	therapy	prep_of	55	SENT_226	[p18l521t244r807b325],
61	.	.	O	.	_	0	SENT_226	[p18l521t244r807b325],

1	Although	IN	O	although	mark	7	SENT_227	[p18l862t244r1200b325],
2	clinical	JJ	O	clinical	amod	3	SENT_227	[p18l1251t244r1513b307],
3	measurement	NN	O	measurement	nsubj	7	SENT_227	[p18l1564t254r2044b307],
4	is	VBZ	O	be	cop	7	SENT_227	[p18l2094t244r2149b307],
5	not	RB	O	not	neg	7	SENT_227	[p18l7t364r121b418],
6	a	DT	O	a	det	7	SENT_227	[p18l164t375r201b418],
7	component	NN	O	component	advcl	15	SENT_227	[p18l242t364r640b436],
8	of	IN	O	of	_	0	SENT_227	[p18l682t355r760b418],
9	RECIST	NN	O	recist	nn	10	SENT_227	[p18l795t355r1103b418],
10	classiﬁcation	NN	O	classiﬁcation	prep_of	7	SENT_227	[p18l1146t355r1633b429],
11	,	,	O	,	_	0	SENT_227	[p18l1146t355r1633b429],
12	that	WDT	O	that	det	13	SENT_227	[p18l1677t355r1812b418],
13	methodology	NN	O	methodology	nsubjpass	15	SENT_227	[p18l1852t355r2148b418, p18l8t466r209b547],
14	was	VBD	O	be	auxpass	15	SENT_227	[p18l236t486r371b529],
15	designed	VBN	O	design	_	0	SENT_227	[p18l401t466r719b547],
16	with	IN	O	with	_	0	SENT_227	[p18l745t466r902b529],
17	radiographic	JJ	O	radiographic	amod	18	SENT_227	[p18l927t466r1380b547],
18	measurements	NNS	O	measurement	prep_with	15	SENT_227	[p18l1409t475r1920b529],
19	in	IN	O	in	_	0	SENT_227	[p18l1949t466r2016b528],
20	the	DT	O	the	det	22	SENT_227	[p18l2043t466r2150b529],
21	metastatic	JJ	O	metastatic	amod	22	SENT_227	[p18l7t577r370b640],
22	setting	NN	O	setting	prep_in	18	SENT_227	[p18l467t577r701b658],
23	in	IN	O	in	_	0	SENT_227	[p18l794t577r862b639],
24	mind	NN	O	mind	prep_in	22	SENT_227	[p18l953t577r1154b640],
25	.	.	O	.	_	0	SENT_227	[p18l953t577r1154b640],

1	Conversely	RB	O	conversely	advmod	16	SENT_228	[p18l1251t577r1677b658],
2	,	,	O	,	_	0	SENT_228	[p18l1251t577r1677b658],
3	pathologic	JJ	O	pathologic	amod	4	SENT_228	[p18l1771t577r2149b658],
4	response	NN	O	response	nsubj	16	SENT_228	[p18l6t708r339b769],
5	,	,	O	,	_	0	SENT_228	[p18l6t708r339b769],
6	a	DT	O	a	det	9	SENT_228	[p18l389t708r426b751],
7	more	RBR	O	more	advmod	8	SENT_228	[p18l470t708r652b751],
8	conventional	JJ	O	conventional	amod	9	SENT_228	[p18l698t688r1161b751],
9	endpoint	NN	O	endpoint	appos	4	SENT_228	[p18l1207t688r1521b769],
10	for	IN	O	for	_	0	SENT_228	[p18l1565t688r1669b751],
11	neoadjuvant	JJ	O	neoadjuvant	amod	12	SENT_228	[p18l1712t688r2152b769],
12	studies	NNS	O	study	prep_for	9	SENT_228	[p18l10t799r274b873],
13	,	,	O	,	_	0	SENT_228	[p18l10t799r274b873],
14	can	MD	O	can	aux	16	SENT_228	[p18l314t809r552b862],
15	not	RB	O	not	neg	16	SENT_228	[p18l314t809r552b862],
16	differentiate	VB	O	differentiate	_	0	SENT_228	[p18l588t799r1026b862],
17	among	IN	O	among	_	0	SENT_228	[p18l1064t819r1304b880],
18	drugs	NNS	O	drug	prep_among	16	SENT_228	[p18l1342t799r1537b880],
19	given	VBN	O	give	partmod	18	SENT_228	[p18l1575t799r1772b880],
20	preoperatively	RB	O	preoperatively	advmod	19	SENT_228	[p18l1806t819r2148b880, p18l7t910r210b991],
21	so	RB	O	so	advmod	24	SENT_228	[p18l253t929r326b972],
22	would	MD	O	would	aux	24	SENT_228	[p18l367t910r589b973],
23	have	VB	O	have	aux	24	SENT_228	[p18l628t910r795b973],
24	introduced	VBN	O	introduce	ccomp	19	SENT_228	[p18l835t910r1219b972],
25	considerable	JJ	O	considerable	amod	26	SENT_228	[p18l1259t910r1711b972],
26	noise	NN	O	noise	dobj	24	SENT_228	[p18l1751t910r1938b972],
27	from	IN	O	from	_	0	SENT_228	[p18l1979t910r2151b972],
28	the	DT	O	the	det	29	SENT_228	[p18l7t1021r114b1083],
29	inclusion	NN	O	inclusion	prep_from	24	SENT_228	[p18l149t1021r478b1083],
30	of	IN	O	of	_	0	SENT_228	[p18l512t1021r589b1083],
31	anthracycline	NN	O	anthracycline	prep_of	29	SENT_228	[p18l619t1021r1100b1102],
32	and	CC	O	and	_	0	SENT_228	[p18l1137t1021r1263b1083],
33	antimetabolite	JJ	O	antimetabolite	amod	34	SENT_228	[p18l1298t1021r1811b1083],
34	effect	NN	O	effect	prep_from	24	SENT_228	[p18l1847t1021r2050b1083],
35	in	IN	O	in	_	0	SENT_228	[p18l2083t1021r2151b1083],
36	the	DT	O	the	det	38	SENT_228	[p18l7t1131r114b1193],
37	efﬁcacy	NN	O	efﬁcacy	nn	38	SENT_228	[p18l174t1131r455b1212],
38	estimates	NNS	O	estimate	prep_in	34	SENT_228	[p18l514t1131r865b1193],
39	.	.	O	.	_	0	SENT_228	[p18l514t1131r865b1193],

1	Furthermore	RB	O	furthermore	advmod	29	SENT_229	[p18l927t1131r1395b1204],
2	,	,	O	,	_	0	SENT_229	[p18l927t1131r1395b1204],
3	the	DT	O	the	det	4	SENT_229	[p18l1456t1131r1563b1193],
4	ability	NN	O	ability	nsubjpass	29	SENT_229	[p18l1623t1131r1850b1212],
5	to	TO	O	to	aux	6	SENT_229	[p18l1908t1140r1975b1193],
6	use	VB	O	use	infmod	4	SENT_229	[p18l2033t1150r2150b1193],
7	response	NN	O	response	dobj	6	SENT_229	[p18l6t1263r319b1324],
8	to	TO	O	to	_	0	SENT_229	[p18l360t1253r427b1306],
9	the	DT	O	the	det	11	SENT_229	[p18l469t1243r575b1306],
10	AC	NN	O	ac	nn	11	SENT_229	[p18l617t1244r737b1306],
11	component	NN	O	component	prep_to	6	SENT_229	[p18l780t1253r1179b1324],
12	of	IN	O	of	_	0	SENT_229	[p18l1220t1243r1297b1306],
13	therapy	NN	O	therapy	prep_of	11	SENT_229	[p18l1332t1243r1598b1324],
14	as	IN	O	as	_	0	SENT_229	[p18l1643t1263r1712b1306],
15	an	DT	O	a	det	17	SENT_229	[p18l1756t1263r1836b1306],
16	internal	JJ	O	internal	amod	17	SENT_229	[p18l1877t1243r2150b1306],
17	control	NN	O	control	prep_as	6	SENT_229	[p18l8t1354r259b1417],
18	for	IN	O	for	_	0	SENT_229	[p18l310t1354r413b1417],
19	the	DT	O	the	det	20	SENT_229	[p18l461t1354r568b1417],
20	speciﬁcity	NN	O	speciﬁcity	prep_for	17	SENT_229	[p18l621t1354r986b1435],
21	of	IN	O	of	_	0	SENT_229	[p18l1037t1354r1114b1417],
22	the	DT	O	the	det	23	SENT_229	[p18l1156t1354r1263b1417],
23	ﬁndings	NNS	O	ﬁndings	prep_of	20	SENT_229	[p18l1315t1354r1599b1435],
24	for	IN	O	for	_	0	SENT_229	[p18l1650t1354r1754b1417],
25	paclitaxel	NN	O	paclitaxel	prep_for	23	SENT_229	[p18l1800t1354r2150b1435],
26	would	MD	O	would	aux	29	SENT_229	[p18l8t1465r230b1528],
27	have	VB	O	have	aux	29	SENT_229	[p18l263t1465r430b1528],
28	been	VBN	O	be	auxpass	29	SENT_229	[p18l463t1465r633b1528],
29	lost	VBN	O	lose	_	0	SENT_229	[p18l667t1465r812b1528],
30	.	.	O	.	_	0	SENT_229	[p18l667t1465r812b1528],

1	There	EX	O	there	expl	2	SENT_230	[p18l851t1465r1057b1528],
2	is	VBZ	O	be	_	0	SENT_230	[p18l1092t1465r1148b1528],
3	a	DT	O	a	det	5	SENT_230	[p18l1185t1485r1222b1528],
4	documented	VBN	O	document	amod	5	SENT_230	[p18l1255t1465r1694b1528],
5	relationship	NN	O	relationship	nsubj	2	SENT_230	[p18l1726t1465r2149b1546],
6	between	IN	O	between	_	0	SENT_230	[p18l6t1576r306b1639],
7	clinical	JJ	O	clinical	amod	8	SENT_230	[p18l363t1576r626b1639],
8	measurement	NN	O	measurement	prep_between	5	SENT_230	[p18l683t1586r1163b1639],
9	and	CC	O	and	_	0	SENT_230	[p18l1221t1576r1347b1639],
10	pathologic	JJ	O	pathologic	amod	12	SENT_230	[p18l1402t1576r1780b1657],
11	response	NN	O	response	nn	12	SENT_230	[p18l1838t1596r2149b1657],
12	[	NN	O	[	prep_between	5	SENT_230	[p18l13t1687r148b1763],
13	35	CD	NUMBER	35	number	14	SENT_230	[p18l13t1687r148b1763],
14	]	CD	NUMBER	]	dep	12	SENT_230	[p18l13t1687r148b1763],
15	supporting	VBG	O	support	partmod	5	SENT_230	[p18l200t1687r579b1768],
16	the	DT	O	the	det	17	SENT_230	[p18l622t1687r730b1750],
17	use	NN	O	use	dobj	15	SENT_230	[p18l773t1707r890b1750],
18	of	IN	O	of	prep	17	SENT_230	[p18l934t1687r1011b1750],
19	easily	RB	O	easily	pcomp	18	SENT_230	[p18l1049t1687r1255b1768],
20	obtained	VBN	O	obtain	partmod	17	SENT_230	[p18l1300t1687r1608b1750],
21	serial	JJ	O	serial	amod	23	SENT_230	[p18l1654t1687r1843b1750],
22	clinical	JJ	O	clinical	amod	23	SENT_230	[p18l1887t1687r2150b1750],
23	measurements	NNS	O	measurement	nsubj	28	SENT_230	[p18l7t1808r519b1861],
24	in	IN	O	in	_	0	SENT_230	[p18l558t1798r625b1860],
25	the	DT	O	the	det	27	SENT_230	[p18l661t1798r768b1861],
26	palpable	JJ	O	palpable	amod	27	SENT_230	[p18l805t1798r1108b1879],
27	lesions	NNS	O	lesion	prep_in	23	SENT_230	[p18l1146t1798r1392b1861],
28	relevant	JJ	O	relevant	xcomp	20	SENT_230	[p18l1429t1798r1720b1861],
29	in	IN	O	in	_	0	SENT_230	[p18l1755t1798r1823b1860],
30	this	DT	O	this	det	31	SENT_230	[p18l1859t1798r1985b1861],
31	setting	NN	O	setting	prep_in	28	SENT_230	[p18l2026t1808r2148b1861, p18l7t1909r163b1990],
32	.	.	O	.	_	0	SENT_230	[p18l2026t1808r2148b1861, p18l7t1909r163b1990],

1	The	DT	O	the	det	3	SENT_231	[p18l204t1909r340b1971],
2	reported	VBN	O	report	amod	3	SENT_231	[p18l376t1909r676b1990],
3	relationship	NN	O	relationship	nsubj	9	SENT_231	[p18l710t1909r1133b1990],
4	between	IN	O	between	_	0	SENT_231	[p18l1169t1909r1469b1972],
5	clinical	JJ	O	clinical	amod	8	SENT_231	[p18l1505t1909r1768b1971],
6	and	CC	O	and	_	0	SENT_231	[p18l1806t1909r1933b1971],
7	pathological	JJ	O	pathological	amod	8	SENT_231	[p18l1967t1909r2148b1990, p18l8t2020r296b2101],
8	response	NN	O	response	prep_between	3	SENT_231	[p18l335t2039r647b2101],
9	indicates	VBZ	O	indicate	_	0	SENT_231	[p18l688t2020r1004b2082],
10	that	IN	O	that	complm	14	SENT_231	[p18l1046t2020r1180b2082],
11	our	PRP$	O	we	poss	12	SENT_231	[p18l1220t2039r1338b2082],
12	ﬁnding	NN	O	ﬁnding	nsubj	14	SENT_231	[p18l1377t2020r1627b2101],
13	may	MD	O	may	aux	14	SENT_231	[p18l1668t2039r1820b2101],
14	have	VB	O	have	ccomp	9	SENT_231	[p18l1860t2020r2027b2083],
15	an	DT	O	a	det	17	SENT_231	[p18l2070t2039r2151b2082],
16	important	JJ	O	important	amod	17	SENT_231	[p18l7t2130r356b2211],
17	inﬂuence	NN	O	inﬂuence	dobj	14	SENT_231	[p18l380t2129r707b2192],
18	on	IN	O	on	_	0	SENT_231	[p18l732t2149r819b2192],
19	survival	NN	O	survival	prep_on	17	SENT_231	[p18l845t2130r1152b2203],
20	;	:	O	;	_	0	SENT_231	[p18l845t2130r1152b2203],
21	however	RB	O	however	advmod	25	SENT_231	[p18l1179t2130r1506b2203],
22	,	,	O	,	_	0	SENT_231	[p18l1179t2130r1506b2203],
23	it	PRP	O	it	nsubj	25	SENT_231	[p18l1533t2130r1582b2192],
24	is	VBZ	O	be	cop	25	SENT_231	[p18l1604t2130r1660b2192],
25	essential	JJ	O	essential	parataxis	9	SENT_231	[p18l1686t2130r1993b2192],
26	that	IN	O	that	complm	30	SENT_231	[p18l2018t2130r2152b2192],
27	these	DT	O	these	det	28	SENT_231	[p18l7t2242r189b2305],
28	ﬁndings	NNS	O	ﬁndings	nsubjpass	30	SENT_231	[p18l236t2242r520b2323],
29	are	VBP	O	be	auxpass	30	SENT_231	[p18l569t2262r674b2305],
30	conﬁrmed	VBN	O	conﬁrmed	conj_and	30	SENT_231	[p18l721t2242r1084b2305],
31	with	IN	O	with	_	0	SENT_231	[p18l1129t2242r1286b2305],
32	pathological	JJ	O	pathological	amod	36	SENT_231	[p18l1330t2242r1775b2323],
33	or	CC	O	or	_	0	SENT_231	[p18l1821t2262r1895b2305],
34	radiographic	JJ	O	radiographic	amod	36	SENT_231	[p18l1937t2242r2148b2305, p18l8t2353r273b2434],
35	tumor	NN	O	tumor	nn	36	SENT_231	[p18l308t2362r522b2416],
36	measurements	NNS	O	measurement	prep_with	30	SENT_231	[p18l553t2363r1065b2416],
37	before	IN	O	before	_	0	SENT_231	[p18l1099t2353r1327b2416],
38	and	CC	O	and	_	0	SENT_231	[p18l1362t2353r1489b2416],
39	after	IN	O	after	_	0	SENT_231	[p18l1522t2353r1685b2416],
40	taxane	NN	O	taxane	nn	41	SENT_231	[p18l1716t2362r1950b2416],
41	therapy	NN	O	therapy	prep_before	30	SENT_231	[p18l1982t2353r2148b2416, p18l9t2484r134b2545],
42	in	IN	O	in	_	0	SENT_231	[p18l168t2464r236b2526],
43	independent	JJ	O	independent	amod	45	SENT_231	[p18l268t2464r708b2545],
44	patient	NN	O	patient	nn	45	SENT_231	[p18l738t2464r983b2545],
45	cohorts	NNS	O	cohort	prep_in	30	SENT_231	[p18l1016t2464r1296b2527],
46	.	.	O	.	_	0	SENT_231	[p18l1016t2464r1296b2527],

1	Two	CD	NUMBER	two	num	3	SENT_232	[p18l110t2577r270b2638],
2	previous	JJ	O	previous	amod	3	SENT_232	[p18l304t2575r612b2656],
3	groups	NNS	O	group	nsubj	5	SENT_232	[p18l648t2595r887b2656],
4	have	VBP	O	have	aux	5	SENT_232	[p18l923t2575r1090b2638],
5	reported	VBN	O	report	dep	38	SENT_232	[p18l1125t2575r1424b2656],
6	that	IN	O	that	complm	20	SENT_232	[p18l1457t2575r1592b2638],
7	patients	NNS	O	patient	nsubj	20	SENT_232	[p18l1624t2575r1902b2656],
8	carrying	VBG	O	carry	partmod	7	SENT_232	[p18l1939t2595r2148b2656, p18l7t2686r119b2767],
9	CYP2C8	NN	O	cyp2c8	nn	10	SENT_232	[p18l160t2687r566b2749],
10	*	NN	O	*	dobj	8	SENT_232	[p18l160t2687r566b2749],
11	3	CD	NUMBER	3	nsubj	12	SENT_232	[p18l160t2687r566b2749],
12	are	VBP	O	be	rcmod	10	SENT_232	[p18l612t2706r717b2749],
13	at	IN	O	at	_	0	SENT_232	[p18l759t2696r821b2749],
14	a	DT	O	a	det	16	SENT_232	[p18l860t2706r897b2749],
15	higher	JJR	O	higher	amod	16	SENT_232	[p18l935t2686r1165b2767],
16	risk	NN	O	risk	prep_at	12	SENT_232	[p18l1201t2686r1337b2749],
17	of	IN	O	of	_	0	SENT_232	[p18l1375t2686r1452b2749],
18	paclitaxel	NN	O	paclitaxel	nn	19	SENT_232	[p18l1484t2686r2151b2767],
19	—	NN	O	—	prep_of	16	SENT_232	[p18l1484t2686r2151b2767],
20	induced	VBD	O	induce	ccomp	5	SENT_232	[p18l1484t2686r2151b2767],
21	peripheral	JJ	O	peripheral	amod	23	SENT_232	[p18l6t2797r371b2878],
22	neuropathy	NN	O	neuropathy	nn	23	SENT_232	[p18l416t2797r818b2878],
23	[	NN	O	[	dobj	20	SENT_232	[p18l869t2798r999b2873],
24	10	CD	NUMBER	10	tmod	20	SENT_232	[p18l869t2798r999b2873],
25	,	,	O	,	_	0	SENT_232	[p18l869t2798r999b2873],
26	11	CD	NUMBER	11	num	27	SENT_232	[p18l1056t2798r1183b2873],
27	]	NN	O	]	appos	24	SENT_232	[p18l1056t2798r1183b2873],
28	,	,	O	,	_	0	SENT_232	[p18l1056t2798r1183b2873],
29	but	CC	O	but	_	0	SENT_232	[p18l1230t2797r1345b2860],
30	this	DT	O	this	det	31	SENT_232	[p18l1388t2797r1514b2860],
31	ﬁnding	NN	O	ﬁnding	nsubjpass	34	SENT_232	[p18l1561t2797r1811b2878],
32	was	VBD	O	be	auxpass	34	SENT_232	[p18l1857t2817r1992b2860],
33	not	RB	O	not	neg	34	SENT_232	[p18l2038t2807r2152b2860],
34	observed	VBN	O	observe	dep	38	SENT_232	[p18l8t2908r331b2971],
35	in	IN	O	in	_	0	SENT_232	[p18l361t2908r429b2970],
36	other	JJ	O	other	amod	37	SENT_232	[p18l462t2908r646b2971],
37	studies	NNS	O	study	prep_in	34	SENT_232	[p18l679t2908r922b2971],
38	[	VBP	O	[	_	0	SENT_232	[p18l961t2908r1092b2984],
39	16	CD	NUMBER	16	nsubj	38	SENT_232	[p18l961t2908r1092b2984],
40	,	,	O	,	_	0	SENT_232	[p18l961t2908r1092b2984],
41	36	CD	NUMBER	36	appos	39	SENT_232	[p18l1130t2908r1233b2982],
42	,	,	O	,	_	0	SENT_232	[p18l1130t2908r1233b2982],
43	37	CD	NUMBER	37	num	44	SENT_232	[p18l1271t2908r1404b2984],
44	]	NN	O	]	appos	41	SENT_232	[p18l1271t2908r1404b2984],
45	.	.	O	.	_	0	SENT_232	[p18l1271t2908r1404b2984],

1	All	DT	O	all	nsubj	6	SENT_233	[p18l1440t2908r1552b2970],
2	of	IN	O	of	_	0	SENT_233	[p18l1585t2908r1662b2971],
3	these	DT	O	these	det	4	SENT_233	[p18l1688t2908r1870b2971],
4	studies	NNS	O	study	prep_of	1	SENT_233	[p18l1906t2908r2149b2971],
5	primarily	RB	O	primarily	advmod	6	SENT_233	[p18l6t3019r340b3100],
6	included	VBD	O	include	_	0	SENT_233	[p18l401t3019r710b3081],
7	patients	NNS	O	patient	dobj	6	SENT_233	[p18l769t3019r1046b3100],
8	who	WP	O	who	nsubj	9	SENT_233	[p18l1109t3019r1260b3081],
9	were	VBD	O	be	dep	6	SENT_233	[p18l1321t3038r1492b3081],
10	on	IN	O	on	_	0	SENT_233	[p18l1555t3038r1641b3081],
11	combination	NN	O	combination	nn	12	SENT_233	[p18l1703t3019r2151b3081],
12	therapy	NN	O	therapy	prep_on	9	SENT_233	[p18l7t3130r274b3211],
13	or	CC	O	or	_	0	SENT_233	[p18l315t3149r388b3192],
14	who	WP	O	who	nsubjpass	18	SENT_233	[p18l425t3130r575b3192],
15	had	VBD	O	have	aux	18	SENT_233	[p18l615t3130r744b3192],
16	been	VBN	O	be	auxpass	18	SENT_233	[p18l780t3130r949b3192],
17	previously	RB	DATE	previously	advmod	18	SENT_233	[p18l987t3130r1365b3211],
18	treated	VBN	O	treat	dep	6	SENT_233	[p18l1404t3130r1648b3192],
19	with	IN	O	with	_	0	SENT_233	[p18l1687t3130r1844b3192],
20	chemotherapy	NN	O	chemotherapy	prep_with	18	SENT_233	[p18l1883t3130r2148b3192, p18l7t3242r293b3323],
21	.	.	O	.	_	0	SENT_233	[p18l1883t3130r2148b3192, p18l7t3242r293b3323],

1	Our	PRP$	O	we	poss	2	SENT_234	[p18l341t3243r478b3305],
2	results	NNS	O	result	nsubj	17	SENT_234	[p18l517t3242r770b3316],
3	,	,	O	,	_	0	SENT_234	[p18l517t3242r770b3316],
4	in	IN	O	in	_	0	SENT_234	[p18l815t3242r882b3304],
5	previously	RB	DATE	previously	advmod	6	SENT_234	[p18l922t3242r1301b3323],
6	untreated	JJ	O	untreated	amod	7	SENT_234	[p18l1343t3242r1677b3305],
7	patients	NNS	O	patient	prep_in	2	SENT_234	[p18l1717t3242r1995b3323],
8	not	RB	O	not	prep	7	SENT_234	[p18l2038t3251r2152b3305],
9	receiving	VBG	O	receive	dep	8	SENT_234	[p18l6t3353r339b3434],
10	combination	NN	O	combination	nn	11	SENT_234	[p18l375t3353r823b3416],
11	therapy	NN	O	therapy	dobj	9	SENT_234	[p18l856t3353r1123b3434],
12	with	IN	O	with	_	0	SENT_234	[p18l1158t3353r1315b3416],
13	other	JJ	O	other	amod	14	SENT_234	[p18l1350t3353r1533b3416],
14	neurotoxins	NNS	O	neurotoxin	prep_with	9	SENT_234	[p18l1564t3353r2006b3427],
15	,	,	O	,	_	0	SENT_234	[p18l1564t3353r2006b3427],
16	are	VBP	O	be	cop	17	SENT_234	[p18l2045t3373r2150b3416],
17	consistent	JJ	O	consistent	_	0	SENT_234	[p18l8t3464r366b3527],
18	with	IN	O	with	_	0	SENT_234	[p18l393t3464r550b3527],
19	those	DT	O	those	prep_with	17	SENT_234	[p18l577t3464r764b3527],
20	of	IN	O	of	_	0	SENT_234	[p18l794t3464r871b3527],
21	Leskela	NNP	LOCATION	Leskela	prep_of	19	SENT_234	[p18l892t3464r1171b3527],
22	et	FW	O	et	nn	24	SENT_234	[p18l1199t3474r1262b3527],
23	al.	FW	O	al.	nn	24	SENT_234	[p18l1290t3464r1368b3527],
24	[	FW	O	[	dep	21	SENT_234	[p18l1407t3465r1465b3540],
25	1	CD	NUMBER	1	num	26	SENT_234	[p18l1407t3465r1465b3540],
26	l	NN	O	l	dobj	24	SENT_234	[p18l1484t3465r1542b3540],
27	]	NN	O	]	dep	26	SENT_234	[p18l1484t3465r1542b3540],
28	and	CC	O	and	_	0	SENT_234	[p18l1577t3464r1704b3527],
29	Green	NNP	PERSON	Green	dobj	24	SENT_234	[p18l1732t3464r1948b3527],
30	et	FW	O	et	dep	29	SENT_234	[p18l1976t3474r2039b3527],
31	al.	FW	O	al.	nn	32	SENT_234	[p18l2067t3464r2146b3527],
32	[	FW	O	[	dep	24	SENT_234	[p18l13t3575r149b3650],
33	10	CD	NUMBER	10	num	34	SENT_234	[p18l13t3575r149b3650],
34	]	NN	O	]	dep	32	SENT_234	[p18l13t3575r149b3650],
35	and	CC	O	and	_	0	SENT_234	[p18l210t3575r336b3637],
36	suggest	VBP	O	suggest	conj_and	34	SENT_234	[p18l392t3584r657b3656],
37	that	IN	O	that	complm	43	SENT_234	[p18l709t3575r843b3637],
38	there	EX	O	there	expl	43	SENT_234	[p18l896t3575r1074b3637],
39	may	MD	O	may	aux	43	SENT_234	[p18l1128t3594r1280b3656],
40	be	VB	O	be	cop	43	SENT_234	[p18l1333t3575r1416b3637],
41	a	DT	O	a	det	43	SENT_234	[p18l1472t3594r1509b3637],
42	true	JJ	O	true	amod	43	SENT_234	[p18l1561t3584r1698b3637],
43	association	NN	O	association	ccomp	36	SENT_234	[p18l1754t3575r2151b3637],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_235	[p18l52t3731r142b3756],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_235	[p18l155t3731r255b3756],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_235	[p18l267t3731r318b3756],
4	Treat	NNP	ORGANIZATION	Treat	dep	10	SENT_235	[p18l331t3731r406b3756],
5	(	CD	NUMBER	(	num	6	SENT_235	[p18l419t3731r510b3761],
6	2012	CD	DATE	2012	dep	4	SENT_235	[p18l419t3731r510b3761],
7	)	CD	NUMBER	)	num	8	SENT_235	[p18l419t3731r510b3761],
8	l34	NN	O	l34	dep	10	SENT_235	[p18l528t3731r710b3756],
9	:40	CD	NUMBER	:40	num	10	SENT_235	[p18l528t3731r710b3756],
10	l	NN	O	l	dep	13	SENT_235	[p18l528t3731r710b3756],
11	—	CD	NUMBER	—	num	12	SENT_235	[p18l528t3731r710b3756],
12	4l0	NN	O	4l0	dep	10	SENT_235	[p18l528t3731r710b3756],
13	407	CD	NUMBER	407	_	0	SENT_235	[p18l2055t3731r2106b3756],

1	between	IN	O	between	_	0	SENT_236	[p19l6t98r305b161],
2	CYP2C8	CD	NUMBER	cyp2c8	number	3	SENT_236	[p19l331t99r736b161],
3	*	CD	NUMBER	*	pobj	1	SENT_236	[p19l331t99r736b161],
4	3	CD	NUMBER	3	dep	3	SENT_236	[p19l331t99r736b161],
5	and	CC	O	and	_	0	SENT_236	[p19l767t98r894b161],
6	risk	NN	O	risk	conj_and	3	SENT_236	[p19l917t98r1052b161],
7	of	IN	O	of	_	0	SENT_236	[p19l1076t98r1153b161],
8	peripheral	JJ	O	peripheral	amod	9	SENT_236	[p19l1171t98r1534b179],
9	neuropathy	NN	O	neuropathy	prep_of	6	SENT_236	[p19l1560t98r1980b179],
10	.	.	O	.	_	0	SENT_236	[p19l1560t98r1980b179],

1	The	DT	O	the	det	15	SENT_237	[p19l2010t98r2147b161],
2	difference	NN	O	difference	nn	15	SENT_237	[p19l8t209r369b272],
3	between	IN	O	between	_	0	SENT_237	[p19l396t209r694b272],
4	our	PRP$	O	we	poss	5	SENT_237	[p19l722t229r840b272],
5	study	NN	O	study	prep_between	2	SENT_237	[p19l868t209r1056b290],
6	and	CC	O	and	_	0	SENT_237	[p19l1085t209r1211b272],
7	that	IN	O	that	advmod	10	SENT_237	[p19l1237t209r1371b272],
8	of	IN	O	of	_	0	SENT_237	[p19l1397t209r1475b272],
9	Leskela	NNP	LOCATION	Leskela	prep_of	7	SENT_237	[p19l1495t209r1774b272],
10	et	FW	O	et	nn	15	SENT_237	[p19l1801t219r1864b272],
11	al.	FW	O	al.	nn	12	SENT_237	[p19l1891t209r1970b272],
12	[	FW	O	[	dep	10	SENT_237	[p19l2007t210r2065b285],
13	1	CD	NUMBER	1	number	14	SENT_237	[p19l2007t210r2065b285],
14	1	CD	NUMBER	1	dep	12	SENT_237	[p19l2084t210r2141b285],
15	]	NN	O	]	nsubj	19	SENT_237	[p19l2084t210r2141b285],
16	is	VBZ	O	be	cop	19	SENT_237	[p19l7t320r63b382],
17	the	DT	O	the	det	19	SENT_237	[p19l108t320r215b382],
18	event	NN	O	event	nn	19	SENT_237	[p19l260t329r453b382],
19	rate	NN	O	rate	_	0	SENT_237	[p19l495t329r646b382],
20	.	.	O	.	_	0	SENT_237	[p19l495t329r646b382],

1	Their	PRP$	O	they	poss	2	SENT_238	[p19l695t320r890b382],
2	study	NN	O	study	nsubj	3	SENT_238	[p19l934t320r1122b401],
3	included	VBD	O	include	_	0	SENT_238	[p19l1167t320r1476b382],
4	grade	NN	O	grade	dobj	3	SENT_238	[p19l1519t320r1715b401],
5	2	CD	NUMBER	2	num	4	SENT_238	[p19l1761t320r1868b389],
6	+	CC	O	+	_	0	SENT_238	[p19l1761t320r1868b389],
7	neurotoxicity	NN	O	neurotoxicity	dobj	3	SENT_238	[p19l1915t339r2145b382, p19l7t431r299b512],
8	,	,	O	,	_	0	SENT_238	[p19l1915t339r2145b382, p19l7t431r299b512],
9	a	DT	O	a	det	13	SENT_238	[p19l335t450r372b493],
10	substantially	RB	O	substantially	advmod	11	SENT_238	[p19l406t431r855b512],
11	more	JJR	O	more	amod	13	SENT_238	[p19l886t450r1068b493],
12	common	JJ	O	common	amod	13	SENT_238	[p19l1101t450r1412b493],
13	phenotype	NN	O	phenotype	appos	7	SENT_238	[p19l1442t431r1814b512],
14	than	IN	O	than	_	0	SENT_238	[p19l1847t431r2000b493],
15	our	PRP$	O	we	poss	16	SENT_238	[p19l2031t450r2149b493],
16	grade	NN	O	grade	prep_than	3	SENT_238	[p19l8t541r204b622],
17	3	CD	NUMBER	3	dep	16	SENT_238	[p19l238t541r344b609],
18	+	CC	O	+	_	0	SENT_238	[p19l238t541r344b609],
19	endpoint	NN	O	endpoint	prep_than	3	SENT_238	[p19l379t541r710b622],
20	,	,	O	,	_	0	SENT_238	[p19l379t541r710b622],
21	but	CC	O	but	prep	19	SENT_238	[p19l743t541r857b603],
22	one	CD	NUMBER	one	dep	21	SENT_238	[p19l888t560r1014b603],
23	that	WDT	O	that	nsubj	26	SENT_238	[p19l1045t541r1178b603],
24	does	VBZ	O	do	aux	26	SENT_238	[p19l1209t541r1368b603],
25	not	RB	O	not	neg	26	SENT_238	[p19l1401t550r1514b603],
26	require	VB	O	require	rcmod	22	SENT_238	[p19l1543t541r1795b622],
27	a	DT	O	a	det	28	SENT_238	[p19l1829t560r1866b603],
28	change	NN	O	change	dobj	26	SENT_238	[p19l1895t541r2146b622],
29	in	IN	O	in	_	0	SENT_238	[p19l7t653r75b715],
30	therapy	NN	O	therapy	prep_in	28	SENT_238	[p19l122t653r409b734],
31	,	,	O	,	_	0	SENT_238	[p19l122t653r409b734],
32	unlike	IN	O	unlike	_	0	SENT_238	[p19l460t653r682b716],
33	higher	JJR	O	higher	amod	34	SENT_238	[p19l730t653r960b734],
34	grades	NNS	O	grade	prep_unlike	3	SENT_238	[p19l1007t653r1236b734],
35	of	IN	O	of	_	0	SENT_238	[p19l1287t653r1364b716],
36	neuropathy	NN	O	neuropathy	prep_of	34	SENT_238	[p19l1405t653r1807b734],
37	as	IN	O	as	mark	39	SENT_238	[p19l1857t673r1926b716],
38	were	VBD	O	be	auxpass	39	SENT_238	[p19l1976t673r2146b716],
39	measured	VBN	O	measure	advcl	3	SENT_238	[p19l7t764r351b827],
40	in	IN	O	in	_	0	SENT_238	[p19l383t764r451b826],
41	this	DT	O	this	det	42	SENT_238	[p19l484t764r610b827],
42	study	NN	O	study	prep_in	39	SENT_238	[p19l648t764r855b845],
43	.	.	O	.	_	0	SENT_238	[p19l648t764r855b845],

1	Additionally	RB	O	additionally	advmod	4	SENT_239	[p19l893t764r1365b845],
2	,	,	O	,	_	0	SENT_239	[p19l893t764r1365b845],
3	they	PRP	O	they	nsubj	4	SENT_239	[p19l1401t764r1554b845],
4	used	VBD	O	use	_	0	SENT_239	[p19l1587t764r1750b827],
5	a	DT	O	a	det	8	SENT_239	[p19l1785t784r1822b827],
6	cumulative	JJ	O	cumulative	amod	8	SENT_239	[p19l1855t764r2145b827, p19l7t875r139b938],
7	dose	NN	O	dose	nn	8	SENT_239	[p19l186t875r674b938],
8	—	NN	O	—	dobj	4	SENT_239	[p19l186t875r674b938],
9	to	TO	O	to	_	0	SENT_239	[p19l186t875r674b938],
10	—	CD	NUMBER	—	num	12	SENT_239	[p19l186t875r674b938],
11	event	NN	O	event	nn	12	SENT_239	[p19l186t875r674b938],
12	analysis	NN	O	analysis	prep_to	4	SENT_239	[p19l720t875r1023b956],
13	,	,	O	,	_	0	SENT_239	[p19l720t875r1023b956],
14	which	WDT	O	which	nsubj	16	SENT_239	[p19l1072t875r1289b938],
15	is	VBZ	O	be	cop	16	SENT_239	[p19l1334t875r1390b938],
16	consistent	JJ	O	consistent	rcmod	12	SENT_239	[p19l1436t875r1794b938],
17	with	IN	O	with	_	0	SENT_239	[p19l1839t875r1995b938],
18	the	DT	O	the	det	20	SENT_239	[p19l2040t875r2147b938],
19	cumulative	JJ	O	cumulative	amod	20	SENT_239	[p19l8t986r405b1049],
20	nature	NN	O	nature	prep_with	16	SENT_239	[p19l430t996r652b1049],
21	of	IN	O	of	_	0	SENT_239	[p19l678t986r755b1049],
22	neurotoxicity	NN	O	neurotoxicity	prep_of	20	SENT_239	[p19l774t986r1270b1067],
23	.	.	O	.	_	0	SENT_239	[p19l774t986r1270b1067],

1	This	DT	O	this	nsubj	4	SENT_240	[p19l1299t986r1454b1049],
2	was	VBD	O	be	cop	4	SENT_240	[p19l1481t1006r1615b1049],
3	not	RB	O	not	neg	4	SENT_240	[p19l1641t996r1755b1049],
4	feasible	JJ	O	feasible	_	0	SENT_240	[p19l1778t986r2054b1049],
5	in	IN	O	in	_	0	SENT_240	[p19l2080t986r2148b1048],
6	our	PRP$	O	we	poss	7	SENT_240	[p19l8t1117r126b1160],
7	study	NN	O	study	prep_in	4	SENT_240	[p19l152t1097r341b1178],
8	given	VBN	O	give	partmod	7	SENT_240	[p19l367t1097r564b1178],
9	the	DT	O	the	det	12	SENT_240	[p19l589t1097r696b1160],
10	relatively	RB	O	relatively	advmod	11	SENT_240	[p19l721t1097r1059b1178],
11	small	JJ	O	small	amod	12	SENT_240	[p19l1089t1097r1277b1160],
12	number	NN	O	number	iobj	8	SENT_240	[p19l1303t1097r1577b1160],
13	of	IN	O	of	_	0	SENT_240	[p19l1601t1097r1678b1160],
14	patients	NNS	O	patient	prep_of	12	SENT_240	[p19l1696t1097r1973b1178],
15	(	CD	NUMBER	(	number	16	SENT_240	[p19l2004t1098r2145b1175],
16	12	CD	NUMBER	12	num	17	SENT_240	[p19l2004t1098r2145b1175],
17	)	NN	O	)	dobj	8	SENT_240	[p19l2004t1098r2145b1175],
18	who	WP	O	who	nsubj	19	SENT_240	[p19l8t1208r158b1271],
19	experienced	VBD	O	experience	rcmod	17	SENT_240	[p19l185t1208r619b1289],
20	grade	NN	O	grade	dobj	19	SENT_240	[p19l645t1208r840b1289],
21	3	CD	NUMBER	3	num	20	SENT_240	[p19l870t1208r905b1271],
22	or	CC	O	or	_	0	SENT_240	[p19l937t1227r1009b1270],
23	higher	JJR	O	higher	amod	24	SENT_240	[p19l1033t1208r1263b1289],
24	neuropathy	NN	O	neuropathy	conj_or	20	SENT_240	[p19l1287t1208r1707b1289],
25	.	.	O	.	_	0	SENT_240	[p19l1287t1208r1707b1289],

1	In	IN	O	in	_	0	SENT_241	[p19l1737t1209r1810b1270],
2	fact	NN	O	fact	prep_in	6	SENT_241	[p19l1836t1208r1987b1282],
3	,	,	O	,	_	0	SENT_241	[p19l1836t1208r1987b1282],
4	it	PRP	O	it	nsubj	6	SENT_241	[p19l2017t1208r2066b1270],
5	is	VBZ	O	be	cop	6	SENT_241	[p19l2090t1208r2146b1270],
6	important	JJ	O	important	_	0	SENT_241	[p19l7t1319r356b1400],
7	to	TO	O	to	aux	8	SENT_241	[p19l395t1328r462b1381],
8	note	VB	O	note	xcomp	6	SENT_241	[p19l502t1328r654b1381],
9	that	IN	O	that	complm	21	SENT_241	[p19l694t1319r828b1381],
10	a	DT	O	a	det	12	SENT_241	[p19l869t1338r906b1381],
11	general	JJ	O	general	amod	12	SENT_241	[p19l945t1319r1207b1400],
12	limitation	NN	O	limitation	nsubj	21	SENT_241	[p19l1248t1319r1596b1381],
13	of	IN	O	of	_	0	SENT_241	[p19l1637t1319r1714b1381],
14	the	DT	O	the	det	16	SENT_241	[p19l1748t1319r1854b1381],
15	current	JJ	DATE	current	amod	16	SENT_241	[p19l1895t1328r2149b1381],
16	study	NN	O	study	prep_of	12	SENT_241	[p19l10t1430r198b1511],
17	is	VBZ	O	be	cop	21	SENT_241	[p19l232t1430r287b1492],
18	the	DT	O	the	det	21	SENT_241	[p19l321t1430r428b1492],
19	modest	JJ	O	modest	amod	21	SENT_241	[p19l462t1430r720b1492],
20	sample	NN	O	sample	nn	21	SENT_241	[p19l755t1430r1004b1511],
21	size	NN	O	size	ccomp	8	SENT_241	[p19l1041t1430r1193b1492],
22	.	.	O	.	_	0	SENT_241	[p19l1041t1430r1193b1492],

1	The	DT	O	the	det	4	SENT_242	[p19l109t1541r246b1604],
2	paclitaxel	NN	O	paclitaxel	nn	4	SENT_242	[p19l280t1541r630b1622],
3	parent	NN	O	parent	nn	4	SENT_242	[p19l664t1551r889b1622],
4	compound	NN	O	compound	nsubjpass	11	SENT_242	[p19l923t1541r1318b1622],
5	,	,	O	,	_	0	SENT_242	[p19l923t1541r1318b1622],
6	not	RB	O	not	neg	8	SENT_242	[p19l1356t1551r1470b1604],
7	its	PRP$	O	its	poss	8	SENT_242	[p19l1503t1541r1583b1604],
8	metabolites	NNS	O	metabolite	appos	4	SENT_242	[p19l1620t1541r2053b1615],
9	,	,	O	,	_	0	SENT_242	[p19l1620t1541r2053b1615],
10	is	VBZ	O	be	auxpass	11	SENT_242	[p19l2090t1541r2146b1604],
11	thought	VBN	O	think	_	0	SENT_242	[p19l7t1652r281b1733],
12	to	TO	O	to	aux	14	SENT_242	[p19l315t1662r382b1715],
13	be	VB	O	be	cop	14	SENT_242	[p19l417t1652r500b1715],
14	responsible	JJ	O	responsible	xcomp	11	SENT_242	[p19l536t1652r943b1733],
15	for	IN	O	for	_	0	SENT_242	[p19l980t1652r1084b1715],
16	the	DT	O	the	det	17	SENT_242	[p19l1117t1652r1224b1715],
17	drug	NN	O	drug	poss	19	SENT_242	[p19l1262t1652r1486b1733],
18	’s	POS	O	’s	_	0	SENT_242	[p19l1262t1652r1486b1733],
19	efﬁcacy	NN	O	efﬁcacy	prep_for	14	SENT_242	[p19l1524t1652r1805b1733],
20	and	CC	O	and	_	0	SENT_242	[p19l1844t1652r1970b1715],
21	toxicity	NN	O	toxicity	conj_and	19	SENT_242	[p19l2005t1661r2145b1715, p19l7t1763r165b1844],
22	[	CD	NUMBER	[	number	23	SENT_242	[p19l213t1764r371b1839],
23	38	CD	NUMBER	38	num	24	SENT_242	[p19l213t1764r371b1839],
24	]	NN	O	]	dep	21	SENT_242	[p19l213t1764r371b1839],
25	.	.	O	.	_	0	SENT_242	[p19l213t1764r371b1839],

1	Paclitaxel	NN	O	paclitaxel	nn	3	SENT_243	[p19l416t1763r769b1826],
2	clinical	JJ	O	clinical	amod	3	SENT_243	[p19l812t1763r1074b1826],
3	outcomes	NNS	O	outcome	nsubj	5	SENT_243	[p19l1116t1773r1456b1826],
4	are	VBP	O	be	cop	5	SENT_243	[p19l1501t1783r1606b1826],
5	related	JJ	O	related	dep	30	SENT_243	[p19l1647t1763r1891b1826],
6	to	TO	O	to	_	0	SENT_243	[p19l1931t1773r1998b1826],
7	the	DT	O	the	det	8	SENT_243	[p19l2040t1763r2147b1826],
8	amount	NN	O	amount	prep_to	5	SENT_243	[p19l9t1882r276b1935],
9	of	IN	O	of	_	0	SENT_243	[p19l305t1873r382b1935],
10	time	NN	O	time	prep_of	8	SENT_243	[p19l405t1873r562b1935],
11	the	DT	O	the	det	14	SENT_243	[p19l592t1873r699b1935],
12	total	JJ	O	total	amod	14	SENT_243	[p19l728t1873r886b1935],
13	drug	NN	O	drug	nn	14	SENT_243	[p19l916t1873r1076b1954],
14	concentration	NN	O	concentration	nsubj	15	SENT_243	[p19l1107t1873r1595b1935],
15	remains	VBZ	O	remain	rcmod	10	SENT_243	[p19l1623t1873r1904b1935],
16	above	IN	O	above	_	0	SENT_243	[p19l1937t1873r2146b1935],
17	a	DT	O	a	det	19	SENT_243	[p19l9t2005r46b2048],
18	threshold	NN	O	threshold	nn	19	SENT_243	[p19l70t1985r404b2048],
19	level	NN	O	level	prep_above	15	SENT_243	[p19l429t1985r601b2048],
20	[	CD	NUMBER	[	number	21	SENT_243	[p19l634t1986r764b2061],
21	39	CD	NUMBER	39	dep	19	SENT_243	[p19l634t1986r764b2061],
22	,	,	O	,	_	0	SENT_243	[p19l634t1986r764b2061],
23	40	CD	NUMBER	40	num	24	SENT_243	[p19l792t1986r904b2061],
24	]	NN	O	]	prep_above	15	SENT_243	[p19l792t1986r904b2061],
25	and	CC	O	and	_	0	SENT_243	[p19l938t1985r1064b2048],
26	the	DT	O	the	det	28	SENT_243	[p19l1089t1985r1196b2048],
27	cumulative	JJ	O	cumulative	amod	28	SENT_243	[p19l1223t1985r1621b2048],
28	exposure	NN	O	exposure	conj_and	19	SENT_243	[p19l1648t2005r1968b2066],
29	may	MD	O	may	aux	30	SENT_243	[p19l1995t2005r2147b2066],
30	determine	VB	O	determine	_	0	SENT_243	[p19l8t2096r365b2159],
31	the	DT	O	the	det	32	SENT_243	[p19l400t2096r507b2159],
32	extent	NN	O	extent	dobj	30	SENT_243	[p19l543t2106r761b2159],
33	of	IN	O	of	_	0	SENT_243	[p19l795t2096r872b2159],
34	neuropathy	NN	O	neuropathy	nn	35	SENT_243	[p19l900t2096r1302b2177],
35	development	NN	O	development	prep_of	32	SENT_243	[p19l1338t2096r1801b2177],
36	[	CD	NUMBER	[	num	37	SENT_243	[p19l1841t2097r1971b2172],
37	10	CD	NUMBER	10	nsubj	30	SENT_243	[p19l1841t2097r1971b2172],
38	,	,	O	,	_	0	SENT_243	[p19l1841t2097r1971b2172],
39	41	CD	NUMBER	41	num	40	SENT_243	[p19l2007t2097r2143b2172],
40	]	NN	O	]	appos	37	SENT_243	[p19l2007t2097r2143b2172],
41	.	.	O	.	_	0	SENT_243	[p19l2007t2097r2143b2172],

1	The	DT	O	the	det	5	SENT_244	[p19l7t2207r144b2270],
2	CYP2C8	NN	O	cyp2c8	nn	5	SENT_244	[p19l180t2207r586b2270],
3	*	NN	O	*	nn	5	SENT_244	[p19l180t2207r586b2270],
4	3	CD	NUMBER	3	num	5	SENT_244	[p19l180t2207r586b2270],
5	variant	NN	O	variant	nsubj	7	SENT_244	[p19l625t2207r873b2270],
6	has	VBZ	O	have	aux	7	SENT_244	[p19l906t2207r1022b2270],
7	diminished	VBN	O	diminish	dep	25	SENT_244	[p19l1059t2207r1456b2270],
8	in	FW	O	in	nn	11	SENT_244	[p19l1490t2207r1558b2269],
9	vitro	FW	O	vitro	dep	11	SENT_244	[p19l1592t2207r1758b2270],
10	metabolic	JJ	O	metabolic	amod	11	SENT_244	[p19l1793t2207r2146b2270],
11	activity	NN	O	activity	advmod	7	SENT_244	[p19l9t2319r275b2400],
12	for	IN	O	for	_	0	SENT_244	[p19l313t2319r417b2381],
13	paclitaxel	NN	O	paclitaxel	prep_for	7	SENT_244	[p19l451t2319r801b2400],
14	[	CD	NUMBER	[	number	15	SENT_244	[p19l844t2319r1114b2395],
15	42	CD	NUMBER	42	num	16	SENT_244	[p19l844t2319r1114b2395],
16	—	NN	O	—	dep	13	SENT_244	[p19l844t2319r1114b2395],
17	45	CD	NUMBER	45	num	18	SENT_244	[p19l844t2319r1114b2395],
18	]	NN	O	]	dep	13	SENT_244	[p19l844t2319r1114b2395],
19	and	CC	O	and	_	0	SENT_244	[p19l1158t2319r1285b2381],
20	carriers	NNS	O	carrier	conj_and	13	SENT_244	[p19l1322t2319r1587b2381],
21	of	IN	O	of	_	0	SENT_244	[p19l1627t2319r1704b2381],
22	this	DT	O	this	det	23	SENT_244	[p19l1735t2319r1860b2381],
23	variant	NN	O	variant	prep_of	20	SENT_244	[p19l1899t2319r2149b2381],
24	have	VBP	O	have	aux	25	SENT_244	[p19l7t2430r174b2493],
25	decreased	VBN	O	decrease	_	0	SENT_244	[p19l216t2430r569b2492],
26	clearance	NN	O	clearance	dobj	25	SENT_244	[p19l609t2430r947b2492],
27	of	IN	O	of	_	0	SENT_244	[p19l989t2430r1066b2492],
28	free	JJ	O	free	amod	29	SENT_244	[p19l1100t2430r1237b2492],
29	paclitaxel	NN	O	paclitaxel	prep_of	26	SENT_244	[p19l1277t2430r1646b2511],
30	,	,	O	,	_	0	SENT_244	[p19l1277t2430r1646b2511],
31	and	CC	O	and	_	0	SENT_244	[p19l1691t2430r1818b2492],
32	a	DT	O	a	det	34	SENT_244	[p19l1859t2449r1896b2492],
33	corresponding	JJ	O	corresponding	amod	34	SENT_244	[p19l1936t2449r2144b2492, p19l10t2541r333b2622],
34	increase	NN	O	increase	dobj	25	SENT_244	[p19l377t2541r669b2604],
35	in	IN	O	in	_	0	SENT_244	[p19l713t2541r781b2603],
36	drug	NN	O	drug	nn	37	SENT_244	[p19l824t2541r984b2622],
37	exposure	NN	O	exposure	prep_in	34	SENT_244	[p19l1029t2561r1350b2622],
38	[	CD	NUMBER	[	num	37	SENT_244	[p19l1399t2541r1558b2617],
39	46	CD	NUMBER	46	num	40	SENT_244	[p19l1399t2541r1558b2617],
40	]	NN	O	]	nsubj	25	SENT_244	[p19l1399t2541r1558b2617],
41	.	.	O	.	_	0	SENT_244	[p19l1399t2541r1558b2617],

1	These	DT	O	these	det	2	SENT_245	[p19l1606t2541r1817b2604],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_245	[p19l1862t2541r2146b2622],
3	provide	VBP	O	provide	_	0	SENT_245	[p19l6t2652r278b2733],
4	a	DT	O	a	det	6	SENT_245	[p19l317t2672r354b2715],
5	rational	JJ	O	rational	amod	6	SENT_245	[p19l388t2652r662b2715],
6	mechanism	NN	O	mechanism	dobj	3	SENT_245	[p19l699t2652r1108b2715],
7	for	IN	O	for	_	0	SENT_245	[p19l1143t2652r1246b2715],
8	the	DT	O	the	det	12	SENT_245	[p19l1280t2652r1387b2715],
9	increased	VBN	O	increase	amod	12	SENT_245	[p19l1425t2652r1762b2715],
10	paclitaxel	NN	O	paclitaxel	nn	12	SENT_245	[p19l1797t2652r2147b2733],
11	treatment	NN	O	treatment	nn	12	SENT_245	[p19l7t2772r348b2826],
12	response	NN	O	response	prep_for	6	SENT_245	[p19l372t2783r683b2844],
13	and	CC	O	and	_	0	SENT_245	[p19l713t2763r839b2826],
14	toxicity	NN	O	toxicity	conj_and	12	SENT_245	[p19l865t2763r1137b2844],
15	seen	VBN	O	see	partmod	14	SENT_245	[p19l1168t2783r1322b2826],
16	in	IN	O	in	_	0	SENT_245	[p19l1348t2763r1416b2825],
17	CYP2C8	NN	O	cyp2c8	prep_in	15	SENT_245	[p19l1443t2763r1848b2826],
18	*	CD	NUMBER	*	number	19	SENT_245	[p19l1443t2763r1848b2826],
19	3	CD	NUMBER	3	num	20	SENT_245	[p19l1443t2763r1848b2826],
20	carriers	NNS	O	carrier	dobj	15	SENT_245	[p19l1881t2763r2145b2826],
21	in	IN	O	in	_	0	SENT_245	[p19l7t2874r75b2936],
22	this	DT	O	this	det	23	SENT_245	[p19l107t2874r233b2937],
23	study	NN	O	study	prep_in	20	SENT_245	[p19l270t2874r477b2955],
24	.	.	O	.	_	0	SENT_245	[p19l270t2874r477b2955],

1	It	PRP	O	it	nsubj	4	SENT_246	[p19l109t2987r163b3048],
2	is	VBZ	O	be	cop	4	SENT_246	[p19l194t2985r249b3048],
3	not	RB	O	not	neg	4	SENT_246	[p19l283t2995r397b3048],
4	possible	JJ	O	possible	_	0	SENT_246	[p19l427t2985r719b3066],
5	to	TO	O	to	aux	6	SENT_246	[p19l752t2995r818b3048],
6	distinguish	VB	O	distinguish	xcomp	4	SENT_246	[p19l853t2985r1244b3066],
7	the	DT	O	the	det	8	SENT_246	[p19l1276t2985r1383b3048],
8	inﬂuence	NN	O	inﬂuence	dobj	6	SENT_246	[p19l1416t2985r1743b3048],
9	of	IN	O	of	_	0	SENT_246	[p19l1777t2985r1854b3048],
10	each	DT	O	each	prep_of	8	SENT_246	[p19l1881t2985r2043b3048],
11	of	IN	O	of	_	0	SENT_246	[p19l2076t2985r2153b3048],
12	the	DT	O	the	det	17	SENT_246	[p19l7t3096r114b3159],
13	two	CD	NUMBER	two	num	17	SENT_246	[p19l145t3106r276b3159],
14	non	JJ	O	non	amod	17	SENT_246	[p19l308t3116r922b3177],
15	—	NN	O	—	nn	17	SENT_246	[p19l308t3116r922b3177],
16	synonymous	JJ	O	synonymous	amod	17	SENT_246	[p19l308t3116r922b3177],
17	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_246	[p19l953t3096r1509b3177],
18	in	IN	O	in	_	0	SENT_246	[p19l1541t3096r1609b3158],
19	CYP2C8	NN	O	cyp2c8	prep_in	17	SENT_246	[p19l1640t3097r2044b3159],
20	*	CD	NUMBER	*	number	21	SENT_246	[p19l1640t3097r2044b3159],
21	3	CD	NUMBER	3	num	19	SENT_246	[p19l1640t3097r2044b3159],
22	in	IN	O	in	_	0	SENT_246	[p19l2080t3096r2148b3158],
23	this	DT	O	this	det	24	SENT_246	[p19l7t3207r133b3269],
24	population	NN	O	population	prep_in	6	SENT_246	[p19l168t3207r551b3288],
25	because	IN	O	because	_	0	SENT_246	[p19l584t3207r867b3269],
26	of	IN	O	of	prepc_because_of	6	SENT_246	[p19l902t3207r979b3269],
27	the	DT	O	the	det	29	SENT_246	[p19l1007t3207r1114b3269],
28	complete	JJ	O	complete	amod	29	SENT_246	[p19l1149t3207r1476b3288],
29	concordance	NN	O	concordance	pobj	6	SENT_246	[p19l1512t3207r1983b3281],
30	,	,	O	,	_	0	SENT_246	[p19l1512t3207r1983b3281],
31	and	CC	O	and	_	0	SENT_246	[p19l2022t3207r2148b3269],
32	it	PRP	O	it	nsubjpass	35	SENT_246	[p19l7t3318r56b3380],
33	will	MD	O	will	aux	35	SENT_246	[p19l86t3318r222b3381],
34	be	VB	O	be	auxpass	35	SENT_246	[p19l253t3318r336b3380],
35	difﬁcult	VBN	O	difﬁcult	conj_and	4	SENT_246	[p19l368t3318r651b3380],
36	to	TO	O	to	aux	37	SENT_246	[p19l680t3327r747b3380],
37	do	VB	O	do	xcomp	35	SENT_246	[p19l780t3318r865b3380],
38	this	DT	O	this	dobj	37	SENT_246	[p19l896t3318r1021b3380],
39	in	IN	O	in	_	0	SENT_246	[p19l1054t3318r1122b3380],
40	any	DT	O	any	det	42	SENT_246	[p19l1154t3337r1279b3399],
41	clinical	JJ	O	clinical	amod	42	SENT_246	[p19l1311t3318r1573b3380],
42	study	NN	O	study	prep_in	38	SENT_246	[p19l1608t3318r1797b3399],
43	based	VBN	O	base	_	0	SENT_246	[p19l1827t3318r2030b3380],
44	on	IN	O	on	prepc_based_on	37	SENT_246	[p19l2061t3337r2148b3380],
45	their	PRP$	O	they	poss	48	SENT_246	[p19l7t3428r172b3490],
46	high	JJ	O	high	amod	48	SENT_246	[p19l209t3428r368b3509],
47	linkage	NN	O	linkage	nn	48	SENT_246	[p19l408t3428r669b3509],
48	disequilibrium	NN	O	disequilibrium	pobj	37	SENT_246	[p19l711t3428r1251b3509],
49	.	.	O	.	_	0	SENT_246	[p19l711t3428r1251b3509],

1	However	RB	O	however	dep	5	SENT_247	[p19l1296t3429r1641b3501],
2	,	,	O	,	_	0	SENT_247	[p19l1296t3429r1641b3501],
3	in	FW	O	in	dep	1	SENT_247	[p19l1685t3428r1752b3489],
4	vitro	FW	O	vitro	pobj	3	SENT_247	[p19l1792t3428r1958b3490],
5	data	NNS	O	datum	nsubj	6	SENT_247	[p19l2001t3428r2149b3490],
6	suggest	VBP	O	suggest	_	0	SENT_247	[p19l10t3549r276b3621],
7	that	IN	O	that	complm	13	SENT_247	[p19l332t3540r467b3603],
8	the	DT	O	the	det	10	SENT_247	[p19l524t3540r631b3603],
9	causative	JJ	O	causative	amod	10	SENT_247	[p19l691t3540r1023b3603],
10	SNP	NN	O	snp	nsubj	13	SENT_247	[p19l1085t3541r1244b3603],
11	is	VBZ	O	be	cop	13	SENT_247	[p19l1302t3540r1357b3603],
12	the	DT	O	the	det	13	SENT_247	[p19l1418t3540r1525b3603],
13	K399R	NN	O	k399r	ccomp	6	SENT_247	[p19l1586t3541r1841b3604],
14	variant	JJ	O	variant	amod	17	SENT_247	[p19l1899t3540r2149b3603],
15	(	NN	O	(	nn	17	SENT_247	[p19l10t3651r486b3728],
16	rslO50968l	NN	O	rslo50968l	nn	17	SENT_247	[p19l10t3651r486b3728],
17	)	NN	O	)	dep	13	SENT_247	[p19l10t3651r486b3728],
18	that	IN	O	that	nsubj	26	SENT_247	[p19l530t3651r682b3725],
19	,	,	O	,	_	0	SENT_247	[p19l530t3651r682b3725],
20	unlike	IN	O	unlike	_	0	SENT_247	[p19l726t3651r949b3714],
21	the	DT	O	the	det	23	SENT_247	[p19l991t3651r1098b3714],
22	Rl39K	NN	O	rl39k	nn	23	SENT_247	[p19l1141t3651r1399b3715],
23	variant	NN	O	variant	prep_unlike	26	SENT_247	[p19l1439t3651r1706b3725],
24	,	,	O	,	_	0	SENT_247	[p19l1439t3651r1706b3725],
25	has	VBZ	O	have	aux	26	SENT_247	[p19l1750t3651r1866b3714],
26	diminished	VBN	O	diminish	rcmod	13	SENT_247	[p19l1911t3651r2145b3714, p20l7t24r195b87],

1	paclitaxel	NN	O	paclitaxel	nn	3	SENT_248	[p20l230t24r580b105],
2	metabolic	JJ	O	metabolic	amod	3	SENT_248	[p20l617t24r969b87],
3	activity	NN	O	activity	_	0	SENT_248	[p20l1010t24r1276b105],
4	when	WRB	O	when	advmod	7	SENT_248	[p20l1314t24r1505b87],
5	each	DT	O	each	nsubjpass	7	SENT_248	[p20l1543t24r1705b87],
6	is	VBZ	O	be	auxpass	7	SENT_248	[p20l1741t24r1797b87],
7	tested	VBN	O	test	dep	3	SENT_248	[p20l1835t24r2044b87],
8	in	IN	O	in	_	0	SENT_248	[p20l2080t24r2148b86],
9	isolation	NN	O	isolation	prep_in	7	SENT_248	[p20l7t135r316b198],
10	[	CD	NUMBER	[	number	11	SENT_248	[p20l375t136r505b211],
11	42	CD	NUMBER	42	dep	9	SENT_248	[p20l375t136r505b211],
12	,	,	O	,	_	0	SENT_248	[p20l375t136r505b211],
13	47	CD	NUMBER	47	num	14	SENT_248	[p20l560t136r696b211],
14	]	NN	O	]	appos	9	SENT_248	[p20l560t136r696b211],
15	.	.	O	.	_	0	SENT_248	[p20l560t136r696b211],

1	If	IN	O	if	mark	4	SENT_249	[p20l754t135r817b197],
2	this	DT	O	this	nsubj	4	SENT_249	[p20l863t135r989b198],
3	were	VBD	O	be	cop	4	SENT_249	[p20l1045t155r1216b198],
4	true	JJ	O	true	advcl	10	SENT_249	[p20l1270t145r1426b210],
5	,	,	O	,	_	0	SENT_249	[p20l1270t145r1426b210],
6	then	RB	O	then	advmod	10	SENT_249	[p20l1483t135r1636b198],
7	it	PRP	O	it	nsubj	10	SENT_249	[p20l1689t135r1738b198],
8	would	MD	O	would	aux	10	SENT_249	[p20l1790t135r2012b198],
9	be	VB	O	be	cop	10	SENT_249	[p20l2064t135r2147b198],
10	important	JJ	O	important	_	0	SENT_249	[p20l7t247r356b328],
11	for	IN	O	for	_	0	SENT_249	[p20l406t247r509b310],
12	future	JJ	DATE	future	amod	13	SENT_249	[p20l558t247r769b310],
13	researchers	NNS	O	researcher	prep_for	10	SENT_249	[p20l819t247r1220b310],
14	to	TO	O	to	aux	15	SENT_249	[p20l1273t257r1339b310],
15	focus	VB	O	focus	xcomp	10	SENT_249	[p20l1390t247r1580b310],
16	their	PRP$	O	they	poss	17	SENT_249	[p20l1632t247r1797b310],
17	analyses	NNS	O	analysis	dobj	15	SENT_249	[p20l1847t247r2145b328],
18	speciﬁcally	RB	O	speciﬁcally	advmod	15	SENT_249	[p20l10t358r414b439],
19	on	IN	O	on	_	0	SENT_249	[p20l441t378r528b421],
20	the	DT	O	the	det	22	SENT_249	[p20l553t358r660b421],
21	K399R	NN	O	k399r	nn	22	SENT_249	[p20l687t359r944b422],
22	variant	NN	O	variant	prep_on	15	SENT_249	[p20l968t358r1217b421],
23	that	WDT	O	that	nsubj	26	SENT_249	[p20l1241t358r1375b421],
24	is	VBZ	O	be	cop	26	SENT_249	[p20l1400t358r1455b421],
25	sometimes	RB	O	sometimes	advmod	26	SENT_249	[p20l1485t358r1863b421],
26	present	JJ	DATE	present	rcmod	22	SENT_249	[p20l1889t368r2149b439],
27	in	IN	O	in	_	0	SENT_249	[p20l7t469r75b531],
28	patients	NNS	O	patient	prep_in	26	SENT_249	[p20l106t469r383b550],
29	without	IN	O	without	_	0	SENT_249	[p20l418t469r692b532],
30	the	DT	O	the	det	33	SENT_249	[p20l723t469r830b531],
31	R139K	NN	O	r139k	nn	33	SENT_249	[p20l863t469r1122b532],
32	variant	JJ	O	variant	amod	33	SENT_249	[p20l1153t469r1401b531],
33	[	NN	O	[	prep_without	26	SENT_249	[p20l1439t469r1598b545],
34	48	CD	NUMBER	48	num	35	SENT_249	[p20l1439t469r1598b545],
35	]	NN	O	]	dep	33	SENT_249	[p20l1439t469r1598b545],
36	.	.	O	.	_	0	SENT_249	[p20l1439t469r1598b545],

1	These	DT	O	these	det	2	SENT_250	[p20l109t580r321b642],
2	patients	NNS	O	patient	nsubjpass	4	SENT_250	[p20l357t580r634b661],
3	were	VBD	O	be	auxpass	4	SENT_250	[p20l672t599r843b642],
4	treated	VBN	O	treat	_	0	SENT_250	[p20l880t580r1124b642],
5	according	VBG	O	accord	_	0	SENT_250	[p20l1161t580r1512b661],
6	to	TO	O	to	prepc_according_to	4	SENT_250	[p20l1548t589r1614b642],
7	standard	JJ	O	standard	amod	9	SENT_250	[p20l1655t580r1955b642],
8	neoadjuvant	JJ	O	neoadjuvant	amod	9	SENT_250	[p20l1990t599r2144b642, p20l9t690r316b771],
9	protocols	NNS	O	protocol	pobj	4	SENT_250	[p20l343t690r695b771],
10	,	,	O	,	_	0	SENT_250	[p20l343t690r695b771],
11	which	WDT	O	which	nsubj	12	SENT_250	[p20l728t690r945b752],
12	specify	VBP	O	specify	rcmod	9	SENT_250	[p20l977t689r1231b771],
13	an	DT	O	a	det	16	SENT_250	[p20l1262t709r1343b752],
14	appropriate	JJ	O	appropriate	amod	16	SENT_250	[p20l1373t690r1779b771],
15	treatment	NN	O	treatment	nn	16	SENT_250	[p20l1809t699r2148b752],
16	dose	NN	O	dose	dobj	12	SENT_250	[p20l8t802r188b877],
17	,	,	O	,	_	0	SENT_250	[p20l8t802r188b877],
18	schedule	NN	O	schedule	conj_and	16	SENT_250	[p20l224t802r553b876],
19	,	,	O	,	_	0	SENT_250	[p20l224t802r553b876],
20	and	CC	O	and	_	0	SENT_250	[p20l588t802r714b865],
21	duration	NN	O	duration	dobj	12	SENT_250	[p20l743t802r1058b865],
22	.	.	O	.	_	0	SENT_250	[p20l743t802r1058b865],

1	Recent	JJ	O	recent	amod	2	SENT_251	[p20l1092t804r1341b865],
2	data	NNS	O	datum	nsubj	3	SENT_251	[p20l1370t802r1518b865],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_251	[p20l1548t802r1984b865],
4	that	IN	O	that	complm	18	SENT_251	[p20l2014t802r2148b865],
5	the	DT	O	the	det	9	SENT_251	[p20l7t914r114b977],
6	3	CD	NUMBER	3	num	9	SENT_251	[p20l143t914r473b995],
7	—	NN	O	—	nn	9	SENT_251	[p20l143t914r473b995],
8	week1y	JJ	O	week1y	amod	9	SENT_251	[p20l143t914r473b995],
9	regimen	NNS	O	regimen	nsubj	18	SENT_251	[p20l499t914r793b995],
10	received	VBN	O	receive	partmod	9	SENT_251	[p20l817t914r1123b977],
11	by	IN	O	by	_	0	SENT_251	[p20l1147t914r1235b995],
12	20	CD	PERCENT	20	num	13	SENT_251	[p20l1263t914r1348b977],
13	%	NN	PERCENT	%	agent	10	SENT_251	[p20l1385t914r1449b977],
14	of	IN	O	of	_	0	SENT_251	[p20l1480t914r1557b977],
15	these	DT	O	these	det	16	SENT_251	[p20l1577t914r1759b977],
16	patients	NNS	O	patient	prep_of	13	SENT_251	[p20l1785t914r2062b995],
17	is	VBZ	O	be	cop	18	SENT_251	[p20l2090t914r2146b977],
18	inferior	JJ	O	inferior	ccomp	3	SENT_251	[p20l7t1025r276b1088],
19	to	TO	O	to	_	0	SENT_251	[p20l316t1034r383b1088],
20	the	DT	O	the	det	21	SENT_251	[p20l425t1025r532b1088],
21	weekly	JJ	SET	weekly	prep_to	18	SENT_251	[p20l575t1025r831b1106],
22	or	CC	O	or	_	0	SENT_251	[p20l875t1045r948b1088],
23	every	DT	SET	every	det	25	SENT_251	[p20l988t1045r1184b1106],
24	2-week	JJ	SET	2-week	amod	25	SENT_251	[p20l1227t1025r1490b1088],
25	regimen	NN	O	regimen	conj_or	21	SENT_251	[p20l1529t1025r1823b1106],
26	[	CD	NUMBER	[	number	27	SENT_251	[p20l1871t1025r2030b1101],
27	49	CD	NUMBER	49	num	28	SENT_251	[p20l1871t1025r2030b1101],
28	]	NN	O	]	dep	25	SENT_251	[p20l1871t1025r2030b1101],
29	.	.	O	.	_	0	SENT_251	[p20l1871t1025r2030b1101],

1	In	IN	O	in	_	0	SENT_252	[p20l2075t1027r2148b1087],
2	follow	VB	O	follow	prepc_in	14	SENT_252	[p20l8t1136r358b1217],
3	—	CD	NUMBER	—	dobj	2	SENT_252	[p20l8t1136r358b1217],
4	up	IN	O	up	_	0	SENT_252	[p20l8t1136r358b1217],
5	analyses	NNS	O	analysis	prep_up	2	SENT_252	[p20l418t1136r738b1217],
6	,	,	O	,	_	0	SENT_252	[p20l418t1136r738b1217],
7	multivariable	JJ	O	multivariable	amod	8	SENT_252	[p20l799t1136r1277b1199],
8	models	NNS	O	model	nsubjpass	14	SENT_252	[p20l1335t1136r1590b1199],
9	that	WDT	O	that	nsubj	10	SENT_252	[p20l1649t1136r1783b1199],
10	included	VBD	O	include	rcmod	8	SENT_252	[p20l1840t1136r2149b1199],
11	treatment	NN	O	treatment	nn	12	SENT_252	[p20l7t1257r347b1310],
12	schedule	NN	O	schedule	dobj	10	SENT_252	[p20l382t1247r690b1310],
13	were	VBD	O	be	auxpass	14	SENT_252	[p20l723t1267r895b1310],
14	analyzed	VBN	O	analyze	_	0	SENT_252	[p20l929t1247r1245b1328],
15	to	TO	O	to	aux	16	SENT_252	[p20l1277t1257r1343b1310],
16	see	VB	O	see	xcomp	14	SENT_252	[p20l1380t1267r1488b1310],
17	if	IN	O	if	mark	43	SENT_252	[p20l1521t1247r1580b1309],
18	schedule	NN	O	schedule	nsubj	43	SENT_252	[p20l1609t1247r1918b1310],
19	had	VBD	O	have	aux	43	SENT_252	[p20l1950t1247r2079b1310],
20	a	DT	O	a	det	22	SENT_252	[p20l2112t1267r2149b1310],
21	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_252	[p20l10t1358r381b1439],
22	inﬂuence	NN	O	inﬂuence	dobj	43	SENT_252	[p20l398t1358r724b1421],
23	on	IN	O	on	_	0	SENT_252	[p20l745t1378r831b1421],
24	the	DT	O	the	det	25	SENT_252	[p20l848t1358r956b1421],
25	achievement	NN	O	achievement	prep_on	22	SENT_252	[p20l977t1358r1430b1421],
26	of	IN	O	of	_	0	SENT_252	[p20l1448t1358r1525b1421],
27	clinical	JJ	O	clinical	amod	29	SENT_252	[p20l1537t1358r1800b1421],
28	complete	JJ	O	complete	amod	29	SENT_252	[p20l1820t1358r2147b1439],
29	response	NN	O	response	prep_of	25	SENT_252	[p20l6t1488r338b1550],
30	,	,	O	,	_	0	SENT_252	[p20l6t1488r338b1550],
31	which	WDT	O	which	dobj	33	SENT_252	[p20l368t1469r585b1532],
32	it	PRP	O	it	nsubj	33	SENT_252	[p20l610t1469r660b1531],
33	did	VBD	O	do	rcmod	29	SENT_252	[p20l685t1469r797b1531],
34	not	RB	O	not	neg	35	SENT_252	[p20l822t1478r936b1531],
35	(	JJ	O	(	amod	37	SENT_252	[p20l963t1469r1414b1546],
36	uncorrected	JJ	O	uncorrected	amod	37	SENT_252	[p20l963t1469r1414b1546],
37	p	NN	O	p	dobj	33	SENT_252	[p20l1431t1490r1480b1549],
38	=	JJ	O	=	amod	37	SENT_252	[p20l1518t1497r1578b1521],
39	0.100	CD	NUMBER	0.100	tmod	38	SENT_252	[p20l1614t1469r1831b1543],
40	,	,	O	,	_	0	SENT_252	[p20l1614t1469r1831b1543],
41	data	NNS	O	datum	npadvmod	42	SENT_252	[p20l1862t1469r2010b1531],
42	not	RB	O	not	neg	43	SENT_252	[p20l2035t1478r2149b1531],
43	shown	VBN	O	show	advcl	16	SENT_252	[p20l10t1580r287b1657],
44	)	NN	O	)	dobj	43	SENT_252	[p20l10t1580r287b1657],
45	.	.	O	.	_	0	SENT_252	[p20l10t1580r287b1657],

1	The	DT	O	the	det	4	SENT_253	[p20l315t1580r451b1642],
2	predeﬁned	JJ	O	predeﬁned	amod	4	SENT_253	[p20l474t1580r853b1661],
3	treatment	NN	O	treatment	nn	4	SENT_253	[p20l875t1589r1216b1642],
4	duration	NN	O	duration	nsubj	6	SENT_253	[p20l1239t1580r1536b1642],
5	also	RB	O	also	advmod	6	SENT_253	[p20l1561t1580r1700b1642],
6	ensures	VBZ	O	ensure	_	0	SENT_253	[p20l1725t1599r1989b1642],
7	that	IN	O	that	complm	16	SENT_253	[p20l2014t1580r2149b1642],
8	the	DT	O	the	det	9	SENT_253	[p20l7t1690r114b1752],
9	assessment	NN	O	assessment	nsubjpass	16	SENT_253	[p20l166t1699r562b1752],
10	of	IN	O	of	_	0	SENT_253	[p20l612t1690r689b1752],
11	response	NN	O	response	prep_of	9	SENT_253	[p20l731t1709r1043b1771],
12	and	CC	O	and	_	0	SENT_253	[p20l1095t1690r1221b1752],
13	neuropathy	NN	O	neuropathy	conj_and	11	SENT_253	[p20l1270t1690r1672b1771],
14	is	VBZ	O	be	auxpass	16	SENT_253	[p20l1722t1690r1777b1752],
15	not	RB	O	not	neg	16	SENT_253	[p20l1828t1699r1942b1752],
16	confounded	VBN	O	confound	ccomp	6	SENT_253	[p20l1991t1709r2144b1752, p20l8t1802r300b1865],
17	by	IN	O	by	_	0	SENT_253	[p20l337t1802r425b1883],
18	dramatic	JJ	O	dramatic	amod	19	SENT_253	[p20l465t1802r776b1865],
19	differences	NNS	O	difference	agent	16	SENT_253	[p20l818t1802r1213b1865],
20	in	IN	O	in	_	0	SENT_253	[p20l1254t1802r1322b1864],
21	cumulative	JJ	O	cumulative	amod	22	SENT_253	[p20l1361t1802r1758b1865],
22	paclitaxel	NN	O	paclitaxel	prep_in	16	SENT_253	[p20l1797t1802r2147b1883],
23	received	VBD	O	receive	partmod	22	SENT_253	[p20l6t1913r329b1976],
24	.	.	O	.	_	0	SENT_253	[p20l6t1913r329b1976],

1	Only	RB	O	only	quantmod	2	SENT_254	[p20l374t1913r548b1994],
2	12	CD	NUMBER	12	num	3	SENT_254	[p20l598t1913r676b1975],
3	patients	NNS	O	patient	_	0	SENT_254	[p20l715t1913r992b1994],
4	discontinued	VBN	O	discontinue	amod	5	SENT_254	[p20l1035t1913r1492b1976],
5	paclitaxel	NN	O	paclitaxel	dep	3	SENT_254	[p20l1530t1913r1880b1994],
6	before	IN	O	before	_	0	SENT_254	[p20l1919t1913r2146b1976],
7	receiving	VBG	O	receive	prepc_before	5	SENT_254	[p20l6t2024r339b2105],
8	the	DT	O	the	det	10	SENT_254	[p20l373t2024r480b2087],
9	full	JJ	O	full	amod	10	SENT_254	[p20l514t2024r636b2087],
10	course	NN	O	course	dobj	7	SENT_254	[p20l670t2044r900b2087],
11	of	IN	O	of	_	0	SENT_254	[p20l935t2024r1012b2087],
12	therapy	NN	O	therapy	prep_of	10	SENT_254	[p20l1039t2024r1325b2105],
13	,	,	O	,	_	0	SENT_254	[p20l1039t2024r1325b2105],
14	11	CD	NUMBER	11	conj_and	10	SENT_254	[p20l1370t2025r1441b2086],
15	for	IN	O	for	_	0	SENT_254	[p20l1482t2024r1586b2087],
16	toxicity	NN	O	toxicity	prep_for	14	SENT_254	[p20l1616t2024r1909b2105],
17	,	,	O	,	_	0	SENT_254	[p20l1616t2024r1909b2105],
18	and	CC	O	and	_	0	SENT_254	[p20l1947t2024r2073b2087],
19	1	CD	NUMBER	1	conj_and	10	SENT_254	[p20l2114t2025r2140b2086],
20	because	IN	O	because	_	0	SENT_254	[p20l6t2135r289b2198],
21	of	IN	O	of	prepc_because_of	7	SENT_254	[p20l333t2135r410b2198],
22	disease	NN	O	disease	nn	23	SENT_254	[p20l448t2135r703b2198],
23	progression	NN	O	progression	pobj	7	SENT_254	[p20l745t2135r1163b2216],
24	during	IN	O	during	_	0	SENT_254	[p20l1206t2135r1436b2216],
25	treatment	NN	O	treatment	prep_during	7	SENT_254	[p20l1479t2145r1836b2198],
26	.	.	O	.	_	0	SENT_254	[p20l1479t2145r1836b2198],

1	Indeed	RB	O	indeed	advmod	10	SENT_255	[p20l1883t2135r2144b2209],
2	,	,	O	,	_	0	SENT_255	[p20l1883t2135r2144b2209],
3	carriers	NNS	O	carrier	nsubj	10	SENT_255	[p20l8t2246r273b2309],
4	of	IN	O	of	_	0	SENT_255	[p20l298t2246r375b2309],
5	the	DT	O	the	det	7	SENT_255	[p20l390t2246r497b2309],
6	CYP2C8	NN	O	cyp2c8	nn	7	SENT_255	[p20l521t2247r926b2309],
7	*	NN	O	*	prep_of	3	SENT_255	[p20l521t2247r926b2309],
8	3	CD	NUMBER	3	number	9	SENT_255	[p20l521t2247r926b2309],
9	variant	JJ	O	variant	amod	7	SENT_255	[p20l952t2246r1201b2309],
10	received	VBD	O	receive	_	0	SENT_255	[p20l1221t2246r1526b2309],
11	a	DT	O	a	det	13	SENT_255	[p20l1548t2266r1585b2309],
12	similar	JJ	O	similar	amod	13	SENT_255	[p20l1608t2246r1855b2309],
13	number	NN	O	number	dobj	10	SENT_255	[p20l1875t2246r2149b2309],
14	of	IN	O	of	_	0	SENT_255	[p20l8t2358r85b2421],
15	cycles	NNS	O	cycle	prep_of	13	SENT_255	[p20l101t2358r322b2439],
16	(	CD	NUMBER	(	num	17	SENT_255	[p20l348t2358r638b2435],
17	median	NN	O	median	dep	28	SENT_255	[p20l348t2358r638b2435],
18	=	JJ	O	=	amod	20	SENT_255	[p20l673t2387r734b2410],
19	4	CD	NUMBER	4	tmod	18	SENT_255	[p20l769t2359r840b2435],
20	)	NN	O	)	dep	17	SENT_255	[p20l769t2359r840b2435],
21	and	CC	O	and	_	0	SENT_255	[p20l865t2358r991b2421],
22	weeks	NNS	DURATION	week	dep	28	SENT_255	[p20l1013t2358r1232b2421],
23	of	IN	O	of	_	0	SENT_255	[p20l1256t2358r1334b2421],
24	therapy	NN	O	therapy	prep_of	22	SENT_255	[p20l1349t2358r1616b2439],
25	(	CD	NUMBER	(	num	26	SENT_255	[p20l1641t2359r1861b2435],
26	mean	NN	O	mean	dep	28	SENT_255	[p20l1641t2359r1861b2435],
27	=	JJ	O	=	amod	28	SENT_255	[p20l1897t2387r1957b2411],
28	9.99	CD	NUMBER	9.99	dep	13	SENT_255	[p20l1994t2359r2146b2422],
29	vs.	CC	O	vs.	prep	28	SENT_255	[p20l7t2487r102b2530],
30	9.60	CD	NUMBER	9.60	num	31	SENT_255	[p20l135t2467r316b2545],
31	)	NN	O	)	dep	29	SENT_255	[p20l135t2467r316b2545],
32	compared	VBN	O	compare	_	0	SENT_255	[p20l347t2468r700b2549],
33	with	IN	O	with	prepc_compared_with	13	SENT_255	[p20l728t2468r885b2530],
34	wild	JJ	O	wild	amod	37	SENT_255	[p20l913t2468r1254b2549],
35	—	NN	O	—	nn	37	SENT_255	[p20l913t2468r1254b2549],
36	type	NN	O	type	nn	37	SENT_255	[p20l913t2468r1254b2549],
37	patients	NNS	O	patient	pobj	13	SENT_255	[p20l1282t2468r1559b2549],
38	so	IN	O	so	mark	41	SENT_255	[p20l1592t2487r1665b2530],
39	it	PRP	O	it	nsubj	41	SENT_255	[p20l1694t2468r1743b2530],
40	is	VBZ	O	be	cop	41	SENT_255	[p20l1770t2468r1825b2530],
41	unlikely	JJ	O	unlikely	advcl	10	SENT_255	[p20l1854t2468r2147b2549],
42	that	IN	O	that	complm	49	SENT_255	[p20l7t2579r141b2641],
43	differences	NNS	O	difference	nsubj	49	SENT_255	[p20l164t2579r559b2641],
44	in	IN	O	in	_	0	SENT_255	[p20l585t2579r653b2640],
45	response	NN	O	response	prep_in	43	SENT_255	[p20l675t2598r986b2660],
46	or	CC	O	or	_	0	SENT_255	[p20l1011t2598r1084b2641],
47	neurotoxicity	NN	O	neurotoxicity	prep_in	43	SENT_255	[p20l1105t2579r1583b2660],
48	are	VBP	O	be	cop	49	SENT_255	[p20l1609t2598r1714b2641],
49	attributable	JJ	O	attributable	ccomp	41	SENT_255	[p20l1740t2579r2147b2641],
50	to	TO	O	to	_	0	SENT_255	[p20l7t2699r74b2752],
51	differences	NNS	O	difference	prep_to	49	SENT_255	[p20l102t2689r498b2752],
52	in	IN	O	in	_	0	SENT_255	[p20l526t2690r594b2751],
53	cumulative	JJ	O	cumulative	amod	54	SENT_255	[p20l621t2690r1018b2752],
54	paclitaxel	NN	O	paclitaxel	prep_in	51	SENT_255	[p20l1046t2690r1395b2771],
55	administered	VBN	O	administer	partmod	54	SENT_255	[p20l1425t2690r1904b2752],
56	.	.	O	.	_	0	SENT_255	[p20l1425t2690r1904b2752],

1	Numerous	JJ	O	numerous	amod	2	SENT_256	[p20l109t2804r479b2865],
2	groups	NNS	O	group	nsubj	4	SENT_256	[p20l522t2822r760b2883],
3	have	VBP	O	have	aux	4	SENT_256	[p20l802t2802r969b2865],
4	investigated	VBN	O	investigate	_	0	SENT_256	[p20l1010t2802r1444b2883],
5	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_256	[p20l1482t2802r2038b2883],
6	in	IN	O	in	_	0	SENT_256	[p20l2080t2802r2148b2864],
7	other	JJ	O	other	amod	8	SENT_256	[p20l8t2913r191b2976],
8	genes	NNS	O	gene	prep_in	5	SENT_256	[p20l223t2933r422b2994],
9	relevant	JJ	O	relevant	xcomp	4	SENT_256	[p20l456t2913r746b2976],
10	to	TO	O	to	_	0	SENT_256	[p20l777t2922r843b2976],
11	paclitaxel	NN	O	paclitaxel	nn	12	SENT_256	[p20l875t2913r1225b2994],
12	exposure	NN	O	exposure	prep_to	9	SENT_256	[p20l1259t2933r1580b2994],
13	or	CC	O	or	_	0	SENT_256	[p20l1614t2933r1686b2976],
14	mechanism	NN	O	mechanism	prep_to	9	SENT_256	[p20l1717t2913r2143b2976],
15	.	.	O	.	_	0	SENT_256	[p20l1717t2913r2143b2976],

1	The	DT	O	the	det	2	SENT_257	[p20l7t3024r144b3086],
2	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_257	[p20l182t3024r737b3105],
3	in	IN	O	in	_	0	SENT_257	[p20l777t3024r845b3086],
4	CYP3A4	NN	O	cyp3a4	prep_in	2	SENT_257	[p20l883t3024r1207b3087],
5	and	CC	O	and	_	0	SENT_257	[p20l1248t3024r1374b3086],
6	CYP3A5	NN	O	cyp3a5	prep_in	2	SENT_257	[p20l1412t3024r1733b3087],
7	have	VBP	O	have	aux	10	SENT_257	[p20l1774t3024r1941b3087],
8	been	VBN	O	be	auxpass	10	SENT_257	[p20l1978t3024r2147b3086],
9	independently	RB	O	independently	advmod	10	SENT_257	[p20l7t3135r515b3216],
10	interrogated	VBN	O	interrogate	_	0	SENT_257	[p20l543t3135r976b3216],
11	and	CC	O	and	_	0	SENT_257	[p20l1005t3135r1131b3198],
12	typically	RB	O	typically	advmod	15	SENT_257	[p20l1158t3135r1471b3216],
13	do	VBP	O	do	aux	15	SENT_257	[p20l1499t3135r1585b3198],
14	not	RB	O	not	neg	15	SENT_257	[p20l1613t3145r1727b3198],
15	show	VB	O	show	conj_and	10	SENT_257	[p20l1755t3135r1938b3198],
16	associations	NNS	O	association	dobj	15	SENT_257	[p20l1968t3155r2145b3198, p20l8t3246r283b3309],
17	with	IN	O	with	_	0	SENT_257	[p20l306t3246r463b3309],
18	outcome	NN	O	outcome	prep_with	15	SENT_257	[p20l484t3256r790b3309],
19	[	CD	NUMBER	[	number	20	SENT_257	[p20l817t3247r947b3322],
20	13	CD	NUMBER	13	dobj	10	SENT_257	[p20l817t3247r947b3322],
21	,	,	O	,	_	0	SENT_257	[p20l817t3247r947b3322],
22	36	CD	NUMBER	36	appos	20	SENT_257	[p20l973t3246r1077b3320],
23	,	,	O	,	_	0	SENT_257	[p20l973t3246r1077b3320],
24	50	CD	NUMBER	50	num	25	SENT_257	[p20l1102t3246r1236b3322],
25	]	NN	O	]	appos	22	SENT_257	[p20l1102t3246r1236b3322],
26	,	,	O	,	_	0	SENT_257	[p20l1102t3246r1236b3322],
27	though	IN	O	though	mark	31	SENT_257	[p20l1260t3246r1508b3327],
28	associations	NNS	O	association	nsubjpass	31	SENT_257	[p20l1529t3246r1958b3309],
29	have	VBP	O	have	aux	31	SENT_257	[p20l1979t3246r2146b3309],
30	been	VBN	O	be	auxpass	31	SENT_257	[p20l6t3357r175b3419],
31	reported	VBN	O	report	advcl	10	SENT_257	[p20l199t3357r499b3438],
32	[	CD	NUMBER	[	num	34	SENT_257	[p20l529t3357r688b3433],
33	51	CD	NUMBER	51	num	34	SENT_257	[p20l529t3357r688b3433],
34	]	NN	O	]	dobj	31	SENT_257	[p20l529t3357r688b3433],
35	.	.	O	.	_	0	SENT_257	[p20l529t3357r688b3433],

1	However	RB	O	however	advmod	5	SENT_258	[p20l718t3358r1064b3431],
2	,	,	O	,	_	0	SENT_258	[p20l718t3358r1064b3431],
3	recent	JJ	O	recent	amod	4	SENT_258	[p20l1091t3366r1312b3419],
4	data	NNS	O	datum	nsubj	5	SENT_258	[p20l1337t3357r1485b3419],
5	suggest	VBP	O	suggest	_	0	SENT_258	[p20l1513t3366r1777b3438],
6	that	IN	O	that	complm	29	SENT_258	[p20l1802t3357r1936b3419],
7	looking	VBG	O	look	csubj	29	SENT_258	[p20l1961t3357r2145b3419, p20l7t3467r119b3548],
8	at	IN	O	at	_	0	SENT_258	[p20l140t3476r202b3529],
9	the	DT	O	the	det	12	SENT_258	[p20l218t3467r325b3529],
10	CYP3A4	NN	O	cyp3a4	nn	12	SENT_258	[p20l346t3467r710b3530],
11	*	CD	NUMBER	*	num	12	SENT_258	[p20l346t3467r710b3530],
12	1B/3A5	NN	O	1b/3a5	prep_at	7	SENT_258	[p20l725t3466r1040b3530],
13	*	CD	NUMBER	*	num	15	SENT_258	[p20l725t3466r1040b3530],
14	1A	NN	O	1a	nn	15	SENT_258	[p20l1055t3467r1154b3528],
15	variants	NNS	O	variant	dobj	7	SENT_258	[p20l1172t3467r1452b3529],
16	as	IN	O	as	_	0	SENT_258	[p20l1474t3486r1543b3529],
17	a	DT	O	a	det	21	SENT_258	[p20l1564t3486r1601b3529],
18	high	JJ	O	high	amod	21	SENT_258	[p20l1618t3467r1776b3548],
19	metabolic	JJ	O	metabolic	amod	21	SENT_258	[p20l1793t3467r2146b3529],
20	activity	NN	O	activity	nn	21	SENT_258	[p20l9t3578r275b3659],
21	haplotype	NN	O	haplotype	prep_as	15	SENT_258	[p20l299t3578r651b3659],
22	may	MD	O	may	aux	29	SENT_258	[p20l675t3597r827b3659],
23	be	VB	O	be	cop	29	SENT_258	[p20l849t3578r932b3640],
24	a	DT	O	a	det	29	SENT_258	[p20l957t3597r994b3640],
25	superior	JJ	O	superior	amod	29	SENT_258	[p20l1020t3578r1310b3659],
26	strategy	NN	O	strategy	nn	29	SENT_258	[p20l1334t3587r1613b3659],
27	[	CD	NUMBER	[	number	28	SENT_258	[p20l1643t3577r1802b3653],
28	26	CD	NUMBER	26	num	29	SENT_258	[p20l1643t3577r1802b3653],
29	]	NN	O	]	ccomp	5	SENT_258	[p20l1643t3577r1802b3653],
30	.	.	O	.	_	0	SENT_258	[p20l1643t3577r1802b3653],

1	We	PRP	O	we	nsubj	3	SENT_259	[p20l1829t3579r1951b3640],
2	were	VBD	O	be	cop	3	SENT_259	[p20l1976t3597r2146b3641],
3	unable	JJ	O	unable	_	0	SENT_259	[p20l7t3690r244b3753],
4	to	TO	O	to	aux	5	SENT_259	[p20l271t3700r338b3753],
5	identify	VB	O	identify	xcomp	3	SENT_259	[p20l365t3690r642b3771],
6	a	DT	O	a	det	9	SENT_259	[p20l671t3710r708b3753],
7	statistically	RB	O	statistically	advmod	8	SENT_259	[p20l735t3690r1140b3771],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_259	[p20l1171t3690r1541b3771],
9	association	NN	O	association	dobj	5	SENT_259	[p20l1568t3690r1963b3753],
10	with	IN	O	with	_	0	SENT_259	[p20l1991t3690r2148b3753],
11	paclitaxel	NN	O	paclitaxel	nn	13	SENT_259	[p21l6t22r356b103],
12	treatment	NN	O	treatment	nn	13	SENT_259	[p21l393t31r733b85],
13	outcomes	NNS	O	outcome	prep_with	5	SENT_259	[p21l770t31r1110b85],
14	for	IN	O	for	_	0	SENT_259	[p21l1149t22r1252b85],
15	either	CC	O	either	preconj	20	SENT_259	[p21l1288t22r1492b85],
16	the	DT	O	the	det	20	SENT_259	[p21l1527t22r1634b85],
17	CYP3A4	NN	O	cyp3a4	nn	20	SENT_259	[p21l1673t22r2142b85],
18	*	CD	NUMBER	*	num	20	SENT_259	[p21l1673t22r2142b85],
19	lB	NN	O	lb	nn	20	SENT_259	[p21l1673t22r2142b85],
20	variant	NN	O	variant	prep_for	13	SENT_259	[p21l7t133r256b196],
21	alone	RB	O	alone	amod	20	SENT_259	[p21l282t133r473b196],
22	or	CC	O	or	_	0	SENT_259	[p21l500t153r572b196],
23	the	DT	O	the	det	25	SENT_259	[p21l595t133r703b196],
24	two	CD	NUMBER	two	num	25	SENT_259	[p21l728t143r859b196],
25	variants	NNS	O	variant	conj_or	20	SENT_259	[p21l886t133r1166b196],
26	in	IN	O	in	_	0	SENT_259	[p21l1193t133r1261b195],
27	combination	NN	O	combination	prep_in	5	SENT_259	[p21l1287t133r1753b196],
28	.	.	O	.	_	0	SENT_259	[p21l1287t133r1753b196],

1	The	DT	O	the	det	3	SENT_260	[p21l109t245r246b308],
2	ABCBI	NNP	O	ABCBI	nn	3	SENT_260	[p21l296t246r574b308],
3	variants	NNS	O	variant	nsubj	8	SENT_260	[p21l632t245r913b308],
4	have	VBP	O	have	aux	8	SENT_260	[p21l964t245r1131b308],
5	also	RB	O	also	advmod	8	SENT_260	[p21l1183t245r1322b308],
6	been	VBN	O	be	cop	8	SENT_260	[p21l1372t245r1541b308],
7	the	DT	O	the	det	8	SENT_260	[p21l1590t245r1697b308],
8	focus	NN	O	focus	_	0	SENT_260	[p21l1747t245r1937b308],
9	of	IN	O	of	_	0	SENT_260	[p21l1990t245r2067b308],
10	a	DT	O	a	det	11	SENT_260	[p21l2112t265r2149b308],
11	number	NN	O	number	prep_of	8	SENT_260	[p21l7t357r282b420],
12	of	IN	O	of	_	0	SENT_260	[p21l339t357r416b420],
13	retrospective	JJ	O	retrospective	amod	14	SENT_260	[p21l468t357r931b438],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_260	[p21l989t357r1602b438],
15	studies	NNS	O	study	prep_of	11	SENT_260	[p21l1666t357r1928b431],
16	,	,	O	,	_	0	SENT_260	[p21l1666t357r1928b431],
17	with	IN	O	with	_	0	SENT_260	[p21l1991t357r2148b420],
18	inconsistent	JJ	O	inconsistent	amod	19	SENT_260	[p21l7t468r436b531],
19	results	NNS	O	result	prep_with	8	SENT_260	[p21l484t468r735b531],
20	.	.	O	.	_	0	SENT_260	[p21l484t468r735b531],

1	Variants	NNS	O	variant	nsubjpass	8	SENT_261	[p21l790t468r1091b531],
2	at	IN	O	at	_	0	SENT_261	[p21l1145t478r1208b531],
3	the	DT	O	the	det	5	SENT_261	[p21l1256t468r1363b531],
4	3435	CD	DATE	3435	num	5	SENT_261	[p21l1417t468r1588b531],
5	position	NN	O	position	prep_at	1	SENT_261	[p21l1641t468r1930b549],
6	have	VBP	O	have	aux	8	SENT_261	[p21l1979t468r2146b531],
7	been	VBN	O	be	auxpass	8	SENT_261	[p21l6t579r175b642],
8	associated	VBN	O	associate	_	0	SENT_261	[p21l224t579r590b642],
9	with	IN	O	with	_	0	SENT_261	[p21l637t579r793b642],
10	shorter	JJR	O	shorter	amod	12	SENT_261	[p21l843t579r1088b642],
11	overall	JJ	O	overall	amod	12	SENT_261	[p21l1134t579r1381b642],
12	survival	NN	O	survival	prep_with	8	SENT_261	[p21l1431t579r1715b642],
13	and	CC	O	and	_	0	SENT_261	[p21l1764t579r1890b642],
14	worse	JJR	O	worse	amod	15	SENT_261	[p21l1936t599r2146b642],
15	progression	NN	O	progression	conj_and	12	SENT_261	[p21l6t691r424b772],
16	free	JJ	O	free	amod	17	SENT_261	[p21l499t691r635b753],
17	survival	NN	O	survival	dobj	8	SENT_261	[p21l713t691r997b754],
18	in	IN	O	in	_	0	SENT_261	[p21l1073t691r1140b753],
19	paclitaXel	NN	O	paclitaxel	nn	20	SENT_261	[p21l1213t691r1841b772],
20	—	NN	O	—	prep_in	17	SENT_261	[p21l1213t691r1841b772],
21	treated	VBN	O	treat	partmod	20	SENT_261	[p21l1213t691r1841b772],
22	cancer	NN	O	cancer	nn	23	SENT_261	[p21l1915t710r2149b753],
23	patients	NNS	O	patient	nsubj	24	SENT_261	[p21l6t801r283b882],
24	[	VBP	O	[	ccomp	21	SENT_261	[p21l318t801r403b877],
25	8	CD	NUMBER	8	dobj	24	SENT_261	[p21l318t801r403b877],
26	,	,	O	,	_	0	SENT_261	[p21l318t801r403b877],
27	9	CD	NUMBER	9	num	28	SENT_261	[p21l434t801r523b877],
28	]	NN	O	]	appos	25	SENT_261	[p21l434t801r523b877],
29	.	.	O	.	_	0	SENT_261	[p21l434t801r523b877],

1	Variants	NNS	O	variant	nsubj	17	SENT_262	[p21l553t801r854b864],
2	at	IN	O	at	_	0	SENT_262	[p21l884t810r946b863],
3	the	DT	O	the	dep	4	SENT_262	[p21l971t801r1078b863],
4	3435	CD	DATE	3435	prep_at	1	SENT_262	[p21l1108t800r1278b864],
5	and	CC	DATE	and	_	0	SENT_262	[p21l1311t801r1437b863],
6	2677	CD	DATE	2677	prep_at	1	SENT_262	[p21l1464t801r1637b864],
7	position	NN	O	position	nsubjpass	10	SENT_262	[p21l1665t801r1954b882],
8	have	VBP	O	have	aux	10	SENT_262	[p21l1979t801r2146b864],
9	been	VBN	O	be	auxpass	10	SENT_262	[p21l6t913r175b976],
10	implicated	VBN	O	implicate	rcmod	1	SENT_262	[p21l214t913r594b994],
11	in	IN	O	in	_	0	SENT_262	[p21l632t913r699b975],
12	higher	JJR	O	higher	amod	13	SENT_262	[p21l738t913r967b994],
13	risk	NN	O	risk	prep_in	10	SENT_262	[p21l1004t913r1139b976],
14	of	IN	O	of	_	0	SENT_262	[p21l1177t913r1254b976],
15	paclitaXel	NN	O	paclitaxel	nn	16	SENT_262	[p21l1286t913r1951b994],
16	—	NN	O	—	prep_of	13	SENT_262	[p21l1286t913r1951b994],
17	induced	VBD	O	induce	_	0	SENT_262	[p21l1286t913r1951b994],
18	neutropenia	NN	O	neutropenia	nn	21	SENT_262	[p21l1990t933r2144b976, p21l7t1024r302b1105],
19	[	CD	NUMBER	[	num	21	SENT_262	[p21l330t1025r465b1100],
20	l7	NN	O	l7	nn	21	SENT_262	[p21l330t1025r465b1100],
21	]	NN	O	]	nsubj	26	SENT_262	[p21l330t1025r465b1100],
22	and	CC	O	and	_	0	SENT_262	[p21l496t1024r623b1087],
23	docetaxel	NN	O	docetaxel	nn	25	SENT_262	[p21l646t1024r989b1087],
24	treatment	NN	O	treatment	nn	25	SENT_262	[p21l1012t1034r1353b1087],
25	outcomes	NNS	O	outcome	conj_and	21	SENT_262	[p21l1376t1034r1716b1087],
26	[	VBP	O	[	ccomp	17	SENT_262	[p21l1748t1025r1907b1100],
27	27	CD	NUMBER	27	num	28	SENT_262	[p21l1748t1025r1907b1100],
28	]	CD	NUMBER	]	dobj	26	SENT_262	[p21l1748t1025r1907b1100],
29	.	.	O	.	_	0	SENT_262	[p21l1748t1025r1907b1100],

1	In	IN	O	in	_	0	SENT_263	[p21l1935t1026r2007b1086],
2	our	PRP$	O	we	poss	3	SENT_263	[p21l2031t1044r2149b1087],
3	study	NN	O	study	prep_in	16	SENT_263	[p21l10t1135r218b1216],
4	,	,	O	,	_	0	SENT_263	[p21l10t1135r218b1216],
5	the	DT	O	the	det	6	SENT_263	[p21l271t1135r378b1198],
6	variants	NNS	O	variant	nsubj	16	SENT_263	[p21l428t1135r709b1198],
7	of	IN	O	of	_	0	SENT_263	[p21l762t1135r839b1198],
8	ABCBI	NN	ORGANIZATION	abcbus	prep_of	6	SENT_263	[p21l882t1135r1161b1198],
9	tested	VBN	O	test	partmod	8	SENT_263	[p21l1218t1135r1427b1198],
10	individually	RB	O	individually	dep	9	SENT_263	[p21l1476t1135r1908b1216],
11	or	CC	O	or	_	0	SENT_263	[p21l1959t1155r2032b1198],
12	in	IN	O	in	conj_or	10	SENT_263	[p21l2080t1135r2148b1197],
13	haplotypes	NNS	O	haplotype	pobj	12	SENT_263	[p21l7t1245r393b1326],
14	did	VBD	O	do	aux	16	SENT_263	[p21l427t1245r540b1307],
15	not	RB	O	not	neg	16	SENT_263	[p21l570t1254r683b1307],
16	have	VB	O	have	_	0	SENT_263	[p21l713t1245r881b1307],
17	a	DT	O	a	det	20	SENT_263	[p21l914t1264r951b1307],
18	statistically	RB	O	statistically	advmod	19	SENT_263	[p21l985t1245r1389b1326],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_263	[p21l1425t1245r1796b1326],
20	effect	NN	O	effect	dobj	16	SENT_263	[p21l1827t1244r2030b1307],
21	on	IN	O	on	_	0	SENT_263	[p21l2061t1264r2148b1307],
22	paclitaxel	NN	O	paclitaxel	nn	24	SENT_263	[p21l6t1357r356b1438],
23	treatment	NN	O	treatment	nn	24	SENT_263	[p21l389t1367r729b1420],
24	outcome	NN	O	outcome	prep_on	20	SENT_263	[p21l762t1367r1086b1420],
25	.	.	O	.	_	0	SENT_263	[p21l762t1367r1086b1420],

1	CYPlBl	NN	O	cyplbl	nsubjpass	4	SENT_264	[p21l111t1469r423b1531],
2	is	VBZ	O	be	auxpass	4	SENT_264	[p21l460t1468r516b1531],
3	not	RB	O	not	neg	4	SENT_264	[p21l547t1478r661b1531],
4	involved	VBN	O	involve	_	0	SENT_264	[p21l690t1468r1002b1531],
5	in	IN	O	in	_	0	SENT_264	[p21l1032t1468r1099b1530],
6	taxane	NN	O	taxane	nn	7	SENT_264	[p21l1129t1478r1361b1531],
7	metabolism	NN	O	metabolism	prep_in	4	SENT_264	[p21l1392t1468r1811b1531],
8	[	CD	NUMBER	[	num	10	SENT_264	[p21l1847t1468r2007b1544],
9	52	CD	NUMBER	52	num	10	SENT_264	[p21l1847t1468r2007b1544],
10	]	NN	O	]	dep	7	SENT_264	[p21l1847t1468r2007b1544],
11	,	,	O	,	_	0	SENT_264	[p21l1847t1468r2007b1544],
12	yet	RB	O	yet	advmod	7	SENT_264	[p21l2040t1478r2149b1549],
13	an	DT	O	a	det	14	SENT_264	[p21l9t1598r90b1641],
14	association	NN	O	association	pobj	12	SENT_264	[p21l120t1579r517b1641],
15	between	IN	O	between	_	0	SENT_264	[p21l544t1579r842b1642],
16	taxane	NN	O	taxane	nn	17	SENT_264	[p21l871t1588r1103b1641],
17	efﬁcacy	NN	O	efﬁcacy	prep_between	12	SENT_264	[p21l1133t1579r1415b1660],
18	and	CC	O	and	_	0	SENT_264	[p21l1446t1579r1572b1641],
19	the	DT	O	the	det	21	SENT_264	[p21l1600t1579r1707b1641],
20	CYP1Bl	NN	O	cyp1bl	nn	21	SENT_264	[p21l1737t1579r2143b1642],
21	*	NN	O	*	prep_in	4	SENT_264	[p21l1737t1579r2143b1642],
22	3	CD	NUMBER	3	num	23	SENT_264	[p21l1737t1579r2143b1642],
23	variant	NN	O	variant	nsubjpass	27	SENT_264	[p21l7t1690r256b1753],
24	has	VBZ	O	have	aux	27	SENT_264	[p21l311t1690r426b1752],
25	been	VBN	O	be	auxpass	27	SENT_264	[p21l483t1690r652b1752],
26	repeatedly	RB	O	repeatedly	advmod	27	SENT_264	[p21l708t1690r1081b1771],
27	demonstrated	VBN	O	demonstrate	rcmod	21	SENT_264	[p21l1139t1690r1622b1752],
28	[	IN	O	[	_	0	SENT_264	[p21l1684t1690r1814b1766],
29	13	CD	NUMBER	13	prep_[	27	SENT_264	[p21l1684t1690r1814b1766],
30	,	,	O	,	_	0	SENT_264	[p21l1684t1690r1814b1766],
31	53-55	CD	NUMBER	53-55	num	32	SENT_264	[p21l1874t1690r2143b1766],
32	]	NN	O	]	appos	29	SENT_264	[p21l1874t1690r2143b1766],
33	.	.	O	.	_	0	SENT_264	[p21l1874t1690r2143b1766],

1	In	FW	O	in	nn	3	SENT_265	[p21l7t1802r80b1863],
2	vitro	FW	O	vitro	nn	3	SENT_265	[p21l151t1801r317b1864],
3	studies	NNS	O	study	nsubj	45	SENT_265	[p21l393t1801r636b1863],
4	by	IN	O	by	_	0	SENT_265	[p21l708t1801r795b1882],
5	Sissung	NNP	PERSON	Sissung	prep_by	3	SENT_265	[p21l870t1801r1142b1882],
6	et	FW	O	et	nn	8	SENT_265	[p21l1216t1810r1279b1863],
7	al.	FW	O	al.	nn	8	SENT_265	[p21l1351t1801r1430b1863],
8	[	FW	O	[	dep	5	SENT_265	[p21l1512t1801r1648b1877],
9	27	CD	NUMBER	27	num	10	SENT_265	[p21l1512t1801r1648b1877],
10	]	CD	NUMBER	]	nsubj	34	SENT_265	[p21l1512t1801r1648b1877],
11	reveal	VBP	O	reveal	dep	8	SENT_265	[p21l1724t1801r1942b1864],
12	that	IN	O	that	complm	16	SENT_265	[p21l2014t1801r2149b1863],
13	CYPlBl	NN	O	cyplbl	nsubj	16	SENT_265	[p21l8t1913r414b1975],
14	*	CD	NUMBER	*	num	15	SENT_265	[p21l8t1913r414b1975],
15	3	CD	NUMBER	3	dep	13	SENT_265	[p21l8t1913r414b1975],
16	enhances	VBZ	O	enhance	ccomp	11	SENT_265	[p21l459t1912r784b1975],
17	estrogen	NN	O	estrogen	nn	18	SENT_265	[p21l828t1922r1128b1993],
18	metabolism	NN	O	metabolism	dobj	16	SENT_265	[p21l1169t1912r1588b1975],
19	to	TO	O	to	_	0	SENT_265	[p21l1628t1922r1694b1975],
20	compounds	NNS	O	compound	prep_to	16	SENT_265	[p21l1736t1912r2146b1993],
21	that	WDT	O	that	nsubj	22	SENT_265	[p21l7t2023r141b2086],
22	antagonize	VBP	O	antagonize	rcmod	20	SENT_265	[p21l176t2023r562b2104],
23	the	DT	O	the	det	24	SENT_265	[p21l596t2023r703b2086],
24	mechanism	NN	O	mechanism	dobj	22	SENT_265	[p21l737t2023r1146b2086],
25	of	IN	O	of	_	0	SENT_265	[p21l1180t2023r1258b2086],
26	action	NN	O	action	prep_of	24	SENT_265	[p21l1287t2023r1503b2086],
27	of	IN	O	of	_	0	SENT_265	[p21l1538t2023r1615b2086],
28	docetaxel	NN	O	docetaxel	prep_of	26	SENT_265	[p21l1644t2023r1986b2086],
29	and	CC	O	and	_	0	SENT_265	[p21l2022t2023r2148b2086],
30	paclitaxel	NN	O	paclitaxel	conj_and	28	SENT_265	[p21l6t2134r376b2215],
31	,	,	O	,	_	0	SENT_265	[p21l6t2134r376b2215],
32	and	CC	O	and	_	0	SENT_265	[p21l425t2134r551b2197],
33	covalently	RB	O	covalently	advmod	34	SENT_265	[p21l595t2134r967b2215],
34	bind	VBP	O	bind	conj_and	11	SENT_265	[p21l1011t2134r1170b2197],
35	docetaxel	NN	O	docetaxel	dobj	34	SENT_265	[p21l1215t2134r1576b2208],
36	,	,	O	,	_	0	SENT_265	[p21l1215t2134r1576b2208],
37	providing	VBG	O	provide	partmod	34	SENT_265	[p21l1623t2134r1971b2215],
38	two	CD	NUMBER	two	num	40	SENT_265	[p21l2015t2144r2147b2197],
39	plausible	JJ	O	plausible	amod	40	SENT_265	[p21l6t2244r329b2325],
40	mechanisms	NNS	O	mechanism	dobj	37	SENT_265	[p21l373t2244r815b2306],
41	for	IN	O	for	_	0	SENT_265	[p21l860t2243r964b2306],
42	the	DT	O	the	det	44	SENT_265	[p21l1005t2244r1112b2306],
43	decreased	VBN	O	decrease	amod	44	SENT_265	[p21l1158t2244r1511b2306],
44	efﬁcacy	NN	O	efﬁcacy	prep_for	40	SENT_265	[p21l1554t2243r1835b2325],
45	seen	VBN	O	see	_	0	SENT_265	[p21l1882t2263r2036b2306],
46	in	IN	O	in	_	0	SENT_265	[p21l2080t2244r2148b2305],
47	patients	NNS	O	patient	prep_in	45	SENT_265	[p21l6t2356r283b2437],
48	with	IN	O	with	_	0	SENT_265	[p21l316t2356r474b2419],
49	this	DT	O	this	det	53	SENT_265	[p21l503t2356r628b2419],
50	genotype	NN	O	genotype	nn	53	SENT_265	[p21l662t2366r988b2437],
51	[	NN	O	[	nn	53	SENT_265	[p21l1025t2356r1184b2432],
52	53	CD	NUMBER	53	num	53	SENT_265	[p21l1025t2356r1184b2432],
53	]	NN	O	]	prep_with	47	SENT_265	[p21l1025t2356r1184b2432],
54	.	.	O	.	_	0	SENT_265	[p21l1025t2356r1184b2432],

1	We	PRP	O	we	nsubj	2	SENT_266	[p21l1218t2358r1341b2419],
2	found	VBD	O	find	_	0	SENT_266	[p21l1372t2356r1580b2419],
3	no	DT	O	no	det	4	SENT_266	[p21l1609t2376r1695b2419],
4	evidence	NN	O	evidence	dobj	2	SENT_266	[p21l1727t2356r2043b2419],
5	of	IN	O	of	_	0	SENT_266	[p21l2076t2356r2153b2419],
6	a	DT	O	a	det	7	SENT_266	[p21l9t2487r46b2530],
7	link	NN	O	link	prep_of	4	SENT_266	[p21l77t2467r218b2529],
8	between	IN	O	between	_	0	SENT_266	[p21l247t2467r546b2530],
9	CYPlBl	NNP	O	CYPlBl	nn	10	SENT_266	[p21l579t2468r891b2530],
10	genotype	NN	O	genotype	prep_between	7	SENT_266	[p21l933t2477r1258b2548],
11	and	CC	O	and	_	0	SENT_266	[p21l1294t2467r1420b2530],
12	paclitaxel	NN	O	paclitaxel	nn	13	SENT_266	[p21l1451t2467r1800b2548],
13	efﬁcacy	NN	O	efﬁcacy	conj_and	10	SENT_266	[p21l1834t2467r2134b2548],
14	.	.	O	.	_	0	SENT_266	[p21l1834t2467r2134b2548],

1	In	IN	O	in	_	0	SENT_267	[p21l109t2579r182b2640],
2	conclusion	NN	O	conclusion	prep_in	5	SENT_267	[p21l216t2578r623b2652],
3	,	,	O	,	_	0	SENT_267	[p21l216t2578r623b2652],
4	we	PRP	O	we	nsubj	5	SENT_267	[p21l661t2597r761b2641],
5	report	VBP	O	report	_	0	SENT_267	[p21l796t2587r1011b2659],
6	evidence	NN	O	evidence	dobj	5	SENT_267	[p21l1045t2578r1361b2641],
7	that	IN	O	that	complm	14	SENT_267	[p21l1397t2578r1531b2640],
8	CYP2C8	NN	O	cyp2c8	nsubj	14	SENT_267	[p21l1565t2578r1970b2641],
9	*	CD	NUMBER	*	num	8	SENT_267	[p21l1565t2578r1970b2641],
10	3	CD	NUMBER	3	num	11	SENT_267	[p21l1565t2578r1970b2641],
11	carriers	NNS	O	carrier	dep	8	SENT_267	[p21l2011t2597r2145b2640, p21l6t2689r163b2751],
12	are	VBP	O	be	cop	14	SENT_267	[p21l197t2708r302b2751],
13	more	RBR	O	more	advmod	14	SENT_267	[p21l333t2708r515b2751],
14	likely	JJ	O	likely	ccomp	5	SENT_267	[p21l547t2689r749b2770],
15	to	TO	O	to	aux	16	SENT_267	[p21l780t2698r847b2751],
16	achieve	VB	O	achieve	xcomp	14	SENT_267	[p21l880t2689r1150b2752],
17	complete	JJ	O	complete	amod	19	SENT_267	[p21l1183t2689r1510b2770],
18	clinical	JJ	O	clinical	amod	19	SENT_267	[p21l1542t2689r1804b2751],
19	response	NN	O	response	dobj	16	SENT_267	[p21l1835t2708r2146b2770],
20	to	TO	O	to	_	0	SENT_267	[p21l7t2809r74b2862],
21	neoadjuvant	JJ	O	neoadjuvant	amod	22	SENT_267	[p21l118t2800r557b2881],
22	paclitaxel	NN	O	paclitaxel	prep_to	16	SENT_267	[p21l598t2800r966b2881],
23	.	.	O	.	_	0	SENT_267	[p21l598t2800r966b2881],

1	This	DT	O	this	det	2	SENT_268	[p21l1014t2800r1169b2862],
2	association	NN	O	association	nsubj	4	SENT_268	[p21l1216t2800r1612b2862],
3	was	VBD	O	be	cop	4	SENT_268	[p21l1655t2819r1789b2862],
4	independent	JJ	O	independent	_	0	SENT_268	[p21l1835t2800r2144b2881, p21l8t2911r161b2974],
5	of	IN	O	of	_	0	SENT_268	[p21l192t2911r269b2974],
6	other	JJ	O	other	amod	9	SENT_268	[p21l295t2911r478b2974],
7	important	JJ	O	important	amod	9	SENT_268	[p21l507t2911r856b2992],
8	clinical	JJ	O	clinical	amod	9	SENT_268	[p21l886t2911r1149b2974],
9	covariates	NNS	O	covariate	prep_of	4	SENT_268	[p21l1181t2911r1561b2974],
10	.	.	O	.	_	0	SENT_268	[p21l1181t2911r1561b2974],

1	The	DT	O	the	det	2	SENT_269	[p21l1597t2911r1733b2974],
2	odds	NNS	O	odds	nsubj	20	SENT_269	[p21l1766t2911r1930b2974],
3	of	IN	O	of	_	0	SENT_269	[p21l1964t2911r2041b2974],
4	an	DT	O	a	det	5	SENT_269	[p21l2067t2931r2148b2974],
5	individual	NN	O	individual	prep_of	2	SENT_269	[p21l7t3022r370b3085],
6	who	WP	O	who	nsubj	7	SENT_269	[p21l417t3022r567b3085],
7	carried	VBD	O	carry	rcmod	5	SENT_269	[p21l615t3022r863b3085],
8	the	DT	O	the	det	9	SENT_269	[p21l908t3022r1015b3085],
9	*	NN	O	*	nsubj	12	SENT_269	[p21l1066t3023r1144b3085],
10	3	CD	NUMBER	3	number	11	SENT_269	[p21l1066t3023r1144b3085],
11	variant	JJ	O	variant	dep	12	SENT_269	[p21l1195t3022r1444b3085],
12	achieving	VBG	O	achieve	xcomp	7	SENT_269	[p21l1491t3022r1836b3103],
13	clinical	JJ	O	clinical	amod	15	SENT_269	[p21l1884t3022r2147b3085],
14	complete	JJ	O	complete	amod	15	SENT_269	[p21l8t3133r335b3214],
15	response	NN	O	response	dobj	12	SENT_269	[p21l359t3153r671b3214],
16	were	VBD	O	be	cop	20	SENT_269	[p21l697t3153r868b3196],
17	nearly	RB	O	nearly	quantmod	18	SENT_269	[p21l894t3133r1115b3214],
18	four	CD	NUMBER	four	num	19	SENT_269	[p21l1142t3133r1290b3196],
19	times	NNS	O	time	npadvmod	20	SENT_269	[p21l1313t3133r1504b3196],
20	higher	JJR	O	higher	_	0	SENT_269	[p21l1530t3133r1760b3214],
21	than	IN	O	than	_	0	SENT_269	[p21l1783t3133r1935b3196],
22	those	DT	O	those	prep_than	20	SENT_269	[p21l1960t3133r2147b3196],
23	for	IN	O	for	_	0	SENT_269	[p21l8t3242r111b3305],
24	an	DT	O	a	det	25	SENT_269	[p21l163t3262r244b3305],
25	individual	JJ	O	individual	prep_for	22	SENT_269	[p21l295t3243r657b3305],
26	carrying	VBG	O	carry	xcomp	20	SENT_269	[p21l711t3243r1007b3324],
27	two	CD	NUMBER	two	num	31	SENT_269	[p21l1060t3252r1191b3306],
28	wild	JJ	O	wild	amod	31	SENT_269	[p21l1244t3243r1585b3324],
29	—	NN	O	—	nn	31	SENT_269	[p21l1244t3243r1585b3324],
30	type	NN	O	type	nn	31	SENT_269	[p21l1244t3243r1585b3324],
31	alleles	NNS	O	allele	dobj	26	SENT_269	[p21l1640t3243r1883b3305],
32	.	.	O	.	_	0	SENT_269	[p21l1640t3243r1883b3305],

1	Additionally	RB	O	additionally	advmod	5	SENT_270	[p21l1940t3243r2144b3305, p21l7t3355r299b3436],
2	,	,	O	,	_	0	SENT_270	[p21l1940t3243r2144b3305, p21l7t3355r299b3436],
3	our	PRP$	O	we	poss	4	SENT_270	[p21l337t3375r455b3418],
4	results	NNS	O	result	nsubj	5	SENT_270	[p21l486t3355r718b3418],
5	support	VBP	O	support	_	0	SENT_270	[p21l756t3365r1021b3436],
6	the	DT	O	the	det	9	SENT_270	[p21l1052t3355r1160b3418],
7	previously	RB	DATE	previously	advmod	8	SENT_270	[p21l1193t3355r1571b3436],
8	reported	VBN	O	report	amod	9	SENT_270	[p21l1604t3355r1904b3436],
9	possibility	NN	O	possibility	dobj	5	SENT_270	[p21l1935t3355r2145b3436, p21l6t3466r194b3547],
10	that	IN	O	that	complm	15	SENT_270	[p21l225t3466r359b3529],
11	individuals	NNS	O	individual	nsubj	15	SENT_270	[p21l388t3466r785b3529],
12	carrying	VBG	O	carry	partmod	11	SENT_270	[p21l817t3466r1113b3547],
13	this	DT	O	this	det	14	SENT_270	[p21l1143t3466r1270b3529],
14	variant	NN	O	variant	dobj	12	SENT_270	[p21l1302t3466r1550b3529],
15	are	VBP	O	be	ccomp	5	SENT_270	[p21l1581t3486r1686b3529],
16	at	IN	O	at	_	0	SENT_270	[p21l1719t3476r1781b3529],
17	increased	VBN	O	increase	amod	18	SENT_270	[p21l1809t3466r2148b3529],
18	risk	NN	O	risk	prep_at	15	SENT_270	[p21l6t3577r141b3639],
19	of	IN	O	of	_	0	SENT_270	[p21l165t3577r242b3639],
20	experiencing	VBG	O	experience	prepc_of	18	SENT_270	[p21l261t3577r722b3658],
21	paclitaxel	NN	O	paclitaxel	iobj	20	SENT_270	[p21l747t3577r1097b3658],
22	related	JJ	O	related	amod	23	SENT_270	[p21l1120t3577r1365b3639],
23	neuropathy	NN	O	neuropathy	dobj	20	SENT_270	[p21l1389t3577r1810b3658],
24	.	.	O	.	_	0	SENT_270	[p21l1389t3577r1810b3658],

1	Our	PRP$	O	we	poss	2	SENT_271	[p21l1840t3577r1977b3640],
2	data	NNS	O	datum	nsubj	23	SENT_271	[p21l2001t3577r2149b3639],
3	suggest	VBP	O	suggest	_	0	SENT_271	[p21l10t3697r275b3769],
4	a	DT	O	a	det	6	SENT_271	[p21l339t3707r376b3750],
5	potential	JJ	O	potential	amod	6	SENT_271	[p21l437t3688r751b3769],
6	biomarker	NN	O	biomarker	dobj	3	SENT_271	[p21l815t3688r1185b3750],
7	for	IN	O	for	_	0	SENT_271	[p21l1248t3688r1351b3750],
8	identifying	VBG	O	identify	prepc_for	3	SENT_271	[p21l1413t3688r1805b3769],
9	patients	NNS	O	patient	dobj	8	SENT_271	[p21l1869t3688r2145b3769],
10	before	IN	O	before	_	0	SENT_271	[p22l6t22r233b84],
11	treatment	NN	O	treatment	prep_before	8	SENT_271	[p22l290t31r630b84],
12	who	WP	O	who	nsubj	15	SENT_271	[p22l686t22r836b85],
13	are	VBP	O	be	cop	15	SENT_271	[p22l895t41r999b84],
14	more	RBR	O	more	advmod	15	SENT_271	[p22l1056t41r1238b84],
15	likely	JJ	O	likely	rcmod	11	SENT_271	[p22l1295t22r1498b103],
16	to	TO	O	to	aux	17	SENT_271	[p22l1554t31r1620b84],
17	beneﬁt	JJ	O	beneﬁt	xcomp	15	SENT_271	[p22l1675t22r1920b84],
18	from	IN	O	from	_	0	SENT_271	[p22l1976t22r2148b84],
19	therapy	NN	O	therapy	prep_from	17	SENT_271	[p22l7t133r293b214],
20	,	,	O	,	_	0	SENT_271	[p22l7t133r293b214],
21	but	CC	O	but	_	0	SENT_271	[p22l335t133r450b196],
22	may	MD	O	may	aux	23	SENT_271	[p22l488t153r640b214],
23	be	VB	O	be	conj_but	3	SENT_271	[p22l679t133r761b196],
24	at	IN	O	at	_	0	SENT_271	[p22l803t143r865b196],
25	an	DT	O	a	det	27	SENT_271	[p22l905t153r986b196],
26	increased	VBN	O	increase	amod	27	SENT_271	[p22l1024t133r1363b196],
27	risk	NN	O	risk	prep_at	23	SENT_271	[p22l1401t133r1535b196],
28	of	IN	O	of	_	0	SENT_271	[p22l1574t133r1651b196],
29	experiencing	VBG	O	experience	prepc_of	27	SENT_271	[p22l1685t133r2147b214],
30	certain	JJ	O	certain	amod	32	SENT_271	[p22l8t244r250b307],
31	adverse	JJ	O	adverse	amod	32	SENT_271	[p22l305t244r575b307],
32	events	NNS	O	event	dobj	29	SENT_271	[p22l629t254r873b307],
33	.	.	O	.	_	0	SENT_271	[p22l629t254r873b307],

1	The	DT	O	the	det	2	SENT_272	[p22l931t244r1068b307],
2	results	NNS	O	result	dep	9	SENT_272	[p22l1120t244r1351b307],
3	of	IN	O	of	_	0	SENT_272	[p22l1407t244r1484b307],
4	this	DT	O	this	det	6	SENT_272	[p22l1530t244r1656b307],
5	small	JJ	O	small	amod	6	SENT_272	[p22l1713t244r1902b307],
6	study	NN	O	study	prep_of	2	SENT_272	[p22l1958t244r2147b325],
7	warrant	NN	O	warrant	dep	9	SENT_272	[p22l8t365r281b418],
8	further	RB	O	further	advmod	9	SENT_272	[p22l321t355r565b418],
9	investigation	NN	O	investigation	dep	13	SENT_272	[p22l605t355r1069b436],
10	of	IN	O	of	_	0	SENT_272	[p22l1111t355r1188b418],
11	this	DT	O	this	det	12	SENT_272	[p22l1223t355r1349b418],
12	association	NN	O	association	prep_of	9	SENT_272	[p22l1393t355r1789b418],
13	in	IN	O	in	_	0	SENT_272	[p22l1831t355r1898b417],
14	larger	JJR	O	larger	pobj	13	SENT_272	[p22l1940t355r2149b436],
15	neoadjuvantly	RB	O	neoadjuvantly	advmod	16	SENT_272	[p22l7t465r515b546],
16	treated	VBN	O	treat	dep	14	SENT_272	[p22l565t465r809b527],
17	patient	NN	O	patient	nn	18	SENT_272	[p22l857t465r1102b546],
18	cohorts	NNS	O	cohort	dobj	16	SENT_272	[p22l1151t465r1432b539],
19	,	,	O	,	_	0	SENT_272	[p22l1151t465r1432b539],
20	and	CC	O	and	_	0	SENT_272	[p22l1486t465r1612b527],
21	if	IN	O	if	dep	14	SENT_272	[p22l1661t465r1719b526],
22	conﬁrmed	VBN	O	conﬁrmed	dep	21	SENT_272	[p22l1764t465r2144b539],
23	,	,	O	,	_	0	SENT_272	[p22l1764t465r2144b539],

1	@	SYM	O	@	dep	5	SENT_273	[p22l1779t708r1856b803],
2	Springer	NN	PERSON	springer	nn	5	SENT_273	[p22l1886t731r2148b806],
3	408	CD	NUMBER	408	num	5	SENT_273	[p22l52t881r103b906],
4	Breast	NN	ORGANIZATION	breast	nn	5	SENT_273	[p22l1450t881r1540b906],
5	Cancer	NN	ORGANIZATION	cancer	dep	9	SENT_273	[p22l1552t881r1652b906],
6	Res	NNP	ORGANIZATION	Res	nn	7	SENT_273	[p22l1664t881r1716b906],
7	Treat	NNP	ORGANIZATION	Treat	dep	5	SENT_273	[p22l1729t881r1804b906],
8	(	CD	NUMBER	(	num	9	SENT_273	[p22l1817t881r1908b911],
9	2012	CD	DATE	2012	dep	15	SENT_273	[p22l1817t881r1908b911],
10	)	CD	NUMBER	)	num	11	SENT_273	[p22l1817t881r1908b911],
11	l34	NN	O	l34	dep	9	SENT_273	[p22l1925t881r2107b906],
12	:40	CD	NUMBER	:40	num	13	SENT_273	[p22l1925t881r2107b906],
13	l	NN	O	l	tmod	11	SENT_273	[p22l1925t881r2107b906],
14	—	CD	NUMBER	—	num	15	SENT_273	[p22l1925t881r2107b906],
15	4l0	NN	O	4l0	_	0	SENT_273	[p22l1925t881r2107b906],

1	may	MD	O	may	aux	2	SENT_274	[p22l7t1069r159b1130],
2	prompt	VB	O	prompt	_	0	SENT_274	[p22l184t1059r444b1130],
3	studies	NNS	O	study	dobj	2	SENT_274	[p22l472t1049r715b1112],
4	of	IN	O	of	_	0	SENT_274	[p22l743t1049r820b1112],
5	dose	NN	O	dose	nn	6	SENT_274	[p22l841t1049r1001b1112],
6	individualization	NN	O	individualization	prep_of	3	SENT_274	[p22l1027t1049r1637b1112],
7	based	VBN	O	base	_	0	SENT_274	[p22l1662t1049r1866b1112],
8	on	IN	O	on	prepc_based_on	2	SENT_274	[p22l1892t1069r1978b1112],
9	host	NN	O	host	nn	10	SENT_274	[p22l2003t1049r2152b1112],
10	genotype	NN	O	genotype	pobj	2	SENT_274	[p22l8t1167r353b1238],
11	.	.	O	.	_	0	SENT_274	[p22l8t1167r353b1238],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	4	SENT_275	[p22l6t1366r601b1435],
2	We	PRP	O	we	nsubj	4	SENT_275	[p22l680t1368r785b1420],
3	would	MD	O	would	aux	4	SENT_275	[p22l839t1367r1028b1420],
4	like	VB	O	like	_	0	SENT_275	[p22l1081t1367r1193b1420],
5	to	TO	O	to	aux	6	SENT_275	[p22l1247t1375r1304b1420],
6	thank	VB	O	thank	xcomp	4	SENT_275	[p22l1358t1367r1528b1420],
7	Anne	NNP	PERSON	Anne	nn	8	SENT_275	[p22l1580t1367r1742b1420],
8	Misher	NNP	PERSON	Misher	dobj	6	SENT_275	[p22l1796t1367r2012b1420],
9	for	IN	O	for	_	0	SENT_275	[p22l2064t1367r2153b1420],
10	assistance	NN	O	assistance	prep_for	8	SENT_275	[p22l8t1455r310b1508],
11	with	IN	O	with	_	0	SENT_275	[p22l356t1455r491b1508],
12	genotyping	NN	O	genotyping	prep_with	10	SENT_275	[p22l536t1455r877b1523],
13	and	CC	O	and	_	0	SENT_275	[p22l924t1455r1032b1508],
14	Janelle	NNP	PERSON	Janelle	nn	15	SENT_275	[p22l1076t1455r1286b1508],
15	Hoskins	NNP	PERSON	Hoskins	prep_for	8	SENT_275	[p22l1332t1455r1579b1508],
16	for	IN	O	for	_	0	SENT_275	[p22l1625t1455r1713b1508],
17	guidance	NN	O	guidance	prep_for	15	SENT_275	[p22l1758t1455r2031b1523],
18	on	IN	O	on	_	0	SENT_275	[p22l2078t1471r2152b1508],
19	choosing	VBG	O	choose	prepc_on	6	SENT_275	[p22l8t1543r280b1612],
20	candidate	NN	O	candidate	nn	21	SENT_275	[p22l317t1543r608b1596],
21	SNPs	NNS	O	snp	dobj	19	SENT_275	[p22l646t1543r826b1596],
22	.	.	O	.	_	0	SENT_275	[p22l646t1543r826b1596],

1	This	DT	O	this	det	2	SENT_276	[p22l866t1543r998b1596],
2	study	NN	O	study	nsubjpass	4	SENT_276	[p22l1038t1543r1197b1611],
3	was	VBD	O	be	auxpass	4	SENT_276	[p22l1234t1559r1348b1596],
4	supported	VBN	O	support	_	0	SENT_276	[p22l1388t1543r1686b1611],
5	by	IN	O	by	_	0	SENT_276	[p22l1719t1543r1794b1611],
6	the	DT	O	the	det	13	SENT_276	[p22l1831t1543r1922b1596],
7	Breast	NN	ORGANIZATION	breast	nn	13	SENT_276	[p22l1957t1544r2152b1596],
8	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_276	[p22l8t1631r223b1684],
9	Research	NNP	ORGANIZATION	Research	nn	13	SENT_276	[p22l276t1631r555b1684],
10	Foundation	NNP	ORGANIZATION	Foundation	nn	13	SENT_276	[p22l608t1631r955b1684],
11	(	CD	NUMBER	(	num	13	SENT_276	[p22l1012t1631r1227b1696],
12	LAC	NN	O	lac	nn	13	SENT_276	[p22l1012t1631r1227b1696],
13	)	NN	O	)	agent	4	SENT_276	[p22l1012t1631r1227b1696],
14	,	,	O	,	_	0	SENT_276	[p22l1012t1631r1227b1696],
15	Lineberger	NNP	ORGANIZATION	Lineberger	nn	18	SENT_276	[p22l1284t1631r1620b1700],
16	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	18	SENT_276	[p22l1674t1631r2150b1700],
17	Cancer	NNP	ORGANIZATION	Cancer	nn	18	SENT_276	[p22l8t1720r223b1773],
18	Center	NNP	ORGANIZATION	Center	agent	4	SENT_276	[p22l291t1719r509b1782],
19	,	,	O	,	_	0	SENT_276	[p22l291t1719r509b1782],
20	a	DT	O	a	det	21	SENT_276	[p22l582t1736r614b1772],
21	Clinical	JJ	MISC	clinical	agent	4	SENT_276	[p22l683t1719r922b1773],
22	and	CC	O	and	_	0	SENT_276	[p22l993t1719r1101b1772],
23	Translational	JJ	O	translational	amod	26	SENT_276	[p22l1169t1719r1571b1772],
24	Science	NN	O	science	nn	26	SENT_276	[p22l1642t1719r1876b1773],
25	Award	NN	O	award	nn	26	SENT_276	[p22l1945t1719r2152b1773],
26	5ULlRRO25747-04	NN	O	5ullrro25747-04	conj_and	13	SENT_276	[p22l8t1809r631b1872],
27	,	,	O	,	_	0	SENT_276	[p22l8t1809r631b1872],
28	the	DT	O	the	det	30	SENT_276	[p22l668t1809r759b1862],
29	National	NNP	ORGANIZATION	National	nn	30	SENT_276	[p22l793t1809r1055b1862],
30	Institute	NNP	ORGANIZATION	Institute	conj_and	13	SENT_276	[p22l1089t1809r1337b1862],
31	of	IN	ORGANIZATION	of	_	0	SENT_276	[p22l1372t1809r1438b1862],
32	Health-National	NNP	ORGANIZATION	Health-National	nn	33	SENT_276	[p22l1467t1809r1957b1862],
33	Institute	NNP	ORGANIZATION	Institute	prep_of	30	SENT_276	[p22l1992t1809r2149b1862, p22l7t1906r120b1951],
34	of	IN	ORGANIZATION	of	_	0	SENT_276	[p22l144t1898r210b1951],
35	General	NNP	ORGANIZATION	General	nn	38	SENT_276	[p22l229t1898r468b1951],
36	Medical	NNP	ORGANIZATION	Medical	nn	38	SENT_276	[p22l491t1898r740b1951],
37	Sciences	NNPS	ORGANIZATION	Sciences	nn	38	SENT_276	[p22l765t1898r1027b1951],
38	T32GMO8lO57	NN	O	t32gmo8lo57	prep_of	33	SENT_276	[p22l1053t1898r1523b1951],
39	and	CC	O	and	_	0	SENT_276	[p22l1550t1898r1657b1951],
40	NIH	NNP	ORGANIZATION	NIH	nn	41	SENT_276	[p22l1679t1899r1813b1951],
41	SPORE	NNP	ORGANIZATION	SPORE	agent	4	SENT_276	[p22l1838t1898r2071b1951],
42	in	IN	O	in	_	0	SENT_276	[p22l2093t1898r2151b1950],
43	Breast	NN	O	breast	nn	45	SENT_276	[p22l7t1987r201b2039],
44	Cancer	NN	O	cancer	nn	45	SENT_276	[p22l234t1987r449b2039],
45	5P50CA058223	NN	O	5p50ca058223	prep_in	41	SENT_276	[p22l481t1986r985b2040],
46	.	.	O	.	_	0	SENT_276	[p22l481t1986r985b2040],

1	Daniel	NNP	PERSON	Daniel	nn	2	SENT_277	[p22l1021t1986r1222b2039],
2	Hertz	NNP	PERSON	Hertz	nsubj	6	SENT_277	[p22l1255t1987r1422b2039],
3	is	VBZ	O	be	cop	6	SENT_277	[p22l1455t1986r1503b2039],
4	an	DT	O	a	det	6	SENT_277	[p22l1538t2003r1607b2039],
5	American	JJ	ORGANIZATION	american	amod	6	SENT_277	[p22l1638t1986r1939b2039],
6	Foundation	NNP	ORGANIZATION	Foundation	_	0	SENT_277	[p22l1971t1987r2149b2039, p22l8t2075r196b2128],
7	for	IN	ORGANIZATION	for	_	0	SENT_277	[p22l225t2075r314b2128],
8	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	11	SENT_277	[p22l341t2075r811b2128],
9	Education	NNP	ORGANIZATION	Education	nn	11	SENT_277	[p22l841t2075r1150b2128],
10	Pre-Doctoral	NNP	O	Pre-Doctoral	nn	11	SENT_277	[p22l1179t2075r1571b2128],
11	Fellow	NNP	O	Fellow	prep_for	6	SENT_277	[p22l1600t2075r1810b2129],
12	in	IN	O	in	_	0	SENT_277	[p22l1840t2075r1898b2128],
13	clinical	JJ	O	clinical	amod	15	SENT_277	[p22l1927t2075r2150b2128],
14	pharmaceutical	JJ	O	pharmaceutical	amod	15	SENT_277	[p22l6t2164r473b2233],
15	science	NN	O	science	prep_in	11	SENT_277	[p22l511t2164r747b2217],
16	.	.	O	.	_	0	SENT_277	[p22l511t2164r747b2217],

1	They	PRP	O	they	nsubj	3	SENT_278	[p22l787t2164r941b2233],
2	have	VBP	O	have	aux	3	SENT_278	[p22l976t2164r1118b2217],
3	received	VBN	O	receive	_	0	SENT_278	[p22l1153t2164r1412b2217],
4	research	NN	O	research	nn	5	SENT_278	[p22l1446t2164r1700b2217],
5	funding	NN	O	funding	dobj	3	SENT_278	[p22l1734t2164r1969b2233],
6	from	IN	O	from	_	0	SENT_278	[p22l2005t2164r2152b2217],
7	pharmaceutical	JJ	O	pharmaceutical	amod	8	SENT_278	[p22l6t2251r473b2320],
8	companies	NNS	O	company	prep_from	3	SENT_278	[p22l509t2251r832b2320],
9	that	WDT	O	that	nsubjpass	12	SENT_278	[p22l867t2251r981b2304],
10	are	VBP	O	be	auxpass	12	SENT_278	[p22l1016t2268r1105b2304],
11	not	RB	O	not	neg	12	SENT_278	[p22l1139t2259r1236b2304],
12	related	VBN	O	relate	rcmod	8	SENT_278	[p22l1268t2251r1476b2304],
13	to	TO	O	to	_	0	SENT_278	[p22l1510t2259r1567b2304],
14	the	DT	O	the	det	16	SENT_278	[p22l1601t2251r1692b2304],
15	current	JJ	DATE	current	amod	16	SENT_278	[p22l1727t2259r1942b2304],
16	work	NN	O	work	prep_to	12	SENT_278	[p22l1975t2251r2146b2304],
17	:	:	O	:	_	0	SENT_278	[p22l1975t2251r2146b2304],
18	Millennium	NNP	O	Millennium	nn	19	SENT_278	[p22l7t2340r367b2394],
19	Pharmaceuticals	NNP	O	Pharmaceuticals	dep	16	SENT_278	[p22l414t2340r930b2403],
20	,	,	O	,	_	0	SENT_278	[p22l414t2340r930b2403],
21	Roche	NNP	PERSON	Roche	appos	19	SENT_278	[p22l981t2340r1543b2403],
22	.	.	O	.	_	0	SENT_278	[p22l981t2340r1543b2403],

1	—	NN	O	—	_	0	SENT_279	[p22l981t2340r1543b2403],
2	.	.	O	.	_	0	SENT_279	[p22l981t2340r1543b2403],

1	Genentech	NNP	ORGANIZATION	Genentech	_	0	SENT_280	[p22l981t2340r1543b2403],
2	,	,	O	,	_	0	SENT_280	[p22l981t2340r1543b2403],
3	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	conj_and	1	SENT_280	[p22l1596t2340r2148b2403],
4	,	,	O	,	_	0	SENT_280	[p22l1596t2340r2148b2403],
5	and	CC	O	and	_	0	SENT_280	[p22l8t2428r116b2481],
6	Novartis	NNP	ORGANIZATION	Novartis	conj_and	1	SENT_280	[p22l140t2428r400b2481],
7	(	CD	NUMBER	(	num	6	SENT_280	[p22l429t2429r643b2494],
8	ECD	NNP	O	ECD	dep	6	SENT_280	[p22l429t2429r643b2494],
9	)	CD	NUMBER	)	num	8	SENT_280	[p22l429t2429r643b2494],
10	.	.	O	.	_	0	SENT_280	[p22l429t2429r643b2494],

1	This	DT	O	this	det	2	SENT_281	[p22l672t2428r805b2481],
2	report	NN	O	report	nsubj	3	SENT_281	[p22l831t2436r1013b2497],
3	has	VBZ	O	have	_	0	SENT_281	[p22l1037t2428r1135b2481],
4	original	JJ	O	original	amod	5	SENT_281	[p22l1163t2428r1398b2497],
5	material	NN	O	material	dobj	3	SENT_281	[p22l1424t2428r1673b2481],
6	and	CC	O	and	_	0	SENT_281	[p22l1700t2428r1807b2481],
7	there	EX	O	there	expl	13	SENT_281	[p22l1832t2428r1982b2481],
8	have	VBP	O	have	aux	13	SENT_281	[p22l2008t2428r2151b2482],
9	been	VBN	O	be	cop	13	SENT_281	[p22l6t2516r150b2569],
10	no	DT	O	no	det	13	SENT_281	[p22l177t2533r251b2569],
11	other	JJ	O	other	amod	13	SENT_281	[p22l280t2516r436b2569],
12	previous	JJ	O	previous	amod	13	SENT_281	[p22l461t2516r721b2585],
13	reports	NNS	O	report	conj_and	3	SENT_281	[p22l750t2524r959b2585],
14	or	CC	O	or	_	0	SENT_281	[p22l989t2533r1051b2569],
15	publications	NNS	O	publication	conj_and	3	SENT_281	[p22l1077t2516r1448b2585],
16	to	TO	O	to	aux	17	SENT_281	[p22l1477t2524r1534b2569],
17	disclose	VB	O	disclose	infmod	15	SENT_281	[p22l1563t2516r1822b2569],
18	.	.	O	.	_	0	SENT_281	[p22l1563t2516r1822b2569],

1	Conﬂict	NN	O	conﬂict	nsubj	6	SENT_282	[p22l9t2694r264b2748],
2	of	IN	O	of	_	0	SENT_282	[p22l292t2694r359b2748],
3	interest	NN	O	interest	prep_of	1	SENT_282	[p22l381t2694r627b2748],
4	The	DT	O	the	det	5	SENT_282	[p22l705t2694r821b2747],
5	authors	NNS	O	author	dep	3	SENT_282	[p22l852t2694r1072b2747],
6	declare	VBP	O	declare	_	0	SENT_282	[p22l1103t2694r1320b2747],
7	that	IN	O	that	complm	9	SENT_282	[p22l1350t2694r1464b2747],
8	they	PRP	O	they	nsubj	9	SENT_282	[p22l1492t2694r1621b2763],
9	have	VBP	O	have	ccomp	6	SENT_282	[p22l1650t2694r1792b2748],
10	no	DT	O	no	det	11	SENT_282	[p22l1821t2711r1894b2747],
11	conﬂict	NN	O	conﬂict	dobj	9	SENT_282	[p22l1924t2694r2152b2747],
12	of	IN	O	of	_	0	SENT_282	[p22l8t2783r74b2837],
13	interest	NN	O	interest	prep_of	11	SENT_282	[p22l96t2784r335b2837],
14	.	.	O	.	_	0	SENT_282	[p22l96t2784r335b2837],

1	Ethical	JJ	O	ethical	amod	2	SENT_283	[p22l7t2972r238b3026],
2	standards	NNS	O	standard	nsubj	5	SENT_283	[p22l261t2973r579b3026],
3	All	DT	O	all	det	4	SENT_283	[p22l658t2972r754b3025],
4	experiments	NNS	O	experiment	dep	2	SENT_283	[p22l777t2972r1147b3041],
5	comply	VBP	O	comply	_	0	SENT_283	[p22l1172t2972r1398b3041],
6	with	IN	O	with	_	0	SENT_283	[p22l1422t2972r1556b3026],
7	current	JJ	DATE	current	amod	8	SENT_283	[p22l1579t2980r1793b3025],
8	laws	NNS	O	law	prep_with	5	SENT_283	[p22l1816t2972r1952b3025],
9	of	IN	O	of	_	0	SENT_283	[p22l1977t2972r2042b3025],
10	the	DT	O	the	det	12	SENT_283	[p22l2059t2972r2150b3025],
11	United	NNP	LOCATION	United	nn	12	SENT_283	[p22l7t3062r214b3115],
12	States	NNPS	LOCATION	States	prep_of	8	SENT_283	[p22l243t3062r420b3115],
13	of	IN	LOCATION	of	_	0	SENT_283	[p22l450t3061r516b3115],
14	America	NNP	LOCATION	America	prep_of	12	SENT_283	[p22l538t3061r815b3115],
15	.	.	O	.	_	0	SENT_283	[p22l538t3061r815b3115],

1	References	NNS	O	reference	_	0	SENT_284	[p22l8t3277r425b3341],

1	.	.	O	.	_	0	SENT_285	[p23l88t125r97b134],

1	Henningsson	NN	MISC	henningsson	nn	2	SENT_286	[p23l139t81r535b150],
2	A	NN	MISC	a	dep	29	SENT_286	[p23l561t82r630b144],
3	,	,	O	,	_	0	SENT_286	[p23l561t82r630b144],
4	Sparreboom	NN	O	sparreboom	nn	5	SENT_286	[p23l660t81r1031b150],
5	A	NN	O	a	appos	2	SENT_286	[p23l1056t82r1126b144],
6	,	,	O	,	_	0	SENT_286	[p23l1056t82r1126b144],
7	Sandstrom	NNP	PERSON	Sandstrom	nn	8	SENT_286	[p23l1157t81r1480b135],
8	M	NNP	O	M	appos	2	SENT_286	[p23l1504t83r1586b144],
9	,	,	O	,	_	0	SENT_286	[p23l1504t83r1586b144],
10	Freijs	NNP	O	Freijs	nn	11	SENT_286	[p23l1615t81r1786b150],
11	A	NNP	O	A	appos	2	SENT_286	[p23l1813t82r1883b144],
12	,	,	O	,	_	0	SENT_286	[p23l1813t82r1883b144],
13	Larsson	NNP	PERSON	Larsson	nn	14	SENT_286	[p23l1911t83r2151b134],
14	R	NNP	PERSON	R	appos	2	SENT_286	[p23l139t171r204b232],
15	,	,	O	,	_	0	SENT_286	[p23l139t171r204b232],
16	Bergh	NNP	PERSON	Bergh	nn	17	SENT_286	[p23l234t170r419b238],
17	J	NNP	PERSON	J	appos	2	SENT_286	[p23l447t171r491b233],
18	,	,	O	,	_	0	SENT_286	[p23l447t171r491b233],
19	Nygren	NNP	PERSON	Nygren	nn	20	SENT_286	[p23l522t171r749b238],
20	P	NN	O	p	appos	2	SENT_286	[p23l777t171r834b232],
21	,	,	O	,	_	0	SENT_286	[p23l777t171r834b232],
22	Karlsson	NNP	PERSON	Karlsson	nn	24	SENT_286	[p23l866t170r1133b223],
23	MO	NNP	PERSON	MO	nn	24	SENT_286	[p23l1162t170r1281b223],
24	(	NNP	O	(	appos	2	SENT_286	[p23l1313t170r1510b235],
25	2003	CD	DATE	2003	number	26	SENT_286	[p23l1313t170r1510b235],
26	)	CD	NUMBER	)	num	29	SENT_286	[p23l1313t170r1510b235],
27	Population	NNP	O	Population	nn	29	SENT_286	[p23l1540t169r1870b238],
28	pharmacokinetic	JJ	O	pharmacokinetic	amod	29	SENT_286	[p23l1897t170r2149b238, p23l139t257r416b311],
29	modelling	NN	O	modelling	_	0	SENT_286	[p23l446t257r754b326],
30	of	IN	O	of	_	0	SENT_286	[p23l783t257r849b311],
31	unbound	JJ	O	unbound	amod	35	SENT_286	[p23l871t257r1137b311],
32	and	CC	O	and	_	0	SENT_286	[p23l1166t258r1274b311],
33	total	JJ	O	total	conj_and	31	SENT_286	[p23l1301t258r1435b311],
34	plasma	NN	O	plasma	nn	35	SENT_286	[p23l1463t258r1679b326],
35	concentrations	NNS	O	concentration	prep_of	29	SENT_286	[p23l1707t257r2149b311],
36	of	IN	O	of	_	0	SENT_286	[p23l139t345r205b398],
37	paclitaxel	NN	O	paclitaxel	prep_of	35	SENT_286	[p23l227t345r524b414],
38	in	IN	O	in	_	0	SENT_286	[p23l552t345r610b398],
39	cancer	NN	O	cancer	nn	40	SENT_286	[p23l638t362r837b398],
40	patients	NNS	O	patient	prep_in	37	SENT_286	[p23l862t345r1115b414],
41	.	.	O	.	_	0	SENT_286	[p23l862t345r1115b414],

1	Eur	NNP	O	Eur	nn	3	SENT_287	[p23l1146t347r1256b398],
2	J	NNP	O	J	nn	3	SENT_287	[p23l1281t347r1310b399],
3	Cancer	NNP	O	Cancer	_	0	SENT_287	[p23l1337t346r1553b399],
4	39	CD	NUMBER	39	num	3	SENT_287	[p23l1582t345r2107b411],
5	(	CD	NUMBER	(	number	6	SENT_287	[p23l1582t345r2107b411],
6	8	CD	NUMBER	8	num	7	SENT_287	[p23l1582t345r2107b411],
7	)	NN	O	)	dep	3	SENT_287	[p23l1582t345r2107b411],
8	:	:	O	:	_	0	SENT_287	[p23l1582t345r2107b411],
9	l105	CD	NUMBER	l105	dep	3	SENT_287	[p23l1582t345r2107b411],
10	—	CD	NUMBER	—	num	11	SENT_287	[p23l1582t345r2107b411],
11	lll4	NN	O	lll4	dep	9	SENT_287	[p23l1582t345r2107b411],
12	.	.	O	.	_	0	SENT_287	[p23l88t477r97b486],

1	Sparano	NNP	PERSON	Sparano	nn	2	SENT_288	[p23l141t434r386b502],
2	JA	NNP	O	JA	nsubj	30	SENT_288	[p23l410t434r508b496],
3	,	,	O	,	_	0	SENT_288	[p23l410t434r508b496],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_288	[p23l534t435r715b502],
5	M	NNP	PERSON	M	appos	2	SENT_288	[p23l738t435r821b496],
6	,	,	O	,	_	0	SENT_288	[p23l738t435r821b496],
7	Martino	NNP	PERSON	Martino	nn	8	SENT_288	[p23l846t433r1090b486],
8	S	NNP	O	S	appos	5	SENT_288	[p23l1117t434r1171b496],
9	,	,	O	,	_	0	SENT_288	[p23l1117t434r1171b496],
10	Jones	NNP	PERSON	Jones	nn	11	SENT_288	[p23l1197t435r1362b487],
11	V	NNP	O	V	appos	5	SENT_288	[p23l1387t435r1456b496],
12	,	,	O	,	_	0	SENT_288	[p23l1387t435r1456b496],
13	Perez	NNP	ORGANIZATION	Perez	nn	14	SENT_288	[p23l1482t435r1649b486],
14	EA	NN	ORGANIZATION	ea	appos	5	SENT_288	[p23l1673t434r1790b496],
15	,	,	O	,	_	0	SENT_288	[p23l1673t434r1790b496],
16	Saphner	NNP	ORGANIZATION	Saphner	nn	17	SENT_288	[p23l1818t433r2065b502],
17	T	NN	ORGANIZATION	t	appos	5	SENT_288	[p23l2087t435r2149b496],
18	,	,	O	,	_	0	SENT_288	[p23l2087t435r2149b496],
19	Wolff	NNP	ORGANIZATION	Wolff	nn	20	SENT_288	[p23l138t521r324b575],
20	AC	NN	ORGANIZATION	ac	appos	5	SENT_288	[p23l342t522r462b584],
21	,	,	O	,	_	0	SENT_288	[p23l342t522r462b584],
22	Sledge	NNP	ORGANIZATION	Sledge	nn	23	SENT_288	[p23l490t521r693b590],
23	GW	NNP	ORGANIZATION	GW	appos	5	SENT_288	[p23l718t522r858b584],
24	,	,	O	,	_	0	SENT_288	[p23l718t522r858b584],
25	Wood	NNP	ORGANIZATION	Wood	nn	26	SENT_288	[p23l883t521r1069b575],
26	WC	NNP	ORGANIZATION	WC	appos	5	SENT_288	[p23l1091t522r1229b584],
27	,	,	O	,	_	0	SENT_288	[p23l1091t522r1229b584],
28	Davidson	NNP	ORGANIZATION	Davidson	nn	29	SENT_288	[p23l1254t521r1545b575],
29	NE	NNS	ORGANIZATION	ne	appos	5	SENT_288	[p23l1568t523r1667b575],
30	(	VBP	O	(	_	0	SENT_288	[p23l1693t522r1889b587],
31	2008	CD	DATE	2008	num	32	SENT_288	[p23l1693t522r1889b587],
32	)	CD	NUMBER	)	dobj	30	SENT_288	[p23l1693t522r1889b587],
33	Weekly	NNP	SET	Weekly	nn	34	SENT_288	[p23l1914t522r2150b590],
34	paclitaxel	NN	O	paclitaxel	dep	30	SENT_288	[p23l138t610r435b678],
35	in	IN	O	in	_	0	SENT_288	[p23l469t610r527b662],
36	the	DT	O	the	det	38	SENT_288	[p23l560t610r651b663],
37	adjuvant	JJ	O	adjuvant	amod	38	SENT_288	[p23l687t610r948b678],
38	treatment	NN	O	treatment	prep_in	30	SENT_288	[p23l980t617r1269b663],
39	of	IN	O	of	_	0	SENT_288	[p23l1303t610r1369b663],
40	breast	NN	O	breast	nn	41	SENT_288	[p23l1395t610r1578b663],
41	cancer	NN	O	cancer	prep_of	38	SENT_288	[p23l1612t626r1824b663],
42	.	.	O	.	_	0	SENT_288	[p23l1612t626r1824b663],

1	N	NN	O	n	nn	3	SENT_289	[p23l1861t611r1915b663],
2	Engl	NNP	O	Engl	nn	3	SENT_289	[p23l1947t610r2090b679],
3	J	NNP	O	J	nsubj	4	SENT_289	[p23l2123t611r2151b663],
4	Med	VBD	O	med	_	0	SENT_289	[p23l138t698r277b751],
5	358	CD	NUMBER	358	num	6	SENT_289	[p23l306t698r902b764],
6	(	CD	NUMBER	(	dobj	4	SENT_289	[p23l306t698r902b764],
7	16	CD	NUMBER	16	num	8	SENT_289	[p23l306t698r902b764],
8	)	NN	O	)	dep	4	SENT_289	[p23l306t698r902b764],
9	:1663	CD	NUMBER	:1663	number	10	SENT_289	[p23l306t698r902b764],
10	—	CD	NUMBER	—	dep	8	SENT_289	[p23l306t698r902b764],
11	1671	CD	DATE	1671	dep	10	SENT_289	[p23l306t698r902b764],

1	.	.	O	.	_	0	SENT_290	[p23l88t832r97b841],

1	Di	NNP	PERSON	Di	nn	3	SENT_291	[p23l139t787r212b840],
2	Leo	NNP	PERSON	Leo	nn	3	SENT_291	[p23l243t789r359b841],
3	A	NNP	PERSON	A	_	0	SENT_291	[p23l390t788r459b850],
4	,	,	O	,	_	0	SENT_291	[p23l390t788r459b850],
5	Gomez	NNP	PERSON	Gomez	nn	6	SENT_291	[p23l494t788r710b841],
6	HL	NNS	O	hl	nsubj	35	SENT_291	[p23l741t789r857b850],
7	,	,	O	,	_	0	SENT_291	[p23l741t789r857b850],
8	Aziz	NNP	PERSON	Aziz	nn	9	SENT_291	[p23l891t787r1032b840],
9	Z	NNP	O	Z	appos	6	SENT_291	[p23l1063t789r1125b850],
10	,	,	O	,	_	0	SENT_291	[p23l1063t789r1125b850],
11	Zvirbule	NNP	O	Zvirbule	nn	12	SENT_291	[p23l1157t787r1419b841],
12	Z	NNP	O	Z	appos	9	SENT_291	[p23l1449t789r1511b851],
13	,	,	O	,	_	0	SENT_291	[p23l1449t789r1511b851],
14	Bines	NNP	PERSON	Bines	nn	15	SENT_291	[p23l1544t787r1714b841],
15	J	NNP	PERSON	J	appos	9	SENT_291	[p23l1745t789r1774b841],
16	,	,	O	,	_	0	SENT_291	[p23l1779t832r1790b851],
17	Arbushites	NNP	O	Arbushites	nn	18	SENT_291	[p23l1822t787r2150b841],
18	MC	NNP	O	MC	appos	9	SENT_291	[p23l138t877r271b940],
19	,	,	O	,	_	0	SENT_291	[p23l138t877r271b940],
20	Guerrera	NNP	PERSON	Guerrera	nn	21	SENT_291	[p23l303t877r573b930],
21	SF	NNP	O	SF	appos	9	SENT_291	[p23l603t877r700b940],
22	,	,	O	,	_	0	SENT_291	[p23l603t877r700b940],
23	Koehler	NNP	PERSON	Koehler	nn	24	SENT_291	[p23l733t877r977b930],
24	M	NNP	O	M	appos	9	SENT_291	[p23l1003t878r1086b940],
25	,	,	O	,	_	0	SENT_291	[p23l1003t878r1086b940],
26	Oliva	NNP	PERSON	Oliva	nn	27	SENT_291	[p23l1119t877r1287b930],
27	C	NNP	O	C	appos	9	SENT_291	[p23l1315t877r1379b940],
28	,	,	O	,	_	0	SENT_291	[p23l1315t877r1379b940],
29	Stein	NNP	PERSON	Stein	nn	30	SENT_291	[p23l1412t877r1566b930],
30	SH	NNP	O	SH	appos	9	SENT_291	[p23l1596t877r1705b940],
31	,	,	O	,	_	0	SENT_291	[p23l1596t877r1705b940],
32	Williams	NNP	ORGANIZATION	Williams	nn	33	SENT_291	[p23l1736t877r2015b930],
33	LS	NN	ORGANIZATION	l	appos	9	SENT_291	[p23l2045t877r2148b940],
34	,	,	O	,	_	0	SENT_291	[p23l2045t877r2148b940],
35	Dering	VBG	O	der	dep	3	SENT_291	[p23l139t965r348b1034],
36	J	NN	O	j	dobj	35	SENT_291	[p23l389t966r433b1028],
37	,	,	O	,	_	0	SENT_291	[p23l389t966r433b1028],
38	Finn	NNP	O	Finn	nn	39	SENT_291	[p23l475t965r614b1017],
39	RS	NN	O	r	appos	3	SENT_291	[p23l654t965r761b1028],
40	,	,	O	,	_	0	SENT_291	[p23l654t965r761b1028],
41	Press	NNP	O	Press	nn	42	SENT_291	[p23l804t966r961b1018],
42	MF	NN	O	mf	appos	3	SENT_291	[p23l1002t966r1112b1017],
43	(	CD	NUMBER	(	num	42	SENT_291	[p23l1154t965r1351b1031],
44	2008	CD	DATE	2008	num	45	SENT_291	[p23l1154t965r1351b1031],
45	)	CD	NUMBER	)	dep	42	SENT_291	[p23l1154t965r1351b1031],
46	Phase	NN	O	phase	dep	42	SENT_291	[p23l1393t965r1568b1018],
47	III	CD	NUMBER	iii	num	46	SENT_291	[p23l1609t966r1700b1028],
48	,	,	O	,	_	0	SENT_291	[p23l1609t966r1700b1028],
49	double-blind	JJ	O	double-blind	amod	52	SENT_291	[p23l1744t965r2148b1028],
50	,	,	O	,	_	0	SENT_291	[p23l1744t965r2148b1028],
51	randomized	JJ	O	randomized	amod	52	SENT_291	[p23l138t1053r498b1106],
52	study	NN	O	study	appos	3	SENT_291	[p23l533t1053r693b1121],
53	comparing	VBG	O	compare	partmod	52	SENT_291	[p23l726t1052r1050b1121],
54	lapatinib	NN	O	lapatinib	dobj	53	SENT_291	[p23l1083t1052r1348b1121],
55	plus	CC	O	plus	prep	54	SENT_291	[p23l1381t1053r1506b1121],
56	paclitaxel	NN	O	paclitaxel	dep	55	SENT_291	[p23l1538t1052r1835b1121],
57	with	IN	O	with	_	0	SENT_291	[p23l1869t1052r2002b1106],
58	placebo	NN	O	placebo	prep_with	56	SENT_291	[p23l2033t1053r2149b1121, p23l139t1142r280b1195],
59	plus	CC	O	plus	_	0	SENT_291	[p23l313t1142r438b1210],
60	paclitaxel	NN	O	paclitaxel	dobj	53	SENT_291	[p23l471t1142r768b1210],
61	as	IN	O	as	_	0	SENT_291	[p23l804t1158r862b1195],
62	ﬁrst	NN	O	ﬁrst	nn	65	SENT_291	[p23l898t1142r1153b1195],
63	—	CD	NUMBER	—	num	65	SENT_291	[p23l898t1142r1153b1195],
64	line	NN	O	line	nn	65	SENT_291	[p23l898t1142r1153b1195],
65	treatment	NN	O	treatment	prep_as	60	SENT_291	[p23l1187t1149r1476b1195],
66	for	IN	O	for	_	0	SENT_291	[p23l1508t1142r1596b1195],
67	metastatic	JJ	O	metastatic	amod	69	SENT_291	[p23l1628t1142r1936b1195],
68	breast	NN	O	breast	nn	69	SENT_291	[p23l1969t1142r2152b1195],
69	cancer	NN	O	cancer	prep_for	53	SENT_291	[p23l139t1248r351b1284],
70	.	.	O	.	_	0	SENT_291	[p23l139t1248r351b1284],

1	J	NNP	O	J	nn	3	SENT_292	[p23l383t1232r411b1284],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_292	[p23l439t1231r569b1284],
3	Oncol	NNP	PERSON	Oncol	_	0	SENT_292	[p23l597t1231r780b1284],
4	26	CD	NUMBER	26	num	3	SENT_292	[p23l809t1231r1374b1297],
5	(	CD	NUMBER	(	number	6	SENT_292	[p23l809t1231r1374b1297],
6	34	CD	NUMBER	34	num	7	SENT_292	[p23l809t1231r1374b1297],
7	)	NN	O	)	dep	3	SENT_292	[p23l809t1231r1374b1297],
8	:5544	CD	NUMBER	:5544	number	9	SENT_292	[p23l809t1231r1374b1297],
9	—	CD	NUMBER	—	dep	3	SENT_292	[p23l809t1231r1374b1297],
10	5552	CD	NUMBER	5552	dep	9	SENT_292	[p23l809t1231r1374b1297],

1	.	.	O	.	_	0	SENT_293	[p23l88t1363r97b1372],

1	McLeod	NNP	PERSON	McLeod	nn	2	SENT_294	[p23l138t1319r396b1372],
2	HL	NNS	O	hl	nsubj	6	SENT_294	[p23l431t1320r547b1381],
3	,	,	O	,	_	0	SENT_294	[p23l431t1320r547b1381],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_294	[p23l584t1320r768b1372],
5	WE	NNP	O	WE	nsubj	6	SENT_294	[p23l803t1320r921b1372],
6	(	VBD	O	(	_	0	SENT_294	[p23l959t1319r1156b1384],
7	2001	CD	DATE	2001	num	9	SENT_294	[p23l959t1319r1156b1384],
8	)	CD	NUMBER	)	num	9	SENT_294	[p23l959t1319r1156b1384],
9	Pharmacogenomics	NNS	MISC	pharmacogenomic	dobj	6	SENT_294	[p23l1193t1318r1806b1387],
10	:	:	O	:	_	0	SENT_294	[p23l1193t1318r1806b1387],
11	unlocking	VBG	O	unlock	parataxis	6	SENT_294	[p23l1847t1319r2150b1387],
12	the	DT	O	the	det	14	SENT_294	[p23l139t1407r229b1460],
13	human	JJ	O	human	amod	14	SENT_294	[p23l254t1407r461b1460],
14	genome	NN	O	genome	dobj	11	SENT_294	[p23l485t1423r724b1475],
15	for	IN	O	for	_	0	SENT_294	[p23l749t1407r837b1460],
16	better	JJR	O	better	amod	18	SENT_294	[p23l859t1407r1034b1460],
17	drug	NN	O	drug	nn	18	SENT_294	[p23l1057t1407r1194b1475],
18	therapy	NN	O	therapy	prep_for	11	SENT_294	[p23l1219t1407r1461b1475],
19	.	.	O	.	_	0	SENT_294	[p23l1219t1407r1461b1475],

1	Annu	NNP	PERSON	Annu	nn	4	SENT_295	[p23l1489t1407r1656b1460],
2	Rev	NN	PERSON	rev	nn	4	SENT_295	[p23l1681t1408r1801b1460],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_295	[p23l1826t1407r2150b1460],
4	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_295	[p23l139t1496r374b1549],
5	412101-121	CD	NUMBER	412101-121	dep	4	SENT_295	[p23l402t1496r759b1549],

1	.	.	O	.	_	0	SENT_296	[p23l88t1628r97b1637],

1	Hoskins	NNP	ORGANIZATION	Hoskins	nn	2	SENT_297	[p23l139t1584r385b1637],
2	JM	NN	ORGANIZATION	jm	nsubj	15	SENT_297	[p23l428t1585r540b1647],
3	,	,	O	,	_	0	SENT_297	[p23l428t1585r540b1647],
4	Goldberg	NNP	PERSON	Goldberg	nn	5	SENT_297	[p23l586t1584r870b1653],
5	RM	NN	O	rm	appos	2	SENT_297	[p23l913t1585r1046b1647],
6	,	,	O	,	_	0	SENT_297	[p23l913t1585r1046b1647],
7	Qu	NNP	O	Qu	nn	8	SENT_297	[p23l1093t1584r1182b1650],
8	P	NN	O	p	appos	2	SENT_297	[p23l1224t1585r1280b1647],
9	,	,	O	,	_	0	SENT_297	[p23l1224t1585r1280b1647],
10	Ibrahim	NNP	PERSON	Ibrahim	nn	11	SENT_297	[p23l1326t1584r1567b1637],
11	JG	NNP	O	JG	appos	2	SENT_297	[p23l1608t1584r1707b1647],
12	,	,	O	,	_	0	SENT_297	[p23l1608t1584r1707b1647],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_297	[p23l1752t1584r2009b1637],
14	HL	NNS	O	hl	appos	2	SENT_297	[p23l2052t1585r2151b1636],
15	(	VBP	O	(	_	0	SENT_297	[p23l141t1672r337b1737],
16	2007	CD	DATE	2007	num	18	SENT_297	[p23l141t1672r337b1737],
17	)	CD	NUMBER	)	num	18	SENT_297	[p23l141t1672r337b1737],
18	UGT1A1	NN	O	ugt1a1	dobj	15	SENT_297	[p23l372t1672r769b1725],
19	*	CD	NUMBER	*	number	20	SENT_297	[p23l372t1672r769b1725],
20	28	CD	NUMBER	28	num	21	SENT_297	[p23l372t1672r769b1725],
21	genotype	NN	O	genotype	nsubj	25	SENT_297	[p23l805t1680r1082b1740],
22	and	CC	O	and	_	0	SENT_297	[p23l1117t1672r1224b1725],
23	irinotecan	NN	O	irinotecan	nn	24	SENT_297	[p23l1255t1672r1828b1725],
24	—	NN	O	—	conj_and	21	SENT_297	[p23l1255t1672r1828b1725],
25	induced	VBD	O	induce	rcmod	18	SENT_297	[p23l1255t1672r1828b1725],
26	neutrope	NN	O	neutrope	nn	28	SENT_297	[p23l1860t1679r2149b1740],
27	—	CD	NUMBER	—	num	28	SENT_297	[p23l1860t1679r2149b1740],
28	nia	NN	O	nium	dobj	25	SENT_297	[p23l139t1761r246b1814],
29	:	:	O	:	_	0	SENT_297	[p23l139t1761r246b1814],
30	dose	NN	O	dose	nn	31	SENT_297	[p23l280t1761r416b1814],
31	matters	NNS	O	matter	dep	28	SENT_297	[p23l444t1769r683b1814],
32	.	.	O	.	_	0	SENT_297	[p23l444t1769r683b1814],

1	J	NNP	O	J	nn	4	SENT_298	[p23l715t1762r743b1814],
2	Natl	NNP	O	Natl	nn	4	SENT_298	[p23l769t1761r900b1814],
3	Cancer	NNP	O	Cancer	nn	4	SENT_298	[p23l928t1761r1144b1814],
4	Inst	NNP	O	Inst	_	0	SENT_298	[p23l1170t1762r1284b1814],
5	99	CD	NUMBER	99	number	6	SENT_298	[p23l1311t1760r1873b1826],
6	(	CD	NUMBER	(	dep	4	SENT_298	[p23l1311t1760r1873b1826],
7	17	CD	NUMBER	17	num	8	SENT_298	[p23l1311t1760r1873b1826],
8	)	NN	O	)	dep	4	SENT_298	[p23l1311t1760r1873b1826],
9	:1290	CD	NUMBER	:1290	number	10	SENT_298	[p23l1311t1760r1873b1826],
10	—	CD	NUMBER	—	num	11	SENT_298	[p23l1311t1760r1873b1826],
11	1295	CD	DATE	1295	dep	8	SENT_298	[p23l1311t1760r1873b1826],

1	.	.	O	.	_	0	SENT_299	[p23l88t1893r97b1902],

1	Hu	NNP	O	Hu	nn	2	SENT_300	[p23l139t1850r229b1902],
2	Z	NNP	O	Z	dep	15	SENT_300	[p23l251t1850r313b1912],
3	,	,	O	,	_	0	SENT_300	[p23l251t1850r313b1912],
4	Yu	NNP	O	Yu	nn	5	SENT_300	[p23l338t1850r428b1902],
5	Q	NNP	O	Q	appos	2	SENT_300	[p23l452t1849r520b1915],
6	,	,	O	,	_	0	SENT_300	[p23l452t1849r520b1915],
7	Zhao	NNP	PERSON	Zhao	appos	2	SENT_300	[p23l544t1849r699b1902],
8	Y	NN	PERSON	y	dep	15	SENT_300	[p23l722t1850r775b1901],
9	(	CD	NUMBER	(	num	8	SENT_300	[p23l800t1849r996b1914],
10	2010	CD	DATE	2010	number	11	SENT_300	[p23l800t1849r996b1914],
11	)	CD	NUMBER	)	num	13	SENT_300	[p23l800t1849r996b1914],
12	Dose	NN	O	dose	nn	13	SENT_300	[p23l1020t1849r1516b1918],
13	—	NN	O	—	npadvmod	14	SENT_300	[p23l1020t1849r1516b1918],
14	dependent	JJ	O	dependent	amod	15	SENT_300	[p23l1020t1849r1516b1918],
15	association	NN	O	association	dep	19	SENT_300	[p23l1539t1849r1875b1902],
16	between	IN	O	between	_	0	SENT_300	[p23l1897t1849r2151b1902],
17	UGTlAl	NNP	O	UGTlAl	prep_between	15	SENT_300	[p23l138t1937r536b1994],
18	>	JJR	O	>	amod	19	SENT_300	[p23l138t1937r536b1994],
19	x	NN	O	x	dep	20	SENT_300	[p23l138t1937r536b1994],
20	<	JJR	O	<	dep	26	SENT_300	[p23l138t1937r536b1994],
21	28	CD	NUMBER	28	num	22	SENT_300	[p23l138t1937r536b1994],
22	polymorphism	NN	O	polymorphism	dep	20	SENT_300	[p23l567t1936r1013b2005],
23	and	CC	O	and	_	0	SENT_300	[p23l1043t1936r1150b1989],
24	irinotecan	NN	O	irinotecan	nn	25	SENT_300	[p23l1179t1936r1752b1989],
25	—	NN	O	—	dep	20	SENT_300	[p23l1179t1936r1752b1989],
26	induced	VBD	O	induce	_	0	SENT_300	[p23l1179t1936r1752b1989],
27	diarrhoea	NN	O	diarrhoea	dobj	26	SENT_300	[p23l1782t1936r2084b1989],
28	:	:	O	:	_	0	SENT_300	[p23l1782t1936r2084b1989],
29	a	DT	O	a	det	32	SENT_300	[p23l2121t1953r2152b1989],
30	meta	NN	O	meta	nn	32	SENT_300	[p23l139t2025r573b2093],
31	—	NN	O	—	nn	32	SENT_300	[p23l139t2025r573b2093],
32	analysis	NN	O	analysis	dep	27	SENT_300	[p23l139t2025r573b2093],
33	.	.	O	.	_	0	SENT_300	[p23l139t2025r573b2093],

1	Eur	NNP	O	Eur	nn	3	SENT_301	[p23l604t2026r714b2078],
2	J	NNP	O	J	nn	3	SENT_301	[p23l740t2026r768b2078],
3	Cancer	NNP	O	Cancer	_	0	SENT_301	[p23l796t2025r1012b2078],
4	46	CD	NUMBER	46	num	3	SENT_301	[p23l1038t2024r1601b2090],
5	(	CD	NUMBER	(	number	6	SENT_301	[p23l1038t2024r1601b2090],
6	10	CD	NUMBER	10	num	7	SENT_301	[p23l1038t2024r1601b2090],
7	)	NN	O	)	dep	3	SENT_301	[p23l1038t2024r1601b2090],
8	:1856	CD	NUMBER	:1856	number	9	SENT_301	[p23l1038t2024r1601b2090],
9	—	CD	NUMBER	—	dep	3	SENT_301	[p23l1038t2024r1601b2090],
10	1865	CD	DATE	1865	dep	9	SENT_301	[p23l1038t2024r1601b2090],

1	.	.	O	.	_	0	SENT_302	[p23l88t2157r97b2166],

1	Klein	NNP	ORGANIZATION	Klein	nn	2	SENT_303	[p23l140t2113r307b2166],
2	TE	NNP	ORGANIZATION	TE	nsubj	22	SENT_303	[p23l354t2114r462b2176],
3	,	,	O	,	_	0	SENT_303	[p23l354t2114r462b2176],
4	Altman	NNP	PERSON	Altman	nn	5	SENT_303	[p23l512t2113r740b2166],
5	RB	NN	O	rb	appos	2	SENT_303	[p23l787t2114r903b2176],
6	,	,	O	,	_	0	SENT_303	[p23l787t2114r903b2176],
7	Eriksson	NNP	PERSON	Eriksson	nn	8	SENT_303	[p23l952t2113r1218b2166],
8	N	NNP	O	N	appos	2	SENT_303	[p23l1265t2114r1335b2176],
9	,	,	O	,	_	0	SENT_303	[p23l1265t2114r1335b2176],
10	Gage	NNP	PERSON	Gage	nn	11	SENT_303	[p23l1386t2113r1543b2182],
11	BF	NNP	O	BF	appos	2	SENT_303	[p23l1591t2114r1698b2176],
12	,	,	O	,	_	0	SENT_303	[p23l1591t2114r1698b2176],
13	Kimmel	NNP	PERSON	Kimmel	nn	14	SENT_303	[p23l1750t2113r1997b2166],
14	SE	NN	PERSON	se	appos	2	SENT_303	[p23l2047t2113r2148b2176],
15	,	,	O	,	_	0	SENT_303	[p23l2047t2113r2148b2176],
16	International	NNP	ORGANIZATION	International	nn	19	SENT_303	[p23l139t2200r527b2253],
17	Warfarin	NNP	ORGANIZATION	Warfarin	nn	19	SENT_303	[p23l548t2200r824b2253],
18	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	19	SENT_303	[p23l845t2200r1398b2269],
19	Consortium	NNP	ORGANIZATION	Consortium	appos	2	SENT_303	[p23l1422t2200r1781b2253],
20	et	FW	O	et	nn	22	SENT_303	[p23l1801t2208r1855b2253],
21	al	FW	O	al	nn	22	SENT_303	[p23l1877t2200r1928b2253],
22	(	FW	O	(	_	0	SENT_303	[p23l1953t2200r2149b2266],
23	2009	CD	DATE	2009	num	25	SENT_303	[p23l1953t2200r2149b2266],
24	)	CD	NUMBER	)	num	25	SENT_303	[p23l1953t2200r2149b2266],
25	Estimation	NN	O	estimation	dobj	22	SENT_303	[p23l138t2289r469b2342],
26	of	IN	O	of	_	0	SENT_303	[p23l504t2289r570b2342],
27	the	DT	O	the	det	29	SENT_303	[p23l598t2289r689b2342],
28	Warfarin	NNP	MISC	Warfarin	nn	29	SENT_303	[p23l723t2289r980b2342],
29	dose	NN	O	dose	prep_of	25	SENT_303	[p23l1015t2289r1151b2342],
30	with	IN	O	with	_	0	SENT_303	[p23l1186t2289r1319b2342],
31	clinical	JJ	O	clinical	amod	36	SENT_303	[p23l1354t2289r1577b2342],
32	and	CC	O	and	_	0	SENT_303	[p23l1612t2289r1720b2342],
33	pharmacoge	JJ	O	pharmacoge	amod	36	SENT_303	[p23l1752t2289r2149b2357],
34	—	NN	O	—	nn	36	SENT_303	[p23l1752t2289r2149b2357],
35	netic	JJ	O	netic	amod	36	SENT_303	[p23l139t2377r284b2430],
36	data	NNS	O	datum	prep_with	22	SENT_303	[p23l314t2377r455b2430],
37	.	.	O	.	_	0	SENT_303	[p23l314t2377r455b2430],

1	N	NN	O	n	nn	3	SENT_304	[p23l485t2378r539b2430],
2	Engl	NNP	O	Engl	nn	3	SENT_304	[p23l566t2377r709b2446],
3	J	NNP	O	J	nsubj	4	SENT_304	[p23l736t2378r764b2430],
4	Med	VBD	O	med	_	0	SENT_304	[p23l791t2377r930b2430],
5	360	CD	NUMBER	360	number	6	SENT_304	[p23l959t2377r1446b2443],
6	(	CD	NUMBER	(	dobj	4	SENT_304	[p23l959t2377r1446b2443],
7	8	CD	NUMBER	8	num	8	SENT_304	[p23l959t2377r1446b2443],
8	)	NN	O	)	dep	6	SENT_304	[p23l959t2377r1446b2443],
9	:753	CD	NUMBER	:753	num	10	SENT_304	[p23l959t2377r1446b2443],
10	—	NN	O	—	tmod	4	SENT_304	[p23l959t2377r1446b2443],
11	764	CD	NUMBER	764	dep	10	SENT_304	[p23l959t2377r1446b2443],

1	.	.	O	.	_	0	SENT_305	[p23l88t2508r97b2517],

1	Chang	NNP	PERSON	Chang	nn	2	SENT_306	[p23l139t2464r335b2533],
2	H	NNP	PERSON	H	nsubj	40	SENT_306	[p23l365t2465r434b2527],
3	,	,	O	,	_	0	SENT_306	[p23l365t2465r434b2527],
4	Rha	NNP	PERSON	Rha	nn	5	SENT_306	[p23l466t2464r588b2517],
5	SY	NNP	PERSON	SY	dep	24	SENT_306	[p23l618t2465r727b2527],
6	,	,	O	,	_	0	SENT_306	[p23l618t2465r727b2527],
7	Jeung	NNP	PERSON	Jeung	nn	8	SENT_306	[p23l759t2465r934b2533],
8	HC	NNP	O	HC	appos	5	SENT_306	[p23l965t2464r1085b2527],
9	,	,	O	,	_	0	SENT_306	[p23l965t2464r1085b2527],
10	Im	NNP	O	Im	nn	11	SENT_306	[p23l1117t2465r1200b2517],
11	CK	NNP	O	CK	appos	5	SENT_306	[p23l1229t2464r1348b2527],
12	,	,	O	,	_	0	SENT_306	[p23l1229t2464r1348b2527],
13	Noh	NNP	O	Noh	nn	14	SENT_306	[p23l1380t2464r1510b2517],
14	SH	NNP	O	SH	appos	5	SENT_306	[p23l1541t2464r1650b2527],
15	,	,	O	,	_	0	SENT_306	[p23l1541t2464r1650b2527],
16	Kim	NNP	PERSON	Kim	nn	17	SENT_306	[p23l1683t2464r1816b2517],
17	JJ	NN	PERSON	jj	appos	5	SENT_306	[p23l1844t2465r1917b2527],
18	,	,	O	,	_	0	SENT_306	[p23l1844t2465r1917b2527],
19	Chung	NNP	PERSON	Chung	nn	20	SENT_306	[p23l1951t2464r2151b2533],
20	HC	NNP	PERSON	HC	appos	5	SENT_306	[p23l139t2553r241b2605],
21	(	CD	NUMBER	(	dep	24	SENT_306	[p23l274t2552r471b2618],
22	2010	CD	DATE	2010	num	24	SENT_306	[p23l274t2552r471b2618],
23	)	NNP	O	)	nn	24	SENT_306	[p23l274t2552r471b2618],
24	Association	NNP	O	Association	dep	30	SENT_306	[p23l503t2552r862b2605],
25	of	IN	O	of	_	0	SENT_306	[p23l893t2552r959b2605],
26	the	DT	O	the	det	28	SENT_306	[p23l983t2552r1074b2605],
27	ABCB1	NN	O	abcb1	nn	28	SENT_306	[p23l1105t2552r1341b2605],
28	3435C	NN	O	3435c	prep_of	24	SENT_306	[p23l1380t2552r1677b2605],
29	>	JJR	O	>	amod	30	SENT_306	[p23l1380t2552r1677b2605],
30	T	NN	O	t	dep	34	SENT_306	[p23l1380t2552r1677b2605],
31	polymorphism	NN	O	polymorphism	nn	34	SENT_306	[p23l1706t2552r2152b2621],
32	and	CC	O	and	_	0	SENT_306	[p23l140t2641r247b2694],
33	treatment	NN	O	treatment	nn	34	SENT_306	[p23l296t2649r585b2694],
34	outcomes	NNS	O	outcome	dep	2	SENT_306	[p23l634t2649r923b2694],
35	in	IN	O	in	_	0	SENT_306	[p23l973t2641r1031b2693],
36	advanced	JJ	O	advanced	amod	39	SENT_306	[p23l1081t2641r1367b2694],
37	gastric	JJ	O	gastric	amod	39	SENT_306	[p23l1417t2641r1617b2710],
38	cancer	NN	O	cancer	nn	39	SENT_306	[p23l1668t2658r1867b2694],
39	patients	NNS	O	patient	prep_in	34	SENT_306	[p23l1914t2641r2149b2710],
40	treated	VBN	O	treat	_	0	SENT_306	[p23l139t2729r346b2782],
41	with	IN	O	with	_	0	SENT_306	[p23l430t2729r563b2782],
42	paclitaxel-based	JJ	O	paclitaxel-based	amod	43	SENT_306	[p23l646t2729r1143b2798],
43	chemotherapy	NN	O	chemotherapy	prep_with	40	SENT_306	[p23l1227t2729r1674b2798],
44	.	.	O	.	_	0	SENT_306	[p23l1227t2729r1674b2798],

1	Oncol	NNP	O	Oncol	nn	2	SENT_307	[p23l1763t2729r1946b2782],
2	Rep	NNP	O	Rep	_	0	SENT_307	[p23l2030t2730r2150b2798],
3	23	CD	NUMBER	23	num	4	SENT_307	[p23l140t2817r588b2883],
4	(	NN	O	(	dep	2	SENT_307	[p23l140t2817r588b2883],
5	1	CD	NUMBER	1	number	6	SENT_307	[p23l140t2817r588b2883],
6	)	CD	NUMBER	)	dep	4	SENT_307	[p23l140t2817r588b2883],
7	:271	CD	NUMBER	:271	num	8	SENT_307	[p23l140t2817r588b2883],
8	—	NN	O	—	dep	6	SENT_307	[p23l140t2817r588b2883],
9	278	CD	NUMBER	278	dep	2	SENT_307	[p23l140t2817r588b2883],

1	.	.	O	.	_	0	SENT_308	[p23l88t2949r97b2958],

1	Chang	NNP	PERSON	Chang	nn	2	SENT_309	[p23l139t2905r335b2974],
2	H	NNP	PERSON	H	_	0	SENT_309	[p23l356t2907r426b2968],
3	,	,	O	,	_	0	SENT_309	[p23l356t2907r426b2968],
4	Rha	NNP	PERSON	Rha	nn	5	SENT_309	[p23l448t2905r571b2958],
5	SY	NNP	PERSON	SY	appos	2	SENT_309	[p23l592t2906r701b2968],
6	,	,	O	,	_	0	SENT_309	[p23l592t2906r701b2968],
7	Jeung	NNP	ORGANIZATION	Jeung	nn	8	SENT_309	[p23l724t2907r900b2974],
8	H	NN	ORGANIZATION	h	appos	5	SENT_309	[p23l921t2907r1015b2968],
9	-	:	O	-	_	0	SENT_309	[p23l921t2907r1015b2968],
10	,	,	O	,	_	0	SENT_309	[p23l921t2907r1015b2968],
11	Im	NN	O	im	appos	2	SENT_309	[p23l1039t2907r1122b2958],
12	C	NN	O	c	dep	38	SENT_309	[p23l1143t2906r1232b2968],
13	-	:	O	-	_	0	SENT_309	[p23l1143t2906r1232b2968],
14	,	,	O	,	_	0	SENT_309	[p23l1143t2906r1232b2968],
15	Ahn	NNP	PERSON	Ahn	nn	16	SENT_309	[p23l1255t2905r1384b2958],
16	JB	NNP	PERSON	JB	dep	32	SENT_309	[p23l1405t2907r1500b2968],
17	,	,	O	,	_	0	SENT_309	[p23l1405t2907r1500b2968],
18	Kwon	NNP	PERSON	Kwon	nn	19	SENT_309	[p23l1524t2907r1707b2959],
19	WS	NNP	O	WS	appos	16	SENT_309	[p23l1726t2906r1856b2968],
20	,	,	O	,	_	0	SENT_309	[p23l1726t2906r1856b2968],
21	Yoo	NNP	ORGANIZATION	Yoo	nn	22	SENT_309	[p23l1879t2907r2007b2958],
22	NC	NNP	ORGANIZATION	NC	appos	16	SENT_309	[p23l2028t2906r2149b2968],
23	,	,	O	,	_	0	SENT_309	[p23l2028t2906r2149b2968],
24	Roh	NNP	PERSON	Roh	nn	25	SENT_309	[p23l139t2994r264b3047],
25	JK	NNP	O	JK	appos	16	SENT_309	[p23l305t2995r404b3057],
26	,	,	O	,	_	0	SENT_309	[p23l305t2995r404b3057],
27	Chung	NNP	PERSON	Chung	nn	28	SENT_309	[p23l450t2994r650b3063],
28	HC	NNP	PERSON	HC	appos	16	SENT_309	[p23l694t2994r796b3047],
29	(	CD	NUMBER	(	dep	32	SENT_309	[p23l842t2994r1039b3059],
30	2009	CD	DATE	2009	num	32	SENT_309	[p23l842t2994r1039b3059],
31	)	NNP	O	)	nn	32	SENT_309	[p23l842t2994r1039b3059],
32	Association	NNP	O	Association	dep	38	SENT_309	[p23l1083t2994r1442b3047],
33	of	IN	O	of	_	0	SENT_309	[p23l1485t2994r1551b3047],
34	the	DT	O	the	det	35	SENT_309	[p23l1589t2994r1680b3047],
35	ABCB1	NN	O	abcb1	prep_of	32	SENT_309	[p23l1722t2994r1959b3047],
36	gene	NN	O	gene	nn	37	SENT_309	[p23l2009t3011r2151b3063],
37	polymorphisms	NNS	O	polymorphism	nsubj	38	SENT_309	[p23l138t3081r610b3150],
38	2677G	VBP	O	2677g	rcmod	11	SENT_309	[p23l692t3081r1071b3135],
39	>	JJR	O	>	amod	40	SENT_309	[p23l692t3081r1071b3135],
40	T/A	NN	O	t/a	dobj	38	SENT_309	[p23l692t3081r1071b3135],
41	and	CC	O	and	_	0	SENT_309	[p23l1151t3081r1258b3134],
42	3435C	NN	O	3435c	appos	2	SENT_309	[p23l1338t3081r1635b3134],
43	>	JJR	O	>	amod	44	SENT_309	[p23l1338t3081r1635b3134],
44	T	NN	O	t	dep	42	SENT_309	[p23l1338t3081r1635b3134],
45	with	IN	O	with	_	0	SENT_309	[p23l1715t3081r1848b3134],
46	clinical	JJ	O	clinical	prep_with	44	SENT_309	[p23l1927t3081r2150b3134],

1	@	IN	O	@	_	0	SENT_310	[p24l6t88r83b183],
2	Springer	NNP	PERSON	Springer	nn	3	SENT_310	[p24l113t111r376b186],
3	outcomes	NNS	O	outcome	pobj	1	SENT_310	[p24l138t206r426b252],
4	of	IN	O	of	_	0	SENT_310	[p24l459t198r525b252],
5	paclitaxel	NN	O	paclitaxel	nn	6	SENT_310	[p24l550t198r846b267],
6	monotherapy	NN	O	monotherapy	prep_of	3	SENT_310	[p24l878t199r1278b267],
7	in	IN	O	in	_	0	SENT_310	[p24l1309t198r1367b251],
8	metastatic	JJ	O	metastatic	amod	11	SENT_310	[p24l1398t198r1705b252],
9	breast	NN	O	breast	nn	11	SENT_310	[p24l1737t199r1919b252],
10	cancer	NN	O	cancer	nn	11	SENT_310	[p24l1950t215r2148b252],
11	patients	NNS	O	patient	prep_in	6	SENT_310	[p24l136t286r388b355],
12	.	.	O	.	_	0	SENT_310	[p24l136t286r388b355],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_311	[p24l419t287r549b339],
2	Oncol	NNP	PERSON	Oncol	dep	11	SENT_311	[p24l577t286r760b340],
3	20	CD	NUMBER	20	num	4	SENT_311	[p24l789t287r1237b352],
4	(	NN	O	(	dep	2	SENT_311	[p24l789t287r1237b352],
5	2	CD	NUMBER	2	number	6	SENT_311	[p24l789t287r1237b352],
6	)	CD	NUMBER	)	dep	4	SENT_311	[p24l789t287r1237b352],
7	:272	CD	NUMBER	:272	num	8	SENT_311	[p24l789t287r1237b352],
8	—	NN	O	—	dep	11	SENT_311	[p24l789t287r1237b352],
9	277	CD	NUMBER	277	num	11	SENT_311	[p24l789t287r1237b352],
10	Green	NN	O	green	nn	11	SENT_311	[p24l138t375r321b428],
11	H	NN	O	h	dep	25	SENT_311	[p24l362t376r430b437],
12	,	,	O	,	_	0	SENT_311	[p24l362t376r430b437],
13	Soderkvist	NN	O	soderkvist	nn	14	SENT_311	[p24l475t374r798b428],
14	P	NN	O	p	appos	11	SENT_311	[p24l836t376r893b437],
15	,	,	O	,	_	0	SENT_311	[p24l836t376r893b437],
16	Rosenberg	NNP	PERSON	Rosenberg	nn	17	SENT_311	[p24l936t374r1259b443],
17	P	NN	O	p	appos	11	SENT_311	[p24l1300t376r1356b437],
18	,	,	O	,	_	0	SENT_311	[p24l1300t376r1356b437],
19	Horvath	NNP	PERSON	Horvath	nn	20	SENT_311	[p24l1399t374r1646b427],
20	G	NNP	O	G	appos	11	SENT_311	[p24l1687t375r1755b437],
21	,	,	O	,	_	0	SENT_311	[p24l1687t375r1755b437],
22	Peterson	NNP	PERSON	Peterson	nn	23	SENT_311	[p24l1797t376r2058b427],
23	C	NNP	O	C	appos	11	SENT_311	[p24l2099t375r2145b428],
24	(	JJ	O	(	amod	25	SENT_311	[p24l140t462r336b528],
25	2006	CD	DATE	2006	dep	32	SENT_311	[p24l140t462r336b528],
26	)	CD	NUMBER	)	num	28	SENT_311	[p24l140t462r336b528],
27	Mdr	NN	O	mdr	nn	28	SENT_311	[p24l361t463r547b516],
28	—	NN	O	—	dep	25	SENT_311	[p24l361t463r547b516],
29	1	CD	NUMBER	1	num	32	SENT_311	[p24l361t463r547b516],
30	single	JJ	O	single	amod	32	SENT_311	[p24l580t462r757b531],
31	nucleotide	NN	O	nucleotide	nn	32	SENT_311	[p24l781t462r1097b516],
32	polymorphisms	NNS	O	polymorphism	dep	38	SENT_311	[p24l1120t462r1593b531],
33	in	IN	O	in	_	0	SENT_311	[p24l1617t462r1675b515],
34	ovarian	JJ	O	ovarian	amod	36	SENT_311	[p24l1699t462r1926b516],
35	cancer	NN	O	cancer	nn	36	SENT_311	[p24l1950t479r2148b516],
36	tissue	NN	O	tissue	prep_in	32	SENT_311	[p24l137t550r325b603],
37	:	:	O	:	_	0	SENT_311	[p24l137t550r325b603],
38	G2677T/A	NN	O	g2677t/a	_	0	SENT_311	[p24l362t550r689b604],
39	correlates	VBZ	O	correlate	rcmod	38	SENT_311	[p24l720t550r1013b603],
40	with	IN	O	with	_	0	SENT_311	[p24l1046t550r1179b603],
41	response	NN	O	response	prep_with	39	SENT_311	[p24l1209t567r1474b619],
42	to	TO	O	to	_	0	SENT_311	[p24l1505t558r1561b603],
43	paclitaxel	NN	O	paclitaxel	nn	44	SENT_311	[p24l1592t550r1889b619],
44	chemotherapy	NN	O	chemotherapy	prep_to	39	SENT_311	[p24l1920t550r2145b603, p24l137t638r380b707],
45	.	.	O	.	_	0	SENT_311	[p24l1920t550r2145b603, p24l137t638r380b707],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_312	[p24l412t638r541b692],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_312	[p24l569t639r784b692],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_312	[p24l810t640r921b691],
4	12	CD	NUMBER	12	number	5	SENT_312	[p24l958t638r1400b704],
5	(	CD	NUMBER	(	dep	3	SENT_312	[p24l958t638r1400b704],
6	3	CD	NUMBER	3	num	7	SENT_312	[p24l958t638r1400b704],
7	)	NN	O	)	dep	5	SENT_312	[p24l958t638r1400b704],
8	:854	CD	NUMBER	:854	num	9	SENT_312	[p24l958t638r1400b704],
9	—	NN	O	—	dep	3	SENT_312	[p24l958t638r1400b704],
10	859	CD	NUMBER	859	num	12	SENT_312	[p24l958t638r1400b704],
11	Leskela	NN	O	leskelum	nn	12	SENT_312	[p24l137t727r374b781],
12	S	NN	O	s	dep	9	SENT_312	[p24l402t728r456b791],
13	,	,	O	,	_	0	SENT_312	[p24l402t728r456b791],
14	Jara	NNP	PERSON	Jara	nn	15	SENT_312	[p24l485t729r607b781],
15	C	NNP	O	C	appos	3	SENT_312	[p24l633t728r697b790],
16	,	,	O	,	_	0	SENT_312	[p24l633t728r697b790],
17	Leandro	NNP	PERSON	Leandro	appos	3	SENT_312	[p24l726t727r1209b781],
18	.	.	O	.	_	0	SENT_312	[p24l726t727r1209b781],

1	—	NN	O	—	_	0	SENT_313	[p24l726t727r1209b781],
2	.	.	O	.	_	0	SENT_313	[p24l726t727r1209b781],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_314	[p24l726t727r1209b781],
2	L	NNP	PERSON	L	_	0	SENT_314	[p24l1235t729r1297b791],
3	,	,	O	,	_	0	SENT_314	[p24l1235t729r1297b791],
4	Martinez	NNP	PERSON	Martinez	nn	5	SENT_314	[p24l1326t728r1599b781],
5	A	NNP	O	A	appos	2	SENT_314	[p24l1626t728r1695b790],
6	,	,	O	,	_	0	SENT_314	[p24l1626t728r1695b790],
7	Garcia-Donas	NNP	PERSON	Garcia-Donas	nn	8	SENT_314	[p24l1726t727r2145b781],
8	J	NNP	PERSON	J	appos	5	SENT_314	[p24l137t818r180b880],
9	,	,	O	,	_	0	SENT_314	[p24l137t818r180b880],
10	Hemando	NNP	PERSON	Hemando	nn	11	SENT_314	[p24l228t817r526b870],
11	S	NNP	O	S	appos	5	SENT_314	[p24l574t817r628b880],
12	,	,	O	,	_	0	SENT_314	[p24l574t817r628b880],
13	Hurtado	NNP	PERSON	Hurtado	nn	14	SENT_314	[p24l675t817r922b870],
14	A	NNP	O	A	appos	5	SENT_314	[p24l967t817r1037b880],
15	,	,	O	,	_	0	SENT_314	[p24l967t817r1037b880],
16	Vicario	NNP	ORGANIZATION	Vicario	nn	17	SENT_314	[p24l1085t817r1311b870],
17	JCC	NNP	ORGANIZATION	JCC	appos	5	SENT_314	[p24l1356t817r1502b880],
18	,	,	O	,	_	0	SENT_314	[p24l1356t817r1502b880],
19	Montero-Conde	NNP	O	Montero-Conde	nn	20	SENT_314	[p24l1548t817r2033b870],
20	C	NNP	O	C	appos	5	SENT_314	[p24l2080t817r2144b880],
21	,	,	O	,	_	0	SENT_314	[p24l2080t817r2144b880],
22	Landa	NNP	PERSON	Landa	nn	23	SENT_314	[p24l137t904r327b957],
23	I	NNP	O	I	appos	5	SENT_314	[p24l361t906r401b967],
24	,	,	O	,	_	0	SENT_314	[p24l361t906r401b967],
25	Lopez-Jimenez	NNP	O	Lopez-Jimenez	nn	26	SENT_314	[p24l439t904r904b973],
26	E	NNP	O	E	appos	5	SENT_314	[p24l940t906r1001b967],
27	,	,	O	,	_	0	SENT_314	[p24l940t906r1001b967],
28	Cascon	NNP	O	Cascon	nn	29	SENT_314	[p24l1040t905r1262b958],
29	A	NNP	O	A	appos	5	SENT_314	[p24l1297t905r1366b967],
30	,	,	O	,	_	0	SENT_314	[p24l1297t905r1366b967],
31	Milne	NNP	ORGANIZATION	Milne	nn	32	SENT_314	[p24l1404t904r1584b957],
32	RL	NNP	ORGANIZATION	RL	appos	5	SENT_314	[p24l1620t906r1732b967],
33	,	,	O	,	_	0	SENT_314	[p24l1620t906r1732b967],
34	Robeldo	NNP	O	Robeldo	nn	35	SENT_314	[p24l1771t904r2026b957],
35	M	NNP	O	M	appos	5	SENT_314	[p24l2062t906r2144b967],
36	,	,	O	,	_	0	SENT_314	[p24l2062t906r2144b967],
37	Rodriguez	NNP	PERSON	Rodriguez	appos	5	SENT_314	[p24l137t992r704b1061],
38	.	.	O	.	_	0	SENT_314	[p24l137t992r704b1061],

1	—	NN	O	—	_	0	SENT_315	[p24l137t992r704b1061],
2	.	.	O	.	_	0	SENT_315	[p24l137t992r704b1061],

1	Antona	NN	O	antona	nn	2	SENT_316	[p24l137t992r704b1061],
2	C	NN	O	c	nsubjpass	14	SENT_316	[p24l758t993r805b1046],
3	(	CD	NUMBER	(	num	6	SENT_316	[p24l863t993r1059b1058],
4	2011	CD	DATE	2011	num	6	SENT_316	[p24l863t993r1059b1058],
5	)	CD	NUMBER	)	num	6	SENT_316	[p24l863t993r1059b1058],
6	Polymorphisms	NNS	O	polymorphism	dep	2	SENT_316	[p24l1116t992r1591b1061],
7	in	IN	O	in	_	0	SENT_316	[p24l1647t992r1705b1045],
8	cytochromes	NNS	O	cytochrome	nn	10	SENT_316	[p24l1759t992r2145b1061],
9	P450	NN	O	p450	nn	10	SENT_316	[p24l137t1081r291b1134],
10	2C8	NN	O	2c8	prep_in	6	SENT_316	[p24l322t1081r443b1134],
11	and	CC	O	and	_	0	SENT_316	[p24l476t1081r584b1134],
12	3A5	NN	O	3a5	nsubjpass	14	SENT_316	[p24l615t1081r738b1134],
13	are	VBP	O	be	auxpass	14	SENT_316	[p24l772t1097r862b1134],
14	associated	VBN	O	associate	_	0	SENT_316	[p24l893t1081r1204b1134],
15	with	IN	O	with	_	0	SENT_316	[p24l1234t1081r1367b1134],
16	paclitaxel	NN	O	paclitaxel	nn	17	SENT_316	[p24l1395t1081r1692b1149],
17	neurotoxicity	NN	O	neurotoxicity	prep_with	14	SENT_316	[p24l1722t1081r2143b1150],
18	.	.	O	.	_	0	SENT_316	[p24l1722t1081r2143b1150],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nn	2	SENT_317	[p24l137t1169r732b1237],
2	J	NN	O	j	dep	11	SENT_317	[p24l761t1170r789b1222],
3	11	CD	NUMBER	11	num	4	SENT_317	[p24l824t1169r1266b1234],
4	(	NN	O	(	dep	2	SENT_317	[p24l824t1169r1266b1234],
5	2	CD	NUMBER	2	number	6	SENT_317	[p24l824t1169r1266b1234],
6	)	CD	NUMBER	)	num	7	SENT_317	[p24l824t1169r1266b1234],
7	:121	CD	NUMBER	:121	dep	4	SENT_317	[p24l824t1169r1266b1234],
8	—	NN	O	—	dep	11	SENT_317	[p24l824t1169r1266b1234],
9	129	CD	NUMBER	129	num	8	SENT_317	[p24l824t1169r1266b1234],
10	Petros	NNP	PERSON	Petros	nn	11	SENT_317	[p24l137t1258r324b1310],
11	WP	NNP	PERSON	WP	dep	39	SENT_317	[p24l357t1258r486b1320],
12	,	,	O	,	_	0	SENT_317	[p24l357t1258r486b1320],
13	Hopkins	NNP	PERSON	Hopkins	nn	14	SENT_317	[p24l521t1256r775b1325],
14	PJ	NNP	PERSON	PJ	appos	11	SENT_317	[p24l808t1258r894b1319],
15	,	,	O	,	_	0	SENT_317	[p24l808t1258r894b1319],
16	Spruill	NNP	PERSON	Spruill	nn	17	SENT_317	[p24l930t1256r1134b1325],
17	S	NNP	O	S	appos	11	SENT_317	[p24l1168t1257r1222b1319],
18	,	,	O	,	_	0	SENT_317	[p24l1168t1257r1222b1319],
19	Broadwater	NNP	ORGANIZATION	Broadwater	nn	20	SENT_317	[p24l1256t1257r1612b1310],
20	G	NNP	ORGANIZATION	G	appos	11	SENT_317	[p24l1644t1257r1712b1319],
21	,	,	O	,	_	0	SENT_317	[p24l1644t1257r1712b1319],
22	Vredenburgh	NNP	PERSON	Vredenburgh	nn	23	SENT_317	[p24l1747t1257r2147b1325],
23	JJ	NN	PERSON	jj	appos	11	SENT_317	[p24l137t1347r210b1409],
24	,	,	O	,	_	0	SENT_317	[p24l137t1347r210b1409],
25	Colvin	NNP	ORGANIZATION	Colvin	nn	26	SENT_317	[p24l244t1346r450b1399],
26	OM	NNP	ORGANIZATION	OM	appos	11	SENT_317	[p24l482t1346r617b1409],
27	,	,	O	,	_	0	SENT_317	[p24l482t1346r617b1409],
28	Peters	NNP	PERSON	Peters	nn	29	SENT_317	[p24l650t1347r833b1399],
29	WP	NNP	O	WP	appos	11	SENT_317	[p24l865t1347r994b1409],
30	,	,	O	,	_	0	SENT_317	[p24l865t1347r994b1409],
31	Jones	NNP	PERSON	Jones	nn	32	SENT_317	[p24l1028t1347r1193b1399],
32	RB	NN	O	rb	appos	11	SENT_317	[p24l1226t1347r1342b1409],
33	,	,	O	,	_	0	SENT_317	[p24l1226t1347r1342b1409],
34	Hall	NNP	O	Hall	nn	35	SENT_317	[p24l1375t1346r1505b1399],
35	J	NNP	O	J	appos	11	SENT_317	[p24l1536t1347r1564b1399],
36	,	,	O	,	_	0	SENT_317	[p24l1569t1390r1580b1409],
37	Marks	NNP	O	Marks	nn	38	SENT_317	[p24l1613t1346r1804b1399],
38	JR	NNP	O	JR	appos	11	SENT_317	[p24l1836t1347r1916b1399],
39	(	VBD	O	(	_	0	SENT_317	[p24l1949t1346r2145b1411],
40	2005	CD	DATE	2005	num	42	SENT_317	[p24l1949t1346r2145b1411],
41	)	CD	NUMBER	)	num	42	SENT_317	[p24l1949t1346r2145b1411],
42	Associations	NNS	O	association	dobj	39	SENT_317	[p24l137t1434r523b1487],
43	between	IN	O	between	_	0	SENT_317	[p24l553t1434r807b1487],
44	drug	NN	O	drug	nn	46	SENT_317	[p24l837t1434r973b1502],
45	metabolism	NN	O	metabolism	nn	46	SENT_317	[p24l1004t1434r1360b1487],
46	genotype	NN	O	genotype	prep_between	39	SENT_317	[p24l1389t1442r1683b1502],
47	,	,	O	,	_	0	SENT_317	[p24l1389t1442r1683b1502],
48	chemotherapy	NN	O	chemotherapy	nn	49	SENT_317	[p24l1716t1434r2146b1502],
49	pharmacokinetics	NNS	O	pharmacokinetic	prep_between	39	SENT_317	[p24l136t1522r691b1591],
50	,	,	O	,	_	0	SENT_317	[p24l136t1522r691b1591],
51	and	CC	O	and	_	0	SENT_317	[p24l736t1522r843b1575],
52	overall	JJ	O	overall	amod	53	SENT_317	[p24l884t1522r1093b1575],
53	survival	NN	O	survival	prep_between	39	SENT_317	[p24l1137t1522r1378b1575],
54	in	IN	O	in	_	0	SENT_317	[p24l1418t1522r1476b1574],
55	patients	NNS	O	patient	prep_in	39	SENT_317	[p24l1515t1522r1750b1591],
56	with	IN	O	with	_	0	SENT_317	[p24l1793t1522r1926b1575],
57	breast	NN	O	breast	nn	58	SENT_317	[p24l1965t1522r2148b1575],
58	cancer	NN	O	cancer	prep_with	55	SENT_317	[p24l138t1627r350b1664],
59	.	.	O	.	_	0	SENT_317	[p24l138t1627r350b1664],

1	J	NNP	O	J	nn	3	SENT_318	[p24l381t1612r409b1664],
2	Clin	NNP	O	Clin	nn	3	SENT_318	[p24l438t1610r567b1664],
3	Oncol	NNP	O	Oncol	_	0	SENT_318	[p24l595t1611r778b1664],
4	23	CD	NUMBER	23	number	5	SENT_318	[p24l806t1610r1367b1676],
5	(	CD	NUMBER	(	dep	3	SENT_318	[p24l806t1610r1367b1676],
6	25	CD	NUMBER	25	num	7	SENT_318	[p24l806t1610r1367b1676],
7	)	NN	O	)	dep	5	SENT_318	[p24l806t1610r1367b1676],
8	:6117	CD	NUMBER	:6117	number	9	SENT_318	[p24l806t1610r1367b1676],
9	—	CD	NUMBER	—	dep	3	SENT_318	[p24l806t1610r1367b1676],
10	6125	CD	NUMBER	6125	num	12	SENT_318	[p24l806t1610r1367b1676],
11	Marsh	NNP	O	Marsh	nn	12	SENT_318	[p24l137t1699r330b1752],
12	S	NN	O	s	dep	9	SENT_318	[p24l366t1699r420b1762],
13	,	,	O	,	_	0	SENT_318	[p24l366t1699r420b1762],
14	Somlo	NNP	O	Somlo	nn	15	SENT_318	[p24l460t1699r655b1752],
15	G	NNP	O	G	appos	3	SENT_318	[p24l691t1699r759b1762],
16	,	,	O	,	_	0	SENT_318	[p24l691t1699r759b1762],
17	Li	NNP	PERSON	Li	nn	18	SENT_318	[p24l796t1699r862b1751],
18	X	NNP	PERSON	X	appos	15	SENT_318	[p24l897t1700r967b1761],
19	,	,	O	,	_	0	SENT_318	[p24l897t1700r967b1761],
20	Frankel	NNP	PERSON	Frankel	nn	21	SENT_318	[p24l1004t1699r1235b1752],
21	P	NN	O	p	appos	15	SENT_318	[p24l1271t1700r1327b1762],
22	,	,	O	,	_	0	SENT_318	[p24l1271t1700r1327b1762],
23	King	NNP	O	King	nn	24	SENT_318	[p24l1366t1699r1514b1768],
24	CR	NN	O	cr	appos	15	SENT_318	[p24l1551t1699r1666b1762],
25	,	,	O	,	_	0	SENT_318	[p24l1551t1699r1666b1762],
26	Shannon	NNP	PERSON	Shannon	nn	27	SENT_318	[p24l1706t1699r1969b1752],
27	WD	NNP	O	WD	appos	15	SENT_318	[p24l2002t1700r2144b1761],
28	,	,	O	,	_	0	SENT_318	[p24l2002t1700r2144b1761],
29	McLeod	NNP	PERSON	McLeod	nn	30	SENT_318	[p24l137t1787r394b1840],
30	HL	NNS	O	hl	appos	15	SENT_318	[p24l432t1788r548b1850],
31	,	,	O	,	_	0	SENT_318	[p24l432t1788r548b1850],
32	Synold	JJ	O	synold	amod	33	SENT_318	[p24l592t1787r804b1856],
33	TW	NNP	O	TW	appos	15	SENT_318	[p24l843t1788r960b1840],
34	(	CD	NUMBER	(	num	35	SENT_318	[p24l1001t1787r1197b1853],
35	2007	CD	DATE	2007	dep	33	SENT_318	[p24l1001t1787r1197b1853],
36	)	CD	NUMBER	)	num	38	SENT_318	[p24l1001t1787r1197b1853],
37	Pharmacogenetic	JJ	O	pharmacogenetic	amod	38	SENT_318	[p24l1239t1787r1762b1856],
38	analysis	NN	O	analysis	dep	3	SENT_318	[p24l1804t1787r2045b1856],
39	of	IN	O	of	_	0	SENT_318	[p24l2086t1787r2152b1840],
40	paclitaxel	NN	O	paclitaxel	nn	41	SENT_318	[p24l136t1874r433b1943],
41	transport	NN	O	transport	prep_of	38	SENT_318	[p24l484t1883r754b1943],
42	and	CC	O	and	_	0	SENT_318	[p24l805t1875r913b1928],
43	metabolism	NN	O	metabolism	nn	44	SENT_318	[p24l963t1874r1318b1928],
44	genes	NNS	O	gene	conj_and	41	SENT_318	[p24l1369t1891r1539b1943],
45	in	IN	O	in	_	0	SENT_318	[p24l1591t1874r1649b1927],
46	breast	NN	O	breast	nn	47	SENT_318	[p24l1698t1875r1880b1928],
47	cancer	NN	O	cancer	prep_in	38	SENT_318	[p24l1930t1891r2142b1928],
48	.	.	O	.	_	0	SENT_318	[p24l1930t1891r2142b1928],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_319	[p24l137t1963r732b2031],
2	J	NN	O	j	rcmod	1	SENT_319	[p24l761t1964r789b2016],
3	7	CD	NUMBER	7	num	4	SENT_319	[p24l817t1962r1226b2028],
4	(	NN	O	(	dep	11	SENT_319	[p24l817t1962r1226b2028],
5	5	CD	NUMBER	5	number	6	SENT_319	[p24l817t1962r1226b2028],
6	)	CD	NUMBER	)	dep	4	SENT_319	[p24l817t1962r1226b2028],
7	:362	CD	NUMBER	:362	dep	6	SENT_319	[p24l817t1962r1226b2028],
8	—	NN	O	—	dep	11	SENT_319	[p24l817t1962r1226b2028],
9	365	CD	NUMBER	365	num	8	SENT_319	[p24l817t1962r1226b2028],
10	Kroetz	NNP	ORGANIZATION	Kroetz	nn	11	SENT_319	[p24l139t2052r342b2104],
11	DL	NNP	ORGANIZATION	DL	dep	61	SENT_319	[p24l368t2052r484b2114],
12	,	,	O	,	_	0	SENT_319	[p24l368t2052r484b2114],
13	Baldwin	NNP	PERSON	Baldwin	nn	14	SENT_319	[p24l511t2051r768b2104],
14	RM	NN	O	rm	conj_and	11	SENT_319	[p24l794t2052r926b2114],
15	,	,	O	,	_	0	SENT_319	[p24l794t2052r926b2114],
16	Owzar	JJ	ORGANIZATION	owzar	amod	17	SENT_319	[p24l955t2051r1156b2104],
17	K	NN	ORGANIZATION	k	conj_and	11	SENT_319	[p24l1182t2052r1249b2114],
18	,	,	O	,	_	0	SENT_319	[p24l1182t2052r1249b2114],
19	Jiang	NNP	PERSON	Jiang	nn	20	SENT_319	[p24l1277t2051r1435b2120],
20	C	NNP	O	C	conj_and	11	SENT_319	[p24l1462t2051r1526b2114],
21	,	,	O	,	_	0	SENT_319	[p24l1462t2051r1526b2114],
22	Zembutsu	NNP	O	Zembutsu	nn	23	SENT_319	[p24l1554t2051r1857b2104],
23	H	NNP	O	H	conj_and	11	SENT_319	[p24l1883t2052r1952b2114],
24	,	,	O	,	_	0	SENT_319	[p24l1883t2052r1952b2114],
25	Kubo	NNP	PERSON	Kubo	nn	26	SENT_319	[p24l1981t2051r2146b2104],
26	M	NNP	O	M	conj_and	11	SENT_319	[p24l137t2140r219b2202],
27	,	,	O	,	_	0	SENT_319	[p24l137t2140r219b2202],
28	Nakamura	NNP	PERSON	Nakamura	nn	29	SENT_319	[p24l244t2139r562b2193],
29	Y	NN	PERSON	y	conj_and	11	SENT_319	[p24l585t2140r653b2202],
30	,	,	O	,	_	0	SENT_319	[p24l585t2140r653b2202],
31	Shulman	NNP	PERSON	Shulman	nn	32	SENT_319	[p24l682t2139r949b2193],
32	LN	NN	O	ln	conj_and	11	SENT_319	[p24l972t2140r1088b2202],
33	,	,	O	,	_	0	SENT_319	[p24l972t2140r1088b2202],
34	Ratain	NNP	O	Ratain	nn	35	SENT_319	[p24l1114t2139r1312b2192],
35	MJ	NNP	O	MJ	dep	61	SENT_319	[p24l1335t2140r1447b2202],
36	,	,	O	,	_	0	SENT_319	[p24l1335t2140r1447b2202],
37	Cancer	NNP	O	Cancer	dep	61	SENT_319	[p24l1474t2139r1689b2193],
38	and	CC	O	and	_	0	SENT_319	[p24l1712t2139r1820b2192],
39	Leukemia	NNP	ORGANIZATION	Leukemia	nn	42	SENT_319	[p24l1842t2139r2148b2192],
40	Group	NNP	ORGANIZATION	Group	nn	42	SENT_319	[p24l138t2228r328b2296],
41	B.	NNP	ORGANIZATION	B.	nn	42	SENT_319	[p24l363t2229r427b2281],
42	(	NNP	O	(	dep	61	SENT_319	[p24l467t2228r663b2293],
43	2010	CD	DATE	2010	num	44	SENT_319	[p24l467t2228r663b2293],
44	)	CD	NUMBER	)	nsubj	61	SENT_319	[p24l467t2228r663b2293],
45	Inherited	VBN	O	inherit	partmod	44	SENT_319	[p24l698t2228r973b2281],
46	genetic	JJ	O	genetic	amod	47	SENT_319	[p24l1007t2228r1224b2296],
47	Variation	NN	O	variation	dobj	45	SENT_319	[p24l1259t2228r1529b2281],
48	in	IN	O	in	_	0	SENT_319	[p24l1562t2228r1620b2280],
49	EPHA5	NN	O	epha5	prep_in	45	SENT_319	[p24l1653t2228r1904b2291],
50	,	,	O	,	_	0	SENT_319	[p24l1653t2228r1904b2291],
51	FGD4	NN	O	fgd4	prep_in	45	SENT_319	[p24l1940t2228r2144b2291],
52	,	,	O	,	_	0	SENT_319	[p24l1940t2228r2144b2291],
53	and	CC	O	and	_	0	SENT_319	[p24l139t2316r246b2369],
54	NRDG1	NN	O	nrdg1	prep_in	45	SENT_319	[p24l285t2316r529b2369],
55	and	CC	O	and	_	0	SENT_319	[p24l577t2316r684b2369],
56	paclitaxel	NN	O	paclitaxel	nn	58	SENT_319	[p24l723t2316r1019b2385],
57	(	CD	NUMBER	(	num	58	SENT_319	[p24l1062t2316r1418b2381],
58	P	NN	O	p	prep_in	45	SENT_319	[p24l1062t2316r1418b2381],
59	)	SYM	O	)	dep	61	SENT_319	[p24l1062t2316r1418b2381],
60	-	:	O	-	_	0	SENT_319	[p24l1062t2316r1418b2381],
61	induced	VBN	O	induce	dep	2	SENT_319	[p24l1062t2316r1418b2381],
62	peripheral	JJ	O	peripheral	amod	66	SENT_319	[p24l1456t2316r1765b2385],
63	neuropathy	NN	O	neuropathy	nn	66	SENT_319	[p24l1805t2316r2146b2385],
64	(	CD	NUMBER	(	num	66	SENT_319	[p24l140t2404r299b2470],
65	PN	NN	O	pn	nn	66	SENT_319	[p24l140t2404r299b2470],
66	)	NN	O	)	xcomp	61	SENT_319	[p24l140t2404r299b2470],
67	:	:	O	:	_	0	SENT_319	[p24l140t2404r299b2470],
68	results	NNS	O	result	dep	1	SENT_319	[p24l331t2404r528b2457],
69	from	IN	O	from	_	0	SENT_319	[p24l557t2404r704b2457],
70	a	DT	O	a	det	76	SENT_319	[p24l733t2421r764b2457],
71	genome-wide	JJ	O	genome-wide	amod	76	SENT_319	[p24l791t2404r1204b2473],
72	association	NN	O	association	nn	76	SENT_319	[p24l1234t2404r1570b2457],
73	study	NN	O	study	nn	76	SENT_319	[p24l1600t2404r1760b2473],
74	(	CD	NUMBER	(	num	76	SENT_319	[p24l1791t2404r2059b2469],
75	GWAS	NN	O	gwa	nn	76	SENT_319	[p24l1791t2404r2059b2469],
76	)	NN	O	)	prep_from	68	SENT_319	[p24l1791t2404r2059b2469],
77	in	IN	O	in	_	0	SENT_319	[p24l2089t2404r2147b2456],
78	CALGB	NNP	O	CALGB	prep_in	76	SENT_319	[p24l138t2491r388b2544],
79	40101	CD	NUMBER	40101	num	78	SENT_319	[p24l425t2491r629b2544],
80	.	.	O	.	_	0	SENT_319	[p24l425t2491r629b2544],

1	ASCO	NNP	ORGANIZATION	ASCO	_	0	SENT_320	[p24l665t2491r865b2544],
2	Meeting	VBG	O	meet	partmod	1	SENT_320	[p24l898t2491r1150b2560],
3	Abstracts	NNS	O	abstract	dobj	2	SENT_320	[p24l1183t2491r1484b2544],
4	.	.	O	.	_	0	SENT_320	[p24l1183t2491r1484b2544],

1	2010	CD	DATE	2010	num	2	SENT_321	[p24l1522t2492r1671b2544],
2	June	NNP	DATE	June	_	0	SENT_321	[p24l1703t2492r1841b2544],
3	14	CD	DATE	14	num	2	SENT_321	[p24l1881t2491r2144b2557],
4	;	:	O	;	_	0	SENT_321	[p24l1881t2491r2144b2557],
5	28	CD	NUMBER	28	number	6	SENT_321	[p24l1881t2491r2144b2557],
6	(	CD	NUMBER	(	dep	2	SENT_321	[p24l1881t2491r2144b2557],
7	15	CD	NUMBER	15	num	8	SENT_321	[p24l1881t2491r2144b2557],
8	Suppl	NN	O	suppl	dep	6	SENT_321	[p24l139t2580r505b2649],
9	)	NN	O	)	nn	12	SENT_321	[p24l139t2580r505b2649],
10	:3021	CD	NUMBER	:3021	num	12	SENT_321	[p24l139t2580r505b2649],
11	Schneider	NNP	O	Schneider	nn	12	SENT_321	[p24l139t2669r442b2723],
12	BP	NNP	O	BP	dep	72	SENT_321	[p24l472t2670r579b2732],
13	,	,	O	,	_	0	SENT_321	[p24l472t2670r579b2732],
14	Li	NNP	PERSON	Li	nn	15	SENT_321	[p24l614t2669r680b2722],
15	L	NNP	PERSON	L	appos	12	SENT_321	[p24l711t2670r773b2732],
16	,	,	O	,	_	0	SENT_321	[p24l711t2670r773b2732],
17	Miller	NNP	PERSON	Miller	nn	18	SENT_321	[p24l807t2669r998b2722],
18	K	NNP	PERSON	K	appos	12	SENT_321	[p24l1030t2670r1098b2732],
19	,	,	O	,	_	0	SENT_321	[p24l1030t2670r1098b2732],
20	Flockhart	NNP	ORGANIZATION	Flockhart	nn	21	SENT_321	[p24l1131t2669r1423b2722],
21	D	NNP	ORGANIZATION	D	appos	12	SENT_321	[p24l1454t2670r1524b2732],
22	,	,	O	,	_	0	SENT_321	[p24l1454t2670r1524b2732],
23	Radovich	NNP	PERSON	Radovich	nn	24	SENT_321	[p24l1558t2669r1849b2722],
24	M	NNP	O	M	appos	12	SENT_321	[p24l1880t2670r1962b2732],
25	,	,	O	,	_	0	SENT_321	[p24l1880t2670r1962b2732],
26	Hancock	NNP	ORGANIZATION	Hancock	nn	27	SENT_321	[p24l1996t2670r2145b2722, p24l138t2757r281b2810],
27	BA	NN	ORGANIZATION	ba	appos	12	SENT_321	[p24l315t2758r435b2820],
28	,	,	O	,	_	0	SENT_321	[p24l315t2758r435b2820],
29	Kassem	NNP	ORGANIZATION	Kassem	nn	30	SENT_321	[p24l474t2758r713b2810],
30	N	NNP	ORGANIZATION	N	appos	12	SENT_321	[p24l748t2758r817b2820],
31	,	,	O	,	_	0	SENT_321	[p24l748t2758r817b2820],
32	Forourd	NNP	ORGANIZATION	Forourd	nn	33	SENT_321	[p24l855t2757r1099b2810],
33	T	NN	ORGANIZATION	t	appos	12	SENT_321	[p24l1134t2758r1195b2820],
34	,	,	O	,	_	0	SENT_321	[p24l1134t2758r1195b2820],
35	Koller	NNP	ORGANIZATION	Koller	nn	36	SENT_321	[p24l1235t2757r1427b2810],
36	DL	NNP	ORGANIZATION	DL	appos	12	SENT_321	[p24l1462t2758r1578b2820],
37	,	,	O	,	_	0	SENT_321	[p24l1462t2758r1578b2820],
38	Badve	NNP	O	Badve	nn	39	SENT_321	[p24l1616t2757r1809b2811],
39	SS	NNP	O	SS	appos	12	SENT_321	[p24l1847t2757r1943b2820],
40	,	,	O	,	_	0	SENT_321	[p24l1847t2757r1943b2820],
41	Li	NNP	LOCATION	Li	nn	42	SENT_321	[p24l1981t2757r2047b2810],
42	Z	NNP	LOCATION	Z	appos	12	SENT_321	[p24l2083t2758r2144b2820],
43	,	,	O	,	_	0	SENT_321	[p24l2083t2758r2144b2820],
44	Partridge	NNP	ORGANIZATION	Partridge	nn	45	SENT_321	[p24l137t2846r414b2915],
45	AH	NNP	O	AH	appos	12	SENT_321	[p24l436t2846r560b2909],
46	,	,	O	,	_	0	SENT_321	[p24l436t2846r560b2909],
47	O’Nei1l	NNP	O	O’Nei1l	nn	48	SENT_321	[p24l584t2846r814b2899],
48	AM	NNP	O	AM	appos	12	SENT_321	[p24l835t2846r972b2909],
49	,	,	O	,	_	0	SENT_321	[p24l835t2846r972b2909],
50	Sparano	NNP	PERSON	Sparano	nn	52	SENT_321	[p24l997t2846r1242b2915],
51	J	NNP	O	J	nn	52	SENT_321	[p24l1263t2847r1291b2899],
52	A	NNP	O	A	appos	12	SENT_321	[p24l1293t2846r1362b2909],
53	,	,	O	,	_	0	SENT_321	[p24l1293t2846r1362b2909],
54	Dang	NNP	PERSON	Dang	nn	55	SENT_321	[p24l1385t2847r1547b2915],
55	CT	NNP	O	CT	appos	12	SENT_321	[p24l1570t2846r1681b2909],
56	,	,	O	,	_	0	SENT_321	[p24l1570t2846r1681b2909],
57	Northfelt	NNP	O	Northfelt	nn	58	SENT_321	[p24l1704t2846r1983b2899],
58	DW	NNP	O	DW	appos	12	SENT_321	[p24l2003t2847r2144b2909],
59	,	,	O	,	_	0	SENT_321	[p24l2003t2847r2144b2909],
60	Smith	NNP	ORGANIZATION	Smith	nn	61	SENT_321	[p24l139t2934r318b2987],
61	ML	NNP	ORGANIZATION	ML	appos	12	SENT_321	[p24l355t2935r484b2997],
62	,	,	O	,	_	0	SENT_321	[p24l355t2935r484b2997],
63	Railey	NNP	PERSON	Railey	nn	64	SENT_321	[p24l524t2934r721b3003],
64	E	NNP	O	E	appos	12	SENT_321	[p24l759t2935r820b2997],
65	,	,	O	,	_	0	SENT_321	[p24l759t2935r820b2997],
66	Sledge	NNP	ORGANIZATION	Sledge	nn	68	SENT_321	[p24l863t2934r1067b3003],
67	GW	NNP	ORGANIZATION	GW	nn	68	SENT_321	[p24l1105t2934r1230b2987],
68	(	NNP	O	(	appos	12	SENT_321	[p24l1270t2934r1466b3000],
69	2011	CD	DATE	2011	num	72	SENT_321	[p24l1270t2934r1466b3000],
70	)	NNP	O	)	nn	72	SENT_321	[p24l1270t2934r1466b3000],
71	Genetic	NNP	O	Genetic	nn	72	SENT_321	[p24l1507t2934r1741b2987],
72	associations	NNS	O	association	dep	2	SENT_321	[p24l1781t2934r2145b2987],
73	with	IN	O	with	_	0	SENT_321	[p24l138t3021r271b3074],
74	taxane-induced	JJ	O	taxane-induced	amod	75	SENT_321	[p24l306t3021r772b3074],
75	neuropathy	NN	O	neuropathy	prep_with	72	SENT_321	[p24l806t3021r1148b3090],
76	by	IN	O	by	_	0	SENT_321	[p24l1183t3021r1257b3090],
77	a	DT	O	a	det	83	SENT_321	[p24l1294t3038r1326b3074],
78	genome-wide	JJ	O	genome-wide	amod	83	SENT_321	[p24l1361t3021r1773b3090],
79	association	NN	O	association	nn	83	SENT_321	[p24l1811t3021r2147b3074],
80	study	NN	O	study	nn	83	SENT_321	[p24l140t3109r300b3178],
81	(	CD	NUMBER	(	num	83	SENT_321	[p24l334t3110r602b3175],
82	GWAS	NN	O	gwa	nn	83	SENT_321	[p24l334t3110r602b3175],
83	)	NN	O	)	prep_by	75	SENT_321	[p24l334t3110r602b3175],
84	in	IN	O	in	_	0	SENT_321	[p24l636t3109r694b3162],
85	E5103	NN	O	e5103	prep_in	83	SENT_321	[p24l725t3109r937b3163],
86	.	.	O	.	_	0	SENT_321	[p24l725t3109r937b3163],

1	ASCO	NNP	ORGANIZATION	ASCO	_	0	SENT_322	[p24l973t3110r1173b3163],
2	Meeting	VBG	O	meet	partmod	1	SENT_322	[p24l1205t3109r1457b3178],
3	Abstracts	NNS	O	abstract	dobj	2	SENT_322	[p24l1490t3109r1791b3162],
4	.	.	O	.	_	0	SENT_322	[p24l1490t3109r1791b3162],

1	2011	CD	DATE	2011	_	0	SENT_323	[p24l1828t3110r1971b3163],
2	June	NNP	DATE	June	tmod	1	SENT_323	[p24l2009t3111r2146b3163],
3	09	CD	DATE	09	num	2	SENT_323	[p24l138t3198r655b3267],
4	;	:	O	;	_	0	SENT_323	[p24l138t3198r655b3267],
5	29	CD	NUMBER	29	number	6	SENT_323	[p24l138t3198r655b3267],
6	(	CD	NUMBER	(	num	12	SENT_323	[p24l138t3198r655b3267],
7	15_suppl	NN	O	15_suppl	dep	12	SENT_323	[p24l138t3198r655b3267],
8	)	CD	NUMBER	)	num	7	SENT_323	[p24l138t3198r655b3267],
9	:	:	O	:	_	0	SENT_323	[p24l138t3198r655b3267],
10	1000	CD	DATE	1000	num	12	SENT_323	[p24l670t3198r812b3251],
11	Rizzo	NNP	PERSON	Rizzo	nn	12	SENT_323	[p24l137t3285r313b3338],
12	R	NNP	PERSON	R	dep	1	SENT_323	[p24l337t3286r402b3348],
13	,	,	O	,	_	0	SENT_323	[p24l337t3286r402b3348],
14	Spaggiari	NNP	O	Spaggiari	nn	15	SENT_323	[p24l430t3285r718b3354],
15	F	NN	O	f	appos	12	SENT_323	[p24l742t3286r799b3348],
16	,	,	O	,	_	0	SENT_323	[p24l742t3286r799b3348],
17	Indelli	NNP	O	Indelli	nn	18	SENT_323	[p24l824t3285r1021b3338],
18	M	NNP	O	M	appos	12	SENT_323	[p24l1046t3286r1127b3348],
19	,	,	O	,	_	0	SENT_323	[p24l1046t3286r1127b3348],
20	Lelli	NNP	PERSON	Lelli	nn	21	SENT_323	[p24l1153t3285r1296b3338],
21	G	NNP	PERSON	G	appos	12	SENT_323	[p24l1321t3285r1389b3348],
22	,	,	O	,	_	0	SENT_323	[p24l1321t3285r1389b3348],
23	Baricordi	NNP	ORGANIZATION	Baricordi	nn	24	SENT_323	[p24l1415t3285r1701b3338],
24	O	NNP	ORGANIZATION	O	appos	12	SENT_323	[p24l1727t3286r1794b3348],
25	,	,	O	,	_	0	SENT_323	[p24l1727t3286r1794b3348],
26	Rimessi	NNP	PERSON	Rimessi	nn	27	SENT_323	[p24l1820t3285r2064b3338],
27	P	NN	PERSON	p	appos	12	SENT_323	[p24l2088t3286r2144b3348],
28	,	,	O	,	_	0	SENT_323	[p24l2088t3286r2144b3348],
29	Ferlini	NNP	O	Ferlini	nn	30	SENT_323	[p24l137t3373r338b3426],
30	A	NNP	O	A	appos	12	SENT_323	[p24l375t3374r428b3426],
31	(	CD	NUMBER	(	num	34	SENT_323	[p24l467t3374r663b3439],
32	2010	CD	DATE	2010	num	34	SENT_323	[p24l467t3374r663b3439],
33	)	NNP	O	)	nn	34	SENT_323	[p24l467t3374r663b3439],
34	Association	NNP	O	Association	dep	12	SENT_323	[p24l701t3373r1059b3426],
35	of	IN	O	of	_	0	SENT_323	[p24l1097t3373r1163b3426],
36	CYPIBI	NNP	O	CYPIBI	prep_of	12	SENT_323	[p24l1198t3374r1449b3427],
37	with	IN	O	with	_	0	SENT_323	[p24l1491t3373r1625b3427],
38	hypersensitivity	NN	O	hypersensitivity	prep_with	36	SENT_323	[p24l1660t3373r2146b3442],
39	induced	VBN	O	induce	partmod	38	SENT_323	[p24l137t3461r378b3514],
40	by	IN	O	by	_	0	SENT_323	[p24l425t3461r499b3530],
41	taxane	NN	O	taxane	nn	42	SENT_323	[p24l548t3469r745b3514],
42	therapy	NN	O	therapy	agent	39	SENT_323	[p24l794t3461r1020b3530],
43	in	IN	O	in	_	0	SENT_323	[p24l1070t3461r1127b3514],
44	breast	NN	O	breast	nn	46	SENT_323	[p24l1175t3461r1356b3514],
45	cancer	NN	O	cancer	nn	46	SENT_323	[p24l1405t3478r1603b3514],
46	patients	NNS	O	patient	prep_in	42	SENT_323	[p24l1650t3461r1902b3530],
47	.	.	O	.	_	0	SENT_323	[p24l1650t3461r1902b3530],

1	Breast	NN	O	breast	nn	4	SENT_324	[p24l1953t3463r2148b3514],
2	Cancer	NN	O	cancer	nn	4	SENT_324	[p24l138t3550r353b3603],
3	Res	NNP	O	Res	nn	4	SENT_324	[p24l379t3551r490b3603],
4	Treat	NNP	O	Treat	_	0	SENT_324	[p24l519t3551r680b3603],
5	124	CD	NUMBER	124	num	6	SENT_324	[p24l714t3550r1193b3616],
6	(	NN	O	(	dep	4	SENT_324	[p24l714t3550r1193b3616],
7	2	CD	NUMBER	2	number	8	SENT_324	[p24l714t3550r1193b3616],
8	)	CD	NUMBER	)	dep	6	SENT_324	[p24l714t3550r1193b3616],
9	:593	CD	NUMBER	:593	num	10	SENT_324	[p24l714t3550r1193b3616],
10	—	NN	O	—	dep	8	SENT_324	[p24l714t3550r1193b3616],
11	598	CD	NUMBER	598	dep	4	SENT_324	[p24l714t3550r1193b3616],

1	Sissung	NNP	O	Sissung	nn	2	SENT_325	[p25l139t18r371b87],
2	TM	NNP	O	TM	_	0	SENT_325	[p25l406t20r534b81],
3	,	,	O	,	_	0	SENT_325	[p25l406t20r534b81],
4	Mross	NNP	PERSON	Mross	nn	5	SENT_325	[p25l572t20r758b71],
5	K	NNP	PERSON	K	appos	2	SENT_325	[p25l795t20r863b81],
6	,	,	O	,	_	0	SENT_325	[p25l795t20r863b81],
7	Steinberg	NNP	ORGANIZATION	Steinberg	nn	8	SENT_325	[p25l902t18r1190b87],
8	SM	NNP	ORGANIZATION	SM	appos	2	SENT_325	[p25l1227t19r1349b81],
9	,	,	O	,	_	0	SENT_325	[p25l1227t19r1349b81],
10	Behringer	NNP	PERSON	Behringer	nn	11	SENT_325	[p25l1387t18r1692b87],
11	D	NNP	O	D	appos	2	SENT_325	[p25l1724t20r1794b81],
12	,	,	O	,	_	0	SENT_325	[p25l1724t20r1794b81],
13	Figg	NNP	PERSON	Figg	nn	14	SENT_325	[p25l1830t18r1967b87],
14	WD	NNP	O	WD	appos	2	SENT_325	[p25l2002t20r2144b81],
15	,	,	O	,	_	0	SENT_325	[p25l2002t20r2144b81],
16	Sparreboom	NNP	O	Sparreboom	nn	17	SENT_325	[p25l139t106r508b175],
17	A	NNP	O	A	appos	2	SENT_325	[p25l543t107r612b169],
18	,	,	O	,	_	0	SENT_325	[p25l543t107r612b169],
19	Mielke	NNP	PERSON	Mielke	nn	20	SENT_325	[p25l648t106r863b159],
20	S	NNP	O	S	appos	2	SENT_325	[p25l900t107r935b160],
21	(	CD	NUMBER	(	num	24	SENT_325	[p25l975t106r1172b172],
22	2006	CD	DATE	2006	num	24	SENT_325	[p25l975t106r1172b172],
23	)	NNP	O	)	nn	24	SENT_325	[p25l975t106r1172b172],
24	Association	NNP	O	Association	dep	20	SENT_325	[p25l1208t106r1567b159],
25	of	IN	O	of	_	0	SENT_325	[p25l1602t106r1668b159],
26	ABCB1	NN	O	abcb1	nn	27	SENT_325	[p25l1697t107r1934b160],
27	genotypes	NNS	O	genotype	prep_of	2	SENT_325	[p25l1976t123r2145b175, p25l137t203r294b263],
28	with	IN	O	with	_	0	SENT_325	[p25l333t194r467b248],
29	paclitaXel	NN	O	paclitaxel	prep_with	27	SENT_325	[p25l503t194r1107b263],
30	—	CD	NUMBER	—	num	29	SENT_325	[p25l503t194r1107b263],
31	mediated	VBN	O	mediate	partmod	2	SENT_325	[p25l503t194r1107b263],
32	peripheral	JJ	O	peripheral	amod	33	SENT_325	[p25l1143t194r1451b263],
33	neuropathy	NN	O	neuropathy	dobj	31	SENT_325	[p25l1489t195r1830b263],
34	and	CC	O	and	_	0	SENT_325	[p25l1869t195r1977b248],
35	neutropenia	NN	O	neutropenia	dobj	31	SENT_325	[p25l2013t211r2145b248, p25l137t282r401b351],
36	.	.	O	.	_	0	SENT_325	[p25l2013t211r2145b248, p25l137t282r401b351],

1	Eur	NNP	O	Eur	nn	3	SENT_326	[p25l432t283r542b335],
2	J	NNP	O	J	nn	3	SENT_326	[p25l568t283r596b335],
3	Cancer	NNP	O	Cancer	dep	12	SENT_326	[p25l624t282r839b335],
4	42	CD	NUMBER	42	num	3	SENT_326	[p25l865t282r1430b348],
5	(	CD	NUMBER	(	number	6	SENT_326	[p25l865t282r1430b348],
6	17	CD	NUMBER	17	dep	3	SENT_326	[p25l865t282r1430b348],
7	)	NN	O	)	dep	6	SENT_326	[p25l865t282r1430b348],
8	:2893	CD	NUMBER	:2893	num	7	SENT_326	[p25l865t282r1430b348],
9	—	CD	NUMBER	—	dep	12	SENT_326	[p25l865t282r1430b348],
10	2896	CD	DATE	2896	num	12	SENT_326	[p25l865t282r1430b348],
11	Sorlie	NNP	PERSON	Sorlie	nn	12	SENT_326	[p25l139t371r317b433],
12	T	NN	PERSON	t	dep	38	SENT_326	[p25l345t373r406b434],
13	,	,	O	,	_	0	SENT_326	[p25l345t373r406b434],
14	Perou	NNP	ORGANIZATION	Perou	nn	15	SENT_326	[p25l436t373r612b425],
15	CM	NN	ORGANIZATION	cm	appos	12	SENT_326	[p25l641t372r772b434],
16	,	,	O	,	_	0	SENT_326	[p25l641t372r772b434],
17	Tibshirani	JJ	PERSON	tibshirani	amod	18	SENT_326	[p25l802t371r1113b425],
18	R	NN	PERSON	r	appos	12	SENT_326	[p25l1142t373r1207b434],
19	,	,	O	,	_	0	SENT_326	[p25l1142t373r1207b434],
20	Aas	NN	O	aa	nn	21	SENT_326	[p25l1237t372r1352b425],
21	T	NN	O	t	appos	12	SENT_326	[p25l1381t373r1442b434],
22	,	,	O	,	_	0	SENT_326	[p25l1381t373r1442b434],
23	Geisler	NNP	PERSON	Geisler	nn	24	SENT_326	[p25l1473t371r1692b425],
24	S	NNP	O	S	appos	12	SENT_326	[p25l1720t372r1774b434],
25	,	,	O	,	_	0	SENT_326	[p25l1720t372r1774b434],
26	Johnsen	NNP	PERSON	Johnsen	nn	27	SENT_326	[p25l1804t371r2048b425],
27	H	NNP	PERSON	H	appos	12	SENT_326	[p25l2075t373r2144b434],
28	,	,	O	,	_	0	SENT_326	[p25l2075t373r2144b434],
29	Hastie	NNP	ORGANIZATION	Hastie	nn	30	SENT_326	[p25l137t459r329b513],
30	T	NN	ORGANIZATION	t	appos	12	SENT_326	[p25l353t461r414b522],
31	,	,	O	,	_	0	SENT_326	[p25l353t461r414b522],
32	Eisen	NNP	ORGANIZATION	Eisen	nn	33	SENT_326	[p25l439t459r607b513],
33	MB	NNP	ORGANIZATION	MB	appos	12	SENT_326	[p25l630t461r762b522],
34	,	,	O	,	_	0	SENT_326	[p25l630t461r762b522],
35	van	NNP	PERSON	van	nn	37	SENT_326	[p25l788t476r896b513],
36	de	IN	PERSON	de	amod	37	SENT_326	[p25l919t460r988b513],
37	Rijn	NNP	PERSON	Rijn	appos	12	SENT_326	[p25l1011t459r1141b528],
38	M	NN	O	m	dep	63	SENT_326	[p25l1163t461r1245b522],
39	,	,	O	,	_	0	SENT_326	[p25l1163t461r1245b522],
40	Jeffrey	NNP	PERSON	Jeffrey	nn	41	SENT_326	[p25l1270t459r1479b528],
41	SS	NNP	O	SS	appos	38	SENT_326	[p25l1505t460r1601b522],
42	,	,	O	,	_	0	SENT_326	[p25l1505t460r1601b522],
43	Thorsen	NNP	PERSON	Thorsen	nn	44	SENT_326	[p25l1627t460r1875b513],
44	T	NN	O	t	appos	38	SENT_326	[p25l1897t461r1959b522],
45	,	,	O	,	_	0	SENT_326	[p25l1897t461r1959b522],
46	Quist	NNP	O	Quist	nn	47	SENT_326	[p25l1985t459r2148b525],
47	H	NNP	O	H	appos	38	SENT_326	[p25l137t548r206b610],
48	,	,	O	,	_	0	SENT_326	[p25l137t548r206b610],
49	Matese	NNP	ORGANIZATION	Matese	nn	50	SENT_326	[p25l244t548r463b600],
50	JC	NNP	ORGANIZATION	JC	appos	38	SENT_326	[p25l498t547r593b610],
51	,	,	O	,	_	0	SENT_326	[p25l498t547r593b610],
52	Brown	NNP	PERSON	Brown	nn	53	SENT_326	[p25l631t548r837b600],
53	PO	NNP	PERSON	PO	appos	38	SENT_326	[p25l872t548r983b610],
54	,	,	O	,	_	0	SENT_326	[p25l872t548r983b610],
55	Botstein	NNP	PERSON	Botstein	nn	56	SENT_326	[p25l1022t547r1275b600],
56	D	NNP	O	D	appos	38	SENT_326	[p25l1310t548r1380b610],
57	,	,	O	,	_	0	SENT_326	[p25l1310t548r1380b610],
58	Lenning	NNP	ORGANIZATION	Lenning	nn	59	SENT_326	[p25l1417t547r1669b616],
59	PE	NNP	ORGANIZATION	PE	appos	38	SENT_326	[p25l1707t548r1810b610],
60	,	,	O	,	_	0	SENT_326	[p25l1707t548r1810b610],
61	BorresenDale	NNP	O	BorresenDale	nn	62	SENT_326	[p25l1848t548r2144b600, p25l137t635r279b688],
62	A	NNP	O	A	appos	38	SENT_326	[p25l317t636r370b688],
63	(	VBD	O	(	_	0	SENT_326	[p25l410t636r607b701],
64	2001	CD	DATE	2001	num	68	SENT_326	[p25l410t636r607b701],
65	)	CD	NUMBER	)	num	68	SENT_326	[p25l410t636r607b701],
66	Gene	NN	O	gene	nn	68	SENT_326	[p25l647t636r804b689],
67	expression	NN	O	expression	nn	68	SENT_326	[p25l844t635r1167b704],
68	patterns	NNS	O	pattern	nsubj	72	SENT_326	[p25l1204t643r1444b704],
69	of	IN	O	of	_	0	SENT_326	[p25l1484t635r1550b688],
70	breast	NN	O	breast	nn	71	SENT_326	[p25l1581t635r1763b688],
71	carcinomas	NNS	O	carcinoma	prep_of	68	SENT_326	[p25l1801t635r2145b688],
72	distinguish	VBP	O	distinguish	ccomp	63	SENT_326	[p25l138t723r470b792],
73	tumor	NN	O	tumor	nn	74	SENT_326	[p25l493t732r675b777],
74	subclasses	NNS	O	subclass	dobj	72	SENT_326	[p25l699t724r1010b777],
75	with	IN	O	with	_	0	SENT_326	[p25l1035t723r1168b777],
76	clinical	JJ	O	clinical	amod	77	SENT_326	[p25l1192t723r1415b777],
77	implications	NNS	O	implication	prep_with	72	SENT_326	[p25l1438t723r1830b792],
78	.	.	O	.	_	0	SENT_326	[p25l1438t723r1830b792],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_327	[p25l1857t725r1993b777],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_327	[p25l2017t723r2147b777],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_327	[p25l137t813r297b866],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_327	[p25l326t813r419b866],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_327	[p25l446t813r597b866],
6	98	CD	NUMBER	98	number	7	SENT_327	[p25l625t813r1265b878],
7	(	CD	NUMBER	(	dep	5	SENT_327	[p25l625t813r1265b878],
8	19	CD	NUMBER	19	num	9	SENT_327	[p25l625t813r1265b878],
9	)	NN	O	)	dep	7	SENT_327	[p25l625t813r1265b878],
10	:10869	CD	NUMBER	:10869	num	14	SENT_327	[p25l625t813r1265b878],
11	—	CD	NUMBER	—	num	14	SENT_327	[p25l625t813r1265b878],
12	10874	CD	NUMBER	10874	num	14	SENT_327	[p25l625t813r1265b878],
13	Eley	NNP	PERSON	Eley	nn	14	SENT_327	[p25l137t900r275b969],
14	JW	NNP	O	JW	dep	5	SENT_327	[p25l297t902r413b963],
15	,	,	O	,	_	0	SENT_327	[p25l297t902r413b963],
16	Hill	NNP	PERSON	Hill	nn	17	SENT_327	[p25l438t900r554b953],
17	HA	NNP	PERSON	HA	appos	14	SENT_327	[p25l576t901r700b963],
18	,	,	O	,	_	0	SENT_327	[p25l576t901r700b963],
19	Chen	NNP	ORGANIZATION	Chen	nn	20	SENT_327	[p25l726t900r884b954],
20	VW	NNP	ORGANIZATION	VW	appos	14	SENT_327	[p25l905t902r1047b963],
21	,	,	O	,	_	0	SENT_327	[p25l905t902r1047b963],
22	Austin	NNP	LOCATION	Austin	nn	23	SENT_327	[p25l1071t900r1273b953],
23	DF	NNP	O	DF	appos	14	SENT_327	[p25l1294t902r1405b963],
24	,	,	O	,	_	0	SENT_327	[p25l1294t902r1405b963],
25	Wesley	NNP	ORGANIZATION	Wesley	nn	26	SENT_327	[p25l1429t900r1656b969],
26	MN	NN	ORGANIZATION	mn	appos	14	SENT_327	[p25l1679t902r1815b963],
27	,	,	O	,	_	0	SENT_327	[p25l1679t902r1815b963],
28	Muss	NNP	ORGANIZATION	Muss	nn	29	SENT_327	[p25l1840t902r2001b953],
29	HB	NNP	ORGANIZATION	HB	appos	14	SENT_327	[p25l2024t902r2144b963],
30	,	,	O	,	_	0	SENT_327	[p25l2024t902r2144b963],
31	Greenberg	NNP	ORGANIZATION	Greenberg	nn	32	SENT_327	[p25l138t989r456b1057],
32	RS	NN	ORGANIZATION	r	appos	14	SENT_327	[p25l481t989r588b1051],
33	,	,	O	,	_	0	SENT_327	[p25l481t989r588b1051],
34	Coates	NNP	ORGANIZATION	Coates	nn	35	SENT_327	[p25l616t989r820b1042],
35	RJ	NN	ORGANIZATION	rj	appos	14	SENT_327	[p25l846t990r940b1051],
36	,	,	O	,	_	0	SENT_327	[p25l846t990r940b1051],
37	Correa	NNP	PERSON	Correa	nn	38	SENT_327	[p25l968t989r1174b1042],
38	P	NN	PERSON	p	appos	14	SENT_327	[p25l1197t990r1254b1051],
39	,	,	O	,	_	0	SENT_327	[p25l1197t990r1254b1051],
40	Redmond	NNP	ORGANIZATION	Redmond	nn	42	SENT_327	[p25l1280t988r1576b1042],
41	CK	NNP	ORGANIZATION	CK	nn	42	SENT_327	[p25l1601t989r1705b1042],
42	(	NNP	O	(	appos	14	SENT_327	[p25l1730t989r1926b1054],
43	1994	CD	DATE	1994	num	46	SENT_327	[p25l1730t989r1926b1054],
44	)	NNP	O	)	nn	46	SENT_327	[p25l1730t989r1926b1054],
45	Racial	JJ	O	racial	amod	46	SENT_327	[p25l1953t988r2147b1042],
46	differences	NNS	O	difference	dep	5	SENT_327	[p25l138t1078r473b1131],
47	in	IN	O	in	_	0	SENT_327	[p25l495t1078r554b1130],
48	survival	NN	O	survival	prep_in	46	SENT_327	[p25l577t1078r818b1131],
49	from	IN	O	from	_	0	SENT_327	[p25l840t1078r987b1131],
50	breast	NN	O	breast	nn	51	SENT_327	[p25l1006t1078r1188b1131],
51	cancer	NN	O	cancer	prep_from	48	SENT_327	[p25l1209t1094r1421b1131],
52	.	.	O	.	_	0	SENT_327	[p25l1209t1094r1421b1131],

1	Results	NNS	O	result	_	0	SENT_328	[p25l1446t1078r1667b1131],
2	of	IN	O	of	_	0	SENT_328	[p25l1691t1078r1757b1131],
3	the	DT	O	the	det	10	SENT_328	[p25l1773t1078r1864b1131],
4	National	NNP	ORGANIZATION	National	nn	10	SENT_328	[p25l1885t1078r2146b1131],
5	Cancer	NNP	ORGANIZATION	Cancer	nn	10	SENT_328	[p25l138t1166r353b1219],
6	Institute	NNP	ORGANIZATION	Institute	nn	10	SENT_328	[p25l400t1166r649b1219],
7	Black/White	NNP	O	Black/White	nn	10	SENT_328	[p25l697t1166r1082b1219],
8	Cancer	NNP	O	Cancer	nn	10	SENT_328	[p25l1132t1166r1347b1219],
9	Survival	NNP	O	Survival	nn	10	SENT_328	[p25l1396t1166r1651b1219],
10	Study	NNP	O	Study	prep_of	1	SENT_328	[p25l1701t1166r1890b1234],
11	.	.	O	.	_	0	SENT_328	[p25l1701t1166r1890b1234],

1	JAMA	NN	O	jama	nn	4	SENT_329	[p25l1942t1166r2147b1219],
2	272	CD	NUMBER	272	num	4	SENT_329	[p25l138t1254r664b1320],
3	(	NN	O	(	nn	4	SENT_329	[p25l138t1254r664b1320],
4	l2	NN	O	l2	dep	10	SENT_329	[p25l138t1254r664b1320],
5	)	CD	NUMBER	)	num	6	SENT_329	[p25l138t1254r664b1320],
6	:947	CD	NUMBER	:947	dep	4	SENT_329	[p25l138t1254r664b1320],
7	—	NN	O	—	dep	10	SENT_329	[p25l138t1254r664b1320],
8	954	CD	NUMBER	954	num	7	SENT_329	[p25l138t1254r664b1320],
9	Eisenhauer	NNP	PERSON	Eisenhauer	nn	10	SENT_329	[p25l137t1342r476b1396],
10	EA	NN	PERSON	ea	dep	62	SENT_329	[p25l497t1343r614b1405],
11	,	,	O	,	_	0	SENT_329	[p25l497t1343r614b1405],
12	Therasse	NN	O	therasse	nn	13	SENT_329	[p25l639t1342r908b1396],
13	P	NN	O	p	appos	10	SENT_329	[p25l931t1344r988b1405],
14	,	,	O	,	_	0	SENT_329	[p25l931t1344r988b1405],
15	Bogaerts	NNPS	O	Bogaerts	nn	16	SENT_329	[p25l1013t1344r1281b1411],
16	J	NNP	O	J	appos	10	SENT_329	[p25l1305t1344r1333b1396],
17	,	,	O	,	_	0	SENT_329	[p25l1338t1386r1349b1405],
18	Schwartz	NNP	ORGANIZATION	Schwartz	nn	19	SENT_329	[p25l1376t1343r1655b1396],
19	LH	NNP	ORGANIZATION	LH	appos	10	SENT_329	[p25l1679t1344r1795b1406],
20	,	,	O	,	_	0	SENT_329	[p25l1679t1344r1795b1406],
21	Sargent	NNP	ORGANIZATION	Sargent	nn	22	SENT_329	[p25l1823t1343r2053b1411],
22	D	NNP	ORGANIZATION	D	appos	10	SENT_329	[p25l2075t1344r2144b1405],
23	,	,	O	,	_	0	SENT_329	[p25l2075t1344r2144b1405],
24	Ford	NNP	ORGANIZATION	Ford	nn	25	SENT_329	[p25l137t1431r279b1484],
25	R	NNP	ORGANIZATION	R	appos	10	SENT_329	[p25l304t1432r368b1494],
26	,	,	O	,	_	0	SENT_329	[p25l304t1432r368b1494],
27	Dancey	NNP	PERSON	Dancey	nn	28	SENT_329	[p25l396t1432r627b1499],
28	J	NNP	PERSON	J	appos	10	SENT_329	[p25l652t1432r680b1484],
29	,	,	O	,	_	0	SENT_329	[p25l685t1475r696b1493],
30	Arbuck	NNP	O	Arbuck	nn	31	SENT_329	[p25l723t1431r951b1484],
31	S	NNP	O	S	appos	10	SENT_329	[p25l977t1431r1031b1494],
32	,	,	O	,	_	0	SENT_329	[p25l977t1431r1031b1494],
33	Gwyther	NNP	PERSON	Gwyther	nn	34	SENT_329	[p25l1060t1431r1325b1499],
34	S	NNP	O	S	appos	10	SENT_329	[p25l1350t1431r1404b1494],
35	,	,	O	,	_	0	SENT_329	[p25l1350t1431r1404b1494],
36	Mooney	NNP	PERSON	Mooney	nn	37	SENT_329	[p25l1432t1432r1683b1499],
37	M	NNP	O	M	appos	10	SENT_329	[p25l1708t1432r1790b1493],
38	,	,	O	,	_	0	SENT_329	[p25l1708t1432r1790b1493],
39	Rubinstein	NNP	PERSON	Rubinstein	nn	40	SENT_329	[p25l1818t1431r2147b1484],
40	L	NNP	PERSON	L	appos	10	SENT_329	[p25l137t1520r198b1581],
41	,	,	O	,	_	0	SENT_329	[p25l137t1520r198b1581],
42	Shankar	NNP	PERSON	Shankar	nn	43	SENT_329	[p25l229t1518r477b1572],
43	L	NNP	PERSON	L	appos	10	SENT_329	[p25l501t1520r562b1581],
44	,	,	O	,	_	0	SENT_329	[p25l501t1520r562b1581],
45	Dodd	NNP	ORGANIZATION	Dodd	nn	46	SENT_329	[p25l591t1519r759b1572],
46	L	NNP	ORGANIZATION	L	appos	10	SENT_329	[p25l785t1520r846b1581],
47	,	,	O	,	_	0	SENT_329	[p25l785t1520r846b1581],
48	Kaplan	NNP	PERSON	Kaplan	nn	49	SENT_329	[p25l877t1519r1094b1587],
49	R	NNP	PERSON	R	appos	10	SENT_329	[p25l1120t1520r1185b1581],
50	,	,	O	,	_	0	SENT_329	[p25l1120t1520r1185b1581],
51	Lacombe	NNP	PERSON	Lacombe	nn	52	SENT_329	[p25l1214t1519r1496b1572],
52	D	NNP	O	D	appos	10	SENT_329	[p25l1523t1520r1592b1581],
53	,	,	O	,	_	0	SENT_329	[p25l1523t1520r1592b1581],
54	Verweij	NNP	O	Verweij	nn	55	SENT_329	[p25l1622t1518r1860b1587],
55	J	NNP	O	J	appos	10	SENT_329	[p25l1892t1520r1920b1572],
56	(	CD	NUMBER	(	num	62	SENT_329	[p25l1949t1519r2145b1584],
57	2009	CD	DATE	2009	num	62	SENT_329	[p25l1949t1519r2145b1584],
58	)	NNP	O	)	nn	62	SENT_329	[p25l1949t1519r2145b1584],
59	New	NNP	O	New	nn	62	SENT_329	[p25l137t1608r278b1660],
60	response	NN	O	response	nn	62	SENT_329	[p25l310t1623r575b1675],
61	evaluation	NN	O	evaluation	nn	62	SENT_329	[p25l609t1607r925b1660],
62	criteria	NNS	O	criterion	dep	67	SENT_329	[p25l958t1606r1173b1660],
63	in	IN	O	in	_	0	SENT_329	[p25l1205t1607r1263b1659],
64	solid	JJ	O	solid	amod	65	SENT_329	[p25l1297t1606r1442b1660],
65	tumours	NNS	O	tumour	prep_in	62	SENT_329	[p25l1474t1615r1737b1660],
66	:	:	O	:	_	0	SENT_329	[p25l1474t1615r1737b1660],
67	revised	VBN	O	revise	_	0	SENT_329	[p25l1774t1606r1994b1660],
68	RECIST	NNP	O	RECIST	nn	71	SENT_329	[p25l2026t1608r2145b1659, p25l138t1695r300b1748],
69	guideline	NN	O	guideline	nn	71	SENT_329	[p25l329t1695r610b1764],
70	(	NN	O	(	nn	71	SENT_329	[p25l641t1695r886b1760],
71	version	NN	O	version	dobj	67	SENT_329	[p25l641t1695r886b1760],
72	1.1	CD	NUMBER	1.1	num	73	SENT_329	[p25l921t1695r1047b1760],
73	)	NN	O	)	dep	71	SENT_329	[p25l921t1695r1047b1760],
74	.	.	O	.	_	0	SENT_329	[p25l921t1695r1047b1760],

1	Eur	NNP	O	Eur	nn	3	SENT_330	[p25l1078t1696r1189b1748],
2	J	NNP	O	J	nn	3	SENT_330	[p25l1214t1696r1242b1748],
3	Cancer	NNP	O	Cancer	dep	13	SENT_330	[p25l1270t1695r1485b1748],
4	45	CD	NUMBER	45	num	5	SENT_330	[p25l1511t1695r1960b1760],
5	(	NN	O	(	dep	3	SENT_330	[p25l1511t1695r1960b1760],
6	2	CD	NUMBER	2	number	7	SENT_330	[p25l1511t1695r1960b1760],
7	)	CD	NUMBER	)	dep	5	SENT_330	[p25l1511t1695r1960b1760],
8	:228	CD	NUMBER	:228	num	9	SENT_330	[p25l1511t1695r1960b1760],
9	—	NN	O	—	dep	13	SENT_330	[p25l1511t1695r1960b1760],
10	247	CD	NUMBER	247	num	13	SENT_330	[p25l1511t1695r1960b1760],
11	Common	JJ	O	common	amod	13	SENT_330	[p25l138t1783r419b1836],
12	Terminology	NN	O	terminology	nn	13	SENT_330	[p25l462t1783r858b1852],
13	Criteria	NNS	O	criterion	dep	17	SENT_330	[p25l902t1783r1134b1836],
14	for	IN	O	for	_	0	SENT_330	[p25l1176t1783r1264b1836],
15	Adverse	JJ	O	adverse	amod	16	SENT_330	[p25l1305t1783r1556b1836],
16	Events	NNS	O	event	prep_for	13	SENT_330	[p25l1599t1784r1804b1836],
17	(	VBP	O	(	_	0	SENT_330	[p25l1850t1783r2144b1849],
18	CTCAE	NN	O	ctca	nn	20	SENT_330	[p25l1850t1783r2144b1849],
19	)	CD	NUMBER	)	num	20	SENT_330	[p25l1850t1783r2144b1849],
20	version	NN	O	version	dobj	17	SENT_330	[p25l137t1871r360b1924],
21	4.0	CD	NUMBER	4.0	advmod	17	SENT_330	[p25l398t1871r507b1924],
22	.	.	O	.	_	0	SENT_330	[p25l398t1871r507b1924],

1	U.S.	NNP	ORGANIZATION	U.S.	nn	2	SENT_331	[p25l550t1871r679b1924],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_331	[p25l722t1872r1082b1939],
3	of	IN	ORGANIZATION	of	_	0	SENT_331	[p25l1121t1870r1187b1924],
4	Health	NNP	ORGANIZATION	Health	nn	7	SENT_331	[p25l1221t1871r1423b1924],
5	and	CC	ORGANIZATION	and	_	0	SENT_331	[p25l1464t1871r1571b1924],
6	Human	NNP	ORGANIZATION	Human	nn	7	SENT_331	[p25l1610t1872r1832b1924],
7	Services	NNPS	ORGANIZATION	Services	prep_of	2	SENT_331	[p25l1873t1870r2144b1933],
8	,	,	O	,	_	0	SENT_331	[p25l1873t1870r2144b1933],
9	National	NNP	ORGANIZATION	National	nn	10	SENT_331	[p25l136t1960r398b2013],
10	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_331	[p25l440t1960r717b2013],
11	of	IN	ORGANIZATION	of	_	0	SENT_331	[p25l761t1960r827b2013],
12	Health	NNP	ORGANIZATION	Health	prep_of	10	SENT_331	[p25l863t1960r1081b2023],
13	,	,	O	,	_	0	SENT_331	[p25l863t1960r1081b2023],
14	National	NNP	ORGANIZATION	National	nn	16	SENT_331	[p25l1125t1960r1386b2013],
15	Cancer	NNP	ORGANIZATION	Cancer	nn	16	SENT_331	[p25l1429t1960r1644b2013],
16	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_331	[p25l1684t1960r1951b2023],
17	;	:	O	;	_	0	SENT_331	[p25l1684t1960r1951b2023],
18	2010	CD	DATE	2010	dep	2	SENT_331	[p25l1997t1960r2147b2013],
19	June	NNP	DATE	June	tmod	18	SENT_331	[p25l137t2050r274b2102],
20	14	CD	DATE	14	num	19	SENT_331	[p25l310t2049r393b2112],
21	,	,	DATE	,	_	0	SENT_331	[p25l310t2049r393b2112],
22	2010	CD	DATE	2010	num	24	SENT_331	[p25l424t2049r573b2102],
23	Marsh	NNP	O	Marsh	nn	24	SENT_331	[p25l137t2137r330b2190],
24	S	NN	O	s	appos	2	SENT_331	[p25l376t2137r430b2200],
25	,	,	O	,	_	0	SENT_331	[p25l376t2137r430b2200],
26	King	NNP	O	King	nn	27	SENT_331	[p25l479t2137r627b2206],
27	CR	NN	O	cr	appos	2	SENT_331	[p25l672t2137r787b2200],
28	,	,	O	,	_	0	SENT_331	[p25l672t2137r787b2200],
29	Garsa	NNP	O	Garsa	nn	30	SENT_331	[p25l836t2137r1012b2190],
30	AA	NNP	O	AA	appos	2	SENT_331	[p25l1055t2137r1179b2200],
31	,	,	O	,	_	0	SENT_331	[p25l1055t2137r1179b2200],
32	McLeod	NNP	PERSON	McLeod	nn	33	SENT_331	[p25l1225t2137r1483b2190],
33	HL	NNS	O	hl	nsubj	34	SENT_331	[p25l1527t2138r1626b2189],
34	(	VBP	O	(	dep	2	SENT_331	[p25l1673t2137r1870b2202],
35	2005	CD	DATE	2005	num	37	SENT_331	[p25l1673t2137r1870b2202],
36	)	CD	NUMBER	)	num	37	SENT_331	[p25l1673t2137r1870b2202],
37	Pyrosequencing	NN	O	pyrosequencing	dobj	34	SENT_331	[p25l1916t2138r2145b2206, p25l138t2225r414b2293],
38	of	IN	O	of	_	0	SENT_331	[p25l459t2225r525b2278],
39	clinically	RB	O	clinically	advmod	40	SENT_331	[p25l564t2225r846b2293],
40	relevant	JJ	O	relevant	amod	41	SENT_331	[p25l889t2225r1136b2278],
41	polymorphisms	NNS	O	polymorphism	prep_of	37	SENT_331	[p25l1178t2225r1667b2293],
42	.	.	O	.	_	0	SENT_331	[p25l1178t2225r1667b2293],

1	Methods	NNS	O	method	_	0	SENT_332	[p25l1713t2225r1977b2278],
2	Mol	NNP	O	Mol	nn	3	SENT_332	[p25l2022t2225r2147b2278],
3	Biol	NNP	O	Biol	dep	1	SENT_332	[p25l137t2314r266b2367],
4	311297-114	CD	NUMBER	311297-114	dep	1	SENT_332	[p25l296t2314r656b2368],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_333	[p25l52t2443r142b2468],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_333	[p25l155t2443r255b2468],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_333	[p25l267t2443r318b2468],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_333	[p25l331t2443r406b2468],
5	(	CD	NUMBER	(	num	6	SENT_333	[p25l419t2443r510b2473],
6	2012	CD	DATE	2012	dep	4	SENT_333	[p25l419t2443r510b2473],
7	)	CD	NUMBER	)	number	8	SENT_333	[p25l419t2443r510b2473],
8	134:401	CD	NUMBER	134:401	num	9	SENT_333	[p25l528t2443r710b2468],
9	—	NN	O	—	dep	6	SENT_333	[p25l528t2443r710b2468],
10	410	CD	NUMBER	410	number	11	SENT_333	[p25l528t2443r710b2468],
11	409	CD	NUMBER	409	num	9	SENT_333	[p25l2055t2443r2106b2468],

1	Rose	NNP	O	Rose	nn	2	SENT_334	[p25l137t2611r287b2663],
2	CM	NN	O	cm	nsubj	12	SENT_334	[p25l325t2610r457b2672],
3	,	,	O	,	_	0	SENT_334	[p25l325t2610r457b2672],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_334	[p25l496t2610r689b2663],
5	S	NNP	O	S	appos	2	SENT_334	[p25l727t2610r781b2672],
6	,	,	O	,	_	0	SENT_334	[p25l727t2610r781b2672],
7	Ameyaw	NNP	O	Ameyaw	nn	8	SENT_334	[p25l820t2610r1094b2678],
8	MM	NN	O	mm	appos	2	SENT_334	[p25l1131t2611r1280b2672],
9	,	,	O	,	_	0	SENT_334	[p25l1131t2611r1280b2672],
10	McLeod	NNP	PERSON	McLeod	nn	11	SENT_334	[p25l1319t2610r1577b2663],
11	HL	NNS	O	hl	appos	2	SENT_334	[p25l1613t2611r1713b2662],
12	(	VBP	O	(	_	0	SENT_334	[p25l1752t2610r1948b2675],
13	2003	CD	DATE	2003	num	14	SENT_334	[p25l1752t2610r1948b2675],
14	)	CD	NUMBER	)	nn	16	SENT_334	[p25l1752t2610r1948b2675],
15	Pharmacogenetic	JJ	O	pharmacogenetic	amod	16	SENT_334	[p25l1986t2610r2148b2663, p25l137t2697r521b2766],
16	analysis	NN	O	analysis	dobj	12	SENT_334	[p25l573t2697r814b2766],
17	of	IN	O	of	_	0	SENT_334	[p25l865t2697r931b2750],
18	clinically	RB	O	clinically	advmod	19	SENT_334	[p25l975t2697r1257b2766],
19	relevant	JJ	O	relevant	amod	21	SENT_334	[p25l1305t2697r1552b2750],
20	genetic	JJ	O	genetic	amod	21	SENT_334	[p25l1601t2697r1818b2766],
21	polymorphisms	NNS	O	polymorphism	prep_of	16	SENT_334	[p25l1867t2697r2148b2766, p25l137t2785r366b2854],
22	.	.	O	.	_	0	SENT_334	[p25l1867t2697r2148b2766, p25l137t2785r366b2854],

1	Methods	NNS	O	method	_	0	SENT_335	[p25l397t2785r662b2838],
2	Mol	NNP	O	Mol	nn	3	SENT_335	[p25l690t2785r815b2838],
3	Med	NNP	O	Med	dep	1	SENT_335	[p25l843t2785r982b2838],
4	85:225	CD	NUMBER	85:225	dep	3	SENT_335	[p25l1012t2785r1369b2839],
5	—	CD	NUMBER	—	number	6	SENT_335	[p25l1012t2785r1369b2839],
6	237	CD	NUMBER	237	dep	1	SENT_335	[p25l1012t2785r1369b2839],
7	Stephens	NNP	O	Stephens	dep	6	SENT_335	[p25l139t2873r410b2942],
8	M	NN	O	m	nn	11	SENT_335	[p25l460t2875r543b2936],
9	,	,	O	,	_	0	SENT_335	[p25l460t2875r543b2936],
10	Donnelly	NNP	PERSON	Donnelly	dep	11	SENT_335	[p25l594t2874r877b2942],
11	P	NN	PERSON	p	dep	1	SENT_335	[p25l926t2875r967b2926],
12	(	CD	NUMBER	(	num	11	SENT_335	[p25l1018t2874r1215b2939],
13	2003	CD	DATE	2003	num	14	SENT_335	[p25l1018t2874r1215b2939],
14	)	NN	O	)	dep	11	SENT_335	[p25l1018t2874r1215b2939],
15	A	DT	O	a	det	16	SENT_335	[p25l1267t2874r1320b2926],
16	comparison	NN	O	comparison	dep	1	SENT_335	[p25l1370t2873r1724b2942],
17	of	IN	O	of	_	0	SENT_335	[p25l1774t2873r1840b2927],
18	bayesian	JJ	O	bayesian	amod	19	SENT_335	[p25l1884t2873r2150b2942],
19	methods	NNS	O	method	prep_of	16	SENT_335	[p25l137t2961r393b3014],
20	for	IN	O	for	_	0	SENT_335	[p25l425t2961r513b3014],
21	haplotype	NN	O	haplotype	nn	22	SENT_335	[p25l541t2961r841b3030],
22	reconstruction	NN	O	reconstruction	prep_for	19	SENT_335	[p25l872t2961r1308b3014],
23	from	IN	O	from	_	0	SENT_335	[p25l1339t2961r1486b3014],
24	population	NN	O	population	nn	26	SENT_335	[p25l1515t2961r1841b3030],
25	genotype	NN	O	genotype	nn	26	SENT_335	[p25l1873t2969r2150b3030],
26	data	NNS	O	datum	prep_from	22	SENT_335	[p25l138t3050r278b3103],
27	.	.	O	.	_	0	SENT_335	[p25l138t3050r278b3103],

1	Am	VBP	O	be	dep	2	SENT_336	[p25l310t3051r423b3103],
2	J	NN	O	j	dep	4	SENT_336	[p25l449t3052r478b3104],
3	Hum	NNP	O	Hum	nn	4	SENT_336	[p25l505t3052r656b3103],
4	Genet	NNP	O	Genet	nsubj	6	SENT_336	[p25l684t3051r865b3104],
5	73	CD	NUMBER	73	num	6	SENT_336	[p25l892t3050r1418b3116],
6	(	CD	NUMBER	(	_	0	SENT_336	[p25l892t3050r1418b3116],
7	5	CD	NUMBER	5	num	8	SENT_336	[p25l892t3050r1418b3116],
8	)	NN	O	)	dobj	6	SENT_336	[p25l892t3050r1418b3116],
9	:1162	CD	NUMBER	:1162	number	10	SENT_336	[p25l892t3050r1418b3116],
10	—	CD	NUMBER	—	dep	8	SENT_336	[p25l892t3050r1418b3116],
11	1169	CD	DATE	1169	num	13	SENT_336	[p25l892t3050r1418b3116],
12	Stephens	NNP	PERSON	Stephens	nn	13	SENT_336	[p25l139t3138r409b3207],
13	M	NN	O	m	dep	22	SENT_336	[p25l453t3140r535b3201],
14	,	,	O	,	_	0	SENT_336	[p25l453t3140r535b3201],
15	Smith	NNP	ORGANIZATION	Smith	nn	16	SENT_336	[p25l583t3138r762b3192],
16	NJ	NNP	ORGANIZATION	NJ	appos	13	SENT_336	[p25l803t3140r902b3202],
17	,	,	O	,	_	0	SENT_336	[p25l803t3140r902b3202],
18	Donnelly	NNP	PERSON	Donnelly	appos	13	SENT_336	[p25l948t3139r1230b3207],
19	P	NN	O	p	dep	22	SENT_336	[p25l1273t3140r1313b3191],
20	(	CD	NUMBER	(	num	19	SENT_336	[p25l1358t3139r1554b3204],
21	2001	CD	DATE	2001	num	22	SENT_336	[p25l1358t3139r1554b3204],
22	)	NN	O	)	dep	8	SENT_336	[p25l1358t3139r1554b3204],
23	A	DT	O	a	det	26	SENT_336	[p25l1599t3139r1652b3191],
24	new	JJ	O	new	amod	26	SENT_336	[p25l1694t3155r1819b3192],
25	statistical	JJ	O	statistical	amod	26	SENT_336	[p25l1865t3138r2149b3192],
26	method	NN	O	method	dep	22	SENT_336	[p25l137t3227r365b3280],
27	for	IN	O	for	_	0	SENT_336	[p25l391t3226r479b3280],
28	haplotype	NN	O	haplotype	nn	29	SENT_336	[p25l502t3227r802b3295],
29	reconstruction	NN	O	reconstruction	prep_for	26	SENT_336	[p25l828t3227r1265b3280],
30	from	IN	O	from	_	0	SENT_336	[p25l1291t3226r1438b3280],
31	population	NN	O	population	nn	32	SENT_336	[p25l1462t3226r1789b3295],
32	data	NNS	O	datum	prep_from	6	SENT_336	[p25l1815t3227r1955b3280],
33	.	.	O	.	_	0	SENT_336	[p25l1815t3227r1955b3280],

1	Am	VBP	O	be	dep	4	SENT_337	[p25l1984t3227r2098b3279],
2	J	NN	O	j	nn	4	SENT_337	[p25l2122t3228r2150b3280],
3	Hum	NNP	O	Hum	nn	4	SENT_337	[p25l138t3317r288b3368],
4	Genet	NNP	O	Genet	_	0	SENT_337	[p25l317t3316r497b3369],
5	68	CD	NUMBER	68	num	4	SENT_337	[p25l525t3315r974b3381],
6	(	CD	NUMBER	(	number	7	SENT_337	[p25l525t3315r974b3381],
7	4	CD	NUMBER	4	num	8	SENT_337	[p25l525t3315r974b3381],
8	)	NN	O	)	dep	4	SENT_337	[p25l525t3315r974b3381],
9	:978	CD	NUMBER	:978	num	10	SENT_337	[p25l525t3315r974b3381],
10	—	NN	O	—	dep	8	SENT_337	[p25l525t3315r974b3381],
11	989	CD	NUMBER	989	num	13	SENT_337	[p25l525t3315r974b3381],
12	Baker	NNP	LOCATION	Baker	nn	13	SENT_337	[p25l138t3404r319b3457],
13	SD	NN	LOCATION	sd	dep	8	SENT_337	[p25l351t3404r460b3466],
14	,	,	O	,	_	0	SENT_337	[p25l351t3404r460b3466],
15	Verweij	NNP	PERSON	Verweij	nn	16	SENT_337	[p25l494t3403r733b3472],
16	J	NNP	PERSON	J	appos	13	SENT_337	[p25l768t3405r812b3467],
17	,	,	O	,	_	0	SENT_337	[p25l768t3405r812b3467],
18	Cusatis	NNP	O	Cusatis	nn	19	SENT_337	[p25l847t3403r1068b3457],
19	GA	NNP	O	GA	appos	13	SENT_337	[p25l1101t3404r1224b3466],
20	,	,	O	,	_	0	SENT_337	[p25l1101t3404r1224b3466],
21	van	NNP	PERSON	van	nn	23	SENT_337	[p25l1258t3420r1367b3457],
22	Schaik	NNP	PERSON	Schaik	nn	23	SENT_337	[p25l1399t3403r1605b3457],
23	R	NNP	PERSON	R	appos	13	SENT_337	[p25l1634t3405r1699b3466],
24	,	,	O	,	_	0	SENT_337	[p25l1634t3405r1699b3466],
25	Marsh	NNP	PERSON	Marsh	nn	26	SENT_337	[p25l1732t3403r1926b3457],
26	S	NNP	O	S	appos	13	SENT_337	[p25l1958t3404r2013b3467],
27	,	,	O	,	_	0	SENT_337	[p25l1958t3404r2013b3467],
28	Orwick	NNP	ORGANIZATION	Orwick	nn	29	SENT_337	[p25l2048t3404r2148b3457, p25l138t3493r285b3546],
29	SJ	NNP	ORGANIZATION	SJ	appos	13	SENT_337	[p25l311t3493r395b3556],
30	,	,	O	,	_	0	SENT_337	[p25l311t3493r395b3556],
31	Franke	NNP	PERSON	Franke	nn	32	SENT_337	[p25l422t3493r632b3546],
32	RM	NN	O	rm	appos	13	SENT_337	[p25l658t3494r790b3556],
33	,	,	O	,	_	0	SENT_337	[p25l658t3494r790b3556],
34	Hu	NNP	O	Hu	nn	35	SENT_337	[p25l819t3494r909b3546],
35	S	NNP	O	S	appos	13	SENT_337	[p25l937t3493r991b3555],
36	,	,	O	,	_	0	SENT_337	[p25l937t3493r991b3555],
37	Schuetz	NNP	ORGANIZATION	Schuetz	nn	38	SENT_337	[p25l1021t3493r1259b3546],
38	EG	NNP	ORGANIZATION	EG	appos	13	SENT_337	[p25l1284t3493r1400b3556],
39	,	,	O	,	_	0	SENT_337	[p25l1284t3493r1400b3556],
40	Lamba	NNP	PERSON	Lamba	nn	41	SENT_337	[p25l1428t3492r1641b3546],
41	V	NNP	O	V	appos	13	SENT_337	[p25l1665t3494r1734b3556],
42	,	,	O	,	_	0	SENT_337	[p25l1665t3494r1734b3556],
43	Messersmith	NNP	PERSON	Messersmith	appos	13	SENT_337	[p25l1761t3492r2150b3546],

1	WA	NNP	O	WA	nsubj	11	SENT_338	[p26l137t20r279b83],
2	,	,	O	,	_	0	SENT_338	[p26l137t20r279b83],
3	Wolff	NNP	ORGANIZATION	Wolff	nn	4	SENT_338	[p26l314t20r501b73],
4	AC	NN	ORGANIZATION	ac	appos	1	SENT_338	[p26l529t20r649b83],
5	,	,	O	,	_	0	SENT_338	[p26l529t20r649b83],
6	Carducci	NNP	PERSON	Carducci	nn	7	SENT_338	[p26l686t20r959b73],
7	MA	NNP	PERSON	MA	appos	1	SENT_338	[p26l993t20r1130b83],
8	,	,	O	,	_	0	SENT_338	[p26l993t20r1130b83],
9	Sparreboom	NNP	O	Sparreboom	nn	10	SENT_338	[p26l1169t20r1539b88],
10	A	NNP	O	A	appos	1	SENT_338	[p26l1571t20r1625b72],
11	(	VBD	O	(	_	0	SENT_338	[p26l1661t20r1857b85],
12	2008	CD	DATE	2008	number	13	SENT_338	[p26l1661t20r1857b85],
13	)	CD	NUMBER	)	num	16	SENT_338	[p26l1661t20r1857b85],
14	Pharmacogenetic	JJ	O	pharmacogenetic	amod	16	SENT_338	[p26l1893t20r2148b73, p26l138t107r428b176],
15	pathway	NN	O	pathway	nn	16	SENT_338	[p26l458t108r715b176],
16	analysis	NN	O	analysis	dobj	11	SENT_338	[p26l747t107r988b176],
17	of	IN	O	of	_	0	SENT_338	[p26l1019t107r1086b161],
18	docetaxel	NN	O	docetaxel	nn	19	SENT_338	[p26l1110t108r1401b161],
19	elimination	NN	O	elimination	prep_of	16	SENT_338	[p26l1432t107r1794b161],
20	.	.	O	.	_	0	SENT_338	[p26l1432t107r1794b161],

1	Clin	NNP	O	Clin	nn	3	SENT_339	[p26l1829t108r1958b161],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_339	[p26l1986t108r2148b161, p26l137t197r322b250],
3	Ther	NNP	O	Ther	_	0	SENT_339	[p26l351t197r494b250],
4	85	CD	NUMBER	85	num	5	SENT_339	[p26l524t196r969b262],
5	(	NN	O	(	dep	3	SENT_339	[p26l524t196r969b262],
6	2	CD	NUMBER	2	number	7	SENT_339	[p26l524t196r969b262],
7	)	CD	NUMBER	)	dep	5	SENT_339	[p26l524t196r969b262],
8	:	:	O	:	_	0	SENT_339	[p26l524t196r969b262],
9	l55	CD	NUMBER	l55	num	11	SENT_339	[p26l524t196r969b262],
10	—	CD	NUMBER	—	num	11	SENT_339	[p26l524t196r969b262],
11	l63	NN	O	l63	dep	3	SENT_339	[p26l524t196r969b262],
12	Sissung	NNP	O	Sissung	nn	13	SENT_339	[p26l139t285r371b354],
13	TM	NNP	O	TM	dep	11	SENT_339	[p26l406t286r535b347],
14	,	,	O	,	_	0	SENT_339	[p26l406t286r535b347],
15	Baum	NNP	PERSON	Baum	nn	16	SENT_339	[p26l571t286r753b338],
16	CE	NNP	O	CE	appos	13	SENT_339	[p26l787t285r898b347],
17	,	,	O	,	_	0	SENT_339	[p26l787t285r898b347],
18	Deeken	NNP	PERSON	Deeken	nn	19	SENT_339	[p26l935t285r1167b338],
19	J	NNP	PERSON	J	appos	13	SENT_339	[p26l1200t286r1244b348],
20	,	,	O	,	_	0	SENT_339	[p26l1200t286r1244b348],
21	Price	NNP	O	Price	nn	22	SENT_339	[p26l1281t285r1435b338],
22	DK	NNP	O	DK	appos	13	SENT_339	[p26l1470t286r1594b348],
23	,	,	O	,	_	0	SENT_339	[p26l1470t286r1594b348],
24	Aragon	NNP	PERSON	Aragon	appos	13	SENT_339	[p26l1630t285r2069b353],
25	.	.	O	.	_	0	SENT_339	[p26l1630t285r2069b353],

1	—	NN	O	—	_	0	SENT_340	[p26l1630t285r2069b353],
2	.	.	O	.	_	0	SENT_340	[p26l1630t285r2069b353],

1	Ching	VBG	PERSON	ching	_	0	SENT_341	[p26l1630t285r2069b353],
2	J	NN	PERSON	j	dobj	1	SENT_341	[p26l2103t286r2147b348],
3	,	,	O	,	_	0	SENT_341	[p26l2103t286r2147b348],
4	Steinberg	NNP	PERSON	Steinberg	nn	5	SENT_341	[p26l139t373r428b442],
5	SM	NNP	O	SM	appos	2	SENT_341	[p26l482t373r604b436],
6	,	,	O	,	_	0	SENT_341	[p26l482t373r604b436],
7	Dahut	NNP	O	Dahut	nn	8	SENT_341	[p26l658t373r844b426],
8	W	NNP	O	W	appos	2	SENT_341	[p26l894t374r982b436],
9	,	,	O	,	_	0	SENT_341	[p26l894t374r982b436],
10	Sparreboom	NNP	O	Sparreboom	nn	11	SENT_341	[p26l1038t373r1408b442],
11	A	NNP	O	A	appos	2	SENT_341	[p26l1459t373r1528b436],
12	,	,	O	,	_	0	SENT_341	[p26l1459t373r1528b436],
13	Figg	NNP	PERSON	Figg	nn	14	SENT_341	[p26l1582t373r1719b442],
14	WD	NNP	O	WD	appos	2	SENT_341	[p26l1771t374r1896b426],
15	(	VBD	O	(	dep	1	SENT_341	[p26l1952t373r2148b438],
16	2008	CD	DATE	2008	dobj	15	SENT_341	[p26l1952t373r2148b438],
17	)	CD	NUMBER	)	num	20	SENT_341	[p26l1952t373r2148b438],
18	ABCB1	NN	O	abcb1	nn	20	SENT_341	[p26l137t461r374b514],
19	genetic	JJ	O	genetic	amod	20	SENT_341	[p26l426t460r643b529],
20	variation	NN	O	variation	nsubj	21	SENT_341	[p26l690t460r961b514],
21	inﬂuences	VBZ	O	inﬂuences	dep	15	SENT_341	[p26l1005t460r1312b514],
22	the	DT	O	the	det	26	SENT_341	[p26l1359t461r1450b514],
23	toxicity	NN	O	toxicity	nn	26	SENT_341	[p26l1495t460r1727b529],
24	and	CC	O	and	_	0	SENT_341	[p26l1774t460r1882b514],
25	clinical	JJ	O	clinical	nn	26	SENT_341	[p26l1926t460r2149b514],
26	outcome	NN	O	outcome	dobj	21	SENT_341	[p26l138t557r399b602],
27	of	IN	O	of	_	0	SENT_341	[p26l433t549r499b602],
28	patients	NNS	O	patient	prep_of	26	SENT_341	[p26l526t549r761b617],
29	with	IN	O	with	_	0	SENT_341	[p26l796t549r930b602],
30	androgen	NN	O	androgen	nn	31	SENT_341	[p26l965t549r1646b617],
31	—	NN	O	—	prep_with	28	SENT_341	[p26l965t549r1646b617],
32	independent	JJ	O	independent	amod	34	SENT_341	[p26l965t549r1646b617],
33	prostate	NN	O	prostate	nn	34	SENT_341	[p26l1678t556r1918b617],
34	cancer	NN	O	cancer	nsubj	1	SENT_341	[p26l1953t565r2151b602],
35	treated	VBN	O	treat	partmod	34	SENT_341	[p26l137t638r345b691],
36	with	IN	O	with	_	0	SENT_341	[p26l372t638r506b691],
37	docetaxel	NN	O	docetaxel	prep_with	35	SENT_341	[p26l534t638r840b691],
38	.	.	O	.	_	0	SENT_341	[p26l534t638r840b691],

1	Clin	NNP	ORGANIZATION	Clin	nn	6	SENT_342	[p26l873t638r1002b691],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	6	SENT_342	[p26l1030t638r1246b691],
3	Res	NNP	ORGANIZATION	Res	nn	6	SENT_342	[p26l1272t639r1383b691],
4	l4	NN	O	l4	nn	6	SENT_342	[p26l1420t638r1977b704],
5	(	CD	NUMBER	(	num	6	SENT_342	[p26l1420t638r1977b704],
6	l4	NN	O	l4	_	0	SENT_342	[p26l1420t638r1977b704],
7	)	CD	NUMBER	)	number	8	SENT_342	[p26l1420t638r1977b704],
8	:4543	CD	NUMBER	:4543	num	10	SENT_342	[p26l1420t638r1977b704],
9	—	CD	NUMBER	—	number	10	SENT_342	[p26l1420t638r1977b704],
10	4549	CD	NUMBER	4549	dep	6	SENT_342	[p26l1420t638r1977b704],
11	Barnholtz	NNP	O	Barnholtz	dep	10	SENT_342	[p26l137t725r637b779],
12	.	.	O	.	_	0	SENT_342	[p26l137t725r637b779],

1	—	NN	O	—	_	0	SENT_343	[p26l137t725r637b779],
2	.	.	O	.	_	0	SENT_343	[p26l137t725r637b779],

1	Sloan	NNP	O	Sloan	nn	2	SENT_344	[p26l137t725r637b779],
2	JS	NNP	O	JS	nsubj	10	SENT_344	[p26l669t726r756b788],
3	,	,	O	,	_	0	SENT_344	[p26l669t726r756b788],
4	de	FW	PERSON	de	nn	6	SENT_344	[p26l792t726r861b779],
5	Andrade	FW	PERSON	andrade	nn	6	SENT_344	[p26l894t726r1154b779],
6	M	NN	O	m	appos	2	SENT_344	[p26l1187t727r1269b788],
7	,	,	O	,	_	0	SENT_344	[p26l1187t727r1269b788],
8	Chakraborty	NNP	O	Chakraborty	nn	9	SENT_344	[p26l1305t725r1684b794],
9	R	NNP	O	R	appos	6	SENT_344	[p26l1717t727r1767b778],
10	(	VBD	O	(	_	0	SENT_344	[p26l1801t726r1998b791],
11	2001	CD	DATE	2001	num	12	SENT_344	[p26l1801t726r1998b791],
12	)	CD	NUMBER	)	dobj	10	SENT_344	[p26l1801t726r1998b791],
13	The	DT	O	the	det	14	SENT_344	[p26l2033t726r2150b779],
14	impact	NN	O	impact	tmod	10	SENT_344	[p26l137t814r345b882],
15	of	IN	O	of	_	0	SENT_344	[p26l379t814r445b867],
16	population	NN	O	population	nn	17	SENT_344	[p26l472t814r799b882],
17	admixture	NN	O	admixture	prep_of	14	SENT_344	[p26l834t814r1141b867],
18	on	IN	O	on	_	0	SENT_344	[p26l1176t830r1249b867],
19	traditional	JJ	O	traditional	amod	21	SENT_344	[p26l1282t814r1595b867],
20	linkage	NN	O	linkage	nn	21	SENT_344	[p26l1629t814r1853b883],
21	analysis	NN	O	analysis	prep_on	17	SENT_344	[p26l1888t814r2146b882],
22	.	.	O	.	_	0	SENT_344	[p26l1888t814r2146b882],

1	Ethn	NNP	O	Ethn	nn	2	SENT_345	[p26l137t903r280b956],
2	Dis	NNP	O	Dis	dep	12	SENT_345	[p26l307t903r410b956],
3	11	CD	NUMBER	11	number	4	SENT_345	[p26l446t903r884b969],
4	(	CD	NUMBER	(	dep	2	SENT_345	[p26l446t903r884b969],
5	3	CD	NUMBER	3	num	6	SENT_345	[p26l446t903r884b969],
6	)	NN	O	)	dep	4	SENT_345	[p26l446t903r884b969],
7	:5	CD	NUMBER	:5	num	8	SENT_345	[p26l446t903r884b969],
8	l9	NN	O	l9	dep	12	SENT_345	[p26l446t903r884b969],
9	—	NN	O	—	nn	12	SENT_345	[p26l446t903r884b969],
10	531	CD	NUMBER	531	num	12	SENT_345	[p26l446t903r884b969],
11	Garsa	NN	O	garsa	nn	12	SENT_345	[p26l139t992r314b1045],
12	A	NN	O	a	dep	19	SENT_345	[p26l351t992r420b1055],
13	,	,	O	,	_	0	SENT_345	[p26l351t992r420b1055],
14	McLeod	NNP	PERSON	McLeod	nn	15	SENT_345	[p26l460t992r719b1045],
15	H	NNP	O	H	appos	12	SENT_345	[p26l756t993r825b1055],
16	,	,	O	,	_	0	SENT_345	[p26l756t993r825b1055],
17	Marsh	NNP	PERSON	Marsh	nn	18	SENT_345	[p26l865t992r1058b1045],
18	S	NNP	O	S	appos	12	SENT_345	[p26l1097t992r1132b1045],
19	(	VBD	O	(	_	0	SENT_345	[p26l1175t992r1372b1058],
20	2005	CD	DATE	2005	num	22	SENT_345	[p26l1175t992r1372b1058],
21	)	CD	NUMBER	)	num	22	SENT_345	[p26l1175t992r1372b1058],
22	CYP3A4	NN	O	cyp3a4	dobj	19	SENT_345	[p26l1413t992r1688b1045],
23	and	CC	O	and	_	0	SENT_345	[p26l1729t992r1836b1045],
24	CYP3A5	NN	O	cyp3a5	nn	25	SENT_345	[p26l1874t992r2147b1045],
25	genotyping	NN	O	genotyping	dobj	19	SENT_345	[p26l138t1080r479b1149],
26	by	IN	O	by	_	0	SENT_345	[p26l506t1080r581b1148],
27	pyrosequencing	NN	O	pyrosequencing	prep_by	19	SENT_345	[p26l608t1080r1106b1148],
28	.	.	O	.	_	0	SENT_345	[p26l608t1080r1106b1148],

1	BMC	NNP	ORGANIZATION	BMC	nn	3	SENT_346	[p26l1138t1080r1304b1133],
2	Med	NNP	ORGANIZATION	Med	nn	3	SENT_346	[p26l1332t1080r1471b1133],
3	Genet	NNP	ORGANIZATION	Genet	_	0	SENT_346	[p26l1499t1080r1680b1133],
4	6	CD	NUMBER	6	num	5	SENT_346	[p26l1707t1080r1927b1145],
5	(	NN	O	(	dep	3	SENT_346	[p26l1707t1080r1927b1145],
6	l	NN	O	l	tmod	5	SENT_346	[p26l1707t1080r1927b1145],
7	)	CD	NUMBER	)	num	9	SENT_346	[p26l1707t1080r1927b1145],
8	:	:	O	:	_	0	SENT_346	[p26l1707t1080r1927b1145],
9	l9	CD	NUMBER	l9	dep	3	SENT_346	[p26l1707t1080r1927b1145],
10	International	NNP	MISC	International	nn	12	SENT_346	[p26l138t1169r526b1222],
11	HapMap	NNP	MISC	HapMap	nn	12	SENT_346	[p26l586t1170r850b1237],
12	Consortium	NNP	MISC	Consortium	dep	9	SENT_346	[p26l911t1169r1270b1222],
13	(	CD	NUMBER	(	num	12	SENT_346	[p26l1331t1169r1527b1234],
14	2003	CD	DATE	2003	num	15	SENT_346	[p26l1331t1169r1527b1234],
15	)	CD	NUMBER	)	dep	3	SENT_346	[p26l1331t1169r1527b1234],
16	The	DT	O	the	det	19	SENT_346	[p26l1588t1169r1704b1222],
17	international	JJ	O	international	amod	19	SENT_346	[p26l1764t1169r2150b1222],
18	HapMap	NNP	O	HapMap	nn	19	SENT_346	[p26l138t1258r401b1326],
19	project	NN	O	project	dep	15	SENT_346	[p26l429t1257r656b1326],
20	.	.	O	.	_	0	SENT_346	[p26l429t1257r656b1326],

1	Nature	NNP	O	Nature	_	0	SENT_347	[p26l687t1258r893b1310],
2	426	CD	NUMBER	426	num	1	SENT_347	[p26l921t1257r1525b1322],
3	(	CD	NUMBER	(	number	4	SENT_347	[p26l921t1257r1525b1322],
4	6968	CD	NUMBER	6968	dep	1	SENT_347	[p26l921t1257r1525b1322],
5	)	CD	NUMBER	)	num	7	SENT_347	[p26l921t1257r1525b1322],
6	:789	CD	NUMBER	:789	num	7	SENT_347	[p26l921t1257r1525b1322],
7	—	NN	O	—	dep	4	SENT_347	[p26l921t1257r1525b1322],
8	796	CD	NUMBER	796	num	9	SENT_347	[p26l921t1257r1525b1322],
9	NCBI	NN	O	ncbus	dep	1	SENT_347	[p26l137t1346r317b1398],
10	(	CD	NUMBER	(	num	11	SENT_347	[p26l374t1346r571b1411],
11	2010	CD	DATE	2010	dep	9	SENT_347	[p26l374t1346r571b1411],
12	)	CD	NUMBER	)	num	13	SENT_347	[p26l374t1346r571b1411],
13	NCBI	NN	ORGANIZATION	ncbus	dep	1	SENT_347	[p26l628t1346r808b1399],
14	entrez	JJ	O	entrez	amod	16	SENT_347	[p26l864t1353r1047b1398],
15	SNP	NN	O	snp	nn	16	SENT_347	[p26l1106t1345r1241b1398],
16	database	NN	O	database	dep	13	SENT_347	[p26l1296t1345r1572b1398],
17	.	.	O	.	_	0	SENT_347	[p26l1296t1345r1572b1398],

1	Available	JJ	O	available	_	0	SENT_348	[p26l1631t1345r1926b1398],
2	from	IN	O	from	prep	1	SENT_348	[p26l1982t1345r2145b1398],
3	:	:	O	:	_	0	SENT_348	[p26l1982t1345r2145b1398],
4	http://www.ncbi.n1m.nih.gov/sites/entrez?db=snp	NN	O	http://www.ncbi.n1m.nih.gov/sites/entrez?db=snp	dep	1	SENT_348	[p26l137t1434r1664b1502],
5	.	.	O	.	_	0	SENT_348	[p26l137t1434r1664b1502],

1	Accessed	VBN	O	access	_	0	SENT_349	[p26l1712t1434r1998b1487],
2	Oct	NN	DATE	oct	dobj	1	SENT_349	[p26l2043t1434r2151b1487],
3	05	CD	DATE	05	num	2	SENT_349	[p26l138t1522r228b1585],
4	,	,	DATE	,	_	0	SENT_349	[p26l138t1522r228b1585],
5	2008	CD	DATE	2008	num	7	SENT_349	[p26l259t1522r406b1575],
6	Canoe	NNP	O	Canoe	nn	7	SENT_349	[p26l138t1611r326b1663],
7	WG	NNP	O	WG	appos	2	SENT_349	[p26l346t1610r489b1673],
8	,	,	O	,	_	0	SENT_349	[p26l346t1610r489b1673],
9	Carey	NNP	ORGANIZATION	Carey	nn	10	SENT_349	[p26l513t1611r692b1679],
10	LA	NNP	ORGANIZATION	LA	appos	2	SENT_349	[p26l713t1611r829b1673],
11	,	,	O	,	_	0	SENT_349	[p26l713t1611r829b1673],
12	Calvo	NNP	PERSON	Calvo	nn	13	SENT_349	[p26l853t1610r1032b1663],
13	BF	NNP	O	BF	appos	2	SENT_349	[p26l1054t1611r1161b1673],
14	,	,	O	,	_	0	SENT_349	[p26l1054t1611r1161b1673],
15	Sartor	NNP	PERSON	Sartor	nn	16	SENT_349	[p26l1187t1611r1370b1663],
16	C	NNP	PERSON	C	appos	2	SENT_349	[p26l1390t1610r1454b1673],
17	,	,	O	,	_	0	SENT_349	[p26l1390t1610r1454b1673],
18	Sawyer	NNP	PERSON	Sawyer	nn	19	SENT_349	[p26l1480t1611r1706b1679],
19	L	NNP	O	L	appos	2	SENT_349	[p26l1725t1611r1786b1673],
20	,	,	O	,	_	0	SENT_349	[p26l1725t1611r1786b1673],
21	Moore	NNP	PERSON	Moore	nn	22	SENT_349	[p26l1809t1611r2010b1663],
22	DT	NNP	O	DT	appos	2	SENT_349	[p26l2031t1611r2147b1673],
23	,	,	O	,	_	0	SENT_349	[p26l2031t1611r2147b1673],
24	Rosenman	NNP	PERSON	Rosenman	nn	25	SENT_349	[p26l137t1700r458b1752],
25	J	NNP	PERSON	J	appos	2	SENT_349	[p26l486t1700r530b1761],
26	,	,	O	,	_	0	SENT_349	[p26l486t1700r530b1761],
27	Ollila	NNP	PERSON	Ollila	nn	28	SENT_349	[p26l563t1699r736b1752],
28	DW	NNP	O	DW	appos	2	SENT_349	[p26l763t1700r905b1762],
29	,	,	O	,	_	0	SENT_349	[p26l763t1700r905b1762],
30	Graham	NNP	PERSON	Graham	nn	31	SENT_349	[p26l938t1699r1182b1752],
31	M	NNP	O	M	appos	2	SENT_349	[p26l1209t1700r1275b1751],
32	(	VBD	O	(	dep	1	SENT_349	[p26l1306t1699r1503b1764],
33	2002	CD	DATE	2002	num	34	SENT_349	[p26l1306t1699r1503b1764],
34	)	CD	NUMBER	)	dobj	32	SENT_349	[p26l1306t1699r1503b1764],
35	Long	JJ	O	long	amod	38	SENT_349	[p26l1533t1700r1860b1767],
36	—	NN	O	—	nn	38	SENT_349	[p26l1533t1700r1860b1767],
37	term	NN	O	term	nn	38	SENT_349	[p26l1533t1700r1860b1767],
38	outcome	NN	O	outcome	nsubj	1	SENT_349	[p26l1889t1707r2149b1752],
39	of	IN	O	of	_	0	SENT_349	[p26l138t1787r204b1840],
40	neoadjuvant	JJ	O	neoadjuvant	amod	41	SENT_349	[p26l234t1787r607b1856],
41	therapy	NN	O	therapy	prep_of	38	SENT_349	[p26l643t1787r869b1856],
42	for	IN	O	for	_	0	SENT_349	[p26l906t1787r994b1840],
43	locally	RB	O	locally	advmod	44	SENT_349	[p26l1029t1787r1235b1856],
44	advanced	JJ	O	advanced	amod	46	SENT_349	[p26l1273t1787r1559b1840],
45	breast	NN	O	breast	nn	46	SENT_349	[p26l1594t1787r1776b1840],
46	carcinoma	NN	O	carcinoma	prep_for	41	SENT_349	[p26l1811t1787r2144b1840],
47	:	:	O	:	_	0	SENT_349	[p26l1811t1787r2144b1840],
48	effective	JJ	O	effective	amod	50	SENT_349	[p26l138t1874r403b1927],
49	clinical	JJ	O	clinical	amod	50	SENT_349	[p26l450t1874r673b1927],
50	downstaging	NN	O	downstaging	dep	38	SENT_349	[p26l719t1874r1106b1943],
51	allows	VBZ	O	allow	rcmod	50	SENT_349	[p26l1154t1874r1348b1927],
52	breast	NN	O	breast	nn	53	SENT_349	[p26l1394t1874r1576b1927],
53	preservation	NN	O	preservation	dobj	51	SENT_349	[p26l1620t1874r1996b1943],
54	and	CC	O	and	_	0	SENT_349	[p26l2044t1874r2151b1927],
55	predicts	VBZ	O	predict	rcmod	50	SENT_349	[p26l137t1962r376b2031],
56	outstanding	JJ	O	outstanding	amod	58	SENT_349	[p26l438t1962r791b2031],
57	local	JJ	O	local	amod	58	SENT_349	[p26l851t1962r997b2015],
58	control	NN	O	control	dobj	55	SENT_349	[p26l1057t1962r1271b2015],
59	and	CC	O	and	_	0	SENT_349	[p26l1332t1962r1439b2015],
60	survival	NN	O	survival	dobj	55	SENT_349	[p26l1501t1962r1757b2016],
61	.	.	O	.	_	0	SENT_349	[p26l1501t1962r1757b2016],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_350	[p26l1820t1963r1949b2015],
2	Surg	NNP	PERSON	Surg	_	0	SENT_350	[p26l2010t1963r2149b2031],
3	236	CD	NUMBER	236	number	4	SENT_350	[p26l138t2052r627b2118],
4	(	CD	NUMBER	(	dep	2	SENT_350	[p26l138t2052r627b2118],
5	3	CD	NUMBER	3	num	6	SENT_350	[p26l138t2052r627b2118],
6	)	NN	O	)	dep	4	SENT_350	[p26l138t2052r627b2118],
7	:295	CD	NUMBER	:295	num	8	SENT_350	[p26l138t2052r627b2118],
8	—	NN	O	—	dep	2	SENT_350	[p26l138t2052r627b2118],
9	302	CD	NUMBER	302	num	10	SENT_350	[p26l138t2052r627b2118],
10	Discussion	NN	O	discussion	dep	8	SENT_350	[p26l655t2052r1003b2105],
11	:	:	O	:	_	0	SENT_350	[p26l655t2052r1003b2105],
12	302-303	CD	NUMBER	302-303	num	14	SENT_350	[p26l1039t2052r1298b2105],
13	Carey	NNP	ORGANIZATION	Carey	nn	14	SENT_350	[p26l138t2139r317b2208],
14	LA	NNP	ORGANIZATION	LA	dep	8	SENT_350	[p26l351t2140r467b2202],
15	,	,	O	,	_	0	SENT_350	[p26l351t2140r467b2202],
16	Metzger	NNP	PERSON	Metzger	nn	17	SENT_350	[p26l503t2140r758b2208],
17	R	NNP	PERSON	R	appos	14	SENT_350	[p26l790t2140r855b2202],
18	,	,	O	,	_	0	SENT_350	[p26l790t2140r855b2202],
19	Dees	NNP	ORGANIZATION	Dees	nn	20	SENT_350	[p26l891t2140r1040b2192],
20	EC	NNP	ORGANIZATION	EC	appos	14	SENT_350	[p26l1074t2140r1187b2202],
21	,	,	O	,	_	0	SENT_350	[p26l1074t2140r1187b2202],
22	Collichio	NNP	O	Collichio	nn	23	SENT_350	[p26l1224t2139r1505b2192],
23	F	NN	O	f	appos	14	SENT_350	[p26l1540t2140r1596b2202],
24	,	,	O	,	_	0	SENT_350	[p26l1540t2140r1596b2202],
25	Sartor	NNP	PERSON	Sartor	nn	26	SENT_350	[p26l1635t2139r1819b2192],
26	CI	NNP	O	CI	appos	14	SENT_350	[p26l1851t2140r1941b2202],
27	,	,	O	,	_	0	SENT_350	[p26l1851t2140r1941b2202],
28	Ollila	NNP	PERSON	Ollila	nn	29	SENT_350	[p26l1979t2139r2151b2192],
29	DW	NNP	O	DW	appos	14	SENT_350	[p26l137t2228r279b2290],
30	,	,	O	,	_	0	SENT_350	[p26l137t2228r279b2290],
31	Klauber-DeMore	NNP	O	Klauber-DeMore	nn	32	SENT_350	[p26l305t2227r828b2280],
32	N	NNP	O	N	appos	14	SENT_350	[p26l851t2228r921b2290],
33	,	,	O	,	_	0	SENT_350	[p26l851t2228r921b2290],
34	Halle	NNP	PERSON	Halle	nn	35	SENT_350	[p26l947t2227r1110b2280],
35	J	NNP	PERSON	J	appos	14	SENT_350	[p26l1133t2228r1178b2290],
36	,	,	O	,	_	0	SENT_350	[p26l1133t2228r1178b2290],
37	Sawyer	NNP	PERSON	Sawyer	nn	38	SENT_350	[p26l1205t2227r1431b2296],
38	L	NNP	O	L	appos	14	SENT_350	[p26l1452t2228r1514b2290],
39	,	,	O	,	_	0	SENT_350	[p26l1452t2228r1514b2290],
40	Moore	NNP	PERSON	Moore	nn	41	SENT_350	[p26l1539t2228r1740b2280],
41	DT	NNP	O	DT	appos	14	SENT_350	[p26l1764t2228r1880b2290],
42	,	,	O	,	_	0	SENT_350	[p26l1764t2228r1880b2290],
43	Graham	NNP	PERSON	Graham	nn	44	SENT_350	[p26l1907t2227r2151b2280],
44	ML	NNP	O	ML	appos	14	SENT_350	[p26l137t2318r250b2369],
45	(	CD	NUMBER	(	num	46	SENT_350	[p26l277t2316r474b2382],
46	2005	CD	DATE	2005	dep	44	SENT_350	[p26l277t2316r474b2382],
47	)	NNP	O	)	nn	50	SENT_350	[p26l277t2316r474b2382],
48	American	NNP	ORGANIZATION	American	nn	50	SENT_350	[p26l501t2316r802b2369],
49	Joint	NNP	ORGANIZATION	Joint	nn	50	SENT_350	[p26l826t2316r974b2370],
50	Committee	NNP	ORGANIZATION	Committee	dep	2	SENT_350	[p26l999t2316r1337b2370],
51	on	IN	O	on	_	0	SENT_350	[p26l1363t2333r1437b2369],
52	Cancer	NNP	O	Cancer	nn	53	SENT_350	[p26l1463t2317r1678b2370],
53	Tumor	NN	O	tumor	prep_on	50	SENT_350	[p26l1702t2316r2151b2370],
54	.	.	O	.	_	0	SENT_350	[p26l1702t2316r2151b2370],

1	—	NN	O	—	_	0	SENT_351	[p26l1702t2316r2151b2370],
2	.	.	O	.	_	0	SENT_351	[p26l1702t2316r2151b2370],

1	Node	NNP	O	Node	nn	2	SENT_352	[p26l1702t2316r2151b2370],
2	Metastasis	NNP	O	Metastasis	nsubj	3	SENT_352	[p26l137t2404r456b2457],
3	stage	NN	O	stage	_	0	SENT_352	[p26l511t2412r664b2473],
4	after	IN	O	after	_	0	SENT_352	[p26l716t2404r855b2457],
5	neoadjuvant	JJ	O	neoadjuvant	amod	6	SENT_352	[p26l904t2404r1277b2473],
6	chemotherapy	NN	O	chemotherapy	prep_after	3	SENT_352	[p26l1328t2404r1758b2473],
7	and	CC	O	and	_	0	SENT_352	[p26l1812t2404r1920b2457],
8	breast	NN	O	breast	nn	10	SENT_352	[p26l1968t2404r2151b2457],
9	cancer	NN	O	cancer	nn	10	SENT_352	[p26l138t2510r337b2546],
10	outcome	NN	O	outcome	conj_and	6	SENT_352	[p26l364t2501r640b2546],
11	.	.	O	.	_	0	SENT_352	[p26l364t2501r640b2546],

1	J	NNP	O	J	nn	4	SENT_353	[p26l671t2494r699b2547],
2	Natl	NNP	O	Natl	nn	4	SENT_353	[p26l726t2493r856b2546],
3	Cancer	NNP	O	Cancer	nn	4	SENT_353	[p26l885t2494r1100b2546],
4	Inst	NNP	O	Inst	nsubj	6	SENT_353	[p26l1126t2494r1240b2546],
5	97	CD	NUMBER	97	num	6	SENT_353	[p26l1268t2493r1832b2559],
6	(	CD	NUMBER	(	_	0	SENT_353	[p26l1268t2493r1832b2559],
7	15	CD	NUMBER	15	num	8	SENT_353	[p26l1268t2493r1832b2559],
8	)	NN	O	)	dobj	6	SENT_353	[p26l1268t2493r1832b2559],
9	:1137	CD	NUMBER	:1137	number	10	SENT_353	[p26l1268t2493r1832b2559],
10	—	CD	NUMBER	—	dep	8	SENT_353	[p26l1268t2493r1832b2559],
11	1142	CD	DATE	1142	num	13	SENT_353	[p26l1268t2493r1832b2559],
12	Fisher	NNP	PERSON	Fisher	nn	13	SENT_353	[p26l137t2581r327b2634],
13	B	NN	PERSON	b	dep	62	SENT_353	[p26l354t2583r419b2644],
14	,	,	O	,	_	0	SENT_353	[p26l354t2583r419b2644],
15	Bryant	NNP	PERSON	Bryant	nn	16	SENT_353	[p26l449t2583r656b2650],
16	J	NNP	PERSON	J	appos	13	SENT_353	[p26l683t2583r727b2644],
17	,	,	O	,	_	0	SENT_353	[p26l683t2583r727b2644],
18	Wolmark	NNP	O	Wolmark	nn	19	SENT_353	[p26l756t2581r1046b2634],
19	N	NNP	O	N	appos	13	SENT_353	[p26l1072t2583r1142b2644],
20	,	,	O	,	_	0	SENT_353	[p26l1072t2583r1142b2644],
21	Mamounas	NNP	O	Mamounas	nn	22	SENT_353	[p26l1172t2583r1508b2634],
22	E	NNP	O	E	appos	13	SENT_353	[p26l1536t2583r1598b2644],
23	,	,	O	,	_	0	SENT_353	[p26l1536t2583r1598b2644],
24	Brown	NNP	PERSON	Brown	nn	25	SENT_353	[p26l1628t2583r1834b2635],
25	A	NNP	O	A	appos	13	SENT_353	[p26l1862t2582r1931b2644],
26	,	,	O	,	_	0	SENT_353	[p26l1862t2582r1931b2644],
27	Fisher	NNP	PERSON	Fisher	nn	28	SENT_353	[p26l1960t2581r2151b2634],
28	ER	NN	O	er	appos	13	SENT_353	[p26l137t2671r249b2732],
29	,	,	O	,	_	0	SENT_353	[p26l137t2671r249b2732],
30	Wickerham	NNP	ORGANIZATION	Wickerham	nn	31	SENT_353	[p26l300t2669r657b2723],
31	DL	NNP	ORGANIZATION	DL	appos	13	SENT_353	[p26l705t2671r821b2732],
32	,	,	O	,	_	0	SENT_353	[p26l705t2671r821b2732],
33	Begovic	NNP	PERSON	Begovic	nn	34	SENT_353	[p26l873t2669r1124b2738],
34	M	NNP	O	M	appos	13	SENT_353	[p26l1174t2671r1256b2732],
35	,	,	O	,	_	0	SENT_353	[p26l1174t2671r1256b2732],
36	DeCillis	NNP	O	DeCillis	nn	37	SENT_353	[p26l1308t2669r1559b2723],
37	A	NNP	O	A	appos	13	SENT_353	[p26l1610t2670r1678b2732],
38	,	,	O	,	_	0	SENT_353	[p26l1610t2670r1678b2732],
39	Robidoux	NNP	PERSON	Robidoux	nn	40	SENT_353	[p26l1730t2669r2029b2723],
40	A	NNP	O	A	appos	13	SENT_353	[p26l2078t2670r2147b2733],
41	,	,	O	,	_	0	SENT_353	[p26l2078t2670r2147b2733],
42	Margolese	NNP	PERSON	Margolese	nn	43	SENT_353	[p26l137t2757r457b2826],
43	RG	NNP	O	RG	appos	13	SENT_353	[p26l493t2757r613b2820],
44	,	,	O	,	_	0	SENT_353	[p26l493t2757r613b2820],
45	Cruz	NNP	ORGANIZATION	Cruz	nn	46	SENT_353	[p26l651t2757r796b2810],
46	AB	NNP	ORGANIZATION	AB	appos	13	SENT_353	[p26l831t2758r952b2820],
47	,	,	O	,	_	0	SENT_353	[p26l831t2758r952b2820],
48	Hoehn	NNP	PERSON	Hoehn	nn	49	SENT_353	[p26l989t2757r1191b2810],
49	JL	NNP	O	JL	appos	13	SENT_353	[p26l1225t2758r1316b2820],
50	,	,	O	,	_	0	SENT_353	[p26l1225t2758r1316b2820],
51	Lees	NNP	O	Lees	nn	52	SENT_353	[p26l1353t2758r1495b2810],
52	AW	NNP	O	AW	appos	13	SENT_353	[p26l1531t2758r1672b2820],
53	,	,	O	,	_	0	SENT_353	[p26l1531t2758r1672b2820],
54	Dimitrov	NNP	ORGANIZATION	Dimitrov	nn	55	SENT_353	[p26l1710t2757r1988b2810],
55	NV	NNP	ORGANIZATION	NV	appos	13	SENT_353	[p26l2023t2758r2147b2820],
56	,	,	O	,	_	0	SENT_353	[p26l2023t2758r2147b2820],
57	Bear	NNP	O	Bear	nn	59	SENT_353	[p26l137t2847r281b2898],
58	HD	NNP	O	HD	nn	59	SENT_353	[p26l322t2847r428b2898],
59	(	NNP	O	(	appos	13	SENT_353	[p26l474t2846r671b2911],
60	1998	CD	DATE	1998	dep	62	SENT_353	[p26l474t2846r671b2911],
61	)	CD	NUMBER	)	num	62	SENT_353	[p26l474t2846r671b2911],
62	Effect	NN	O	effect	dep	8	SENT_353	[p26l714t2845r901b2898],
63	of	IN	O	of	_	0	SENT_353	[p26l943t2845r1009b2898],
64	preoperative	JJ	O	preoperative	amod	65	SENT_353	[p26l1044t2845r1425b2914],
65	chemotherapy	NN	O	chemotherapy	prep_of	62	SENT_353	[p26l1469t2845r1900b2914],
66	on	IN	O	on	_	0	SENT_353	[p26l1943t2862r2017b2898],
67	the	DT	O	the	det	68	SENT_353	[p26l2058t2845r2149b2898],
68	outcome	NN	O	outcome	prep_on	6	SENT_353	[p26l138t2942r398b2987],
69	of	IN	O	of	_	0	SENT_353	[p26l436t2933r503b2987],
70	women	NNS	O	woman	prep_of	68	SENT_353	[p26l535t2950r757b2987],
71	with	IN	O	with	_	0	SENT_353	[p26l794t2933r928b2987],
72	operable	JJ	O	operable	amod	74	SENT_353	[p26l965t2934r1225b3002],
73	breast	NN	O	breast	nn	74	SENT_353	[p26l1262t2934r1445b2987],
74	cancer	NN	O	cancer	prep_with	70	SENT_353	[p26l1481t2950r1694b2987],
75	.	.	O	.	_	0	SENT_353	[p26l1481t2950r1694b2987],

1	J	NNP	O	J	nn	3	SENT_354	[p26l1734t2935r1763b2987],
2	Clin	NNP	O	Clin	nn	3	SENT_354	[p26l1799t2933r1928b2987],
3	Oncol	NNP	O	Oncol	dep	12	SENT_354	[p26l1967t2934r2149b2987],
4	16	CD	NUMBER	16	num	3	SENT_354	[p26l144t3022r662b3088],
5	(	CD	NUMBER	(	number	6	SENT_354	[p26l144t3022r662b3088],
6	8	CD	NUMBER	8	dep	3	SENT_354	[p26l144t3022r662b3088],
7	)	NN	O	)	dep	6	SENT_354	[p26l144t3022r662b3088],
8	:2672	CD	NUMBER	:2672	num	7	SENT_354	[p26l144t3022r662b3088],
9	—	CD	NUMBER	—	dep	12	SENT_354	[p26l144t3022r662b3088],
10	2685	CD	DATE	2685	num	12	SENT_354	[p26l144t3022r662b3088],
11	Zheng	NNP	PERSON	Zheng	nn	12	SENT_354	[p26l137t3110r330b3179],
12	S	NN	PERSON	s	dep	37	SENT_354	[p26l355t3111r410b3173],
13	,	,	O	,	_	0	SENT_354	[p26l355t3111r410b3173],
14	Zhang	NNP	ORGANIZATION	Zhang	nn	15	SENT_354	[p26l435t3110r628b3179],
15	BL	NN	ORGANIZATION	bl	appos	12	SENT_354	[p26l652t3112r764b3173],
16	,	,	O	,	_	0	SENT_354	[p26l652t3112r764b3173],
17	Zhang	NNP	PERSON	Zhang	nn	18	SENT_354	[p26l789t3110r982b3179],
18	RZ	NNP	PERSON	RZ	appos	12	SENT_354	[p26l1006t3112r1118b3173],
19	,	,	O	,	_	0	SENT_354	[p26l1006t3112r1118b3173],
20	Yang	NNP	PERSON	Yang	nn	21	SENT_354	[p26l1144t3112r1306b3179],
21	JL	NNP	O	JL	appos	12	SENT_354	[p26l1329t3112r1420b3173],
22	,	,	O	,	_	0	SENT_354	[p26l1329t3112r1420b3173],
23	Zou	NNP	PERSON	Zou	nn	24	SENT_354	[p26l1445t3112r1567b3163],
24	SM	NNP	O	SM	appos	12	SENT_354	[p26l1592t3111r1714b3173],
25	,	,	O	,	_	0	SENT_354	[p26l1592t3111r1714b3173],
26	Xue	NNP	O	Xue	nn	27	SENT_354	[p26l1739t3112r1864b3163],
27	LY	NNP	O	LY	appos	12	SENT_354	[p26l1887t3112r2003b3173],
28	,	,	O	,	_	0	SENT_354	[p26l1887t3112r2003b3173],
29	Luo	NNP	PERSON	Luo	nn	30	SENT_354	[p26l2029t3112r2149b3163],
30	W	NNP	O	W	appos	12	SENT_354	[p26l137t3200r224b3261],
31	,	,	O	,	_	0	SENT_354	[p26l137t3200r224b3261],
32	Yuan	NNP	O	Yuan	nn	33	SENT_354	[p26l250t3200r413b3252],
33	YL	NNP	O	YL	appos	12	SENT_354	[p26l436t3200r551b3261],
34	,	,	O	,	_	0	SENT_354	[p26l436t3200r551b3261],
35	Lu	NNP	PERSON	Lu	nn	36	SENT_354	[p26l577t3200r660b3252],
36	N	NNP	PERSON	N	appos	12	SENT_354	[p26l683t3200r737b3252],
37	(	VBD	O	(	_	0	SENT_354	[p26l762t3199r958b3264],
38	2010	CD	DATE	2010	num	40	SENT_354	[p26l762t3199r958b3264],
39	)	CD	NUMBER	)	num	40	SENT_354	[p26l762t3199r958b3264],
40	Differences	NNS	O	difference	dobj	37	SENT_354	[p26l983t3198r1337b3252],
41	between	IN	O	between	_	0	SENT_354	[p26l1361t3198r1615b3252],
42	clinical	JJ	O	clinical	amod	43	SENT_354	[p26l1638t3198r1861b3252],
43	response	NN	O	response	prep_between	40	SENT_354	[p26l1884t3215r2149b3267],
44	and	CC	O	and	_	0	SENT_354	[p26l139t3287r246b3340],
45	pathologic	JJ	O	pathologic	amod	46	SENT_354	[p26l274t3286r595b3355],
46	response	NN	O	response	dobj	37	SENT_354	[p26l626t3303r891b3355],
47	of	IN	O	of	_	0	SENT_354	[p26l922t3286r988b3340],
48	breast	NN	O	breast	nn	49	SENT_354	[p26l1011t3287r1194b3340],
49	cancer	NN	O	cancer	prep_of	46	SENT_354	[p26l1223t3303r1422b3340],
50	after	IN	O	after	_	0	SENT_354	[p26l1452t3286r1590b3340],
51	neoadjuvant	JJ	O	neoadjuvant	amod	52	SENT_354	[p26l1618t3286r1991b3355],
52	chemotherapy	NN	O	chemotherapy	prep_after	37	SENT_354	[p26l2021t3287r2148b3340, p26l138t3374r478b3443],
53	.	.	O	.	_	0	SENT_354	[p26l2021t3287r2148b3340, p26l138t3374r478b3443],

1	Zhonghua	NNP	PERSON	Zhonghua	nn	6	SENT_355	[p26l518t3374r827b3443],
2	Bing	NNP	PERSON	Bing	nn	6	SENT_355	[p26l863t3374r1009b3443],
3	Li	NNP	PERSON	Li	nn	6	SENT_355	[p26l1045t3374r1111b3427],
4	Xue	NNP	PERSON	Xue	nn	6	SENT_355	[p26l1148t3376r1273b3427],
5	Za	NNP	PERSON	Za	nn	6	SENT_355	[p26l1309t3376r1390b3427],
6	Zhi	NNP	PERSON	Zhi	dep	13	SENT_355	[p26l1425t3374r1528b3427],
7	39	CD	NUMBER	39	number	8	SENT_355	[p26l1568t3375r2054b3440],
8	(	CD	NUMBER	(	dep	6	SENT_355	[p26l1568t3375r2054b3440],
9	11	CD	NUMBER	11	num	10	SENT_355	[p26l1568t3375r2054b3440],
10	)	NN	O	)	dep	8	SENT_355	[p26l1568t3375r2054b3440],
11	:734	CD	NUMBER	:734	num	12	SENT_355	[p26l1568t3375r2054b3440],
12	—	NN	O	—	dep	13	SENT_355	[p26l1568t3375r2054b3440],
13	738	CD	NUMBER	738	_	0	SENT_355	[p26l1568t3375r2054b3440],
14	in	IN	O	in	_	0	SENT_355	[p26l2092t3374r2150b3427],
15	Chinese	JJ	LOCATION	chinese	prep_in	13	SENT_355	[p26l138t3463r381b3517],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_356	[p27l137t25r330b78],
2	S	NNP	O	S	_	0	SENT_356	[p27l367t25r421b87],
3	,	,	O	,	_	0	SENT_356	[p27l367t25r421b87],
4	Paul	NNP	PERSON	Paul	nn	5	SENT_356	[p27l459t25r592b78],
5	J	NNP	PERSON	J	appos	2	SENT_356	[p27l627t26r671b87],
6	,	,	O	,	_	0	SENT_356	[p27l627t26r671b87],
7	King	NNP	O	King	nn	8	SENT_356	[p27l710t24r858b93],
8	CR	NN	O	cr	appos	2	SENT_356	[p27l895t25r1010b87],
9	,	,	O	,	_	0	SENT_356	[p27l895t25r1010b87],
10	Gifford	NNP	PERSON	Gifford	nn	11	SENT_356	[p27l1049t24r1275b78],
11	G	NNP	PERSON	G	appos	2	SENT_356	[p27l1310t25r1378b88],
12	,	,	O	,	_	0	SENT_356	[p27l1310t25r1378b88],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_356	[p27l1415t25r1674b78],
14	HL	NNS	O	hl	appos	2	SENT_356	[p27l1708t26r1823b87],
15	,	,	O	,	_	0	SENT_356	[p27l1708t26r1823b87],
16	Brown	JJ	PERSON	brown	amod	17	SENT_356	[p27l1861t26r2067b78],
17	R	NN	PERSON	r	appos	2	SENT_356	[p27l2101t26r2151b77],
18	(	CD	NUMBER	(	num	19	SENT_356	[p27l140t113r336b178],
19	2007	CD	DATE	2007	rcmod	17	SENT_356	[p27l140t113r336b178],
20	)	CD	NUMBER	)	num	22	SENT_356	[p27l140t113r336b178],
21	Pharmacogenetic	JJ	O	pharmacogenetic	amod	22	SENT_356	[p27l359t113r883b181],
22	assessment	NN	O	assessment	dobj	19	SENT_356	[p27l908t121r1244b166],
23	of	IN	O	of	_	0	SENT_356	[p27l1265t113r1331b166],
24	toxicity	NN	O	toxicity	prep_of	22	SENT_356	[p27l1346t113r1578b181],
25	and	CC	O	and	_	0	SENT_356	[p27l1601t113r1709b166],
26	outcome	NN	O	outcome	prep_of	22	SENT_356	[p27l1730t121r1990b166],
27	after	IN	O	after	_	0	SENT_356	[p27l2013t113r2152b166],
28	platinum	NN	O	platinum	prep_after	19	SENT_356	[p27l137t200r408b269],
29	plus	CC	O	plus	_	0	SENT_356	[p27l436t200r560b269],
30	taxane	NN	O	taxane	nn	31	SENT_356	[p27l591t209r788b253],
31	chemotherapy	NN	O	chemotherapy	appos	2	SENT_356	[p27l818t200r1249b269],
32	in	IN	O	in	_	0	SENT_356	[p27l1279t200r1337b253],
33	ovarian	JJ	O	ovarian	amod	34	SENT_356	[p27l1366t200r1593b253],
34	cancer	NN	O	cancer	prep_in	31	SENT_356	[p27l1623t217r1836b253],
35	:	:	O	:	_	0	SENT_356	[p27l1623t217r1836b253],
36	the	DT	O	the	det	39	SENT_356	[p27l1870t200r1961b253],
37	Scottish	JJ	MISC	scottish	amod	39	SENT_356	[p27l1993t201r2148b254, p27l137t289r246b343],
38	randomised	JJ	O	randomised	amod	39	SENT_356	[p27l285t290r642b343],
39	trial	NN	O	trial	dep	2	SENT_356	[p27l681t289r802b343],
40	in	IN	O	in	_	0	SENT_356	[p27l842t289r901b342],
41	ovarian	JJ	O	ovarian	amod	42	SENT_356	[p27l941t289r1168b343],
42	cancer	NN	O	cancer	prep_in	39	SENT_356	[p27l1209t306r1421b343],
43	.	.	O	.	_	0	SENT_356	[p27l1209t306r1421b343],

1	J	NNP	O	J	nn	3	SENT_357	[p27l1465t291r1493b343],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_357	[p27l1533t289r1662b343],
3	Oncol	NNP	PERSON	Oncol	_	0	SENT_357	[p27l1704t290r1887b343],
4	25	CD	NUMBER	25	number	5	SENT_357	[p27l1928t289r2145b355],
5	(	CD	NUMBER	(	dep	3	SENT_357	[p27l1928t289r2145b355],
6	29	CD	NUMBER	29	num	7	SENT_357	[p27l1928t289r2145b355],
7	)	NN	O	)	dep	5	SENT_357	[p27l1928t289r2145b355],
8	:	:	O	:	_	0	SENT_357	[p27l1928t289r2145b355],
9	4528-4535	CD	DURATION	4528-4535	dep	5	SENT_357	[p27l137t379r475b432],

1	Bergmann	NNP	PERSON	Bergmann	nn	2	SENT_358	[p27l138t468r454b535],
2	TK	NN	O	tk	dep	35	SENT_358	[p27l476t468r592b529],
3	,	,	O	,	_	0	SENT_358	[p27l476t468r592b529],
4	Gréen	NN	PERSON	gréen	nn	5	SENT_358	[p27l618t464r802b520],
5	H	NN	O	h	appos	2	SENT_358	[p27l824t468r892b529],
6	,	,	O	,	_	0	SENT_358	[p27l824t468r892b529],
7	Brasch-Andersen	NN	O	brasch-andersen	nn	8	SENT_358	[p27l918t466r1446b519],
8	C	NN	O	c	appos	2	SENT_358	[p27l1469t467r1533b529],
9	,	,	O	,	_	0	SENT_358	[p27l1469t467r1533b529],
10	Mirza	NNP	PERSON	Mirza	nn	11	SENT_358	[p27l1557t466r1740b519],
11	M	NNP	PERSON	M	appos	2	SENT_358	[p27l1760t468r1843b529],
12	,	,	O	,	_	0	SENT_358	[p27l1760t468r1843b529],
13	Herrstedt	NNP	PERSON	Herrstedt	nn	14	SENT_358	[p27l1868t466r2151b519],
14	J	NNP	PERSON	J	appos	2	SENT_358	[p27l137t557r181b619],
15	,	,	O	,	_	0	SENT_358	[p27l137t557r181b619],
16	Hgzslund	NNP	O	Hgzslund	nn	17	SENT_358	[p27l206t556r433b617],
17	B	NNP	O	B	appos	2	SENT_358	[p27l455t557r520b619],
18	,	,	O	,	_	0	SENT_358	[p27l455t557r520b619],
19	du	NNP	O	du	nn	21	SENT_358	[p27l546t556r619b609],
20	Bois	NNP	PERSON	Bois	nn	21	SENT_358	[p27l642t555r778b609],
21	A	NNP	O	A	appos	2	SENT_358	[p27l801t556r870b619],
22	,	,	O	,	_	0	SENT_358	[p27l801t556r870b619],
23	Damkier	NNP	PERSON	Damkier	nn	24	SENT_358	[p27l896t555r1163b609],
24	P	NN	PERSON	p	appos	2	SENT_358	[p27l1184t557r1240b619],
25	,	,	O	,	_	0	SENT_358	[p27l1184t557r1240b619],
26	Vach	NNP	O	Vach	nn	27	SENT_358	[p27l1265t555r1425b609],
27	W	NNP	O	W	appos	2	SENT_358	[p27l1446t557r1533b619],
28	,	,	O	,	_	0	SENT_358	[p27l1446t557r1533b619],
29	Brosen	NNP	PERSON	Brosen	nn	30	SENT_358	[p27l1558t557r1773b609],
30	K	NNP	O	K	appos	2	SENT_358	[p27l1796t557r1864b619],
31	,	,	O	,	_	0	SENT_358	[p27l1796t557r1864b619],
32	Peterson	NNP	PERSON	Peterson	nn	33	SENT_358	[p27l1889t557r2150b609],
33	C	NNP	O	C	appos	2	SENT_358	[p27l138t644r185b697],
34	(	JJ	O	(	amod	35	SENT_358	[p27l218t644r415b709],
35	2011	CD	DATE	2011	_	0	SENT_358	[p27l218t644r415b709],
36	)	CD	NUMBER	)	num	38	SENT_358	[p27l218t644r415b709],
37	Retrospective	JJ	O	retrospective	amod	38	SENT_358	[p27l446t644r865b712],
38	study	NN	O	study	dep	35	SENT_358	[p27l898t644r1058b712],
39	of	IN	O	of	_	0	SENT_358	[p27l1089t644r1155b697],
40	the	DT	O	the	det	41	SENT_358	[p27l1179t644r1271b697],
41	impact	NN	O	impact	prep_of	38	SENT_358	[p27l1300t644r1508b712],
42	of	IN	O	of	_	0	SENT_358	[p27l1538t644r1604b697],
43	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	44	SENT_358	[p27l1627t644r2149b712],
44	variants	NNS	O	variant	prep_of	41	SENT_358	[p27l138t732r376b785],
45	on	IN	O	on	_	0	SENT_358	[p27l427t749r500b785],
46	paclitaxel	NN	O	paclitaxel	nn	47	SENT_358	[p27l548t732r845b801],
47	toxicity	NN	O	toxicity	prep_on	44	SENT_358	[p27l895t732r1126b801],
48	and	CC	O	and	_	0	SENT_358	[p27l1177t732r1284b785],
49	survival	NN	O	survival	prep_on	44	SENT_358	[p27l1335t732r1577b785],
50	in	IN	O	in	_	0	SENT_358	[p27l1625t732r1683b784],
51	patients	NNS	O	patient	prep_in	38	SENT_358	[p27l1730t732r1966b801],
52	with	IN	O	with	_	0	SENT_358	[p27l2017t732r2151b785],
53	ovarian	JJ	O	ovarian	amod	54	SENT_358	[p27l138t820r365b874],
54	cancer	NN	O	cancer	prep_with	51	SENT_358	[p27l393t837r606b874],
55	.	.	O	.	_	0	SENT_358	[p27l393t837r606b874],

1	Eur	NNP	O	Eur	nn	4	SENT_359	[p27l637t822r747b874],
2	J	NNP	O	J	nn	4	SENT_359	[p27l773t822r801b874],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_359	[p27l829t820r958b874],
4	Pharmacol	NNP	PERSON	Pharmacol	nsubj	29	SENT_359	[p27l986t820r1311b874],
5	67	CD	NUMBER	67	num	4	SENT_359	[p27l1340t820r1790b886],
6	(	CD	NUMBER	(	num	7	SENT_359	[p27l1340t820r1790b886],
7	7	CD	NUMBER	7	dep	4	SENT_359	[p27l1340t820r1790b886],
8	)	NN	O	)	nn	13	SENT_359	[p27l1340t820r1790b886],
9	:693	CD	NUMBER	:693	num	13	SENT_359	[p27l1340t820r1790b886],
10	—	CD	NUMBER	—	num	13	SENT_359	[p27l1340t820r1790b886],
11	70O	NNP	O	70O	nn	13	SENT_359	[p27l1340t820r1790b886],
12	Sparreboom	NNP	O	Sparreboom	nn	13	SENT_359	[p27l139t909r510b977],
13	A	NNP	O	A	dep	4	SENT_359	[p27l539t909r609b971],
14	,	,	O	,	_	0	SENT_359	[p27l539t909r609b971],
15	Huizing	NNP	O	Huizing	nn	16	SENT_359	[p27l642t909r885b977],
16	MT	NNP	O	MT	appos	13	SENT_359	[p27l916t910r1045b971],
17	,	,	O	,	_	0	SENT_359	[p27l916t910r1045b971],
18	Boesen	NNP	PERSON	Boesen	nn	19	SENT_359	[p27l1079t910r1302b962],
19	JJB	NNP	PERSON	JJB	appos	13	SENT_359	[p27l1332t910r1456b972],
20	,	,	O	,	_	0	SENT_359	[p27l1332t910r1456b972],
21	Nooijen	NNP	O	Nooijen	nn	22	SENT_359	[p27l1489t909r1734b977],
22	WJ	NNP	O	WJ	appos	13	SENT_359	[p27l1764t910r1880b971],
23	,	,	O	,	_	0	SENT_359	[p27l1764t910r1880b971],
24	Beijnen	NNP	O	Beijnen	nn	25	SENT_359	[p27l1914t909r2150b977],
25	JH	NNP	O	JH	appos	13	SENT_359	[p27l137t998r236b1060],
26	,	,	O	,	_	0	SENT_359	[p27l137t998r236b1060],
27	Tellingen	NNP	PERSON	Tellingen	nn	28	SENT_359	[p27l273t997r565b1066],
28	OV	NNP	O	OV	appos	13	SENT_359	[p27l601t997r707b1050],
29	(	VBD	O	(	_	0	SENT_359	[p27l744t997r941b1062],
30	1995	CD	DATE	1995	num	32	SENT_359	[p27l744t997r941b1062],
31	)	CD	NUMBER	)	num	32	SENT_359	[p27l744t997r941b1062],
32	Isolation	NN	O	isolation	dobj	29	SENT_359	[p27l978t997r1260b1060],
33	,	,	O	,	_	0	SENT_359	[p27l978t997r1260b1060],
34	puriﬁcation	NN	O	puriﬁcation	conj_and	32	SENT_359	[p27l1297t997r1665b1065],
35	,	,	O	,	_	0	SENT_359	[p27l1297t997r1665b1065],
36	and	CC	O	and	_	0	SENT_359	[p27l1704t997r1811b1050],
37	biological	JJ	O	biological	amod	38	SENT_359	[p27l1844t997r2150b1065],
38	activity	NN	O	activity	conj_and	32	SENT_359	[p27l139t1085r365b1154],
39	of	IN	O	of	_	0	SENT_359	[p27l390t1085r455b1138],
40	mono	FW	O	mono	prep_of	38	SENT_359	[p27l473t1102r668b1138],
41	-	:	O	-	_	0	SENT_359	[p27l473t1102r668b1138],
42	and	CC	O	and	_	0	SENT_359	[p27l695t1085r802b1138],
43	dihydroxylated	VBN	O	dihydroxylate	conj_and	29	SENT_359	[p27l826t1085r1287b1154],
44	paclitaxel	NN	O	paclitaxel	nn	45	SENT_359	[p27l1308t1085r1605b1154],
45	metabolites	NNS	O	metabolite	dobj	43	SENT_359	[p27l1629t1085r1979b1138],
46	from	IN	O	from	_	0	SENT_359	[p27l2004t1085r2151b1138],
47	human	JJ	O	human	amod	48	SENT_359	[p27l137t1174r344b1227],
48	feces	NNS	O	fece	prep_from	43	SENT_359	[p27l371t1174r542b1227],
49	.	.	O	.	_	0	SENT_359	[p27l371t1174r542b1227],

1	Cancer	NNP	O	Cancer	nn	3	SENT_360	[p27l574t1174r789b1227],
2	Chemother	NNP	O	Chemother	nn	3	SENT_360	[p27l816t1174r1155b1227],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_360	[p27l1181t1174r1506b1227],
4	36	CD	NUMBER	36	number	5	SENT_360	[p27l1536t1174r1986b1239],
5	(	CD	NUMBER	(	dep	3	SENT_360	[p27l1536t1174r1986b1239],
6	4	CD	NUMBER	4	num	7	SENT_360	[p27l1536t1174r1986b1239],
7	)	NN	O	)	dep	5	SENT_360	[p27l1536t1174r1986b1239],
8	:299	CD	NUMBER	:299	num	9	SENT_360	[p27l1536t1174r1986b1239],
9	—	NN	O	—	dep	3	SENT_360	[p27l1536t1174r1986b1239],
10	304	CD	NUMBER	304	num	12	SENT_360	[p27l1536t1174r1986b1239],
11	Mielke	NNP	PERSON	Mielke	nn	12	SENT_360	[p27l138t1261r352b1315],
12	S	NN	O	s	dep	9	SENT_360	[p27l375t1262r429b1324],
13	,	,	O	,	_	0	SENT_360	[p27l375t1262r429b1324],
14	Sparreboom	NN	O	sparreboom	nn	15	SENT_360	[p27l455t1262r825b1330],
15	A	NN	O	a	appos	3	SENT_360	[p27l844t1262r913b1324],
16	,	,	O	,	_	0	SENT_360	[p27l844t1262r913b1324],
17	Steinberg	NNP	PERSON	Steinberg	nn	18	SENT_360	[p27l939t1261r1226b1330],
18	SM	NNP	O	SM	appos	15	SENT_360	[p27l1250t1262r1372b1324],
19	,	,	O	,	_	0	SENT_360	[p27l1250t1262r1372b1324],
20	Gelderblom	NNP	PERSON	Gelderblom	nn	21	SENT_360	[p27l1397t1261r1759b1315],
21	H	NNP	O	H	appos	15	SENT_360	[p27l1779t1263r1848b1324],
22	,	,	O	,	_	0	SENT_360	[p27l1779t1263r1848b1324],
23	Unger	NNP	PERSON	Unger	nn	24	SENT_360	[p27l1871t1263r2061b1330],
24	C	NNP	O	C	appos	15	SENT_360	[p27l2081t1262r2145b1324],
25	,	,	O	,	_	0	SENT_360	[p27l2081t1262r2145b1324],
26	Behringer	NNP	PERSON	Behringer	nn	27	SENT_360	[p27l138t1349r443b1418],
27	D	NNP	O	D	appos	15	SENT_360	[p27l470t1351r539b1412],
28	,	,	O	,	_	0	SENT_360	[p27l470t1351r539b1412],
29	Mross	NNP	PERSON	Mross	nn	30	SENT_360	[p27l569t1351r756b1402],
30	K	NNP	PERSON	K	appos	15	SENT_360	[p27l787t1351r840b1402],
31	(	CD	NUMBER	(	num	34	SENT_360	[p27l868t1349r1065b1415],
32	2005	CD	DATE	2005	num	34	SENT_360	[p27l868t1349r1065b1415],
33	)	NNP	O	)	nn	34	SENT_360	[p27l868t1349r1065b1415],
34	Association	NNP	O	Association	dep	3	SENT_360	[p27l1095t1349r1453b1402],
35	of	IN	O	of	_	0	SENT_360	[p27l1482t1349r1547b1402],
36	paclitaxel	NN	O	paclitaxel	nn	37	SENT_360	[p27l1570t1349r1867b1418],
37	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	34	SENT_360	[p27l1894t1349r2145b1418, p27l139t1437r445b1490],
38	with	IN	O	with	_	0	SENT_360	[p27l492t1437r625b1490],
39	the	DT	O	the	det	40	SENT_360	[p27l670t1437r761b1490],
40	development	NN	O	development	prep_with	37	SENT_360	[p27l807t1437r1200b1506],
41	of	IN	O	of	_	0	SENT_360	[p27l1245t1437r1311b1490],
42	peripheral	JJ	O	peripheral	amod	43	SENT_360	[p27l1349t1437r1658b1506],
43	neuropathy	NN	O	neuropathy	prep_of	40	SENT_360	[p27l1704t1437r2045b1506],
44	in	IN	O	in	_	0	SENT_360	[p27l2090t1437r2148b1490],
45	patients	NNS	O	patient	prep_in	43	SENT_360	[p27l137t1525r372b1594],
46	with	IN	O	with	_	0	SENT_360	[p27l391t1525r524b1579],
47	advanced	JJ	O	advanced	amod	48	SENT_360	[p27l542t1526r827b1579],
48	cancer	NN	O	cancer	prep_with	45	SENT_360	[p27l844t1542r1057b1579],
49	.	.	O	.	_	0	SENT_360	[p27l844t1542r1057b1579],

1	Clin	NNP	O	Clin	nn	3	SENT_361	[p27l1078t1525r1207b1579],
2	Cancer	NNP	O	Cancer	nn	3	SENT_361	[p27l1224t1526r1439b1579],
3	Res	NNP	O	Res	dep	10	SENT_361	[p27l1453t1527r1564b1579],
4	l1	NN	O	l1	dep	3	SENT_361	[p27l1589t1525r2147b1591],
5	(	CD	NUMBER	(	number	6	SENT_361	[p27l1589t1525r2147b1591],
6	13	CD	NUMBER	13	dep	4	SENT_361	[p27l1589t1525r2147b1591],
7	)	NN	O	)	dep	10	SENT_361	[p27l1589t1525r2147b1591],
8	:4843	CD	NUMBER	:4843	num	7	SENT_361	[p27l1589t1525r2147b1591],
9	—	CD	NUMBER	—	number	10	SENT_361	[p27l1589t1525r2147b1591],
10	4850	CD	NUMBER	4850	dep	44	SENT_361	[p27l1589t1525r2147b1591],
11	de	IN	O	de	_	0	SENT_361	[p27l139t1613r208b1666],
12	Jonge	NNP	O	Jonge	nn	13	SENT_361	[p27l240t1615r415b1682],
13	ME	NNP	O	ME	prep_de	10	SENT_361	[p27l447t1615r576b1676],
14	,	,	O	,	_	0	SENT_361	[p27l447t1615r576b1676],
15	van	NNP	PERSON	van	nn	18	SENT_361	[p27l611t1630r719b1667],
16	den	NN	PERSON	den	nn	18	SENT_361	[p27l752t1613r860b1666],
17	Bongard	NNP	PERSON	Bongard	nn	18	SENT_361	[p27l891t1613r1152b1682],
18	HJGD	NNP	O	HJGD	dep	42	SENT_361	[p27l1184t1614r1392b1676],
19	,	,	O	,	_	0	SENT_361	[p27l1184t1614r1392b1676],
20	Huitema	NNP	ORGANIZATION	Huitema	nn	21	SENT_361	[p27l1427t1613r1689b1666],
21	ADR	NNP	ORGANIZATION	ADR	appos	18	SENT_361	[p27l1720t1614r1894b1676],
22	,	,	O	,	_	0	SENT_361	[p27l1720t1614r1894b1676],
23	Mathot	NNP	ORGANIZATION	Mathot	nn	24	SENT_361	[p27l1929t1611r2149b1666],
24	RAA	NNP	ORGANIZATION	RAA	appos	18	SENT_361	[p27l138t1702r313b1764],
25	,	,	O	,	_	0	SENT_361	[p27l138t1702r313b1764],
26	Rosing	NNP	PERSON	Rosing	nn	27	SENT_361	[p27l340t1701r553b1770],
27	H	NNP	PERSON	H	appos	18	SENT_361	[p27l578t1703r647b1764],
28	,	,	O	,	_	0	SENT_361	[p27l578t1703r647b1764],
29	Baas	NNP	PERSON	Baas	nn	30	SENT_361	[p27l674t1703r818b1754],
30	P	NN	PERSON	p	appos	18	SENT_361	[p27l844t1703r900b1764],
31	,	,	O	,	_	0	SENT_361	[p27l844t1703r900b1764],
32	van	NN	PERSON	van	nn	34	SENT_361	[p27l928t1718r1036b1754],
33	Zandwijk	NNP	PERSON	Zandwijk	nn	34	SENT_361	[p27l1060t1701r1353b1770],
34	N	NNP	PERSON	N	appos	18	SENT_361	[p27l1375t1703r1444b1764],
35	,	,	O	,	_	0	SENT_361	[p27l1375t1703r1444b1764],
36	Beijnen	NNP	O	Beijnen	nn	37	SENT_361	[p27l1471t1701r1707b1770],
37	JH	NNP	O	JH	appos	18	SENT_361	[p27l1731t1703r1830b1764],
38	,	,	O	,	_	0	SENT_361	[p27l1731t1703r1830b1764],
39	Schellens	NNP	O	Schellens	nn	40	SENT_361	[p27l1859t1701r2146b1755],
40	JHM	NNP	O	JHM	appos	18	SENT_361	[p27l138t1791r287b1843],
41	(	CD	NUMBER	(	dep	42	SENT_361	[p27l338t1790r534b1855],
42	2004	CD	DATE	2004	dep	44	SENT_361	[p27l338t1790r534b1855],
43	)	CD	NUMBER	)	dep	42	SENT_361	[p27l338t1790r534b1855],
44	Bayesian	JJ	O	bayesian	_	0	SENT_361	[p27l585t1790r863b1858],
45	pharmacokinetically	RB	O	pharmacokinetically	advmod	46	SENT_361	[p27l911t1789r1534b1858],
46	guided	VBN	O	guide	partmod	44	SENT_361	[p27l1584t1789r1789b1858],
47	dosing	NN	O	dosing	dobj	46	SENT_361	[p27l1838t1789r2038b1858],
48	of	IN	O	of	_	0	SENT_361	[p27l2087t1789r2153b1843],
49	paclitaxel	NN	O	paclitaxel	prep_of	47	SENT_361	[p27l137t1878r434b1946],
50	in	IN	O	in	_	0	SENT_361	[p27l483t1878r541b1930],
51	patients	NNS	O	patient	prep_in	46	SENT_361	[p27l589t1878r825b1946],
52	with	IN	O	with	_	0	SENT_361	[p27l876t1878r1009b1931],
53	non	JJ	O	non	amod	58	SENT_361	[p27l1058t1878r1361b1931],
54	—	JJ	O	—	amod	58	SENT_361	[p27l1058t1878r1361b1931],
55	small	JJ	O	small	amod	58	SENT_361	[p27l1058t1878r1361b1931],
56	cell	NN	O	cell	nn	58	SENT_361	[p27l1412t1878r1520b1931],
57	lung	NN	O	lung	nn	58	SENT_361	[p27l1570t1878r1702b1947],
58	cancer	NN	O	cancer	prep_with	46	SENT_361	[p27l1753t1894r1965b1931],
59	.	.	O	.	_	0	SENT_361	[p27l1753t1894r1965b1931],

1	Clin	NNP	O	Clin	nn	5	SENT_362	[p27l2019t1878r2148b1931],
2	Cancer	NNP	O	Cancer	nn	5	SENT_362	[p27l139t1967r354b2020],
3	Res	NNP	O	Res	nn	5	SENT_362	[p27l380t1968r491b2019],
4	l0	NN	O	l0	nn	5	SENT_362	[p27l528t1967r1047b2032],
5	(	NN	O	(	dep	13	SENT_362	[p27l528t1967r1047b2032],
6	7	CD	NUMBER	7	num	7	SENT_362	[p27l528t1967r1047b2032],
7	)	NN	O	)	dep	5	SENT_362	[p27l528t1967r1047b2032],
8	:2237	CD	NUMBER	:2237	number	9	SENT_362	[p27l528t1967r1047b2032],
9	—	CD	NUMBER	—	dep	7	SENT_362	[p27l528t1967r1047b2032],
10	2244	CD	DATE	2244	num	11	SENT_362	[p27l528t1967r1047b2032],
11	van	NN	O	van	dep	13	SENT_362	[p27l138t2072r247b2109],
12	Gerven	NNP	ORGANIZATION	Gerven	nn	13	SENT_362	[p27l280t2056r502b2109],
13	JMA	NNP	ORGANIZATION	JMA	dep	36	SENT_362	[p27l534t2056r700b2119],
14	,	,	O	,	_	0	SENT_362	[p27l534t2056r700b2119],
15	Moll	NNP	PERSON	Moll	nn	16	SENT_362	[p27l735t2056r881b2109],
16	JWB	NNP	PERSON	JWB	appos	13	SENT_362	[p27l914t2057r1081b2119],
17	,	,	O	,	_	0	SENT_362	[p27l914t2057r1081b2119],
18	van	NNP	O	van	nn	21	SENT_362	[p27l1116t2072r1224b2109],
19	den	NN	O	den	nn	21	SENT_362	[p27l1257t2055r1365b2109],
20	Bent	NNP	O	Bent	nn	21	SENT_362	[p27l1397t2057r1541b2109],
21	MJ	NNP	ORGANIZATION	MJ	appos	13	SENT_362	[p27l1572t2057r1683b2119],
22	,	,	O	,	_	0	SENT_362	[p27l1572t2057r1683b2119],
23	Bontenbal	NNP	PERSON	Bontenbal	nn	24	SENT_362	[p27l1719t2055r2031b2109],
24	M	NNP	PERSON	M	appos	13	SENT_362	[p27l2063t2057r2145b2119],
25	,	,	O	,	_	0	SENT_362	[p27l2063t2057r2145b2119],
26	van	NNP	PERSON	van	nn	29	SENT_362	[p27l138t2160r247b2197],
27	der	NNP	PERSON	der	nn	29	SENT_362	[p27l269t2144r366b2197],
28	Burg	NNP	PERSON	Burg	nn	29	SENT_362	[p27l387t2145r536b2213],
29	MEL	NN	PERSON	mel	appos	13	SENT_362	[p27l559t2145r735b2206],
30	,	,	O	,	_	0	SENT_362	[p27l559t2145r735b2206],
31	Verweij	NNP	PERSON	Verweij	nn	32	SENT_362	[p27l761t2144r999b2212],
32	J	NNP	PERSON	J	appos	13	SENT_362	[p27l1026t2145r1054b2197],
33	,	,	O	,	_	0	SENT_362	[p27l1059t2188r1070b2207],
34	Vecht	NNP	O	Vecht	nn	35	SENT_362	[p27l1096t2144r1277b2197],
35	CJ	NNP	O	CJ	appos	13	SENT_362	[p27l1300t2144r1377b2197],
36	(	CD	NUMBER	(	dep	39	SENT_362	[p27l1402t2144r1598b2209],
37	1994	CD	DATE	1994	num	39	SENT_362	[p27l1402t2144r1598b2209],
38	)	NNP	O	)	nn	39	SENT_362	[p27l1402t2144r1598b2209],
39	Paclitaxel	NN	O	paclitaxel	dep	43	SENT_362	[p27l1623t2144r1923b2197],
40	(	CD	NUMBER	(	num	42	SENT_362	[p27l1949t2144r2146b2209],
41	taxol	NN	O	taxol	nn	42	SENT_362	[p27l1949t2144r2146b2209],
42	)	NN	O	)	dep	39	SENT_362	[p27l1949t2144r2146b2209],
43	induces	VBZ	O	induce	_	0	SENT_362	[p27l138t2232r368b2285],
44	cumulative	JJ	O	cumulative	amod	46	SENT_362	[p27l419t2232r756b2285],
45	mild	JJ	O	mild	amod	46	SENT_362	[p27l805t2232r944b2285],
46	neurotoxicity	NN	O	neurotoxicity	dobj	43	SENT_362	[p27l993t2232r1413b2301],
47	.	.	O	.	_	0	SENT_362	[p27l993t2232r1413b2301],

1	Eur	NNP	O	Eur	nn	3	SENT_363	[p27l1466t2233r1576b2285],
2	J	NNP	O	J	nn	3	SENT_363	[p27l1624t2233r1651b2285],
3	Cancer	NNP	O	Cancer	_	0	SENT_363	[p27l1701t2232r1916b2285],
4	30	CD	NUMBER	30	number	5	SENT_363	[p27l1965t2232r2142b2298],
5	(	CD	NUMBER	(	dep	3	SENT_363	[p27l1965t2232r2142b2298],
6	8	CD	NUMBER	8	num	7	SENT_363	[p27l1965t2232r2142b2298],
7	)	NN	O	)	dep	5	SENT_363	[p27l1965t2232r2142b2298],
8	:	:	O	:	_	0	SENT_363	[p27l1965t2232r2142b2298],
9	1074-1077	CD	DATE	1074-1077	dep	5	SENT_363	[p27l145t2321r477b2374],

1	Rowbotham	NNP	PERSON	Rowbotham	nn	2	SENT_364	[p27l138t2409r510b2462],
2	SE	NN	O	se	nsubj	15	SENT_364	[p27l546t2409r647b2472],
3	,	,	O	,	_	0	SENT_364	[p27l546t2409r647b2472],
4	Boddy	NNP	ORGANIZATION	Boddy	nn	5	SENT_364	[p27l684t2409r885b2477],
5	AV	NNP	ORGANIZATION	AV	appos	2	SENT_364	[p27l920t2409r1044b2472],
6	,	,	O	,	_	0	SENT_364	[p27l920t2409r1044b2472],
7	Redfern	NNP	ORGANIZATION	Redfern	nn	8	SENT_364	[p27l1081t2409r1326b2462],
8	CPF	NNP	ORGANIZATION	CPF	appos	2	SENT_364	[p27l1361t2409r1509b2471],
9	,	,	O	,	_	0	SENT_364	[p27l1361t2409r1509b2471],
10	Veal	NNP	O	Veal	nn	11	SENT_364	[p27l1546t2409r1688b2462],
11	GJ	NNP	O	GJ	appos	2	SENT_364	[p27l1725t2409r1822b2472],
12	,	,	O	,	_	0	SENT_364	[p27l1725t2409r1822b2472],
13	Daly	NNP	PERSON	Daly	nn	14	SENT_364	[p27l1859t2409r2005b2477],
14	AK	NNP	PERSON	AK	appos	2	SENT_364	[p27l2040t2409r2150b2461],
15	(	VBD	O	(	_	0	SENT_364	[p27l141t2497r337b2562],
16	2010	CD	DATE	2010	num	18	SENT_364	[p27l141t2497r337b2562],
17	)	CD	NUMBER	)	num	18	SENT_364	[p27l141t2497r337b2562],
18	Relevance	NN	O	relevance	dobj	15	SENT_364	[p27l361t2497r677b2550],
19	of	IN	O	of	_	0	SENT_364	[p27l701t2497r766b2550],
20	nonsynonymous	JJ	O	nonsynonymous	amod	22	SENT_364	[p27l782t2513r1279b2565],
21	CYP2C8	NN	O	cyp2c8	nn	22	SENT_364	[p27l1303t2497r1572b2550],
22	polymorphisms	NNS	O	polymorphism	prep_of	18	SENT_364	[p27l1595t2497r2067b2565],
23	to	TO	O	to	_	0	SENT_364	[p27l2090t2504r2147b2550],
24	13-cis	JJ	O	13-cis	amod	26	SENT_364	[p27l145t2585r322b2638],
25	retinoic	JJ	O	retinoic	amod	26	SENT_364	[p27l360t2585r591b2638],
26	acid	NN	O	acid	prep_to	15	SENT_364	[p27l633t2585r758b2638],
27	and	CC	O	and	_	0	SENT_364	[p27l797t2585r905b2638],
28	paclitaxel	NN	O	paclitaxel	nn	29	SENT_364	[p27l942t2585r1238b2654],
29	hydroxylation	NN	O	hydroxylation	prep_to	15	SENT_364	[p27l1277t2585r1719b2654],
30	.	.	O	.	_	0	SENT_364	[p27l1277t2585r1719b2654],

1	Drug	NN	O	drug	nn	3	SENT_365	[p27l1762t2586r1915b2654],
2	Metab	NNP	O	Metab	nn	3	SENT_365	[p27l1954t2585r2147b2638],
3	Dispos	NNP	O	Dispos	dep	12	SENT_365	[p27l138t2674r346b2742],
4	38	CD	NUMBER	38	num	5	SENT_365	[p27l377t2674r901b2739],
5	(	CD	NUMBER	(	dep	3	SENT_365	[p27l377t2674r901b2739],
6	8	CD	NUMBER	8	num	7	SENT_365	[p27l377t2674r901b2739],
7	)	NN	O	)	dep	12	SENT_365	[p27l377t2674r901b2739],
8	:1261	CD	NUMBER	:1261	num	12	SENT_365	[p27l377t2674r901b2739],
9	—	CD	NUMBER	—	num	12	SENT_365	[p27l377t2674r901b2739],
10	1266	CD	DATE	1266	num	12	SENT_365	[p27l377t2674r901b2739],
11	Soyama	NNP	O	Soyama	nn	12	SENT_365	[p27l140t2762r383b2830],
12	A	NNP	O	A	dep	18	SENT_365	[p27l423t2762r492b2825],
13	,	,	O	,	_	0	SENT_365	[p27l423t2762r492b2825],
14	Saito	NNP	PERSON	Saito	nn	15	SENT_365	[p27l538t2762r690b2815],
15	Y	NN	PERSON	y	appos	12	SENT_365	[p27l733t2763r801b2825],
16	,	,	O	,	_	0	SENT_365	[p27l733t2763r801b2825],
17	Hanioka	FW	ORGANIZATION	hanioka	appos	12	SENT_365	[p27l846t2762r1103b2815],
18	N	NN	ORGANIZATION	n	dep	40	SENT_365	[p27l1143t2763r1212b2824],
19	,	,	O	,	_	0	SENT_365	[p27l1143t2763r1212b2824],
20	Murayama	NN	PERSON	murayama	nn	21	SENT_365	[p27l1255t2763r1586b2830],
21	N	NN	O	n	appos	18	SENT_365	[p27l1626t2763r1695b2824],
22	,	,	O	,	_	0	SENT_365	[p27l1626t2763r1695b2824],
23	Nakajima	NNP	PERSON	Nakajima	nn	24	SENT_365	[p27l1739t2762r2035b2830],
24	O	NNP	PERSON	O	appos	18	SENT_365	[p27l2077t2762r2145b2825],
25	,	,	O	,	_	0	SENT_365	[p27l2077t2762r2145b2825],
26	Katori	NNP	PERSON	Katori	nn	27	SENT_365	[p27l140t2851r330b2904],
27	N	NNP	PERSON	N	appos	18	SENT_365	[p27l364t2852r434b2914],
28	,	,	O	,	_	0	SENT_365	[p27l364t2852r434b2914],
29	Ishida	NNP	LOCATION	Ishida	nn	30	SENT_365	[p27l470t2851r655b2904],
30	S	NNP	LOCATION	S	appos	18	SENT_365	[p27l690t2851r744b2914],
31	,	,	O	,	_	0	SENT_365	[p27l690t2851r744b2914],
32	Kimie	NNP	PERSON	Kimie	nn	33	SENT_365	[p27l781t2851r968b2904],
33	S	NNP	PERSON	S	appos	18	SENT_365	[p27l1005t2851r1059b2914],
34	,	,	O	,	_	0	SENT_365	[p27l1005t2851r1059b2914],
35	Ozawa	NNP	PERSON	Ozawa	nn	36	SENT_365	[p27l1096t2851r1305b2904],
36	S	NNP	O	S	appos	18	SENT_365	[p27l1340t2851r1394b2914],
37	,	,	O	,	_	0	SENT_365	[p27l1340t2851r1394b2914],
38	Sawada	NNP	PERSON	Sawada	nn	39	SENT_365	[p27l1432t2851r1666b2904],
39	J	NNP	PERSON	J	appos	18	SENT_365	[p27l1698t2852r1726b2904],
40	(	VBD	O	(	_	0	SENT_365	[p27l1762t2851r1958b2917],
41	2001	CD	DATE	2001	num	42	SENT_365	[p27l1762t2851r1958b2917],
42	)	CD	NUMBER	)	dobj	40	SENT_365	[p27l1762t2851r1958b2917],
43	Nonsynonymous	JJ	O	nonsynonymous	amod	46	SENT_365	[p27l1993t2852r2146b2904, p27l141t2955r520b3007],
44	single	JJ	O	single	amod	46	SENT_365	[p27l554t2938r732b3007],
45	nucleotide	NN	O	nucleotide	nn	46	SENT_365	[p27l763t2938r1080b2992],
46	alterations	NNS	O	alteration	nsubj	47	SENT_365	[p27l1112t2938r1426b2992],
47	found	VBN	O	find	dep	40	SENT_365	[p27l1459t2938r1635b2992],
48	in	IN	O	in	_	0	SENT_365	[p27l1665t2938r1722b2991],
49	the	DT	O	the	det	52	SENT_365	[p27l1753t2939r1844b2992],
50	CYP2C8	NN	O	cyp2c8	nn	52	SENT_365	[p27l1876t2939r2145b2992],
51	gene	NN	O	gene	nn	52	SENT_365	[p27l139t3043r280b3095],
52	result	NN	O	result	prep_in	47	SENT_365	[p27l303t3027r472b3080],
53	in	IN	O	in	_	0	SENT_365	[p27l494t3027r552b3079],
54	reduced	VBN	O	reduce	prepc_in	47	SENT_365	[p27l573t3027r814b3080],
55	in	FW	O	in	nn	56	SENT_365	[p27l836t3027r895b3079],
56	vitro	FW	O	vitro	advmod	54	SENT_365	[p27l917t3027r1058b3080],
57	paclitaxel	NN	O	paclitaxel	nn	58	SENT_365	[p27l1081t3027r1378b3095],
58	metabolism	NN	O	metabolism	dobj	54	SENT_365	[p27l1401t3027r1772b3080],
59	.	.	O	.	_	0	SENT_365	[p27l1401t3027r1772b3080],

1	Biol	NNP	ORGANIZATION	Biol	nn	3	SENT_366	[p27l1799t3027r1928b3080],
2	Pharm	NNP	ORGANIZATION	Pharm	nn	3	SENT_366	[p27l1951t3027r2149b3080],
3	Bull	NNP	ORGANIZATION	Bull	dep	12	SENT_366	[p27l138t3116r267b3169],
4	24	CD	NUMBER	24	num	5	SENT_366	[p27l296t3116r860b3182],
5	(	CD	NUMBER	(	dep	3	SENT_366	[p27l296t3116r860b3182],
6	12	CD	NUMBER	12	num	7	SENT_366	[p27l296t3116r860b3182],
7	)	NN	O	)	dep	12	SENT_366	[p27l296t3116r860b3182],
8	:1427	CD	NUMBER	:1427	num	12	SENT_366	[p27l296t3116r860b3182],
9	—	CD	NUMBER	—	num	12	SENT_366	[p27l296t3116r860b3182],
10	1430	CD	DATE	1430	num	12	SENT_366	[p27l296t3116r860b3182],
11	Bahadur	NNP	PERSON	Bahadur	nn	12	SENT_366	[p27l138t3203r396b3256],
12	N	NNP	PERSON	N	dep	53	SENT_366	[p27l419t3204r488b3266],
13	,	,	O	,	_	0	SENT_366	[p27l419t3204r488b3266],
14	Leathart	NNP	ORGANIZATION	Leathart	nn	15	SENT_366	[p27l515t3203r769b3256],
15	JBS	NNP	ORGANIZATION	JBS	appos	12	SENT_366	[p27l792t3204r929b3266],
16	,	,	O	,	_	0	SENT_366	[p27l792t3204r929b3266],
17	Mutch	NNP	PERSON	Mutch	nn	18	SENT_366	[p27l956t3203r1154b3256],
18	E	NNP	O	E	appos	12	SENT_366	[p27l1178t3204r1239b3266],
19	,	,	O	,	_	0	SENT_366	[p27l1178t3204r1239b3266],
20	Steimel-Crespi	NNP	PERSON	Steimel-Crespi	nn	21	SENT_366	[p27l1268t3203r1721b3272],
21	D	NNP	PERSON	D	appos	12	SENT_366	[p27l1747t3204r1816b3266],
22	,	,	O	,	_	0	SENT_366	[p27l1747t3204r1816b3266],
23	Dunn	NNP	ORGANIZATION	Dunn	nn	24	SENT_366	[p27l1843t3204r2010b3256],
24	SA	NNP	ORGANIZATION	SA	appos	12	SENT_366	[p27l2036t3203r2145b3266],
25	,	,	O	,	_	0	SENT_366	[p27l2036t3203r2145b3266],
26	Gilissen	NNP	ORGANIZATION	Gilissen	nn	27	SENT_366	[p27l140t3293r386b3346],
27	R	NNP	ORGANIZATION	R	appos	12	SENT_366	[p27l431t3294r496b3356],
28	,	,	O	,	_	0	SENT_366	[p27l431t3294r496b3356],
29	Houdt	NNP	PERSON	Houdt	nn	30	SENT_366	[p27l545t3293r734b3346],
30	JV	NNP	O	JV	appos	12	SENT_366	[p27l778t3294r876b3356],
31	,	,	O	,	_	0	SENT_366	[p27l778t3294r876b3356],
32	Hendrickx	NNP	PERSON	Hendrickx	nn	33	SENT_366	[p27l925t3293r1244b3346],
33	J	NNP	PERSON	J	appos	12	SENT_366	[p27l1289t3294r1317b3346],
34	,	,	O	,	_	0	SENT_366	[p27l1322t3337r1333b3356],
35	Mannens	NNP	O	Mannens	nn	36	SENT_366	[p27l1381t3294r1657b3346],
36	G	NNP	O	G	appos	12	SENT_366	[p27l1705t3293r1773b3356],
37	,	,	O	,	_	0	SENT_366	[p27l1705t3293r1773b3356],
38	Bohets	NNP	O	Bohets	nn	39	SENT_366	[p27l1821t3293r2029b3346],
39	H	NNP	O	H	appos	12	SENT_366	[p27l2076t3294r2145b3356],
40	,	,	O	,	_	0	SENT_366	[p27l2076t3294r2145b3356],
41	Williams	NNP	ORGANIZATION	Williams	nn	42	SENT_366	[p27l137t3381r415b3434],
42	FM	NNP	ORGANIZATION	FM	appos	12	SENT_366	[p27l470t3382r594b3444],
43	,	,	O	,	_	0	SENT_366	[p27l470t3382r594b3444],
44	Armstrong	NNP	ORGANIZATION	Armstrong	nn	45	SENT_366	[p27l650t3381r977b3450],
45	M	NNP	ORGANIZATION	M	appos	12	SENT_366	[p27l1031t3382r1113b3444],
46	,	,	O	,	_	0	SENT_366	[p27l1031t3382r1113b3444],
47	Crespi	NNP	ORGANIZATION	Crespi	nn	48	SENT_366	[p27l1170t3381r1365b3450],
48	CL	NN	ORGANIZATION	cl	appos	12	SENT_366	[p27l1420t3381r1530b3444],
49	,	,	O	,	_	0	SENT_366	[p27l1420t3381r1530b3444],
50	Daly	NNP	PERSON	Daly	nn	51	SENT_366	[p27l1587t3381r1732b3450],
51	AK	NNP	PERSON	AK	appos	12	SENT_366	[p27l1786t3381r1895b3433],
52	(	CD	NUMBER	(	num	53	SENT_366	[p27l1950t3381r2146b3446],
53	2002	CD	DATE	2002	_	0	SENT_366	[p27l1950t3381r2146b3446],
54	)	CD	NUMBER	)	num	56	SENT_366	[p27l1950t3381r2146b3446],
55	CYP2C8	NN	O	cyp2c8	nn	56	SENT_366	[p27l139t3468r408b3521],
56	polymorphisms	NNS	O	polymorphism	dep	53	SENT_366	[p27l430t3468r902b3537],
57	in	IN	O	in	_	0	SENT_366	[p27l925t3468r982b3521],
58	Caucasians	NNPS	MISC	Caucasians	prep_in	56	SENT_366	[p27l1003t3468r1325b3521],
59	and	CC	O	and	_	0	SENT_366	[p27l1349t3468r1456b3521],
60	their	PRP$	O	they	poss	61	SENT_366	[p27l1476t3468r1616b3521],
61	relationship	NN	O	relationship	conj_and	56	SENT_366	[p27l1634t3468r1993b3537],
62	with	IN	O	with	_	0	SENT_366	[p27l2015t3468r2148b3521],
63	paclitaxel	NN	O	paclitaxel	prep_with	61	SENT_366	[p27l137t3556r434b3625],
64	60	CD	NUMBER	60	num	63	SENT_366	[p27l473t3556r944b3625],
65	¢	SYM	O	¢	dep	69	SENT_366	[p27l473t3556r944b3625],
66	-	:	O	-	_	0	SENT_366	[p27l473t3556r944b3625],
67	hydroxylase	NN	O	hydroxylase	nn	68	SENT_366	[p27l473t3556r944b3625],
68	activity	NN	O	activity	npadvmod	69	SENT_366	[p27l984t3556r1209b3625],
69	in	IN	O	in	dep	53	SENT_366	[p27l1248t3556r1305b3609],
70	human	JJ	O	human	amod	72	SENT_366	[p27l1342t3556r1549b3609],
71	liver	NN	O	liver	nn	72	SENT_366	[p27l1586t3556r1726b3609],
72	microsomes	NNS	O	microsome	pobj	69	SENT_366	[p27l1762t3556r2144b3609],
73	.	.	O	.	_	0	SENT_366	[p27l1762t3556r2144b3609],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_367	[p27l138t3646r413b3699],
2	Pharmacol	NNP	ORGANIZATION	Pharmacol	_	0	SENT_367	[p27l440t3646r764b3699],
3	64	CD	NUMBER	64	number	4	SENT_367	[p27l794t3646r1356b3711],
4	(	CD	NUMBER	(	dep	2	SENT_367	[p27l794t3646r1356b3711],
5	11	CD	NUMBER	11	num	6	SENT_367	[p27l794t3646r1356b3711],
6	)	NN	O	)	dep	2	SENT_367	[p27l794t3646r1356b3711],
7	:1579	CD	NUMBER	:1579	number	8	SENT_367	[p27l794t3646r1356b3711],
8	—	CD	NUMBER	—	num	9	SENT_367	[p27l794t3646r1356b3711],
9	1589	CD	DATE	1589	dep	6	SENT_367	[p27l794t3646r1356b3711],

1	Dai	NN	PERSON	daus	nn	2	SENT_368	[p28l138t18r246b71],
2	D	NN	PERSON	d	dep	24	SENT_368	[p28l267t19r336b81],
3	,	,	O	,	_	0	SENT_368	[p28l267t19r336b81],
4	Zeldin	NNP	PERSON	Zeldin	nn	5	SENT_368	[p28l358t18r557b71],
5	DC	NNP	O	DC	appos	2	SENT_368	[p28l577t19r696b81],
6	,	,	O	,	_	0	SENT_368	[p28l577t19r696b81],
7	Blaisdell	NNP	PERSON	Blaisdell	nn	8	SENT_368	[p28l720t18r989b71],
8	JA	NNP	O	JA	appos	2	SENT_368	[p28l1010t19r1109b81],
9	,	,	O	,	_	0	SENT_368	[p28l1010t19r1109b81],
10	Chanas	NNP	O	Chanas	nn	11	SENT_368	[p28l1132t18r1353b71],
11	B	NNP	O	B	appos	2	SENT_368	[p28l1374t19r1439b81],
12	,	,	O	,	_	0	SENT_368	[p28l1374t19r1439b81],
13	Coulter	NNP	PERSON	Coulter	nn	14	SENT_368	[p28l1464t18r1692b71],
14	SJ	NNP	O	SJ	appos	2	SENT_368	[p28l1712t19r1796b81],
15	,	,	O	,	_	0	SENT_368	[p28l1712t19r1796b81],
16	Ghanayem	NNP	O	Ghanayem	nn	17	SENT_368	[p28l1820t18r2148b87],
17	BI	NNP	O	BI	appos	2	SENT_368	[p28l138t107r229b169],
18	,	,	O	,	_	0	SENT_368	[p28l138t107r229b169],
19	Goldstein	NNP	PERSON	Goldstein	nn	20	SENT_368	[p28l279t106r573b159],
20	JA	NNP	O	JA	appos	2	SENT_368	[p28l619t107r702b159],
21	(	CD	NUMBER	(	num	24	SENT_368	[p28l750t106r947b172],
22	2001	CD	DATE	2001	num	24	SENT_368	[p28l750t106r947b172],
23	)	CD	NUMBER	)	num	24	SENT_368	[p28l750t106r947b172],
24	Polymorphisms	NNS	O	polymorphism	_	0	SENT_368	[p28l995t106r1471b175],
25	in	IN	O	in	_	0	SENT_368	[p28l1519t106r1576b159],
26	human	JJ	O	human	amod	29	SENT_368	[p28l1622t106r1829b159],
27	CYP2C8	NN	O	cyp2c8	nn	29	SENT_368	[p28l1876t106r2145b159],
28	decrease	NN	O	decrease	nn	29	SENT_368	[p28l139t195r399b248],
29	metabolism	NN	O	metabolism	prep_in	24	SENT_368	[p28l433t195r789b248],
30	of	IN	O	of	_	0	SENT_368	[p28l823t195r888b248],
31	the	DT	O	the	det	34	SENT_368	[p28l917t195r1008b248],
32	anticancer	JJ	O	anticancer	amod	34	SENT_368	[p28l1043t195r1356b248],
33	drug	NN	O	drug	nn	34	SENT_368	[p28l1389t195r1525b264],
34	paclitaxel	NN	O	paclitaxel	prep_of	29	SENT_368	[p28l1558t195r1855b264],
35	and	CC	O	and	_	0	SENT_368	[p28l1891t195r1998b248],
36	arachidonic	JJ	O	arachidonic	amod	37	SENT_368	[p28l2033t212r2146b248, p28l139t283r398b336],
37	acid	NN	O	acid	prep_of	29	SENT_368	[p28l429t283r568b336],
38	.	.	O	.	_	0	SENT_368	[p28l429t283r568b336],

1	Pharmacogenetics	NNS	O	pharmacogenetic	dep	10	SENT_369	[p28l599t283r1152b352],
2	11	CD	NUMBER	11	num	3	SENT_369	[p28l1189t283r1630b348],
3	(	NN	O	(	dep	1	SENT_369	[p28l1189t283r1630b348],
4	7	CD	NUMBER	7	number	5	SENT_369	[p28l1189t283r1630b348],
5	)	CD	NUMBER	)	dep	3	SENT_369	[p28l1189t283r1630b348],
6	:597	CD	NUMBER	:597	num	7	SENT_369	[p28l1189t283r1630b348],
7	—	NN	O	—	dep	10	SENT_369	[p28l1189t283r1630b348],
8	607	CD	NUMBER	607	num	10	SENT_369	[p28l1189t283r1630b348],
9	Bergmann	NNP	PERSON	Bergmann	nn	10	SENT_369	[p28l138t371r454b439],
10	TK	NN	O	tk	dep	53	SENT_369	[p28l478t371r593b433],
11	,	,	O	,	_	0	SENT_369	[p28l478t371r593b433],
12	Brasch-Andersen	NN	O	brasch-andersen	nn	13	SENT_369	[p28l619t370r1147b423],
13	C	NN	O	c	appos	10	SENT_369	[p28l1171t371r1235b433],
14	,	,	O	,	_	0	SENT_369	[p28l1171t371r1235b433],
15	Green	NNP	PERSON	Green	nn	16	SENT_369	[p28l1262t370r1445b423],
16	H	NNP	PERSON	H	appos	10	SENT_369	[p28l1468t371r1537b433],
17	,	,	O	,	_	0	SENT_369	[p28l1468t371r1537b433],
18	Mirza	NNP	PERSON	Mirza	nn	19	SENT_369	[p28l1563t370r1745b423],
19	M	NNP	PERSON	M	appos	10	SENT_369	[p28l1766t371r1849b433],
20	,	,	O	,	_	0	SENT_369	[p28l1766t371r1849b433],
21	Pedersen	NNP	PERSON	Pedersen	nn	22	SENT_369	[p28l1874t370r2148b423],
22	RS	NN	O	r	appos	10	SENT_369	[p28l138t459r245b521],
23	,	,	O	,	_	0	SENT_369	[p28l138t459r245b521],
24	Nielsen	NNP	ORGANIZATION	Nielsen	nn	25	SENT_369	[p28l285t458r516b511],
25	F	NN	ORGANIZATION	f	appos	10	SENT_369	[p28l553t460r610b521],
26	,	,	O	,	_	0	SENT_369	[p28l553t460r610b521],
27	Skougaard	NNP	O	Skougaard	nn	28	SENT_369	[p28l652t458r975b527],
28	K	NNP	O	K	appos	10	SENT_369	[p28l1012t460r1080b521],
29	,	,	O	,	_	0	SENT_369	[p28l1012t460r1080b521],
30	Wihl	NNP	PERSON	Wihl	nn	31	SENT_369	[p28l1119t458r1271b511],
31	J	NNP	PERSON	J	appos	10	SENT_369	[p28l1308t460r1352b521],
32	,	,	O	,	_	0	SENT_369	[p28l1308t460r1352b521],
33	Keldsen	NNP	PERSON	Keldsen	nn	34	SENT_369	[p28l1394t458r1640b511],
34	N	NNP	O	N	appos	10	SENT_369	[p28l1677t460r1746b521],
35	,	,	O	,	_	0	SENT_369	[p28l1677t460r1746b521],
36	Damkier	NNP	O	Damkier	nn	37	SENT_369	[p28l1786t458r2053b511],
37	P	NN	O	p	appos	10	SENT_369	[p28l2089t460r2145b521],
38	,	,	O	,	_	0	SENT_369	[p28l2089t460r2145b521],
39	Friberg	NNP	ORGANIZATION	Friberg	nn	40	SENT_369	[p28l138t547r360b616],
40	LE	NNP	ORGANIZATION	LE	appos	10	SENT_369	[p28l383t548r491b610],
41	,	,	O	,	_	0	SENT_369	[p28l383t548r491b610],
42	Peterson	NNP	PERSON	Peterson	nn	43	SENT_369	[p28l516t548r777b600],
43	C	NNP	O	C	appos	10	SENT_369	[p28l800t547r864b610],
44	,	,	O	,	_	0	SENT_369	[p28l800t547r864b610],
45	Vach	NNP	O	Vach	nn	46	SENT_369	[p28l889t547r1049b600],
46	W	NNP	O	W	appos	10	SENT_369	[p28l1070t548r1157b610],
47	,	,	O	,	_	0	SENT_369	[p28l1070t548r1157b610],
48	Karlsson	NNP	PERSON	Karlsson	nn	49	SENT_369	[p28l1184t547r1451b600],
49	MO	NNP	DURATION	MO	appos	10	SENT_369	[p28l1474t547r1610b610],
50	,	,	O	,	_	0	SENT_369	[p28l1474t547r1610b610],
51	Brosen	NNP	PERSON	Brosen	nn	52	SENT_369	[p28l1635t548r1849b600],
52	K	NNP	PERSON	K	appos	10	SENT_369	[p28l1873t548r1926b599],
53	(	VBD	O	(	_	0	SENT_369	[p28l1950t547r2146b612],
54	2011	CD	DATE	2011	num	56	SENT_369	[p28l1950t547r2146b612],
55	)	CD	NUMBER	)	num	56	SENT_369	[p28l1950t547r2146b612],
56	Impact	NN	O	impact	dobj	53	SENT_369	[p28l138t635r349b703],
57	of	IN	O	of	_	0	SENT_369	[p28l397t634r463b687],
58	CYP2C8	NN	O	cyp2c8	prep_of	56	SENT_369	[p28l506t634r850b687],
59	*	CD	NUMBER	*	number	60	SENT_369	[p28l506t634r850b687],
60	3	CD	NUMBER	3	dep	58	SENT_369	[p28l506t634r850b687],
61	on	IN	O	on	_	0	SENT_369	[p28l902t651r975b687],
62	paclitaxel	NN	O	paclitaxel	nn	63	SENT_369	[p28l1021t634r1318b703],
63	clearance	NN	O	clearance	prep_on	60	SENT_369	[p28l1367t634r1669b687],
64	:	:	O	:	_	0	SENT_369	[p28l1367t634r1669b687],
65	A	DT	O	a	det	66	SENT_369	[p28l1723t635r1776b687],
66	population	NN	O	population	dep	60	SENT_369	[p28l1822t634r2148b703],
67	pharmacokinetic	JJ	O	pharmacokinetic	amod	70	SENT_369	[p28l137t722r645b791],
68	and	CC	O	and	_	0	SENT_369	[p28l672t722r779b775],
69	pharmacogenomic	JJ	O	pharmacogenomic	conj_and	67	SENT_369	[p28l801t722r1364b791],
70	study	NN	O	study	dep	66	SENT_369	[p28l1392t722r1552b791],
71	in	IN	O	in	_	0	SENT_369	[p28l1576t722r1633b775],
72	93	CD	NUMBER	93	num	73	SENT_369	[p28l1657t723r1727b776],
73	patients	NNS	O	patient	prep_in	53	SENT_369	[p28l1753t722r1989b791],
74	with	IN	O	with	_	0	SENT_369	[p28l2015t722r2148b775],
75	ovarian	JJ	O	ovarian	amod	76	SENT_369	[p28l139t811r366b864],
76	cancer	NN	O	cancer	prep_with	73	SENT_369	[p28l394t827r606b864],
77	.	.	O	.	_	0	SENT_369	[p28l394t827r606b864],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_370	[p28l638t810r1232b879],
2	J	NN	O	j	dep	1	SENT_370	[p28l1261t812r1289b864],
3	1l	NN	O	1l	nn	4	SENT_370	[p28l1324t811r1767b876],
4	(	NN	O	(	dep	2	SENT_370	[p28l1324t811r1767b876],
5	2	CD	NUMBER	2	number	6	SENT_370	[p28l1324t811r1767b876],
6	)	CD	NUMBER	)	dep	1	SENT_370	[p28l1324t811r1767b876],
7	:	:	O	:	_	0	SENT_370	[p28l1324t811r1767b876],
8	ll3	CD	NUMBER	ll3	num	9	SENT_370	[p28l1324t811r1767b876],
9	—	CD	NUMBER	—	dep	6	SENT_370	[p28l1324t811r1767b876],
10	l20	NN	O	l20	nn	12	SENT_370	[p28l1324t811r1767b876],
11	Gao	NN	O	gao	nn	12	SENT_370	[p28l140t898r262b951],
12	Y	NN	O	y	dep	9	SENT_370	[p28l307t899r376b961],
13	,	,	O	,	_	0	SENT_370	[p28l307t899r376b961],
14	Liu	NNP	PERSON	Liu	nn	15	SENT_370	[p28l423t898r527b951],
15	D	NNP	PERSON	D	appos	1	SENT_370	[p28l571t899r640b961],
16	,	,	O	,	_	0	SENT_370	[p28l571t899r640b961],
17	Wang	NNP	PERSON	Wang	nn	18	SENT_370	[p28l686t899r866b967],
18	H	NNP	PERSON	H	appos	1	SENT_370	[p28l911t899r980b961],
19	,	,	O	,	_	0	SENT_370	[p28l911t899r980b961],
20	Zhu	NNP	PERSON	Zhu	nn	21	SENT_370	[p28l1026t898r1148b951],
21	J	NNP	PERSON	J	appos	1	SENT_370	[p28l1191t899r1235b961],
22	,	,	O	,	_	0	SENT_370	[p28l1191t899r1235b961],
23	Chen	NNP	O	Chen	nn	24	SENT_370	[p28l1283t898r1441b951],
24	C	NNP	O	C	appos	1	SENT_370	[p28l1486t898r1532b951],
25	(	JJ	O	(	amod	24	SENT_370	[p28l1580t898r1776b964],
26	2010	CD	DATE	2010	tmod	25	SENT_370	[p28l1580t898r1776b964],
27	)	CD	NUMBER	)	num	29	SENT_370	[p28l1580t898r1776b964],
28	Functional	JJ	O	functional	amod	29	SENT_370	[p28l1822t898r2147b951],
29	characterization	NN	O	characterization	dep	1	SENT_370	[p28l139t986r625b1039],
30	of	IN	O	of	_	0	SENT_370	[p28l678t986r744b1039],
31	ﬁve	NN	O	ﬁve	nn	33	SENT_370	[p28l791t986r901b1039],
32	CYP2C8	NN	O	cyp2c8	nn	33	SENT_370	[p28l954t987r1222b1040],
33	Variants	NNS	O	variant	prep_of	29	SENT_370	[p28l1277t986r1515b1039],
34	and	CC	O	and	_	0	SENT_370	[p28l1569t986r1677b1039],
35	prediction	NN	O	prediction	dep	1	SENT_370	[p28l1726t986r2035b1055],
36	of	IN	O	of	_	0	SENT_370	[p28l2087t986r2153b1039],
37	CYP2C8	NN	O	cyp2c8	prep_of	35	SENT_370	[p28l139t1075r408b1128],
38	genotype-dependent	JJ	O	genotype-dependent	amod	39	SENT_370	[p28l455t1074r1072b1143],
39	effects	NNS	O	effect	dep	1	SENT_370	[p28l1115t1074r1315b1127],
40	on	IN	O	on	prep	39	SENT_370	[p28l1361t1091r1434b1127],
41	in	IN	O	in	pcomp	40	SENT_370	[p28l1477t1074r1534b1127],
42	Vitro	NNP	O	Vitro	pobj	41	SENT_370	[p28l1577t1074r1718b1127],
43	and	CC	O	and	_	0	SENT_370	[p28l1764t1074r1871b1127],
44	in	IN	O	in	conj_and	40	SENT_370	[p28l1914t1074r1971b1127],
45	Vivo	NNP	LOCATION	Vivo	nn	49	SENT_370	[p28l2015t1074r2147b1128],
46	drug	NN	O	drug	nn	49	SENT_370	[p28l139t1162r453b1231],
47	—	CD	NUMBER	—	num	49	SENT_370	[p28l139t1162r453b1231],
48	drug	NN	O	drug	nn	49	SENT_370	[p28l139t1162r453b1231],
49	interactions	NNS	O	interaction	pobj	44	SENT_370	[p28l481t1162r851b1216],
50	.	.	O	.	_	0	SENT_370	[p28l481t1162r851b1216],

1	Xenobiotica	NNP	O	Xenobiotica	nn	3	SENT_371	[p28l883t1162r1256b1216],
2	40	CD	NUMBER	40	num	3	SENT_371	[p28l1282t1162r1730b1228],
3	(	NN	O	(	nsubj	15	SENT_371	[p28l1282t1162r1730b1228],
4	7	CD	NUMBER	7	number	5	SENT_371	[p28l1282t1162r1730b1228],
5	)	CD	NUMBER	)	num	6	SENT_371	[p28l1282t1162r1730b1228],
6	:467	CD	NUMBER	:467	dep	3	SENT_371	[p28l1282t1162r1730b1228],
7	—	NN	O	—	nn	10	SENT_371	[p28l1282t1162r1730b1228],
8	475	CD	NUMBER	475	num	10	SENT_371	[p28l1282t1162r1730b1228],
9	Speed	NN	O	speed	nn	10	SENT_371	[p28l140t1250r323b1319],
10	WC	NN	O	wc	dep	3	SENT_371	[p28l360t1251r498b1313],
11	,	,	O	,	_	0	SENT_371	[p28l360t1251r498b1313],
12	Kang	NNP	PERSON	Kang	nn	13	SENT_371	[p28l541t1252r702b1319],
13	SP	NN	O	sp	appos	3	SENT_371	[p28l744t1251r840b1313],
14	,	,	O	,	_	0	SENT_371	[p28l744t1251r840b1313],
15	Tuck	VB	O	tuck	_	0	SENT_371	[p28l881t1250r1038b1303],
16	DP	NN	O	dp	nsubj	22	SENT_371	[p28l1075t1252r1186b1313],
17	,	,	O	,	_	0	SENT_371	[p28l1075t1252r1186b1313],
18	Harris	NNP	ORGANIZATION	Harris	nn	19	SENT_371	[p28l1227t1250r1414b1303],
19	LN	NN	ORGANIZATION	ln	appos	16	SENT_371	[p28l1454t1252r1570b1313],
20	,	,	O	,	_	0	SENT_371	[p28l1454t1252r1570b1313],
21	Kidd	NNP	ORGANIZATION	Kidd	nn	22	SENT_371	[p28l1613t1250r1762b1303],
22	KK	NNP	ORGANIZATION	KK	xcomp	15	SENT_371	[p28l1802t1252r1910b1303],
23	(	CD	NUMBER	(	num	25	SENT_371	[p28l1949t1251r2146b1316],
24	2009	CD	DATE	2009	num	25	SENT_371	[p28l1949t1251r2146b1316],
25	)	NN	O	)	dep	22	SENT_371	[p28l1949t1251r2146b1316],
26	Global	JJ	O	global	amod	27	SENT_371	[p28l140t1338r343b1392],
27	Variation	NN	O	variation	dep	22	SENT_371	[p28l391t1338r661b1392],
28	in	IN	O	in	_	0	SENT_371	[p28l708t1338r765b1391],
29	CYP2C8	NN	O	cyp2c8	prep_in	27	SENT_371	[p28l813t1339r1396b1392],
30	.	.	O	.	_	0	SENT_371	[p28l813t1339r1396b1392],

1	—	NN	O	—	_	0	SENT_372	[p28l813t1339r1396b1392],
2	.	.	O	.	_	0	SENT_372	[p28l813t1339r1396b1392],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_373	[p28l813t1339r1396b1392],
2	functional	JJ	O	functional	amod	3	SENT_373	[p28l1445t1338r1752b1391],
3	haplotypes	NNS	O	haplotype	dep	1	SENT_373	[p28l1800t1338r2144b1407],
4	.	.	O	.	_	0	SENT_373	[p28l1800t1338r2144b1407],

1	Pharmacogenomics	NNS	O	pharmacogenomic	dep	103	SENT_374	[p28l138t1427r733b1495],
2	J	NN	O	j	dep	103	SENT_374	[p28l762t1428r790b1480],
3	9	CD	NUMBER	9	dep	103	SENT_374	[p28l818t1427r1230b1492],
4	(	NN	O	(	dep	103	SENT_374	[p28l818t1427r1230b1492],
5	4	CD	NUMBER	4	dep	103	SENT_374	[p28l818t1427r1230b1492],
6	)	CD	NUMBER	)	dep	103	SENT_374	[p28l818t1427r1230b1492],
7	:283	CD	NUMBER	:283	dep	103	SENT_374	[p28l818t1427r1230b1492],
8	—	NN	O	—	dep	103	SENT_374	[p28l818t1427r1230b1492],
9	29O	NN	O	29o	dep	103	SENT_374	[p28l818t1427r1230b1492],
10	Seidman	NN	PERSON	seidman	dep	103	SENT_374	[p28l140t1514r403b1568],
11	AD	NN	O	ad	dep	103	SENT_374	[p28l425t1515r549b1577],
12	,	,	O	,	_	0	SENT_374	[p28l425t1515r549b1577],
13	Berry	NNP	PERSON	Berry	dep	103	SENT_374	[p28l573t1516r745b1583],
14	D	NNP	O	D	dep	103	SENT_374	[p28l767t1516r836b1577],
15	,	,	O	,	_	0	SENT_374	[p28l767t1516r836b1577],
16	Cirrincione	NNP	ORGANIZATION	Cirrincione	dep	103	SENT_374	[p28l861t1514r1206b1568],
17	C	NNP	ORGANIZATION	C	dep	103	SENT_374	[p28l1229t1515r1293b1577],
18	,	,	O	,	_	0	SENT_374	[p28l1229t1515r1293b1577],
19	Harris	NNP	PERSON	Harris	dep	103	SENT_374	[p28l1318t1514r1505b1567],
20	L	NNP	O	L	dep	103	SENT_374	[p28l1528t1516r1589b1577],
21	,	,	O	,	_	0	SENT_374	[p28l1528t1516r1589b1577],
22	Muss	NNP	O	Muss	dep	103	SENT_374	[p28l1613t1516r1775b1567],
23	H	NNP	O	H	dep	103	SENT_374	[p28l1798t1516r1867b1577],
24	,	,	O	,	_	0	SENT_374	[p28l1798t1516r1867b1577],
25	Marcom	NNP	ORGANIZATION	Marcom	dep	103	SENT_374	[p28l1891t1516r2149b1567],
26	PK	NNP	ORGANIZATION	PK	dep	103	SENT_374	[p28l138t1604r249b1665],
27	,	,	O	,	_	0	SENT_374	[p28l138t1604r249b1665],
28	Gipson	NNP	PERSON	Gipson	dep	103	SENT_374	[p28l295t1602r511b1671],
29	G	NNP	PERSON	G	dep	103	SENT_374	[p28l554t1603r623b1665],
30	,	,	O	,	_	0	SENT_374	[p28l554t1603r623b1665],
31	Burstein	NNP	PERSON	Burstein	dep	103	SENT_374	[p28l667t1602r924b1655],
32	H	NNP	O	H	dep	103	SENT_374	[p28l966t1604r1035b1665],
33	,	,	O	,	_	0	SENT_374	[p28l966t1604r1035b1665],
34	Lake	NNP	LOCATION	Lake	dep	103	SENT_374	[p28l1079t1602r1230b1655],
35	D	NNP	LOCATION	D	dep	103	SENT_374	[p28l1273t1604r1342b1665],
36	,	,	O	,	_	0	SENT_374	[p28l1273t1604r1342b1665],
37	Shapiro	NNP	ORGANIZATION	Shapiro	dep	103	SENT_374	[p28l1389t1602r1621b1671],
38	CL	NN	ORGANIZATION	cl	dep	103	SENT_374	[p28l1665t1603r1775b1665],
39	,	,	O	,	_	0	SENT_374	[p28l1665t1603r1775b1665],
40	Ungaro	NNP	ORGANIZATION	Ungaro	dep	103	SENT_374	[p28l1820t1604r2046b1671],
41	P	NN	ORGANIZATION	p	dep	103	SENT_374	[p28l2089t1604r2145b1665],
42	,	,	O	,	_	0	SENT_374	[p28l2089t1604r2145b1665],
43	Norton	NNP	ORGANIZATION	Norton	dep	103	SENT_374	[p28l138t1692r352b1744],
44	L	NNP	ORGANIZATION	L	dep	103	SENT_374	[p28l373t1692r434b1754],
45	,	,	O	,	_	0	SENT_374	[p28l373t1692r434b1754],
46	Winer	NNP	PERSON	Winer	dep	103	SENT_374	[p28l457t1690r649b1744],
47	E	NNP	O	E	dep	103	SENT_374	[p28l669t1692r730b1754],
48	,	,	O	,	_	0	SENT_374	[p28l669t1692r730b1754],
49	Hudis	NNP	PERSON	Hudis	dep	103	SENT_374	[p28l754t1690r933b1744],
50	C	NNP	O	C	dep	103	SENT_374	[p28l956t1691r1003b1744],
51	(	CD	NUMBER	(	dep	103	SENT_374	[p28l1028t1691r1225b1756],
52	2008	CD	DATE	2008	dep	103	SENT_374	[p28l1028t1691r1225b1756],
53	)	NNP	O	)	dep	103	SENT_374	[p28l1028t1691r1225b1756],
54	Randomized	NNP	O	Randomized	dep	103	SENT_374	[p28l1249t1690r1633b1744],
55	phase	NN	O	phase	dep	103	SENT_374	[p28l1654t1691r1826b1759],
56	III	CD	NUMBER	iii	dep	103	SENT_374	[p28l1848t1692r1922b1743],
57	trial	NN	O	trial	dep	103	SENT_374	[p28l1943t1690r2064b1744],
58	of	IN	O	of	dep	103	SENT_374	[p28l2088t1690r2153b1744],
59	weekly	JJ	SET	weekly	dep	103	SENT_374	[p28l139t1779r356b1847],
60	compared	VBN	O	compare	dep	103	SENT_374	[p28l394t1779r693b1847],
61	with	IN	O	with	dep	103	SENT_374	[p28l729t1779r863b1832],
62	eVery	NN	O	every	dep	103	SENT_374	[p28l900t1779r1344b1847],
63	—	CD	NUMBER	—	dep	103	SENT_374	[p28l900t1779r1344b1847],
64	3	CD	NUMBER	3	dep	103	SENT_374	[p28l900t1779r1344b1847],
65	—	NN	O	—	dep	103	SENT_374	[p28l900t1779r1344b1847],
66	weeks	NNS	DURATION	week	dep	103	SENT_374	[p28l900t1779r1344b1847],
67	paclitaxel	NN	O	paclitaxel	dep	103	SENT_374	[p28l1382t1779r1678b1847],
68	for	IN	O	for	dep	103	SENT_374	[p28l1716t1779r1804b1832],
69	metastatic	JJ	O	metastatic	dep	103	SENT_374	[p28l1839t1779r2146b1832],
70	breast	NN	O	breast	dep	103	SENT_374	[p28l137t1866r319b1919],
71	cancer	NN	O	cancer	dep	103	SENT_374	[p28l341t1883r554b1929],
72	,	,	O	,	_	0	SENT_374	[p28l341t1883r554b1929],
73	with	IN	O	with	dep	103	SENT_374	[p28l578t1866r711b1920],
74	trastuzumab	NN	O	trastuzumab	dep	103	SENT_374	[p28l732t1866r1102b1919],
75	for	IN	O	for	dep	103	SENT_374	[p28l1125t1866r1213b1919],
76	all	DT	O	all	dep	103	SENT_374	[p28l1234t1866r1307b1919],
77	HER-2	NN	O	her-2	dep	103	SENT_374	[p28l1329t1867r1542b1919],
78	overexpressors	NNS	O	overexpressor	dep	103	SENT_374	[p28l1564t1883r2017b1935],
79	and	CC	O	and	dep	103	SENT_374	[p28l2041t1866r2149b1919],
80	random	JJ	O	random	dep	103	SENT_374	[p28l137t1955r370b2008],
81	assignment	NN	O	assignment	dep	103	SENT_374	[p28l400t1954r741b2023],
82	to	TO	O	to	dep	103	SENT_374	[p28l769t1962r826b2008],
83	trastuzumab	NN	O	trastuzumab	dep	103	SENT_374	[p28l856t1955r1226b2008],
84	or	CC	O	or	dep	103	SENT_374	[p28l1258t1971r1320b2008],
85	not	RB	O	not	dep	103	SENT_374	[p28l1348t1962r1444b2008],
86	in	IN	O	in	dep	103	SENT_374	[p28l1472t1954r1530b2007],
87	HER	NN	O	her	dep	103	SENT_374	[p28l1559t1955r1772b2007],
88	—	NN	O	—	dep	103	SENT_374	[p28l1559t1955r1772b2007],
89	2	CD	NUMBER	2	dep	103	SENT_374	[p28l1559t1955r1772b2007],
90	nonoVereX	NN	O	nonoverex	dep	103	SENT_374	[p28l1802t1971r2145b2008],
91	—	NN	O	—	dep	103	SENT_374	[p28l1802t1971r2145b2008],
92	pressors	NNS	O	pressor	dep	103	SENT_374	[p28l137t2059r401b2111],
93	:	:	O	:	_	0	SENT_374	[p28l137t2059r401b2111],
94	ﬁnal	JJ	O	ﬁnal	dep	103	SENT_374	[p28l440t2043r572b2096],
95	results	NNS	O	result	dep	103	SENT_374	[p28l603t2043r800b2096],
96	of	IN	O	of	dep	103	SENT_374	[p28l834t2043r899b2096],
97	cancer	NN	O	cancer	dep	103	SENT_374	[p28l927t2059r1126b2096],
98	and	CC	O	and	dep	103	SENT_374	[p28l1158t2043r1265b2096],
99	leukemia	NN	O	leukemia	dep	103	SENT_374	[p28l1296t2043r1576b2096],
100	group	NN	O	group	dep	103	SENT_374	[p28l1608t2059r1782b2111],
101	B	NN	O	b	dep	103	SENT_374	[p28l1815t2044r1859b2095],
102	protocol	NN	O	protocol	dep	103	SENT_374	[p28l1894t2043r2147b2111],
103	9840	CD	NUMBER	9840	_	0	SENT_374	[p28l139t2132r303b2186],
104	.	.	O	.	_	0	SENT_374	[p28l139t2132r303b2186],

1	J	NNP	O	J	nn	3	SENT_375	[p28l334t2133r362b2185],
2	Clin	NNP	O	Clin	nn	3	SENT_375	[p28l390t2132r520b2185],
3	Oncol	NNP	O	Oncol	_	0	SENT_375	[p28l548t2132r731b2185],
4	26	CD	NUMBER	26	number	5	SENT_375	[p28l760t2132r1323b2197],
5	(	CD	NUMBER	(	dep	3	SENT_375	[p28l760t2132r1323b2197],
6	10	CD	NUMBER	10	num	7	SENT_375	[p28l760t2132r1323b2197],
7	)	NN	O	)	dep	5	SENT_375	[p28l760t2132r1323b2197],
8	:1642	CD	NUMBER	:1642	number	9	SENT_375	[p28l760t2132r1323b2197],
9	—	CD	NUMBER	—	dep	3	SENT_375	[p28l760t2132r1323b2197],
10	l649	NN	O	l649	nn	12	SENT_375	[p28l760t2132r1323b2197],
11	Henningsson	NN	O	henningsson	nn	12	SENT_375	[p28l138t2220r534b2288],
12	A	NN	O	a	dep	9	SENT_375	[p28l574t2220r643b2282],
13	,	,	O	,	_	0	SENT_375	[p28l574t2220r643b2282],
14	Marsh	NNP	PERSON	Marsh	nn	15	SENT_375	[p28l687t2220r880b2273],
15	S	NNP	O	S	conj_and	3	SENT_375	[p28l923t2220r977b2282],
16	,	,	O	,	_	0	SENT_375	[p28l923t2220r977b2282],
17	Loos	NNP	PERSON	Loos	nn	18	SENT_375	[p28l1019t2221r1169b2273],
18	WJ	NNP	O	WJ	appos	15	SENT_375	[p28l1210t2221r1327b2282],
19	,	,	O	,	_	0	SENT_375	[p28l1210t2221r1327b2282],
20	Karlsson	NNP	PERSON	Karlsson	nn	21	SENT_375	[p28l1372t2220r1639b2273],
21	MO	NNP	PERSON	MO	appos	15	SENT_375	[p28l1679t2220r1816b2282],
22	,	,	O	,	_	0	SENT_375	[p28l1679t2220r1816b2282],
23	Garsa	NNP	O	Garsa	nn	24	SENT_375	[p28l1861t2220r2036b2273],
24	A	NNP	O	A	appos	15	SENT_375	[p28l2076t2220r2145b2282],
25	,	,	O	,	_	0	SENT_375	[p28l2076t2220r2145b2282],
26	Mross	NNP	PERSON	Mross	nn	27	SENT_375	[p28l138t2309r324b2361],
27	K	NNP	PERSON	K	appos	15	SENT_375	[p28l360t2309r428b2370],
28	,	,	O	,	_	0	SENT_375	[p28l360t2309r428b2370],
29	Mielke	NNP	PERSON	Mielke	nn	30	SENT_375	[p28l464t2308r679b2361],
30	S	NNP	O	S	appos	15	SENT_375	[p28l714t2308r769b2371],
31	,	,	O	,	_	0	SENT_375	[p28l714t2308r769b2371],
32	Vigano	NNP	PERSON	Vigano	nn	33	SENT_375	[p28l805t2308r1027b2377],
33	L	NNP	PERSON	L	appos	15	SENT_375	[p28l1061t2309r1122b2371],
34	,	,	O	,	_	0	SENT_375	[p28l1061t2309r1122b2371],
35	Locatelli	NNP	PERSON	Locatelli	nn	36	SENT_375	[p28l1158t2308r1428b2361],
36	A	NNP	O	A	appos	15	SENT_375	[p28l1463t2308r1532b2370],
37	,	,	O	,	_	0	SENT_375	[p28l1463t2308r1532b2370],
38	Verweij	NNP	O	Verweij	nn	39	SENT_375	[p28l1568t2308r1806b2376],
39	J	NNP	O	J	appos	15	SENT_375	[p28l1845t2309r1889b2371],
40	,	,	O	,	_	0	SENT_375	[p28l1845t2309r1889b2371],
41	Sparre	NNP	O	Sparre	nn	44	SENT_375	[p28l1927t2308r2146b2376],
42	—	NN	O	—	nn	44	SENT_375	[p28l1927t2308r2146b2376],
43	boom	NN	O	boom	nn	44	SENT_375	[p28l137t2397r311b2450],
44	A	NN	O	a	appos	15	SENT_375	[p28l335t2397r404b2460],
45	,	,	O	,	_	0	SENT_375	[p28l335t2397r404b2460],
46	McLeod	NNP	PERSON	McLeod	appos	15	SENT_375	[p28l431t2397r689b2450],
47	HL	NN	O	hl	nn	51	SENT_375	[p28l714t2398r814b2449],
48	(	CD	NUMBER	(	num	51	SENT_375	[p28l841t2397r1038b2462],
49	2005	CD	DATE	2005	num	51	SENT_375	[p28l841t2397r1038b2462],
50	)	NNP	O	)	nn	51	SENT_375	[p28l841t2397r1038b2462],
51	Association	NNP	O	Association	dep	3	SENT_375	[p28l1065t2397r1424b2450],
52	of	IN	O	of	_	0	SENT_375	[p28l1450t2397r1515b2450],
53	CYP2C8	NNP	O	CYP2C8	prep_of	51	SENT_375	[p28l1536t2397r1824b2460],
54	,	,	O	,	_	0	SENT_375	[p28l1536t2397r1824b2460],
55	CYP3A4	NN	O	cyp3a4	conj_and	3	SENT_375	[p28l1853t2397r2145b2460],
56	,	,	O	,	_	0	SENT_375	[p28l1853t2397r2145b2460],
57	CYP3A5	NN	O	cyp3a5	conj_and	3	SENT_375	[p28l139t2484r431b2547],
58	,	,	O	,	_	0	SENT_375	[p28l139t2484r431b2547],
59	and	CC	O	and	_	0	SENT_375	[p28l456t2485r564b2538],
60	ABCBl	NN	O	abcbl	nn	61	SENT_375	[p28l584t2485r820b2538],
61	polymorphisms	NNS	O	polymorphism	conj_and	3	SENT_375	[p28l848t2484r1320b2553],
62	with	IN	O	with	_	0	SENT_375	[p28l1343t2484r1477b2538],
63	the	DT	O	the	det	64	SENT_375	[p28l1497t2484r1588b2538],
64	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	61	SENT_375	[p28l1609t2484r2146b2553],
65	of	IN	O	of	_	0	SENT_375	[p28l139t2572r205b2626],
66	paclitaxel	NN	O	paclitaxel	prep_of	64	SENT_375	[p28l226t2572r538b2641],
67	.	.	O	.	_	0	SENT_375	[p28l226t2572r538b2641],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_376	[p28l571t2572r700b2626],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_376	[p28l728t2573r943b2626],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_376	[p28l969t2574r1080b2626],
4	ll	NN	O	ll	dep	3	SENT_376	[p28l1116t2573r1674b2638],
5	(	CD	NUMBER	(	number	6	SENT_376	[p28l1116t2573r1674b2638],
6	22	CD	NUMBER	22	num	7	SENT_376	[p28l1116t2573r1674b2638],
7	)	NN	O	)	dep	4	SENT_376	[p28l1116t2573r1674b2638],
8	:8097	CD	NUMBER	:8097	number	9	SENT_376	[p28l1116t2573r1674b2638],
9	—	CD	NUMBER	—	dep	3	SENT_376	[p28l1116t2573r1674b2638],
10	8l04	NN	O	8l04	dep	9	SENT_376	[p28l1116t2573r1674b2638],
11	Gandara	NNP	PERSON	Gandara	nn	12	SENT_376	[p28l139t2661r396b2714],
12	DR	NN	O	dr	dep	3	SENT_376	[p28l425t2662r544b2724],
13	,	,	O	,	_	0	SENT_376	[p28l425t2662r544b2724],
14	Kawaguchi	NNP	PERSON	Kawaguchi	nn	15	SENT_376	[p28l579t2661r922b2729],
15	T	NN	O	t	appos	12	SENT_376	[p28l953t2662r1014b2724],
16	,	,	O	,	_	0	SENT_376	[p28l953t2662r1014b2724],
17	Crowley	NNP	PERSON	Crowley	nn	18	SENT_376	[p28l1047t2661r1306b2729],
18	J	NNP	PERSON	J	appos	12	SENT_376	[p28l1337t2662r1365b2714],
19	,	,	O	,	_	0	SENT_376	[p28l1370t2705r1381b2724],
20	Moon	NNP	PERSON	Moon	nn	21	SENT_376	[p28l1413t2662r1593b2714],
21	J	NNP	PERSON	J	appos	12	SENT_376	[p28l1622t2662r1650b2714],
22	,	,	O	,	_	0	SENT_376	[p28l1655t2705r1666b2724],
23	Furuse	NNP	O	Furuse	nn	24	SENT_376	[p28l1698t2662r1904b2714],
24	K	NNP	O	K	appos	12	SENT_376	[p28l1936t2662r2003b2724],
25	,	,	O	,	_	0	SENT_376	[p28l1936t2662r2003b2724],
26	Kawahara	NNP	PERSON	Kawahara	nn	27	SENT_376	[p28l2037t2662r2146b2714, p28l139t2750r357b2803],
27	M	NNP	O	M	appos	12	SENT_376	[p28l393t2751r475b2813],
28	,	,	O	,	_	0	SENT_376	[p28l393t2751r475b2813],
29	Teramukai	NNP	O	Teramukai	nn	30	SENT_376	[p28l514t2750r843b2803],
30	S	NNP	O	S	appos	12	SENT_376	[p28l882t2750r936b2813],
31	,	,	O	,	_	0	SENT_376	[p28l882t2750r936b2813],
32	Ohe	NNP	O	Ohe	nn	33	SENT_376	[p28l977t2750r1100b2803],
33	Y	NN	O	y	appos	12	SENT_376	[p28l1138t2751r1206b2813],
34	,	,	O	,	_	0	SENT_376	[p28l1138t2751r1206b2813],
35	Kubota	NNP	PERSON	Kubota	nn	36	SENT_376	[p28l1247t2750r1469b2803],
36	K	NNP	PERSON	K	appos	12	SENT_376	[p28l1505t2751r1573b2813],
37	,	,	O	,	_	0	SENT_376	[p28l1505t2751r1573b2813],
38	Williamsoon	NNP	ORGANIZATION	Williamsoon	appos	12	SENT_376	[p28l1612t2750r2006b2803],
39	ST	JJ	ORGANIZATION	st	amod	42	SENT_376	[p28l2044t2750r2145b2813],
40	,	,	O	,	_	0	SENT_376	[p28l2044t2750r2145b2813],
41	Gautschi	JJ	PERSON	gautschi	amod	42	SENT_376	[p28l139t2838r407b2892],
42	O	NN	PERSON	o	dep	3	SENT_376	[p28l439t2839r506b2902],
43	,	,	O	,	_	0	SENT_376	[p28l439t2839r506b2902],
44	Lenz	NNP	PERSON	Lenz	nn	45	SENT_376	[p28l539t2840r690b2892],
45	HJ	NNP	O	HJ	appos	42	SENT_376	[p28l721t2840r819b2901],
46	,	,	O	,	_	0	SENT_376	[p28l721t2840r819b2901],
47	McLeod	NNP	PERSON	McLeod	nn	48	SENT_376	[p28l851t2839r1109b2892],
48	HL	NNS	O	hl	appos	42	SENT_376	[p28l1139t2840r1255b2902],
49	,	,	O	,	_	0	SENT_376	[p28l1139t2840r1255b2902],
50	Lara	NNP	PERSON	Lara	nn	51	SENT_376	[p28l1288t2840r1427b2892],
51	PN	NNP	O	PN	appos	42	SENT_376	[p28l1456t2840r1567b2902],
52	,	,	O	,	_	0	SENT_376	[p28l1456t2840r1567b2902],
53	Coltman	NNP	PERSON	Coltman	nn	54	SENT_376	[p28l1601t2839r1862b2892],
54	CA	NNP	O	CA	appos	42	SENT_376	[p28l1893t2839r2012b2902],
55	,	,	O	,	_	0	SENT_376	[p28l1893t2839r2012b2902],
56	Fukuoka	NNP	LOCATION	Fukuoka	nn	57	SENT_376	[p28l2044t2840r2146b2892, p28l137t2926r324b2980],
57	M	NNP	O	M	appos	42	SENT_376	[p28l347t2928r429b2989],
58	,	,	O	,	_	0	SENT_376	[p28l347t2928r429b2989],
59	Saijo	NNP	ORGANIZATION	Saijo	nn	60	SENT_376	[p28l459t2926r611b2995],
60	N	NNP	ORGANIZATION	N	appos	42	SENT_376	[p28l637t2928r706b2989],
61	,	,	O	,	_	0	SENT_376	[p28l637t2928r706b2989],
62	Fukushima	NNP	PERSON	Fukushima	nn	63	SENT_376	[p28l733t2926r1071b2980],
63	M	NNP	O	M	appos	42	SENT_376	[p28l1095t2928r1177b2990],
64	,	,	O	,	_	0	SENT_376	[p28l1095t2928r1177b2990],
65	Mack	NNP	PERSON	Mack	nn	70	SENT_376	[p28l1205t2927r1379b2980],
66	PC	NNP	O	PC	nn	70	SENT_376	[p28l1401t2927r1491b2980],
67	(	NNP	O	(	nn	70	SENT_376	[p28l1520t2927r1716b2992],
68	2009	CD	DATE	2009	num	70	SENT_376	[p28l1520t2927r1716b2992],
69	)	CD	NUMBER	)	num	70	SENT_376	[p28l1520t2927r1716b2992],
70	Japanese	NNS	MISC	japanese	appos	42	SENT_376	[p28l1743t2927r2144b2995],
71	.	.	O	.	_	0	SENT_376	[p28l1743t2927r2144b2995],

1	—	NN	O	—	_	0	SENT_377	[p28l1743t2927r2144b2995],
2	.	.	O	.	_	0	SENT_377	[p28l1743t2927r2144b2995],

1	US	NNP	LOCATION	US	nn	3	SENT_378	[p28l1743t2927r2144b2995],
2	common-arm	JJ	O	common-arm	amod	3	SENT_378	[p28l139t3031r549b3068],
3	analysis	NN	O	analysis	_	0	SENT_378	[p28l576t3015r817b3083],
4	of	IN	O	of	_	0	SENT_378	[p28l846t3015r912b3068],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_378	[p28l932t3015r1229b3083],
6	plus	CC	O	plus	_	0	SENT_378	[p28l1255t3015r1380b3083],
7	carboplatin	NN	O	carboplatin	conj_plus	3	SENT_378	[p28l1409t3015r1750b3083],
8	in	IN	O	in	_	0	SENT_378	[p28l1777t3015r1835b3067],
9	advanced	JJ	O	advanced	amod	12	SENT_378	[p28l1863t3015r2149b3068],
10	non-small-cell	JJ	O	non-small-cell	amod	12	SENT_378	[p28l138t3103r577b3156],
11	lung	NN	O	lung	nn	12	SENT_378	[p28l618t3103r750b3172],
12	cancer	NN	O	cancer	prep_in	7	SENT_378	[p28l792t3120r1005b3156],
13	:	:	O	:	_	0	SENT_378	[p28l792t3120r1005b3156],
14	a	DT	O	a	det	15	SENT_378	[p28l1051t3120r1083b3156],
15	model	NN	O	model	dep	3	SENT_378	[p28l1121t3103r1310b3156],
16	for	IN	O	for	_	0	SENT_378	[p28l1351t3103r1439b3156],
17	assessing	VBG	O	assess	prepc_for	15	SENT_378	[p28l1478t3103r1757b3172],
18	populationrelated	JJ	O	populationrelated	amod	19	SENT_378	[p28l1796t3103r2146b3172, p28l137t3191r345b3244],
19	pharmacogenomics	NNS	O	pharmacogenomic	dobj	17	SENT_378	[p28l371t3191r979b3259],
20	.	.	O	.	_	0	SENT_378	[p28l371t3191r979b3259],

1	J	NNP	O	J	nn	3	SENT_379	[p28l1011t3192r1039b3244],
2	Clin	NNP	O	Clin	nn	3	SENT_379	[p28l1067t3190r1196b3244],
3	Oncol	NNP	O	Oncol	_	0	SENT_379	[p28l1225t3191r1407b3244],
4	27	CD	NUMBER	27	num	6	SENT_379	[p28l1437t3190r2000b3256],
5	(	CD	NUMBER	(	num	6	SENT_379	[p28l1437t3190r2000b3256],
6	2l	NN	O	2l	dep	3	SENT_379	[p28l1437t3190r2000b3256],
7	)	CD	NUMBER	)	number	8	SENT_379	[p28l1437t3190r2000b3256],
8	:3540	CD	NUMBER	:3540	num	10	SENT_379	[p28l1437t3190r2000b3256],
9	—	CD	NUMBER	—	number	10	SENT_379	[p28l1437t3190r2000b3256],
10	3546	CD	DATE	3546	dep	6	SENT_379	[p28l1437t3190r2000b3256],

1	@	IN	O	@	_	0	SENT_380	[p28l1779t3421r1856b3516],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_380	[p28l1886t3444r2148b3519],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_381	[p28l1448t3594r1538b3619],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_381	[p28l1551t3594r1651b3619],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_381	[p28l1663t3594r1714b3619],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_381	[p28l1728t3594r1802b3619],
5	(	CD	NUMBER	(	num	6	SENT_381	[p28l1815t3594r1907b3624],
6	2012	CD	DATE	2012	dep	4	SENT_381	[p28l1815t3594r1907b3624],
7	)	CD	NUMBER	)	num	8	SENT_381	[p28l1815t3594r1907b3624],
8	l34	NN	O	l34	dep	6	SENT_381	[p28l1924t3594r2106b3619],
9	:40	CD	NUMBER	:40	num	10	SENT_381	[p28l1924t3594r2106b3619],
10	l	NN	O	l	tmod	6	SENT_381	[p28l1924t3594r2106b3619],
11	—	CD	NUMBER	—	num	12	SENT_381	[p28l1924t3594r2106b3619],
12	4l0	NN	O	4l0	dep	4	SENT_381	[p28l1924t3594r2106b3619],

1	Boumique	JJ	MISC	boumique	amod	2	SENT_382	[p29l112t35r260b67],
2	B	NN	O	b	nsubj	6	SENT_382	[p29l282t35r312b64],
3	,	,	O	,	_	0	SENT_382	[p29l282t35r312b64],
4	Lemarié	NNP	O	Lemarié	nn	5	SENT_382	[p29l334t33r451b60],
5	A	NNP	O	A	appos	2	SENT_382	[p29l473t35r497b60],
6	(	VBD	O	(	_	0	SENT_382	[p29l519t35r610b66],
7	2002	CD	DATE	2002	number	8	SENT_382	[p29l519t35r610b66],
8	)	CD	NUMBER	)	num	12	SENT_382	[p29l519t35r610b66],
9	Docetaxel	NNP	O	Docetaxel	nn	12	SENT_382	[p29l633t35r775b60],
10	(	CD	NUMBER	(	num	12	SENT_382	[p29l798t35r932b66],
11	taxotere	NN	O	taxotere	nn	12	SENT_382	[p29l798t35r932b66],
12	)	NN	O	)	dobj	6	SENT_382	[p29l798t35r932b66],
13	is	VBZ	O	be	auxpass	15	SENT_382	[p29l955t35r976b60],
14	not	RB	O	not	neg	15	SENT_382	[p29l999t39r1043b60],
15	metabolized	VBN	O	metabolize	rcmod	12	SENT_382	[p29l112t76r285b101],
16	by	IN	O	by	_	0	SENT_382	[p29l300t76r335b108],
17	recombinant	JJ	O	recombinant	amod	19	SENT_382	[p29l350t76r527b101],
18	human	JJ	O	human	amod	19	SENT_382	[p29l543t76r638b101],
19	CYP1B1	NN	O	cyp1b1	agent	15	SENT_382	[p29l654t76r776b101],
20	in	FW	O	in	nn	21	SENT_382	[p29l796t76r822b100],
21	vitro	FW	O	vitro	advmod	15	SENT_382	[p29l838t76r911b105],
22	,	,	O	,	_	0	SENT_382	[p29l838t76r911b105],
23	but	CC	O	but	_	0	SENT_382	[p29l928t76r973b101],
24	acts	VBZ	O	act	conj_but	6	SENT_382	[p29l989t80r1042b101],
25	as	IN	O	as	_	0	SENT_382	[p29l113t125r140b142],
26	an	DT	O	a	det	27	SENT_382	[p29l163t125r195b142],
27	effector	NN	O	effector	prep_as	24	SENT_382	[p29l217t117r326b142],
28	of	IN	O	of	_	0	SENT_382	[p29l348t117r378b142],
29	this	DT	O	this	det	30	SENT_382	[p29l397t117r447b142],
30	isozyme	NN	O	isozyme	prep_of	27	SENT_382	[p29l469t117r593b149],
31	.	.	O	.	_	0	SENT_382	[p29l469t117r593b149],

1	Drug	NN	O	drug	nn	3	SENT_383	[p29l617t118r688b149],
2	Metab	NNP	O	Metab	nn	3	SENT_383	[p29l710t117r799b142],
3	Dispos	NNP	O	Dispos	dep	13	SENT_383	[p29l821t117r917b149],
4	30	CD	NUMBER	30	num	3	SENT_383	[p29l941t117r1040b148],
5	(	CD	NUMBER	(	number	6	SENT_383	[p29l941t117r1040b148],
6	11	CD	NUMBER	11	num	7	SENT_383	[p29l941t117r1040b148],
7	)	NN	O	)	dep	3	SENT_383	[p29l941t117r1040b148],
8	:	:	O	:	_	0	SENT_383	[p29l941t117r1040b148],
9	1	CD	NUMBER	1	number	10	SENT_383	[p29l116t159r126b183],
10	149-1	CD	NUMBER	149-1	dep	7	SENT_383	[p29l133t158r214b183],
11	152	CD	NUMBER	152	dep	13	SENT_383	[p29l222t158r270b183],
12	Sissung	NNP	O	Sissung	nn	13	SENT_383	[p29l113t199r220b231],
13	TM	NNP	O	TM	dep	57	SENT_383	[p29l231t200r290b228],
14	,	,	O	,	_	0	SENT_383	[p29l231t200r290b228],
15	Danesi	NNP	ORGANIZATION	Danesi	nn	16	SENT_383	[p29l302t199r398b224],
16	R	NNP	ORGANIZATION	R	appos	13	SENT_383	[p29l409t200r439b228],
17	,	,	O	,	_	0	SENT_383	[p29l409t200r439b228],
18	Price	NNP	O	Price	nn	19	SENT_383	[p29l450t199r522b224],
19	DK	NNP	O	DK	appos	13	SENT_383	[p29l532t200r590b228],
20	,	,	O	,	_	0	SENT_383	[p29l532t200r590b228],
21	Steinberg	NNP	ORGANIZATION	Steinberg	nn	22	SENT_383	[p29l602t199r735b231],
22	SM	NNP	ORGANIZATION	SM	appos	13	SENT_383	[p29l747t199r803b228],
23	,	,	O	,	_	0	SENT_383	[p29l747t199r803b228],
24	de	FW	O	de	appos	13	SENT_383	[p29l815t199r847b224],
25	Wit	NN	O	wit	nn	26	SENT_383	[p29l857t199r910b224],
26	R	NN	O	r	dep	24	SENT_383	[p29l919t200r949b228],
27	,	,	O	,	_	0	SENT_383	[p29l919t200r949b228],
28	Zahid	NNP	PERSON	Zahid	nn	29	SENT_383	[p29l961t199r1043b224],
29	M	NNP	PERSON	M	appos	13	SENT_383	[p29l112t241r150b269],
30	,	,	O	,	_	0	SENT_383	[p29l112t241r150b269],
31	Gaikwad	NNP	PERSON	Gaikwad	nn	32	SENT_383	[p29l165t240r292b265],
32	N	NNP	PERSON	N	dep	51	SENT_383	[p29l305t241r337b269],
33	,	,	O	,	_	0	SENT_383	[p29l305t241r337b269],
34	Cavalieri	NNP	ORGANIZATION	Cavalieri	nn	35	SENT_383	[p29l352t240r480b265],
35	E	NNP	ORGANIZATION	E	appos	32	SENT_383	[p29l494t241r523b269],
36	,	,	O	,	_	0	SENT_383	[p29l494t241r523b269],
37	Dahut	NNP	O	Dahut	nn	38	SENT_383	[p29l538t240r623b265],
38	WL	NNP	O	WL	appos	32	SENT_383	[p29l636t241r698b269],
39	,	,	O	,	_	0	SENT_383	[p29l636t241r698b269],
40	Sackett	NNP	PERSON	Sackett	nn	41	SENT_383	[p29l714t240r817b265],
41	DL	NNP	O	DL	appos	32	SENT_383	[p29l830t241r884b269],
42	,	,	O	,	_	0	SENT_383	[p29l830t241r884b269],
43	Figg	NNP	PERSON	Figg	nn	44	SENT_383	[p29l898t240r962b272],
44	WD	NNP	O	WD	appos	32	SENT_383	[p29l976t241r1041b269],
45	,	,	O	,	_	0	SENT_383	[p29l976t241r1041b269],
46	Sparreboom	NNP	O	Sparreboom	nn	47	SENT_383	[p29l113t281r284b313],
47	A	NNP	O	A	appos	32	SENT_383	[p29l297t281r322b306],
48	(	CD	NUMBER	(	dep	51	SENT_383	[p29l335t281r427b312],
49	2008	CD	DATE	2008	num	51	SENT_383	[p29l335t281r427b312],
50	)	NNP	O	)	nn	51	SENT_383	[p29l335t281r427b312],
51	Association	NNP	O	Association	dep	57	SENT_383	[p29l441t281r607b306],
52	of	IN	O	of	_	0	SENT_383	[p29l620t281r651b306],
53	the	DT	O	the	det	55	SENT_383	[p29l661t281r703b306],
54	CYP1B1	NN	O	cyp1b1	nn	55	SENT_383	[p29l717t281r877b306],
55	*	NN	O	*	prep_of	51	SENT_383	[p29l717t281r877b306],
56	3	CD	NUMBER	3	num	57	SENT_383	[p29l717t281r877b306],
57	allele	NN	O	allele	_	0	SENT_383	[p29l892t281r967b306],
58	with	IN	O	with	_	0	SENT_383	[p29l981t281r1043b306],
59	survival	NN	O	survival	prep_with	57	SENT_383	[p29l113t322r225b347],
60	in	IN	O	in	_	0	SENT_383	[p29l236t322r262b347],
61	patients	NNS	O	patient	prep_in	59	SENT_383	[p29l272t322r381b355],
62	with	IN	O	with	_	0	SENT_383	[p29l393t322r455b347],
63	prostate	NN	O	prostate	nn	64	SENT_383	[p29l465t326r576b355],
64	cancer	NN	O	cancer	prep_with	61	SENT_383	[p29l587t330r679b347],
65	receiving	VBG	O	receive	partmod	64	SENT_383	[p29l688t322r819b355],
66	docetaxel	NN	O	docetaxel	dobj	65	SENT_383	[p29l831t322r972b347],
67	.	.	O	.	_	0	SENT_383	[p29l831t322r972b347],

1	Mol	NNP	O	Mol	nn	3	SENT_384	[p29l985t322r1042b347],
2	Cancer	NNP	O	Cancer	nn	3	SENT_384	[p29l113t363r212b388],
3	Ther	NNP	O	Ther	dep	15	SENT_384	[p29l224t363r291b388],
4	7	CD	NUMBER	7	num	6	SENT_384	[p29l303t363r459b394],
5	(	CD	NUMBER	(	num	6	SENT_384	[p29l303t363r459b394],
6	l	NN	O	l	dep	3	SENT_384	[p29l303t363r459b394],
7	)	CD	NUMBER	)	number	8	SENT_384	[p29l303t363r459b394],
8	:19	CD	NUMBER	:19	dep	6	SENT_384	[p29l303t363r459b394],
9	—	NN	O	—	dep	15	SENT_384	[p29l303t363r459b394],
10	26	CD	NUMBER	26	num	9	SENT_384	[p29l303t363r459b394],
11	Pastina	NNP	O	Pastina	nn	15	SENT_384	[p29l112t404r214b429],
12	I	PRP	O	I	dep	15	SENT_384	[p29l226t405r245b433],
13	,	,	O	,	_	0	SENT_384	[p29l226t405r245b433],
14	Giovannetti	NNP	PERSON	Giovannetti	dep	15	SENT_384	[p29l260t404r425b429],
15	E	NNP	O	E	dep	43	SENT_384	[p29l438t405r467b433],
16	,	,	O	,	_	0	SENT_384	[p29l438t405r467b433],
17	Chioni	NNP	O	Chioni	nn	18	SENT_384	[p29l482t404r576b429],
18	A	NNP	O	A	appos	15	SENT_384	[p29l590t405r622b433],
19	,	,	O	,	_	0	SENT_384	[p29l590t405r622b433],
20	Sissung	NNP	O	Sissung	nn	21	SENT_384	[p29l637t404r744b436],
21	TM	NNP	O	TM	appos	15	SENT_384	[p29l758t405r817b433],
22	,	,	O	,	_	0	SENT_384	[p29l758t405r817b433],
23	Crea	NNP	O	Crea	nn	24	SENT_384	[p29l832t404r898b429],
24	F	NN	O	f	appos	15	SENT_384	[p29l911t405r937b433],
25	,	,	O	,	_	0	SENT_384	[p29l911t405r937b433],
26	Orlandini	NNP	O	Orlandini	nn	27	SENT_384	[p29l952t404r1041b429, p29l113t445r166b470],
27	C	NNP	O	C	appos	15	SENT_384	[p29l179t445r209b474],
28	,	,	O	,	_	0	SENT_384	[p29l179t445r209b474],
29	Price	NNP	O	Price	nn	30	SENT_384	[p29l222t445r294b470],
30	DK	NNP	O	DK	appos	15	SENT_384	[p29l306t446r364b474],
31	,	,	O	,	_	0	SENT_384	[p29l306t446r364b474],
32	Cianci	NNP	ORGANIZATION	Cianci	nn	33	SENT_384	[p29l377t445r468b470],
33	C	NNP	ORGANIZATION	C	appos	15	SENT_384	[p29l481t445r511b474],
34	,	,	O	,	_	0	SENT_384	[p29l481t445r511b474],
35	Figg	NNP	PERSON	Figg	nn	36	SENT_384	[p29l524t445r588b477],
36	WD	NNP	O	WD	appos	15	SENT_384	[p29l600t446r666b474],
37	,	,	O	,	_	0	SENT_384	[p29l600t446r666b474],
38	Ricci	NNP	PERSON	Ricci	nn	39	SENT_384	[p29l680t445r753b470],
39	S	NNP	O	S	appos	15	SENT_384	[p29l767t445r792b474],
40	,	,	O	,	_	0	SENT_384	[p29l767t445r792b474],
41	Danesi	NNP	PERSON	Danesi	nn	42	SENT_384	[p29l805t445r902b470],
42	R	NNP	PERSON	R	appos	15	SENT_384	[p29l915t446r937b470],
43	(	CD	NUMBER	(	dep	45	SENT_384	[p29l951t445r1042b476],
44	2010	CD	DATE	2010	num	45	SENT_384	[p29l951t445r1042b476],
45	)	NN	O	)	_	0	SENT_384	[p29l951t445r1042b476],

1	@	IN	O	@	_	0	SENT_385	[p29l51t552r87b597],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_385	[p29l100t563r222b598],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_386	[p29l1175t35r1349b67],
2	450	CD	NUMBER	450	num	3	SENT_386	[p29l1361t35r1413b60],
3	1B1	NN	O	1b1	nsubj	8	SENT_386	[p29l1428t35r1480b60],
4	(	CD	NUMBER	(	num	7	SENT_386	[p29l1496t35r1643b66],
5	CYPIB1	NN	O	cypib1	nn	7	SENT_386	[p29l1496t35r1643b66],
6	)	CD	NUMBER	)	num	7	SENT_386	[p29l1496t35r1643b66],
7	polymorphisms	NNS	O	polymorphism	dep	3	SENT_386	[p29l1656t35r1875b67],
8	associated	VBN	O	associate	_	0	SENT_386	[p29l1888t35r2032b60],
9	with	IN	O	with	_	0	SENT_386	[p29l2044t35r2106b60],
10	response	NN	O	response	prep_with	8	SENT_386	[p29l1175t84r1297b108],
11	to	TO	O	to	_	0	SENT_386	[p29l1323t80r1349b101],
12	docetaxel	NN	O	docetaxel	prep_to	8	SENT_386	[p29l1375t76r1509b101],
13	in	IN	O	in	_	0	SENT_386	[p29l1535t76r1561b100],
14	castration-resistant	JJ	O	castration-resistant	amod	16	SENT_386	[p29l1586t76r1853b101],
15	prostate	NN	O	prostate	nn	16	SENT_386	[p29l1877t80r1988b108],
16	cancer	NN	O	cancer	prep_in	8	SENT_386	[p29l2014t84r2106b101],
17	(	CD	NUMBER	(	num	20	SENT_386	[p29l1176t117r1287b147],
18	CRPC	NN	O	crpc	nn	20	SENT_386	[p29l1176t117r1287b147],
19	)	CD	NUMBER	)	num	20	SENT_386	[p29l1176t117r1287b147],
20	patients	NNS	O	patient	dep	16	SENT_386	[p29l1300t117r1417b149],
21	.	.	O	.	_	0	SENT_386	[p29l1300t117r1417b149],

1	BMC	NNP	O	BMC	nn	2	SENT_387	[p29l1431t117r1508b142],
2	Cancer	NNP	O	Cancer	_	0	SENT_387	[p29l1522t117r1621b142],
3	27	CD	NUMBER	27	number	4	SENT_387	[p29l1634t117r1786b148],
4	(	CD	NUMBER	(	dep	2	SENT_387	[p29l1634t117r1786b148],
5	10	CD	NUMBER	10	num	6	SENT_387	[p29l1634t117r1786b148],
6	)	NN	O	)	dep	4	SENT_387	[p29l1634t117r1786b148],
7	:511	CD	NUMBER	:511	num	9	SENT_387	[p29l1634t117r1786b148],
8	Figg	NNP	O	Figg	nn	9	SENT_387	[p29l1175t158r1239b190],
9	WD	NNP	O	WD	dep	2	SENT_387	[p29l1251t159r1316b187],
10	,	,	O	,	_	0	SENT_387	[p29l1251t159r1316b187],
11	Li	NNP	PERSON	Li	nn	12	SENT_387	[p29l1329t158r1360b183],
12	H	NNP	PERSON	H	appos	9	SENT_387	[p29l1372t159r1404b187],
13	,	,	O	,	_	0	SENT_387	[p29l1372t159r1404b187],
14	Sissung	NNP	ORGANIZATION	Sissung	nn	15	SENT_387	[p29l1418t158r1526b190],
15	T	NN	ORGANIZATION	t	appos	9	SENT_387	[p29l1538t159r1566b187],
16	,	,	O	,	_	0	SENT_387	[p29l1538t159r1566b187],
17	Retter	NNP	PERSON	Retter	nn	18	SENT_387	[p29l1580t159r1666b183],
18	A	NNP	O	A	appos	9	SENT_387	[p29l1678t158r1709b187],
19	,	,	O	,	_	0	SENT_387	[p29l1678t158r1709b187],
20	Wu	NNP	O	Wu	nn	21	SENT_387	[p29l1722t159r1773b183],
21	S	NNP	O	S	appos	9	SENT_387	[p29l1786t158r1811b187],
22	,	,	O	,	_	0	SENT_387	[p29l1786t158r1811b187],
23	Gulley	NNP	PERSON	Gulley	nn	24	SENT_387	[p29l1825t158r1919b190],
24	JL	NNP	O	JL	appos	9	SENT_387	[p29l1931t159r1973b187],
25	,	,	O	,	_	0	SENT_387	[p29l1931t159r1973b187],
26	Arlen	NNP	PERSON	Arlen	nn	27	SENT_387	[p29l1987t158r2066b183],
27	P	NN	PERSON	p	appos	9	SENT_387	[p29l2078t159r2104b187],
28	,	,	O	,	_	0	SENT_387	[p29l2078t159r2104b187],
29	Wright	NNP	PERSON	Wright	nn	31	SENT_387	[p29l1175t199r1275b231],
30	J	NNP	O	J	nn	31	SENT_387	[p29l1285t200r1319b228],
31	]	NNP	O	]	appos	9	SENT_387	[p29l1285t200r1319b228],
32	,	,	O	,	_	0	SENT_387	[p29l1285t200r1319b228],
33	Parnes	NNP	PERSON	Parnes	nn	34	SENT_387	[p29l1331t200r1424b224],
34	H	NNP	O	H	appos	9	SENT_387	[p29l1435t200r1467b228],
35	,	,	O	,	_	0	SENT_387	[p29l1435t200r1467b228],
36	Fedenko	NNP	PERSON	Fedenko	nn	37	SENT_387	[p29l1479t199r1599b224],
37	K	NNP	PERSON	K	appos	9	SENT_387	[p29l1611t200r1643b228],
38	,	,	O	,	_	0	SENT_387	[p29l1611t200r1643b228],
39	Latham	NNP	PERSON	Latham	nn	40	SENT_387	[p29l1655t199r1762b224],
40	L	NNP	PERSON	L	appos	9	SENT_387	[p29l1773t200r1801b228],
41	,	,	O	,	_	0	SENT_387	[p29l1773t200r1801b228],
42	Steinberg	NNP	PERSON	Steinberg	nn	43	SENT_387	[p29l1814t199r1948b231],
43	SM	NNP	O	SM	appos	9	SENT_387	[p29l1960t199r2016b228],
44	,	,	O	,	_	0	SENT_387	[p29l1960t199r2016b228],
45	Jones	NNP	PERSON	Jones	nn	46	SENT_387	[p29l2028t200r2105b224],
46	E	NNP	O	E	appos	9	SENT_387	[p29l1175t241r1203b269],
47	,	,	O	,	_	0	SENT_387	[p29l1175t241r1203b269],
48	Chen	NNP	O	Chen	nn	49	SENT_387	[p29l1214t240r1287b265],
49	C	NNP	O	C	appos	9	SENT_387	[p29l1297t240r1327b269],
50	,	,	O	,	_	0	SENT_387	[p29l1297t240r1327b269],
51	Dahut	NNP	O	Dahut	nn	52	SENT_387	[p29l1338t240r1423b265],
52	W	NNP	O	W	appos	9	SENT_387	[p29l1432t241r1465b265],
53	(	CD	NUMBER	(	num	54	SENT_387	[p29l1475t240r1566b271],
54	2007	CD	DATE	2007	dep	52	SENT_387	[p29l1475t240r1566b271],
55	)	CD	NUMBER	)	number	56	SENT_387	[p29l1475t240r1566b271],
56	Pre-clinical	JJ	O	pre-clinical	dep	2	SENT_387	[p29l1576t240r1738b265],
57	and	CC	O	and	_	0	SENT_387	[p29l1749t240r1799b265],
58	clinical	JJ	O	clinical	amod	59	SENT_387	[p29l1808t240r1911b265],
59	evaluation	NN	O	evaluation	conj_and	56	SENT_387	[p29l1921t240r2068b265],
60	of	IN	O	of	_	0	SENT_387	[p29l2078t240r2108b265],
61	estramustine	NN	O	estramustine	nn	66	SENT_387	[p29l1175t281r1361b310],
62	,	,	O	,	_	0	SENT_387	[p29l1175t281r1361b310],
63	docetaxel	NN	O	docetaxel	nn	66	SENT_387	[p29l1378t281r1513b306],
64	and	CC	O	and	_	0	SENT_387	[p29l1530t281r1580b306],
65	thalidomide	NN	O	thalidomide	nn	66	SENT_387	[p29l1595t281r1763b306],
66	combination	NN	O	combination	prep_of	56	SENT_387	[p29l1780t281r1956b306],
67	in	IN	O	in	_	0	SENT_387	[p29l1972t281r1998b306],
68	androgen-independent	JJ	O	androgen-independent	amod	70	SENT_387	[p29l2015t281r2105b306, p29l1176t322r1410b355],
69	prostate	NN	O	prostate	nn	70	SENT_387	[p29l1423t326r1534b355],
70	cancer	NN	O	cancer	prep_in	66	SENT_387	[p29l1547t330r1645b347],
71	.	.	O	.	_	0	SENT_387	[p29l1547t330r1645b347],

1	BJU	NNP	O	BJU	nn	2	SENT_388	[p29l1660t323r1722b348],
2	Int	NNP	O	Int	_	0	SENT_388	[p29l1734t323r1773b347],
3	99	CD	NUMBER	99	number	4	SENT_388	[p29l1786t322r2028b353],
4	(	CD	NUMBER	(	dep	2	SENT_388	[p29l1786t322r2028b353],
5	5	CD	NUMBER	5	num	6	SENT_388	[p29l1786t322r2028b353],
6	)	NN	O	)	dep	4	SENT_388	[p29l1786t322r2028b353],
7	:	:	O	:	_	0	SENT_388	[p29l1786t322r2028b353],
8	l047	CD	NUMBER	l047	dep	4	SENT_388	[p29l1786t322r2028b353],
9	—	CD	NUMBER	—	num	10	SENT_388	[p29l1786t322r2028b353],
10	l055	NN	O	l055	dep	8	SENT_388	[p29l1786t322r2028b353],

